ML18017A216: Difference between revisions
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
| (10 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
| issue date = 12/31/1997 | | issue date = 12/31/1997 | ||
| title = Annual Effluent & Waste Disposal Rept for 970101-1231. W/980330 Ltr | | title = Annual Effluent & Waste Disposal Rept for 970101-1231. W/980330 Ltr | ||
| author name = | | author name = Barclay R, Carson B, Doty R | ||
| author affiliation = PENNSYLVANIA POWER & LIGHT CO. | | author affiliation = PENNSYLVANIA POWER & LIGHT CO. | ||
| addressee name = | | addressee name = | ||
| Line 16: | Line 16: | ||
=Text= | =Text= | ||
{{#Wiki_filter: | {{#Wiki_filter:SUSQUEHANNA STEAM ELECTRIC STATION ANNUALEFFLUENT AND WASTE DISPOSAL REPORT REPORT PERIOD: 01/01/97 - 12/31/97 Prepared by: | ||
gZv~~~g~ | |||
R. K. Barclay Health Physicist Reviewed by: | |||
. H. Carson Health Physicist Appro ed by: | |||
R. L. oty Superv or - Operations Tec nology Pennsylvania Power & Light Company Two North Ninth Street Allentown, Pennsylvania 18101 9804090293 | |||
TABLE OF CONTENTS SECTION PAGE | |||
: 1. Introduction and Supplemental Information | |||
: 2. Effluent and Waste Disposal Data 13 | |||
: 3. Meteorological Data and Dispersion Estimates 38 | |||
: 4. Dose Measurements and Assessments 68 | |||
: 5. Changes to the Offsite Dose Calculation Manual 77 and the Solid Waste Process Control Program | |||
: 6. Reports of Exception to the SSES Effluent 80 Monitoring Program | |||
: 7. Correction to Doses Reported in Previous 82 Semiannual or Annual Effluent and Waste Disposal Report | |||
: 8. Effluent from Additional Monitored Release Points 84 Appendix A Revisions to SSES ODCM Appendix B Revisions to SSES Solid Waste Process Control Program (NDAP-QA-0646) | |||
LIST OF TABLES PAGE Table 1: Technical Specification Limits 10 Table 2: Airborne Effluent-Summation of All Releases 16 Table 3: Airborne Effluent 17 Table 4: Waterborne Effluent - Summation of All Releases 20 Table 5: Waterborne Effluent 21 Table 6: Annual Effluent and Waste Disposal Report 26 Solid Waste and Irradiated Fuel Shipments Table 7-9: These tables deliberately left blank 26A Table 10: Incinerated DAW - Class A 27 Strong Tight Container Table11: Condensate Demineralizer/RadwasteDemineralizer-ClassA 28 Steel Liner (Solidified) | |||
Table 12: Processed DAW - Class A 29 Strong Tight Container Table 13: Ultrasonic Resin Cleaning Waste - Class A 30 HIC (Dewatered) | |||
Table 14: Non-Processed DAW - Class C 31 Strong Tight Container HIC Table 15: Cartridge Filters - Class C 32 HIC (Dewatered) | |||
Table 16: Cartridge Filters - Class A 33 HIC (Dewatered) | |||
Table 17: Liquid Radwaste Filter Media - Class A 34 HIC (Dewatered) | |||
Estimated Total Errors Associated with 35 Effluent Measurements | |||
LIST OF TABLES (cont.) | |||
PAGE Table 19: Annual Effluent and Waste Disposal Report 37 Data Not Reported in Previous Annual Report Table 20: Meteorological Data Availability 40 Table 21: Joint Wind Frequency Distribution by Stability Class 44 Table 22: Average Annual Relative Concentrations 54 Table 23: Site-Specific Parameters Used for Ladtap II 69 Calculations (Danville Receiver): for 1997 Table 24: Summary of Maximum Individual Qffsite Doses and 71 Dose Commitments to Members of the Public Table 25: Calculated Collective Doses to Members of the 74 Public Within the Riverlands/Information Center Complex Table 26: Calculated Doses for Individuals and Locations within the 75 SSES Site Boundary and Nearest Dairy Table 27: Calculated Doses from Noble Gases for Locations within 76 the SSES Site Boundary and Nearest Dairy | |||
LIST OF FIGURES PAGE Figure 1: SSES Airborne Effluent Release Points Figure 2: SSES Waterborne Effluent Release Pathway Figure 3: Susquehanna River Monthly Average Flow Rates 22 Figure 4: SSES Monthly Liquid Radwaste Discharge Totals 23 Figure 5: SSES Wind Rose: 10-meter Sensors 41 Figure 6: SSES Wind Rose: 60-meter Sensors 42 Figure 7: SSES Pasquill Stability Class Prevalences 43 Figure 8: Areas Within the SSES Site Boundary for which 73 Dose Calculations are Performed | |||
SECTION 1 INTRODUCTIONAND SUPPLEMENTAL INFORMATION | |||
INTRODUCTION The Susquehanna Steam Electric Station (SSES) is located in Salem Township, Luzerne County, Pennsylvania. It is on the west bank of the Susquehanna River, 8 km northeast of Berwick. The Station consists of two boiling water reactor generating units, each with about 1,100 MW net electrical capacity. The reactor and generating units were supplied by General Electric, while the Bechtel Corporation served as architect-'engineer and constructor. | |||
Construction of the Station began in the early 1970s. Fuel load began in Unit 1 in July of 1982. Initial criticality was achieved in the Unit 1 reactor on September 10, 1982. The reactor reached 100% power for the first time on February 4, 1983. Commercial operation of Unit 1 was declared on June 8, 1983. | |||
Initial criticality of Unit 2 occurred on May 8, 1984. Unit 2 was declared commercial on February 12, 1985. | |||
Airborne effluents are released from the Susquehanna Station via five rooftop vents on the reactor building (see Figure 1). Each vent is continuously monitored, and a program of periodic sampling and analysis is conducted as specified in the plant Technical Specifications. All waterborne effluents are released in batch mode and are sampled and analyzed prior to release. Waterborne effluents from the site are released into the cooling tower blowdown line for dilution prior to release to the Susquehanna River (see Figure 2): Blowdown line flow rates are at least 5,000 gpm during periods of liquid radwaste release. The diluted effluent is introduced to the river by way of a perforated diffuser pipe placed on the river bed. The diffuser serves to rapidly and uniformly mix the station discharge with the main flow of the river. | |||
This report presents a summary of the quantities of radioactive materials which were released from the Susquehanna Steam Electric Station during the period from January 1, 1997 to December 31, 1997. In addition, this report serves as a medium for notifying the US Nuclear Regulatory Commission staff of changes to PP8L's Offsite Dose Calculation Manual (ODCM) and Solid Waste Process Control Program (PCP) and documentation of any exceptions to the SSES effluent monitoring program which must be reported per Technical Specifications 3.3.7.10 and 3.3.7.11. A section containing corrections to a previously reported dose is also included. | |||
Airborne and.waterborne radioactive effluent releases to the environment during the report period were sampled and analyzed in accordance with the requirements of the Technical Specifications. All radioactive effluent releases were within the concentration and release limits specified in the Radiological Effluent Technical Specifications (RETS). Calculations and terms utilized in this report are those outlined in the SSES Offsite Dose Calculation Manual (ODCM). | |||
Section 1 contains supplemental information pertaining to effluents from the Susquehanna plant. Included are regulatory limits (Table 1), sampling and analysis methods, and characterization of the number and duration of batch and abnormal releases, if any. | |||
Section 2 contains effluent and waste disposal data for the report period. Table 2 contains a summation of all airborne releases, grouped into the radionuclide categories of gases, particulates, iodines, and tritium. Average release rates are presented and compared to the applicable limits. Table 3 presents the activity totals of specific radionuclides in airborne effluents. | |||
Waterborne effluents are summarized in Table 4. Average diluted concentrations are presented and compared to the applicable limits. Table 5 presents the release quantities of specific radionuclides in waterborne effluents over the report period. | |||
Figure 3 lists the Susquehanna River monthly average flow rates for 1997 while Figure 4 presents the SSES monthly liquid radwaste discharge totals for 1997. | |||
Tables 6 through 17 present a characterization of the solid radioactive waste shipped offsite during the report period (Tables 7 through 9 are reserved blank in this report). Included are the volumes and curie contents associated with each type of solid waste. An estimate of major nuclide composition is presented for each waste type, as well as the number of waste shipments from the'site, how they were transported, and their final destination. | |||
Table 18 contains estimates of the errors associated with the measurements involved in quantifying effluents. Sampling errors, counting errors, and errors associated with determining effluent flow rates and volumes all contribute to the total error of effluent measurements. Error estimates are presented for each category of radionuclide detected in airborne and waterborne effluents and solid wastes during the report period. | |||
Table 19 presents effluent data from previous report periods which was not available at preparation time for the associated annual report. | |||
Section 3 of this report contains the meteorological data associated with the year 1997. Availability data for the SSES meteorological data are shown in Table 20. | |||
Meteorological data for the calendar year is presented in the form of joint wind frequency distributions by atmospheric stability class. These distributions are presented in Table 21. Figures 5 and 6 are wind rose plots for the SSES primary meteorological 10-meter and 60-meter sensors, respectively. Figure 7 presents the relative prevalences of the Pasquill stability classes. In addition, the meteorological data from the report year were used to generate annual average relative concentrations (X/Qs) and deposition rates (D/Qs). These values are | |||
presented in Table 22, and are required input for use of the GASPAR code for calculation of the doses resulting from airborne releases. | |||
Section 4 of this report contains an assessment of the calculated doses attributed to the reported radiological effluents,for the calendar year. The LADTAP II code was used for calculation of doses from waterborne effluents. Table 23 contains site-specific parameters used for LADTAP II calculations for the Danville receiver. | |||
The GASPAR code was used for calculation of doses from airborne effluents. The calculated doses and direct radiation estimates can be used to estimate the doses to maximally exposed members of the public. Table 24 summarizes maximum calculated doses and dose commitments to members of the public from airborne and waterborne effluents and direct radiation. Table 25 presents calculated collective doses to members of the public within the Riverlands/Information Center Complex. Table 26 summarizes the calculated doses for residences and other occupied areas within the SSES site boundary. Table 27 reports gamma and beta air doses from noble gas effluent for the same locations as Table 26. | |||
Section 5 of this report is reserved for documentation of changes to the Offsite Dose Calculation Manual and the Solid Waste Process Control Program. A copy of revision 7 of the SSES ODCM is included in Appendix A. A copy of changes to the Solid Waste Process Control Program is included in Appendix B. | |||
Section 6 presents a listing of cases (if any) in which airborne or waterborne effluent monitoring instrumentation was declared inoperable and was not restored to operability within the time period specified in Technical Specification Table 3.3.7.10-1 or 3.3.7.11-1 Action Statements. | |||
Section 7 contains corrections to doses reported in previous Semi-Annual or Annual Effluent and Waste Disposal Reports. | |||
Section 8 contains information on effluent and offsite dose from additional monitored release points. | |||
FIGURE I SSES AIRBORNE EFFLUENT RELEASE POINTS NLRBCf0 IIAICOCAI AT87~F II0IT A'fOP@ | |||
~t2&f IT~ | |||
000000 C010 AT CfN | |||
'120+S | |||
$ 4LCO AT ~~iR~S C0II'T VNfI | |||
'TWIIQ4 WILONOR RCICAQST | |||
~ eN LI 010'oI i tl 000'4 ~ | |||
0 O~ | |||
~ ~~~ | |||
~a~ | |||
~ ~or o OWTIOI. WILCWC 0II"r I'r+ j)v+0'e+rC | |||
!I'4 IO NOTE: LISTED FLOW RATES SHOULD NOT BE CONSIDERED ABSOLUTE FOR ANY GIVEN PLANT CONDITION | |||
FIGURE 2 SSES WATERBORNE EFFLUENT PATHWAY | |||
~ a\ a<<e i ~ | |||
~ | |||
I~ | |||
4ISQtEWINL /gag ~ ~~ ~ ~<<<<<<<<o roe os oooo ~ | |||
~ ~ oa | |||
~ 'm tygOCI 'lktNFlllOCNCMTCI 00 4N ut CPNOQ lllIllCITVC taeeaHC Ml* | |||
'Mlle litt TCMTQQIT ltd 44hl CO@ 4AI. TIACTC HCCM Kiur TCCATNCNT lNlO CtltI4 4 4ACTao OAHICCL CCWRATTO | |||
+TIOCAt CICllICAlo N0Ttl 44 ETC SHOW~ | |||
4TaoOo crsc ATOAKOCAH OAAIWtTtATCQbe4T WlttfC TCCATI&lf 4 | |||
PLOWS WLTtJL ~ | |||
IAAPQaL Ct4IAATCO IlOWC IIOT SHOWN ON TNS Ou44AI4. | |||
PA4NC IOTA 4CTUAIl ~ 'ASH t0 ting Nalll ~ l04I IA HCf OL ACACAOTD4 CO 4lCOvtHT rlLTCR 400 ~ | |||
OUI APO IVXVI I IAATCt NCRCAltO WQNC PCROOC 04ANACCOF COCua TOWCR SASWS lunar tl etO MAT Ct 4ICACASCO $ 000 Ctll Q. OCWCK A<<AC>> 'l.rA44A AOOITgWS C e CAlCITIC ~ a OCLYMUI CLeOCXIOC C e Ctle0444TOI CHCMCAI F a PL%lAIO OC a <<ae<< <<oe I ~+OCT I b44aegr r-~-~~Wq KAT | |||
+IU++4Nkv a<<aae o eaeO aaa aaa<< | |||
A or | |||
: t. a<<<<aaaa a<<o <<<<a<<a J IOCASCTI Iomy4<< | |||
P oo SPRAT l PRO 04PCALTION it CPg L o IO,CNO 44N NOTE: LISTED FLOW RATES SHOULD NOT BE CONSIDERED ABSOLUTE FOR ANY GIVEN PLANT CONDITION | |||
SUPPLEMENTAL INFORMATION | |||
~ I | |||
: 1. Re ulato Limits Technical Specifications 3/4.11.1 and 3/4.11.2 outline requirements for release of radioactive liquid and gaseous effluents, respectively. Concentration of radioactive materials released in liquid effluents and dose or dose commitment resultant thereof are limited in unrestricted areas. Dose and dose rate due to | |||
~ | |||
radioactive materials released in gaseous effluents are limited in areas at or beyond the site boundary. Technical Specification limits are listed in Table 1. | |||
: 2. Maximum Permissible Concentrations in Waterborne Effluents The concentrations of radioactive materials in waterborne effluents are limited to the concentrations specified in 10 CFR Part 20 Appendix B Table II, Column 2, for radionuclides other than dissolved or entrained noble gases. | |||
For dissolved or entrained noble gases, the concentrations are limited to the following values, as stated in the applicable Technical Specification: | |||
Nuclide MPC uCi/ml 85mK 2.0E-04 85K 5.0E-04 87K 4.0E-05 88K 9.0E-05 4'Ar 7.0E-05 133m 5.0E-04 133xe 6.0E-04 135mXe 2.0E-04 135Xe 2.0E-04 | |||
: 3. ~AE Based on gaseous effluent releases for the report period average beta energy is 0.319 MeV and average gamma energy is 0.249 MeV. | |||
: 4. Measurements and A roximations of Total Radioactivi Analyses of specific radionuclides in effluent samples are used to evaluate the radioactive composition and concentration of effluents. | |||
: 5. Methods of uanti in Effiuents | |||
: a. Fission and Activation Gases: Gas samples are routinely collected monthly and analyzed with a high resolution (Ge[Li] or HPGE) detector system which incorporates a data reduction program to determine radionuclide composition in terms of specific activity. Data tapes from the continuous vent monitors are used to determine the average concentration of noble gases. The high resolution (Ge[Li] or HPGE) isotopic scan is used to convert the continuous vent monitor activity to actual activity based on the determined nuclide mixture. The vent and sample flow rates are continuously monitored and the average flow rates for each vent are used to calculate the total activity released in a given time period. When the continuous monitors are out of service, manual grab samples are taken from each vent once each eight hours (once each four hours for the standby gas treatment vent). | |||
: b. lodines: iodine is continuously collected via an isokinetic sampling assembly in each vent. Filters are normally exchanged once per week and analyzed on a high resolution (Ge[Li] or HPGE) system. The daily average flow rates for the vents and sample pumps are averaged for the duration of the sampling period and a ratio of vent flow rate to sample flow rate is determined. The ratio is used to determine the total activity of each isotope released during the time period in question. When the continuous monitors are out of service, iodine is continuously collected on charcoal cartridges | |||
'ttached to air samplers which draw directly from the affected rooftop vent(s) or from alternate sampling ports available on the sample lines. | |||
Particulates: Particulates are continuously collected via an isokinetic sampling assembly in each vent. Filters are normally exchanged once per week and analyzed on a | |||
==Reference:== | ==Reference:== | ||
NRC IE Bulletin No. 80-1 0). The evaluation will determine the significance of any potential effluents pathways and extent of sampling and/or monitoring required. The frequency of sampling or monitoring will be determined based on the potential for contamination, the potential for inadvertent releases, the potential levels of contamination and releases, and the potential impact on station offsite doses. | |||
~ | r Results of sampling and/or evaluation will be used to classify potential effluent pathways into one of the following categories: | ||
: a. Not an Effluent Pathwa: Realistic evaluation (e.g., engineering design, system operation, radionuclide inventory) demonstrates that the pathway has no potential for release of radioactive material Appv k-c4. | |||
Date 2'/ | |||
Rev. 7 43 | |||
(Table 8). Although not required, periodic sampling may at times be performed to confirm the result of the evaluation. | |||
: b. Insi nificant Effluent Pathwa: Evaluation and/or periodic sampling demonstrate that the pathway may contain radioactive effluents, however, these effluents may not be reasonably expected to exceed 10 percent of the appropriate unrestricted area MPC value (fractional MPCs summed when appropriate) listed in Table II of Appendix B to 10 CFR 20 (Table 9). A release pathway which falls'in this category will be sampled periodically. | |||
: c. Si nificant Effluent Pathwa: Evaluation and/or periodic sampling demonstrate that the pathway may'contain radioactive effluents, and these effluents may be reasonably expected to exceed 10 percent of the appropriate unrestricted area MPC value (fractional MPCs summed when appropriate) listed in Table II of Appendix B to 10 CFR 20 (Table 10). A release pathway which falls in this category will be sampled continuously. | |||
If sampling indicates a non-radioactive system has become contaminated, further use of the system shall be restricted until the cause of the contamination has been corrected and the system is decontaminated. If continued operation of the system as contaminated is necessary, a 10CFR50.59 safety evaluation of the operation of the system as a radioactive system shall be performed immediately by the system operator/engineer. The safety evaluation will include any changes in the. | |||
effluent pathways and the impacts to offsite doses. (Ref. NRC IE Bulletin 80-10). Systems with NRC I/E Bulletin applicability are designed to be used as non-radioactive, but which could possibly become radioactive through interface(s) with radioactive systems, and which have a path for unmonitored and/or uncontrolled release to the environment. (Table 11)- | |||
Positively detected radioactive material in samples collected from all airborne and waterborne offsite release pathways will be reported in the Annual Effluent and Waste Disposal Report. | |||
10A Flow from the SGTS Vent when the S stem is Not in Use When the Standby Gas Treatment is not being used, there remains a small amount of flow from the SGTS vent. This residual flow is exhaust from the battery rooms in the control structure. Because there are no identifiable sources of radioactivity in these rooms, auxiliary particulate and iodine sample and noble gas grab sample at 4-hour intervals are not required from the SGTS vent when the SGTS continuous vent monitor is out of service, trrovided that-Appv Date Rev. 7 | |||
: a. the Standby Gas Treatment System is not being used, | |||
: b. there are proper administrative controls in place to ensure that the required sampling will begin within 4 hours if the treatment system is operated. | |||
10.5 ODCM Set pints are U er Limit Values Effluent monitor alarm/trip setpoints calculated in accordance with the ODCM shall be considered upper limit values. Higher (less conservative) setpoints shall not be used, however lower (more conservative) setpoints may be used as required to maximize the utility of the monitor. | |||
10.6 Definition of "A ro riate Treatment" for Li uid Wastes Technical Specification 3.11.1.3 requires that the appropriate portions of liquid waste treatment system be operable and be used to reduce | |||
'he radioactivity in liquid wastes prior to their release when projected doses from each reactor unit to unrestricted areas would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31 day period. | |||
o The normal treatment, which is considered appropriate for each subsystem, is as follows: | |||
Filtration is considered appropriate treatment for the Liquid Radwaste Laundry Processing Subsystem, which consists of high | |||
-'conductivity liquid wastes, such as those from equipment washdown and personnel decontamination facilities, or laundry. | |||
The atmospheric demineralizer (a vendor-supplied system which is directed to the Distillate Sample Tank) is considered appropriate for the Liquid Radwaste Chemical Processing Subsystem. | |||
Demineralization and filtration are considered appropriate treatment for low conductivity/low organic contaminant liquid wastes entering the Liquid Radwaste Processing Subsystem (LRW collection tanks), except for batches which yield projected doses prior to treatment of less than or equal to 6.45-04 mrem to the total body and 2.15E-03 mrem to any organ, where filtration alone is appropriate, of Appv Date Rev. 7 | |||
~ For batches which have no identified gamma activity above the Technical Specification Liquid Effluent LLD level (Table 4.11.1.1.1-1), | |||
release without treatment is considered appropriate. | |||
BASES The projected dose threshold values used are derived by dividing the site-total maximum projected doses without treatment (0.12 and 0.4 mrem) by 31 days and by 6, the maximum possible number of batches released per day, to yield per-batch dose action levels..The two levels of "appropriate" treatment are in place so as not to require application of demineralization for treating low activity, high conductivity water | |||
. (e.g., from Circulating or Service Water leakage). This would increase the overall efficiency of the solid radwaste program while ensuring calculated doses remain at a suitable fraction of 10 CFR 50 design objectives and Technical Specification 3.11.1.2 limit."'"'0.7 Monitor Line Loss Corrections In order to correct for airborne effluent monitor sample line loss, the following correction factors shall be applied to monitor data and sample analysis results: | |||
CORRECTION FACTORS Routine Effluent Monitors iodine Particulates Reactor Building Unit 1 1.5 3.2 Reactor Building Unit 2 1.5 3.2 Turbine Building Unit 1 1.6 3.6 Standby Gas Treatment 1.5 3.9 Turbine Building Unit 2 1.6 3.6 | |||
"'Reference Calculation No. OT-RKB-92-001: Calculation of Liquid Isotope Offsite Dose Consequences for Use of Atmospheric Demineralizer System, PLI-70360, t | |||
2/4/92. | |||
+Reference Letter R. K. Barclay to R. A. Breslin: Atmospheric Demineralizer Effluent Results, PLI-70612, 3/4/92. | |||
Appv Date Rev. 7 46 | |||
CORRECTION FACTORS Post-Accident Vent Monitors iodine Particulates Turbine Building Unit 1 1.7 4.2 Standby Gas Treatment 1.6 44 Turbine Building Unit 2 1.7 4.3 Each indicated iodine and particulates concentration shall be multiplied by the appropriate correction factor to estimate the actual concentration at the inlet to the sample line. | |||
10.8 Selection of Data for Determination of Dose Rate Com liance Airborne effluent monitor setpoints are maintained in accordance with Section 2.2 to alarm before the dose rate limits of Specification 3.11.2.1 are exceeded. Station alarm response procedures contain instructions for investigation and verification of monitor alarms. Because setpoint calculations must include assumptions about the composition of the monitored effluent, a monitor high alarm does not necessarily indicate that a dose rate limit has been exceeded. | |||
Valid ten-minute averaged data should be the primary information used to determine the compliance status of an incident. One-minute averaged data should also be reviewed if available, but they may or may not provide additional information depending on the magnitude of the release due to the manner in which the monitors update values to be stored and associated statistical considerations. Averages over a longer period should be used only when data with higher resolution is not available. | |||
Grab sample analyses should be performed whenever possible to confirm or disprove monitor data, and to provide indication of the nuclide-specific composition of the effluent. When grab sample data are available which, based on vent monitor data, are indicative of the period of elevated release, dose rate calculations should be performed using the actual effluent mix. The determination of compliance status should not be based on monitor data alone when it is possible to collect and analyze a vent sample which will be representative of the period of elevated release. | |||
Appv . c--~ | |||
Date ~ 7 Rev. 7 | |||
10.9 Low-Level Radioactivi in the Sewa e Treatment Plant Like all sewage processing facilities, the SSES sewage treatment plant can under certain conditions receive low levels of radioactive materials. | |||
The most notable scenario is when individuals who work on-site have been subjected to the medical administration of radiopharmaceuticals for diagnostic or therapeutic purposes. In these cases, normal biological elimination processes can easily result in levels of radioactivity in sewage treatment plant solutions and suspensions which are within the detection capabilities of the associated sampling and analysis program. | |||
Because disposal of sewage treatment plant sludge by controlled dispersal on specified tracts of land is a common practice, the following guidelines have been established: | |||
: a. All sludge collected in the sludge holding tank should be sampled and analyzed prior to land disposal to quantify any radioactivity above natural background levels. 'resent | |||
: b. Sludge containing nuclides with short half-lives, for example iodine-131, should be contained on-site to permit decay to less than detectable levels. | |||
When sludge is contaminated with nuclides which have half-lives sufficientl long to make hold-up for decay impractical, the following options should be considered: | |||
: 1. Dispose of the sludge as low level radioactive waste. | |||
: 2. Obtain a special permit pursuant to the requirements of 10 CFR 20.2002. | |||
: d. The sewage treatment plant liquid effluent should be sampled monthly for radioactivity. This can be accomplished by drawing a sample from the chlorine contact chamber. | |||
Appv Date Rev. 7 48 | |||
TA8LE 8 SYSTEMS CLASSIFIED AS NOT AN EFFLUENT PATHWAY(Page 1 of 3) | |||
'-""'-'::: 'i:-:"'<:::.'::::-','3i'lg@M::-:;!i::;::,';,::SYSTEM;9ESCRIPTIOM:;-;I!':-:4!i'i''ll!':;::;:.ll'i",:iiii~."i'l Water I:'omestic | |||
~ t River Water Makeup Intake Compressed Air Screens and Screenwash Fire Protection Water Fire Protection CO2 Fire Protection Ha!on Turbine Building Closed Cooling Water Building Drains: NON RAD | |||
~ I Water Pretreatment Condensate and Refuel Water Transfer Low Pressure Air Condensate Demins Lube Oil Transfer/Purification Cooling Tower Acid/Chlorination Circulating Water Condenser Tube Cleaning Feedwater Extraction Steam | |||
~ I Feedwater Heaters Residual Heat Removal Reactor Core Isolation Cooling Core Spray High Pressure Coolant Injection Standby Liquid Control Control Rod Drives (1) PP&L Calculation EC-ENVR-1008 Appv Date Rev. 7 49 | |||
TABLE 8 SYSTEMS CLASSIFIED AS NOT AN EFFLUENT PATHWAY(Page 2 of 3) | |||
- ": -----"'-'.- -'~- >'"SYSTENI DESCRIPTION""'~"("":~ "'~":"::::"""~::~~~ ';::::::REFEREIIICE~" | |||
Suppression Pool Primary. Containment Vacuum Breakers Suppression Pool Cleanup Reactor Water Cleanup Reactor Pressure Vessel Reactor Recirculation System Radwaste Chilled Water Solid Radwaste/Cement Silo LRW Collection/Tb and Cond. Outer Area Sumps LRW Processing/Radwaste Evaporator Gaseous Radwaste'Recombiner Closed Cooling Water Nitrogen Storage Hydrogen Storage Sampling Stations Post Accident Sampling System Bypass Steam Main Steam Isolation Valves/ Nuclear Steam Supply System Shutoff Automatic Depressurization System MSIV Leakage Control Moisture Separators Turbine Steam Seals Electrohydraulic Control Stator Cooling Main Generator Storm Drains (1) PPBL Calculation EC-ENVR-1008 Appv Date Rev. 7 50 | |||
TABLE 8 SYSTEMS CLASSIFIED AS NOT AN EFFLUENT PATHWAY, (Page 3 of 3) | |||
YSTEM'SCRIPTIOt4,",:.!i.:i! | |||
Makeup Demineralizers Fuel Oil Containment Instrument Gas Control Structure Chilled Water Turbine Bldg. Chilled Water Reactor Bldg. Chilled Water Auxiliary Boilers Fuel Pool Cooling Fuel Pool Demineralizers Fuel Pools. | |||
Temporary SDHR System Temporary Laundry Facility (1) PP8 L Calculation EC-ENVR-1 008 (2) Safety Evaluation NL-95-001: Refueling Outage Decay Heat Removal and Tie-In of the SDHR Temporary Cooling Equipment Safety Evaluation NL-9029: Temporary Laundry Facility Appv Date ~r 4 Rev. 7 51 | |||
TABLE 9 SYSTEMS CLASSIFIED AS INSIGNIFICANTEFFLUENT PATHWAY S'YSTEIli5ESCRIPTIO'N:.j,:.'j>,'v'i,,'!."l=';i',ll:,l>>".,",";;;l~4';"~j:;:.~;:RE'FERENC'E..4 H2 Seal Oil Condensate Storage Tank and Berm Main Turbine/RFPT Lube Oil (i)(4) | |||
Second Sort (DAW Volume Reduction) Facility Low Level Radwaste Handling Facility Sewage Treatment Plant | |||
( I) PPRL Calculation EC-ENVR-1008 (2) Safety Evaluation NL-89-002: Dry Active Waste Volume Reduction System (3) Safety Evaluation NL-92-007: Operation of LLRWHF at SSES (4) Main Tb/RFPT Lube Oil are designed to be operated as non-radioactive systems. They are classified as Insignificant Effluent Pathways based on source terms and offsite dose rate results for consideration of a contaminated source term. | |||
(5) Sewage treatment plant is designed to be operated as a non-radioactive system. | |||
Classification as an insignificant Effluent Pathway is in accordance with Safety NL-95-015. 'valuation Appv Date Rev. 7 52 | |||
TABLE 10 SYSTEMS CLASSIFIED AS SIGNIFICANT EFFLUENT PATHWAY | |||
:-: "'::-:.'"''.~;:;.:',";,.:".,:..:SYSTEMlDESgRlPTfON ':,'-',,",:i;,::',',,::;.;:":::,':I~ j"','";-'i,'I+~PP,::,'j":;":,i!i;,,";.~"'REFERENCEl'::;:i':g.''.,i::ii.:'::ll::i::.":.::i:::ii:::"'::l4 Liquid Waste Management Systems Gaseous Waste Management Systems (1) SSES FSAR Chapter 11.2 (2) SSES FSAR Chapter 11.3 Appv Date Rev. 7 53 | |||
TABLE 11 SYSTEMS WITH NRC I/E BULLETIN80-10 APPLICABILITY Service Water (F/P HTX Discharge) 16 RHR Service Water 18 instrument Air 19 Service Air 27 Auxiliary Boilers | |||
- 35 Shutdown Decay Heat Removal System 40 Batch Lube Oil Tank 48 Feedwater Pump Turbine Lube Oil 52 H2 Seal Oil Tank Emergency Service Water 93 Main Turbine Lube Oil 99D Sewage Treatment Plant Appv Date Rev. 7 54 | |||
TABLE 12 VENTILATIONEXHAUST TREATMENT SYSTEMS WHICH REQUIRE OFF SITE VENT EVALUATIONSWHEN BYPASSED, DEGRADED, OR OTHERWISE RENDERED INOPERABLE Unit 1 Turbine Building 1F157NB 1F158NB N/A Unit 2 Turbine Building 2F157NB 2F158NB N/A Unit 1 Zone 1 Reactor Building 1F255NB 1F257A/8 1F258NB Unit 1 Zone 3 Reactor Building 1F216A/B 1F217NB 1F218A/B Unit 2 Zone 2 Reactor Building 2F255NB 2F257NB 2F258NB Unit 2 Zone 3 Reactor Building 2F216NB 2F217A/B 2F218NB Radwaste Building Exhaust OF355A/B N/A NIA Radwaste Tank Vent OF358 OF359 N/A Radwaste Degasifier OF372 OF373 OF374 Control Structure Sample Room OF134 OF135 N/A Control Structure Rad Chem Lab OF137 OF138 NIA Control Structure Rad Chem Lab OF140 OF141 N/A Control Structure Decon Area OF143 OF144 N/A S8A Building OF716 N/A N/A Appv 4~ | |||
Date Rev. 7 55 | |||
11.0 ODCM REVIEW AND REVISION CONTROL The Supervisor-Environmental Services-Nuclear shall ensure that a total review of the ODCM is performed during each even-numbered year. Comments shall be documented and revisions initiated as appropriate. | |||
Revisions to the ODCM shall be initiated in accordance with NEPM-QA-1011. | |||
Each ODCM page shall be numbered and provided with an approval and date box. The ODCM Table of Contents shall present the current revision date for each page so that any manual holder can check manual completeness based on a current Table of Contents. | |||
All ODCM revisions shall be reviewed by PORC after approval by the Manager-Nuclear Technology. PORC review shall be indicated'by PORC chairperson or designee signature on ODCM cover. | |||
ODCM copies shall be issued in a controlled fashion by SSES Document Control Services'. The distribution list shall be maintained by SSES Document Control Services. | |||
Any comments on ODCM contents or proposed revisions should be directed to the Supervisor-Environmental Services-Nuclear. | |||
Appv Date Rev. 7 56 | |||
APPENDIX A | |||
'SAMPLE CALCULATIONS OF ODCM PARAMETERS A. 1 SETPOINTS A. 1 . 1 Waterborne Effluent Moni tors | |||
'.l.l.l Li uid Radwaste Oischar e Line Monitor For an unidentified mixture with an assumed MPC of IE-7 uCi/ml, an actual activity concentration of lE-5 uCi/ml, and a blowdown flow setpoint of 5000 gpm, the high radiation setpoint concentration, c, can be determined from c x(A). If x 3, then the actual high radiation setpoint concentration is: | |||
c ~ 3 (A) ~ 3 (lE-5) c 3E-5 uCi/ml The Alert radiation setpoint is 0.8 times the high radiation setpoint, or 1.6 times the actual activity concentration. The setpoint value for the liquid effluent monitors is then determined by Equation 3 in the ODCM. For the above release conditions, the setpoint value, assuming a typical calibration factor of 1.3 x 10 uCi/ml per cpm, would be. | |||
Setpoint cpm + Background (cpm) | |||
Cal. Factor Setpoint cpm 3E-5 + Background 1.3 x 10 Setpoint cpm 2.3E3 + Background The LRW discharge f'low setpoint is then determined as follows: | |||
A-1 | |||
F where Y is made equal to 10. | |||
5000+/'0 (1E-5) f 1E-7 f 5 gpm For an identified mixture with an actual HPC of 7.22E-7 uCi/ml and the same activity concentration, blowdown flow and X and Y values as above, the LRW discharge monitor setpoint value and LRW discharge flow setpoint become: | |||
High radiation setpoint concentration (c) 3E-5 uCi/ml High radiation setpoint value 2.3E3 cpm + Background LRW discharge flow setpoint (f) 36 gpm A. 1.1.2 Service Mater Monitor Background 300 cps Calibration Factor - 1.5E-8 uCi/ml per cps Activity concentration 2E-5 uCi/ml (2E-5)/Cal. Factor-', = 1333 cps Because 300 cps is less than 1333 cps: | |||
HI RAD Setpoint 0.5 Background + (2E-5)/Cal. Factor 0.5 (300 cps) + (2E-5)/(1.5E-B) | |||
= 150 cps + 1333 cps ~ 1483 cps DOWNSCALE Setpoint - 0.5 Background (0.5)'(300 cps) 150 cps Cal ibration Factor 1.5E-8 uCi/ml per cps (2E-5)/Cal. Factor 1333 cps Because 1400 cps is greater than 1333 cps: | |||
HI RAO Setpoint = Background + (0.5)(2E-5)/Cal. Factor | |||
= 1400 cps + (lE-5)/(1.5E-8) 2067 cps A-2 | |||
DOWNSCALE Setpoint = Background 0.5 (2E-5)/Cal. | |||
Factor, 1400 cps'- 0.5 (2E-5)/1.5E-8) | |||
~ 1400 cps 667 cps 733 cps A. 1. 1.3 RHR Service Water Monitor k d = 160 cpm Calibration Factor = 3.9E-9 uCi/ml per cpm (2E-5)/Cal. Factor 5128 cpm Because 160 cpm is less than 5128 cpm: | |||
HI RAD Setpoint 0.5 Background + (2E-5)/Cal. Factor | |||
- 0.5 (160 cpm) + (2E-5)/(3.9E-9) 80 cpm + 5128 cpm 5208 cpm LOW RAD Setpoint 0.5 Background 0.5 (160 cpm) 80 cpm Setpoint = 0.8 HI Setpoint 4166 cpm d>> | |||
ALERT RAD d k d Calibration Factor = 3.9E-9 uCi/ml per cpm (2E-5)/Cal. Factor 5128 cpm Because 6000.cpm is greater than 5128 cpm: | |||
'HI RAD Setpoint Background + (0.5)(2E-5)/Cal. Factor | |||
- 6000 cpm + (lE-5)/(3.9E-9) | |||
= 6000 cpm + 2564 cpm | |||
- 8564 cpm LOW RAD Setpoint - Background 0.5 (2E-5)/Cal. Factor 6000 cpm 0.5 (2E-5)/(3.9E-9) | |||
= 6000 cpm 2564 cpm = 3436 cpm ALERT Setpoint - 0.8 HI RAD Setpoint - 6851 cpm A.l.2 Gaseous Effluent Monitors k | |||
A.l.2.1 Noble Gas Monitor To determine the release rate limit for noble gases, an isotopic mixture representative of plant effluents is selected. For example, the following mixture from Table 4.4 of the SSES Final Environmental Statement (FES) can be used: | |||
rut'V Rev. 6 A-3 DAT | |||
Argon-41 25 Ci/yr per reactor Krypton-83m 4 Krypton-85m 1,700 Krypton-85 270 Krypton-87 32 Krypton-88 660 Xenon-131m 71 Xenon-133m 14 Xenon-133 12,500 Xenon-135m 220 Xenon-135 590 Xenon-138 290 Total 16,376 Ci/yr per reactor The above annual release quantities are entered into GASPAR with the following annual average dispersion estimates ( | |||
==Reference:== | ==Reference:== | ||
1982 SSES Heteorology Report): | |||
Relative Concentration 4.1E-5 sec/m 3 Decayed Relative Concentration 4.1E-5 sec/m Decayed Depleted Relative Concentration 3.8E-5 sec/m 4.2E-8 m | |||
-2 Deposition Rate This set of annual aver age meteorological parameters's the most conservative over the period 1973-1982. | |||
The total body dose via the plume pathway which results is 18.3 mrem. Equation 5 of the ODCM is then used to calculate the limiting release rate from each of the five plant release points: | |||
Limiting Release Rate 32 752 Ci 500 mrem r = 8.95E4 Ci/yr per vent (36.6 mrem) (5 vents) | |||
A-4 | |||
This limiting release rate is then converted to limiting (setpoint) concentrations using Equation 6 of the ODCH and high limit vent flow rates. | |||
Sample High Limit Vent Flow Rates: | |||
Unit I Reactor Building Vent 4.77E9 cc/min Unit 2 Reactor Building Vent 4.77E9 cc/min Standby Gas Treatment System Vent 5.05E8 cc/min Unit I Turbine Building Vent 8.64E9 cc/min Unit 2 Turbine Building Vent 6.52E9 cc/min Limiting Vent Concentration = | |||
8.9SE4 Ci r vent IE6 uCi Ci 3.57E-5 uCi/cc (5.26ES min/yr) (4.77E9 cc/min) , | |||
for Reactor Buildings 152 Substituting the other vent flow rates into Equation 6 as above, the following noble gas high radiation set-point concentrations are calculated for the remaining vents: | |||
Standby Gas Treatment System 3.37E-4 uCi/cc Unit I Turbine Building 1.97E-S uCi/cc Unit 2 Turbine Building 2.61E-S uCi/cc A.1.2.2 Iodine -131 Honitor When the FES expected annual release quantity for I-131 (2.40E-I curies) is entered into GASPAR with the dispersion estimates of A.I.2.1, the maximum calculated organ dose via the inhalation pathway is 4.88 mrem to the child thyroid. Using Equation 5 of the ODCH, the limiting 1-131 release rate is calcu-lated as follows: | |||
A-5 | |||
, Limiting Release Rate = | |||
.24 Ci 1500 mrem r 1.48E1 Ci/yr/ven | |||
,(4.88 mrem) (5 vents) | |||
Using Equation 6 of the ODCM, the limiting (setpoint) | |||
I-131 concentrations can be calculated for each of the five plant vents. | |||
Limiting Vent Concentration 14.8 Ci r vent lE6 uCi Ci 5.90E-9 uCi/cc for. | |||
(5.26E5 min/yr) (4.77E9 cc/min) Reactor Buildings 15.2 Substituting the other vent flow rates into Equation 6 of the ODCM above, the high radiation setpoints for the remaining plant vents are calculated to be the following: | |||
Standby Gas Treatment System 5.57E-B uCi/cc Unit 1 Turbine Building 3.26E-9 uCi/c" Unit 2 Turbine Building 4.32E-9 uCi/cc A. 1.2.3 Particulate Monitor Following are the SSES Final Environmental Statement (FES) expected annual release quantities for particu-late radionuclides: | |||
A-6 | |||
Cr-51 1.2E-4 Ci/yr per reactor Hn-54 3.6E-4 Fe-59 1. 6E-4 Co-58 5.8E-5 Co-60 1.1E-3 Zn-65 5.5E-5 Sr-89 1.8E-5 Sr-90 3. 1E-6 Zr-95 8.7E-6 Sb-124 5.1E-6 Cs-134 1.3E-4 | |||
.Cs-136 1.3E-3 Cs-137 2: lE-4 Ba-140 4.2E-5 Ce-141 2.9E-B Total 3.6E-3 Ci/yr per reactor Mhen the above annual. release quantities are entered into GASPAR=with the annual average dispersion esti-'ates oF A. 1.2. 1, the maximum calculated organ dose | |||
'ia the inhalation pathway is 1.33E-2 mrem to the teen lung. Using Equation 5 of the ODCM, the limiting release rate of particulates can be calculated: | |||
Limiting Release Rate 7.2E-3 Ci 1500 mrem r 8.12E1 Ci/yr/vent (2.66E-2 mrem) (5 vents) | |||
Using Equation 6 of the ODCH, the limiting (setpoint) particulate concentrations can be calculated for each of the f'ive plant vents | |||
Latest revision as of 22:30, 23 February 2020
| ML18017A216 | |
| Person / Time | |
|---|---|
| Site: | Susquehanna  |
| Issue date: | 12/31/1997 |
| From: | Barclay R, Carson B, Doty R PENNSYLVANIA POWER & LIGHT CO. |
| To: | NRC OFFICE OF INFORMATION RESOURCES MANAGEMENT (IRM) |
| References | |
| PLA-4868, NUDOCS 9804090293 | |
| Download: ML18017A216 (381) | |
Text
SUSQUEHANNA STEAM ELECTRIC STATION ANNUALEFFLUENT AND WASTE DISPOSAL REPORT REPORT PERIOD: 01/01/97 - 12/31/97 Prepared by:
gZv~~~g~
R. K. Barclay Health Physicist Reviewed by:
. H. Carson Health Physicist Appro ed by:
R. L. oty Superv or - Operations Tec nology Pennsylvania Power & Light Company Two North Ninth Street Allentown, Pennsylvania 18101 9804090293
TABLE OF CONTENTS SECTION PAGE
- 1. Introduction and Supplemental Information
- 2. Effluent and Waste Disposal Data 13
- 3. Meteorological Data and Dispersion Estimates 38
- 4. Dose Measurements and Assessments 68
- 5. Changes to the Offsite Dose Calculation Manual 77 and the Solid Waste Process Control Program
- 6. Reports of Exception to the SSES Effluent 80 Monitoring Program
- 7. Correction to Doses Reported in Previous 82 Semiannual or Annual Effluent and Waste Disposal Report
- 8. Effluent from Additional Monitored Release Points 84 Appendix A Revisions to SSES ODCM Appendix B Revisions to SSES Solid Waste Process Control Program (NDAP-QA-0646)
LIST OF TABLES PAGE Table 1: Technical Specification Limits 10 Table 2: Airborne Effluent-Summation of All Releases 16 Table 3: Airborne Effluent 17 Table 4: Waterborne Effluent - Summation of All Releases 20 Table 5: Waterborne Effluent 21 Table 6: Annual Effluent and Waste Disposal Report 26 Solid Waste and Irradiated Fuel Shipments Table 7-9: These tables deliberately left blank 26A Table 10: Incinerated DAW - Class A 27 Strong Tight Container Table11: Condensate Demineralizer/RadwasteDemineralizer-ClassA 28 Steel Liner (Solidified)
Table 12: Processed DAW - Class A 29 Strong Tight Container Table 13: Ultrasonic Resin Cleaning Waste - Class A 30 HIC (Dewatered)
Table 14: Non-Processed DAW - Class C 31 Strong Tight Container HIC Table 15: Cartridge Filters - Class C 32 HIC (Dewatered)
Table 16: Cartridge Filters - Class A 33 HIC (Dewatered)
Table 17: Liquid Radwaste Filter Media - Class A 34 HIC (Dewatered)
Estimated Total Errors Associated with 35 Effluent Measurements
LIST OF TABLES (cont.)
PAGE Table 19: Annual Effluent and Waste Disposal Report 37 Data Not Reported in Previous Annual Report Table 20: Meteorological Data Availability 40 Table 21: Joint Wind Frequency Distribution by Stability Class 44 Table 22: Average Annual Relative Concentrations 54 Table 23: Site-Specific Parameters Used for Ladtap II 69 Calculations (Danville Receiver): for 1997 Table 24: Summary of Maximum Individual Qffsite Doses and 71 Dose Commitments to Members of the Public Table 25: Calculated Collective Doses to Members of the 74 Public Within the Riverlands/Information Center Complex Table 26: Calculated Doses for Individuals and Locations within the 75 SSES Site Boundary and Nearest Dairy Table 27: Calculated Doses from Noble Gases for Locations within 76 the SSES Site Boundary and Nearest Dairy
LIST OF FIGURES PAGE Figure 1: SSES Airborne Effluent Release Points Figure 2: SSES Waterborne Effluent Release Pathway Figure 3: Susquehanna River Monthly Average Flow Rates 22 Figure 4: SSES Monthly Liquid Radwaste Discharge Totals 23 Figure 5: SSES Wind Rose: 10-meter Sensors 41 Figure 6: SSES Wind Rose: 60-meter Sensors 42 Figure 7: SSES Pasquill Stability Class Prevalences 43 Figure 8: Areas Within the SSES Site Boundary for which 73 Dose Calculations are Performed
SECTION 1 INTRODUCTIONAND SUPPLEMENTAL INFORMATION
INTRODUCTION The Susquehanna Steam Electric Station (SSES) is located in Salem Township, Luzerne County, Pennsylvania. It is on the west bank of the Susquehanna River, 8 km northeast of Berwick. The Station consists of two boiling water reactor generating units, each with about 1,100 MW net electrical capacity. The reactor and generating units were supplied by General Electric, while the Bechtel Corporation served as architect-'engineer and constructor.
Construction of the Station began in the early 1970s. Fuel load began in Unit 1 in July of 1982. Initial criticality was achieved in the Unit 1 reactor on September 10, 1982. The reactor reached 100% power for the first time on February 4, 1983. Commercial operation of Unit 1 was declared on June 8, 1983.
Initial criticality of Unit 2 occurred on May 8, 1984. Unit 2 was declared commercial on February 12, 1985.
Airborne effluents are released from the Susquehanna Station via five rooftop vents on the reactor building (see Figure 1). Each vent is continuously monitored, and a program of periodic sampling and analysis is conducted as specified in the plant Technical Specifications. All waterborne effluents are released in batch mode and are sampled and analyzed prior to release. Waterborne effluents from the site are released into the cooling tower blowdown line for dilution prior to release to the Susquehanna River (see Figure 2): Blowdown line flow rates are at least 5,000 gpm during periods of liquid radwaste release. The diluted effluent is introduced to the river by way of a perforated diffuser pipe placed on the river bed. The diffuser serves to rapidly and uniformly mix the station discharge with the main flow of the river.
This report presents a summary of the quantities of radioactive materials which were released from the Susquehanna Steam Electric Station during the period from January 1, 1997 to December 31, 1997. In addition, this report serves as a medium for notifying the US Nuclear Regulatory Commission staff of changes to PP8L's Offsite Dose Calculation Manual (ODCM) and Solid Waste Process Control Program (PCP) and documentation of any exceptions to the SSES effluent monitoring program which must be reported per Technical Specifications 3.3.7.10 and 3.3.7.11. A section containing corrections to a previously reported dose is also included.
Airborne and.waterborne radioactive effluent releases to the environment during the report period were sampled and analyzed in accordance with the requirements of the Technical Specifications. All radioactive effluent releases were within the concentration and release limits specified in the Radiological Effluent Technical Specifications (RETS). Calculations and terms utilized in this report are those outlined in the SSES Offsite Dose Calculation Manual (ODCM).
Section 1 contains supplemental information pertaining to effluents from the Susquehanna plant. Included are regulatory limits (Table 1), sampling and analysis methods, and characterization of the number and duration of batch and abnormal releases, if any.
Section 2 contains effluent and waste disposal data for the report period. Table 2 contains a summation of all airborne releases, grouped into the radionuclide categories of gases, particulates, iodines, and tritium. Average release rates are presented and compared to the applicable limits. Table 3 presents the activity totals of specific radionuclides in airborne effluents.
Waterborne effluents are summarized in Table 4. Average diluted concentrations are presented and compared to the applicable limits. Table 5 presents the release quantities of specific radionuclides in waterborne effluents over the report period.
Figure 3 lists the Susquehanna River monthly average flow rates for 1997 while Figure 4 presents the SSES monthly liquid radwaste discharge totals for 1997.
Tables 6 through 17 present a characterization of the solid radioactive waste shipped offsite during the report period (Tables 7 through 9 are reserved blank in this report). Included are the volumes and curie contents associated with each type of solid waste. An estimate of major nuclide composition is presented for each waste type, as well as the number of waste shipments from the'site, how they were transported, and their final destination.
Table 18 contains estimates of the errors associated with the measurements involved in quantifying effluents. Sampling errors, counting errors, and errors associated with determining effluent flow rates and volumes all contribute to the total error of effluent measurements. Error estimates are presented for each category of radionuclide detected in airborne and waterborne effluents and solid wastes during the report period.
Table 19 presents effluent data from previous report periods which was not available at preparation time for the associated annual report.
Section 3 of this report contains the meteorological data associated with the year 1997. Availability data for the SSES meteorological data are shown in Table 20.
Meteorological data for the calendar year is presented in the form of joint wind frequency distributions by atmospheric stability class. These distributions are presented in Table 21. Figures 5 and 6 are wind rose plots for the SSES primary meteorological 10-meter and 60-meter sensors, respectively. Figure 7 presents the relative prevalences of the Pasquill stability classes. In addition, the meteorological data from the report year were used to generate annual average relative concentrations (X/Qs) and deposition rates (D/Qs). These values are
presented in Table 22, and are required input for use of the GASPAR code for calculation of the doses resulting from airborne releases.
Section 4 of this report contains an assessment of the calculated doses attributed to the reported radiological effluents,for the calendar year. The LADTAP II code was used for calculation of doses from waterborne effluents. Table 23 contains site-specific parameters used for LADTAP II calculations for the Danville receiver.
The GASPAR code was used for calculation of doses from airborne effluents. The calculated doses and direct radiation estimates can be used to estimate the doses to maximally exposed members of the public. Table 24 summarizes maximum calculated doses and dose commitments to members of the public from airborne and waterborne effluents and direct radiation. Table 25 presents calculated collective doses to members of the public within the Riverlands/Information Center Complex. Table 26 summarizes the calculated doses for residences and other occupied areas within the SSES site boundary. Table 27 reports gamma and beta air doses from noble gas effluent for the same locations as Table 26.
Section 5 of this report is reserved for documentation of changes to the Offsite Dose Calculation Manual and the Solid Waste Process Control Program. A copy of revision 7 of the SSES ODCM is included in Appendix A. A copy of changes to the Solid Waste Process Control Program is included in Appendix B.
Section 6 presents a listing of cases (if any) in which airborne or waterborne effluent monitoring instrumentation was declared inoperable and was not restored to operability within the time period specified in Technical Specification Table 3.3.7.10-1 or 3.3.7.11-1 Action Statements.
Section 7 contains corrections to doses reported in previous Semi-Annual or Annual Effluent and Waste Disposal Reports.
Section 8 contains information on effluent and offsite dose from additional monitored release points.
FIGURE I SSES AIRBORNE EFFLUENT RELEASE POINTS NLRBCf0 IIAICOCAI AT87~F II0IT A'fOP@
~t2&f IT~
000000 C010 AT CfN
'120+S
$ 4LCO AT ~~iR~S C0II'T VNfI
'TWIIQ4 WILONOR RCICAQST
~ eN LI 010'oI i tl 000'4 ~
0 O~
~ ~~~
~a~
~ ~or o OWTIOI. WILCWC 0II"r I'r+ j)v+0'e+rC
!I'4 IO NOTE: LISTED FLOW RATES SHOULD NOT BE CONSIDERED ABSOLUTE FOR ANY GIVEN PLANT CONDITION
FIGURE 2 SSES WATERBORNE EFFLUENT PATHWAY
~ a\ a<<e i ~
~
I~
4ISQtEWINL /gag ~ ~~ ~ ~<<<<<<<<o roe os oooo ~
~ ~ oa
~ 'm tygOCI 'lktNFlllOCNCMTCI 00 4N ut CPNOQ lllIllCITVC taeeaHC Ml*
'Mlle litt TCMTQQIT ltd 44hl CO@ 4AI. TIACTC HCCM Kiur TCCATNCNT lNlO CtltI4 4 4ACTao OAHICCL CCWRATTO
+TIOCAt CICllICAlo N0Ttl 44 ETC SHOW~
4TaoOo crsc ATOAKOCAH OAAIWtTtATCQbe4T WlttfC TCCATI&lf 4
PLOWS WLTtJL ~
IAAPQaL Ct4IAATCO IlOWC IIOT SHOWN ON TNS Ou44AI4.
PA4NC IOTA 4CTUAIl ~ 'ASH t0 ting Nalll ~ l04I IA HCf OL ACACAOTD4 CO 4lCOvtHT rlLTCR 400 ~
OUI APO IVXVI I IAATCt NCRCAltO WQNC PCROOC 04ANACCOF COCua TOWCR SASWS lunar tl etO MAT Ct 4ICACASCO $ 000 Ctll Q. OCWCK A<<AC>> 'l.rA44A AOOITgWS C e CAlCITIC ~ a OCLYMUI CLeOCXIOC C e Ctle0444TOI CHCMCAI F a PL%lAIO OC a <<ae<< <<oe I ~+OCT I b44aegr r-~-~~Wq KAT
+IU++4Nkv a<<aae o eaeO aaa aaa<<
A or
- t. a<<<<aaaa a<<o <<<<a<<a J IOCASCTI Iomy4<<
P oo SPRAT l PRO 04PCALTION it CPg L o IO,CNO 44N NOTE: LISTED FLOW RATES SHOULD NOT BE CONSIDERED ABSOLUTE FOR ANY GIVEN PLANT CONDITION
SUPPLEMENTAL INFORMATION
~ I
- 1. Re ulato Limits Technical Specifications 3/4.11.1 and 3/4.11.2 outline requirements for release of radioactive liquid and gaseous effluents, respectively. Concentration of radioactive materials released in liquid effluents and dose or dose commitment resultant thereof are limited in unrestricted areas. Dose and dose rate due to
~
radioactive materials released in gaseous effluents are limited in areas at or beyond the site boundary. Technical Specification limits are listed in Table 1.
- 2. Maximum Permissible Concentrations in Waterborne Effluents The concentrations of radioactive materials in waterborne effluents are limited to the concentrations specified in 10 CFR Part 20 Appendix B Table II, Column 2, for radionuclides other than dissolved or entrained noble gases.
For dissolved or entrained noble gases, the concentrations are limited to the following values, as stated in the applicable Technical Specification:
Nuclide MPC uCi/ml 85mK 2.0E-04 85K 5.0E-04 87K 4.0E-05 88K 9.0E-05 4'Ar 7.0E-05 133m 5.0E-04 133xe 6.0E-04 135mXe 2.0E-04 135Xe 2.0E-04
- 3. ~AE Based on gaseous effluent releases for the report period average beta energy is 0.319 MeV and average gamma energy is 0.249 MeV.
- 4. Measurements and A roximations of Total Radioactivi Analyses of specific radionuclides in effluent samples are used to evaluate the radioactive composition and concentration of effluents.
- 5. Methods of uanti in Effiuents
- a. Fission and Activation Gases: Gas samples are routinely collected monthly and analyzed with a high resolution (Ge[Li] or HPGE) detector system which incorporates a data reduction program to determine radionuclide composition in terms of specific activity. Data tapes from the continuous vent monitors are used to determine the average concentration of noble gases. The high resolution (Ge[Li] or HPGE) isotopic scan is used to convert the continuous vent monitor activity to actual activity based on the determined nuclide mixture. The vent and sample flow rates are continuously monitored and the average flow rates for each vent are used to calculate the total activity released in a given time period. When the continuous monitors are out of service, manual grab samples are taken from each vent once each eight hours (once each four hours for the standby gas treatment vent).
- b. lodines: iodine is continuously collected via an isokinetic sampling assembly in each vent. Filters are normally exchanged once per week and analyzed on a high resolution (Ge[Li] or HPGE) system. The daily average flow rates for the vents and sample pumps are averaged for the duration of the sampling period and a ratio of vent flow rate to sample flow rate is determined. The ratio is used to determine the total activity of each isotope released during the time period in question. When the continuous monitors are out of service, iodine is continuously collected on charcoal cartridges
'ttached to air samplers which draw directly from the affected rooftop vent(s) or from alternate sampling ports available on the sample lines.
Particulates: Particulates are continuously collected via an isokinetic sampling assembly in each vent. Filters are normally exchanged once per week and analyzed on a high resolution (Ge[Li] or HPGE) system. Flow rate corrections are performed as for iodines. When the continuous vent monitors are out of service, particulates are continuously sampled directly from the affected rooftop vent(s) or from alternate sampling ports available on the sample lines.
Tritium: Airborne tritium is collected monthly via bubbler sampler. The sample is collected for one hour at a flow rate of approximately 1000 ccjmin.
Tritium activity in the bubbler sample is determined by liquid scintillation counting. The liquid sample tritium concentration is converted to air concentration by volume proportion, then compared to the Technical Specification Table 4.11.2.1.2-1 Lower Limit of Detection (1 E-6 uCi/cc).
I
- e. Waterborne Effluents: Each tank of liquid radwaste is sampled and analyzed for principal gamma emitters prior to release. Each sample tank is recirculated for a sufficient amount of time prior to sampling to ensure that a representative sample is obtained. Samples are analyzed on a high resolution (Ge[Li] or HPGE) system and release permits are generated based on the values obtained from the isotopic analysis and the most recent values for tritium, gross alpha, iron-55, and strontium-89 and -90. An aliquot based on release volume is saved and added to monthly and quarterly composite containers. The monthly tritium analysis is done in-house. The monthly liquid radwaste composite sample is also analyzed offsite for P-32. The quarterly composite is sent to a vendor laboratory for iron-55, strontium-89 and -90, and gross alpha analyses.
The concentration of each radionuclide in each batch is decay corrected from the time of counting to the midpoint of the release period, and is then multiplied by the volume of the batch to determine the total quantity of each nuclide released in each batch. The isotopic totals for each are summed to determine the total source term for the report period.
TABLE 1
- 1. TECHNICAL SPECIFICATION LIMITS A. NOBLE GASES:
- 1. s500 mrem - TOTAL BODY
%000 mrem - SKIN annual site total "instantaneous" limits (Tech Spec. 3.11.2.1)
- 2. s5 mrad - AIR GAMMA s10 mrad - AIR BETA quarterly air dose limits per reactor unit (Tech Spec. 3.11.2.2)
- 3. s10 mrad - AIR GAMMA MO mrad - AIR BETA annual air dose limits per reactor unit (Tech Spec. 3.11.2.2)
B. AIRBORNE l-131, TRITIUM, PARTICULATES WITH HALF-LIVES> 8 DAYS:
- 1. c1 500 mrem - ORGAN (inhalation pathways only) annual site total "instantaneous" limits (Tech Spec. 3.11.2.1)
- 2. s7.5 mrem - ORGAN quarterly dose limits per reactor unit (Tech Spec. 3.11.2.3)
- 3. s15 mrem - ORGAN annual dose limits per reactor unit (Tech Spec. 3.11.2.3) 4 10
U. ~LI UIUEFFLUEETE'.
- 1. <3 mrem - TOTAL BODY s10 mrem ORGAN quarterly dose limits per SSES site Tech. Spec. 3.11.1.2, as interpreted in License Action Request 97-002
- 2. <6 mrem - TOTAL BODY MO mrem - ORGAN annual dose limits per SSES site Tech. Spec. 3.11.1.2, as interpreted in License Action Request 97-002 D. AIRBORNE EFFLUENT: BASES FOR PERCENT OF APPLICABLE TECHNICAL SPECIFICATION LIMIT Fission and Activation Gases A derived release rate limit based on the Technical Specification limit of 500 mrem/yr was calculated from the expected mix of noble gas radionuclides presented in Table 4.4 of the SSES Final Environmental Statement (NUREG-0564). The limit is 8.51 E+05 uCi/min (1.42E+04 uCi/sec).
Iodine-131 A derived release rate limit based on the Technical Specification limit of 1500 mrem/yr from l-131, tritium and particulates with half-lives greater than 8 days was calculated from the annual release quantity of I-131 provided in Table 4.4 of the SSES Final Environmental Statement (NUREG-0564). The limit is 1.41 E+02 uCi/min (2.35E+00 uCi/sec).
Particulates A derived release rate limit based on the Technical Specification limit of 1500 mrem/yr from l-131, tritium and particulates with half-lives greater than 8 days was calculated based on the expected mix of particulate radionuclides presented in Table 4.4 of the SSES Final Environmental Statement (NUREGFE 0564). The limit is 7.72E+02 uCi/min (1.29E+01 uCi/sec).
Tritium A derived release rate was calculated based on the 10 CFR 20 Appendix B, Table II, Column 1, Maximum Permissible Concentration for tritium (2.0E-07 uCi/cc) to unrestricted areas. A relative concentration of 4.1E-05 sec/m'as assumed. The limit is 2.93E+05 uCi/min (4.88E+03 uCi/sec).
11
E. WATERBORNE EFFLUENT: BASES FOR PERCENT OF APPLICABLE TECHNICAL SPECIFICATION LIMIT Fission and Activation Products Concentrations of fission and activation products in liquid effluent from radwaste effluent are determined for each batch prior to release. Each isotope concentration is compared to 10CFR20 Appendix B, Table II, Column 2 Maximum Permissible Concentration Limits such that, with dillution, the sum of isotope concentrations divided by Maximum Permissible Concentrations must be <1.0. No Technical Specification limit for the total concentration of fission and activation products in liquid effluents is applicable for this category.
Tritium Liquid effluent quarterly tritium concentrations are compared to the 10 CFR 20 Appendix B, Table II, Column 2, Maximum Permissible Concentration limit of 3.0E-03 uCi/ml to unrestricted areas.
Dissolved and Entrained Gases Liquid effluent quarterly concentration totals for dissolved and entrained gases are compared to the most restrictive Maximum Permissible Concentration for a noble gas 4.0E-05 uCi/ml (Kr-87) from the SSES Technical Specification Table 3.11.1.1-1.
12
SECTION 2 EFFLUENT AND i%AS TE DISPOSAL DATA
Airborne Effluents Summaries of the radionuclide total curie activities and average release rates are included in Tables 2 and 3.
- 1. Number of Batch Releases: 0
- 2. Total Time Period for Batch Release: NA
- 3. Maximum Time Period for a Batch Release: NA
- 4. Average Time Period for a Batch Release: NA
- 5. Minimum Time Period for a,Batch Release: NA Abnormal Releases
- 1. Number of Releases 0
- 2. Total Activity Released NA If a radionuclide was not detected, zero activity was used for that isotope in dose calculations. A zero activity indicates that no activity was positively detected in any sample when samples were analyzed with techniques which achieved the required Lower Limits of Detection (LLD) as specified in the SSES Technical Specification Table 4.11.2.1.2-1, Radioactive Gaseous Waste Sampling and Analysis Program.
ln all cases, these LLDs were less than the levels required by Technical Specifications. The following are typical LLDs.
Radionuclide LLD (uCi/cc)
Kr-87 4.6 E-08 Kr-88 5.3 E-08 Xe-133 5.4 E-08 Xe-133m 1.3 E-07 Xe-135 1.5 E-08 Xe-135m 5.0E-08 Xe-138 1.2 E-07 Mn-54 2.9 E-14 Fe-59 2.8 E-14 Co-58 1.8 E-14 Co-60 3.8 E-14 Zn-65 4.4 E-14 Mo-99 3.3 E-13 Cs-134 2.4 E-14 14
Radionuclide LLD (uCi/cc)
Cs-137 2.1 E-14 Ce-141 1.5 E-14 Ce-144 7.0 E-14, I-131 4.4 E-14 Sr-89 2.0 E-15 Sr-90 3.0 E-16 H-3 2.6 E-08 Gross Alpha 5.0 E-16 15
TABLE 2 ANNUALEFFLUENT AND WASTE DISPOSAL REPORT (1997)
AIRBORNE EFFLUENT - SUMMATIONOF ALLRELEASES First Second Third Fourth A. Fission and Activation Gas Unit uarter uarter uarter uarter Total Release Ci 2.91E+00 8.82E+00 1.99E+00 4.30E+00 Average Release Rate for Period pCi/sec 3.74E-01 1.12E+00 2.51E-01 5.43E-01 Percent of Technical Specification Limit 2.63E-03 7.90E-03 1.77E-03 3.82E-03 B. Iodines Total I-131 Ci O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Average Release Rate for Period pCi/sec O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Percent of Technical Specification Limit 0.00E+00 i'0.00E+00 0.00E+00 0.00E+00 C. Particulate Particulate vnth Half-Lcves > 8 Days* Ci 3.32E-04 8.25E-04 2.36E-04 8.06E-05 Average Release Rate for Period pCi/sec 4.27E-05 1.05E-04 2.98E-05 1.02E-05 Percent of Technical Specification Limit 3.31E-04 8.14E-04 2.31E-04 7.89E-05 Gross Alpha Radioactivity~ Ci 4.98E-07 8.94E-07 9.97E-07 8.91E-07 D. Tritium Total Release Ci 1.41E+01 7.80E+00 1.24E+01 2.12E+01 Average Release Rate for Period pCi/sec 1.81E+00 9.92E-'01 1.56E+00 2.68E+00 Percent of Technical Specification Limit 3.72E-02 2.03E-02 3.21E-02 5.48E-02
- Sr-89, Sr-90 and Gross Alpha values for the fourth quarter 1997 are estimated based on third quarter 1997 sample analyses and fourth quarter 1997 ventilation exhaust rates.
16
TABLE 3 ANNUALEFFLUENT AND WASTE DISPOSAL REPORT (1997) 0 AIRBORNE EFFLUENT Releases in Continuous Mode First Second Third Fourth Nuclides Released Unit Quarter Quarter Quarter Quarter A. Fission and Activation Gases Ci 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Kr-85m Ci O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Xe-133 Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Xe-135 Ci 2.91E+00 8.82E+00 1.99E+00 4.30E+00 Total for Period Ci 2.91E+00 8.82E+00 1.99E+00 4.30E+00 B. Iodines I-131 Ci 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 I-133 Ci 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 I-135 Ci 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Total for Period Ci 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 C. Particulate Ci Cr-51 Ci 2.63E-05 O.OOE+00 0.00E+00 O.OOE+00 Mn-54 Ci 2.63E-04 4.86E-04 6.91E-05,. 4.36E-05 Fe-59 Ci 1.25E-05 1.93E-04 0.00E+00 0.00E+00 Co-58 Ci 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Co-60 Ci 2.97E-05 1.46E-04 1.67E-04 3.70E-05 Zn-65 Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Sr-89* Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Sr-90* Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Cs-134 Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Cs-137 Ci O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Ce-141 Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Ce-144 Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Total for Period* Ci 3.32E-04 8.25E-04 2.36E-04 8.06E-05
- Reported values for the fourth quarter 1997 are estimated based on third quarter 1997 "sample analyses and fourth quarter 1997 ventilation exhaust rates.
17
Waterborne EfAuents Summaries of the radionuclide total curie activities, average diluted concentrations, and percent of applicable Technical Specification limits are included in Tables 4 and 5.
1.
Batch Releases" Number ofBatch Releases gtr I 49
.Qtr .gtr.
52 2
28 3 gtr. 4 15
- 2. Total Time Period for a Batch Release 6.46E+03 6.41E+03 2.01E+03 9.22E+02
- 3. Maximum Time Period for a Batch 3.30E+02 2.95E+02 2.70E+02 8.70E+01 Release
- 4. Average Time Period for a Batch Release 1.32E+02 1.23E+02 7.19E+01 6.15E+01
- 5. Minimum Time Period for a Batch 2.50E+01 2.50E+01 2.40E+01 2.20E+01 Release
- 6. Average Cooling Tower Blowdown 7.16E+03 6.97E+03 9.96E+03 9.53E+03 Flow Rate During Periods of Release (Average Cooling Tower Blowdown Flow Rate)
- 7. Susquehanna River Flow Rate 8.44E+06 6.45E+06 6.09E+06 3.05E+06 (Susquehanna River Flow Rate)
- Units of time and flow are expressed in minutes and gallons per minute (gpm), respectively.
Abnormal Releases
- 1. Number of Releases 0 0
- 2. Volume Released N/A N/A
- 3. Total ActivityReleased N/A N/A Ifa radionuclide was not detected, zero activity was used for that isotope in dose calculations. A'zero activity indicates that no activity was positively detected in any sample when samples were analyzed with techniques which achieved the required Lower Limits of Detection (LLD) as specified in the SSES Technical Specification Table 4.11.1.1.1-1, Radioactive Liquid Waste Sampling and Analysis Program. In all cases, these LLDs were less than the levels required by Technical Specifications. The following are typical LLDs.
Radionuclide LLD Ci/ml Mn-54 4.5 E-08 Fe-59 5.0 E-08 Co-58 2.4 E-08 Co-60 5.4 E-08 Zn-65 4.9 E-08 Mo-99 1.7 E-07 I-131 2.0 E-08 Cs-134 2.2 E-08 18
Radionuclide LLD Ci/ml Cs-137 2.6 E-08 Ce-141 3.2 E-08 Ce-144 1.3 E-07 Sr-89 4.0 E-08 Sr-90 4.0 E-09 Fe-55 1.0 E-06 H-3 4.6 E-06 Gross Alpha 3.0 E-OS 19
TABLE 4 ANNUALEFFLUENT AND WASTE DISPOSAL REPORT (1997)
WATERBORNE EFLUENT - SUMMATIONOF ALLRELEASES First Second Third Fourth A. Fission and Activation Products Unit Quarter Quarter Quarter Quarter
- 1. Total Release (not including Tritium, Gases, Al ha
- Ci 3.58E-03 2.78E-03 1.47E-03 1.79E-03
- 2. Average Diluted Concentration During PeQod Ci/ml 2.05E-08 1.65E-08 2.00E-08 5.33E-08 B. Tritium
- 1. Total Release Ci 1.44E+01 1.42E+01 4.38E+00 1.68E+00
- 2. Average Diluted Concentration During Period Ci/ml 8.23E-05 8.45E-05 5.95E-05 5.01E-05
- 3. Percent of A licable Limit 2.74E+00 2.82E+00 1.98E+00 1.67E+00 C. Dissolved and Entrained Gases
- 1. Total Release Ci 1.02E-03 8.50 E-05 1.58E-06 1.52E-07 Average Diluted Concentration During 5.83E-09 5.06E-10 2.15E-11 4.53E-12 Peri d Percent of A licable Limit 1.46E-02 1.26E-03 5.37E-05 1.13E-05 D. Gross Al ha Radioactivi
- 1. Total Release Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 E. Volume of Waste Released Gallons 4.97E+05 4.95E+05 1.43E+05 6.25E+04 (Prior to Dilution) Liters 1.88E+06 1.87E+06 5.41E+05 2.36E+05 F. Volume of Dilution Water Gallons 4.63E+07 4.44E+07 1.94E+07 8.88E+06 Used During Period ofRelease Liters 1.75E+08 1.68E+08 7.36E+07 3.36E+07 G. Volume of Dilution Water Gallons 9.28E+08 9.13E+08 1.31E+09 1.26E+09 Used Over Entire Period Liters 3.51E+09 3.46E+09 4.97E+09 4.76E+09
- Reported values for the fourth quarter 1997 are estimated based on third quarter 1997 sample analyses and fourth quarter 1997 discharge volumes for samples composited in fourth quarter.
20
TABLE 5 ANNUALEFFLUENT AND WASTE DISPOSAL REPORT (1997)
WATERBORNE EFFLUENT Releases in Batch Mode Nudides Unit First Second Third Fourth Released Quarter Quarter Quarter Quarter A. Fission and Activation Products F-18 Ci 3.98E-15 1.79E47 O.OOE+00 O.OOE+00 Na-24 Ci 1.76E46 0.00EWO O.OOE+00 0.00E+00 P-320 Ci 4.46E44 0.00E+00 0.00E+00 O.OOE~
Cr-51 Ci 8.41E44 6.62E45 5.15E44 3.50FA4 Ci 7.38E44 7.17E44 2.02E44 Ci 0.00E+00 1.14E43 4.06E44 1.06E03 Fe-59 Ci 7.02E45 6.73E05 O.OOE~ 0.00E~
Co-58 Ci 8.45~5 7.84E45 4.05M% 3.32E47 Ci 8.51E44 6.07E44 1.96E04 1.21E44 Ci 4.36M)4 1.04E44 4.61E45 4.21E05 As-76 Ci 0.00E+OO 0.00E+00 O.OOE+00 0.00E~
Sr%9~ Ci O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Sr-90'r-92 Ci 0.00E~ 0.00E+00 0.00E+00 O.OOE~
Ci 2.43E47 0.00E+00 1.83E47 O.OOE+OO Tc-99m Ci 1.13&08 O.OOE+00 O.OOE+00 O.OOE+00 A -110m Ci 4.32E46 2.84E45 0.00E+00 1.09'.54E46 1-131 Ci 0.00E+00 O.OOE+00 0.00E+00 Cs-134 Ci '.00E+00 0.00E+00 0.00E+00 0.00E~
Cs-137 Ci 5.65E46 0.00E+00 O.OOE+00 1;51E45 W-187 Ci 0.00E+00 O.OOE+00 O.OOE+OO O.OOE+00 Total for Period Ci 3.58E-O3 2.78K-03 1.47E43 1.79E43 B Tritium H-3 Ci 1.44E+01 1.42E+01 4.38E+00 1.68E+00 Total for Period Ci 1.44E+01 1.42E+01 4.38E+00 1.68E+00 C. Dissolved and Entrained Gases Areal Ci O.OOE+OO O.OOE+00 0.00E+00 O.OOE+00 Kr-86m Ci O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Kr-85 Ci 8.66E44 0.00E+00 0.00E+00 0.00E+00 Kr-87 Ci 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Kr-88 Ci O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Xe-131m Ci O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Xe-133m Ci O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Xe-133 Ci 4.58E45 0.00E+00 O.OOEt00 1.31'.00E+00 Xe-135m Ci O.OOE+00 O.OOE+00 0.00E+OO Xe-135 Ci 2.54E45 3.92E45 1.58E46 1.52E47 Total for Period Ci 1.02E-03 8.50K-05 1.58~6 1.52'&07
- Reported values for the fourth quarter are estimated based on third quarter 1997 sample analyses and fourth quarter 1997 discharge volumes for samples composited in fourth quarter.
21
FIGURE 3 SUSQUEHANNA RIVER MONTHLYAVERAGE FLOW RATES DATA PERIOD: 1997 GALLONS PER MINUTE x 1E6 14
'to 0
JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC
't 997 22
FIGURE 4 SSES MONTHLYLIQUID RADWASTE DISCHARGE TOTALS DATA PERIOD: 1997 GALLONS X 't E3 500 400 300 200 100 0
JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC 1997 23
SUSQUEHANNA STEAM ELECTRIC STATION RADIOACTIVEWASTE REPORT ANNUALEFFLUENT AND WASTE DISPOSAL REPORT SOLID RADIOACTIVEWASTE DATA PERIOD: JANUARY 1 1997- DECEMBER 31 1997 PREPARED BY:
T. M. KALINOWSKI- HEALTH PHYSICIST APPROVED BY:
CURT SAXTON - EFFLVENTS MANAGEMENT'SVPV.
24
REPORT NOTES
- 1. All activities reported in millicuries (mCi) unless otherwise noted.
- 2. Reported activities, as indicated with the (<) sign, are comprised in whole or part of MDL Values.
25
TABLE 6 ANNUALEFFLUENT AND WASTE DISPOSAL REPORT SOLID WASTE AND IRRADIATED FUEL SHIPMENTS DATA PERIOD: JANUARY 1, 1997 - DECEMBER 31, 1997 A.* SOLID WASTE SHIPPED OFFSITE FOR BURIAL OR DISPOSAL Number of Shi ments Mode of Trans ortation Destination Truck Barnwell, SC B. IRRADIATED FUEL SHIPMENTS Number of Shi ments Mode of Trans ortation Destination None Not Applicable Not Applicable The number of shipments listed in A include only the shipments from SSES to a disposal site. It does not include. shipments made to or from volume reduction vendors.
26
TABLES 7-9 ARE BLANK; HELD IN RESERVE 26A
TABLE 10 CLASS A SOURCE OF WAS'IZ: INCINERATED DAW TYPE OF CONTAINER: STRONG TIGHT CONTAINER
'METHOD OF PROCESS: .
N/A ISOTOPES ACTIVITY(mCi) % OF TOTAL Ag-Ilpm 0.000E40 P 00%
Am-241 I.OOOE44 0.00%
C-14 <9.800E43 P.00%
Ce-144 4.487EAI 0 23%
Cm-242 I.OOOE44 P PP%
Cm-243 0.00%
1.000'.000E+00 Cm-244 P PP%
Co-58 1.924E+00 0.99%
CMO 3.049E+01 ~ 15.83%
Cr-51 3.077E+00 1.59%
Cs-134 0.000E~ 0.00%
Q-137 4.880E42 P PP%
Fe-55 1.351E+01 7 01%
Fe-59 2.343E+01 12.17%
H-3 6.395E+00 3 30%
I-129 . <0.000E+00 P PP%
I-131 I.700E%3 0.00%
K-40 1.330E%2 P PP%
Mn-54 1.065E+02 55 32%
Nb-95 9.229' P 48%
N143 <2.796' P 20%
Pb-212 2. IOQEA3 ppp Pu-238 I.OOQE44 P P0%
Pu-239 I.QQOEA4 0 00'/
Pu-241 2.535EWI 0.20%
Ru-106 7.798EZI 0.40%
Sb-124 ~ Q.QQOE+00 P 00%
Sr-89 0.000E+00 0 00%
Sr-90 <1.350E<2 0 00%
Tc-99 <1.000EW4 P OP Zn45 4.080E+00 2 11%
Zr-95 3.369EI 0.17%
TOTAL ACTIVITY(Ci) 0.193 100.00%
CONTAINER VOLUME 34').500 A3 9.897 m3 27
TABLE 11 CLASS A SOURCE OF WAS': CONDENSATE DEMINERALIZEW RADWASTE DEMINERALIZER TYPE OF CONTAINER: STEEL LINER METHOD OF PROCESS: SOLIDIFIED ISOTOPES ACTIVITY(mCi) ohio OF TOTAL Ag-I lpm 7.160E+00 0 04%
Am-241 1.430EWI P PP%
C-14 8.970E+00 0.05%
Cm-242 3.020E%2 P 00%
Cm-244 0.000E40 0.00%
Co-58 3.840E+02 2 14'1.94%
Co%0 1.290E+04 Cr-51 1.780EN7 P PP%
Cs-134 8.360E%2 P PP%
Cs-137 3.810E+OO 0.02%
Fe-55 1.360E+02 0 76%
Fe-59 4.070El P PP%
H-3 3.540E+0 l 0.19%
1-129 (O.OOOE+00 0.00%
l-131 0.000E+00 P 00%
Mn-54 4. 140E+03 23.08%
Ni43 1.230E+02 0 69%
Pu-238 2.840E41 0.00%
Pu-239/240 3.490' 0.00%
Pu-241 7.760E+01 0 43%
Sb-124 3.180EW7 0 00%
Sr-89 O.OOOE+00 0.00%
Sr-90 3.300E+00 0.02%
Tc-99 8.590E+00 0.05%
Zn<5 9.73OE+0 l 0 54%
Ce-144 9.190E+00 0 05%
Cm-243 1.290' 0.00%
TOTAL ACTIVITY(Ci} 17.933 100.00%
CONTAINER VOLUME 93.360 A3 2.644 m3 28
TABLE 12 CLASS A SOURCE OF WASTE: PROCESSED DAW TYPE OF CONTAINER STRONG TIGHT CONTAINER MEHiOD OF PROCESS: N/A ISOTOPES ACTIVITY(mCi) % OF TOTAL Ag-I ipm 0.000E+00 0.00%
Am-241 1.738E43 0.00%
C-14 <9.000E44 0.00%
Cm-242 1.098E+00 0.11%
Cm-244 9.449E44 0 00%
Co-58 1.02%
1.002E+01'.445E+02 Co40 14 75%
Cr-51 2.034' 2 08%
Cs-134 O.OOOE+00 0.00%
Cs-137 1.716E41 0.02%
Fe-55 5.574E+01 5 Fe-59 1.438E+02 69'4.68%
H-3 1.735E+01 1 77%
1-129 <0.000E40 P PP%
I-131 0.000E+00 0.00%
Mn-54 5.598E+02 57 14%
Ni<3 <9.531EA1 0 10%
Pu-238 1.902E43 0.00%
Pu-239 1.962EA3 0.00%
Pu-241 4.3 14' P P4%
Sb-124 0.000E+00 P PP%
Sr%9 0.000E+00 P PP%
Sr-90 <5.606EW2 ppi Tc-99 <1.000E44 P P0%
Zn45 1.213 E+01 Ce-144 1.690E+00 0.17%
Cm-243 3.000E4 0.00%
Nb-95 5.931E+00 0.60%
Ru-106 5.518E+00 0 56%
Zr-95 L852ECI 0 02%
TOTAL ACTIVITY(C1) 0.980 100 00%
CONTAINER VOLUME 2107.800 f13 59.687 m3 29
TABLE 13 CLASS A SOURCE OF ULTRASONIC RESIN CLEANING WASTE WAS'YPE OF CONTAINER:
METHOD OF PROCESS: DE WATERED ISOTOPES ACTIVITY(mCI) % OF TOTAL Ag-llpm 1.624E+02 0.17%
Am-241 8.100E-03 0.00%
C-14 1.423E+02 0 15%
Cm-242 5.160E<3 'PP0%
Cm-244 1.032 E%2 0.00%
Co-58 8.860E+02 0.91%
Co%0 1.669E+04 17.22%
Cr-51 5.130E+03 5 29%
Cs-134 '.000E+00 P PP%
Cs-137 1.696E+01 0.02%
Fe-55 1.322E+04 13.64%
Fe-59 8.089E+03 8.35%
H-3 8.070E+0 I 0.08%
1-129 (O.OOQE+00 P PQ%
1-131 0.000E+00 0.00%
Mn-54 5.002E+04 51.62%
Ni<3 2.418E+02 0.25%
Pu-238 1.728EC2 P PP%
Pu-239/240 1.596 E2 ppp Pu-241 3.910 E+00 0.00%
Sb-124 1.258E+02 P 13 Sr-89 O.OOOE+00 0 00%
Sr>>90 C 89OE<l 0.00%
Tc-99 I.074 E+00 Q 00%
Zn45 I.G I 9E+03 I.G7%
Ni-59 3.830 E+0 I 0.05%
Nb-95 2,517E+02 0.27%
Sr-92 1.3GOE-IO 0.00%
Zr-95 1.59OE+(12 0 17%
Ce-144 7,44OE+Op 0 01%
TOTAL ACTIVITY(C)) 9G.900 100.00%
CONTAINER VOLUME 404.200 fl3 11.446 m3
TABLE 14 CLASS C SOURCE OF WASTE: NON-PROCESSED DAW TYPE OF CONTAINER: STRONG TIGHT CONTAINERHIC METHOD OF PROCESS: N/A ISOTOPES ACTIVITY(mCi) % OF TOTAL Ag-I lpm 0.000E+00 0.00%
Am-241 4.126E43 Q OP%
C-14 <0.000E+00 P PP%
Cm-242 7.319E3 0.00%
Cm-244/243 1.162E43 0.00%
Co-58 2.959E+01 1 17%
Cohp 3.412E+02 13.54%
Cr-51 7.704E+0 1 3.06%
Cs-134 0.000E&0 P PP%
Cs-137 3.721E1 0.01%
Fe-55 1.330E+02 5 28%
Fe-59 4.729E+02 18.77%
H-3 3.663EA2 P PP%
1-129 <0.000E+Pp Q OQ%
I-131 0.000E+P0 0.00%
Mn-54 1.393E+03 55 28%
Ni<3 <2.242E+00 0 09%
Pu-238 4.331E3 P P0%
Pu-239/240 4.502E<3 P PP%
Pu-241 1.029E+00 pp
, Sb-124 0.000 E+00 Q 00'/
Sr-89 0.000E+00 0.00%
Sr-90 < L292EA 1 P P1%
Tc-99 <0.000 E+00 0.00%
Zn<5 2.857E+0 1 1.13%
Ru-106 L503E+01 Q 6P'/
Nb-95 2.096E+0 l 0.84%
Ce-144 4.443 E+00 0 18%
" TOTAL ACTIVITY(Ci) 2.519 100.00%
CONTAINER VOLUME 55.800 n3 l.580 u>3 31
TABLE 15 CLASS C SOURCE OF WASTE: CARTRIDGE FILTERS TYPE OF CONTAINER:
METHOD OF PROCESS: DEWATERED ISOTOPES ACTIVITY(mCj) % OF TOTAL Ag-I lpm , 1.516E+01 'PP1%
Am-241 1.699E&0 0.00%
C-14 <0.000E&0 0.00%
~ Cm-242 2.334E+00 0.00%
Cm-244/243 1.996E+00 P PP%
Co-58 4.537E+02 0 22%
Co%0 9.024E&4 44 73%
Cr-51 6.653 E+03 3 3Q%
Cs-134 0.000E+00 P PP%
Cs-137 1.062 E+03 0 53%
Fe-55 1.604E+04 7.95%
Fe-59 5.274E+03 2.61%
H-3 9.439E+00 0.00%
1-129 <O.OQOE+00 P PP%
1-131 0.000E+00 Q P0%
Mn-54 7.314E+04 36 26%
Nj<3 1.615E+03 0.80%
Pu-238 2.963E&0 p ppo Pu-239 3. 128E+00 0.00%
Pu-241 6.921E+02 0.34%
Sb-124 0.000 E+00 Q PO%
Sr-89 O.WOE+00 0.00%
Sr-90 <3.657 E+02 0.18%
Tc-99 Q.QOOE+00 Q 00'I Zn45 5.664E+03 2.81%
RU-106 l.059E+00 P PP%
Nb-95 1.239E+00 Q OQ%
Cc-144, 5.129E+02 0.26 TOTAL ACTIVITY(Cjl 201.789 1pp 00%
CONTAINER VOLUME 721.100 fl3 20.420 m3
TABLE 16 CLASS A SOURCE OF WASTE: CARTIDGE FILTERS TYPE OF CONTAINER:
METHOD OF PROCESS: DE WATERED ISOTOPES ACTIVITY(mCi) % OF TOTAL Ag-1 10m 0.000E+00 P P0%
Am-241 4.260E%3 0.00%
C-14 <0.000 E+00 P 00%
Cm-242 2.960E43 0.00%
Cm-244/243 4.230E43 P PP%
Co-58 1.610E+02 0 43%
~0 Cr-51 7.500E&3 20 26%
0.000E+00 P PP%
Cs-134 0.000E+00 P P0%
Cs-137 1.560E+01 0.04%
Fe-55 1 470E+03 3.96%
FQ-59 9. 170E+02 2 47%
H-3 5.370EW2 P PP%
1-129 <0.000E+00 0:00%
1-131 0.000E+00 0.00%
Mn-54 2.670E+04 72.15%
Ni43 7.810Et00 0.02%
Pu-238 2.840E43 0.00%
Pu-239/240 2.840E%3 0.00%
Pu-241 8 430El P PP%
Sb-124 0.000 E+00 ppp Sr-89 0.000E+00 0.00%
Sr-90 < L270E41 P PP%
Tc-99 0.000 E+00 0.00%
Zn45 2.270E+02 0.61%
Ce-144 2.3 10E+01 0.06%
TOTAL ACTlVITY (Ci) ~ 37.000 100.00%
CONTAINER VOLUME 132400 A3 3.749 m3 33
TABLE 17 CLASS A SOURCE OF WAS'IK: LIQUID RADWASTE FILTER MEDIA lorn TYPE OF CONTAINER:
METHOD OF PROCESS: DEWATERED ISOTOPES ACTIVITY(mCI) % OF TOTAL Ag-1 5.360E+02 0 16%
Am-241 2.073 EA2 0.00%
C-14 5.820E42 P PP%
Cm-242 2.046E42 0.00%
Cm-244 1.580E<2 0.00%
Co-58 5.370E&3 1.64%
0 4.580E+04 14.00%
Cr-51 2.096 E+04 6.41%
Cs-134 0.000E+00 0.00%
Cs-137 2.53 I E+O1 P P1%
Fe-55 2.709E+04 8 28%
Fe-59 2.486E+04 7 60%
H-3 5.740E+0 I 0.02%
1-129 <Q.QOOE+00 P P0%
1-131 0.000E+00 0.00%
Mn-54 1.876E+05 57 34%
Ni<3 2.492E+02 P P8%
Pu-238 1.04 IEW I 0.00%
Pu-239 1.04 IEW I O.QO%
Pu-241 4.155E+0 I P PI%
Sb-124 4.990E+02 P 15/
Sr-89 1.874 E+Ol P Q1%
Sr-90 1.040E+00 P PP%
Tc-99 4.350E+00 0.00%
Zn<5 1.34GE+04 4.11%
Ni-59 2 4 I IE+01 0 01%
Nb-95 5.670E+02 0 17%
Ce-144 1.25GE+0 I 0.00%
TOTAL ACTIVITY(Ci) 327.100 l00.00%
CONTAINER VOLUME 348.600 n3 9.87l m3 34
TABLE 18 ANNUALEFFLUENT AND WASTE DISPOSAL REPORT ESTIMATED TOTAL ERRORS ASSOCIATED WITH EFFLUENT MEASUREMENTS, DATA PERIOD: January 1, 1997 - December 31, 1997 Measurement Estimated Total Error
- 1. Airborne Effluents
- a. Fission and Activation Gases 15 9%
- b. I-131 13 3%
- c. Particulates 15 8%
- d. Tritium 13.6%
- 2. Waterborne Effluents
- a. Fission and Activation Products 5P
- b. Tritium 33%
- c. Dissolved and Entrained Gases 8.4%
- d. Gross Alpha Activity 6.P
- e. Volume of Waste Released 5.0%
(Prior to Dilution)
- f. Volume of Dilution Water Used During 15 0%
Period
- 3. Solid Wastes
- a. Condensate Demineralizerl 15.1%
Radwaste Demineralizer (Dewatered - HIC)
- b. Liquid Radwaste Filter Media 15 1%
(Dewatered - HIC)
- c. Ultrasonic Resin Cleaning Waste 151%
(Dewatered - HIC) -'5
- d. Cartridge Filters 0%
(Dewatered - HIC) 35
Measurement Estimated Total Error
- 3. Solid Wastes (cont.)
- e. Processed DAW 25 0%
(Strong Tight Container)
- f. Incinerated DAW 25 0%
(Strong Tight Container)
- g. Non-Processed DAW 25 0%
(Strong Tight Container) 36
TABLE 19
'I ANNUALEFFLUENT AND WASTE DISPOSAL REPORT DATA NOT REPORTED IN PREVIOUS ANNUALREPORT NUCLIDE CATEGORY UNIT FOURTH QUARTER 1996 A. Airborne Effluents
- 1. Sr-89 Ci O.OOE+00
- 2. Sr-90 Ci O.OOE+00
- 3. Gross Alpha Ci 5.33E-07 B. Waterborne Effluents
- 1. Sr-89 Ci 6.30E-05
- 2. Sr-90 Ci O.OOE+00
- 3. Fe-55 Ci 1.54E-02
- 4. Gross Alpha Ci O.OOE+00 37
SECTION 3 METEOROLOGICAL DATA AND DISPERSION ESTIMATES 38
METEOROLOGY AND DISPERSION DATA Meteorological data have been collected at the Susquehanna SES site since the early 1970s. At the present time, the meteorological system is based on a 300-foot high tower located approximately 1,000 feet to the southeast of the plant. Wind sensors are mounted at the 10-meter and 60-meter elevations on this tower.
Vertical temperature differential is measured with redundant sensor pairs between the 10m and 60m levels. Sigma theta (the standard deviation of horizontal wind direction) is calculated from wind direction at both levels. Dew point and ambient temperature sensors are present at the 10m level. Precipitation is measured at ground level.
A back-up meteorological tower was erected in 1982. It is a 10-meter tower providing alternate measurements of wind speed, wind direction, and sigma theta.
SSES meteorological data is transmitted to the plant control room, Technical Support Center, and Emergency Operations Facility for emergency response availability. The data is also transmitted via telephone line data-link to the PP&L corporate computer in Allentown.
Dispersion modeling for effluents from normal operation of SSES is done using XOQDOQ, a straight-line air flow Gaussian plume model designed to estimate average relative concentrations. The model was developed in accordance with Regulatory Guide 1.111. Calm periods are distributed as the first non-zero wind-speed class in the input joint frequency distribution file.
XOQDOQ uses terrain correction factors to account for the temporal and spatial variations in the airflow in the region, since a straight-line trajectory model assumes that a constant mean wind transports and diffuses effluents in the direction of air flow at the release point within the entire region of interest. The SSES terrain correction factors were determined by the ratio of the results of the straight-line model to the puff-advection model, and are incorporated into Table 22.
39
TABLE 20 ANNUALEFFLUENT AND WASTE DISPOSAL REPORT METEOROLOGICAL DATA AVAILABILITY DATA PERIOD: 1997 PERCENT OF VALIDHOURS PARAMETER DURING PERIOD'.
Wind speed
- a. 10-Meter Sensors 99%
- b. 60-Meter Sensor 96
- 2. Wind direction
- a. 10-Meter Sensors 99%
- b. 60-Meter Sensor 99%
- 3. Indicator of Atmospheric Stability (Primary Tower)
- a. Temperature Differential between 10 96 and 60 meters (Delta-TA)
- b. Temperature Differential between 10 98%
and 60 meters (Delta-TB) c.
d.
Sigma Theta Sigma Theta II 10 Meters 60 Meters 99%
99%
- 4. Percent of hours for which valid 10-meter 97%
wind speed, 10-meter wind direction, and temperature differential were available.
- 5. Percent of hours for which valid 60-meter 97%
wind speed, 60-meter wind direction, and temperature differential were available.
'To be conservative, values are rounded down to nearest whole number.
40
FlGURE5 0
0 0
CALM O.O ss ANNUAL 8678 OBS.
HERB WIND DIRECTION FREQUENCY (PERCENT)
WZ3 MEAN WIND SPEED ( MI/HR )
SSES 33 Ft. Pr imar y 'Tower 1997 Annual Wind Rose 10-METER ANNUALWIND ROSE -1997
FIGURE 6 0
0 0
CALM 0.0 ss ANNUAL B665 OBS.
HKZEI WIND DIRECT ION FREQU=NCY (PERCENT)
~D MEAN WIND SPEED ( MI g HR )
SSES 200 FT Pr imar y Tower 1997 Annual Wand Rose 60-METER ANNUALWIND ROSE - 1997 42
SSES PASQUIL STAB!LITY CLASS PREVALENCES Data Period: 1997 Based on Joint Frequency Distributions at IO Meters (8557 Valid Observations)
D 38.8% 'C 5.5%B
~<~p~+Qk4QNX ~ 3.7%
A 5.0%
G 6.2%
F
'I 2.9%
E 28.0%
43
Page 1 of10 TABLE 21 JOINT WIND FREQUENCY DISTRIBUTION BY STABILITYCLASS PENNSYLVANIA POMKR 8 LIOHT CO(PAMY (PPCL) - Susquchatns Steai Electric Stat3on 1/22/199S PACE 62 TINE OF OAYI 8(39I4C PROGRAM JFD VERSIONT PC le2 1997 Prlsery ToMer Data foot Level SITE IOENTIFIERt DATA PERICO EXAHINEOT 1/ 1/97 - 12/31/97 ANNUAL STAB I LITT CLASS A STASILITY BASED Olt DELTA T BKTMEEN 200.0 AMO 33.0 FED Ml ND KEASUREO ATz 33.0 FED MIND THRESHOLD AT 50 HPH JOINT fREOUENCY DISTRIBVTIOI Of MIND SPEED AND DIRECTIOM IM NDURS AT 33.00 FED SPEED ESK SE SSE S SSM SM MSM M MMM MM NMM TOTAL (HPH) N NME NE EME E CALH 0
4 2 2 0 0 0 0 0 13
~ 51- 3.40 0 0 3 0 0 3.C1- 6.70 0
0 0 4 1 1 0 1
0 1
6 14 51 55 7 2 0 0 0'41 6.71-11.20 2 7 3 0 0 0 5 4 10 21 109 30 6 2 0 11.21-16.80 1 0 0 0 0 0 0 0 0 1 30 37 0 0 0 16.81 22 40 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0
>22.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TOTAL. 3 7 7 4 1 0 6 11 28 75 196 7S ~ 8 2 0 0 426 STABILITY CLASS 8 S'IABII.ITY BASED OM DELTA T BETMEEN 200,0 AMD 33.0 FEET 33.0 fEET I
MIMO HEASVREO AT:
MIND THRESHOLD ATI .50 HPH JOINT FREOUENCY OISTRIBVTIOM Of MIND SPEED ANO DIRECTION IN HOURS AT 33.00 fEEI SPEED (HPH) N NME NE ENE E ESK SE SSE S SSM SM MSM M MMM NM NHM TOTAL CALM 0
.51. 3.40 0 0 0 1 0 3 1 1 1 6 0 0 0 0 0 0 13 3.41 ~ 6.70 0 8 9 5 0 3 2 6 11 , 26 38 5 3 1 3 1 121
- 6. 71-11. 20 6 11 6 1 0 0 4 3 2 2 43 30 16 8 7 1 140
- 11. 21-16. 80 0 0 0 0 0 0 0 0 0 0 3 2C 5 1 2 1 36 lb.S1.ZZ.C0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 3
>22.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TOTAL 6 19 15
' 0 6 7 10 1C 3C 84 62 24 10 12 3 313
Page 2 of 10 TABLE 21 JOINT WIND FREQUENCY DISTRIBUTION BY STABILITYCLASS PENNSYLVANIA POVER 4 LIGHT CONPANY (PPCL) - Suaquehstno Stele Electric Station 1/22/1998 PAGE 63 TINE OF DAYI 8I39l44 PROGRANI JFO VERSIONY PC-1 2 1997 Prisary Toker Dsts Foot Level SITE IDENTIFIERI DATA PERIOD EXAHINEDI 'I/ 1/97 12/31/97 ANNUAL STARILIYT CLASS C STABILITY SASED ON: DELTA T 8ETVEEN 200,0 AND 33 0 fEET VIMD NEASURED AT: 33.0 fEET VIKD THRESHOLD AT: .50 NPH JOINT FREDUEMCY OISTRISUYION OF VlkD SPEED AND DIRECTION lk HMRS AT 33o00 FEET SPEED INPH) N kME ME ENE E ESE SE SSE S SSV SV VSV V VNV NV NNV TOTAL CALN 0
.51 3 40 0 1 3 3 8 1 3 10 3 1 1 0 0 0 38 3.Cl 6.70 13 20 1'7 5 2 3 7 12 25 43 9 5 4 6 5 'I 85 6.71 11.20 1C 17 4 0 0 0 3 4 46 22 14 16 12 23 181 e
- 11. 21.16. 80 3 0 0 0 0 0 0 0 6 26 10 4 13 64 16.81 22.CO
>22.40 0
0 1
0 0
0 0
0, 0
0 0
0 0
0 0
0 0
0 0 0 0
0 0 2 0
0 0
1 0
0 0
0 2
0 TOTAL 30 .39 2C 6 5 11 11 15 18 39 98 58 32 21 22 41 C70 STABILITY CLASS D STASILITY 8ASED ON: DELTA 1 BETVEEK 200.0 AND 33.0 FEET Vlgl MEASURED ATI 33.0 FEET MIND THRESHOLD AT 50 NPk JOlkT fREOUEKCT DISYRISUTION Of VlkD SPEED AMD DIRECTION IN HOURS AT 33.00 FEET SPEED (NPH) N NKE KE EKE E ESE SE SSE S SS'V SV VSV V VNV kV NMV TOTAL CALM 0
.51 ~ 3.40 17 57 90 67 66 51 C7 51 52 63 35 19 11 5 4 5 6CO 3.C1. 6.70 109 111 117 62 51 31 Co 61 62 89 132 70 52 55 63 114 1228 6.71-11. 20 11.21. 16. 80
- 16. 81. 22. 40 108 25 26 0
0 20 0
0 12 0
0 4'0 7
0 7 9 0
17 0
31 0
0 19 0
157 C7 155 84 108 70 6
85 32 120 20 218 54 1099 332 1 0 0. 0 0 3 9 0 0 0 19
>22.40 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 2 lOYAL 260 194 227 1C1 124 89 105 129 1C5 171 374 338 2C8 177 207 391 3320 45
Page 3 of 10 TABLE 21 JOINT WIND FREQUENCY DISTRIBUTION BY STABILITYCLASS PENNSYLVANIA POMER 6 LIGHT coHPANY (PPLL) - Susquehanna Stesol Electric Stat(on 1/22/199S PAGE 64 TINE OF DAYI 8(39:44 PROGRAM: JFD VERSIONT PC Ie2 1997 Prlasry Teer Data foot Itvet SITE IDENTIFIER:
DATA PERICO EXAHIKEDT 1/ 1/97 12/31/97 ANNUAL STABILITY CLASS E STABILITY'BASED O)lt DELTA T SETMEEN 200.0 AMD 33,0 FEET lllkO HEASURED AT: 33.0 FEET IIIND TMRESkOLD AT.,50 HPH JOINT FREOUENCY DISTRIBUTION OF MlkD SPEED AMD DIRECTION Ik HOURS AT 33,00 FEET SPEED (HPM) M NNE KE EKE ESE SE SSE S SQI Ql MSM V MMM NM NMM TOTAL CAN 3
~ 51 ~ 3AO 24 100 194 278 186 127 '119 1'll 1CO 117 66 21 6 9 9 2 1509 3.41 ~ 6.70 35 133 79 43 14 9 10 24 51 98 113 36 1C 15 25 30 729 6.71.11.20 8 11 10 9 5 1 2 2 12 20 37 18 5 0 2 5 11.2I.16.80 0 0 0 0 0 1 1 0 0 1 3 4 0 0 0 0 16.8'I 22AD 0 0 0 0 0 0 0 0
' 0 0 2 0 0 0 0
>22.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TOTAL 67 244 283 330 205 13S 132 137 203 236 219 81 25 2C 36 37 2400 STABILITY CLASS f STABILI1Y BASED ON: DELTA 1 - SETMEEN 200.0 AND 33.0 FEET Ml MD MEASURED AT: 33.0 FEET MIND THRESHOLD AT: F 50 HPH JOINT fREOUENCY DISTRIBUTIOM OF MIND SPEED AKD DIRECTION IN HOURS AT 33+00 FEET SPEED (HPH) N NNE NE EHE E 'ESE SE SSE S SSM Ql MSM M Mil NM NkM TOTAL CAN 0
~ 51. 3.40 4 22 125 452 187 67 40 36 50 23 14 1 2 0 I 1 3 1027 3.C1 6.70 I 5, 5 45 . 0 0 0 0 4 6 6 0 0 1 0 0 73
- 6. 71.11. 20 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1
- 11. 21 ~ 16.80 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.81.22.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 s22.40 0 0 0 0 0 D 0 0 0 0 0 0 0 0 0 0 0 TOTAL 5 27 130 C97 187 67 CO 36 5C 29 21 I 2 '1 1 3 1101 46
Page 4 of 10 TABLE 21 JOINT WIND FREQUENCY DISTRIBUTION BY STABILITYCLASS PENMSYLVANIA PDMER 8 LIGKT COH'AMY (PPSL) Suequehems Steee E(ectrlc Stetion 1/22/1998 PAGE es TINE OF DATY d(39(44 PROGRAKY JfD VERSIOkl PC-1~2 1997 Priaery Tooer Date . 33.foot Lewt SITE IDENTIFIERT DATA PERIOD EXANIKEDT I/ 1/97 - 12/31/97 ANNUAL STABILITY CLASS G STA81LIYY BASED Okl DELTA T BETMEEk 200.0 AMD 33.0 FEET MI ND MEASURED A'l 33.0 FEET VIND THRESHOLD AYT 50 KPN JOINT FREOUEMCY OISTRIBUTIOM OF MIND SPEED AMD DIRECTION lk NDURS AT 33.00 FEET SPEED (HPH) K kME ME EME E ESE SE SSE S SSV SV VSM V VMV NM NMM TOTAL CALK 0
.51 3AO 0 8 73 296 69 21 13 6 3 .1 0 0 0 1 494 3.41- 6.70 0 0 1 32 0 0 0 0 0 0 0 0 0 0 33 6.71.11,20 0 0 0 0 0 0 0 0 0 0 0 0 . 0 0 0 1'1.ZI 16.80 0 0 0 0 0 0 0 0 0 0 0 0 0, 0 0 16.81
~ 22AD 0 0 0 0 0 0 0 0 0 0 . 0 0 0 0 0
>>22.CO
~ 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TOTAL 0 8 74 328 69 21 13 6 3 1 2 I 0 0 0 I 527 STABILITY CLASS ALL STABILITY BASED OH: DELTA 1 BETMEEM 200.0 AND 33.0 FEET MIND MEASURED AT: 33.0 fEET MIND THRESHOLD AT: .50 HPH JOINT FREOUEMCY DISTRIBUTION OF MIND SPEED AND DIREC'IIOM IN HOURS AT 33.00 FEET SPEED (HPH) K KRE'E EKE E ESE SE SSE S SSM SV VSV M MMV 'M NHM TOTAL CALM 3
.51 3.40 45 188 485 1098 511 277 222 209 253 222 122 43 20 14 14 11 373C 3.41 6.70 158 277 232 193 68 C6 68 106 154 295 387 127 76 76 97 150 2510
- 6. 71-11. 20 138 72 43 22 12 8 23 29 58 66 393 255 1C9 111 141 247 1767
'I'I 21-16.80 29 0 0 0 1 1 0 0 2 89 175 85 3C 26 68 511 16.81.22.40 1 0 0 0 0 0 0 0 0 0 3 18 8 0 0 0 30
>>22.40 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 2 TOTAL 371 538 7eo 1313 591 332 314 344'65 585 994 619 339 235 278 47( 8557
Page 5 of 10 TABLE 21 JOINT WIND FREQUENCY DISTRIBUTION BY STABILITYCLASS PENNSYLVANIA PCMIER 8 LIGHT CCNPAMY (PPBL) - Susquehsms Stescs Electric Ststlon 1/22/1998 PAGE 66 TINE OF DAYc ~ BI39I44 PROGRAHI JFD VERSION: PC To2 1997 Priary Tcwer Dsts foot level SITE IDENTIFIER:
DATA PER Its EXAMINEDI 1/ 1/97 ~ 12/31/97 ANNUAL STABILITY BASED OM. DELTA T BETMEEN 200.0 AMD 33.0 FEET MIND MEASURED AT: 33.0 FEET MIND THRESHOLD AT: 50'HPM TOTAL NISIBER OF OBSERVAYIONSI 8760 TOTAL NSNER OF VALID OBSERVATIONS: 8557 TOTAL MNNER OF MISSING DBSERVATIDMSI 203 PERCENI'ATA RECOVERY fOR THIS PERIOD. 97 7 X MEAN MIND SPEED fOR THIS PERICOI 5,1 NPM NUNBER OF OBSERVATIONS VITN BACKUP STABILITY: 0 TOTAL NISCBER OF OBSERVATIONS VITH BACKUP DATA: 0 PERCENTAGE OCCURRENCE OF STABILITY CLASSES A 8 C D E F 0 4.98 3.66 5.49 38.80 28.05 12.87 e. 16 DISTRIBUTION OF MIND DIRECTION VS STABILITY M NME NE ENE E ESE SE SSE S SSM SV VSV M MMM NV NNV CALM A 3 7 4 1 0 6 11 28 75 196 78 8 2 0 0 0 8 6 19 'IS 7 0 e 7 10 14 34 84 62 24 10 12 3 0 C 30 39 24 6 5 11 11 15 18 39 98 58 32 21 41 0 22'77 D 260 194 227 141 124 89 105 129, 145 171 374 338 248 207 391 0 E
f G
5'7, 67 0
244 8
283 130 74 330 497 328 205 187 69 138 67 21 132 40 13 137 36 6
203 54 3
236 29 I
219 21 2
81 1
I 25 2
0 24 I
0 36 0
37 3
I 3
0 0
'IOTAL 371 538 760 1313 591 332 314 344 465 585 994 619 339 235 278 476 3 48
Page 6 of 10 TABLE 21 JOINT WIND FREQUENCY DISTRIBUTION BY STABILITYCLASS e
PENNSYLVANIA POVER S LIGHT C(SIPANY (PAL) - Susquehanna Steaa Electric Station 1/22/1998 PACE 62 TIME OF DATT 9(19:52 PROGRAHT JfD VERSION: PC 1.2 1997 Pr(sary Touer Data - 200-foot Iwel SITE IDENTIFIER)
DATA PERIOD EXAHINEDT 1/ 1/97 ~ 12/31/97 ANNUAL STABILITY CLASS A STABILITY BASED Oll DELTA 1 BETVEEN 200,0 AND 33.0 FEET VI ND HEASURED AT: 200.0 FEET VINO THRESHOLD AT: .50 HPH JOINT FREOUENCT DISTRIBUTION OF MIND SPEED AND DIRECTION IN NOURS AT200.00 FEET SPEED (HPH) N NHE NE ENE E ESE SE SSE S SSV SV VSV V VNV NV NNV TOTAL CALH 0
.51- 3.40 0 0 0' 0 0 1 0 2 1 0 0 0 0 0 6 3.41. 6.70 0 0 2 1 0 0 0 3 12 12 0 0 0 0 0 30 6.71 11.20 '0 3 3 0 0 1 3 4 26 8I 25 2 0 0 0 'ICS 11.21.16.80 1 6 5 0 0 0 2 10 17 69 57 8 2 0 0 177 16.81 22.CO ~ 0 0 0 0 0 0 0 I 3 C 38 6 0 0 0 52
>>22.40
~ 0 0 0 0 0 0 0 0 0 4 8 1 0 0 0 13 TOTAL 9 10 3 0 0 1 6 18 60 171 128 17 2 0 0 C26 STABILITY CLASS 8 STABILITT BASED ON: DELTA T BETVEEN 200.0 AND 33.0 fEET MIND MEASURED AT: 200.0 FEET VIND THRESHOLD AT .50 HPH JOIN'I FREOUENCY DISTRIBUTION Of VINO SPEED AND DIRECTION IM NOURS AT200.00 FEET SPEED (HPH) H NKE NE ENE E ESE SE SSE S SSV SV VSV V VNV NV NNV TOTAL CALM 0
,51 3,40 0 0 0 0 2 1 0 0 0 0 0 0 0 0 3 341 670 0 3 4 3 0 0 2 15 21 4 1 2 0 1 61 6.71 11 20 2 10 9 2 0 I 3 7 34 17 12 C 5 0 111 11.21.16. 80 4 6 4 0 0 0 0 5 18 33 15 6 4 2 106 16.8'2.40 0 0 0 0 0 0 rO I 3 15 7 0 =
0 0 26
>>22.40 0 0 0 0 0 0 0 0 0 6 0 0 0 0 6 TOTAL 6 19 17 5 2 2 5 S 11 28 76 75 35 12 9 3 313 49
Page 7 of 10 TABLE 21 JOINT WIND FREQUENCY DISTRIBUTION BY STABILITYCLASS pENNBYLYANIA pOMER 8 LIBNT cOHpANY IppBL) - susquehanna steea Electr)a station 1/22/1998 PACE 63 TIKE OF DATt 9l19l52 PROCRAHl JfD VERSION) PC"1.2 1997 Prlssry lover Data - 200-Foot Level SITE IDENT!F IER)
DATA PERICO EXAHINEOT 1/ I/97 12/31/97 e>>e AMNVAL STABILITY CLASS C STABILITY BASED ON: DELTA 1 BETMEEN 200K AMD 33.0 FEET llI ND HEASVREO AT: 200.0 fEET MIND THRESHOLD AT: ,50 HPH JOINT FREQUENCY DISTRIBVTION OF MIND SPEED AND DIRECTION IN HOIRS AT200,00 FEET SPEED IHPH) N NNE NE EME E ESE SE SSE S SSM Sll MSM M MNM Mll NNV TOTAL CALH 0
~ 51 ~ 3 40 0 0 3 4 2 0 2 2 1 I 0 0 0 0 0 0 15 3.41 ~ 6.70 6 12 14 5 3 2 0 1 5 17 31 5 0 1 5 2 109 6.71-11.20 11 18 8 1 0 2 4 7 4 9 25 22 10 8 9 12
- 11. 21 ~ 16.80 9 11 3 0 0 0 0 1 3 6 24 31 17 11 14 16 16.81-22.40 2 1 0 0 0 0 0 1 1 1 2 14 17 0 0 4
>>22.CO 0 0 0 0 0 0 0 0 0 0 0 5 2 0 0 0 TOTAL 28 42 28 10 5 4 6 12 1C 34 82 77 C6 20 28 34 C70 STABILITY CLASS D STABILITY BASED OM: DELTA T BETMEEN 200.0 AN 33.0 fEEl MIND HEASVRED Al: 200.0 fEET MIN THREBHDLD AT'50 HpH JOINT FREOVENCY DISTRIBVTIOH Of )i)MD SPEED AND DIRECTION IN HIRIRS AT200,00 FEET SPEED (HPH) N MME ME EKE E ESE SE SSE s ssu su usv M uuu Nu HHv 'TDTAL CALM 0
~ 51. 3.CO 11 20 37 32 27 12 31 20 21 28 27 7 3 ' 1 2 282 3.41 ~ 6.70 31 74 101 56 24 15 30 29 49 85 C1 24 17 25 24 654
- 6. 71 ~ 11.20 109 74 72 26 28 26 23 39 32 40 73 105 9C 81 125 184 1131 11.21.16.80 59 25 19 13 8 13 2 26 29 36 6C 217 155 86 91 141 984 16.81 22 40 7 0 0 0 0 ~ 1 0 0 8 7 10 90 61 18 2 19 223
>>22.40 1 0 0 0 0 0 0 0 0 0 2 27 16 0 0 0 46 TOTAL 218 193 229 ~ 127 87 ~ 67 86 11C 119 160 261 487 353 205 244 370 3320 50
Pa'ge 8 of 10 TABLE 21 JOINT WIND FREQUENCY DISTRIBUTION BY STABILITYCLASS pEMNsTLYANIA poiJER 4 LIGHT ccacpANY (ppcL) - sucqueharna stela Electric stat(on 1/22/1998 PAGE 64 TINE OF DATT 9c19c52 PROGRAH: JFD VERSION) PC-1.2 1997 Prisary Tcacer Pats - 200-Foot level Sl'IE IDENTIFIERt DATA PERIOD EXAHINEDt 1/ 1/97 - 12/31/97 ANNUAL STABILITY CLASS E STABILITY BASED OMT DELTA T BETVEEM 200.0 AMD 33.0 FEET V I KD HEASURE0 AT: 200oO fEET V IKD THRESHOLD AT: F 50 HPH JOINT fREOUENCY OISTRIBUTIOM OF V)MD SPEED AND DIRECTION IM HOURS AT200.00 FEET SPEED (HPH) N MME NE ENE E ESE SE SSE 5 SSV SV VSV V VNV MV NMV TOTAL CALH 1
.51- 3.CD 12 50 100 86 58 45 45 44 59 54 44 11 6 5 4 5 628 3.41- 6.70 45 164 120 38 23 12 35 35 '43 67 94 50 17 17 17 6 783 6.71 ~ 11.20 29 89 72 25 , 16 7 10 23 38 73 117 112 22 12 37 16 698 I
11.21 16.80 4 14 17 13 3 4 3 4 9 35 45 82 11 4 2C9 16.81-22 ~ 40 0 0 0 0 2 '1 1 .0 5 10 4 6 0 0 0 0 29
>22.CO
~ 0 0 0 0 0 0 0 0 0 1 0 2 2 0 0 0 5
'TOTAL 90 31'7 309 162 102 69 9C 106 15C 2CO 304 263 58 34 59 31 2393 STABILITY CLASS f STABILI'TY BASED ONt DELTA T SETVEEN 200.0 AND 33.0 FEET V IKD MEASURED AT: 200.0 fEET VIMD THRESHOLD AT F 50 HPH JOINT FREOUEMCY DISTRIBUTION OF VIKD SPEED AMD DIRECTION IN HOURS AT200.00 fEET SPEED (HPN) H NNE NE EKE E ESE SE ~ SSE S SSV SV VSV V VNV NV MMV TOTAL CALM 0
.51. 3.40 9 6C 104 51 61 37 CO 30 29 22 10 4 3 1 2 0 467 3.41. 6.70 41 210 83 12 7 6 8 5 31 30 39 10 6 6 8 7 509 6.71 11.20 5 9 5 2 0 0 0 0 4 11 42 21 1 1 2 1 104
- 11. 21 ~ lb. 80
- 16. 81. 22. 40
>22.40 0,
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
1 0
0 1
0 0
13 2
0 0
0 0
0 0
0 0
0 0
0 0
0 15 2
0 TOTAL 55 283 192 65 68 C3 CB 35 64 64 92 ~
50 10 8 12 8 1097 51
Page 9 of 10 TABLE 21 JOINT WIND FREQUENCY DISTRIBUTION BY STABILITYCLASS PENNSYLVANIA POVER 8 LIGHT CCHPANY (PPCL) - Susquehsrns Stests,E(ectrie Ststlon 1/22/199S PAGE
'5 TINE OF DAY'I19 52 PROGRAH: JFD VERSIOIY PC 1 2 1997 Prishsry Tover Osts - 200-foot level SITE IDENTIFIER I DATA PERIOD EXAHINEDY 1/ 1/97 12/31/97
~ et ANNUAL eat STAR ILI TY CLASS 0 STASILCTY SASED (N(t DELTA 1 SETMEEN 200 0 AND 33.0 FEET VlkD HEASURED AT: 200.0 FEET MlkD THRESHOLD AT: F 50 NPH JOINT FREOUENCY DISTRISUTION OF MIND SPEED AND DIRECTION Ik HOURS AT200.00 FEET SPEED (HPH) N kkE NE ENE E ESE SE SSE S SSV SM MSM V VNM NV NNV TOTAL CALH 0
.51. 3AO 3 34 CC 30 20 21 22 14 9 8 C 2 0 0 0 I 212 3 Al~ 6,70 22 122 57 9 C 2 9 0, 14 20 13 3 2 1 1 282 6.'71 ~ 11. 20 5 1 4 0 0 0 0 0 0 4 10 6 0 0 0 0 30 11.21 ~ 16. 80 0 0 0 0 0 0 0
~
0 0 0 0 0 1 0 0 0 1
- 16. 81.22.CD 0 0 0 0 0 0 0 0 0 0 0 0 0 0 o o o
>22 AO 0 0 -0 '0 0 0 '0 0 0 0 0 0 0 0 TOTAL 30 157 105 39 24 23 31 14 23 32 27 12 2 I 3 2 525 STAR ILITY CLASS ALL STASILITY SASED ONY DELTA T SETVEEN 200.0 AND 33.0 fEET MIND HEASURED AT: 200,0 FEET MIND THRESHOLD AT'50 HPH JOINT FREOUEKCY DISTRISUTION OF MIND SPEED AND DIRECTION IN HOURS AT200.00 fEET SPEED (HPH) N NNE NE ENE E ESE SE SSE S SSV SM VSV V VNV NV NNV TOTAL CALH I
.51 ~ 3.CD 35 168 288 205 170 116 140 111 119 115 86 24 12 9 7 8 1613 3.CI- 6.70 145 585 381 124 . 61 37 84 72 12S 210 295 113 50 CC 58 Cl 2428 6.71-11.20 161 20C 173 56 44 36 C I- 75 84 170 382 308 141 106 178 213 2372 11.2 I 16.80 77 62 CS 26 11 17 5 36 57 100 22'I 434 206 105 110 163 1678 16.81.22.CO 9 1 0 0 2 2 1 1 15 22 23 165 91 18 2 23 375 s22.40 0 0 0 0 0 0 0 0 1 6 48 21 0 0 0 77 TOTAL 428 1020 890 411 288 208 271 295 403 618 1013 1092 52'I 282 355 448 85C4 52
Page 10 of 10 TABLE 21 JOINT WIND FREQUENCY DISTRIBUTION BY STABILITYCLASS PENNSYLVANIA PNIER 8 LIGHT COHPANY (PPSL) - Svaqochsrna Stesa Electric Station 1/22/1998 PAGE TINE OF DAY: 9 19:52 PROGRAH: JFD VERSIOHT PC.1 2 1997 Priairy Tooer Oats - 200 Foot level SITE IDENTIFIER:
DATA PERl EXAlilNEOT 1/ 1/97 . 12/31/97
~ ea ANNUAL oct STABILITY BASED INIT DELTA 1 BETVEEN 200.0 AND 33.0 FEET VINO HEASURED AT: 200.0 FEET VINO THRESHOLD AT F 50 HPH TOTAL NNNER OF OBSERVATIONS: 8760 TOTAL NIRISER OF VALID OBSERVATIONS 8544 TOTAL HISSER OF HISSING OBSERVATIONS: 216 PERCENT DATA RECOVERT FOR THIS PERIOD: 97.5 X NEAN HIND SPEED FOR THIS PERICO: 8.1 HPH NUHBER OF OBSERVATIONS VITH BACKUP STABILITY: 0 TOTAL NNNER OF OBSERVATIONS VITH BACKUP DATA: 0 PERCENTAGE OCCURRENCE OF STABILITY CLASSES A 8 C D E F 0 4.99 3.66 5.50 38.86 28.01 12.84 6.14 DISTRIBUTION OF VINO DIRECTION VS STABILITY N NNE NE ENE E ESE SE SSE S SSV SV VSV V VNV A 1 9 10 3 0 0 1 6 18 60 171 128 17 2 0 0 0 8 6 19 17 5 2 2 5 8 11 28 76 75 35 12 9 3 0 C 28 42 28 10 5 4 6 12 14 34 82 77 46 20 28 34 0 D 218 193 229 127 87 67 86 114 119 160 261 487 353 205 24C 370 0 E 90 317 309'92 162 102 69 94 106 154 2CO 304 '263 58 34 59 31 1 F 55 283 65 68 C3 CB 35 64 64 92 50 10 8 12 8 0 0 30 157 105 39 24 23 31 14 23 32 27 12 2 1 3 2 0 TOTAL 428 1020 890 '411 288 208 271 295 C03 618 1013 1092 521 282 355 CCB 1 53
Page 1 of 14 AVERAGE ANNUAL RELATIVE CONCENTRATIONS TABLE 22
~ I S 9.C3CE 06 3,35CE 06 I 918E 06 I.ZI9K 06 6,CC2E-OT 4.089E 07 2.841E.OT 1 978E 07 1.C2CE.07 1.097E.07 8.618E 08 SSV 2.C32E 05 7.733K-OS 4.568E OS 2.d93E.OS 1.686E 06 1.097K.OS 7.840E 07 5.C7CE 07 3.917K 07 3.016E 07 2.3C8E 07 SM C SSCK 05 1 522E 05 9e038E 06 5 928E 06 3e306E 06 2e178K 06 1 581K 06 I 152K 06 8 63CE 07 6 768E 07 Se3'97E 07 VSM 1 165E 04 3eQCE 05 2e209E 05 1 502E 05 8.626E 06 5,970E 06 4.546E 06 3.331K 06 2.502E 06 2.037E OS 1.691E 06 V Se945E 05 1.828E 05 9e536E;06 6 005K 06 3.222E OS 2e 107K 06 I 513E 06 1.091E 06 8.107K 07 6.546E.OT Se3558 07 MMM 3.122E 05 9 716E.06 5.4038-06 3.CCSE.OS 1.972E 06 I.ZTSE 06 9e030E 07 d.629E 07 5.0COE 07 Ce083E 07 3.361E 07 HM 2 916E 05 9,17ZE 06 5 336E 06 3.3SSE.OS 1.927E.OS '1.253E.OS 8.973E ~ 07 d.7$ 0E.OT 5.2CCE 07 4 217E-07 3.C49E.07 2.141E 05 7 249K 06 4eSBE 06 3.074E 06 1.659f-OS 1.096E Od 7 940K 07 5.739E 07 C.279K 07 3.577K 07 3.045E 07 M 2A76E 05 7.754E 06 Ce375E 06 2.747E 06 '1.637E OS 1.136E 06 8.624E 07 6.30TE 07 4.785K 07 3.9C9E 07 3.317E 07 NME 2e253E 05 7-963K OS 4.527K 06 3.115E 06 1.684E 06 1.149K 06 8.59CE 07 6.277K 07 4.76CE'07 3e934E 07 3.310E 07 ME 2.120K 05 6.975K 06 4e028E 06 2 557E 06 leC62E 06 9e952E 07 7 C16E 07 5.5BE 07 4.285K 07 3.574E 07 3e037E 07 ERE 1.043E 05 3.537E 06 2e037E 06 1.37CE 06 7.272E 07 C.922E 07 3.667K 07 2.799E 07 2.222K 07 1.866E 07 IA04E 07 K 5.620E 06 'I 969K 06 le08TE 06 6.520E 07 3eC16E 07 Ze19CE 07 I 55CK 07 I 120E 07 8.403K Od 6.749E.OS 5.552K Od fSE Se223E 06 1.735E 06 9 73CE.DT 5.840E 07 2.974E 07 1.820E 07 I ZZCE 07 8e773E 08 6.541E 08 4e924E 08 3.769K 08 SK 5.712E.OS 1.967E.06 I.TQK 06 7.573E 07 3.917K.07 2ACCE 07 1.670E 07 1.127K 07 7edlSE.08 5.770E.OS C.313E 08 SSE 9e178E 06 3e397E 06 1.955E 06 1 17)K 06 6.017E 07 3.889E 07 2.761K 07 1 9C8E 07 1.C19E'07 I 037E'07 7.603E OS ANIMAL AVERACE CHI/O <SEC/HETER CLSKD) DISTANCE IM MILES SKARIMO 5.000 7.500 10.000 15.000 20.000 25 000 30.000 35.000 COe000 45 000 50.000 S 7.096K 08 3.1Clf 08 le595E 08 3.682E 09 1.6C2E 09 5.742E 10 3,0QE 10 1.366E. 10 9.0C2E. II 5.739K 1'I C.9CCE.II SQl 1.9C7E.OT 8.878E.DS C.SC7E 08 1 544K 08 6.938E 09 2.558K 09 I 261E 09 4.2QE 10 2.848E 10 le215E 10 1. 05CK ~ 10 SM 4 536E 07 2 ~ 239E 07 1 eBOE 07 3.684E 08 le852E 08 8.COIE 09 C.910E 09 2.607K 09 1.798K 09 1.032E 09 9.022E 10 VQI I 439E 06 7 481E 07 C.13OE 07 1 173E 07 S.460E Od 1.966E 08 1 073E 08 4.0958.09 2.316E.09 1 . 002E.09 8.806E 10 V CeSOSE 07 2.138K 07 I 158f 07 3e237E 08 1.371E.OS 3.816E 09 2.117E 09 7e456E 10 C ~ 196E 10 1.808E 10 1.5S2E.10 VNM 2,8COE 07 I.CC9E 07 8 ISLE 08 2.805E.08 1.302E.08 C.9CCE.09 2 150K.09 3.298K 10 1.848E 10 6.3C7E-11 5.539E ll HM 2.925E 07 1.52CE 07 8.673E 08 3.108K 08 1.332E.OS 4.088K 09 1.967K.09 Se065K 10 2.831E.IO 1.212E.IO 1.0568.10 NNM 2.606E 07 1.433E 07 8.00CE 08 2.701K.08 1.180E 08 3.945E.09 2.432K.09 Ie369K 09 8.26FE 10 C 3478.10 3.7TTK 10 N 3.001K'07 2.115E.07 1.132E.OT 3 lblf 08,1.552E 08 7.099K 09 3.54CE 09 1,2CSE.09 7.226E 10 NME '.82CE 07 le521E 07 8.248E 08 2.528K'08 1,134E Od C.174E 09 2.339K 09 1.072E.09 6.878E 10 3,C3OE 10 2.980E 10 4.105E 10 3.560K 10 ME 2.598E 07 1.4C2E.07 8.296E.OS 3.213E 08 1.377E.OS 4.279E 09 2.369K.09 1.067E.09 6.526E '10 3.541E 10 3.071E 10 EME 1.372E 07 7 465E 08 4e761E 08 2.357E.OS 1.258E.OS 6.939E 09 3.753K.09 1.726E.09 1.073E 09 5.865E 10 5.0QE 10 E C.682K 08 2.417E 08 1.358E 08 SiTOZE 09 2.613E 09 le356E 09 6.880E-IO 2.679E 10 1.596E 10 8.295K-II 7.132E 11 ESE 3e066E Od 1.283E 08 7.289E.09 2.832K 09 1.503E 09 8.Z90K 10 3.9388.10 1.090K 10 5.993K 11 2. 529E-11 2.173'1 SE 3.C73f 08 1.325E.OS 7.d22E.09 3.016K 09 1.27FE 09 4.132K 10 2.054E.ID 7.C74E 11 3.700E 11 1.042K 11 8.956E-12 SSE 6.127E 08 2.421K 08 1.3C9E.OS 5.004K.09 2.170E 09 T.SCTE 10 3.909E 10 1.5QE 10 9.199E 11 4.656E-II C.OOOE 11 CHI/O (SEC/HETER CVSKD) FOR EACH SECHEMT SECHKNT SOmeDARIES IH MILES DIRECTION .5 1 1-2 2.3 3.4 4-5 5 ~ 10 10.20 20.30 30.CO 40 F 50 FROI SITE
'S 1.935E 06 6.717E.07 2.829E 07 1. C58E. 07 8. 751K. 08 3.333E 08 5.501E 09 7.518E.10 1.675E-IO 6.423E 11 SQI C.527K.06 1.692E-06 7.727K 07 4.018E 07 2.397K.OT 9.4CZE 08 1.900E'08 3.207E 09 6.108E. 10 1.Q9E 10 SM '9.029E.OS 3.38FE.06 I 569E 06 8.7C98-07 5.C85E-07 2.301E.07 4.784K Od 9.703K 09 2 957E 09 1 211K 09 VQI 2.212E 05 d.867K.06 4.4COE. 06 2.562K.06 1 700K 06 7 528E 07 07 '.551E 2.540E.08 5.313E 09 1.3CSE 09
'M 9.909K 06 3.34SE.06 1.503K 06 8.31CE.07 5.3938.07 2.229K.DT C.261f 08 5.776E 09 1.013K-09 2.432E 10 VNM SA91E 06 1.990E.OS 9.065E.07 5.1298.07 3.382E.07 1.476E 07 3.322E. 08 5.981E 09 7.945E.10 9,6CCE.11 MM 5.321E 06 le951f 06 9.023E F 07 5.27FE.OT 3.483E-07 I 543E 07 3.555E 08 5.701K.09 8.3878-10 1,634f 10 HNM 4,418E 06 1.7238.06 7.864K 07 C. 429E.07 3eOCOE.07 1.413E.07 3.20CE ~ 08 S.C358.09 I ~ 466K 09 5.297E 10 H C,C03f 06 1e661E OS S.C27E 07 C.90IE.OT 3.387E.OT 1.875E 07 4.253E 08 7.924K 09 1. TOCK. 09 C 3ddf 10 NNE 4 6QK OS 1.76CE 06 S.C39E 07 4.880K 07 3.315E 07 'I.SDIE 07 3.179E 08 5.35OE.09 1. 287E. 09 C.725E 10 NE 4. 029K. 06 I.C98E 06 7e335E 07 C.367E.OT 3.034E.OT I.C2TE.07 3.527K.OS 6.047E-09 1. 281E. 09 4.251E. I 0 fNE 2.076E.06 7.665K 07 3.654K 07 2.251E 07 1.596K 07 7.652E 08 2.C03E 08 7.1688.09 2.057E.09 7.010E 10 E 1.090K 06 3.562E.07 1.551'7 8.571K.OS 5.584K.08 2.C50E 08 5.880K.09 I.C2CE.09 10 '.C67E 1.01CE 10 54
Page 2 of 14 TABLE 22 AVERAGE ANNUALRELATIVE CONCENTRATIONS ESE 9 49SE 07 3.09SE 07 T,KAAE.OT 6.SQE 04 3,0$ 1E OS T.(33E Od 3,232K 09 d 3(4( 10 1.717E 10 3 A2)E ~ 11 SE I ~ 141E'D6 A.DTSE 07 '1.6S9E 07 0.02(f'OS 4.43(f OS I.SS2E Dd 3.247E 09 $ .60(f 'Io 9.74CE 11 1.77)E 1'I SSE I 930E'04 6.3$ 1E 07 2.737E 07 1.42(f'07 7,076E OS 2.749K Od $ .431K 09 O.d9SK 10 1.9SSE 10 S.TSTE "ll VENT ANO NJILDINC DARANKTERST RELEASE NEICNT (NEIERS) 9 60 R(t, VINO NKICNT (NEJKRS) 10.0 DIANETER (Nf'TERS),00 SO)LOINS NET CNT (NETERS) 61,3 EXIT VELOCITT (N/SEC ) .OO SLDC.NIN.CRS,SEC.AREA (SO.NEIERS) 2373.0 NEAT ENISSION RATE (CAL/SKC) ,0 AT TNE RELfASE NEICNls I AT TNE NKASVtfo NIND NEICNT ( 10 0 NEIKRS)l
~VENT Rf LEASE NCOK VINO SRHD (NflfRS/SKC) I VENT REHASE NOOK NIND SPEED (NEHRS/HC) NIND STEED (NHERS/SfC)
I STASLE CONDITIONS WSTASLE/NKNRAL CONOITICNS fLEVATED LESS 1NAN,OOO I E LEVA'Tfo LESS TNAN .000 LESS TRAN ,000 NIX(0 DE)NEER .000 ANO,DOO I NIXED Sf ToffN .OOO AND .000 Sf)VEEN ,000 ANO ,000 CROWD LEVEL ASOVE .000 I CROWD LEVEL ASOVE Doo ASOVK .000 55
Page 3 of 14 TABLE 22 AVERAGE ANNUALRELATIVE CONCENTRATIONS Cucquclwuu dcccu EIcclrlc Slctlon - acANO LEVEL RELEASE - 199F tetdo OAT DK4Y, IROEPLETKO CDRRECIEO fOR OPEN TERRAIN RCCIRCVLATICN VSINC SPECIAL TERRAIN AD/VCINCNT lACICRS AINAIAL AVKRACE DNI/O ISKC/NCTCR CVSKDI DISTANCE IN NILKS SECTOR 2$ 0 $ 00 .7$ 0 1.000 1.$ 00 t.ooo 2.$ 00 3.000 3.$ 00 C.ooo 4.$ 00 5 P.CZCC 06 3.3CTE.06 1.913E.06 1.23CE.06 4AOCE 01 C.OSFE.DF Z.SISE.OF 1.9$ $ E Ol 'I.COCE.OF 1.01PE 07 S.Cbtf DS
$$V Z.CZCC 0$ 7 712K 06 C SCPK 06 2.57$ C 06 1.47ZE Od '1.085E 06 7,73CE 07 $ .384K 07 3.5C3E 07 2.9$ 1E 07 Z.ZOIE'01 SV C.dl7E 0$ 1.51lf.0$ 5.996E 06 S.891E Db 3.ZFSE ~ Od t,lslE 06 1.5$ 6C 06 1.131E.od D.CCbf 07 6.600K 07 $ ,244E 01 Vlu 1,143C OC S.bttE 0$ 2 195f'0$ 1,493E'0$ d SCSC'M S $ 93E Od CoCTSC 06 3.268K'M 2 CC6E 06 'I 95$ f'M lobLZE'06 V $ .935K 0$ l.dttf 0$ 9AS9E Ob $ .945K 06 3.190E 06 2,07PE 06 I.C86C 06 1.070f 06 7.9ttf 07 d.37$ E'07 $ .195K'07 3.114E ~ 0$ 9.65CC 06 $ .3lbt 06 3.Cttf 04 1,9$ 3E 06 1,260K'06 8.582K ~ 07 6.C98E 07 C.9ZCE 07 3.916K 07 S.tdtf'07 Z.OIIE 0$ 9,1Ctf D6 5 31DE 06 3,363K'04 I 905E 06 1,234K 06 D.dtdt 07 6,$ 99C Ol $ ~ Itbf'07 C.IME 07 3.3C9E'01 2.137E Osr.t26E 06 4.303K 06 3.0$ CE Od 1.443K 06 l,odtf'06 7.51$ E 07 5,631K 07 4.15$ E 07 3A87E 07 2.9$ 9E Ol N Z.CTSC.0$ 7.7$ 1E 06 4.3$ $ E.06 t,l31E 06 1.6ttE Ob l,lttf 06 d.C92E-07 6.191E.O'F C.682E 07 3,8$ 2E.OT S.ttdt 07 NNE Z.tsot.os 7.941K.M c.sodf.ob 3.095K.ob I.blot.ob I.I36E-M 5.473K or 6.ITIC or c.brat.or 3.546K-or 3.ttbc or Nt 2.115K.os 6.940K 06 C.DISE.06 2,$ C4E.06 I,CS2f 06 9,544E 07 7,33$ E.OT SA50E.OT C.219E-07 3.$ 11E.OT 2.918E 01 ENE I.DCZE 0$ 3.$ 31E 06 2.031K'Db 1.349K.od 7,23LE 07 C.SSFE 07 3.43$ E 07 2.769E ~ 07 Z.IOCE 07 I.SSOE-DF I.Sldf 07 E S.dllf 06 1.966K'06 1,08$ f 06 6.SOOE'07 3AOOE Ol 2,18OE 01 I.SCIE 07 I.IOOE 07 8.31IE 08 6.664K 08 S.CllE 05 KSE S,ZIPE 04 1,732K 04 9.FIIE 07 s,dtlE Ol t,960E 07 1,609K 07 'I.tlCE 01 D.dddf 08 6.C67K 06 4.640E 08 3,11CE 05 Sf S.707K 06 1.964K 06 I ~ lblt 06 7 S5OE'07 S.d9OE 07 ZAZOE'01 I.bsrt 07 1.117K 07 7.73'IE'08 $ .698K 08 4.2$ ZE N
$$E 9,172E ~ 06 3.392K.ob 1,9$ 2K ~ 06 1.17$ E.06 $ .99SE ~ 07 3.dlof 07 2.7CCE ~ 07 I,PRE 07 1.406K ~ 07 1.026K.ol 7.514E 08 ANNVAL AVKRACK CNI/O ISCC/NEIER Cudto) 01$ 'IANCE IN NICKS .
~ tAR INC 5.000 7 $ 00 10.000 1$ ,000 20.000 25,000 30.000 3$ .000 Co.ooo CS.OOO 50.000
$ 6.9$ 3E 05 3.044E 08 1,$ 3OE 08 3.46CK ~ 09 1.$ 1tf M $ .171E ~ 10 2,704E ~ 10 I.ldst ~ 10 7.668E 11 4.769K.I I C.otrf ~ 11
$$ u I t 59$ 01 D.SZSE'M C.SOOK 08 I,CZSC 05 6.ZZCE'09 2.23CK 09 I.ortf 09 3.$ 30E ~ 10 Z.t97t 10 9.$ CCC I'I d.069K ~ 'll Su C 3MK 07 2.136E 07 1.1$ $ E Ol 3.3$ ~ 06 1.633K 08tf 7.171E 09 C.066E ~ 09 t.OOZE 09 I,SOPC 09 7.179K 10 d.SOSE 10 VSV 1,394K 06 7,129C 07 3.81tt 07 1.04$ C'01 4.803E 06 1.415E 08 8 ~ 8$ 7E 09 3.27CE'OP 1.79CE ~ 09 7.519E 10 4.CotE 10 V C.sbot 01 2.03$ t.ol 1.0$ CE.OT 2.93SE M I.ZOSC.M 3.23OC ~ 09 I 13OE 09 $ .93OC ~ 10 3,23lt ~ 10 1.347K'10 I.ICZK~ lo Vuu Z,TCSE 07 I 379E 01 1,4LSE 08 t,self 08 I,ICZE DS C.IPdf 09 ).766E 09 Z.bttf 10 I.CBE 10 C.731E ~ ll 3.99dt ll Nu t,831E.OT 'I.CSIE.07 5.1ZCE 08 2.815K.M 1,16OE 08 3.CFdE 09 1.6ZOE 09 C.OCOE 10 2.188E ~ 10 9.07$ E 'll 7,6$ $ f 11 Ncu 2.$ 2$ E F 01 1.566E 07 T.slit.od Z.csbt 06 I.OLDE.OS 3.31DE 09 2.013E 09 1.099K 09 dASSE ~ 10 3.260K 10 2.16CE 10 Z.PDOE.OT 2.019E 07 1.06CE ~ 0'F 2.863K F 05 ).$ 7$ E 08 d.odlf 09 2.949E 09 1,00$ E 09 $ .66CE 10 2.609K ~ lo Z.ZOOE 10 Nct Z.TCSC 07 I.C$ 7K'07 7.7OCE 08 2.325K'M 1.01M 08 3.6$ 0E OO 1.950E OO 8.830K.lo S Slbf 10 3.206C 10 2.70FE'10 NE 2.SLIER 07 1.39$ E 07 7.93CC N 3.005'8 I tblt'08 3 63tt 09 2,076E 09 9,1$ 1C 10 S,CDOE'10 2.911K 10 t.CTSE 10 KNK '1.3CFE'07 7 t4CE M C.S90C M Z.t31C 08 1.169K 08 6.336K.OO 3 366E 09 I.stlf 09 9,293K 10 C.991E 10 C.tsst'10 C C.605K'Dd 2,3$ PC'N 1.5ISC 05 C.dsOI 09 2 CC5E DO I 2$ 0E'09 6.23$ C ~ 10 2.3OOC 10 I.COIE.10 7.167K ll 6.04$ f ll ESE 3.01$ E 08 I tSZE 08 7.0COE 09 ZAOSC 09 'I.LOSE DO 7 dtM 10 3,$ 61C 10 9AO8E F 11 S,ZCCE F 11 t 177E ~ 11 I,DLOK~ ll SE 3A'IOE'08 l,tOCt 05 7.35IC 09 2.5FCE ~ 09 1.197E.DO 3.511E 10 I.SALE 10 6.47$ E.II 3.2$ 1E ll 9.006E Lt T.bttf'It CNI/O SSE 4.0CSE OS 2 37CE'08 1,3'ICE'08 C.SOSC 09 Z.oslt 09 Ilfc/NfltR CVSKO) FOR EACN SCCNCNT 7 ICDE 10 3.$ 99E 10 IAIRCF 10 8.23tt 11 C 106E 11 S.CTPE ll SCCNKNI SOVNOAR Its IN NILKS DIRC O'I ION .5;I 1 2 3.4 C.S 5 ~ 10 10 20 20 30 SO.CO Co $ 0 SROI 5 I IE
$ I.OSOC Db e.bdof or 2.60IE 07 l. CSSE 01
~ D.SOLE ~ 08 3.2CIE 08 $ .226E.09 6.5$ OC 10 I. CSOC ~ 10 $ .3$ 3E ~ 11
$$V C,SOPC 06 I.brpf 06 7,6tst 01 3.OCCE'01 2.3COE 07 9 DOSED 08 1.771 E ~ 06 2.5$ $ C 09 $ .11$ E F 10 1.291E F 10 SV 3 3$ 7E 06 I.SCsf.ob 8.561E F 01 $ .33ZE Ol
~ Z.totE. OF C A09E.OS 8.31st 09 t.392K F 09 9.181E ~ 10 VSV 2.201E 0$ 5,75Cf 06 C 510K'06 2.$ 0$ C Od I.bstf ~ Od 7 IPCC O' I.C\9E.07 2.193K 08 C.sost 09 1.01PE 09 V 9 663K 06 3.313E 06 1,C79E 06 S 124E 01 $ .236K.DF 2.1 ZOE. 07 3.921K ~ 05 C ~ 983K 09 d. 177E ~ 10 I,SZOC 10 ICAI 5,465K Ob 1.971E 06 8,919E 07 S.oltf 01 3.26$ E 01 I,COOL 01 3.OCbf . 08 $ .1C9E ~ 09 6.Cdlf-lo 7.27CE.II S.296E ~ 06 1.933E F 06 d.'STPC 07 S,ISOE 01 3.38tt 07 I.CTCE F 07 3.Z6$ E 08 C.PZSE 09 6.8DCE ~ 10 I.ZSCE ~ 10 ~
NNV 4.398E 06 1.707K 06 7.1CZE'01 C.sstf 01 2.9$ 5E 07 I.ssof. 07 2.9$ 0E M 4.70tt.oO 1.156f 09 4.023E ~ 10 8 C.383E ~ 06 1.444E 06 d.299K 07 C.791E 01 S.ZOIC 01 1.793K 07 3.930K'08 6.81DE 09 I 3OCC 09 3.363K 10 lAtE C.6CCf 06 1,7$ 0E 06 8.321E 07 C.78$ 01t 3.23LE 07 I.CCZE 07 Z.OSFC M C.TOLE 09 I.olof.09 3.706K 10 NE C.017E 06 IICSSE 06 6E Ol ',2$
C,SOIE F 01 2.914E 01 'I 36ZC 07 3.3tsE.OD S.CCOC 09 I 107K 09 3oSIOC. I 0 CNK 2.070E Ob 7.427K'07 3,6ttf 01 Z.ttsf 01 I.srof.ol 7.CSSE 05 2.263K 08 e.srdf Do I.dtst 09 5.986E 10 E 1.081E 06 3.$ CTK.OF 1.$ 3OC Ol 5.41$ C 08 $ .$ 0$ E F 08 2;3OSE 08 $ .63OE 09~ 1.319K 09 3.1 13K ~ 10 5.785K 11 56
Page 4 of 14 TABLE 22 AVERAGE ANNUALRELATIVE CONCENTRATIONS KSE 9.875K'07 5 08(E'07 I 25$ f 07 dANE 08 '5,79$ E 08 1AOIE 08 5.089K 09 7.7LSE 10 I.SLIE '10 2.981( ll SE 1,1$ 9E Od C,OSTE 07 I.d(TE.07 7.958(.08 d,572K 08 1,$ 19E.OS 5.150K 09 $ .208E-IO 8.787E ~ 11 1.$ 4dt ~ 11 Slt To92df Od do526f'07 2.720f 07 IA12t 07 7 788E 08 2.719K 08 SA55E 09 9 298E10 1.81$ E'10 $ .097E ~ 11 VKNT ANO SVILDIXC PARNCTERSI RELEASE NE ICNT (NETS RS) 9.80 REP. VINO XEICXI (NfTERS) 10.0 DIANE TER (NET( RS),,00 SVILDINC NEICNI (ICTERS) 81.5 EXIT VELOCITY (N/Sf C ),00 SLOC.NIN.CRS ~ SEC.AREA (SO.NETERS) 2$ 7$ ~ 0 NEAT ENISSION RATE (CAL/SKC) ,0 AT TIC RELEASE ICICXI I AT TRE NEASVRED VINO ICICNT ( 10.0 Nf'TERS)1 VENT RfLEASE NCDE VIXD SPEED (ICIERS/StC) VKNT RELEASE NOOK VIIR) SPEED (ICTERS/SEC) VINO SPEED (ICTERS/SKC)
I STASLE CONDITIONS VNSTASLK/REVISAL CCNO IT ICNS fLEVA(ED Lf$$ TNAN,000 ELKYATKO Lf$$ TRAN,OOO LESS TRAN,000 Nl XEO Sf(VEEN,DOO ANO 000 f NI XKD SETVEEN,OOO AND .000 SETNEKN,OOO AXO,000 CR(XNX) LfVEL ASOVE .000 I CR(XND LEVEL ASOVE ~ 000 ASOYE .000 57
Page 5 of 14 TABLE 22 AVERAGE ANNUALRELATIVE CONCENTRATIONS SKNTaahama Stem Elactrlc Statlcaa CROwD LKTEL RKLKACE 1997 8,000 DAT DECAT ~ OCTLKFCD CCRRKCTKD FOR CRKN TKRRAIN RKCIRCVLATIDN VSIRC SFCCIAL TERRAIN AD/I/ltNCNF FACTORS SECTOR 2$ 0,$ 00,7$
NNAIAL AYCRACK Oll/0 <SCC/Ntttt CVSKD) 0 1.000 DISTANCE IN Nl LES 1,$ 00 2.000 2 $ 00 3.000 '.$ 00 C.OOO C.$ 00 5 8.926E Cb 3.061K'IS I 705E 06 I.OQK Ob $ AQE 07 3,378K 07 2.29$ E'01 I $ 66E 07 I IDFE 07 8.5QE'OS 6.CS?t 08 SCV 2.300K 0$ 7.0$ 6C'06 C.obbl'06 t.$ 29E 06 I C25E 04 9.0$ 3E 07 4,324E'07 C.325E 07 3.0lot 07 2,3OIE'07 1.7QE 07 SV C 6?OE 0$ 1.35CC'0$ 8.OCSE Ol $ 15OE 06 ?.SOOE 06 1.797E 06 1,27$ f Ob 9.10$ E 07 6.69$ E 07 $ .1$ 9E 07 C.OCSE 07 1.102E'OC 3o316E 0$ I o946E 0$ I e313K.0$ 7.306K 06 C.92$ E 06 3.664E'04 2.63tE Ob 1.9COE 06 1.$ $ 3E'06 le?bdt 06 V SAZM 0$ 1,665E ~ 0$ SAdbf 06 S 2C7E'06 2.729E 06 1 135E 06 1,22OE'06 SA?OE ~ 07 6.26$ 07 C.988E 07 C.DISE 01 f WV 2.9$ 3f 0$ 8.86CE 06 C.dodt 06 3.0'IOE 04 1.670K.IS 1.053K.Ob T.tdOC.OT $ .236K.OT 3.907t 07 3.11lf 07 t.$ ?OE 01 2.758K-O$ 5,36CC.06 C.TCSE 04 2.957K.ob I.Q?t 06 I OQE.04 7 235K 07 $ .316E.OT C.obbl.ol 3,2QE 07 2.$ 66E-OF 2.0?M-0$ 6.41CE 06 3.8CTE 06 2.45bf 06 I.COSE.06 9,039K.OT 4AQE Ol 4,$ 3CE.DT 3.31St.DT 2.724E 07 Z.tSCE.DT N 2.3QE 0$ To07$ E ~ 06 3.89CE Ob ZAOIK 04 I 357E 06 9.37CE 07 6.9$ 6E'07 C.DSCE 07 '3.711E'07 3.010E'07 2.CSSE'07 NKC 2.13?f 0$ 7.244E'06 CIO?9E 06 2.72?f 06 I,C21E 06 9.CSIE 07 4.933t 01 Cr96?E'07 5.696E ~ 07 3.00lf 07 ?.CSCE 07 KE ?.Oobt 0$ 6,345E IS 3.$ 86E 06 2.236K 06 1.239E 06 8,2?IE.OT $ ,955K Ol C.STOE 07 3,3?9E 07 2.730E 07 2.25CE.DF ENE 9 dlM 06 S.t?SE 06 I.dlCE Ol Ie?O?t 06 4 lblt 07 C.067K 07 2 963t'01 2 216E 01 1.727E OT I.Ct7E 07 1.?OTK'Ol E $ 31lt IS '1.791K 06 9 6QE 07 $ .70?t 07 2,897K 07 I SIM Ol 1 254K 07 8.8TOC 05 6,$ 31K 05 $ .16?E 08 C.ISIE 05 Ctt C,DC?K.IS I,SQE ~ 04 SA49E 07 $ ,107E.OT 2.$ 23E.OT 1.$ 0$ f.ol 9.593K DS 4.949E 05 $ .055K.od 3.766K 05 Z.QSK 05 SE SAOCE 06 I 79$ E 06 1.036K 06 4.QCK.OT 3.32?K.DF 2.0tOE.DT 1.3$ 0E 07 6.9Z9f 05 6.050K 05 C.CICC 08 3.ME 08 SSE 8.65CE Ob 3 101E'06 'I.TC?t 06 1.03OC 06 $ .10$ E 01 3.216E 07 2.23M 01 1.$ CCE'07 I ~ 10$ E 07 7.935K ~ 05 5 ~ 730E 05 NCNAL AKCRACC CNI/O (SKC/NttER CVSCD) DISIANCE IN NILfS SCAR INC 5 000 7,$ 00 10,000 1$ .000 ?0.000 2$ ,000 30,000 35000 CO.DOO C$ 000 $ 0,000 5 5+259K'05 t.19$ E 08 1.0$ 9t 05 2,?COE ~ 09 9.34$ E ~ 10 3.05Cf 10 I $ $ 9E'10 6.615K I'I C,lilt 11 2,$ 39E'll t.098E 11 SSV I,CCIE 07 4,151K 05 3,206K 55 9,35?l 09 3,9?TE 09 1,341E 09 6.3C4C ~ 10 t.035C ~ 10 1.295K 10 $ ,259E ~ I'I C.ÃbE tl SV 3 3$ ?E 07 1,5$ 8C 07 8.11$ E OS 2.230K.od I.OLCE OS C.CCSE.09 2,CSCE 09 l,t36E ~ 09 8.117E ~ 10 C.CCCE 10 3.717K 10 VSV I.OQE ~ 06 $ .203K ~ 07 2.7?CE'07 7.096K.od 3.07M 08 I 039E 05 $ .360K 09 1.9COK 09 I.DCSK 09 C.SUE 10 3.QCE 10 V 3.3?dt 01 1.456E 07 7.QSE ~ 08 1.9$ 7t.od 7.71bf.09 t.olbE.09 1,0$ 6E.09 3I$ 27E ~ 10 I,fdtf~ 10 T.TQE ~ 11 6A97E ~ 11 WV 2.097E'07 1,007E 07 $ 3QK 05 1.696E 05 7.3?bt 09 t.bill 09 1.07tt 09 1.$ $ 9E 10 S.317K 11 2.72$ E 11 Z,ZFCE ll NV 2.160E 07 I o0$ 9E 07 $ .719K 08 I.dFDE 08 7A9$ E ~ 09 2.160E.09 9.813E 10 2.397K 10 1.27$ E 10 $ .209K 11 C,335K 11 1,92M.OF 9.961E 05 5 tdlt 05 I.QSE OS 4ACSE.09 Z.odlt 09 1.21$ 09 6ASTE ~ 10 f 3.729K ~ 10 1.671K'10 1.5$ $ E 10 N 2.217E 07 I C72E 07 F CTCE 08 'l,90?f 05 8.7$ ?E 09 3.7$ 9E 09 I.TTM 09 $ .9?7K ~ 10 3.266E ~ 10 I.CCOE'IO 1.23OC ~ 10 NKC t,oddt.ol 1.0$ 9E 07 SAStE OS 1.$ 3CE 08 6AIDK 09 2,219f 09 1.1FCE 09 $ .'llbt ~ 10 3,129E 10 I.TDCE ~ 10 I.CS?E ~ 10 NE I 92$ E 07 I,OOFK 07 5 503K Cd 1,96OE 05 7.5C?t'09 2,29CE 09 I.ZOM 09 $ ,1$ 2E. 10 3.0CCE ~ 10 1,$ 6?t ~ 10 1.299E 10 EKC 1.011K 07 $ .?t?K.OS 3 ~ 165K.OS I.CCSC.DS 7.19tl ~ 09 3.MOC.09 I.oldf O9 8.399K ~ IO C.990K IO ?.bt?C.IO 2.16SK-IO E 3.C7CE 05 1.49ZE 05 9.0CIE 09 3.125K.O9 I.C95C.09 7.3?9C 10 5.$ ?FK ~ 10 1,309K 10 7,C$ 3E ~ 11 3.7ltf 11 3.045K F 11 ESE t,t'/Cf 05 8,9Qf 09 C,SSOE 09 I 73bt 09 S.blot IO C,C71E 10 2.017E 10 $ .3?of 11 te79M ~ 11 I 130K I 9.3tlf lt Sl 2.$ 7FE 05 9.?SOE 09 5 OTCK ~ 09 I 8$ 0t 09 7.3?ot 10 2,23CE 10 1.0$ 5C 10 3.6$ 1E 11 1.725E I'I C.461K 12 3.dlOE ~ I?
5tt C,SSIE 05 '1,495E 05 8.995t'09 S,olbt ~ 09 I,ZCDC 09 C,ICDC 10 2,01M 10 7,673l'll C 521E 11 Z,D97E ll 1.73lt ll CNI/O ItfC/Nttfa CVICD) FOR CACN SCCINKI SCCNIKL ROWDARI CS IN Nl LES DIRECTION ,$ 1 I 2 t.3 $ C C'$ $ 10 10 ZO 20 30 30.CO CO.$ 0 Sacra SITE 5 1,731faob S.nof.07 2.29?f 07 1.136K 01 9?f 05 2.371K.OS 3.$ 19E.09 C.IC9l 10 8.?$ 1'1 2.562K 11 SSV C,DCFE 06 I .CCOC ~ 06 4,2$ CE 07 3.124C 01 I 503K ~ 07 4.488C 05 1.2OOE ~ 05 1.7$ $ f.09 2.981K F 10 7.ttbt 11 SV 2.5Qt 06 I,tbdt 06 4.795K F 07 C.IITCF 07 I 62$ E 01 F
3.011E.OS $ .2CSE 09 I.C?tt.09 S.Z63E F 10 VSV 1.91$ E'0$ 7.5CIE 06 3.$ 58C Ob 1.99Cf 06 1.?lbl 04 $ .308K 07 9.756E.OS 1.381E 05F 2.$ 16E F 09 S.SFM.ID V d.dbbE.06 ?.SCdt 06 1,21$ E ~ 06 6.C$ 8t 07 C.OCdt 07 1.$ 7CE'07 2.69?E 05 3.1$ tE 09 C.912K F 10 1.0$ 9E F 10 C.OIDE'06 1.69CE.06 7.MDE.07 5.9QE 07 2.535K 07 t.oQE F 05 3.?$ 3E.O9 I.OCOE OF~
3.899E 10 C.tllE F 11 C.TSTK ~ 06 1.660K.ob '.tDCK.OF C.095K.OT 2.61CE F 07 1.057'7 2.23OC.OS 3,Ills 09 C.oddt 10 7 1?M 11 IHN IACFK~ 06 6.3$ 5f 01 3.CADE 01 2.25?t 01 9.9Cdt.od 2.DICED 05 t.9$ CE ~ 09 7 0$ CE 05'.$ 10 2.30$ E F 10 N 3.937K ~ 06 I.CI?t 04 4.812E.DT 3.805E Ol 2.$ C?t 01 1.31M 07 t.bdCE 05 C.296E 09 6.25$ C 10 'I 9llf 10 KKE 4.166E'Ob 1.$ 0?f 06 b.dtCE 07 3.79M.OT 2.490E 07 1.0$ 9E.OT 2.91'TE.09 2.008K F 05 6.2$ 6E 10 2.0lof 10 Nf 3.60CK 06 l.tltf 06 $ .936'7 3.398K 07 2:?QE 07 1.005E 07 2.22$ E 05 3.337E F 09 6.?99'0 1.69M 10 CNI 1.8$ 6C 06 6.$ 3CE 07 t.9$ 9f.ol 1.7$ 2E 07 1.202C 07 5.LOSE 05 1.$ 0CK.OS 3.93?E.09 l,oldt 09 3.1$ 1E F 10 E 9,7$ $ E 07 3.039K.o'1 1.257K.OF 6.68OE. OS C,tl OE ~ 05 1,735K ~ 3.715K ADO 7.8Cdt 10 I.T?df. 10 C.SSIE F 11 58
Page 6 of 14 TABLE 22 AVERAGE ANNUALRELATIVE CONCENTRATIONS EKE 0 47SE 07 2.4LSE 07 1.009E.07 $ ,1(df OS t,90(K.OS 1.020K OS 2,0)94.09 4.$ 9$ f 10 0.401E 11 1.$ $ 0E 11 SE I 029K 04 3,477K'07 I,SASK 07 4,2$ 9E 00 3,34$ K OS 1 10SE OS t,049E 09 $ ,11SE ~ 10 A.SSLK ~ 11 S.'IOOK 12 SSfl 727E'04 $ .420K'07 tet)PE'07 1.112E'07 $ .9(7K OS 1.977K 00 3.$ 79E'09 $ .$ 111 10 9.9$ 4E 11 2.420K 11 ~
VENT AN) SUILOIXC PARANETERST RELEASE NE I CRT (NfTERS) 9.40 RKP II(NO Nf I CRT (NETERS) 10.0 OIANETER (NET(RS) 00 SUILOIXC xEI CRT (NETERS) 41.$
EXIT VELOCITY (N/Sf C ) .00 SLOC.NIN.CRS.SKC.AREA (SO.NETfRS) 2$ 7$ ,0 NEAT KNICK(OX RATE (CAL/SfC),0 AT 'Ikf RELEASE REICNT: I AT Tkf NEASURKO VINO REICNT ( 10.0 NETKRS)1 VIXI RKLEASK INOE UIXO SPEKO (XETKRS/SKC) I VENT Rf(EASE NOOK UIXD SPKKO (NETERSISKC) UIXO SPfEO (NET(AS/SKC)
I STASLE COXOITIONS UXS (AS ( K/XfUT RA( CORO IT I OXS fLEVATKO LESS TRAN,OOO I fLEVATEO LESS TRAN .OCO LESS IXAN .000 NI XEO SETO(EN .000 AXO .000 ( NIX(0 SETO(EX .000 AXO .000 Sf(VEIN,000 AXO .000 CROUIO LEVEL ASOVE,000 CRO/NO LEVEL ASOVK .000 ASOVE .000 59
Page 7 of 14 TABLE 22 AVERAGE ANNUALRELATIVECONCENTRATIONS succpelws $ )cue tlcclrlc s)c) lon - caoao LETEL RELEA)E 1997 coaatcTCD FOR OPEN TCRRAIR RECIRORAT)ok Uslxa sPECIAL TEaaAIV AD)Us)ACR) FACTCR)
RELATIVE Dtfoslflcu Pfa UNIV AREA IR ~ 2) AT FIXED Polals $$ Dcuuu)VD stc)oas DIRECT)ou 0 ISTAREES IN IIILES FROI SITE ~ 2$ ~ 50 .7$ 1.00 1.$ 0 2.00 t.SO 3.00 3.$ 0 C.oo C.SO 5 $ 900E OS 2 072E 05 )+090K 05 4.5S5K'09 3 INE 09 I 537K'N Ie?OCE N7 9?DE ~ 10'S.CNf 10 Ciobtt ~ lo 3.077E ~ 10 ssu 5,376K 08 2,79$ E.N 1.$ ?CE 08 d.9dPE 09 CAd)f 09 2,78?E 09 1.6CPC.DP 1,?'ICE.09 5.22?f 10 d.o)OE 10 C.C9'lK ~ 10 su 9.776E'06 5 SCIE'08 $ .930K 08 1.16$ E 08 $ .8$ 2E N 3.483K'09 2.5)DE 09 I.S40E 09 1.09cc 09 5.081E 10 6.108E 10 usu 1,$ 38E 07 SATOE 08 3.39$ E 08 2.179E N I.ID)t.od 6,791K.N 4.449E 09 3.)lbf N 2.167K 09 1.648K 09 1,287E N u Pe)QE'N 3.139E 08 I.d19E OS 9 SISE'09 C.C66E 09 t.619E'09 )eTDPE'09 I ~ '135E N 7.5dlf $ 0 S PS?E'10 C.btdf 10 W So?3?f 05 I 946E 05 ),O)df)05 d.)40E.N 3.10)K.09 1,419E 09 I ~ 141E N 8.060K.)0 $ .7$ )f.)0 C.COSE 10 3.CCCE ~ 10 au 6,'STPE 08 2,'157K 05 1.14)E 08 4.9$ 9E'09 3,$ 03E 09 2.070E 09 $ ,367K'09 9.$ 7)E 10 7.022E 10 $ .3$ 1E ~ 10 C.ICPE 10 a)AI SATCE 05 1,9d9E 05 $ ,096K 08 7,2Z6E 09 3ASCE 09 2.080E.09 $ .394K.N 9.4$ CE 10 6ASTK 10 $ .289K ~ 10 C.299K 10 4 4,53?f N t,t89E.DS I.t03E.DS 6.952K 09 3.64SE 09 2 3)CE 09 $ ,6?bf 09 I,'I'ICE.09 7.978K 'IO 4,t)SE 10 $ .0)bt 10 RVK dA3)f'OS 3 ICTC'N 1.6$ 0f 05 Icos)E'04 SaoPCE N 3 191E'09 2.?ZTK'09 ).$ 3?K'N I ~ )03K 09 S.d9ZC 10 7.006E 10 at ~ 1.460E 07 Soo?TE'N 2.710E'05 1.4)CC'05 5.33)E 09 S 2CSE'N 3.645E'N 2.$ 8?E 09 1.906E 09 1.$ tlE 09 ).ZC?f'09 Eat 9,9?TE N 5.37)E DS I.SDCE 08 I ~ ICSE 08 $ ,$ 66E.09 3.$ 2CE 09 t,CQE 09 IAOCE.OP $ ,375K 09 I ~ 110E ~ 09 P.todt.lo E $ .299K.OS $ ,800K.OS 9.260K.09 S.t)dt 09 2,$ 36E.N 1.$ )IE 09 $ .030K 09 7.10)E ~ 10 $ .12CE.ID 3.97?E 10 3.1QE 10 ESE 4 3'IOC OS ).357K 08 7 )TPE ~ 09 C.D)tt N ).893K.N 'I.NTK 09 d.95?E 10 C.TATE 10 3.399K 10 2.CCTE 10 $ .5?TK 10 Sf CANE'N I $ 46E 08 d.CtTE 09 5 ~ 1$ 4t'09 Z.CCOC 09 IN?M'09 9.22$ f 10 S.PC?E.)0 3.9SCE 10 2.51?E ~ 10 2.03tt 10 SSE 5.?CSC.N 2.919E 08 1.$ 46t.od D.NCE.OP C.'ITTC.OP 2.$ 33E.09 1.706E.09 1,1$ DC 09 S.DCCE 10 SA68E ~ 'IO C,ot)E 10 DIRECT)DR DTSTAVCts Iu II!LES FRO$ slit S.DO 7,$ 0 10.00 1$ 00 ?D.DO 2$ .00 30.00 3$ .00 Co.oo C$ .00 $ 0.00 5 t,CSOE'10 9.666K 11 CA')6E ~ 11 9,589t 12 C.OCDE 12 $ ,30CE lt 4A70E Q 2,699E ).679E 13 ~ 13 1,006E'l3 8.?IOE'IC SSU 3,S74E 10 I.C13E 10 7 t37f.ll ?,OCCK 11 4.248E ~ I? 2.74)E ~ 'lt 1.2$ 1E.)t 3.91)E.Q ?.Q)f 13 9.7tdE IC 7.939K ~ IC Su C.490E.)0 2.0?PE.)0 1.0?ZC ~ 10 2.QSE.II 1.14SE 11 C.729E lt ?.SOCE 12 1.217E 12 T.TCIE ~ 13 C.l?2E ~ 13 3.36$ E 13 u)u 1.036K 09 CAISE.IO 2.199E 10 $ ,251f.l'I 2.1'l9E ll 6.7CCE 12 3308K lt 1.147K.'It .943E $ Q 2.37CC ~ 13 1.93CC 13 u '3.702K 10 ),Cbbf 10 '7.2$ 0E 11 1,73Cf.ll d.Q9f 12 $ ,$ 99E lt 5.0?DE ~ 13 2.SSIE 13 1.338E 13 S,3QE ~ 14
~ ~ 4,361E IC VN 2.775K ~ 10 I ?0)E'10 d.219E 11 IA60E 11 T.QTE 12 ?.do)t lt $ ,030K It I.CSOE ~ 13 7.$ 'ITK 'l4 Z.CO?E $ 4 $ .960K IC au 3,55)E'10 1,$ 0$ E 10 7 9$ 3E ~ 11 t,CPtf'll P.SDCC'lt 2.63CE )2 I ~ 1$ )E')t ?,TQE 13 1.42?E 13 $ .679E'IC CA)M'IC uuu SoSZTE-$ 0 1.47lf-lo 5.712E I) 2.59?E.II ),OIM.II 3.07)E-I? $ .734K 12
~
9.01CE-)3 $ .06?E 13 ?.C88E.)3 2.031E-13 N C,SCSE 10 2,QPE 10 I 319E 10 3,2tCE 11 ),C?bf 11 $ .9'IM lt 2,70CE lt 5.50DC 13 C TSTE 13 2 lotf 13 1.716E 13 RRE S.TCbf 10 ?APSE F 10 $ ,373K F 10 3.7QE ~ 'll 1,510E 11 $ ,06CE lt 2.605K F 12 1.107E 'It 6.620E 13 5,702K 13 3.0?)E 13 af 1.023E'09 4 971E 10 2.700E ~ 10 PACOE 11 SADSE 11 $ .02)t 11 So?OOC )2
~
lt to)6)C ~ $ .237K 12 d.tddt 13 $ .13tE 13 ERE T,d)7t 10 'S.dPCE 10 2.2$ ?E 10 1.01)E.)0 C.PQE 1$ 2.$ )lf Il 1.2$ 9E 11 SAOCE 12 3.1$ )E ~ 12 $ ,62?C )t I 3?CE '12 E 2,SSTE 10 )o?OCE ~ 10 d.$ ?)f I) t.2)PE 11 ).066E ~ 'll $ .)m 12 Z.QOE 12 SATdt 13 4.95$ E ~ )3 t.CSIE ~ 13 2.000E ~ 13 EIE I.CCIE.IO 5.C31E ~ 11 2.97CE 11 1.06)E ~ $ 1 $ .213E 12 2.469E 12 ).)5CE 12 3.077K 13 ).$ 9$ E'l3 4.37)E ~ IC S.ZOOE IC SE 1.58)f'10 S.CSZE'll 3 00)E 'll I 093K 11 C ?dot 12 $ .?TCC 12 5 9?SE'$5 Z.ottf 13 P.QCE'IC to$ 1?E'IC t.o)DE IC SSE 3.1CSE F 10 1.)ZOE 10 6.0?CE ~ )I 2.04tf 11 8.?$ CE ~ 12 2.703K 12 1.291E 12'C.SC7E.)3 2,69?E D )3 1.290E.13 1.0$ 3C F 13 tt\t&ttttteowlottotit af LA'TIVE DIPOSI Tlou Pf a URII Aaf* Iuoo 2) $ $ ODUVVIIO SECTORS oootoooteottt1tltotooooo stO)f a) OOAOAA IE) Iu II)LES DIRECT IOV S I I 2 2 3 3 C C 5 5 ~ 10 10 20 20 30 30 CO 40.$ 0 FROI SITE S ).116E ~ Od 3.314K OP I.t)OE OP $ .4$ Ct )0 3.136K.)0 ).OTM.)0 ).$ )M-) I ).77)f lt 3.388K.)3 )ASTE-13 Ssu $ .$ ?dt'05 C.75)E'09 ).5CCC 09 4.$ 0)f 10 C.dodt 10 ).$ 5CK 10 2.6$ 6E ll 3A2)E 12 $ .808K 13 1.3CDE ~ '13 Su 1,91?E 05 4 )3?f'09 t.323E 09 ).$ )8E N 6.?CIE 10 2.217E 'ID 3865K 11 SASSE lt I.CICE I? C 9)CE ~ )3 u)u 3.3)bt ~ 05 1,1$ M 04 C.40)E.OP ?.24 1 E N 1.301E DP C.7$ 2E 10 T.STPE 11 9.223K I? ).SSCE 12 3.270E 13 u ).bbof 08 4.747E 09 1.7t3E 09 8.'156E 10 C ~ 686E 10 1.633E ~ 10 2A7$ E ~ 11 2.$ 7)E 12 5.6blf.13 7,361E IC uvu 1.0$ ?E'05 Set)SE 09 1.201t 09 S 497E'10 S.CSIE 10 I ZPCK 10 2.3C)C ll 3 ~ '317E 12 3.7ltf'13 3.75CE )C au 1.$ 5?E.N 3.QCE 09 1.391E 09 7,11CE'10 C.ttdE 10 1.607E 10 3.0?OE ~ ll 3.d75f 12 C.TblE ~ 13 T.SZZE 14 acu l,l?CE N S,bdlf iN 1,394E ~ 09 6.93)t ~ 10 4.306K 10 ~ 1,728E 10 3 2)OE I) C.C?DC'12 9ASTE ~ 13 3,081K ~ 13 u I,t20f 08 3,80)E 09 I 60)E 09 5.2?CE'10 5 )36E ~ 10 2.C32E'10 Cob)PE 11 4AS)E )2 'l,t44E lt 2.740K 13 wt 1.715E ~ 08 $ .46?E'N 2.'?06E 09 IASTE'09 7.039E 10 2.75$ E ~ 10 C.971E ll 6.7$ 9E ~ 12 $ .366K ~ )t 4,3)CE ~ 13 at 2.738K.N 4A9$ E 09 SA)ct 09 1.9$ )C 09 l,?CM 09 $ .130C.)0 1.07tf.lo 1.$ 11E ll 2,680K 12 T.bbtf ~ $ 3 CCC I,abot 08 $ .972E 09 ZAPOC 09 'I 397K OP 9.')78E ~ 10 3.92)f 10 1.0)df 10 2.6$ 9E ~ 11 6ADOE.)2 $ ,96$ E ~ $ 2 f 9AtPE 09 tAPCE 09 '1,036E 09 5 ~ ?)DC 10 3 169E 10 I tbbE 10 2.677E ll $ .$ ?TE 12 1,150E lt 3.03$ t 13 E)t 7.277E 09 2.01$ E'09 7.108E 10 3.4?PE'10 1.87CC 10 4.33CE 11 I.tCSE ~ 11 2.7$ M ~ 12 $ .016E ~ 13 d.)76E IC SE LSSM 09 2,$ 9?f 09 9,2$ 2E ~ 10 C.087E 10 t.098E 10 6ACPE 11 1.2?lf ~ 11 1,799E ~ 12 2.726K 13 C.39?E ~ IC SSE 1.$ 66E 05 4.49)f 09 I.TOCE N S.ltbt 10 C ~ 15CE 10 )339K 10 2.393K 11 3.6)PE 12 6.330K 13 I.dldE 13 vENT AVD SUILDIac pARAAKIER)f 60
Page 8 of 14 TABLE 22 AVERAGE ANNUALRELATIVE CONCENTRATIONS RELEASE NEISNT OCT(AS) 9 40 REP VINO NEICNT (ICIERS) 'IO,O 0 IANETER (ICTERS),00 SUI (DIRC NE I CNT '(ICTERS) 41 N EXIT VELOCITT (H/SEC ) +00 ~ LOC.NIN,CRS,SEC.AREA (SO,NETERS) 2$ 7$ 0 NEAT ENISSION RATE (CAl/SEC) 0 A'I TNE RElEASE NEICNTT AT TRE NEASUREO VINO NEICNT ( 10.0 ICTERS)I VKN'I RflEASE NCOE VINO SPEED (NEIKRS/SEC) I VENT RELfALE NCOE VINO SPEED (NETERS/SEC) VINO SPEED (ICTKRS/SEC)
I STASLK CONDITIONS UNSTASLE/NEUTRAL CONDITIONS ELEVATED. LESS TRAN oOOO ELEVATED LESS TNAN,OOO LESS TNAN 000 NIXEO Sf)VEEN,OOO ANO .OCO I NI RED Sf TVKEN,OOO ANO 000 RE)VEEN ,000 ANO .000 SRUTI lEVEL ASOVK,OOO CR(UND lEVEL ASOVE,OOO ASOVE .000 61
~
Page 9 of 14 TABLE 22 AVERAGE ANNUALRELATIVECONCENTRATIONS suaque)I ~ KIe stew Electric slellorI . Skoeo-LKYKL RKLKAsf 1997 SPECIFIC POINTS Of INTEREST ORELEASE TYPE Of DIRECT IOI DISTANCf X/0 X/0 X/0 0/0 ID LDCATICN INILES) INETERS) ISKC/CVR.NETER) ISKC/CVS.NKTER) ISEC/CVS.NEfER) IPER SD.NETER)
NO DECAY 2,260 DAY DKCAY 8.COO DAY DECAY VkDEPLETED VKDKPLETED DEPLETED 5 $ 11E SOINDARY $ C.9CZE 06 4.935E 06 C.Sbbt 06 3.1$ 3E 05 S SITE SOJCIARY SSV .39 632. I.ICIE 05 I ~ 139E ~ 05 1.0$ 6E.05 C.147E.05
.S SITE SOKOARY SV .dl 955. 1,179E ~ 05 I.'ITCE 0$ 1,061E'0$ 2. SC9E. 05 5 SITE SOVNDARY VSV 1.2Z 19bt. 1,1CIE 0$ 1.132E 0$ 9.626K 06 1.5$ 9E.06 S SITE SONOARY V 1.03 1451 ~ 5,767E 06 5.725E.06 5.030E 06 'P.OCCE 09 5 Slit SONOARY .61 7.375K 04 7 3CSK 06 d. 639E. Od I.CCSE Db S SITE SOAOARY NV 1063. 4.093K 06 4. Obit. 06 S.C416 06 1.360K 05 8 SITE SONDARY 59 $ .511E 06 $ 790f 06 S.ZCSE IS 1.535K F 08 S SITE SONOARY r N ~ $9 4. 2728. 04 4.2CPE'06 5. 663E ~ 06 I 796E 06 S SITE SOROARY NKK 1251. C ZCOE 06 C.ttlE 06 3. 746E. 06 I $ 33E 06 5 SITE SOROARY NE .70 1120. C,463K ~ 04 CATOE 06 C.OOSf 06 3.0$ 9E 06 S SITE SOKOARY EKE 1374. 1.702K 06 1.697E 06 1.$ 03E 06 I.C46E 05 S SITE SOKOARY K 1253, 9.918K . 07 9.S9CE F 07 5.50lf 07 8 3664.09 S SITE SONCIARY )SK .50 1.751E 06 1.7C9E IS 1.599f.db 1.403E 05 5 SITE SOACIARY SE A3 2.476K.06 Z.C73E 06 t.tdtE.06 1.996K ~ 05 S 5 I IE SCWOARY SSE .Cl C 3368.06 C,33CE 06 C.006E 06 3.5CSE OS S RESIDENCE 5 1.00 1609. 1.239E 06 I.t3CE 06 I.053K F 06 6.555 E. 09 5 RESIDENCE SSV .90 ICC6. 3A50$ .06 3.463E 06 3.063K 06 1.11DE 05 5 RfSIDENCE SV 1.50 ZC1$ . 3.30$ f 06 3 ZTCE 06 2.799K 06 5.5SOE 09 5 RESIOEKCE VSV 1.10 1770. 1.319K.05 1.309K 0$ I.ICCE 05 I 560K ~ 05 S RESIDEKCE V I.ZO 1931 C.SSCE. 06 C.SZOE Od 3.9266.06 6.506K ~ 09 5 RtSIDKKCE 1257. S.OCCK 06 5.017E.04 C.CllE 06 9.5'PCE ~ 09 S ~ tSIDEKCE NV 1tbl, C.P)TE ~ 06 C.971E.04 CA'30E 06 1. 093K ~ 05 6 RESIDENCE $ .616E 04 5.59)E 06 S.ISSE 06 1,478E ~ 08 S RESIDENCE N 1.30 209t: 1.966E SCLERA Ob 1.950E Ob 1.665K 06 4.60CK ~ 09 S RESIDENCE Nkt 1.00 1609 3,115K ~ 06 3.096K.06 2.722K-06 I+055K 05 S Rf SIDE wCE NE 2.30 3702. d.tfbE.OT d.lPCE 07 4.7CZK.DT C. I93K.09 S RtSIDINCE ENE 2 10 3361. C ~ 60dt 07 C.STRE 07 3.759K.OT 3.2$ 9E'09 S RES)Of NCE E 1.CD tt$ 3. 3.511E 07 3.79CE 07 3 tSOE 07 2.670K 09 5 RtSIDKNCE ESE .50 1.73)E 06 1,73CE 06 '1,$ 5ZE 04 1 386K 05 4 RKS1DKNCE SE AO 6CC, Z.TCSE'06 2.7CZE F 06 2.$ 36E 06 t.t26E 05 S RESIDENCE SSE 966. 2.431E F 06 2.62)E ~ 06 2.37CK ~ 06 2.1d9E ~ 06 S CARDfN 8 I ~ 10 1770. 1.063E ~ Dd '1.0$ 9E 06 9.237K 07 5.$ 27E ~ 09 8 4RDEN SSV 1.20 1931. Z.tddt 06 Z.2$ 1E 06 1.9$ CE.06 b.dlPE ~ 09 S CAkDKN QI 1.90 3059. 2 06 2.3'16E 06 \.9CCE.04 3.52$ E.09 5 CARDKN VQI 1.10 1770. I 3IPE 0$ 1.309K ~ 05 1.1CCE ~ 0$ 1.560E ~ 05 S CARDKN V 1.20 1931. C.556K 04 C.52CE ~ 06 3.926E 06 6.605E 09 S CARDEN 1.30 t092. 2.CDIE 06 2.351E 06 2.056K.06 3. 960E. 09 S CARDEN 1287, C,997K ~ 06 C.Diff 06 C.C)OE.04 I ~ 093E F 06 5 CARDfK NNV C.OO 6C38. 3.5766.07 3.456E 07 2.726$ .07 $ .257E ~ 10 S CARDEW N 5151. 5 A)DE ~ 07 S.SZOE Ol C.CICE 07 9. 707E-10 S CARDEII Kkt 1.10 1770. 2.6966 04 2 d79E'06 2.3CDE 06 8.597K 09 4 CARPER Nt 2.30 3702. 8.276K F 07 d 19CE 07 6.7CZE 07 C.193E 09 8 CAROfw Kkt 2AO 3.870K F 07 3. 637K. 07 3.1COE 07 2.6CSE.09 8 CAkDEN f I.CO 2253. 3.511E 07 3.79CE F 07 3.250E ~ 0. 2.d70E 09 S CARPER KSK 2.50 COZC. I.ZZCE F 07 1.21CE F 07 9.69lf.06 4.930K 10 S CARDfk Sf .60 I.SZIK.06 1.516E. 06 1.372E 06 1.151E ~ 05 S CARDEK Slt 128T. 1.759E ~ Db 1.755K 06 1.567E 06 I.CISE 05 6 DAIRY S 3.90 1.15tf.07 1,13CE 07 5.83)E.OS C t99E ~ lD S DAIR'r SSV 3.00 5.C73E F 07 5,35CE F 07 C.527E-07 1.2)3$ .09 S DAIR'I 2.00 3220. $ .967K F 06 5,591E ~ IS C.9tSE 06 6.757E ~ 09 62
Page 10 of 14 TABLE 22 AVERAGE ANNUAL RELATIVE CONCENTRATIONS
$ DAIRY U $ .00 0049, 4.SO(f 07 4.3$ SE 07 3.326E.07 3.700( 10 S DAIRY HHU 4.20 d760. 3.340E-07 3.2$ 2E 07 2.529E 07 4.04$ ( 10
$ DAIRY K 4.$ 0 7244, $ .$ $ 0E 0$ $ .471E OS 4,179f 0$ 3.161( ~ 10 3 DAIRY ESE 2.70 4346. 1.0672.07 1.0$ SE.OZ S.S$ 4E 05 $ .930E ~ 10 S DAIRY SE 2.60 4)0$ . 1.$ 39(.07 1.$ 26('07 1 ~ 23SE 07 0.416E IO
$ SPECIAL LOCATIOH UTU .$ 0 $ 0$ . 5.630E.0$ 3.d19E 0$ 3.312E.OS $ .46$ ( OS
$ SPECIAL LOCATICH VEIIT NR) RUILOIKC PARANETERS)
NE,70 1127, 4.441E.06 4.42KK 06 3. 970E. 06 3.027E OS RELEASE XEICXT (NETERS) 9,60 R(P, UILD XEI CRT (X(TERS) 10.0 OIANKTER EXIT VELOCITY (NKTERS)
(N/$(C ) '0 00 SUILOIKC HEI CRT SLOC.NIH.CRS.SEC.AREA Rf AT EN ITS I OX RATE (NEIERS)
(SO.NETERS)
(CAL/SEC) dl,3 2$ 7$ .0 0
AT THE RELEASE NEICXT) AT TXE N(ASURED UIXD NEICHT ( 10.0'NKTERS)I VERT RELEASE PCOE UIHD SPEED (X(TERS/$ (C) VERI RELEASE NOOK UIHO SPEED (NflfRSISEC) UISO SPEED (NKIERSISEC)
I STASLE (XXO l110HS INSIASLK/XEUIRAL CORDI(IOUS ELEVATED LESS TXAH e000 ELEVATED Lt$ $ THAR .000 LESS THAN,000 NI XEO RE'IUKEH .000 Ne,000 Nl XKD SETUEE)I,OOO AHO 000 SETUEKH DOO AXO .000 CROWD LEVEL ASOVE,000 CR(XHO LEVEL ASOV( .000 ASOVE ',(CO 63
Page 11 of 14 TABLE 22 AVERAGE ANNUALRELATIVE CONCENTRATIONS
'TTACHMENT1 1997 ATMOSPHERIC DISPERSION ESTIMATES FOR GASPAR INPUT SELECTED LOCATIONS Sector Direction Location Miles X/Q X/QDec X/QDec&De De osition 11 SW Max.Site Bound. NQ 0.61 1.179E-05 1.174 E-05 1.061 E<5 2.549E<8 9 S Closest Site Bound NQ 0.38 4.942E-06 4.935E-06 4.586E-06 3.153E<8 12 7
12 WSW SE WSW Max. X/Q Residence Max. D/Q Residence Max. D/Q Garden
'.40 1.10 1.10 1.319E-05 2.745E-06 1.319E-05 1.309E-05 2.742E-06 1.309E-OS 1.144E-05 2.538 E-06 1.144E-05 1.860E<8 2.226E<8 1.860E<8 12 WSW Max. X/Q Dai 2.00 5.967E-06 5.891E-06 4.923E-06 6.787E49 12 WSW ToweVs Club 0.5 3.630E-05 3.619E-05 3.312E-OS 5.465E-OB 3 NE Riverlands/EIC 0.7 4.441 E-06 4.428 E-06 3.970E-06 3.027' X/Q: RELATIVE CONCENTRATION SEC/M NO DECAY UNDEPLETED NQ Dec: DECAYED SEC/M HALF-LIFE2.26DAYS UNDEPLETED X/Q Dec & De: DECAYED AND DEPLETED SEC/M HALF-LIFE 8 DAYS De osition: RELATIVE DEPOSITION RATE 1/M
Page 12 of 14 TABLE 22 AVERAGE ANNUALRELATIVE CONCENTRATIONS ATTACHMENT2 1997 ATMOSPHERIC DISPERSION ESTIMATES FOR GASPAR INPUT NEAREST RESIDENCE WITHIN 5 MILES OF SSES Sector Direction Location Miles X/Q Dec X/QDec&De De osition Residence 1.30 1.966 E-06 1.950E46 1.685 E-06 4.604 E-09 2 NNE Residence 1.00 3.115E-06 3.098E-06 2.722E-06 1.055E-08 3 NE Residence 2.30 8.276E<7 8.194E<7 6.742E-07 4.193E-09 4 ENE Residence 2.10 4.606E-07 4.572E-07 3.789 E-07 3.259 E-09 5 E Residence 1.40 3.811 E-07 3.794E-07 3.250 E-07 2.870E-09 6 ESE Residence 0.50 1.733E-06 1.730E-06 1.582E-06 1.386E-08 7 SE Residence 0.40 2.745E-06 2.742E-06 2.538E-06 2.226E-08 8 SSE Residence 0.60 2.631 E-06 2.627 E-06 2.374E-06 2.189 E-08 9 S Residence . 1.00 1.239E-06 1.234E-06 1.083E-06 6.585E-09 10 SSW Residence 0.90 3.480E-06 3.463EZ6 3.063E-06 1.110E-08 11 SW Residence 1.50 3.305E-06 3.274E-06 2.799E-06 5.850E-09 12 WSW Residence 1.10 1.319E-05 1.309E-05 1.144 E-05 1.860E-08 13 W Residence 1.20 4.556E-06 4.520E-06 3.928E-06 6.808E-09 14 WNW Residence 0.80 5.044 E-06 5.017E-06 4.471 E-06 9.594E-09 15 NW Residence 0.80 4.997E-06 4.971E-06 4.430E-06 1.093E-08 16 NNW Residence 0.60 5.618E-06 5.597E-06 5.065 E-06 1.478E-08 RELATIVECONCENTRATION SEC/M NO DECAY, UNDEPLETED X/Q Dec: DECAYED SEC/M HALF-LIFE2.26 DAYS, UNDEPLETED X/Q Dec & De: DECAYED AND DEPLETED SEC/M HALF-LIFE 8 DAYS De osition: RELATIVE DEPOSITIONRATE 1/M 65
Page 13 of 14 TABLE 22 AVERAGE ANNUALCONCENTRATIONS ATTACHMENT3 1997 ATMOSPHERIC DISPERSION ESTIMATES FOR GASPAR INPUT NEAREST GARDEN WITHIN A 5-MILE RADIUS OF SSES BY SECTOR Sector Direction Location Miles X/QDec X/QDec8 De De ositlon 1 N Garden 3.20 5.630E-07 5.520E-07 4.414 E-O? 9.707E-10 2 NNE Garden 1.10 2.696 E-06 2.679 E-06 2.340 E-06 8.897E-09 3 NE Garden 2.30 8.276 E-07 8.194E-07 6.742E<7 4.193E-09 4 ENE Garden 2.40 3.870E-07 3.837E-07 3.140 E-07 2.648E-09 5 E Garden 140 3.811E-07 3.794E-07 3.250E-07 2.870E-09 6 ESE Garden 2.50 1.224E-07 1.214 E-07 9.891E-08 6.930E-1 0 7 SE Garden 0.60 1.521E-06 1.518E-06 1.372E-06 1.151E-08 8 SSE Garden 0.80 1.789E-06 1.785E-06 1.58?E<6 1 415E-08 9 S Garden 1.10 1.063E-06 1.059E-06 9.237E-07 5.527E-09 10 SSW Garden 1.20 2.266 E-06 2.251E-06 1.954E~ 6.679E-09 11 SW Garden 1.90 2.344E-06 2.316E-06 1.944 E<6 3.825E-09 12 WSW Garden 1.10 1.319E-05 1.309E-05 1.144E-05 1.860E-08 13 W Garden 1.20 4.556E-06 4.520E-06 3.928 E-06 6.808E-09 14 WNW Garden 1.30 2.401 E-06 2.381E-06 2.058 E-06 3.960E-09 15 NW Garden 0.80 4.997E-06 4.971E-06 4.430E-06 1.093E-08 NNW Garden 4.00 3.5?6E-07 3.486 E<7 2.726E-07 5.287E-10 X/Q: RELATIVE CONCENTRATION SEC/M NO DECAY, UNDEPLETED X/Q Dec: DECAYED SEC/M HALF-LIFE2.26 DAYS, UNDEPLETED X/Q Dec 8 De: DECAYED AND DEPLETED SEC/M HALF-LIFE 8 DAYS De osition: RELATIVE DEPOSITIONRATE 1/M 66
Page 14 of 14 TABLE 22 AVERAGE ANNUALRELATIVE CONCENTRATIONS ATTACHMENT4 1997 ATMOSPHERIC DISPERSION ESTIMATES FOR GASPAR INPUT NEAREST DAIRYANIMALWITHIN A 5-MILE RADIUS OF SSES BY SECTOR Sector Direction Location Mlles X/Q X/QDec X/QDecRDe De osition DAIRY 4.50 5.550E-08 5.471 E-08 4.179E-08 3.161E<<1 0 ESE DAIRY 2.70 1.067E-07 1.058 E-07 8.554E-08 5.930E-1 0 SE DAIRY 2.60 1.539 E-07 1.526 E-07 1.238 E-07 8.416E-1 0 DAIRY 3.90 1.152E-07 1.134 E-07 8.833E-08 4.299E-1 0 10 SSW DAIRY 3.00 5.473 E-07 5.384E-07 4.327E-07 1.213E-09 12 WSW DAIRY 2.00 5.967E-06 5.891 E-06 4.923E-06 6.787E-09 13 W DAIRY 5.00 4.504 E-07 4.358 E-07 3.326E-07 3.700E-1 0 16 NNW DAIRY 4.20 3.340E-07 3.252E-07 2.529E-07 4.845E-1 0 X/Q RELATIVE CONCENTRATION SEC/M NO DECAY, UNDEPLETED X/Q Dec: DECAYED SEC/M HALF-LIFE2.26 DAYS, UNDEPLETED X/Q Dec 8 De: DECAYED AND DEPLETED SEC/M HALF-LIFE 8 DAYS De osition: RELATIVE DEPOSITIONRATE 1/M 67
SECTION 4 DOSE MEASUREMENTS AND ASSESSMENTS 68
Summaries of maximum individual doses resulting from airborne and waterborne radioactive effluent releases are given in Table 24. Meteorological data from Section 3 were used to calculate the dose from airborne effluents.
Technical Specification 6.9.1.11 requires assessment of radiation doses from radioactive airborne and waterborne effluent to members of the public within the site boundary. There are no significant exposure pathways from waterborne effluents in these areas. Onsite doses are assessed relative to offsite dose values and are adjusted for appropriate dispersion and occupancy factors. Summaries of the calculated maximum doses within the site boundary and selected locations resulting from airborne effluents are presented in Tables 25 through 27.
70
TABLE 24
SUMMARY
OF MAXIMUMINDIVIDUALOFFSITE DOSES AND DOSE COMMITMENTS TO MEMBERS OF THE PUBLIC DATA PERIOD'/1/9? TO 12/31/97
'-.'PERCENT;-'-:;
,':;"',OF!L:"'fMlT;:i; DIST AFFECTED LES SECTOR Ll TOTAL BODY 3.07E-03 0.05 md"'HILD tud"'I CHILD BONE 3.00E-02 0.15 20 Noble Gas N/A AIRDOSE 1.31E-02 1.10 WSW 0.13 10 (GAMMA-MRAD Noble Gas N/A AIRDOSE 1.68E-02 1.10 WSW 0.08 20 ETA-MRAD Iodine and CHILD LUNG 1.20E-01 1.10 WSW 0.80 15 Particulates stimated dose is based on a site total activity release.
"'10 CFR 50, Appendix I limits are in terms of mrad or mrem/reactor-year for airborne effluent and mrem per year for the two reactors for waterborne effluent.
@Doses from liquid effluent are estimated from fish ingestion and shoreline exposure at the site outfall and from the drinking water pathway at Danville, PA.
AIRBORNE PATHWAYS ANALYZED: 0.40 (SE): PLUME, GROUND, INHALATION;1.10 (WSW)
PLUME, GROUND, VEGETATION, INHALATION;2.00 (WSW) DAIRY: PLUME, GROUND, VEGETATION, COW MILK, INHALATION,0.61 (SW) SITE BOUNDARY: PLUME The maximum calculated dose from all 1997 SSES waterborne effluent (combined pathways) was 3.00E-02 mrem (CHILD, BONE).
71
DOSES TO MEMBERS OF THE PUBLIC WITHIN THE SITE BOUNDARY SSES Technical Specification 6.9.1.11 requires that the Annual Effluent Release Reports include an assessment of the radiation dose from radioactive effluents to members of the public within the site boundary. Within the SSES Site Boundary there are several areas frequented by members of the public. The SSES Riverlands Energy Information Center is a representative nearby location visited by members of the public. Doses from airborne effluent are calculated for members of the public for this location. The Riverlands, selected residences within the Site Boundary, and the maximum site boundary location for which dose calculations are performed are shown in Figure 8.
In the area comprising the Riverlands recreation area, which surrounds the Energy Information Center, three pathways of radiation exposure can be identified; plume, ground and inhalation. There are no significant exposure pathways from waterborne effluents in this area. There are approximately 100,000 visitors to the Riverlands/Information Center complex each year. For dose calculations, the visitor stays in the area for one hour.
0 I'se of the GASPAR code yields calculated doses for the Riverlands area for the report period. These doses are the total doses at the location from gaseous effluents,during the report period. In order to compute doses to members of the public who stay for only short periods of time, these doses are converted to dose rates which are averages for the entire year. Taking into account the estimated 100,000 person-hours of occupa'ncy, the collective (person-rem) doses shown in Table 25 are calculated.
Table 27 contains beta and gamma air doses from noble gas effluent at the same locations as Table 26, with resulting percent Tech. Spec. limits.
72
FIGURE 8 AREAS WITHIN THE SSES SITE BOUNDARY FOR WHICH DOSE CALCULATIONSARE PERFORMED N NNE e Me ee
~ 'l 6
e ee beer e eeee~ewe NE SUSG. ENERGY l iNFO: CENTER T<36
~
.I 4e e 1
Oti I
1 e
1
~
~4< prop6riy 1.166 Me M e 'w e eeewe e T-416 866tep
'Mei.
I ~ ~
j W 1
6'.436 V6t ~
6 I'>
6
\~
1 t
ESE ' ~
3T 450 Wsw eeeeee 4 1
1 1 r~~eee e+eme4 \e 1
ul
1 r
ssw s SUSQUK~WA 8~ ~CT@t-QTE BOUNDAAY D1STANCES
'STATtOM LEGEND PP&L property Boundary QlSTANCES IN FEEYl Sector Wheel (22r5 deg.)
PENMSYLVANlA POWER 4 UGHT Roads Railroads Locations for dose calcs.
See4e e ~ re66 HALLNURTON NUS 0 000 3OCO aeoa November 02, 1993 73
TABLE 25 CALCULATEDCOLLECTIVE DOSES TO MEMBERS OF THE PUBLIC WITHIN THE RIVERLANDS/INFORMATIONCENTER COMPLEX DATA PERIOD: 1/1/97 TO 12/31/97
<."';.;:COL>L'ECTIVE'-'>;':'--:-;
';-'='AP,.P,.L" ICABLE'.".: D-OSE.'RATE
- ~':~>;:EFFLUENT;m> .'.:.-',Inhalatio'ri':,'. !:-,;.'<<.';:;;;Total'..:;j.: '.
A'ge,Groupf'.::'-.'-',
rnrem "4,'-'::;i-:.',~/'::L1mlt~,"-:.'.::.::.:::.:.';-.",,Or"'an';:.'.";-:;"",::.":
1.10 MILES WSW: 8.66E-03 2.29E-02 3.93E-03 3.89E-02 1.53E-02 0.45 Child/Lung (Max. X/Q Res. Garden) ~ 2 4.85E-04 1.28E-03 1.64E-03 4.34E-02 1.62E-02 0.41 Child/Lung 0.40 MILES SE 1.85E-03 4.89E-03 4.71E-03 3.20E-03 0.07 Teen/Lung (Max. D/Q Residence) 1.03E-04 2.74E-04 1.96E-03 3.39E-03 0.04 Teen/Lung 0.61 MILES SW 7.70E-03 2.04E-02 (Max. Site Boundang X/Q) 2 4.31E-04 1.14E-03 2.00 MILES WSW 3.78E-03 1.00E-02 1.44E-03 1.75E-02 1.08E-02 6.87E-03 0.27 Teen/Lung (Max. D/Q Dairy) 2.12E-04 5.60E-04 6.00E-04 1.96E-02 1.21E-02 7.32E-03 0.27 Teen/Lung The maximum calculated dose from all 1S97airborne effluent (both units) for all locations, age groups, and pathways was 1.29E-01 mrem from iodine/particulate/tritium. The maximum calculated plume dose from noble gas effluent (both units) was 1.47E-02 mrem total body and 2.42E-02 mrem skin dose.
The calculated dose from all 1997 airborne effluent (both units) at Maximum D/Q Residence, 0.40 miles SE, was 1.52E-02 mrem to,teen lung from iodine/particulate/tritium; 8.62E-03 mrem total body dose and 5.16E-03 mrem skin dose from noble gas eNuent.
The calculated dose from all 1997 airborne effluent (both units) at Maximum X/Q Residence and Garden, 1.10 miles WSW, was 1.29E-01 mrem to child lung from iodine/particulate/tritium; 1.47E-02 mrem total body dose and 2.42E-02 mrem skin dose from noble gas effluent.
The calculated dose from all 1997 airborne effluent (both units) at Maximum Site Boundary, 0.61 miles SW, was 8.13E-03 mrem total body dose and 2.15E-02 mrem skin dose from noble gas effluent.
The calculated dose from all 1S97 airborne effluent (both units) at Maximum Dairy, 2.00 mites WSW, was 8.02E-02 mrem to child lung from iodine/particulate/tritium; 6.03E-03 mrem total body dose and 1.06E-02 mrem skin dose from noble gas effluent.
75
TABLE 27 CALCULATEDDOSES FROM NOBLE GASES FOR LOCATIONS WITHIN THE SSES SITE BOUNDARYAND NEAREST DAIRY 0.40 MILES SE: 2.80E-03 0.03 3.59E-03 0.02 (Max. D/Q Residence) 1.57E-04 <<0.01 2.01E-04 <0.0'I 1.10 MILES WSW: 1.31E-02 0.13 1.68E-02 0.08 (Max. D/Q Residence, Gas!en) 7.35E-04 <0.01 9.41E-04 <0.01 0.61 MILES SW: 1.17E-02 0.12 1.50E-02 0.08 (Max. Site Boundary X/Q) 6.53E-04 <0.01 8.37E-04 <0.01 2.00 MILES WSW: 5.73E-03 0.06 7.34E-03 0.04 (Max. D/Q Dairy) 3.21E-04 <0.01 4.11E-04 <0.01 76
SECTION 5 CHANGES TO THE OFFSITE DOSE CALCULATIONMANUAL AND THE SOLID WASTE PROCESS CONTROL PROGRAM 77
CHANGES TO THE OFFSITE DOSE CALCULATIONMANUAL The SSES ODCM was revised once in 1997. The Temporary Laundry Facility was deleted from Table 9 (Systems Classified as Insignificant Effluent Pathway), and added to Table 8 (Systems Classified as Not an Effluent Pathway), based on Revision 2 of Safety Evaluation NL-90-029.
Pursuant to Condition Report 96-1310, methodology and parameters to determine dose from Radiological Environmental Monitoring Program (REMP) samples have been added to Section 9.0. This addition includes four equations and Tables 6-2 through 6-
- 6. These Tables include dose calculation factors for all applicable age groups, environmental pathways and organs in Reg. Guide 1.109. Table 6 was re-designated Table 6-1.
Two systems (instrument air and service air) were deleted from Table 9 (Systems Classified as Insignificant Effluent Pathway). Both these systems are included in Table 11 (Systems with NRC I/E Bulletin 80-10 Applicability). This deletion clarifies the classification of these systems.
Pursuant to Condition Report 96-0226, Table 12 was added. This table lists specific HVAC systems and components which require off site vent evaluations to be performed when they are bypassed, degraded or otherwise rendered inoperable. Table 12 is also referred to in Section 8.2.
Pursuant to Condition Report 96-0755, a statement was added to Section 5.0 which directs attention to review any changes to dose input parameters applied to FSAR Section 11.2.
Technical Specification 3.11.2.2 and 3.11.2.3 statements were added to Section 4.0.
These statements were entered since dose calculation methodology in Section 4.0 (including equations 7,8 and 9) applies to these Specifications as well as to Specification 3.11.2.1 listed.
Table 7, based on Tech. Spec. Table 4.12.1-1, had editorial revision to remove footnotes, which were lengthy. Reference is now made to Tech. Spec. Table 4.12.1-1.
Section 7.0 has been revised'eference PPKL Calculation EC-ENVR-1025, and to remove the statement that there are no other fuel cycle facilities within twenty (20) miles of SSES, in anticipation of the SSES ISFSI.
This revision to the ODCM does not reduce accuracy or reliability of dose calculations or setpoint determinations made via methodology and parameters therein.
78
CHANGES TO THE SOLlD WASTE PROCESS CONTROL PROGRAM NDAP-QA-0646 did not undergo full revision during the report period (1997).
PCAF N-97-0017 (1/7/97) adds step 4.15.13 to ensure that radwaste tanks are prepared with Operations support. This step was incorporated into the PCP to prevent recurrence of Condition Report 96-0630. This PCAF does not reduce the overall conformance of the solidified waste program to existing criteria. A copy of SSES Radioactive Waste Process Control Program, NDAP-QA-0646, Revision 4, is included under separate cover as Appendix B.
79
SECTION 6 REPORTS OF EXCEPTION TO THE SSES EFFLUENT MONITORING PROGRAM 80
REPORTS OF EXCEPTION TO THE SSES EFFLUENT MONITORING PROGRAM Three events occurred during the reporting period which were determined to be reportable under Technical SpeciTication 3.3.7.11 Action b, with specific references to Table 3.3.7.11 - 1 Actions 111, 112 (first event), Action 112 (second event) and Action 113 (third event).
The first event occurred on 1/2/97, at 08:30, when Instrumentation and Controls (l&C) noted during investigation of a TSC SPING terminal printing problem that the Control Room terminal was not communicating with the field units. The loss of communication included the Control Room SPING alarms, which were declared inoperable. As a results, all SPINGS were declared INOP, and LCOs 3.3.7.5 and 3.3.7.11 were entered. Preliminary investigation revealed the problem initiated when SPING software was changing dates from 1996 to 1997.
The most important issue with this event was the delay in discovery of the problem: until the following day. SPING terminals were reset, observed for a period of time, and appeared to function normally. SPING effluent information remained available throughout the event, since SPING field units communicate directly with Safety Parameter Display System. The SPING terminal in the Control Room contains set points and alarms that satisfy Technical requirements. NSE confirmed that at no time during the event did effluent
'pecification exceed Tech. Spec. limits. A previous Condition Report (¹96-125) was issued to address the problem of the Eberline SPING equipment encountering difficulty adjusting itself to new dates.
Additionally, a recent modiTication to the PICSY made adjustments to enable the SPING system to update itself correctly. A PCAF was also prepared to add SPING terminals to the operations rounds sheet to verify correct function of the units. Long-term corrective actions include the computer group to add a flag if data is determined to be discrepant after twenty (20) minutes, and review the potential to remove PICSY from time correction activity and perform this activity manually, as in the past. Also, the SPING terminals will be upgraded to add alarm capability in case of lock-up problems. Since the signal was not formerly available, .
the station did not enter appropriate LCO actions statements in a timely manner, and compensatory actions were not met. The condition is considered reportable, therefore.
Condition Report 97-0004 and License Event Report 387/97-001 have been issued for this event.
The second event occurred on 3/25/97, at 18:20, when continuous sampling was lost from the Unit 2 Reactor Building SPING for twenty (20) minutes. Unit 2 was in OPCON 5 (0% power) at the time of this event. Chemistry was notified by the Unit 2 Shift Supervisor that the LCO on the Unit 2 Reactor Building SPING could be cleared. Chemistry personnel proceeded to the refuel floor to restore normal sampling from the alternate pump. At 18:30, with the alternate pump off and disassembly in progress to remove particulate and iodine filters, a Unit 2 spent fuel pool criticality alarm was received. This event necessitated immediate evacuation of the refuel floor. Chemistry personnel were escorted by Health Physics to the Unit 2 Reactor Building SPING at 18:50, and normal sampling was resumed. Condition Report 97-0851 and License Event Report 388/97-005 have been issued for this event.
The main significance of the second event was that continuous sampling was lost, although for only a brief period.
'81
The third event occurred on 4/22/97, at 11:00. This event began with investigation of a problem related to Unit 2 by Chemistry Engineering when a gradual decrease in Unit 1 Turbine Building vent flow was noted. This vent flow had shown a continual decrease since 3/31/97, and was at an all-time low for power operation. SPING sample flow during this same period was not noted to decrease. A printout of SPING daily flow averages for the Unit 1 Turbine Building revealed that vent flow dropped unexpectedly to zero on 3/30/97, due to a disconnection of signal tubing from the AMC panel, which was corrected by l8 C and returned to service later that day. No alarms were present: the low flow condition was not low enough to bring in the low flow alarm. The condition would have been caught in the near future by either performance of the quarterly l&C surveillance (within two weeks of this occurrence), or by an alarm if the low flow setpoint had been attained. I8C performed the quarterly functional surveillance (SI-179-234) on all of the SPINGS; no problems were identified with this SPING.
At the time the event was noted, however, the SPING would not have met the surveillance criteria in Sl-179-234. This discrepancy raised an issue whether the station should be in an LCO prior to the actual time the LCO was entered. Thus, the event was determined to be reportable per 10CFR50.71(a)(2)(i)(b) within the time as required under Technical Specification 3.3.7.11 Action b, with specific reference to Table 3.3.7.11 - 1 Action 113. Condition Report 97-1430 and License Event Report 387/97-011 have been issued for this event.
81A
SECTION 7 CORRECTION TO DOSES REPORTED IN PREVIOUS SEMIANNUALOR ANNUALEI=FLUENTAND WASTE DISPOSAL REPORT 82
CORRECTIONS TO DOSES REPORTED IN PREVIOUS SEMIANNUALOR ANNUALEFFLUENT AND WASTE DISPOSAL REPORTS No corrections to previous semiannual or Annual Effluent and Waste Disposal Reports are submitted in this period.
83
SECTION 8 EFFLUENT FROM ADDITIONALMONITORED RELEASE POINTS 84
EFFLUENT FROM ADDITIONALNIONITORED RELEASE POINTS The Dry Active Waste (DAW) facility is a processing system located in a trailer near the administration building. Since the facility is used to reduce DAW volume, the trailer atmosphere is sampled routinely for airborne activity. The effluent potential for this system was determined in Safety Evaluation NL-89-002. It has been classified as an Insignificant Effluent Pathway in the ODCM. In 1997, air samples taken from this facility indicated no airborne activity above Minimum Detection Level.
85
APPENDIX A REVISIONS TO SSES ODCM
PENNSYLVANIAPOWER 8 LIGHT COMPANY SUSQUEHANNA STEAM ELECTRIC STATION OFFSITE DOSE CALCULATIONMANUAL Revision 7 Prepared by:
'eviewed by: r ~e/qy Supervisor Environmental Services - Nuclear Approved by:
Manager - Nuclear Technology Reviewed by: //>"/~'/
PORC/Meeting No.
OFFSITE DOSE CALCULATION Pennsylvania Power 5 Light Company Two North Ninth Street Allentown, Pennsylvania 18101-1179 Iffllfflll/flfff1fif8lflffi OQCf I Ilff3flffflffflf/f!f)flf/f(Nffff
SUMMARY
Of ODCM CHANGES Temporary Laundry Facility has been deleted from Table 9 (Systems Classified as Insignificant Pathway) and added to Table 8 (Systems Classified as Not an Effluent Pathway), based on Revision 2 of Safety Evaluation NL-90-029.
Pursuant to Condition Report 96-1310, methodology and parameters to determine dose from Radiological Environmental Monitoring Program (REMP) samples have been added in Section 9. This addition includes four equations (19-22), and Tables 6-2 through 6-6, which include dose calculation factors for all applicable age groups, environmental pathways and organs in Regulatory Guide 1.109. Table 6 has been redesignated Table 6-1.
Two systems (instrument air and service air) have been deleted from Table 9, Systems Classified as Insignificant Effluent Pathway. Both these systems are included in Table 11, Systems with NRC I/E Bulletin 80-10 Applicability. This deletion clarifies the classification of these systems.
Pursuant to Condition Report 96-0226, Table 12 has been added. This table lists specific HVAC systems and components which require off-site vent evaluations to be performed when they are bypassed, degraded or otherwise rendered inoperable.
A reference to this table is added in Section 8.2.
Several minor editorial changes have been made, which will not be detailed here.
The OOCM has been repaginated to accommodate additions of tables and new word processing; in some cases pages are revised only for the page numbe..
Pursuant to Condition Report 96-0755, a statement has been added in Section 5.0 which directs attention to review any changes to dose input parameters to FSAR Section 11.2.
Technical Specification 3.11.2.2 and 3.11.2.3 statements have been added to Section 4.0. These statements have been entered to the document because the dose calculation methodology in Section 4.0 (including Equations 7-9) apply to these SpeciTications as well as to Specification 3.11.2.1 currently listed.
Table 7, which is based on Technical Specification Table 4.12.1-1, has editorial revision to remove technical footnotes, which are lengthy. Reference is now made to Technical Specification Table 4.12.1-1.
Section 7.0 has been revised to reference PPRL Calculation EC-ENVR-1025, and to remove the statement that there are no other fuel cycle facilities within 20 miles of SSES, in anticipation of the SSES ISFSI.
- 10. This revision does not reduce the accuracy or reliability of dose calculations or setpoint determinations.
Appv r--.': ~
Date Rev. 7
TABLE OF CONTENTS
~
PORC Rev. Approval
~Pa e Date Date
1.0 INTRODUCTION
1 7/14/95 7/20/95 2 7/14/95 7/20/95 3 11/9/93 3/11/94 2.0 SETPOINTS 2/5/92 2/21/92 2.1 Waterborne Effluent Monitors 2/5/92 2/21/92 12/11/89 12/11/89 2/5/92 2/21/92 12/11/89 12/11/89 12/11/89 12/11/89 2.2 Airborne Effluent Monitors 9 2/5/92 2/21/92 .
10 12/11/89 12/11/89 11 12/11/89 12/11/89 12 11/21/92 11/25/92 3.0 WATERBORNE EFFLUENT CONCENTRATION 13 2/5/92 2/21/92 MEASUREMENTS 14 2/5/92 2/21/92 4.0 AIRBORNE EFFLUENT DOSE RATES 15 1/30/97 1/24/97 4.1 Noble Gases 15 1/30/97 1/24/97 4.2 Radionuclides Other Than Noble Gases 16 1/30/97 1/28/97 17 1/30/97 1/24/97 18 2/5/92 2/21/92 19 12/11/89 12/11/89 20 12/1/92 12/4/92 5.0 INDIVIDUALDOSE DUE TO WATERBORNE EFFLUENT 21 1/30/97 1/24/97 5.1 Fish Pathway Liquid Effluent Dose Calculation Methodology 21 1/30/97 1/28/97 5.2 Potable Water Pathway Effluent Dose Calculation Methodology 22 1/30/97 1/28/97 5.3 Shoreline Exposure Pathway 23 1/30/97 1/28/97 5.4 Projected Dose From Liquid Effluent 23 1/30/97 1/28/97 24 1/30/97 1/28/97 6.0 INDIVIDUALDOSE DUE TO AIRBORNE EFFLUENT 25 1/30/97 1/28/97 6.1 Noble Gases 25 1/30/97 1/28/97 6.2 Radionuclides Other Than Noble Gases 26 1/30/97 1'/28/97 27 1/30/97 1/24/97 7.0 TOTAL DOSE 28 1/30/97 1/24/97 Appv Date ~ .'i li I 'ev. 7 Rev. 7
~
r PORC Rev. Approval
~Pa e Date Date 8.0 OPERABILITY OF WASTE TREATMENT SYSTEMS 29 10/29/93 3/1 1/94 8.1 Liquid Waste Treatment 29 1/30/97 1/24/97 8.2 Gaseous Waste Treatment 30 1/30/97 1/24/97 31 1/30/97 1/24/97 8a3 Solid Waste Treatment 32 1/30/97 1/24/97 33 1/30/97 1/24/97 9.0 RADIOLOGICALENVIRONMENTALMONITORING 1/30/97 1/24/97 PROGRAM 9.1 Definitions 34 1/30/97 1/24/97 9.2 Monitoring Program 34 1/30/97 1/24/97 35 1/30/97 1/24/97 36 1/30/97 1/24/97 9.3 Census Program 37 1/30/97 1/24/97 .
9.4 Interlaboratory Comparison Program 38 1/30/97 1/24/97 10.0 DOSE ASSESSMENT POLICY STATEMENTS 43 1/30/97 1/24/97 10.1 Selection of Analysis Results for Dose Calculations 43 1/30/97 1/24!97 10.2 Assignment of Releases to the Reactor Units 43 1/30/97 1/24/97 10.3 Evaluation And Monitoring Criteria for Effluent 43 1/30/97 1/24/97 Pathways 10.4 Flow From the Sgts Vent When the System is Not 44 1/30/97 1/24/97 In Use 10.5 ODCM Setpoints Are Upper Limit Values 45 1/30/97 1/24/97 10.6 Definition of "Appropriate Treatment" for 45 1/30/97 1/24/97 Liquid Wastes e
10.7 Monitor Line-Loss Corrections 46 1/30/97 1/24/97 10.8 Selection of Data For Determination of Dose 47 1/30/97 1/24/97 Rate Compliance 10.9 Low-Level Radioactivity In The Sewage 48 1/30/97 1/24/97 Treatment Plant 11.0 ODCM REVIEW AND REVISION CONTROL 56 1/30/97 1/24/97 Appendix A - Sample Calculations of ODCM Parameters A-1 2/5/92 2/21/92 A-2 2/5/92 2/21/92 A-3 5/9/96 5/3/96 AA 2/5/92 2/21/92 A-5 10/29/93 3/11/94 A-6 10/29/93 3/11/94 A-7 10/29/93 3/11/94 Appv Rev. 7 Rev. 7
PORC Rev. Approval
~Pa e Date Date Appendix A - Sample Calculations of ODCM Parameters A-8 10/29/93 3/1 1/94 (continued) A-9 2/5/92 2/21/92 A-10 2/5/92 2/21/92 A-11 10/29/93 3/11/94 A-12 10/29/93 3/11/94 A-13 10/29/93 3/1 1/94 Appendix B - Reporting Requirements B-1 12/11/89 12/11/89 B-2 10/29/93 3/1 1/94 B-3 12/11/89 12/11/89 12/11/89 12/1 1/89 Appendix C - Site Specific Information Used by Gaspar Code C-11 12/11/89 12/11/89 Appendix D - Site Specific Information Used by Ladtap Code D-1 10/1 0/94 10/1 4/94 Date Rev. 7 i ."/
->" Rev. 7
LIST OF TABLES PORC Rev. Approval Table ~Pa e Date Date 1 Radiological Effluent Objectives and Standards 11/9/93 3/1 1/94 2 Dose Factors for Noble Gases 18 2/5/92 2/21/92 3 Sample Annual Average Relative Concentrations and Deposition Rates 19 11/9/93 3/11/94 4 Dose Factors for Inhalation, Ingestion and Ground Exposure Pathways: Radionuclides Other Than Noble Gases 20 5/9/96 5/3/96 5-1a Dose Factors for Fish Pathway, Maximum Hypothetical Adult (2pp) 5-1a(1,2) 10/1 0/94 10/14/94 5-1b Dose Factors for Fish Pathway, Maximum Hypothetical Teen (2pp) 5-1b(1,2) 10/1 0/94 10/1 4/94 5-1c Dose Factors for Fish Pathway, Maximum Hypothetical Child (2pp) 5-1c(1,2) 10/1 0/94 10/14/94 5-2a Dose Factors for Potable Water Pathway, Maximum Hypothetical Adult (2pp) 5-2a(1,2) 10/29!93 3!1 1/94 5-2b Dose Factors for Potable Water Pathway, Maximum Hypothetical Teen (2pp) 5-2b(1,2) 10/29/93 3/11/94 5-2c Dose Factors for Potable Water Pathway, Maximum Hypothetical Child (2pp) 5-2c(1,2) 10/29/93 3/11/94 5-2d Dose Factors for Potable Water Pathway, Maximum Hypothetical Infant (2pp) 5-2d(1,2) 10/29/93 3/11/94 5-3 Radioactive Decay Constants 5-3 10/29/93 3/11/94 5Q Dilution Factors and Transit Times for SSES Effluents to Danville, PA 5A(1,2) 10/29/93 3/1 1/94 5-5 Dose Factors for Shore Exposure Pathway, AII Age Groups (2pp) 5-5(1,2) '1 0/29/93 3/1 1/94 5-6a Composite Dose Factors: Maximum Hypothetical Adult (2pp) 5-6a(1,2) 10/10/94 10/14/94 5-6b Composite Dose Factors: Maximum Hypothetical Teen (2pp) 5-6b(1,2) 10/10/94 10/14/94 Appv IV Rev. 7 Rev. 7
PORC Rev. Approval Table ~Pa e Date Date 5-6c Composite Dose Factors: Maximum Hypothetical Child (2pp) 5-6c(1,2) 2/1 8/94 3/11/94 5-6d Water Ingestion Dose Factors: Maximum Hypothetical Infant (2pp) 5-6d(1,2) 2/1 8/94 3/1 1/94 6-1 Operational Radiological Environmental MonitOring Program 6-1 (1) 1/30/97 1/24/97 6-1 (2) 1/30/97 1/24/97 6-1(3) 1/30/97 1/24/97 6-2a REMP Dose Factors for Adult Age Group; 6-2a 1/30/97 1/24/97 Milk Sample 6-2b REMP Dose Factors for Adult Age Group; 6-2b 1/30/97 1/24/97 Leafy Vegetable Sample 6-2c REMP Dose Factors for Adult Age Group; 6-2c 1/30/97 1/24/97 Fruit Sample 6-2d REMP Dose Factors for Adult Age Group; 6-2d 1/30/97 1/24/97 Meat Sample 6-2e REMP Dose Factors for Adult Age Group; 6-2e 1/30/97 1/24/97 Fish Sample 6-2f REMP Dose Factors for Adult Age Group; 6-2f 1/30/97 1/24/97 Drinking Water Sample 6-2g REMP Dose Factors for Adult Age Group; 6-2g 1/30/97 1/24/97 Inhalation - Quarterly Sampling 6-2h REMP Dose Factors for Adult Age Group; 6-2h 1/30/97 1/24/97 Inhalation- Weekly Sampling 6-3a REMP Dose Factors for Teen Age Group; 6-3a 1/30/97 1/24/97 Milk Sample 6-3b REMP Dose Factors for Teen Age Group; 6-3b 1/30/97 1/24/97 Leafy Vegetable Sample 6-3c REMP Dose Factors for Teen Age Group; 6-3c 1/30/97 1/24/97 Fruit Sample 6-3d REMP Dose Factors for Teen Age Group; 6-3d 1/30/97 1/24/97 Meat Sample 6-3e REMP Dose Factors for Teen Age Group; 6-3e 1/30/97 1/24/97 Fish Sample 6-3f REMP Dose Factors for Teen Age Group; 6-3f 1/30/97 1/24/97 Drinking Water Sample Appv
'ate Rev. 7 Rev. 7
PORC Rev. Ap proval Table Pacae Date Date 6-3g REMP Dose Factors for Teen Age Group; 6-3g 1/30/97 1/28/97 Inhalation - Quarterly Sampling 6-3h REMP Dose Factors for Teen Age Group; 6-3h 1/30/97 1/24/97 Inhalation - Weekly Sampling REMP Dose Factors for Child Age Group; 6-4a 1/30/97 1/24/97 Milk Sample REMP Dose Factors for Child Age Group; 6Mb 1/30/97 1/24/97 Leafy Vegetable Sample 6-4c REMP Dose Factors for Child Age Group; 6-4c 1/30/97 1/24/97 Fruit Sample 6-4d REMP Dose Factors for Child Age Group; 64d 1/30/97 1/24/97 '
Meat Sample 6-4e REMP Dose Factors for Child Age Group; 6-4e 1/30/97 1/24/97 Fish Sample 6-4f REMP Dose Factors for Child Age Group; 6<f 1/30/97 1/24/97 Drinking Water Sample 6-4g REMP Dose Factors for Child Age Group; 6-4g 1/30/97 1/24/97 Inhalation - Quarterly Sampling 6-4h REMP Dose Factors for Child Age Group; 1/30/97 1/24/97 Inhalation - Weekly Sampling 6-5a REMP Dose Factors for Infant Age Group; 6-5a 1/30/97 1/24/97 Milk Sample 6-5b REMP Dose Factors for Infant Age Gro'p; 6-5b 1/30/97 1/24/97 Drinking Water Sample 6-5c REMP Dose Factors for Infant Age Group; 6-5c 1/30/97 1/24/97 Inhalation - Quarterly Sampling 6-5d REMP Dose Factors for Infant Age Group; '6-5d 1/30/97 1/24/97 Inhalation - Weekly Sampling 6-ea REMP Dose Factors for Adult Age Group; 6-ea 1/30/97 1/24/97 Shoreline/Sediment Total body and Skin Dose 6-6b REMP Dose Factors for Teen Age Group; 6-6b 1/30/97 1/24/97 Shoreline/Sediment Total body and Skin Dose 6-6c REMP Dose Factors for Child Age Group; 6-6c 1/30/97 1/24/97 Shoreline/Sediment Total body and Skin Dose Appv VI Rev. 7 Rev. 7
PORC Rev. Approvai Table ~Pa e Date Date 7 Detection Capabilities for Environmental Sample Analysis 41 1/30/97 1/28/97 42 1/30/97 1/24/97 8 Systems Classified as Not an Effluent Pathway 49 11/18/96 11/21/96 50 1/30/97 1/24/97 51 1/30/97 1/24/97 9 Systems Classified as Insignificant Effluent Pathway 52 1/30/97 1/24/97 10 Systems Classified as Significant Effluent Pathway 53 1/30/97 1/24/97 11 Systems with NRC I/E Bulletin 80-10 Applicability 1/30/97 1/24/97 12 Ventilation Exhaust Treatment Systems which 55 1/30/97 1/24/97 Require Vent Evaluations when Bypassed, Degraded, or Otherwise Rendered Inoperable B-1 Radiological Environmental Monitoring Program Annual Summary B-3 12/1 1/89 12/1 1/89 t B-2 D-1 Reporling Levels for Nonroutine Operating Reports Dilution Factors and Transit Times for SSES Effluents to Danville, PA D-1 12/11/89 11/9/93 Sewage Treatment Plant added in response to PORC Meeting 95-098 Action Item E05532.
12/11/89 3/11/94 Appv VII Rev. 7 Rev. 7
LlST OF FIGURES PORC Rev. Approval Fitiure ~Pa e Date Date 1 Liquid Radwaste System Flow Diagram 33A 1/30/97 1/24/97 2 Offgas and Recombiner System Flow Diagram 338 1/30/97 1/24/97 3 Solid Waste Management System Flow Diagram 33C 1/30/97 1/24/97 k
4 SSES Dry Contaminated Waste Processing 33D 1/30/97 1/24/97 5 Environmental Monitoring Locations Within One Mile of SSES 39 1/30/97 ~
1/24/97 6 Environmental Monitoring Locations Greater than One Mile from SSES 40 1/30/97 1/24/97 Appv Date I.=- /" 1 VIII Rev. 7 Rev. 7
The purpose of this manual is to provide the parameters and methodology to be used in calculating offsite doses and effluent monitor setpoints for the Susquehanna Steam Electric Station, Units 1 and 2. Included are methods for determining maximum individual, whole-body, and organ doses due to waterborne and airborne effluents to ensure compliance with the dose limitations in the Technical Specifications. Methods are included for performing dose calculations to ensure compliance with the waterborne and airborne treatment system operability sections of the Technical Specifications. This manual includes the methods used for determining quarterly individual doses for inclusion in Annual Effluent and Waste Disposal Reports.
The dose models consider two release modes: airborne and waterborne. All airborne effluents are treated as ground-level releases. Dose to each of the seven organs listed in Regulatory Guide 1.109 (bone, liver, total body, thyroid,'idney, lung, and GI-LLI) are computed based on the individual nuclide composition of the effluent. The largest of the doses are compared to 10CFR50, Appendix I design objectives.
Liquid effluents discharged into a river undergo mixing prior to consumption as either potable water or through the flish'pathway. For releases to the Susquehanna River, river model dilution factors are used. Doses to the seven critical organs are determined from individual nuclide contributions and are compared to the 10CFR50 Appendix I design objectives. Compliance with the 10CFR20 maximum permissible concentrations is done on a batch-by-batch basis prior to discharge. Henceforth in this document, reference to MPC limits of 10CFR20 Appendix B applies to those limits in e'ffect prior to January 1, 1994, and continuing in effect until such time that revised 10CFR20 Appendix 8 limits are implemented at SSES.
OAV >' Rev. 5
This manual discusses the methodology to be used in determining effluent monitor alarm/trip setpoints to be used to ensure compliance with the instantaneous release rate limits in the Technical Specifications. Methods are described for determining the annual cumulative dose to a real individual from liquid effluents, gaseous effluents, and direct radiation for critical organs to ensure compliance with 40 CFR 190 limits. The calculational methodology for doses are based on models and data that make it unlikely to substantially underestimate the actual exposure of an individual through any of the appropriate pathways.
The Radiological Environmental Monitoring Program is described in Section 9.0 of the manual, which includes the annual land use census survey and interlaboratory comparison program.
It is the responsibility of the Superintendent of Plant-Susquehanna to ensure that this manual is used in performance of the surveillance requirements and for compliance with the limiting conditions of operations stated in the Technical Specifications. It is the responsibility of the Manager-Nuclear Technology to ensure adequacy and correctness of calculational approaches.
2 Rev. 5
ABLE 1 RADIOLOGICAL EF EHT OBJECTIVES 5 STANDARDS 10 CFR 50 40 CFR 190 IOCFR 20 APPENDIX I STANDARDS* STANDARDS**
DESIGN OBJECTIVES (BOTH REACTOR (BOTH REACTOR (PER REACTOR UNIT) UNITS COMBINED) UNITS COMBINED)
WATERBORNE EFFLUEHTS Dose to Total Body From all Pathways .3 mrem/year Dose to any Organ From all Pathways 10 m'rem/year AIRBORNE NOBLE GAS EFFLUEHTS Dose Rate to Total Body 500 mrem/year Dose Rate to Skin 3000 mrem/year Gamma Dose in Air- 10 mrad/year Beta Dose in Air 20 mrad/year Dose to Total Body of an Individual Dose to Skin of an Individual - - - -- 15 5 mrem/year mrem/year AIRBORNE RADIOIODIHES AND PARTICULATES Dose Rate to any Organ 1500 mrem/year Dose to any Organ From all Pathways -. 15 mrem/year TOTAL URAHIUH FUEL CYCLE Dose to Whole Body From all Fuel Cycle Operations 25 mrem/year Dose to Thyroid From all Fuel Cycle Operations 75 mrem/year Dose to any Other Organ From all Fuel Cycle Operations 25 mrem/year
- As currently reflected in Technical Specification 3. 11.4.
- Technical Specification limits set to ensure compliance with 10 CFR 20 limits DAT
- 2. 0 SETPOINTS
- 2. 1 WATERBORNE EFFLUENT MONITORS SPECIFICATION -
3.3.7.l0 THE RADIOACTIYE LIQUID EFFLUENT MONITORING INSTRUMENTATION SHOMN IN TABLE 3.3.7.10-1 SHALL BE OPERABLE WITH THEIR ALARM/TRIP SETPOINTS SET TO ENSURE THAT THE LIMITS OF SPECIFICATION 3-11-1-1 ARE NOT EXCEEDED. THE ALARM/TRIP SETPOINTS OF THESE CHANNELS SHALL BE DETERMINED IN ACCORDANCE WITH THE METHODOLOGY AND PARAMETERS DESCRIBED IN THE OFFSITE DOSE CALCULATION MANUAL (ODCM) .
A gross radioactivity monitor providing automatic termination of liquid effluent releases is present on the liquid radwaste effluent line. Flow rate measurement devices are also present on the liquid radwaste effluent line and the discharge line (cooling tower blowdown). Precautions, limitations, and setpoints applicable to the operation of the Susquehanna Steam Electric Station liquid effluent monitors are provided in the applicable plant procedures. Setpoint values are to be calculated to ensure that alarm and trip actions occur upon approaching the MPC limits of 10 CFR 20, Appendix 8, Table II, Column 2 at the release point to the unrestricted area. The calculated alarm and trip action setpoints for the liquid effluent monitor and each flow measurement device must satisfy the following equation:
cP
( C (Eq. 1) where:
C the liquid effluent concentration limit implementing 10 CFR 20 for unrestricted areas (uCi/ml).
c the setpoint (uCi/ml) of the radioactive liquid effluent monitor measuring the. radioactivity concentration in the effluent line prior to dilution and subsequent release.
0
the radwaste discharge flow setpoint, in volume per unit time, in the same units as F.
<he dilution {cooling tower blowdown) water flow setpoi nt as measured prior to injection of the radwaste, in volume per unit time.
Radioactive liquid effluents from the SSES are only discharged as batch releases and are discharged through the liquid radwaste effluent line. The radioactive liquid waste stream is diluted .in 4
the plant discharge (cooling tower blowdown) line prior to entering the Susquehanna River. The limiting batch release concentration (c) corresponding to the 'liquid radwaste effluent line monitor set'point is calculated from the above -expression. The HPC value used for the liquid effluent concentration limit {C) in the above expression for.
the liquid radwaste effluent line monitor setpoint is 1 x 10 1
uCi/ml or the actual MPC for identified mixtures. Therefore, the expression for determining the setpoint on the liquid radwaste effluent line monitor becomes:
c < (1 x 10 ) f (Uci/ml) (Eq- 2)
In order to prevent spurious isolations by the LRM effluent radiation monitor, the setpoint concentration, {c) can be defined I
as:
c = X{A) where (A) is the actual tank concentration and X P l-The setpoint dilution factor must then be some factor, Y (where Y >
X), times the minimum dilution factor.
F+ F) ~A where F + f I) the minimum dilution factor.
P HPC where F + f the setpoint dilution factor f
The requirements of Equation (2) are then met as follows:
Y(A) = HPC F + f f
Since, by definition, Y > X and Y(A) > X{A), then:
c X(A)'-< MPC 'F + f f
The setpoint concentration (c) can be converted to a setpoint coun rate by use of the monitor calibration factor.
(Eq. 3)
Setpoint (cpm) = + Background (cpm)
Cal. Factor (uCi/ml per cpm)
The setpoint for the dilution'ater flow (cooling tower blowdown) is 5000 gpm from both cooling tower basins. The- setpoint for the LRM discharge flow can then be determined from:
F+ f ~YA (Eq. 4)
MPC Sample calculations for determining the release concentration limits and setpoints are given in Section A.l.l of Appendix A.
The Service Mater System provides screened water from the cooling tower basin for cooling plant systems and equipment. The Residual Heat Removal (RHR) Service Mater System provides water from the
Engineered Safeguard Service Mater (ESSW) spray pond to the RHR heat exchangers. In post-accident condi tions, RHR Service Mater can supply water for vessel and containment flooding. The Service 'Mater and RHR Service Mater Systems are not normal pathways for liquid effluents. Radiation monitors are in place on these systems to provide indication of leaks across heat exchangers into the service water. The high radiation setpoints for these monitors are set at ZE-5 uCi/cc cesium-137 equivalent. Considering the radionuclides predominant'n SSES liquid effluents, e.g., Co-58, Co-60, Fe-59, Nn-54 and Cr-51, use of a setpoint based on the Cs-137 MPC is conservative based on the following parameters:
- 1) photon abundance (85K)
- 2) magnitude of applicable MPC (ZE-5 uCi/cc)
Because Service Mater k RHR Service Mater are not normal release.
pathways for liquid effluents, no credit should be taken for possible dilution scenarios. All service water should be maintained below 2E-5 uCi/cc Cs-137 equivalent.
In order to minimize the chance of a change in the background of a monitor masking a significant trend in monitored activity, the alarm setpoints for the Service Mater and RHR Service Mater monitors are I determined as follows:
a .. When moni tor. background ~ (ZE-5)/Cal. Factor:
I HI RAO Setpoint = 0.5 Background + (ZE-5)/Cal. Factor DOWNSCALE or LOM RAO Setpoint = 0.5 Background
- b. Mhen monitor background >(2E-5)/Cal. Factor:
Hl RAD Setpoint = Background + 0.5 (ZE-5)/Cal. Factor OOMHSCALE or LOM RAD Setpoint = Background - 0.5 (2E-5)/Cal. Factor Mhere:
Setpoint = Alarm threshold value to be entered into monitor.
(cps for Service Mater, cpm for RHR Service Mater).
Background = Monitor background at most recent background determination (cps for Service Mater, cpm for RHR Service Mater).
(2E-5) = Cs-137 Maximum Permissible Concentration (uCi/ml).
Cal. Factor = Honitor response factor per unit Cs-137 concentration determined during most recent OEC g g l989
calibration (uCi/ml per cps for Service Water, uCi/ml per cpm for RHR Service Water).
The ALERT RAD setpoints for the RHR Service Mater monitors are maintained at BOX of the applicable HI RAD setpoint (cpm).
2.2 AIRBORNE EFFLUENT MONITORS 1
SPECIFICATION 3.3.7.11 THE RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION CHANNELS SHOMN IN TABLE 3.3.7.11-1 SHALL BE OPERABLE WITH THEIR ALARM/TRIP SETPOINTS SET TO ENSURE THAT THE LIHITS OF SPECIFICATION 3.11.2.1 ARE NOT EXCEEDED. THE ALARH/TRIP SETPOINTS OF THESE CHANNELS SHALL BE DETERHINED IN ACCORDANCE MITH THE METHODOLOGY AND PARNETERS IN THE OOCM.
Noble gas activity monitors, iodine samplers and monitors, and particulate samplers and monitors are present on the reactor building ventilation system (Units 1 and 2), the turbine building ventilation system (Units 1 and 2), and the standby gas treatment system exhaust vents. Effluent system flow rate and sampler flow rate are measured on all of the systems allowing the vent monitor microprocessor to calculate release rates based on measured flow rates. Precautions, limitations, and setpoints applicable to the operation of the SSES airborne effluent monitors are provided in the applicable plant procedures. Setpoihts are conservatively established for each effluent monitor so that the instantaneous dose rates corresponding to annual dose limits in 10 CFR 20.105 for unrestricted areas will not be exceeded.
The general methodology for establishing plant ventilation airborne effluent monitor setpoints is based upon vent release rates derived from site-specific meteorological dispersion conditions, vent flow
rates, and measured or expected radionuclide mixtures in the gaseous effluents The vent release rate can then be converted to vent concentrations for input as setpoints for the applicable detectors.
Since the vent monitors are programed to calculate concentrations of iodine-131 and particulate being released based on the rate of accumulation of activity on the filters, setpoints can be established for the iodine and particulate channels.
The folIowing method is used for calculating vent monitor high radiation alarm setpoints:
I
- 1. An isotopic mixture is selected for the detector jn question, if applicable. Noble gas and particulate detector setpoints are based on actual isotopic mixtures obtained from vent sample analysis or the FSAR/FES expected release mixtures if actual samples do not contain sufficient detectable activity to accurately estimate the mixtures. The assumed isotopic mixtures are periodically reviewed to verify that they remain representative of plant effluents.
- 2. The selected noble gas or particulate mixture ~s used in the GASPAR program run to calculate the associated doses. The total source term (tota1 curies used for the calculation) does not matter as long as the proper nuclides are present in the relative proportions indicated in sample analysis data or FSAR/FES tables.
For the iodine-131 setpoint, any release total for L-L31 can be entered. The highest calculated annual average relative 10
V concentrations (X/Os) at the site boundary are used for these GASPAR ca 1 cu1 a tions.
- 3. The following ratio concept is used to calculate a release rate limit for the assumed mixture (or I-131):
Cal cul a ted Dose mrem Oose Rate Limit (mrem/ r)
Tota GASPAR Source erm Ci Limiting Release Rate Ci/yr The limiting release rate of the assumed mixture (or I-131) can therefore be calculated:
Limiting Release (Ci/yr )
(Eq. 5)
Total GASPAR Source Term, Ci Dose Rate Limit, mrem/ r a cu ated Dose, mrem For the noble gas setpoint, the calculated whole body and skin dose rates via the plume pathway are subject to the 10 CFR 20-derived limits of 500 and 3000 mrem/yr, respectively. The whole-body dose rate limit is usually most restrictive. For particulates and for the maximum calculated organ dose rate via the 'odine-131, inhalation pathway is subject to the limit of 1500 mrem/yr.
- 4. The limiting release rates are converted to limiting vent concentrations using high limit vent flow rates.
11
Limiting Vent Concentration, uCi/cc Limitino Release Rate Ci r lE6uCi Ci (Eq. 6)
(5.26E5 min/yr) (Vent Flow Rate, cc/min)
Sample calculations of waterborne and airborne effluent monitor setpoints are presented in Section A.l.2 of Appendix A.
Vent flow rates and sample flow rates are monitored and recorded for.
each of the five SSES release points. The measured flow rates are used to calculate vent concentrations and release rates. Flow channel setpoints are set at approximately 10K and 90X of .the calibrated sensor ranges to provide indication of possibly abnormal flow rates.
SPECTFTCATTOH 3.11.2.6 - THE CONCENTRATION OF HYDROGEN OR OXYGEN IN THE MAIN CONDENSER OFFGAS TREATMENT SYSTEM SHALL BE LIMITED TO LESS THAN OR EgVAL TO 4X BY VOLUME.
Hydrogen recombiners are used at SSES to maintain the relative concentration of components of potentially explosive gas mixtures outside the explosive envelope. The main condenser offgas treatment system explosive gas monitoring system (offgas hydrogen analy2'.ers) have setpoints to alarm at 1X and 2X hydrogen.
'SPECTFTCATTOH 3.11.2.7 The radioactivity rate of the noble gases Kr-85m, Kr-87, Kr-88, Xe-133, Xe-135 and Xe-138 measured at the motive steam jet condenser discharge shall be limited to less than or equal to 330 millicuries/second.
The main condenser offgas pre-treatment monitor provides indication of offgas activity prior to input to the holdup system. Alarm setpoints are based on the Tech. Spec. 3.11.2.7 noble gas release rate limit of 330 millicuries/second or less at the motive steam jet condenser discharge.
12
-0 WATERBORNE EFF U HT CONC NTRATI N ME S R HTS SPECIFICATION 3.11.1.1 THE CONCENTRATION OF RADIOACTIVE MATERIAL RELEASED IH LIQUID EFFLUEHTS TO UNRESTRICTED AREAS (SEE FIGURE 5.1.3-1)
SHALL BE LIMITED TO THE CONCENTRATIONS SPECIFIED IH 10 CFR PART 20, APPENDIX B, TABLE II, COLUMN 2 FOR RADIONUCLIDES OTHER THAN DISSOLVED OR ENTRAINED NOBLE GASES. FOR DISSOLVED OR ENTRAINED NOBLE GASES, THE CONCENTRATION SHALL BE LIMITED TO THE CONCENTRATIONS SPECIFIED IN TABLE 3.11.1.1-1.
Liquid batch releases are controlled individually and each batch release is authorized based upon sample analysis and the existing dilution flow in the discharge line. The methods for sampling and analysis of each batch prior to release are given in the applicable plant procedures. A release rate limit is calculated for each batch based upon analysis, dilution flow and all procedural conditions being met before it is t
authorized for release.
Table 3.11.1-1 mentioned in Specification 3.11.1.1 contains the following "Maximum Permissible Concentrations of Dissolved or Entrained Noble Gases Released From the Site to Unrestricted Areas in Liquid Waste":
Nuclide MPC uCi ml Kr-85m 2E-4 Kr-85 5E-4 Kr-87 4E-5.
Kr-88 9E-5 Ar-41 7E-5 Xe-131m 7E-4 Xe-133m 5E-4 Xe-133 6E-4 Xe-135m 2E-4 Xe-135 2E-4 These values were computed using Equation 20 of ICRP2 (1959), adjusted for infinite cloud submersion in water, with R equal to 0.01 rem/week, 13
the density of water equal to 1.0 gm(cm~, and Pw(pt equal to 1.0, where Pw(Pt is stopping power of water relative to tissue, and R is the dose rate limit for total body exposure. The HPC value for other liquid effluents is the actual HPC for identified mixtures, or'lE-7 uCi/ml for unidentified mixtures.
The liquid radwaste effluent stream entering the discharge line is monitored and will automatically be terminated if the pre-selected monitor setpoint is exceeded as described in Section 2.1.
Additiona1 monthly and quarterly analyses shall be performed in accordance with Table 4.11-1 of the SSES Technical Specifications.
SPECIFICATION 3.11.2.1. THE DOSE RATE DUE TO RADIOACTIVE MATERIALS RELEASED IN GASEOUS EFFLUENTS FROM THE SITE (SEE FIGURE 5.1.3-1) SHALL BE LIMITEDTO THE FOLLOWING:
- a. FOR NOBLE GASES: LESS THAN OR EQUAL TO 500 MREM/YR TO THE TOTAL BODY AND LESS THAN QR EQUAL TO 3000 MREM/YR TO THE SKIN, AND
- b. FOR IODINE-131, FOR TRITIUM, AND FOR ALL RADIONUCLIDES IN PARTICULATE FORM WITH HALF-LIVES GREATER THAN 8 DAYS:
LESS THAN OR EQUAL TO 1500 MREM/YR TO ANY ORGAN (INHALATIONPATHWAY ONLY).
SPECIFICATION 3.11.2.2. THE AIR DOSE DUE TO NOBLE GASES RELEASED IN GASEOUS EFFLUENTS, FROM EACH REACTOR UNIT, TO AREAS AT AND BEYOND THE SITE BOUNDARY (SEE FIGURE 5.1.3-1)
SHALL BE LIMITEDTO THE FOLLOWING:
- a. DURING ANY CALENDAR QUARTER: LESS THAN OR EQUAL TO 5 MRADS FOR GAMMARADIATIONAND LESS THAN OR EQUAL,TO 10 MRADS FOR BETA RADIATION,AND 7
- b. DURING ANY CALENDAR YEAR: LESS THAN OR EQUAL TO 10 MRADS FOR GAMMARADIATIONAND LESS THAN OR EQUAL TO 20 MRADS BETA RADIATION.
SPECIFICATION 3.11.2.3. THE DOSE TO A MEMBER OF THE PUBLIC FROM IODINE-131, TRITIUM, AND ALL RADIONUCLIDES IN PARTICULATE FORM WITH HALF-LIVES GREATER THAN 8 DAYS IN GASEOUS EFFLUENTS RELEASED, FROM EACH REACTOR UNIT, TO AREAS AT AND BEYOND THE SITE BOUNDARY (SEE FIGURE 5.1.3-1) SHALL BE LIMITEDTO THE FOLLOWING:
- a. DURING ANY CALENDAR QUARTER: LESS THAN OR EQUAL TO 7.5 MREIVIS TO ANY ORGAN, AND
- b. DURING ANY CALENDAR YEAR: LESS THAN OR EQUAL TO 15 MREMS TO ANY ORGAN.
Date
~
Rev. 7 4.1 Noble Gases Noble gas activity monitor setpoints are established at release rates which permit some margin for corrective action to be taken before exceeding 15
offsite dose rates corresponding to the 10 CFR 20 annual dose limits as described in Section 2.2. The methods for sampling and analysis of continuous ventilation releases are given in the applicable plant procedures.
The dose rate in unrestricted areas due to radioactive materials released in airborne effluents may be determined by the following equation for whole body dose:
D~ =g (Ki)(X/Q)v (Q)(SF)
I and by the following equation for skin dose:
Ds =g p i+((1.11 (Mi)(SF))J (X/Q)(Q'>) (Eq. 8)
I Where:
the whole-body dose factor due to gamma emissions for each identified noble gas radionuclide (i) (mrem/yr per ljCi/m') from Table 2.
Q'i the release rate of radionuclide (i) from vent (v)
(pCi/sec).
(x/Q)v the highest calculated annual average relative concentration for any area at or beyond the site boundary in an unrestricted area from vent release point (v) (sec/m ) such as from Table 3.
the annual whole-body dose (mrem/yr).
L; the skin dose factor due to the beta emissions for each identified noble gas radionuclide (i) (mrem/yr per pCi/m') from Table 2.,
the air dose factor due to gamma emissions for each identified noble gas radionuclide (i) (mrad/yr per pCi/m') from Table 2 (conversion constant of 1.1 converts air dose-mrad to skin dose-mrem).
Ds the annual skin dose (mrem/yr).
SF the gamma shielding'factor (0.7 for maximally exposed individual)
Appv Dete 2" c ~
Rev. 7 16
Sample calculations for determining whole body and skin doses from noble gas radionuclides released from the SSES are given in Section A.2.1 of Appendix A.
4.2 Radionuclides Other Than Noble Gases The methods for sampling and analysis of continuous ventilation releases for radioiodines and radioactive particulates are given in the applicable plant procedures. Additional monthly and quarterly analyses shall be performed in accordance with Table 4.11.2.1.2-1 of the SSES Technical Specifications. The dose rate in unrestricted areas due to inhalation of.
radioactive materials released in airborne effluents may be determined by the following equation for any organ:
(Eq. 9)
Where:
Rt the dose rate parameter based on inhalation pathway for radionuclides other than noble gases for the inhalation pathway (mrem/yr per pCi/m') from Table 4.
Wy the highest annual average dispersion parameter for estimating the dose to the critical receptor; relative concentration (X/Q) (sec/m') for the inhalation pathway, such as from Table 3.
Q'~ = the release rate of radionuclide (i) from vent (v)
(pCi/sec).
Dc = the annual organ dose mrem/yr).
Sample calculations for determining doses to critical organs from radionuclides other than noble gases released from the SSES are given in Section A.2.2 of Appendix A.
Appv Rev. 7 17
TABLE 2 DOSE FACTORS FOR HOSLE GASES' Whole Body Gamma Air Beta Air Dose Factor Skin Dose Factor Dose Factor Dose Factor K L H' H ic de e C e C s
C ad Kr-83m 7.56E-02 1.93E+01 2,88E+02 kr-85m 1.17E<03 1.46E<03 1.23E+03 1.97E+03 Kr-85 1.61E101 1.34E403 1.72E+01 1.95E+03 Kr-87 5.92E+03 9.73E103 6.17E+03 1.03E+04 Kr-88 1.47E~04 2.37E~03 1.52E+04 2.93E+03 Kr-89 1.66E<04 1.01E+04 1.73E+04 1.06E+04 Kr-90 1.56Et04 7.29E+03 1$ 3E+04 7.83E+03 Xe-13 lm 9.15E>01 4.76E<02 1. 56E+02 l,llE+03 Xe- l33m 2.51E<02 9.94E<02 3.27E+02 1.48E+03 Xe-133 2.94B02 3.06E102 3.53E+02 1.05E+03 F Xe-135m 3.12E<03 7.11Ew02 3.36E+03 7.39B02 Xe-135 1.81E+03 1.86E+03 1.92E+03 2.46E+03 Xe-137 1.42E<03 1.22E404 1.51E+03 1.27E+04 Xe-138 8.83E+03 4.13E403 9,21E+03 4.75E+03 Ar-41 8,84E+03 2'.69E~03 9.30E+03 3.28E+03 The listed dose factors are for radionuclides that may be detected in airborne effluents and derived from Table B-1 in Reg. Guide'. 109.
7.56E-02 7.56 x 10
TABLE 3
'SANPLE ANNUAL AV'ERAGE REI ATIVE CONCENTRATIONS AND DEPOSITION RATES RiLATIYE RELATIYE RELATIYE SITE - CONCENTRATIONS CONCENTRATIONS DEPOSITION DOMNM1'ND BOUNDARY UNDECAYED/UNDEP)ETED DECAYED, DEPLEIED RATES SECTOR ~MILES I sec m 0 m HNE .78 4.7E-6 3.9E-6 1.4E 8 NE .61 4.9E-6 4.,5E-6 2.8E-8 ENE .53 3.3E-6 3.1E-6 2.7E-S E .53 1.8E-6 1.4E-6 1.2E-S ESE .51 2.1E-6 1.8E-6 1.4E-S SE .42 2.8E-6 2. SE>>6 2m 3E-8 SSE .34 5.6E-6 4.7E-6 4.0E-S S .34 S.OE-6 6.6E-6 3. 6E-8 SSW .41 1.2E-5 1. OE-5 4. 1E-8 SW. .83 6.4E-6 5.7E-6 1.5E-S MSM 1.03 1.3E-5 1.1E-5 1. 9E-8 1.02 5. 7E-'6 5.2E-6 l. 1E-8
~ 62 7.0E-6 6.2E-6 1. 6E-8
.65 6.6E-6 k
5.4E-6 1 7E8
.59 6. 1E-6 5.8E-6 1.8E-S
.59 6.3E-6 5.7E-6 2. 1E-8 From SSES 1992 Heteorological Sulteary, Haliburton NUS Corporation, 5/93.
Site Boundary distances are approximate, and current as of 5/93.
19
DOSE FACTORS FOR INHALATION, INGESTION ANO GROUND EXPOSURE PAT1NAYS: RADIONUCLIDES OTHER THAN NOBLE GASES(l) *
(2)
(1)Reference letter R. K. Barclay to File R9-5: Technical Documentation of Lotu~ 1-2-3 OOCMTAB and TGTHSTR files: Gaseous Dose Factor Calculation using NUREG-0133/Reg. Guide 1.109 Nethodology, PL1 69605, 11/8/91.
(2)Reference letter R. K. Barclay to File R9-5: Technical Documentation:
OOCMTAB.WKl Revision 1 Correction of Tritium in Yegetation Pathway Dose Calculations Factor Algorithms, PL1 T2980, 11/24/92..
V 20 DWTE l
O.O.C.H. MAXIMUM PATHMAY QQSE FACTORS: RAOIONUCLIOES OTHER THAN NOBLE GASES>>
Pf: H-3 MAY AGE GROUP BONE LIVER T.BODY THYROID K IONE Y LUNG G.I. SKIN GROUND ADULT Q.QOE+00 Q.QQE+QQ 0.00f+00 Q.QQEe00 Q.QQE+00 Q.QQE+QQ Q.QQE+00 O.OOE+00 TEEN 0.00E+00 0.00f+00. 0.00f+00 Q.QOE+00 0.00E+00 0.00E+00 0,00f+00 Q.OQE+00 CHILD 0.00E+00 0.00f+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 INFANT 0.00f+00 0.00E+00 0.00E+00 0.00E+00 Q.QQE+00 0.00E+00 0.00E+00 Q.OOE+00 GOAT ADULT 0.00E+00 1.38E+03 1.38E+03 1.38E+03 1.38E+03 1.38E+03 1.38E+03 H/A'/A MILK TEEH Q.QQE+00 1.80E+03 1.80f+03 1.80E+03 1.80E+03 1.80E+03 1.80E+03 CHILD 0.00E+00 2.84E+03 2.84E+03 2.84E+03 2.84E+03 2.84E+03 2.84E+03 H/A INFANT Q.OOE+00 4.3 If+03 4.3lf+03 4.31E+03 4.31E+03 4.31E+03 4.31E+03 N/A COW ADULT Q.OOE+00 6.77f+02 6.7?E+02 6.77E+02 6.77E+02 6.77E+02 6.7?f+02 H/A HII K TEEN O.OOE+00 8.82f+02 8.82E+02 8.82E+02 8.82E+02 8.82E+02 8.82E+02 H/A CHILD Q.QOE+00 1.39f+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03 INFANT 0.00E+00 2.11E+03 2-llE+03 2.11E+03 2.11E+03 2-llE+03 Z.llf+03 'H/A MEAT ADULT 0-00E+00 2.89E+02 2.89E+02 2.89E+02 2.89E+02 2.89E+02 2.89E+02 H/A TEEH Q.QOE+00 1.72f+02 1.72E+02 1.72E+02 1.72E+02 1.72E+02 1.72E+02 H/A CHILD O.OOE+00 2.08f+02 2.08E+02 2.08E+02 2.08E+02 2.08E+02 2.08E+02 H/A INFANT 0.00E+00 Q.QQE+00 Q.QQE+00 0.00E+00 0.00E+00 O.OQE+00 Q.QQE+00 N/A YEGTBLE ADULT Q.OOE+00 1.82f+03 1.82E+03 1.82E+03 1.82E+03 1..82E+03 1.82E+03 H/A TEEN 0.00E+00 2.18E+03 2.18E+03 2.18E+03 2.18E+03 2.18E+03 2.18E+03, N/A CHILD 0.00E+00 3.42f+03 3.42E+03 3.4ZE+03 3.42E+03 3.42E+03 3.42E+03 N/A INFANT O.OOE+00 O.QOE+00 O.OOE+00 Q.QQE+OD O.DOE+00 O.OOE+00 O.QOE+00 N/A TO ADULT 0.00E+00 4.17f+Q3 4.17E+03 4. I? E+03 4.17E+03 4. 1T E+03 4. ITE+03 H/A INGEST. TEEN 0.00E+00 5.03f+03 5.03E+03 5.03E+03 5.03E+03 5.03E+03 5.03E+03 H/A CHILD 0.00E+00 7.86f+03 ?.86E+03 7.86E+03 7.86E+03 7.86E+03 7.86E+03 H/A IHFAHT 0.00E+00 6.43f+03 6.43E+03 6.43E+03 6.43E+03 6.43E+03 6.43E+03 N%A IHHAL. ADULT Q.QQE+00 1.26f+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 1.26E+03 H/A TEEH Q.QOE+00 I.ZTE+03 1.2?E+03 1.27E+03 1.27E+03 1.27E+03 1.27E+03 H/A CHILD 0.00E+00 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 H/A INFANT 0.00E+00 6.47f+02 6.47E+02 6.47E+02. 6.47E+02 6.47E+02 6.4?f+OZ N/A BONE LIVER T.BODY THYROID KIONEY LUNG G.I. SKIN "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"""MAXIMUMVALUFS FOR PATHMAYS*~"
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK MfAT'EGTBLE: INGEST: IHHAL.
Q.QOE+00 O.QOE+00 4.31f+03 2.11E+03 2.89E+02 3.42E+03 7.86E+03 1.27f+03 4-1
P.O.C.H MAXIMUM PATHWAY OPSE FACTORS: RADIPNUCLIOES OTHER THAN NOBLE GASES" 3PE: C-14 r.,iHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY G.!. SKIN GROUND ADULT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Q.OQE+00 TEEN O.OOE+00 0.00f+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.ppE+pQ CHILD 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Q.ppf+QQ INFANT 0.00E+00 0.00E+00 0.00f+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OPE+OP
.GOAT ADULT 1.69E+08 3.39E+07 3.39E+07 3.39E+07 3.39E+07 3.39E+07 3.39E+07 H/A
.'MILK TEEN 3. IZE+08 6.24f+07 6.24'E+07 6.24E+07 6.24E+07 6.24E+07 6.24E+07 N/A CHILD 7.68E+08 1.54E+OB 1.54E+08 1.54E+08 1.54E+08 1.54E+08 1.54E+08 N/A INFANT 1.50E+09'.21E+08 3.21E+08 3.21E+08 3.21E+08 3.21E+08 3.21E+08 N/A COW ADULT 1.35E+08 2.71E+0? 2.71E+07 2.71E+07 2.71E+07 2.71E+07 2.71E+07 H/A MILK TEEN 2.50E+08 4.99E+07 4.99E+07 4.99E+07 4.99E+07 4.99E+07 4;99E+07 H/A CHILD 6. 14f+08 1.23E+QB 1.23E+08 1.23E+08 1.23E+08'.23E+08 1.23E+08 H/A INFANT 1.20E+09 Z.57E+08 2.5?E+08 2.5?E+08 2.57E+08 2.5?E+08 2.57E+08 .H/A MEAT ADULT 1.36E+08 2.72E+07 2.72E+07 2.72E+07 2.72E+07 2.72E+07 2.72E+07 N/A TEEN 1.15E+08 2.30E+07.2.30E+O? 2.30E+07 2.30E+07 2.30E+07 2.30E+07 CHILD 2.16E+08 4.33E+07 4.33E+07 4.33E+07 4.33E+07 4.33E+07 4.33E+07 H/A INFANT O.OOE+00 O.OOE+00 O.OQE+00 O.OOE+00 O.OOE+00 O.OOE+00 0 OOE+00 N/A VEGTBLE ADULT 2.06E+08 4.13E+0? 4.13E+07 4.13E+07 4.13E+07 4.13E+07 4.13E+07 H/A TEEN 3.49E+08 6.98E+07 6.98E+07 6.98E+07 6.98E+07 6.98E+07 6.98E+07 H/A CHILD 8.53f+08 1.7IE+08 1.71E+08 1.71E+08 1.71E+08 1.7IE+08 1.?IE+08 H/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A TOTAL ADULT 6.4?E+08 1.29E+08 1.29E+08 1.29E+08 1.29E+08 1.29E+08 1.29E+08 H/A INGEST. TEEH 1.03E+09 2.Q5E+08 2.05E+08 2.05E+08 Z.OSE+08 2.05E+08 2:05f+08 HCA CHILD 2.45E+09 4.90E+08 4.90E+08 4.90E+08 4.90E+08 4.90E+08 4.9'OE+08'.7IE+09 N/A INFANT 5.78E+08 5.78E+08 5.78F+QB 5.78E+08 5.78E+08 5.78E+08 N/A IHHAL. ADULT 1.82E+04 3.41E+03 3.41E+03 3.41E+03 3.4IE+Q3 3.41E+Q3 3.41E+03 H/A TEEN 2.60E+04 4.87E+03 4.8?E+03 4'.87E+03 4.87E+03 4.87E+03 4.87E+Q3 N/A CHILD 3.59f+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 N/A .
INFANT 2.6SE+04 5.31E+03 5.31E+03 5.31E+03 5.31E+03 5.31E+03 5.3IE+03 H/A BONE LIVER T.BODY THYROID KIONEY LUNG G. I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
""+MAXIMUMVALUES FOR PATHWAYS~**
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK- MEAT: 'EGTBLE: INGEST: INHAL.
O.OOE+00 O.OOE+00 1.50E+09 1.20E+09 Z.'16E+08 8 53E+08 2.?IE+09 3.59E+04 PAGE: 4-2
O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*
I E P-32 i
t-~iHWAY AGE GROUP BONE L I VER T. BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 0.00E+00 0.00f+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 TEEN 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00f+00 0.00E+00 O.OOE+00 0.00E+00 CHILD 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 GOAT ADULT 9.28E+09 5.77E+08 3.59E+08 O.OOE+00 O.OOE+00 0:OOE+00 1.04f+09 H/A MILK TEEN l. 71E+10 1.06E+09 6.64E+08 O.OOE+00 O.OOE+00 O.OOE+00 1.44E+09 H/A CHILD 4. 22E+10 1.98E+09 1.63f+09 0.00E+00 0.00E+00 0.00E+00 1.17E+09 H/A INFANT 7. 25E+10 5.12E+09 3.3?f+09 O.OOE+00 0.00E+00 0.00E+00 1.18E+09 NfA COW ADULT 4.36E+09 2.71E+08 1.69E+08 0.00E+00 0.00E+00 O.OOE+00 4.91E+08 H/A MILK TEEN 8.05E+09 4.99E+08 3.12E+08 0.00E+00 0.00E+00 0.00E+00 6.77E+08 N/A CHILD 1.99E+10 9.29E+08 7.65E+08 O.OOE+00 O.OOE+00 O.OOE+00 5.49E+08 N/A INFANT 4.09E+10 2.41E+09 1.59E+09 O.OOE+00 O.OOE+00 O.OOE+00 5.54E+08 N/A MEAT ADULT ~
1.55E+09 9.63E+07 5.99E+07 0.00E+00 0.00E+00 0.00E+00 1.74E+08 N/A TEEN 1.31E+09 8.11E+07 5.07E+07 0.00E+00 0.00E+00 0.00E+00 1.10E+08 N/A CHILD 2.4?E+09 1.15f+08 9.51f+07 O.oof+00 O.OOE+00 O.OOE+00 6.82E+07 N/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 N/A aTBLE ADULT ?.09E+08 4.41E+07 2.74E+07 0.00E+00 0.00E+00 0.00E+00 7.98E+07 N/A TEEN 9.57E+08 5.93E+07 3.71E+07 0.00E+00 0.00E+00 0.00E+00 8.05E+07 N/A CHILD 2.16E+09 1.01E+08 8.34E+07 0.00E+00 0.00E+00 0.00E+00 5.98E+07 N/A IHFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A OTAL ADULT 1.59E+10 9.89f+08 6.15f+08 0.00E+00 0.00E+00 0.00E+00 1.79E+09 H/A HGEST. TEEN 2.74E+10 1.70f+09 1.06E+09 O.OOE+00 O.OOE+00 0.00f+00 2.31E+09 ,N/A CHILD 6.67E+10 3.12E+09 2.57E+09 0.00E+00 0.00E+00 0.00E+00 1.84E+09 N/A INFANT 1.13f+11 7.53E+09 4.96E+09 0.00E+00 0.00E+00 0.00E+00 1.73E+09 H/A HHAL. ADULT 1.32E+06 7.71E+04 5.01E+04 O.OOE+00 O.DOE+00 O.oof+00 8.64E+04 H/A TEEN 1.89E+06 1.10E+05 7.16E+04 O.OOE+00 O.OOE+00 O.OOE+00 9.28E+04 N/A CHILD 2.60E+06 l."14E+05 9.88E+04 0.00E+00 0.00E+00 0.00E+00 4.22E+04 N/A INFANT 2.03E+06 1.12E+05 7.74E+04 0.00E+00 0.00E+00 O.OOE+00 1.61E+04 H/A BONE LIVER T.BODY THYROID . KIDNEY LUNG G.I. SKIN "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"" MAXIMUM VALUES FOR PATHWAYS*~~
GROUND: GROUND: GOAT COW TOTAL T. B./ORG. SK IH MILK: MILK: HEAT: VfGTBLE: INGEST: IHHAL.
0.00E+00 0.00E+00 ?.25f+10 4.09E+10 2.47E+09 2.16E+09 1.13f+11 2.60E+06 PAGE: 4-3
O-D.C.M. HAXIHUH PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*
IS .~PE: Cr-51 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 4.61E+06 4.61E+06 4.6)E+06 4.61E+06 4.6)E+06 4.61E+06 4.6)E+06 5.45E+06 TEEN 4.61E+06 4.61E+06 4.6)E+06 4.61E+06 4.6)E+06 4.61E+06 4.61E+06 5.45E+06 CHILD 4.61E+06 4.6)f+06 4.6)E+06 4.6)E+06 4.61E+06 4.61E+06 4.6)E+06 5.45E+06 INFANT, 4.61E+06 4.6)E+06 4.6)E+06 4.61E+06 4.6)E+06 4.61E+06 4.61E+06 5.45E+06 GOAT 'ADULT 0.00E+00 O.OOE+00 1.61E+03 9.64E+02 3.55E+02 2.14E+03 4.06E+05 H/A
/ILK TEEN O.OOE+00 0.00E+00 2.82E+03 1.56E+03 6.17E+02 4.02E+03 4.73E+05 H/A CHILD O.OOE+00 0.00E+00 5.74E+03 3.19E+03 8.7)E+02 5.82E+03 3.05E+05 H/5 INFANT O.OOE+00 0.00f+00 9.)Of+03 5.94E+03 1.30E+03 1.16E+04 2.65E+05 H/A COW ADULT 0.00f+00 0.00E+00 7.99E+03 4.77E+03 1.76f+03 1.06E+04 2.01E+06 H/A HILK TfEH O.OOE+00 0.00E+00 1.39E+04 7.75E+03 3.06E+03 1.99E+04 2;34E+06 N/A CHILD 0.00E+00 O.OOE+00 2.84E+04 1.58E+04 4.32E+03 2.88E+04 1.51E+06 H/A INFANT O.OOE+00 0.00f+00 4.5)E+04 2.94E+04 6.43E+03 5.72E+04 1.31E+06 N/A HEAT ADULT O.OOE+00 O.OOE+00 2.50E+03 1.49E+03 5.50E+02 3.31E+03 6.28E+05 N/A TEfN 0-OOE+00 0.00E+00 2.00E+03 I.IIE+03 4.38E+02 2.85E+03 3.36E+05 H/A CHILD 0.00E+00 0.00E+00 3.)IE+03 1.73E+03 4.72E+02 3.16E+03 1.65E+05 H/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A VEGA'BLE ADULT 0.00E+00 0.00E+00 3.35E+04 2.01E+04 7.39E+03 4.45E+04 8.44E+06 H/A TEEN 0.00E+00 0.00E+00 5.02E+04 2.79E+04 1.10E+04 7.17E+04 8.44E+06 N/A CHILD 0.00E+00 0.00E+00 9.96E+04 5.53E+04 1.51E+04 ).OIE+05 5.28E+06 H/A INFANT 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 H/A TOTAL ADULT O.OOE+00 O.OOE+00 4.56E+04 2.73E+04 1.0)E+04 6.06E+04 1.15E+07 N/A INGEST. TEEN 0.00E+00 0.00E+00 6.90E+04 3.83E+04 1.5IE+04 9.85E+04 1.16E+07 H/A CHILD O.OOE+00 0.00E+00 1.37E+05 7'.60E+04 2.08E+04 1.39E+05 7.26E+06 N/A INFANT 0.00E+00 0.00E+00 5.42E+04 3.53E+04 7.72f+03 6.88E+04 1.58E+06 H/A IHHAL. ADULT O.OOE+00 0.00E+00 1.00E+02 5.95E+Ol 2.28E+Ol 1.44E+04 3.32E+03 N/A TEEN O.OOE+00 0.00f+00 1.35E+02 7.50E+01 3.07E+Ol 2.10E+04 3.00E+03 H/A CHILD O.OOE+00 O.OOE+00 1.54E+02 8.55E+01 2.43E+01 1.70E+04 ).OBE+03 H/A INFANT O.OOE+00 0.00f+00 8.95E+01 5.75E+Ol 1.32E+0) 1.28E+04 3.57E+02 N/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.
SKIN'Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"**HAXIMUM VALUES FOR PATHWAYS"*"
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN: HILK: H ILK: HEAT: VEGTBLE: INGEST: IHHAL.
4.61E+06 5.45E+06 4.73E+05 2.34E+06 6.28E+05 8.44E+06 ).)6E+07 2.)OE+04 PAGE: 4-4 H
OAl'
O-O-C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIOfS OTHER THAN NOBLE GASES*
I E: Mn-54 PATHWAY AGE GROUP BONE LUNG G.I. SKIN GROUND ADULT 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.61E+09 TEEN ~
1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.61E+09 CHILD 1.37E+09 1.37E+09'.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.61E+09 INFANT 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09 1.37E+09.1.61E+09 N/A'.37E+09 GOAT ADULT 0.00E+00 6.14E+05 1.17E+05,0.00E+00 1.83E+05 O.OOF+00 1.88E+06 N/A MILK TEEN 0.00E+00 1.02E+06 2.03E+05 0.00E+00 3.05E+05 O.OOE+00 2.10E+06 '/A CHILD 0.00E+00 1.53E+06 4.07E+05 0.00E+00 4.29E+05 O.OOE+00 1.28E+06 N/A INFANT O.OOE+00 2.84E+06 6.45E+05 O.OOE+00 6.30E+05 O.OOE+00 1.04E+06 COW ADULT O.OOE+00 3.92E+06 7.49E+05 O.OOE+00 1.17E+06 O.OOE+00 1.20f+07 H/A ILK TEEN O.OOE+00 6.54E+06 1.30E+06 O.OOE+00 1.95E+06 O.OOE+00 1.34E+07 H/A CHILD 0.00E+00 9.78E+06 ?.61E+06 0.00E+00 2.74E+06 0.00E+00 8.21E+06 H/A INFANT 0.00f+00 1.82E+07 4.12E+06 0.00E+00 4.03E+06 0.00E+00 6.68E+06 N/A EAT ADULT O.OOE+00 4.79E+06 9.14E+05 0.00E+00 1.43E+06 0.00E+00 1.47E+07 N/A TEEN O.OOE+00 3.65E+06 7.25E+05 O.OOE+00 1;09E+06 O.OOE+00 7.49E+06 H/A CHiLD 0.00E+00 4.18E+06 1.11E+06 0.00E+00 1.17E+06 0.00E+00 3.51E+06 H/A INFANT O.OOE+00 0.00E+00 0.00f+00 0.00E+00,0.'OOE+00 0.00E+00 0.00E+00 N/A GTBLE ADULT 0.00E+00 2.80E+08 5.35E+07 0.00E+00 8.34E+07 0.00E+00 8.58E+08 N/A TEEN O.OOE+00 4.27E+08 8.46E+07 0.00E+00 1.27E+08 0.00E+00 8.75E+08 N/A CHILD O.OOE+00 6.34E+08 1.69E+08 O.OOE+00 1.78E+08 O.OOE+00 5.32E+08 H/A INFANT 0.00E+00 0.00E+00 0.00E+00'0.00E+00 0.00E+00 0.00E+00 O.OOE+00 H/A OTAL ADULT 0.00E+00 2.90E+08 5.53E+07 0.00E+00 8.62E+07 0.00E+00 8.87E+08 N/A NGEST. TEEN 0.00E+00 4.38E+08 8.69E+07 0.00E+00 1.31E+08 0.00E+00 8.98E+08 H/A CHILD 0.00E+00 6.49E+08 1.73E+08 0.00E+00 1.82E+08 0.00E+00 5.45E+08 H/A INFANT O.OOE+00 2.10E+07 4.77E+06 O.OOE+00 4.66E+06 O.OOE+00 7.73E+06 H/A HHAL. ADULT 0.00E+00 3.96E+04,6.30E+03 0.00E+00 9.84E+03 1.40E+06 7.74E+04 '/A TEEN 0.00E+00 5.11E+04 8.40E+03 0.00f+00 1.27E+04 1.9BE+06 6.68E+04'/A CHILD 0.00E+00 4.29E+04 9.51E+03 0.00E+00 1.00E+04 1.58E+06 2.29E+04 H/A INFANT 0.00E+00 2.53E+04 4.98E+03 0.00E+00 4.98E+03 1.00E+06 7.06E+03 H/A BONE LIVER T. BODY,THYROID KIDNEY LUNG G.l. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
<<<<<<MAXIMUM VALUES FOR PATHWAYS<<'
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MI LK: HEAT: VEGTBLE: INGEST: INHAL.
1.37E+09 1.61E+09 2.84E+06 1.82E+07 1.47E+07 8.75E+08 8.98E+08 1.98E+06 PAGE: 4-5 OAT
O.D.C.M. MAXIMUM PATHWAY DOSE 'FACTORS: RADIONUCLIDfS OTHER THAN NOBLE GASES*
a APE Fe-55 PATHWAY AGE GROUP BONE LIVfR T-BODY THYROID KIDNfY G.I. SKIN GROUND ADULT Q.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.QOE+00 0.00E+00 0.00E+00 O.OOE+00 TEEN O.OOF+OO O.OOE+00 O.QOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOF+OO CHILD 0.00E+00 Q.oof+QQ Q.QOE+00 O.QOE+00 Q.QQE+00 Q.QOE+00 0.00E+00 0.00E+00 INFANT O.OOE+00 O.OQE+00 O.OOE+OO O.OOE+00 0;OOE+QO O.QOE+QQ Q.oof+QQ Q.QQE+00 GOAT ADULT 2.06E+05 1.42f+05 3.32E+04 O.oof+00 0.00E+00 7.94E+04 8.16E+04 H/A MILK TEEN 3.65E+05 2.59f+05 6.04E+04 0.00E+00 0.00E+00 1.64E+05 1.12E+05 N/A CHILD 9.17E+05 4.86E+05 1.5IE+05 O.QQE+00 0.00E+00 2.75E+05 9.01E+04 H/A INFAHT 8.52E+07 7.16f+05 1.91E+05 O.QQE+00 O.QOE+00 3.50E+05 9.09E+04 H/A COW ADULT 1.25E+07 8.64f+06 2.01E+06 Q.QQE+00 Q.QQE+00 4.82E+06 4.95E+06 N/A MILK TEEN 2.22E+07 1.5?f+07 3.67E+06 O.OOE+00 O.QOE+00 9.97E+06 6.80f+06 H/A CHILD 5.56E+07 2.95f+07 9.14E+06 0.00E+00 0.00E+00 1.67E+07 5.47E+06 H/A INFANT 6.73E+07 4.34E+07 1.16E+07 0.00E+00 O.OOE+00 2.12E+07 5.52E+06 N/A IMEAT ADULT 1.61E+08 1.11E+08 2 60E+07 O.OOE+00 O.QOE+00 6.22E+07 6.39E+07 H/A TEEN 1.31E+Q8 9.29f+OT Z.l?E+OT Q.QQE+00 O.QOF+00 5.89E+07 4.02E+07 H/A CHILD 2.51E+08 1.33E+Q8 4.13E+0? 0.00E+00 0.00E+00 7.54E+07 2..47E+07 N/A IHFAHT O.OOE+OO O.OOf+OQ O.OOE+OO O.QOE+00 O.OOE+QO O.QOE+00 Q.QQE+00 H/A VEGTBLE ADULT 1.89E+08 1.31f+08 3.05E+07 0.00E+00 O.oof+00 7.30E+07 7.50E+07 H/A TEEN 3.08E+08 2.18E+08 5.09E+07 0.00E+00 0.00E+00 1.38E+08 9.44E+07 N/A CHILD 7.67E+08 4.0? f+08 1.26E+08 0.00E+00 O.OOE+00 2.30E+08 7.53E+07, N/A INFANT Q.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OQE+00 0.00E+00 O.OQE+00 H/A TOTAL ADULT 3.63E+08 2.51f+08 5'.85E+07 0.00E+00 0.00E+00 1.40E+08 1.44E+08 H/A INGEST. TEEN 4.61E+08 3.27E+08 7.62E+07 0.00E+00 O.OOE+00 2.07E+08 1.41E+08 H/A CHILD 1.07E+09 5.70f+08 1.77E+08 0.00E+00 0.00E+00 3.22E+08 1.06E+08 N/A INFANT 1.52E+08 4.42E+07 1.18E+07 Q.QQE+00 O.OOE+00 2.16E+07 5.61E+06 N/A IHHAL. ADULT 2.46E+04 1.70E+04 3.94E+03 0..00E+00 O.OOE+00'7.21E+04 6.03E+03 H/A TfEN 3.34E+04 2.38f+04 5.54E+03 0.00E+00 0.00E+00 1.24f+05 6.39f+03 N/A CHILD 4.74E+04 2.52f+O4 7.77E+03 O.OOE+Oo O.OOE+OO 1.11E+05 2.87E+03 N/A INFANT 1.97E+04 1.17E+04 3.33E+03 Q.QQE+00 0.00E+00 8.69f+04 1.09E+03 H/A BONE LIVER T. BODY THYROID KIONEY LUNG G.I. SKIN, "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
""*MAXIMUMVALUES FOR PATHWAYS~~~
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: IHHAL.
0.00E+00 0.00E+00 8.52f+0? 6.73E+07 2.51E+08 7.67E+08 1.07E+09 1.24E+05 PV D~TE PAGE: 4-6 0
O.O.C-M- MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIOES OTHER THAN NOBLE GASES*
IS ~PE: Mn-56 PATHWAY AGE GROUP BONE LIVER T. BODY -
THYROID KIOHEY LUNG G. I. SKIN GROUND ADULT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TEEN 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 CHILD 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.0.00f+00 0.00E+00 7.17E-04 1.27E-04 0.00E+00 9.11E-04 0.00E+00 2.29E-02 H/A MILK'DULT GOAT TEEN 0.00E+00 1.27E-03 2.26E-04 0.00E+00 1.61E-03 0.00E+00 8.37E-02 H/A CHILD 0.00E+00 2.22E-03 5.01E-04 0.00E+00 2.68E-03 0.00E+00 3.2IE-Ol H/A INFANT 0.00E+00 5.43E-03 9.36E-04 0.00E+00 4;67E-03 0.00E+00 4.93E-Ol H/A COW ADULT 0.00E+00 1.05E-03 1.86E-04 O.OOE+00 1.33E-03 0.00E+00 3.34E-02 H/A ILK TEEN 0.00E+00 1.85E-03 3.30E-04 0.00E+00 2.35E.-03 0.00E+00 1.22E-01 N/A CHILD 0.00E+00 3.23E-03 7.30E-04 0.00E+00 3.91E-03 0.00E+00 4.69E-Ol H/A INFANT O.OOE+00 7.92E-03 1.37E-03 0.00E+00 6.81E-03 0.00E+00 7.19E'-01 H/A ..
EAT ADULT 0.00E+00 5.00E-54 8.86E-55 0.00E+00 6.34E-54 O.OOE+00 1.59E-52 H/A TEEN 0.00E+00 4.06E-54 7.21E-55 0.00E+00 5.14E-54 O.OOE+00 2.676-52 H/A ~
CHILD 0.00E+00 5.41E-54 1.22E-54 0.00E+00 6.54E-54 O.OOE+00 7.84E-52 H/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 H/A
.~T E ADULT 0.00E+00 5.25E+00 9.31E-Ol 0.00E+00 6.66E+00 0.00E+00 1.67E+02 H/A TEEN 0.00E+00 4.73E+00 8.42E-01 0.00E+00 5.99E+00 O.OOE+00 3.11E+02 H/A CHILD 0.00E+00 6.19E+00 1.40E+00 0.00f+00 7.49E+00 0.00E+00 8.97f+02 H/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 N/A OTAL ADULT 0.00E+00 5.25E+00 9.31E-Ol 0.00E+00 6.66E+00 0.00E+00 1.68E+02 H/A HGEST. TEEN 0.00E+00 4.73E+00 8.42E-Ol 0.00E+00 5.99E+00 0.00E+00. 3.12f+02 H/A CHILD 0.00E+00 6.20E+00 1.40E+00 0.00E+00 7.50E+00.0.00E+00 8.98E+02 H/A INFANT 0.00E+00 1.34E-02 2.30E-03 0.00f+00 1.15E-02 0.00E+00 1.21E+00 H/A HHAL. ADULT 0.00E+00 1.24E+00 1.83E-01 0.00E+00 1.30E+00 9.44E+03 2.02E+04 H/A TEEN 0.00E+00 1.70E+00 2.52E-01 0.00f+00 1.79f+00 1.52E+04 5.74E+04 H/A CHILD 0.00E+00 1.66E+00 3.12E-OI 0.00E+00 1.67E+00 1.31E+04 1.23E+05 H/A INFANT 0.00E+00 1.54E+00 2.21f-01 0.00E+00 1.10E+00 1.25E+04 7.17E+04 H/A BONE LIVER T. BODY TH ROID KIDNEY LUNG G. I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec "MAXIMUM VALUES FOR PATHWAYS"""
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK- MEAT: VfGTBLE: INGEST: INHAL.
O.OOE+00 O.OOE+00 4.93E-01 7.19E-01 7.84E-52 8.97E+02 8.98E+02 1.23E+05 PAGE: 4-7
O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE.GASES*
I
<'OPE: Co-58 PATHWAY AGE GROUP BONE LIVER T. BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 3.75E+08 3.75E+08 3.75E+08 3.75E+08 3.7SE+08 3-75E+08 3-75E+08 4.39E+08 TEEN, 3.75E+08 3.75E+08 3.75E+08 3.75E+08 3.75E+08 3.75E+08 3.75E+08 4.39E+08 CHILD 3.75E+08 3.75E+08 3.75E+08 3.75E+08 3.75E+08 3-75E+08 3-75E+08 4.39E+08 INFANT 3.75E+08 3.75E+08 3.75E+08 3.75E+08 3.T5E+08 3.75E+08 3.TSE+08 4.39E+08 GOAT ADULT 0.00E+00 3.00E+05 6.72E+05 0.00E+00 0.00E+00 O.OOE+00 6.07E+06 H/A MILK TEEN O.OOE+00 S.OSE+05 1.16E+06 O.OOE+00 O.OOE+00 O.OOE+00 6.96E+06 N/A CHILD 0.00E+00 7.71E+05 2.36E+06 0.00E+00 0.00E+00 0.00f+00 4.50E+06 'H/A INFANT O.OOE+00 1.54E+06 3.85E+06 O.OOE+00 O.OOE+00 O.OOE+00 3.84E+06 H/A COW ADULT 0.00E+00 1.70E+06 3.81E+06 0.00E+00 0.00E+00 0.00E+00 3.44E+07 H/A MILK TEEN O.OOE+00 2.86E+06 6.59E+06 O.OOE+00 O.OOE+00 O.OOE+00 3.94E+07 N/A CHILD O.OOE+00 4.37E+06 1.34E+07 0.00E+00 O.OOE+00 0.00E+00 2.55E+07 N/A INFANT O.OOE+00 8.74E+06 2.18E+07 0.00E+00 O.OOE+00 0.00E+00 2.18E+07 'N/A MEAT ADULT 0.00E+00 7.78E+06 1.74E+07 0.00E+00 0.00E+00 0.00E+00 1.58E+08 N/A-TEEN 0.0QE+00 6.00E+06 1.38E+07 0.00E+00 0.00E+00 0.00E+00 8.27E+OT N/A CHILD O.OOE+00 7.01E+06 2.14E+07 0-OOE+00 O.OOE+00 O.OOE+00 4-09E+07 N/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 H/A VEGTBLE ADULT 0.00E+00 2.61E+07 5.86E+07 0.00E+00 0.00E+00 0.00E+00 5.29E+08 H/A TEEN O.OOE+00 3.96E+07 9.14E+07 0.00E+00 0.00E+00 O.OOE+00 5.47E+08 N/A CHILD 0.00E+00 5.99E+07 1.83E+08 O.OOE+00 0.00E+00 0.00E+00 3.49E+08 H/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 H/A TOTAL ADULT O.OOE+00 3.59E+07 8.05E+07 O.OOE+00 O.OOE+00 O.OOE+00 7.28E+08 N/A INGEST. TEEN 0.00E+00 4.90E+07 1.13E+08 0.00E+00 0.00E+00 O.OOE+00 6.76E+08 H/A CHILD 0.00f+00 7.20f+07 2.20E+08 '0.00E+00 0.00E+00 0.00E+00 4.20E+08 H/A INFANT O.OOE+00 1.03E+07 2.56E+07 O.OOE+00 0.00E+00 0.00E+00 2.56E+07 H/A IHHAL. ADULT 0.00E+00 1.58E+03 2.07E+03 0.00E+00 0.00E+00 9.28E+05 1.06E+05 H/A TEEN 0.00E+00 2.07E+03 2.78E+03 0.00E+00 0.00E+00 1.34E+06 9.52E+04 H/A CHILD 0.DOE+00 1.77E+03 3.16E+03 0.00E+00 0.00E+00 1.11E+06 3.44E+04 H/A INFANT O.OOE+00 1.22E+03 1.82E+03 0.00E+00 O.OOE+00 7.77E+05 1.11E+04 H/A BON f L IVER T. BODY THYROID KIDNEY LUNG G. I. SKIN "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"*MAXIMUMVALUES FOR PATHWAYS*"
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK:, MILK- MEAT: VEGTBLE: INGfST: INHAL.
3.7SE+08, 4.39E+08 6.96E+06 3.94E+07 1.58E+08 5 ~ 47E+08 7.28E+08 1. 34E+06 PAGE- 4-8
O.D.C.M.
~ ~ MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*
PE- Fe-59 PATHWAY AGE GROUP BONE LUNG G.I. SKIN GPOUNO ADULT 2.70E+08 2.70f+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 3.17E+08 TEEN 2.70E+08 2.70E+08 2.70E+0& 2.70E+08 2.70E+08 2.70E+08 2.70E+08 3.17E+08 CHILD 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 3.17E+08 INFANT 2-70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 2.70E+08 3.17E+08 GOAT ADULT 1.92E+05 4.52f+05 1.73E+05 0.00f'+00 0.00E+00 1.26E+05 1.51E+06 N/A MILK TEEN 3.35E+05 7.83E+Q5 3.02E+05 Q.QQE+QQ Q.QQF+00 2.47E+QS 1.85E+06 N/A CHILD 7.78E+05 1.26E+06 6.27E+05 0.00E+00 0.00E+00 3.65E+05 1.3lf+06 N/A INFANT 1.12E+08 2.54E+06 9.99E+05 0.00E+00 0.00E+00 7.49E+05 1.21E+06 N/A COW ADULT 9.41E+06 2.21E+07 8.47E+06 0.00E+00 0.00E+00 6.18E+06 7.37E+07 N/A HIL'K TEEN 1.64E+07 3.83E+07 1.48E+Q7 0.00E+00 Q.QQE+00 1.21E+Q7 9.06E+0? H/A CHILD 3.81E+07 6.16E+07 3.07E+07 0.00E+00 0.00f+00 1.79E+07 6.41E+07 H/A INFANT 7.11E+07 1.24E+08 4.89E+07 0.00E+00 0.00E+00 3.67E+07 5.93E+07 ~
H/A HEAT ADULT 1.03E+08 -2.42f+08 9.27E+07 Q.OQE+00 Q.OOE+00 6.76E+07 8.06E+08 N/A TEEN 8.23E+07 1.92E+08 7.41E+07 0.00E+00 Q.QQE+QO 6.05E+07 4.54E+08 H/A CHILD 1.46E+08 2.36E+08 1.18E+08 0.00E+00 0.00E+00 6.84f+07 2.46E+08 N/A IHFAHT Q.QOE+00 O.QQE+00 0.00E+00 0.00E+00 Q.OOE+00 O.OOE+00 O.OOE+00 -
N/A 3TBLE ADULT 1.02E+08 2.39E+08 9.17E+07 0.00E+00 0.00E+00 6.68E+07 7.97E+08 N/A i
I
~
h'ovA<
TEEN CHILD INFANT 1.58E+08 3.68E+08 1.42E+08 O.QQE+QQ 3.60E+08 5.8ZE+08 2.90E+08 0.00E+00 Q.QQE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1.16E+08 1.69E+08 0.00E+00 8.7IE+08 6.06E+08 Q.OOE+00 N/A N/A ADULT 2.14E+08 5.04E+08 1.93E+08 0.00E+00 Q.OOE+00 1.41f+08 1.68E+09 N/A
(
INGEST. TEEN 2.57E+08 5.99E+08 2.31E+08 0.00E+00 Q.OQF+00 1.89E+08 1.42E+09 N/A CHILD 5.45E+08 8.81E+08 4.39E+08 0.00E+00 0.00E+00 2.55E+08 9.18E+08 H/A INFANT 1.83E+08 I.Z7E+08 4.99E+07 O.QQE+00 Q.OOE+00 3.74E+07 6.05E+07 N/A INHAL. ADULT 1.18E+04 2.78E+04 1.06E+04 0.00E+00 0.00E+00 1.02E+06 1.88E+05 N/A TEEN 1.59E+04 3.70E+04 1.43E+04 0.00E+00 Q.OQE+00 1.53E+06 1.78f+05 N/A CHILD 2.07E+04 3.34E+04 1.67E+04 0.00E+00 0.00E+00 1.27E+06 7.07E+04 N/A INFANT 1.36E+04 2.35E+04 9.48E+03 O.OQE+00 0.00E+00 1.01E+06 2.48E+04 N/A BONE LIVER T. BODY THYROID KIDNEY LUNG G.I. SKIN Airborne pathways and tritium ingestion: units are mr em/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
- ~MAXIMUMVALUES FOR PATHWAYS~*~
GROUND: GROUND: GOAT COW TOTAL T. B./ORG. SKIN MILK: MILK- MEAT: VEGTBLE: INGEST: INHAL.
2.TOE+08 3.17E+08 I.IZE+08 1.24E+08 8.06E+08 8.71E+08 ).68E+09 1.53E+06 PAGE: 4-9
O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHfR THAN NOBLE GASES*
POPE: Co-60 PATHWAY AGE. GROUP BONE L I VfR T. BODY THYROID KIONfY LUNG G. I. SKIN GROUND ADULT 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.51E+10 TEEN 2.13E+10 2.13E+10 2-13E+10 2-13E+10 2.13E+10 2.13E+10 2-13E+10 2.5IE+10 CHILD 2.13E+10 2.13f+10 2.13E+10 2.13E+10,2.13E+10 2.13E+10 2.13E+10 2.51E+10 IHFANT 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2.13E+10 2-13E+1'0 2.5lf+10 GOAT ADULT 0.00E+00 1.25E+06 2.76E+06 0.00f+00 0.00E+00 0.00E+00 2.35E+07 H/A MILK TEEN O.OOE+00 2.12E+06 4.7&E+06 0.00f+00 O.OOE+00 O.OOE+00 2.77E+07 H/A CHILD Q.OOE+00 3.30E+06 9.72E+06 0.00E+00 0.00E+00 O.OOE+00 1.83E+07 'H/A INFANT 0.00E+00 6.73E+06 1.59E+07 0.00E+00 0.00E+00 0.00E+00 1.60E+07 COW ADULT Q.OOE+00 8.29f+06 1.83E+07 0.00E+00 0.00E+00 Q.OOE+00 1.56E+08 N/A MILK TEEN O.OOE+00 1.4lf+07 3.17E+07 O.OOE+00 O.OOE+00 O.OOE+00 1.83E+08 H/A CHILD 0.00E+00 2.1SE+07 6.44E+07 O.OQE+00 O.OQE+00 O.OOE+00 1.21E+0& H/A INFANT, 0.00E+00 4.46E+07 1.05E+08 0.00E+00 0.00E+00 0.00E+00 1.06E+08 'N/A HEAT ADULT O.OOE+00 4.19f+07'.23E+07 O.OOE+00 O.OOE+00 O.OOE+00 7.86E+08 N/A TEEN 0.00E+00 3.25f+07 7.32E+07 O.QQE+00 O.OQE+00 O.OOE+00 4.23E+0& H/A CHILD 0.00E+00 3.86E+07 1.14E+08 0.00E+00 0.00E+00 0.00E+00 2.14E+08 H/A IHFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 N/A VEGTBLE ADULT 0.00E+00 1.51E+08 3.34E+08 O.OOE+00 Q.OQE+00 O.OOE+00 2.84E+09 N/A
'EEN O.OOE+00 2.35E+08 5.29E+08 O.QOE+QQ 0.00E+00 Q.OOE+QO 3.Q6E+Q9 H/A CHILD 0.00E+00 3.62E+08 1.07E+09 0.00f+00 O.OOE+00 0.00E+00 2.01E+09 H/A INFANT O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00f+00 0.00E+00 N/A TOTAL ADULT 0.00E+00 2.03E+08 4.47E+08 O.OOE+QQ O.QOE+OQ Q.OOE+00 3.81E+09 H/A INGEST. TEEN O.OOE+00 2.84E+08 6.39E+08 0.00E+00 0.00E+00 O.OOE+00 3.69E+09 H/A CHILD O.OOE+00 4.26E+08 1.26f+09 0.00E+00 0.00E+00 0.00E+00 2.36E+09 H/A INFAHT O.OOE+00 5.13E+07 1.21E+0& O.OOE+00 O.OOE+00 O.OOE+00 1.22E+08 N/A IHHAL. ADULT 0.00E+00 l. 15f+04 1.4&E+04 0.0OE+00 0.00E+00 5.97E+06 2.85E+05 H/A TEEN Q.OOE+00 1.51E+04 1.9&E+04 0.00E+00 0.00E+00 8.72f+06 2.59E+05
'/A CHILD O.OOE+00 1.31E+04 2.26E+04 0.00f+00 O.OOE+00 7.07E+06 9.62E+04 N/A INFANT O.OOE+00 8.02E+03 1.18E+04 0.00f+00 O.OOE+00 4.51E+06 3.19E+04 N/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.I.
SKIN'Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"""MAXIMUMVALUES FOR PATHWAYS""~
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: HEAT: VEGTBLE: INGEST: INHAL.
2.13E+10 2.5lE+10 2.77E+07 1.83E+08 7.86E+08 3.06E+09 3.&if+09 8.72E+06 PAGE: 4-10 -0
O.D.C.M. MAXIMUM PATHWAY
~ DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*
OPE:~ Ni-63 rHTHWAY AGE GROUP. BONf LUNG G.I. SKIN GROUND ADULT O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TEEN 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 CHILD 0.00E+00 0.00E+00 O.oaf+00 0.00E+00 0-00E+00 0.00E+00 0.00E+00 O.OOE+00 INFANT a.aaf+oo o.oof+oo o.'ooE+oo o.oof+oo o.oof+oo o.oof+oo o.ooE+oo o.oof+oo GOAT ADULT 5.19E+08 3.59E+07 1.74E+07 O.OOE+Oa O.OOE+00 O.OOE+00 7.50E+06 H/A MILK TEEN 9.11E+08 6.43E+07 3.09E+07 O.oaf+00 O.OOE+00 0.00E+00 1.02E+07 N/A CHILD 2.28E+09 1.22f+08 7.77E+07 O.OOE+00 O.OOE+00 O.oaf+00 8.24E+06 H/A INFANT 2.24E+10'.66E+08 9.34E+07 0.00E+00 O.OOE+00 0.00E+00 B.ZBE+06 N/A COW ADULT 3.45E+09 2.39E+08 1.16E+08 0.00E+00 O.OOE+00 O.OOE+00 5.00E+07 N/A MILK TEEN 6.07E+09 4.29E+08 2.06E+08 0.00E+00 0.00E+00 0.00E+00 6.82E+07 N/A CHILD 1.52E+10 8.15E+08 5.18E+08 O.OOE+00 0.00E+00 O.oaf+00 5.49E+07 H/A INFANT 1.79E+10 1.11E+09 6.22E+08 O.OOF+00 O.OOE+00 O.OOE+00 5..52E+OT .H/A MEAT ADULT 1.06E+10 7.38E+08 3.57E+08 O.OOE+00 O.OOE+00 O.OOE+00 1.54E+08 N/A TEEN 8.56E+09 6.05E+08 2.90E+08 0.00E+00 0.00E+00 0.00E+00 9.63E&7 N/A CHILD 1.64E+10 8.79E+08 5.59E+08 0.00E+00 0.00E+00 0.00E+00 5.92E+07 H/A INFANT o.ooE+oo o.ooE+oo o.ooE+oa o.aoE+oo o.oaE+oo a.oof+oo o.ooE+oo H/A uTBLE ADUI T 9.43E+09 6.54E+08 3.16E+08 0.00E+00 O.OOE+00 0.00E+00 1.36E+08 . N/A TEEN 1.52E+10 1.07E+09 5.15E+08 O.OOE+00 0-oaf+00 0.00E+00 1-TIE+08 N/A CHILD 3.79E+10 2.03E+09 1.29E+09 0.00E+00 0.00E+00 0.00E+00 1.37E+08 H/A INFANT o.oof+oo o.ooE+00 O.aoE+00 O.oof+oo o.ooE+oa o.aaE+aa o.ooE+ao H/A TOTAL ADULT 2.40E+10 1.67E+09 8.07E+08 O.OOE+00 O.OOE+00 O.OOE+00 3.48E+08 H/A INGEST. TEEN 3.07E+10 2.17E+09 1.04f+09.0.00E+00 0'.00E+00 0.00E+00 3.46E+08 , H/A CHILD 7.18E+10 3.84E+09 2.44E+09 0.00E+00 0.00E+00 0.00E+00 2.59E+08 N/A INFANT 4.04E+10 1.28E+09 7.16E+08 0.00E+00 0.00E+00 Q.QOE+00 6.34E+OT H/A INHAL. ADULT 4.32E+05 3.14E+04 1.45E+04 O.OOE+00 O.OOE+00 1.78E+05 1.34E+04 H/A TEEN 5.80E+05 4.34E+04 1.98E+04 0.00E+00 0.00E+00 3.07E+05 1.42E+04 N/A CHILD 8.21E+05 4.63E+04 2.80E+04 0.00E+00 0.00E+00 2.75E+05 6'.33E+03 N/A INFANT 3.39E+05 2.04E+04 1.16E+04 0.00E+00 0.00E+00 2.09E+05 2.42E+03 H/A BONE LIVER T. BODY THYROID KIDNEY G.'I. SKIN Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
~**MAXIMUMVALUES FOR PATHWAYS*~*
GROUND: GROUND: GOAT COW TOTAL T. 8-/ORG. SKIN MILK: MILK: HEAT: VfGTBLE: INGEST: INHAL.
0.00E+00 O.OOE+00 2.24E+10 1.79E+10 1.64E+10 3.79E+10 7.18E+10 8.21E+05 PAGE: 4-11 vs
Q.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RAOIOHUCLIDES OTHER THAN NOBLE GASES*
I 3PE: Zn-65 PRIHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G. I. SKIN GROUND ADULT 7.40E+08 7.40E+08 7.40E+08. 7.40E+08 7.40E+08 7.40E+08 7-40E+08 8.50E+08 TEEN 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 8.50E+08 CHILD 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 7.40E+08 8.50E+08 INFANT 7.40E+08 7.40f+08 7.40E+08 7.40E+OB 7.40E+QB 7.40E+08 7.40E+08 8.50E+08 GOAT ADULT 9.87E+07 3.14E+08 1.42E+08 0.00E+00 2.10E+08 0.00E+00 1:98E+08 H/A MILK TEEN 1.51E+08 5.26E+08 2.45E+08 O.OOE+00 3.37E+08 O.OOE+00 2.23E+08 H/A CHILD 2.97E+08 7.92E+08 4.93E+08 O.OOE+00 4.99E+08 O.OOE+00 1.39E+08 H/A INFANT 3.33E+09 1.37E+09 6.31E+08 O.OOE+00 6.64E+08 0.00E+00 1.16E+09 H/A COM ADULT 6.24E+08 1.99E+09 8.97E+08 O.OOE+00 1.33E+09 O.OOE+00 1.25E+09 N/A.
MILK TEEN 9.58E+08 3.33E+09 1.55E+09 O.OQE+00 2.13E+09 0.00E+00 1.41E+09 N/A CHILD 1.88E+09 5.0'If+09 3.12E+09 O.QOf+00 3.16E+09 O.QOE+00 8.80E+08 N/A INFANT 2.53E+09 8.66E+09 3.99E+09 0.00E+00 4.20E+09 0.00E+00 7.31E+09 N/A MEAT ADULT 1.82E+08 5.79E+08 2.62E+08 O.OOE+00 3.87E+08 O.OOE+00 3.65E+08 H/A 1.28E+08 4.44E+08 2.07E+08 O.OOE+00 2.84E+08 O.OOE+00 1.88E+08 .
TEEN H/A CHILD 1.92E+08 5.11E+08 3.18E+08 O.OOE+00 3.22f+08 O.OOE+00 8.98E+07 N/A INFANT O.QOE+00 O.OOE+00 O.QOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 H/A VEGTBLE ADULT 2.83E+08 9.01E+08 4.07f+08'O.OOE+QO 6.03E+08 Q.QOE+00 5.68E+08 N/A TEEN 3.97E+08 1.38E+09 6.43E+08 O.OOE+00 8.83E+08 O.OOE+00 5.84f+08 N/A CHILD 7.73E+08 2.06E+09 1.28E+09 0.00E+00 1.30f+09 O.QOE+00 3.62E+08 N/A INFANT O.OOE+00 O.QOE+00 O.OOE+00 O.OOE+00 Q.OOE+00 O.OOE+00 O.OOE+00 H/A "
TOTAL ADULT 1-19E+09 3.78E+09 1.71E+09 O.OOE+00 2.53E+09 O.OOE+00 2.38E+09 N/A INGEST. TEEN 1.63E+09 5.68E+09 2.65E+09 O.OOE+00 3.63E+09 O.QOE+00 2.40E+09 N/A CHILD 3.14E+09 8.37E+09 5.21E+09 O.OOE+00 5.28E+09 O.OOE+00 1.47E+09 N/A INFANT 5.85E+09 1.00E+10 4.63E+09 0.00f+OQ 4.86E+09 Q.OQE+00 8.47E+09 H/A IHHAL. ADULT 3.24E+04 1.03E+05 4.66E+04 0.00E+00 6.90f+04 8.64E+05 5.34E+04 N/A TEEN 3.86E+04 1.34E+05 6.24E+04 O.OOE+00 8.64E+04 1.24E+06 4.66E+04 H/A CHILD 4.25E+04 1.13E+05 7.03E+04 0.00E+00 7.14E+04 9.95E+05 1.63E+04 N/A INFANT 1.93E+04 6.26E+04 3.11E+04 O.OQE+00 3.25E+04 6.47E+05 5.14E+04 H/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"""MAXIMUMVALUES FOR PATHWAYS"~~
GROUND: GROUND: GOAT CQM TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: !NHAL.
7.40E+08 8.50E+08 3.33E+09 8.66E+09 5.79E+08 2.06E+09 1.00E+10 1.24E+06 PAGE: 4-12
O.D.C.H.
~ ~ ~ ~ MAXIHUH PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*
PE: Rb-86 rATHMAY AGE GROUP BQHE LUNG G.I. SKIN GROUND ADULT 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 1.02E+07 TEEN 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 1.02E+07 CHILD 8.89f+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 1.02E+07 INFANT 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 8.89E+06 1.02E+07 GOAT ADULT Q.DOE+00 1.42F+0& 6.63E+QT O.DOE+00 O.DOE+00 0.DOE+00 2.80E+07 N/A MILK TEEN O.DOE+00 2.59E+08 1.22E+08 O.DOE+00 O.DOE+00 O.DOE+00 3.84E+07 N/A CHILD O.DOE+00 4.81E+08 2.96E+08 O.OOE+QD Q.DOE+00 O.DOE+00 3.09E+07 H/A 1NFANT 0.DOE+00 1.22E+09 6.03E+08 D.DDE+00 D.DOE+00 0.DOE+00 3.12'E+07 H/A'OM ADULT ,Q.DOE+00 6.78E+08 3.16E+08 0.DOE+00 0.DOE+00 0.DOE+00 1.34E+08 H/A MILK TEEN .0.DOE+00 1.24E+09 5.80E+08 0.DOE+00 0.DOE+00 0.DOE+00 1.83E+08 N/A CHILD D.DOE+00 2.29E+09 1.41E+09 0.DOE+00 0.DOE+00 0.DOE+00 1.47E+08 N/A INFANT O.DOE+00 5.81E+09 2.87E+09 O.OOE+QO O.DOE+00 O.DOE+00 1;-49E+0& '..H/A HEAT ADULT 0.DOE+00 1.65E+08 7.67E+07 0.DOE+00 0.DOE+00 0.DOE+00 3.25E+07 N/A TEEN 0.DOE+00 1.37E+08 6.45E+07 0.DOE+00 D.DOE+00 O.DOE+00 2.03E+07 H/A CHILD Q.DOE+00 1.95E+08 1.20E+08 0.DOE+00 0.DOE+00 0.DOE+00 1.25E+07 H/A INFANT O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 H/A
. aTBLE ADULT Q.DOE+00 1.32E+08 6.1TE+07 O.DOE+00 0.DOE+00 0.DOE+00 2.61E+07 H/A TEEN 0.DOE+00 1.93E+08 9.07E+07 0.DOE+00 0.DOE+00 0.DOE+00 2.86E+07 N/A CHILD O.DOE+00 3.40E+08 2.09E+08 O.DOE+00 O.DOE+00 O.DOE+00 2.19E+07 N/A INFANT O.DOE+00 D.DOE+00 O.OOE+OD D.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 N/A TOTAL ADULT Q.DOE+00 1.12E+09 5.20E+08 O.DOE+00 O.DOE+00 O.DOE+00 2.20E+08 H/A INGEST. TEEN O.DOE+00 1.83E+09 8.57E+08 O.DOE+00 O.DOE+00 O.DOE+00 2.70E+08 N/A CHILD O.DOE+00 3.31E+D9 2.03E+09 D.DOE+00 O.DOE+00 O.DOE+00 2.13E+08 N/A INFANT 0.DOE+00 7.03E+Q9 3.48E+Q9 Q.DOE+00 0.DOE+00 0.DOE+00 1.80E+08 N/A IHHAL. ADULT Q.DOE+00 1.35E+05 5.90E+04 0.DOE+00 D.DOE+00 0.DOE+00 1.66E+04 N/A TEEN Q.DOE+00 1.90E+05'.40E+04 O.ODE+00 O.DOE+00 O.DOE+00 1.77E+04 N/A CHILD 0.DOE+00 1'.98E+05 1;14E+05 O.DOE+00'Q.DOE+00 D.DOE+00 7.99E+03 H/A INFANT O.DOE+00 1.90E+05 8.82E+04 O.OOE+00 O.DOE+00 O.DOE+00 3.04E+03 H/A BONE LIVER T. BODY THYROID KIDNEY ~ LUNG G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"""MAXIMUMVALUES FOR PATHWAYS~~~
GROUND GROUND: GOAT COM TOTAL T.B./ORG. SKIN HILK: MILK- HEAT: VEGTBLE: INGEST: IHHAL.
8.89E+06 1.02E+07 1.2ZE+09 5.81E+09 1.95E+08 3.40E+08 7.03E+09 1.98E+05 PAGE: 4-13
Q.D C.N. HAXIHUH PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*
i DPE: Sr-89 PATHMAY AGE GROUP BONE LIVER T-BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.49E+04 TEEN 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.49E+04 CHILD 2.14E+04 2.14E+04 2.14f+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.49E+04 INFANT 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.14E+04 2.49E+04 IGOAT ADULT 1.54E+09 0.00E+00 4.43E+07" O.oaf+00 0.00E+Qa 0.00E+Qa 2.47E+08 N/A IMILK TEEN 2.84E+09 O.oaf+00 8.14E+07 0.00E+00 0.00E+00 0.00E+00 3.39E+08, N/A CHILD 7.04E+09 0.00E+00 2.01E+08 0.00E+00 0.00E+00 0.00E+00 2.72E+08 N/A INFANT 6.37E+09 0.00E+00 3.84E+08 0.00E+00 0.00E+00 0.00E+00 2.75E+08 N/A
~COM ADULT 4.76E+08 O.OaE+QQ l.37E+07 O.OOE+00 O.OOE+OO O.OOE+00 7.64E+07 N/A'/A HILK TEEN s.7sE+os o.oof+oo 2.51E+o7 o.ooE+oo a.ooE+oo o.ooE+00 l.o5E+os CHILD 2. 17E+09 0.00E+00 6.20E+07 0.00E+00 0.00E+00 0.00E+00 8.41E+07 N/A INFANT 4.13E+09 0.00E+00 1.18E+08 0.00E+00 0.00E+00 0.00E+00 8.49E+07 N/A HEAT ADULT 1.20E+08 Q.QOE+00 3.44E+06 Q.QOE+00 O.OOE+00 Q.QOE+00 1.92E+07 N/A TEEN 1.01E+08 0.00E+00 2.90E+06 0.00E+00 0.00E+00 0.Oaf+00 1.21E+07 N/A CHILD 1.92E+08 0.00E+00 5.48E+06 Q.QQE+00 0.00E+00 O.oaf+00 7.42E+06 N/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Q.QQE+QQ 0.00E+00 Q.QQf+00 N/A VEGTBLE ADULT 8.19E+09 O.QOE+00 2.35E+08 O.OOE+00 0.00E+00 O.OOE+00 1.31E+09 N/A TEEN 1.35E+10 Q.oaf+00 3.86E+08 Q.OQE+00 0.00E+00 0.00E+00 1.60E+09 CHILD 3.29E+10 0.00E+00 9.39E+08 0.Oaf+00 0.00E+00 0.00E+00 1.27E+09 N/A INFANT o.aof+ao a.aof+oo 'O.ooE+oo o.ooE+oo o.oof+oo o.oof+oo o.ooE+oo N/A TOTAI ADULT 1.03E+10 0.00E+00 2.96E+08 0.00E+00 0.00E+00 0.00E+00 1.66E+09 N/A INGEST. TEEN 1.73E+lo o.ooE+oo 4.95E+os o.ooE+oo Q.QQE+oo o.oof+oo 2.a6E+09 N/A CHILD 4.23E+10 0.00E+00 1.21E+09 0.00E+00 0.00E+00 0.00E+00 1.64E+09 N/A-INFANT 1.05E+10 0.00E+00 5.02E+08 0.00E+00 Q.QQE+00 O.OQE+00 3.60E+08 N/A INHAL. ADULT 3.04E+05 0.00E+00 8.72E+03 0.00E+00 0.00E+00 1.40E+06 3.50E+05 N/A TEEN 4.34E+05 Q.QQE+00 1.25E+Q4 0.00E+OQ O.OOE+00 2.42E+06 3.71E+05 N/A CHILD 5.99E+05 0.00E+00 1.72E+04 Q.OQE+00 0.00E+00 2.16E+06 1.67E+05 N/A INFANT 3.98E+05 0.00E+00 1.14E+04 0.00E+00 0.00E+00 2.03E+06 6..40E+04 N/A BON f LIVER T. BODY THYROID KIDNEY LUNG G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
~**HAXIHUNVALUES FOR PATHMAYS**"
GROUND: GROUND: GOAT CQM TOTAL T. B./ORG. SKIN HILK: MILK: HEAT'. VEGTBLE: INGEST: INHAL.
2.14f+04 2.49f+04 7.04f+09 4.13E+09 1.92f+08 3.29E+10 4.23E+10 2.42E+06 PAGE: 4-14
O.O.C.M. MAXIMUM PATHMAY DOSE FACTORS: RAOIONucLIDES OTHER THAH NOBLE GASES*
Pf: Sr-90 PATHMAY AGE GROUP BONE L IVER T. BODY THYROID KIDNEY LUHG G. I. SKIN GROUND AOUU O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.aOE+OO O.OOE+OO TEEN '.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 CHILD O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.aaE+OO INFANT O.OOE+00 O.OOE+00 O.oaf+00 O.oaf+00 O.OOE+00 O.OOE+00 O.OOE+00 O.Oaf+00 GOAT ADULT 6.30E+10 O.OOE+00 1.55E+10 O.Oaf+00 O.OOE+00 O.OOE+00 1.82f+09 H/A MILK TEEN 8.91E+lO O.OOE+00 2.2OE+10 O.OOE+00 O.OOE+00 O.OOE+00 2.50f+09 N/A CHILD 1.51E+ll O.OOE+00 3.82E+la O.OOE+00 O.OOE+00 O.OOE+00 2.03E+09 H/A INFANT 7.80E+10 O.OOE+00 4.17E+10 O.OOE+00 O.OOE+00 O.OOE+00 2.0SE+09 H/A COM ADULT 2.40f+10 O.OOE+00 5.88E+09 O.OOE+00 O.OOE+00 O.OOE+00 6.93E+08 H/A MILK TEEN 3.39E+10 0.00E+00 8.37E+09 0.00E+00 0.00E+00 0.00E+00 9.51E+08 H/A CHILD 5.72E+10 O.OOE+00 1.45E+10 O.OOE+00 O.OOE+00 O.OOE+00 7.71E+08 H/A INFANT 6.23E+10 O.OOE+00 1.59E+10 O.OOE+00: O.OOE+00 O.OOE+00 7.78E+08 H/A
'/A MEAT ADULT 7.00E+09 O.OOE+00 1.72E+09 O.OOE+00 O.OOE+00 O.OOE+00 2.02E+08 TEEN 4.53E+09 O.OOE+00 1.12E+09 O.OOE+00 O.OOE+00 O.OOE+00 1.27E+08 H/A CHILD 5.85E+09 O.OOE+00 1.48E+09 O.OOE+00 O.OOE+00 O.,OOE+00 .7.88E+07 H/A INFANT 0-OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 H/A u TBLE ADULT 5.48E+ll O.OOE+00 1.34E+ll O.OOE+00 O.OOE+00 O.OOE+00 1.58E+10 H/A TEEN 7.1QE+ll O,OOE+00 1.75E+11 0.00E+00 O.OOE+00 O.OOE+00 1.99E+10 H/A'/A CHILD 1.19E+12 O.OOE+00 3.02f+11. O.Oaf+00 O.OOE+00 O.OOE+00 1.61E+10 INFANT 0.00E+00 O.OOE+00 0 ~ 00E+00 0.00E+00 0.00E+00 0.00E+00 0-00E+00 N/A TOTAL ADULT 6.42E+11 O.OOE+00 1.58E+11 O.OOE+00 O.OOE+00 O.OOE+00 1.85E+10 N/A INGEST. TEEN 8.37E+ll O.Oaf+00 2.07f+ll O.OOF+00 O.Oaf+00 O.OOE+00 2.35E+10 H/A CHILD ~
1.41E+12 O.OOE+00 3.56E+ll O.OOE+00 O.OOE+00 O.OOE+00 1.89E+10 H/A INFANT 1.4OE+ll O.Oaf+00 5.76E+10 O.aOE+Oa a.aaE+OO O.aaE+OO 2.82E+09 H/A IHHAL. ADULT 9.92E+07 O.OOE+00 6.10E+06 O.OOE+00 O.OOE+00 9.60E+06 7.22E+05 N/A TEEN, 1.08E+08 0.00E+00 6.68E+06 0.00E+00 0.00E+00 1.65E+07 7.65E+05 N/A CHILD 1.01E+08 O.oaf+00 6.44E+06 O.OOE+00 O.OOE+00 1.48E+07 3.43f+05 N/A INFANT 4.09E+07 O.OOE+00 2.59E+06 O.OOE+00 O.OOE+00 1.12E+07 1.31E+05 N/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
""HAXIHUH VALUES FOR PATHMAYS~~~
GROUND: GROUND: GOAT COM TOTAL T.B./ORG. SKIN MILK- MILK: HEAT: VEGTBLE: INGEST: INHAL.
O.OOE+00 O.Oaf+00 1.51f+11 6.23f+10 7.00E+09 1.19f+12 1.41E+12 1.08E+08 PAGE: 4-15 DATE
O-D.C-M- MAXIMUM PATHWAY DOSf FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*
I )PE: Y-90 PH IHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY -. LUNG G.I. SKIN I
GROUND ADULT Q.OQE+00 0.00E+00 0.00f+00 O.OOE+00 O.OOE+00 O.QOE+00 O.OQE+00 O.OOE+00 TEEN 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00f+00 0.00E+00 O.OOE+00 I CHILD O.OQE+00 0.00f+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 INFANT O.OOE+00 O.QOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00
)GOAT ADULT 3.83E+00 0.00f+00 1.03E-Ol 0.00E+00 0.00E+00 0.00E+00 4.06E+04 H/A IMILK TEEN 7.03E+00 0.00E+00 1.89E-01 0.00E+00 O.OQE+00 0.00E+00 5.80E+04 H/A CHILD 1.74E+01 Q.OQE+00 4.66E-Ol 0;OOE+00 O.OOE+00 O.OOE+00 4.95E+04 H/A INFANT 3.07E+02 O.OOE+00 9.86E-01 O.OOE+00 O.OOE+00 O.OOE+00 5.08E+04 H/A COW ADULT 1.79E+01 0.00f+00 4.79E-Ol 0.00E+00 0.00E+00 0.00f+00 1.89E+05 N/A NIL'K TEEN 3.28E+01 O.OOE+00 8.84E-Ol O.OOE+00 O.OOE+00 O.OOE+00 2.71E+05 H/A CHILD 8.12E+Ol O.OOE+00 2.17E+00 O.OOE+00 O.OOE+00 O.OOE+00 2.31E+05 H/A INFANT 1.72E+02 O.OOE+00 4.60E+00 O.OOE+00 O.OOE+00 O.OOE+00 2.37E+05 H/A MEAT ADULT 3.55E+Ol 0.00f+00 9.52E-Ol O.OQE+00 0.00E+00 0.00E+00 3.76E+05 H/A TEEN 2.99E+01 O.OOE+00 8.04E-OI Q.OOE+00 O.OOE+00 O.QQE+OQ 2.46E+QS N/A CHILD 5.65E+01 0.00E+00 1.51E+00 0.00E+00 0.00E+00 0.00E+00 1.61E+05 H/A INFANT O.QOE+00 O.OQE+00 0.00E+00 O.OQE+00 0.00E+00 Q.OOE+00 O.QQE+00 N/A VEGTBLE ADULT 4.39E+03 Q.OQE+00 1.18E+02 O.DOE+00 O.OOE+00 O.DOE+00 4.65E+07 H/A TEEN 4.10E+03 0.00E+00 1.10E+02 0.DOE+00 0.00E+00 0.00E+00 3.38E+07 N/A CHILD 7.61E+03 O.OOE+00 2.04E+02 O.DOE+00 O.OOE+00 O.OQE+00 2.17E+07 H/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.DOE+00 0.00E+00 0.00E+00 0.00E+00 H/A TOTAL ADULT 4.44E+03 0.00E+00 1.19E+02 O.OQE+OQ 0.00E+00 O.OQE+OQ 4.71E+07 N/A INGEST. TEEH 4.17E+03 O.OOE+00 1.12E+02 O.OOE+00 O.OOE+00 O.OQE+00 3.44E+07 H/A CHILD 7.77E+03 0.00E+00 2.08E+02 O.OOE+00 0.00E+00 0.00E+00 2.21E+07 H/A INFANT 4.78E+02 0.00E+00 5.59E+00 0.00E+00 O.OOE+00 0.00E+00 2.88f+05 N/A IHHAL. ADULT 2.09E+03 0.00E+00 5.61E+01 0.00E+00 0.00E+00 1.70E+05 5.06E+05 N/A TEEN 2.98E+03 0.00E+00 8.00E+Ol O.DOE+00 0.00E+00 2.93E+05 5.59E+05 N/A CHILD 4.11E+03 0.00f+00 1.11E+02 0.00E+00 0.00E+00 2.62E+05 2.68E+05 N/A INFANT 3.29E+03 O.OOE+00 8.82E+Ol O.OOE+00 O.OOE+00 2.69E+05 1.04E+05 H/A BONE LIVER T. BODY THYROID KIDNEY LUNG G.I. SKIN I
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
~*"MAXIMUMVALUES FOR PATHWAYS**~
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: HEAT: VEGTBLE: INGEST: INHAL.
0.00f+00 0.00F+00 5.8QE+04 2.7lf+05 3.76E+05 4.65E+07 4.71E+07 5.59E+05 H
OAT PAGE: 4-16 0
O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*
Sr-9l PAirNAY AGE GROUP BONE LIVER T. BODY THYROID KIDNEY LUNG G. I. SKIN ROUND ADULT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 TEEH O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 CHILD O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 .0.00E+00 OAT ADULT 2.73E+04 0.00E+00 1.10E+03 0.00E+00 O.OOE+00,0.00E+00 1'.30E+05 H/A WELK TEEN 5.02E+04 0.00E+00 2.00E+03 0.00E+00 0.00E+00 0.00E+00 2.28E+05 N/A CHILD 1.23E+05 O.OOE+00 4.65E+03 0.00E+00 O.OOE+00 O.OOE+00 2.72E+05 N/A INFANT 1.22E+05 0.00E+00 9.29E+03 0.00E+00 O.OOE+00 O.OOE+00 3.04E+05 N/A'/A OW ADULT 7.29E+03 O.OOE+00 2.94f+02 0,00E+00, 0.00E+00 0.00E+00 3.47E+04 ILK TEEH 1.34E+04 O.OOE+00 5.32E+02 O.OOE+00 O.OOE+00 O.OOE+00 6.07E+04 H/A .
CHILD 3.28E+04 O.OOE+00 1.24E+03 0.00E+00 0.00E+00 0.00E+00 7.25E+04 H/A INFANT 6.84E+04 O.OOE+00 2.48E+03 O.OOE+00 O.OOE+00 O.OOE+00 8.10E+04 N/A i EAT ADULT 5.01E-l 1 0.00E+00 2.02E-12 O.OOE+00 O.DOE+00 O.OOE+00 2.38E-10 N/A TEEN 4. 21E-11 0.00E+00 1.68E-12 O.OOE+00 O.OOE+00 O.OOE+00 1.91E-10
'/A CHILD 7.90E-ll O.OOE+00 2.9BE-12 O.OOE+00 O.OOE+00 0.00E+00 1.74E-10 N/A INFANT 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 N/A aTBLE ADULT 1.01E+05 0.00E+00 4.06E+03 0.00E+00 0.00E+00 0.00E+00 4.79E+05 H/A P TEEN CHILD
,IHFANT 9.39E+04 1.73E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 3.74E+03 6.53E+03 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0QE+00 4.26E+05 O.OOE+00 0.00E+00'3.82E+05 0.00E+00 0.00E+00 0.00E+00 N/A H/A N/A TAL ADULT 1.35E+05 0.00E+00 5.46E+03 0.00E+00 0.00E+00 0.00E+00 '6.44f+05 H/A GEST. TEEN 1.58E+05 0.00E+00 6.27E+03 0.00E+00 0.00E+00 0.00E+00 7.14E+05 ,H/A CHILD 3.29E+05 0.00f+00 1.24E+04 0.00E+00 0.00E+00 0.00E+00 7.26E+05 N/A INFANT 1.91E+05 O.OOE+00 ).18E+04 O.OOE+00 O.OOE+00 0.00E+00 3.85E+05 H/A HAL. ADULT 6.19E+Ol 0.00E+00 2.50E+00 0.00E+00 0.00E+00 3.65E+04 1.91E+05 H/A TEEN 8.80E+01 0.00E+00 3.51E+00 0.00E+00 0.00E+00. 6.07E+04 2.59E+05 H/A CHILD 1.21f+02 0.00E+00 4.59E+00 0.00E+00 0;00E+00 5.33f+04 1.74E+05 N/A INFANT 9.56E+01 0.00E+00 3.46E+00 0.00E+00 0.00E+00 5.26E+04 7.34E+04 H/A BONE LIVER T. BODY THYROID KIDNEY LUNG G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
- "*MAXIMUMVALUES FOR PATHWAYS~*~
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK:, MEAT: VEGTBLE: INGEST: IHHAL.
O.OOE+00 O.OOE+00 3.04E+05 8.10E+04 2.38E-10 4.79E+05 7.26E+05 2.59E+05 PAGE: 4-17 y
ar Wl
O-D-C-M- MAXIMUM PATHWAY DOSE FACTORS: RADIOHUCLIDES OTHER THAN NOBLE GASES*
)Pf: Y-91 f'H!'HMAY AGE GROUP BONE LIVER T. BODY THYROID KIDNEY LUNG G.I. SKIN I
)GROUND ADULT 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1. 06E+06 1.20E+06 TEEH 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.20E+06 CHILD 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.20E+06 INFANT 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.06E+06 1.20E+06
!GOAT ADULT 5.3ZE+02 Q.QOF+QO 1.42E+Q1 Q.DOE+00 Q.DOE+00 O.DOE+00 2.93E+05 N/A
!MILK TEEN 9.79E+02 0.00f+00 2.62E+Ol 0.DOE+00 0.DOE+00 0.DOE+00 4.01E+05 N/A CHILD 2.42E+03 O.DOE+00 6.47E+Ol 0.DOE+00 O.DOE+00 O.DOE+00 3.22E+05 N/A INFANT 3.78E+04 0.DOE+00 1.21E+02 O.DOE+00 D.DOE+00 0.DOE+00 3.25E+05 H/A
.COM
'MILK ADULT TEEN 2.94E+'03 0.DOE+00 7.. 85E+01 '. OQE+00 0;DOE+00 O.DOE+DO 1.62E+06 5.40E+03 O.DOE+00 1.45E+02 O.DOE+00 0.00E+00 Q.DOE+00 2.22E+06 N/A H/A CHILD 1.34E+04 O.DOE+00 3.57E+D2 O.DOE+00 O.DOE+00 O.DOE+00 1.78E+06 H/A INFANT 2.51E+04 0.DOE+00 6.68E+02 O.ODE+DO O.DOE+00 O.OOE+OD 1.80E+06 N/A ,
HEAT ADULT 4.65E+05 Q.DOE+00 1.24E+04 O.DOE+00 O.DOE+00 O.DOE+00 2.56E+08 H/A TEEN 3.91E+05 Q.OQE+00 1.05E+04 Q.DOE+00 0.DOE+00 O.DOE+00 1.60E+08 H/A CHILD 7.39E+05 O.DOE+00 1.98E+04 0.DOE+00 O.DOE+00 O.DOE+00 9.85E+07 N/A INFANT 0.DOE+00 0.DOE+00 0.DOE+00 Q.DOE+00 Q.DOE+00 0.DOE+00 0.DOE+00 H/A VEGTBLE ADULT 4.27E+06 O.QOE+00 1.14E+05 D.DOE+00 0.DOE+00 0.DOE+00 2.35E+09 N/A TEEN 7.05E+06 Q.DOE+00 1.89E+05 D.DOE+00 D.DOE+00'D.DOE+00 2.89E+09 H/A CHILD 1.72E+07 Q.DOE+00 4.60E+05 0.DOE+00 0.DOE+00 0.DOE+00 2.29E+09 N/A IHFANT O.DOE+00 0.00f+00 D.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 H/A
!OTAL ADULT 4.74E+06 D.DOE+00 1.27E+05 0.DOE+00 0.DOE+00 0.DOE+00 2.61f+09 N/A INGEST. TfEH 7.45E+06 Q.DOE+00 2.DOE+05 0.DOE+00 0;DOE+00 0.DOE+00 3.05E+09 N/A CHILD 1.79E+07 O.DOE+00 4.80E+05 O.DOE+00 O.DOE+00 O.DOE+00 2.39E+09 N/A INFANT 6.29E+04 0.DOE+00 7.88E+02 0.DOE+00 0.DOE+00 0.00f+00.2.12E+06 N/A IHHAL. ADULT 4.62E+05 O.DOE+00 .1.24E+04 O.OOE+OD O.DOE+00 1.70E+06 3.85E+05, H/A TEEN . 6.61E+05 Q.QQE+00 1.77E+04 0.'DOE+00 0.DOE+00 2.94E+06 4.09E+05 N/A CHILD 9.14E+05 0.DOE+00 2.44E+04 D.DOE+00 0.DOE+00 2.63E+06 1.84E+05 N/A IHFANT 5.88E+05 O.DOE+00 1.57E+04 O.DOE+00 O.DOE+00 2.45E+06 7.03E+04 H/A BONE LIVER T. BODY THYROID KIDNEY LUNG G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
- MAX!MUMVALUES FOR PATHWAYS*"~
GROUND: GROUND: GOAT COM TOTAL T.B./ORG. SKIN MILK: MILK- MEAT: VEGTBLE: INGEST: INHAL.
1.06E+06 1.20E+06 4.01E+05 2.22E+06 2.56E+08 2.89E+09 3.05E+09 2.94E+06 PAGE: 4-18
O-O-C.M. MAXIMUM PATHWAY DOSE fACTORS: RAOIONUCLIOES OTHER THAN NOBLE GASES*
I E: Hb-95 f'niHWAY AGE GROUP BONE LIVER T. BODY THYROID KIDNEY LUNG G. I. SKIN GROUHD ADULT 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.59E+08 TEEN 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.59E+08 CHILD 1.3SE+08 1;35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.59E+08 INFAHT 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.35E+08 1.59E+08 GOAT ADULT 4.78E+03 2.66E+03 1.43E+03 0.00E+00 2.63E+03 0.00E+00 l. 61E+07 N/A MILK TEEN 8.15E+03 4.52E+03 2.49E+03 0.00E+00 4.38E+03 0.00E+00 1.93E+07 N/A CHILD 1.84E+04 7.17E+03 5.12E+03 0.00E+00 6.73E+03 0.00E+00 1.33E+07 N/A INFANT 2.86E+05 1.42E+04 8.18E+03 0.00E+00 1.01E+04 Q.QOE+00 1. 19E+07 N/A COM ADULT 2-44E+04 1.36E+04 7.31E+03 Q.OOE+00 1.34E+04 0.00E+00 8.25E+07 N/A MILK TEEN 4.17E+04 2.31E+04 1.27E+04 0.00E+00 2.24E+04 0.00E+00 9'89E+07 N/A CHILD 9.41E+04 3.67E+04 2.62E+04 O.QOE+00 3.44E+04 0.00E+00 6-78E+07 N/A INFANT 1.76E+05 7.24E+04 4.18E+04 0.00E+00 5.19E+04 0.00E+00 6:11E+07 N/A HEAT ADULT 8.48E+05 4.72E+05 2.54E+05 0.00E+00 4.66E+05 0.00E+00 2.86E+09 N/A TEEH 6.62E+05 3.67E+05 2.02E+05 0.00E+00 3.56E+05 0.00E+00 1.57E+09 N/A CHILD 1..14E+06 4.45E+05 3.18E+05 0.00'E+00 4.18E+05 0.00E+00 8.23E+08 N/A INFANT 0.00E+00 Q.QQE+00 Q.QQE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 N/A 3TBLE ADULT 1.10E+05 6.11E+04 3.28E+04 0.00E+00 6.04E+04 0.00E+00 3.TIE+08 H/A TEEN 1.64E+05 9-10E+04 5-01E+04 0-00E+00 8-82E+04 0-00E+00 3.89E+08 N/A CHILD 3.63E+05 1.41E+05 1.01E+05 0.00E+00 1.33E+05" 0.00E+00 2.61E+08 N/A IHFAHT Q.QOE+00 0.00E+00 Q.QQE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 H/A l'OTAL ADULT 9.87E+05 5.49E+05 2.95E+05 0.00E+00 5-43E+05 0.00E+00 3.33E+09 N/A NGEST. TEEN 8.76E+O5 4.86E+OS 2.68E+05 Q.QQE+OO 4.71E+OS Q.QOE+00 z.oBE+og N/A CHILD 1.62E+06 6.30E+05 4.50E+05 0.00E+00 5.92E+05 0.00E+00 1.17E+09 H/A'/A INFANT. 4.62E+05 8.65E+04 5.00E+04 0.00E+00 6-20E+04 0.00E+00 7.30E+07 HHAL. ADULT 1.41E+04 7.82E+03 4.21E+03 0.00E+00 7.74E+03 5.05E+05 1.04E+05 H/A TEEN 1.86E+04 1.03E+04.5.66E+03 Q.QOE+00 1.00E+04 7.51E+05 9.68E+04 N/A CHIL'D 2.35E+04 9;18E+03 6.55E+03 0.00E+00 8.62E+03 6.14E+05 3.70E+04 H/A INFANT 1.57E+04 6.43E+03 3.78E+Q3 Q.QQE+QQ 4.72E+03 4.79E+05 1.27E+04 N/A BONE LIVER T. SOOY THYROID KIDNEY LUNG G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
~*"MAXIMUMVALUES FOR PATHWAYS*~~
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: (EAT: VEGTBLE: INGEST: IHHAL.
1.35Ee08 1.59E+08 1-93E+07 9-89f+07 Z.86E+09 3.89E+08 3.33E+09 7.51E+05 PAGE: 4- l 9
O.D.C.M. MAXIMUM PATHWAY POSE FACTORS: RAOIQNUCLIOES OTHER THAN NOBLE GASES*
fOPE: Zr-95 PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G. I- SKIN GROUND ADULT Z.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.81E+08 TEEN 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2.4ZE+08 2-42E+08 2.81E+08 CHILD 2.42E+08 2.42f+08 2.42E+08 2.42E+08 2.42E+08 2.4ZE+08 Z.42E+08 2.81E+08 INFANT 2.42E+08 2.42E+08 2.42E+08 2.42E+08 2-42E+08 2.42E+08 2.42E+08 2.81E+08 GOAT ADULT 5.92E+Ol 1.90E+Ol 1.28E+01 0.00E+00 2.98E+Ol 0.00E+00 6.01E+04 H/A MILK TEEN 1.03E+02 3.26E+Ol 2.25E+Ol 0.00E+00 4.80E+01 0.00E+00 7.53E+04 N/A CHILD 2.40E+02 5.28E+01 4.70E+01 0.00E+00 7.56E+Ol 0.00E+00 5.51E+04 '/A INFANT 3.56E+03 1.04E+02 7.38E+Ol 0.00E+00 1.12E+02 O.OOE+00 5.18E+Q4 N/A COW ADULT 3.31E+02 1.06E+02 7 18E+01 0.00E+00 1.67E+02 O.QOE+00 3.36E+05 H/A MILK TEEN 5.79E+02 1.83E+02 1.26E+02 0.00E+00 2.68E+02 0.00E+00 4.2IE+05 H/A CHILD 1.34f+03 2.95E+02 Z.63E+02 0.00E+00 4.23E+02 O.OOE+00 3.08E+05 H/A INFANT 2.39E+03 5.8ZE+02 4.12E+02 0.00E+00 6.2?E+02 O.OOE+00 2.90E+05 .
H/A ~
MEAT ADULT 7.83E+05 2.51E+05 1.70E+05 0.00E+00 3.94E+05 0.00E+00 7.96E+08 N/A TEEN 6.27E+05 1.98E+05 1.36E+05 0.00E+00 2.91E+05 0.00E+00 4.57E+08 H/A CHILD 1.11E+06 2.45E+05 2.18E+05 0.00E+00 3.50E+05 0.00E+00 2.55E+08 N/A lNFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 N/A VEGTBLE ADULT 9.90E+05 3.17E+05 2.15E+05 Q.OQE+00 4;98E+05 Q.OOE+00 1.01E+09 N/A TEEN 1.56E+06 4.91E+05 3.38E+05 0.00E+00 7.22E+05 0.00E+00 1.13E+09 H/A CHILD 3.57E+06 7.85E+05 6.99E+05 0.00E+00 1.12E+06 0.00E+00 8.19E+08 H/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 H/A TOTAL ADULT 1.??E+06 5.69E+05 3.85E+05 0.00f+00 8.92E+05 0.00E+00 1.80E+09 N/A INGEST. TEEN 2.18E+06 6.89E+05 4.74E+05 Q.OQE+00 1.01E+06 0.00E+00 1.59E+09 H/A CHILD 4.69E+06 1.03E+06 9.17E+05 0.00E+00 1.47E+06 O.OOE+00 1.0?E+09 H/A INFANT 5.94E+03 6.86E+02 4.86f+02 0.00E+00 7.39E+02 0.00E+00 3.41E+05 N/A INHAL. ADULT 1.07E+05 3.44E+04 2.33E+04 0.00E+00 5,.42E+04 1.77E+06 1.50E+05 H/A TEEN 1.46E+05 4.58E+04 3.15E+04 0.00E+00 6.74E+04 2.69E+06 1.49E+05 H/A CHILD 1.90E+05 4.18E+04 3.70E+04 0.00E+00 5.96E+04 2.23E+06 6.11E+04 H/A INFANT 1.15E+05 2.79E+04 2.03E+04 0.00E+00 3.11E+04 1.75E+06 2.17E+04 N/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
- >>>>MAXIMUM VALUES FOR PATHWAYS>>>>>>
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MI LK: MEAT: VEGTBLE: INGEST: INHAL.
2.4ZE+08 2.81E+08 7.53E+04 4.2lf+05 7.96E+08 1.13E+09 1.80E+09 2.69E+06 PAGE: 4-20
O.D.C.M. MAXIMUM PATHMAY DOSE FACTORS: RADIONUCL[OES OTHER THAN NOBLE GASES*
i PE: Mo-99 PATHWAY AGE GROUP BONE LIVER T- BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 0.00E+00 0.00E100 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00B.OO 0.00E+00 TEEN '0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00BOO 0.00E+00 CHILD O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 .O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 INFANT O.OOE+00 O.OOE+00 O.OOE+00 0,.00fw00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 GOAT ADULT 0.00E+00 1.34E+06 2.55E+05 0.00E+00 3.03E+06 0.00E+00 3.10E+06 H/A MILK TEEN 0.00E+00 2.42E+06 4.61E+05 0.00E+00 5.53E+06 0.00E+00'4.33E+06 H/A CHILD 0.00E+00 4.39E+06 1.09E+06 0.00E+00 9.38E+06 0.00E+00 3.63E+06 H/A INFANT 0.00E+00 1. 1ZE+07 2.19E+06 0.00E+00 1.68E+07 0.00E+00 3.70E+06 N/A COM ADULT 0.00E+00 6.24E+06 1.19E+06 0.00E+00 1.41E+07 0.00E+00 1.45fw07 H/A MILK TEEN O.OOE+00 1.13E+07 2.1SE+06 O.OOE+00 2.58E+07 O.OOE+00 2.02E+07 H/A CHILD 0.00E+00 2.05E+07 5.07E+06 0.00E+00 4.38E+07 0.00E+00 1.70E%07 N/A INFANT 0.00E+00 5.24E+07 1.02E+07 O.OOE+00 7.83E+07 0.00E+00 1.73E+07 N/A
)
MEAT ADULT 0.00E+00 3.30E+04 6.27E+03 0.00E+00 7.46E+04 0.00E+00 7.64E+04 N/A TEEN O.OOE+00 2.73E+04 5.20E+03 O.OOE+00 6.24E+04 0.00f+00.4.88E+04 N/A CHILD O.OOE+00 3.79E+04 9.38E+03 O.OOE+00 8.10E+04 O.OOE+00 3.14&04 N/A INFANT 0.00E+00 0.00E+00 0.00f+00 0.00BOO 0.00E+00 0.00E+00 0.00E+00 N/A
~ . uTBLE ADULT 0.00E+00 2.03E+06 3.86E+05 0.00E+00 4.60E+06 0.00E+00 4.71E+06 H/A TEEN 0.00E+00 1.86E+06 3.55E+05 Q.OOE+00 4.27E+06 O.OOE+00 3.34E+06 N/A CHILD 0.00E+00 2.54f+06 6.30E+05. 0.00E+00 5.43E+06 0.00E+00 2.10E+06 H/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 N/A TOTAL ADULT 0.00E+00 9.64E+06 1.83E+06 0.00E+00 2.18f+07 0.00E+00 2.24E+07 N/A iNGEST. TEEN 0.00E+00 1.56E+07 2.97E+06 0.00E+00 3.56E+07 0.00E+00 2.79E+07 H/A CHILD O.OOE+00 2.75E+07 6.80E+06 0.00f+00 5.87E+07 O.OOE+00 2.27f+07 H/A INFANT 0.00E+00 6.37E+07 1.24E+07 0.00E+00 9.51E+07 0.00E+00 2.10E+07 N/A IHHAL. ADULT 0.00f+00 1.21E+02 2.30E+01 0.00E+00 2.91E+02 9.12E+04 2.48E+05 H/A TEEN . 0.00E+00 1.69E+02 3.22E+01 0.00E+00 4.11E+02 1.54f+05 2.69E+05 H/A CHILD O.OOE+00 1.72E+02 4.26E+Ol 0.00fw00 3.92E+02 1.35E+05 1.27E+05 N/A INFANT 0.00E+00 1.65E+02 3.23E+Ol 0.00E+00 2.65E+02 1.35E+05 4.87E+04 N/A BONE LIVER T. BODY THYROID KIDNEY LUNG G.l. SKIN "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
""*MAXIMUMVALUES FOR PATHWAYS***
GROUND: GROUND: GOAT COM TOTAL T.B.'/ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: INHAL.
O.OOE+00 0.00E+00 1.68E+07 7.83E+07 8.10E+04 5.43f+06 9.51E+07 2.69E+05 PAGE 4-2I
O.O.C.M. MAXIMUM PATHWAY DOSE FACTORS- RADIONUCLIOES OTHER THAN NOBLE GASES*
TOPE: Tc-99m rATHWAY AGE GROUP BOHf LIYfR T.BODY THYROID KIDNEY LUNG G. I. SKIN GROUND ADULT O.OOE+00 O.OOE+00 O.OOE+00 Q.OOE+00 O.OOE+00 O.OOE+00 O.OQE+00 O.QQE+00 TEEN O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.DOE+00 O.OOE+00 O.OOE+00 O.QQE+00 CHILD O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.0QE+00 O.QOE+00 Q.QQE+00 INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.QQE+00 GOAT ADULT 1.79E-O) 5.07E-OI 6.46E+00 Q.QOE+00 7.70E+00'.48E-O) 3.00E+02 N/A MILK TEEN 3.11E-O) 8.68E-O) 1.12E+Ol O.OQE+00 1.29E+01 4.82E-O) 5.70E+02 N/A CHILD 7.13E-OI 1.40E+00 2.32E+Ol 0.00E+00 2.03E+Ol 7.10E-O) 7.96E+02 ~
N/A INFANT 1.24E+01 3.06E+00 3.94E+01 Q.QOE+00 3.29E+01 1.60E+00 8.89E+02 N/A COW ADULT 8.37E-O) 2.36E+00 3.0)E+Ol 0.00f+00 3.59E+01 1.16E+00 1.40E+03 H/A MILK TEEN 1.45E+00 4.05E+00 5.25E+0) 0.00E+00 6.03E+01 2.25E+00 2.66E+03 H/A CHILD 3.33E+00 6.53E+00 1.08E+02 Q.OQE+00 9.49E+01 3.31E+00 3.7)E+03 H/A INFANT 6.92E+00 1.43E+Ol 1.84E+02 O.OQE+00 1.54E+02 7.47E+00 4.15E+03 . N/A.
MEAT ADULT 1.47E-21 4.14E-21 5.28E-ZQ O.OOE+00 6.29E-20 2.03E-21 2.45E-IB .H/A TEEN 1.16E-.21 3.25E-ZI 4.2IE-ZO 0.00E+00 4.84E-20 1.80E-21 2.13E-18 N/A CHILD 2.04E-ZI 4.0IE-21 6.64E-20 O.OOE+00 5.82E-20 2.03E-21 2.28E-IB N/A INFANT 0.00E+00 0.00E+00 O.OOE+00 O.QOE+00 0.00f+00 0.00E+00 0.00E+00 H/A VEGTBLE ADULT I.OZE+00 2.89E+00 3.68E+Ol 0.00E+00 4.39E+Ol 1.42E+00 1.71E+03 N/A TEEN 9.03E-OI 2.52E+00 3.26E+Ol 0.00E+00 3.75E+Ol 1.40E+00 1.65E+03 N/A CHILD 1.55E+00 3.05E+00 5.05E+01 O.OOE+00 4.43E+01 1.55E+00 1.73E+03 N/A INFANT O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OQE+00 N/A .
TOTAL ADULT 2.04E+00 5.76E+00 7.34f+01 0.00E+00 8.75E+Ol 2.82E+00 3.41E+03 N/A INGEST. TEEN 2.67E+00 7.43E+00 9.63E+Ol 0.00E+00 1.11E+02 4.13E+00 4.88E+03 H/A CHILD 5.60E+00 I.IOE+Ol 1.82E+02 O.QOE+00 1.59E+02 5.57E+00 6.25E+03 N/A INFANT 1.93E+01 1.73E+01 2.23E+02 O.OOE+00 1.87E+02 9.07E+00 5.04E+03 N/A INHAL. ADULT 1. 03 E-03 2. 91E-03 3. 70E-02 Q.OOE+00 4.42E-OZ 7.64E+02 4.16E+03 H/A jf CHILD EN 1.38E-03 1.78E-03 3.86E-03 3.48E-03 4.99E-OZ O.QQE+00 5.76E-02 1.15E+03 6.13E+03 5.77E-02 0.00E+00 5.07E-02 9.51E+02 4;81E+03 H/A H/A INFANT ).40E-03 2.88E-'03 3.72E-02 0.00E+00 3.11E-02 8.11E+02 2.03E+03 N/A BONE LIVER T. BODY THYROID KIDNEY LUNG G. 1. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
""*MAXIMUMVALUES FOR PATHWAYS~*~
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: IHHAL.
O.OOE+00 O.OOE+00 8.89E+02 4.)5E+03 2.45E-)8 ).73E+03 6.25E+03 6.)3E+03 PAGE: 4-22 ee."Y l OAT~
O.D.C.H.
~ ~ NXIHUH PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES" ISOTOPE:~ Ru-103 PATHWAY AGE GROUP BONE LIVER T. BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.25E+08 TEEN 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.25E'+08 CHILD 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.25E+08 INFANT 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.07E+08 1.25E+08 GOAT ADULT 5.98E+Ol O.OOE+00 2.58E+01 O.OOE+00 2.28E+02 0;OOE+00 6.98E+03 N/A HILK TEEN 1.06E+02 0.00E+00 4.55E+01 0.00Et00 3.75E+02 O.OOE+00 8.88E+03, N/A CHILD 2.52E+02 0.00E+00 9.67E+Ol O.OOE+00 6.33E+02 0.00E+00 6.50E+03 N/A INFANT 4.24E+03 0.00E+00 1.TOE+02 0.00E+00 1;06E+03 O.OOE+00 6.19E+03 N/A COM ADULT 3.11E+02 0.00E+00 1.34E+02 0.00E+00 1.19E+03 0.00E+00 3.63E+04 N/A MILK TEEN 5.53E+02 O.OOE+00 2.37E+02 O.OOE+00 1.95E+03 O.QOE+00 4.62E+04 N/A CHILD 1.3lf+Q3 O.QOE+00 5.03E+02 O.OOE+00 3.29E+03 0.00E+00 3.38E+04 N/A INFANT 2.65E+03 0.00E+00 8.86E+02 0.00E+00 5.51E+03 0.00E+00 N/A 3.22E+04'.64E+09 ADULT 3.97E+07 Q.OOE+00 1.71E+07 O.OOE+00 1.52E+08 0.00E+00 N/A TEEN 3.24E+07 0.00E+00 I.38E+07 0.00E+00 1.14E+08 0.00E+00 2.70E+09 N/A CHILD 5.85E+07 O.OQE+00 2.25E+07 O.OOE+00 1.47E+08 O.OOE+00 1.51E+09 N/A INFANT 0.00E+00 0.00E+QQ Q.OQE+00 0.00E+00 O.OQE+00 0.00E+00 Q.QOE+OQ N/A VEGTBLE ADULT . 3.77E+06 O.OOE+00 1.62E+06 O.OOE+00 1.44E+07 O.OOE+00 4.40Ei08 N/A TEEN 5.91E+06 O.OOE+00 2.53E+06 O.QOE+00 2.08E+07 0.00E+00 4.94E+08 N/A CHILD 1.37E+07 O.OOE+00 5.28E+06 O.OOE+00 3.46E+07 O.OOE+00 3.55E+08 N/A INFANT O.OOE+00 O.OOE+00 Q.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A TOTAL ADULT 4.35E+07 O.OOE+00 1.87E+07 O.OOE+00 1.66E+08 O.OOE+00 5.08E+09 N/A INGEST. TEEN 3.83E+07 O.OOE+00 1.64E+07 O.OOE+00 1.35E+08 O.OOE+00 3.20E+09 N/A CHILD 7.22E+07 O.OOE+00 2.78E+07 0.00E+00 1.82E+QB O.OQE+OQ 1.87E+09 N/A INFANT 6.89E+03 O.OOE+00 1.06E+03 O.OOE+00 6.57E+03 O.OOE+00 3.84E+04 N/A INHAL. ADULT 1.53E+03 0.00E+00 6.58E+02 O.OQE+00 5.83E+Q3 5.05E+05 1. 10E+05 N/A TEEN 2. 10Et03 O.OOE+00 8.96E+02 O.OOE+00 7.43E+03 7.83E+05 1.09E+05 N/A CHILD 2.79E+03 0.00E+00 1.07E+03 .O.OOE+00 7.03E+03 6.62E+05 4.48E+04 N/A INFANT 2.02E+03 O.OOE+00 6.79E+02 O.OOE+00 4.24E+03 5.52E+05 1.61E+04 N/A
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
~
GROUND: GROUND: GOAT COM TOTAL T.B./ORG. SKIN MILK: HILK: MEAT: VEGTBLE: INGEST: INHAL.
1.07E+08 1.25E+08 8.88E+03 4.62E+04 4.64E+09 4.94E+08 5.08E+09 7.83E+05 PAGE: 4-22a Rev. 6
0- D- C. M- MAXIMUM PATHWAY POSE FACTORS: RAOIONUCLIDES OTHER THAN NOBLE GASES"
")PE: Ru-106
.iMAY AGE GROUP BONE LIYfR T. BODY THYROID KIDNEY LUNG G.I. SKIN
'GROUND ADULT 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4..18E+08 4.18E+08 5.01E+08 TEEN 4-18E+08 4.18E+08 4-18E+08 4.18E+08 4 18E+08 4-18E+08 4.18E+08 5.01E+08 CHILD 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4.18f+08 4.18E+08 4.18E+08 5.01E+08 INFANT 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4.18E+08 4.18E+OR 5.01E+08 GOAT ADULT 1.50E+03 O.QOE+00 1.90E+02 O.OOE+00 2.90E+03 O.OOE+00 9.71E+04 H/A MILK TEEN 2.?6E+03 0.00E+00 3.48E+02 O.QOE+00 5.32E+03 0.00E+00 1.32E+05 H/A CHILD 6.79E+03 0.00E+00 8.47E+02 O.OQE+00 9.17E+03 0.00E+00 1.06E+05 N/A INFANT 1.17E+05 0.00E+00 1.75E+03 0.00E+00 1.65E+04 0.00E+00 1.06E+05 H/A COW ADULT 9.65E+03 Q.OQE+00 1.22E+03 O.QQE+00 1.86E+04 Q.OOE+00 6.24E+05 H/A MILK TEEN 1.77E+04 0.00f+00 2.24E+03 0.00E+00 3.42E+04 0.00f+00 8.51f+05 N/A CHILD 4.37E+04 0.00E+00 5.45E+03 0.00E+00 5.90E+04 0.00E+00 6.80E+05 H/A INFANT 9.00E+04 O.QOE+00 1.12E+04. O.OOE+00 1.06E+05 O.OOE+00 6.83E+05 N/A ADULT 1.48E+09 0.00E+00 1.87f+08 0.00E+00 2.85E+09 O.OOE+00 9.56E+10 N/A TEEN 1.24E+09 0.00E+00 1.57E+08 0.00E+00 2.40E+09 0.00E+00 5.97E+10 N/A CHILD 2.34E+09 0.00f+00 2.92E+08 O.OOE+00 3.16E+09 0.00E+00 3.64E+)0 N/A INFANT O.OOE+00 O.oof+00 O.OOE+00 O.Oaf+00 0.'QQE+00 O.OQE+00 O.QOE+00 H/A GTBLE ADULT 1 . 73E+08 0.00E+00 2.19E+07 0.00E+00 3.34E+08 0.00E+00 1.12E+10 N/A TEEN 2.91E+08 O.OOE+00 3.67E+07 O.OOE+00 5.61E+08 'O.OOE+00 1.40E+10 N/A CHILD 7. 11E+08 0.00f+00 8.88E+Q7 O.QQE+00 9.61E+QB O.OOE+00 1.11E+10 N/A INFANT O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 H/A lQTAL ADULT 1.65E+09 O.QQE+00 2.09E+08 O.OOE+00 3.19E+09 0.00E+00 1.07E+11 H/A iNGEST. , TEfN 1.53E+09 0.00E+00 1.93E+08 0.00E+00 2.96E+09 O.QQE+00 7.36E+10 '/A CHILD 3.05E+09 0.00E+00 3.81E+08 0.00f+00 4.1ZE+09 0.00E+00 4.75E+10 H/A INFANT 2.07E+05 0.00E+00 1.30E+04 0.00E+00 1.23E+05 0.00E+00 7.90E+05 N/A
'HHAL. ADULT 6.91E+04 0.00E+00 8.72E+03 0.00E+00 1.34E+05 9.36E+06 9.12E+05 H/A TEEN 9.84E+04 0.00E+00 1.24E+04 0.00E+00 1.90E+05 1.61E+07 9.60E+05 H/A CHILD 1.36E+05 0.00E+00 1.69E+04 0.00f+00 1.84E+05 1.43E+07 4.29E+05 H/A INFANT 8.68E+04 Q.OOE+00 1.09E+04 O.OOE+00 1.07E+05 1.16E+07 1.64E+05 H/A BONE LIVER T.BODY THYROID KIONEY LUNG G. I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec GROUND: GROUND:
T.B./ORG. SKIN GOAT MILK:
'OM
~*"MAXIMUMVALUES FOR PATHWAYS*""
MILK:
TOTAL HEAT: VEGTBLE: INGEST: IHHAL.
4.18E+08 5.01E+08 1.32f+05 8.51E+05 9.56E+10 l.40E+10 1.07E+l1 1. 61E+07 PAGE: 4-23,
O.D.C.H. MAXIMUM PATHWAY DOSE FACTORS: RAOIONUCLIDES OTHER THAN NOBLE GASES*
E: Ag-llom PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G. I. SKIN GROUND ADULT 3.40E+09 3.40E+09 3.40E+Q9 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.97E+09 TEEN 3.40E+09 3.40E+09 3.40E+Q9 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.9?E+09 CHILD 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.40E+09 '3.40E+09 3.40E+09 3.97E+09 INFANT 3.40E+09 3.40E+09 3.40E+09 3.40E+09 3.40E+Q9 3.40E+09 3.4QE+09 3.97E+Q9 GOAT ADULT 4.19E+06 3.88E+06 2.30E+06 O.OOE+00 7.63E+06 O.OOE+00 1.58E+09 8/A MILK TEEN 6.93E+06 6.56E+06 3.99E+06 O.OQE+00 1.25E+07 0.00E+QO 1.84E+09 N/A CHILD 1.50E+07 1.02E+07 8.12E+06 O.OOE+00 1.89E+07 O.OOE+00 1.21E+09 H/A INFANT 2.32E+08 2.03E+07 1.34E+07 Q.OOE+00 2.90E+07 O.OOE+00 1.05E+09 H/A COW ADULT 2.65E+07 2.46E+07 1.46E+07 O.OOE+00 4.83E+07 O.OOE+00 1.00E+10 H/A MILK TEEN 4.39E+07 4.15E+07 2.53E+07 0.00E+00 7.92E+07 0.00E+00 1.17E+10 H/A CHILD 9.52E+07 6.43E+Q7 5.14E+07 O.QQE+00 1.20E+08 O.OQE+00 7.65E+09 H/A INFANT 1.76E+08 1.28E+08 8.50E+07 Q.QOEH)0 1.84E+08 0.00E+00 6.66E+09 H/A MEAT ADULT 3.42E+06 3.1?E+06 1.88E+06 O.QQE+00 6.23E+06 O.OQE+00 1.29E+09 H/A TEEN 2.59E+06 2.45E+06 1.49E+06 O.QOE+00 4.68E+06 O.OOE+00 6.89E+08 H/A CHILD 4.30E+06 2.90E+06 2.32E+06 O.QOE+00 5.41E+06 O.OOE+00 3.45E+08 N/A INFANT O.OOE+00 O.OOE+Qo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+OO H/A VEGTBLE ADULT 9.41E+06 8.70E+06 5.17E+06 O.OOE+00 1.71E+07 O.OOE+00 3.55E+09 H/A TEEH 1.42E+0? 1.34E+07 8.18E+06 O.OOE+00 2.56E+07 O.OOE+00 3.78E+09 H/A CHILD 3.06E+07 2.06E+07 1.65E+07 0.00E+00 3.85E+07 0.00E+00 2.46E+09 H/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Q.OQE+00 H/A TOTAL ADULT 4.36E+07 4.03E+07 2.39E+07 O.OOE+00 7.92E+07 O.OOE+00 1.64E+10 H/A INGEST. TEEN 6.76E+07 6.40E+07 3.89E+07, O.OOE+00 1.22E+08 O.OOE+00 1.80E+10 N/A CHILD 1.45E+08 9.80E+07 7.83E+07 Q.QQF+00 1.83E+08 0.00E+00 1.17E+10 H/A INFANT 4.0?E+08 1.49E+08 9.84E+07 O.OOE+00 2.13E+08 O.OOE+00 7.TIE+09 H/A IHHAL. 'DULT 1.08E+04 1.00E+04 5.94E+03 O.OQE+00 1.97E+04 4.63E+06 3.02E+05 H/A TEEN 1.38E+04 1,31E+04 ?.99E+03 0.00E+00 2.50E+04 6.75E+06 2.73E+05 H/A CHILD 1.69E+04 1.14E+04 9.14E+03 O.OOE+00 2. 12E+04 5.48E+06 1.00E+05 H/A INFANT 9.98E+03 7.22E+03 5.00E+03 O.OOE+00 1.09E+04 3.67E+06 3.30E+04 H/A BONE LIVER T. BODY THYROID KIDNEY LUNG G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"**HAXIHUNVAl UES FOR PATHWAYS**~
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: IHHAL.
3.40E+09 3.97E+09 1.84E+09 I. 1?E+10 1.29E+09 3.?BE+09 1. 80E+10 6.75E+06 4-24
O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIQNUCLIDES OTHER THAN NQBLE GASES*
ISOTOPE: Te-129m PATHWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G. I. SKIN GROUND ADULT 1.96E+07 1.96E+07 1.96E+07 1.96E+07 1.96E+07 1.96E+07 1.96E+07 2.29E+07 TEEN 1.96E+07 1.96E+07 1.96E+07 1.96E+07 1.96Ew07 1.96E+07 1.96E+07 2.29E+07 CHILD 1.96E+07 1.96E+07 1.96E+07 1.96E+07 1.96E+07 1.96E+07 1.96E+07 2.29E+07 INFANT 1.96E+07 1.96E+07 1.96E+07 1.96E+07 1.96E+07 1.96E+07 1.96E+07 2.29E+07 GOAT ADULT 3.47E+06 I.29E+06 5.49E+05 1.19E+06 1.45E+07 O.OOE+00 1.75E+07 N/A MILK TEEN 6.34E+06 2.35E+06 1.00E+06 2.05E+06 2.65E+07 O.OOE+00 2.38E+07
- N/A CHILD 1.56E+07 4.37E+06 2.43E+06 5.04E+06 4.59E+07 0.00E+00 1.91E+07 N/A INFANT 2.68E+08 1.10E+07 4.94E+06 1.23E+07 8.03E+07 O.OOE+00 1.92E+07 N/A COW MILK ADULT TEEN CHILD 1.76E+07 3.22E+07 7.95E+07 6.58E+06 1.20E+07 2.22E+07 2.79E+06 5.10E+06 1.23E+07 6.06E+06 1.04E+07 2.56E+07 7.36E+07 1.35E+08 2.33E+08 0-QOE+00 8.88E+07 0.00E+00 1.2IE+08 0.00E+00 9.69E+07
'/A N/A N/A INFANT 1.63E+08 5.60E+07 2.51E+07 6.27E+07 4.08E+08 O.OOE+00 9.74E+07 N/A MEAT ADULT 4.15E+08 1.55E+08 6.57E+07 1.43E+Q8 1.73E+09 O.OOE+00 2.09E+09 N/A TEEN 3.48E+08 1.29E+08 5.51E+07 1.12E+08 1.46E+09 O.QOE+00 1.31E+09 N/A CHILD 6.56E+08 1.83E+08 1.02E+08 2. IIE+08 1.93E+09 0.00E+00 8.00E+08 N/A INFANT O.OOE+00 Q.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A VEGTBLE ADULT 1.92E+08 7.16E+Q7 3.04E+07 6.59E+Q7 8.01E+08 O.OOE+00 9.66E+08 N/
TEEN 3.06E+08 1.14E+08 4.85E+07 9.89E+07 1.28E+09 O.OOE+00 1.15E+Q9 N/
CHILD 7.39E+08 2.06E+08 1.15E+08 2.38E+08 2.17E+09 O.OOE+00 9.01E+08 N/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OQE+00 O.OQE+00 O.OOE+00 N/A TOTAL ADULT 6.28E+08 2.34E+08 9.94Ee07 2.16E+08 2.62E+09 O.OOE+00 3.16E+09 N/A INGEST. TEEN 6.93E+08 2.57E+08 1.10E+08 2.24E+08 2.90E+09 Q.OOE+00 2.60E+09 N/A CHILD 1.49E+09 4.16E+08 2.31E+08 4.80E+08 4.37E+09 0.00E+00 1.82E+09 N/A INFANT 4.31E+08 6.70E+07 3.01E+07 7.50E+07 4.88E+08 O.OOE+00 1.17E+08 N/A INHAL. ADULT 9.76E+03 4.67E+03 1.58E+03 3.44E+03 3.66E+04 1.16E+06 3.83E+05 N/A TEEN 1.39E+04 6.58E+03 2.25E+03 4.58E+Q3 5.19E+04 1.98E+06 4.05E+05 N/A CHILD 1.92E+04 6.85E+03 3.04E+03 6.33E+03 5.03E+04 1.76E+06 1.82E+05 N/A INFANT 1.41E+04 6.09E+03 2.23E+03 5.47E+03 3.18E+04 1.68E+06 6.90E+04 N/A
<<Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec GROUND: GROUND: GOAT COW TOTAL T.B./QRG. SKIN MILK: MI LK: MEAT: VEGTBLE: INGEST: INHAL.
1.96E+07 2.29E+07 2.68E+08 4.08E+08 2.09E+09 2.17E+09 4.37E+09 1.98E+06 PAGE: 4-24a Rev. 6
MAXIMUM PATHWAY DOSE FACTORS: RADIGNUCLIDES OTHER THAN NOBLE GASES" E: I-)3)
WAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 1.70Et07 1 . 70E+07 1. 70E+07 1. 70E+07 1. 70E+07 1. 70 E+07 1.70E+07 2.07E+07 TEEN 1. 70E+07 1.70E+07 1.TOE+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 2.07E+07 CHILD 1.70E+07 1.70f+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 1.70f+07 2.07E+07 INFANT 1.70E+07 1.70E+07 ).70E+07 1.70E+07 1.70E+07 1.70E+07 1.70E+07 2.07E+07 GOAT ADULT 1.60E+08 2.29E+08 1.31E+08 7.50E+10 3.92E+08 O.DOE+00 6.04E+07 H/A MILK TEEN 2.90E+08 4.06E+08 2. )BE+08 1. 19E+ll 6.99E+08 O.DOE+00 8.04E+07 H/A CHILD 7.04E+08 7.08E+08 4.02E+08 2.34E+ll 1. 16E+09 O.DOE+00 6.30E+07 N/A INFANT 1.22E+09 1.73E+09 7.61E+08 5.69E+ll 2.02f+09 O.OOE+00 6. 18E+07 'H/A
'OW ADULT 7-46E+07 1.07E+08 6.12E+07 3.50E+10 1.-83E+08 0.00E+00 2.82E+07 H/A MILK TEEN 1-35E+08 1.90E+OB 1.02E+08 5.53E+10 3.26E+08 0.00E+00 3.75E+07 N/A CHILD 3-29E+08 3.30E+08 1.88E+08 '1.09E+ll 5.42E+08 0.00E+00 2.94E+07 H/A INFANT 6.86E+08 8.08E+08 3.55E+08 2.65E+11 9.44E+08 0.00E+00 2.88E+07 H/A MEAT ADULT 3-54E+06 5.07E+06 2.90E+06 1.66E+09 8.68E+06 O.OOE+00 1.34E+06 H/A TEEN 2.94E+06 4. 12E+06 2.21E+06 1.20E+09 7.09E+06 O.OOE+00 8. 15E+05 H/A CHILD 5.46E+06 5.49E+06 3.12E+06 1.81E+09 9.01E+06 0.DOE+00 4.89f+05 H/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 H/A ADULT 2.86E+07 4. 10E+07 2.35E+07 1.34E+10 7.02E+07 0.00E+00 1.08E+07 H/A TEEN 2.88E+07 4.03E+07 2.16E+07 1. 18E+10 6.93E+07 0.00E+00 7.96E+06 H/A CHILD 5.54E+07 5.57E+07 3.17E+07 1.84E+10 9.15f+07 O.OOE+00 4.96E+06 N/A INFANT O.OOE+00 O.OOE+00 O.OOE+00. O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+OD ~
H/A TOTAL ADULT 2.67E+08 3.82f+08 2.19E+08 1.25E+ll 6.54E+08 O.DOE+00 1.01E+08 N/A'/A INGEST. TEEN 4.57E+08 6.40f+08 3.44E+08 1.87E+ll 1. 10E+09 O.OOE+00 1.27E+08 CHILD 1.09E+09 1.)DE+09 6.25E+08 3.64E+ll 1.81E+09 0.DOE+00 9,79E+07 H/A INFANT 1.91E+09 2.54E+09 1.12E+09 8.34E+11 2.97E+09 O.OOE+00 9.06E+07 H/A INHAL. ADULT 2.52E+04 3.58E+04 2.05E+04 1. 19E+07 6.13E+04 O.DOE+00 6.28E+03 H/A TEEN 3.54E+04 4.91E+04 2.64E+04 1.46E+07 8.40E+04 O.OOE+00 6.49E+03 H/A CHILD 4.81E+04 4.81E+04 2.73E+04 1.62f+07 7.88E+04 O.DOE+00 2.84E+03 N/A INFANT 3.79E+04 4.44E+04 1.96E+04 1.4QE+07 5.18E+04 O.DOE+00 1.06E+03 N/A BONE LIVER T.BODY THYROID K)DNEY LUNG G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-mZ/yr/uCi/sec
"""MAX)NUMVALUES FOR PATHWAYS""~
GROUND: GROUND: GOAT COW TOTAL T. B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE.: INGEST: INHAL.
).70E+07 2.07E+07 5.69E+1) 2.65E+1) ).8)f+09 ).84E+)0 8.34E+)1.1.62E+07 PAGE: 4-25
O.D. C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NQBLE GASES*
)PE: I -132 I ~ I HWAY AGE GROUP BONE LIVER T. BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 TEEN O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 CHILD O.OOE+00 O.OOE+00 O.OOE+00.0.00E+00 O.OOE+00 0.00f+00 O.OOE+00 0.00E+00 INFANT O.OOE+00 0.00'E+00 O.OOE+00 O.OOE+00 O.OOE+00 Q.OOE+00 O.OOE+00 O.OOE+00 I GOAT ADULT 8.87E-02 2.37E-O) 8.30E-OZ 8.30E+00 3.7BE-O) 0.00E+00 4.46E-02 H/A IMILK TEEH 1.5?E-O) 4.12E-01 1.48E-O) 1.39E+01 6.48E-Ol O.OOE+00 1.79E-O) H/A CHILD 3.72E-01 6.84E-Ql 3.14E-O) 3.17E+Ol 1.05f+00 O.OOE+00 8.05E-O) H/A INFANT 6.44E-01 1.5?f+00 5.58E-Ol 7.35E+Ol 1.75f+00 O.OOE+00 1.27E+00 H/A COW ADULT 4.14E-02 1.1)E-O) 3.87E-OZ 3.8?E+00 1.76E-01 0'.OOE+00 2.08E-02 H/A MILK TEEN ?.34E-02 1.92E-O) 6.89E-OZ 6.47ftOQ 3.03E-O) O.OOE+00 8.37E-02 - H/A CHILD ).74E-01 3.19E-O) 1.47E-01 1.48E+Ql 4.88E-01 Q.OOE+00 3.75E-O) H/A INFANT 3. 60E-01 ? . 31E-01 2. 60E-01 3. 43E+01 8. 16E-01 0.00F+00 5.93E-O) H/A MEAT ADULT 2.30E-59 6.14E-59 2.)5E-59 2.15E-57'.79E-59 O.OOE+00 1.15E-59 N/A TEEN ).87E-59 4.88E-59 1.75E-S9 1.64E-57 7.69E-59 0.00E+00 2.13E-59 N/A CHILD 3.37E-59 6.20E-59 2.85E-59 2.88E-57 9.49E-59 O.OOE+00 7.30E-59 N/A INFANT O.OQE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A VEGTBLE ADULT 1.90E+01 5.0BE+Ol 1.78E+Ol 1.78E+03 8.10E+01 O.OOE+00 9.55E+00 N/A TEEN 1.71E+Ol 4.48E+01 1.6)E+01 ).5)E+03 7.06E+01 0.00E+00 1.95E+0) N/A CHILD 3.04E+Ol 5.59E+0) 2.57E+01 2.59E+03 8.56E+Ol O.OOE+00 6.58E+Ol H/A INFANT O.OOE+00 O.OOE+00 O.DOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 H/A "QTAL ADULT 1.9)E+01 5.12E+Ol 1.79E+01 1.79E+03 8.15E+Ol O.OOE+00 9.61E+00 H/A
'.HGEST. TEEN 1.?4E+Ol 4.54E+01 1.63E+Ol 1.53E+03 7.16E+Ol O.OOE+00 1.98E+Ol N/A CHILD 3.)QE+01 5.69E+01 2.62E+01 2.64E+03 8.71E+Ol 0.00f+00 6.70E+Ol H/A INFANT 1.00E+00 2.30E+00 8.19E-O) 1.08E+02 2.57E+00 O.OOE+00 1.86E+00 H/A
'NHAL. ADULT 1.16E+03 3.26E+03 1.16E+03 1.14E+05 5.18E+03 O.OOE+00 4.06E+02 H/A TEEN 1.59E+03 4.3SE+03 1.58E+03 1.5)E+05 6.92E+03 O.OOE+00 1.27E+03 H/A CHILD 2.12E+03 4.07E+03 1.88E+03 ).94E+QS 6.25E+03 0.00E+00 3.20E+03 H/A INFANT ).69E+03 3.54E+03 1.26E+03 1.69E+05 3.95E+03 0.00E+00 1.90E+03 H/A BONE LIVER T. BODY THYROID KIDNEY G.I. SKEH "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"""MAXIMUMVALUES FOR PATHWAYS*"~
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: HEAT: VEGTBLE: INGEST: IHHAL.
O.OOE+00 O.OOE+00 7.35F+01 3.43E+01 2.88E-57 2.59E+03 2.64E+03 1.94E+05 PAGE: 4-26
C 0-D-C-H- HAXIHUH PATHWAY DOSf FACTORS: RADIONUCLIDES OTHER THAN HOBLf GASES*
I f: Te-132 PesHWAY AGE GROUP BONE LUNG G.I. SKIN GROUND ADULT 0.00E+00 0.00E+00 Q.QQE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TEEN 0.00E+00 0.00E+00 0.00f+00 0.00E+00 0.DOE+00 0.00E+00 0.00E+00 O.OOE+QQ CHILD 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.DOE+00 0.00E+00 0.00E+00 0.DOE+00 INFANT Q.OQE+OQ Q.QQE+QQ 0.00E+00 Q.QQE+00 0.00E+00 O.OQE+00 Q.QQE+00 Q.DOE+00 GOAT ADULT 1.30E+05 8.39E+04 7.8BF+04 9.27E+04 8.08E+05 O.OQE+00 3.97E+06 H/A MILK TEEN 2.32E+05 1.47E+05 1.38E+05 1.55E+05 1.41E+06 0.DOE+00 4.65E+06 H/A
'CVILD 5.53F+05 2.4SE+05 2.96E+05 3.57E+05 2.27E+06 O.DOE+00 2.47E+06 N/A INFANT 9.50E+06 5.64E+05 5.27E+05 8.33E+05 3.53E+06 0.00E+00 2.09E+06 N/A COW ADULT 6.05E+05 3.9IE+05 3.67E+05 4.32E+05 3.77E+06 0.00E+00 I.BSE+07 H/A MILK TEEN 1.08E+06 6.85E+05 6.45E+05 7.22E+05 6.57E+06 0.00E+00 2.17E+07 H/A CHILD 2.58E+06 1.14E+06 1.38E+06 1.66f+06 1.06f+07 0.00E+00 1.15E+07 N/A INFANT 5.32E+06 2.63f+06 2.46E+06 3.89E+06 1.65E+07 0.00E+00 9.74E+06 H/A ADULT 4.68E+05 3.03E+05 2.84E+05 3.34E+05 2.92E+06 0.00E+00 1.43E+07 H/A TEEN 3.83E+05 2.43E+OS 2.28E+05 2.56E+05 2.33E+06 O.DOE+00 7.6BE+06 N/A CHILD 6.99E+05 3.09E+05 3.74E+05 4.51E+05 2.87E+06 O.OOE+00 3.11E+06 H/A INFANT O.OOE+00 O.OOE+00 O.QOE+00 O.DOE+00 O.OOE+00 O.DOE+00 Q.OQE+00. N/A ADULT 1.42E+06 9.18E+05 8.62E+05 1.01E+06 8;84E+06 O.OOE+00 4.34E+07 N/A TEEN 1.29E+06 8.17E+05 7;69E+05 8.61E+05 7.83E+06 0.DOE+00 2.59E+07 N/A CHILD 2.31E+06 1.02E+06 1.24E+06 1.49E+06 9.49E+06 O.OQE+00 1.03E+07 N/A INFANT 0.DOE+00 0.00E+00 0.00E+00 0.00E+00 0.DOE+00 O.OOE+00 O.OOE+00 N/A TOTAL ADULT 2.62E+06 1.70E+06 1.59E+Q6 1.87E+06 1.63E+07 Q.DOE+00 8.0ZE+07 N/A INGEST. TEE H 2.99E+06 1.89E+06 1.78E+06 1.99E+06 1.81E+07 O.OOE+00 5.99E+07 . N/A CHILD 6.15E+06 2.72E+06 3.29E+06 3.96f+06 2.53E+07 O.QOE+00 2.74E+07 N/A INFANT 1.48E+07 3.20E+06 2.98E+06 4.72E+06 Z.OOE+07 0.00E+00 1.18E+07 N/A HHAL. ADULT 2.60E+02 2. ISE+02 1.62E+02 1.90E+02 1.46E+03 2.88E+05 5.10E+05 N/A TEEN 3.60'E+02 2.90E+02 2.19E+02 2.46E+02 1.95E+03 4.49E+05 4.63E+05 N/A CHILD 4.81E+02 2.72E+02 2.63E+02 3.17E+02 1.77E+03 3.77E+05 1.38E+05 N/A IHFANT 3.72E+02 2.37E+02 1.76E+02 2.79E+02 I'.03E+03 3.40E+05 4.41E+04 H/A BONE LIVER T.BODY THYROID KIDNEY LUNG . G.l. SKIN
- Airborne pathways and tr itium ingestion: units are mrem/yr/uCi/m3 Deposi tion pathways: uni ts are mrem-m2/yr/uCi/sec
""*MAXIMUMVALUES FOR PATHWAYS~~~
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN HILK: MILK: HEAT: VEGTBLE: INGEST: IHHAL.
0.00E+00 0.00E+00 9.50E+06 2.17f+07 1.43E+07 4.34E+07 8.02E+07 S.IQf+05 PAGE: 4-27
O.D.C.M. MAXIMUM PATHWAY OQSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*
~TOPE: 1-133
..~THWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 TEEN Q.QOE+00 Q.QOE+00 O.OQE+00 Q.QQE+00 O.oof+00 Q.QQE+00 Q.QOE+00 O.OOE+00 CHILD 0.00E+QO O.QOE+00 Q.OOE+QO O.QOE+QQ Q.QOE+00 0.00E+00 0.00E+00 0.00E+00 INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Q.OOE+00 Q.OOE+00 Q.OOE+00 O.QOE+00 GOAT ADULT 2.09E+06 3.64E+06 1.11E+06 5.34E+08 6.34E+06 0.00E+00 3.27E+06 N/A MILK TEEN 3.82f+06 6.48E+06 1.98f+06 9.04E+08 1.14E+07 O.OOE+00 4.90E+06 H/A CHILD 9.28E+06 l. 15E+07 4.34E+06 2.13E+09 1.91E+07 O.QOE+00 4.62E+06 . N/A INFANT 1.63E+07 2.85E+07 8.35f+06 5. 19f+09 3.35E+07 0.00E+00 4.83E+06 H/A COW ADULT 9.75E+05 1.70E+06 5.17E+05 2.49E+08 2.96f+06 O.QOE+00 1.52E+06 H/A MILK TEfH 1.78E+06 3.02E+06 9.21E+05 4.22E+08 5.30E+06 O.OOE+00 2.29E+06 H/A CHILD 4.33E+06 5.35E+06 2.02E+06 9.94E+08 8.92E+06 O.OOE+00 2.16E+06 H/A INFANT 9. 14E+06 1.33E+07 3.90E+06 2.42E+09 1.56E+07 0.00E+00 2.25E+06 H/A MEAT ADULT 1.20E-OI 2.09E-01 6.38E-02 3.08E+Ol 3.65E-Ol O.OOE+00 1.88E-Ol N/A TEEN 1.01E-01 1. 71E-01 5.2lf-02 2.38E+Ol 3.00E-01 O.OOE+00 1.29E-01 H/A CHILD 1. 87E-01 2. 31E-01 8.75E-'02 4.30E+01 3.86E-Ol O,OOE+00 9.32E-02" N/A INFANT 0.00f+00 O.OOE+00 0.00E+00 0.00E+00 O.QOE+00 0.00E+00 0.00E+00 H/A VEGTBLE ADULT 6.88E+05 1.20E+06 3.65E+05 1.76E+08 2.09E+06 O.OOE+00 1.08E+06 N/A TEEN 6.39E+05 1.08E+06 3.31E+05 1.51E+08 1.90E+06 O.OOE+00 8.20E+05 N/A CHILD l. 17E+06 1.44E+06 5.45E+05 2.68E+08 2.40E+06 O.OOE+00 5.81E+05 N/A INFANT Q.OQE+00 O.OOE+00 O.OOE+00 0.00f+00 O.OOE+00 O.OOE+00 O.OOE+00 H/A TOTAL ADULT 3.75E+06 6.53E+06 1.99E+06 9.59E+08 1.14E+Q7 0.00E+00 5.87E+06 H/A INGEST. TEEN 6.24E+06 1.06E+07 3.23f+06 1.48E+09 1.86E+07 O.OQE+OQ 8. 01E+06 H/A CHILD 1;.48E+07 1.83E+07 6.91E+06 3.39f+09 3.04E+07 O.OOE+00 7.36E+06 N/A INFANT 2.55E+07 4.18f+07 1.22E+07 7.61E+09 4.92f+07 O.OOE+00 7.08E+06 N/A IHHAL. ADULT 8.64E+03 1.48E+04 4.52E+03 2.15E+06 2.58f+04 O.OOE+00 8.88E+03 H/A TEEN 1.22E+04 2.05E+04 6.22E+03 2..92E+06 3.59E+04 0.00E+00 1.03E+04 H/A CHILD 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38f+04 O.OOE+00 5.48E+03 N/A INFANT 1.3ZE+04 1.92E+04 5.60E+03 3.S6E+06 2.24E+04 Q.OOE+00 2. 16E+03 N/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposi tion pathways: uni ts are mrem-m2/yr/uCi/sec
"""MAXIMUMVALUES FOR PATHWAYS*"*
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MI LK: MfAT: VEGTBLE: INGEST: INHAL.
O.OOE+00 O.OQE+00 5. 19E+09 2. 42 f+09 4:30E+0 } 2. 68E+08 7.61F+09 3.85E+06 PAGE: 4-28
O.P.C.M. MAXIMUM PATHWAY DOSE FACTORS: RAOIONUCLIOES OTHER THAN NOBLE GASES*
[-134 .
AY AGE GROUP BONE LIVER T. BODY THYROID KIDNEY LUHG G. I. SKIN GROUND ADULT O.OOE+00 0.00f+00 O.OOE+00 O.OOE+00 O.QOE+00 0.00E+00 Q.OQE+00 0.00E+00 TEEN 0-OQE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Q.OQE+00 CHILD O.OOE+OO O.OOE+OO O.OOE+00 O.OOE+Oo O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+OO IHFAHT O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OQ O.OOE+OO O.OOE+00 O.OOE+OO GOAT ADULT 1.09E-12 2.96E-12 1.06E-12 5.13f-ll 4.71E-I2. OAOE+00 2.58E-15 H/A MILK TEEN 1.94E-12 5.13E-12 1.84E-12 8.55f-ll 8.09E-12 0-00E+00 6-76E-14 H/A CHILD 4.58E-IZ B.SIE-IZ 3.92E-12 1.96f-lo 1.30E-II Q.QOE+QQ S.64E-12 H/A IHFANT 7.92E-12 1.95E-II 6-92E-12 4.54E-IO 2.18E-II O.OOE+00 2.01E-II N/A cow ADULT 5-OBE-13 1.38E-12 4.94E-13 2.39E-ll 2.20E-12 0.00E+QQ 1.2QE-IS H/A MILK TEEN 9.03E-13 2.39E-12 8.60E-I3 3.99f-ll 3.77E-12 0.00E+00 3.15E-14 H/A CHILD 2.14E-12 3.97f-l2 1.83f-l2 9.13f-ll 6.07E-IZ O.OOE+00 2.63E-12 " N/A IHFANT 4-43E-12 9.08E-12 3.23E-12 2.12E-IO 1.02E-II 0.00E+00 9.39E-12 H/A MEAT ADULT 0.00E+00 O.OQE+00 0.0OE+00 0.00f+00 O.OOE+00 O.OOE+00 O.OOE+00 N/A .
TEEN 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 H/A CHILD O.OOE+00. 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Q.oof+00 H/A INFANT O.QQE+00 O.QOE+00 0.00E+00 0.00E+00 0.00E+00 Q.OOE+00 0.00E+00 H/A GTBLE ADULT 3.19E-05 8.65E-OS 3.10E-OS 1.50E-03 1.38E-04 0.00E+00 7.54E-QB H/A TEEN 2.88E-OS 7.63E-QS 2.74E-OS 1.27E-03 I.ZOE-04 O.OOE+00 I.OIE-06 H/A CHILD 5.12E-OS 9.50E-QS 4.37E-05 2.19E-03 1.45E-04 O.QOE+00 6.30E-OS H/A INFANT O.QOE+00 0.00E+00 0.00E+00 O.QOE+00 0.00E+00 0.00E+00 0.00E+00 H/A TOTAL ADULT 3.19E-05 8.65E-OS 3.10E-05 1.50E-03 1.38E-04 O.OOE+00 7.54E-QB H/A INGEST. TEEN 2.88E-QS 7.63E-05 2.74E-OS 1.27E-03 1.20E-04 0.00E+00 I.OIE-06 H/A CHILD 5.12E-QS 9.50E-OS 4.37E-QS 2.19E-03 1.45E-Q4 O.QOE+QQ 6;30E<5 H/A INFANT 1.24E-ll 2.85E-II 1.02E-II 6.66E-IO 3.19E-II 0.00E+00 2.95E-II N/A IHHAL. ADULT 6.44E+02 1.73E+03 6. ISE+02 2.98E+04 2.75E+03 0.00E+00 1.01E+00 TEEN 8.88E+02 2.32E+03 8.40E+02 3.95E+04 3.66E+03 0.00E+00 2.04E+01 H/A CHILD 1.17E+03 2.16E+03 9.95E+02 5.07f+04 3.30E+03 O.OQE+00 9.55E+02 H/A IHFANT 9.21E+02 I'.BBE+03 6.6Sf+02 4.45E+04 2.09E+03 0.00E+00 1.29E+03 N/A LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN
- Airborne pathways and tr'itium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-mZ/yr/uCi/sec
""*MAXIMUMVALUES FOR PATHWAYS"~"
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: IHHAL.
0.00E+00 O.oof+00 4.54f-lO .2.12f-lo O.OOE+00 2.19E-03 2. 19E-03'. 07E+04 PAGE: 4-Z9
0-D-C-M. MAXIMUM PATHMAY DOSE FACTORS: RADIOHUCLIDES OTHER THAN NOBLE GASES*
'~~TOPE: Cs- I34
- HMAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN GROUND ADULT 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6*79E+09 7.92E+09 TEEN 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 7-92E+09.
CHILD 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79f+09 6.79E+09 6.79E+09 7.92E+09 INFANT 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 6.79E+09 7.92E+09 GOAT ADULT ~ 1.06E+10 2.53E+10 2.07E+10 0.DOE+00 8.19E+09 2.72E+09 4.43E+08 N/A MILK TEEN 1.85E+10 4.35E+10 2.02E+10 O.OOE'+00 1.38E+10 5.27E+09 5.41E+08 H/A CHILD 4.26E+10 6.99E+10 1.47E+10'.DOE+00 2.17E+10 7.77E+09 3.77E+08 N/A INFANT 2.29E+10 1:28E+ll 1.29E+10 0.DOE+00 3.30E+10 1.35E+10 3.48E+08 ,N/A COM ADULT 2.79E+09 6.63E+09 5.42E+09 0-DOE+00 2.15E+09 7.12E+08 1.16E+08 H/A MILK TEEN 4.84E+09 1.14'-l0 5.28E+09 0.00E+00 3.62E+09 1.38E+09 1.4ZE+08 N/A CHILD 1. 12E+10 1.83E+10 3.86E+09 O.DOE+00 5.68E+09 2.04E+09 9.87E+07 H/A INFANT 1.80E+10 3.3SE+10 3.39E+09 0.00E+00 8.63E+09 3.54E+09 9.11f+07 H/A HEAT ADULT 3.S9E+08 8.54E+08 6.9BE+08 O.DOE+00 2.76E+08 9.17E+07 1.49E+07 N/A TEEN 2.85E+08 6.71E+08 3.12E+08 0.00E+00 2.13E+08 8.15E+07 8.35E+06 H/A CHILD 5.03E+08 8.26E+08 1.74E+08 O.DOE+00 2.56E+08 9.18E+07 4.45E+06 N/A INFANT O.OOE+00 0 OOE+00 0.00f+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 H/A YEGTBLE ADULT 4.21f+09 1.DOE+10 8.19E+09 O.DOE+00 3.24E+09 1.08E+09 1.75E+08 N/A TEEN 6.70E+09 1;SBE+10 7.31E+09 O.DOE+00 S.D1E+09 1.91E+09 1.96E+08 H/A CHILD 1.53E+10, 2 52E+10 5.31E+09 0.00E+00 7.80f+09 2.80E+09 1.36E+08 H/A .
INFANT O.DOE+00 0.DOE+00 O.DOE+00 0.00E+00 0.DOE+00 O.DOE+00 0.DOE+00 N/A TOTAL ADULT 1.80f+10 4.28E+10 3.50E+10 0.00E+00 1.39E+10 4.60E+09 7.49E+08 N/A INGEST. TEEN 3. 03E+10 7.13E+10 3.31E+10 0.DOE+00 2.27E+10 8.65E+09 8.87E+08 H/A CHILD 6. 96E+10 1.14E+ll 2.41E+10 O.DOE+00 3.54E+10 1.27E+10 E;.16E+08 H/A INFANT 4. 09E+10 1.62E+ll 1.63E+10,0.DOE+00 4.16E+10 1.70E+10 4.39E+08 H/A IHHAL. ADULT 3.73E+05 8.48E+05 7.28E+05 0.DOE+00 2.87E+05 9.76E+04 1.04E+04 H/A TEEN S.OZE+05 1.13E+06 5.49E+05 0.00E+00 3.75E+05 1.46E+OS 9.76E+03 H/A CHILD 6.51E+05 1.01E+06 2.25E+05 0.DOE+00 3.30E+05 1.21E+05 3.85E+03 N/A IHFANT 3.96f+05 7.03E+05 7.45E+04 0.DOE+00 1.90E+05 7.97E+04 1.33E+03 H/A BQHE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"""MAXIMUMVALUES FOR PATHMAYS"**
GROUHD: GROUND. GOAT COM TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: IHGEST: INHAL.
6.79E+09 7 '2E+09 1.28f+ll 3.35E+10 8.54E+08 2. 52E+10 1.62E+ll 1 . 13E+06 PAGE: 4-30
O.D.C.M..MAXIMUM PATHWAY DOSE FACTORS: RAOIONUCLIOES OTHER THAN NOBLE GASES*
E: I -135 AY AGE GROUP BONE LIVER T.BODY THYROID KIONEY LUNG G.I. SKIN GROUND ADULT 0.00f+00 0.00f+00 0.00E+00 0.00E+00 0.00E+00 0.00f+00 0.00E+00 0.00E+00 TEEN 0.00f+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 CHILD . O.OOE+00 0;00E+00 O.OOE+00 O.OOE+00 O.oof+00 O.OOE+00 0.00f+00 O.OOE+00 INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 GOAT ADULT 6.93E+03 1.82E+04 6.70E+03 1.20E+06 2.91E+04 0.00E+00 2.05E+04 H/A MILK TEEN 1.23E+04 3.17E+04 1.18E+04 2.04E'+06 5.01E+04 O.OOE+00 3.51E+04 H/A CHILD 2.92E+04 5.25E+04 2.48E+04 4.65E+06 8.05E+04 O.OOE+00 4.00E+04 H/A INFANT S.05E+04 1.21E+05 4.40E+04 1.08E+07 1.34E+05 O.OOE+00 4.37E+04 N/A
'I COW ADULT 3-24E+03 8.47E+03 3.13E+03 5.59E+05 1.36E+04 O.OOE+00 9.57E+03 H/A MILK TEEN 5.75E+03 1.48E+04 5.48E+03 9.52E+05 2.34E+04 0.00E+00 1.64E+04 N/A CHILD 1.36E+04 2.45E+04 1.16E+04 2.17E+06 3.75E+04 0.00E+00 1.87E+04 H/A INFANT 2.83E+04 5.63E+04 2.05E+04 5.05E+06 6.27E+04 0.00E+00 2.04E+04 H/A MEAT ADULT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 N/A TEEN 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 H/A CHILD 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00f+00 0.00E+00 H/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 H/A GTBLE ADULT 1.29E+04 3.37E+04 1.24E+04 2.22E+06 5.40E+04 0.00E+00 3.80E+04 H/A TEEN 1.16E+04 2.99E+04 1.11E+04 1.92E+06 4.73E+04 0.00E+00 3.32E+04
~
H/A CHILD 2.06E+04 3.72E+04 1.76E+04 3.29E+06 5.70E+04 0.00E+00 2.83E+04 N/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 H/A ITOTAL ADULT 2.30E+04 6.03E+04 2.23E+04 3.98E+06 9.67E+04 0.00E+00 6.81E+04 H/A, INGEST. TEEN 2.97E+04 7.64E+04 2.83E+04 4.92E+06 1.21E+05 0.00E+00 8.47E+04 H/A CHILD 6.34E+04 1.14f+05 5.40E+04 1.01E+07 1:75E+05 0.00E+00-S;70E+04 INFANT 7-88E+04 1.77E+05 6.45E+04 1.59E+07 1.97E+05 0.00E+00 6.'40E+0'4 II/A INHAL. ADULT 2.68E+03 6.98E+03 2.57E+03 4.48E+05 1.11E+04 0.00E+00 5.25E+03 N/A TEEN 3-70E+03 9.44E+03 3.49E+03 6.21E+05 1.49E+04 O.OOE+00 6.95E+03 H/A CHILD 4-92E+03 8.73E+03 4.14E+03 7.92E+05 1.34f+04 0.00E+00 4.44E+03 H/A INFANT 3-86E+03 7.60E+03 2.77E+03 6.96E+05 8.47E+03 O.OOE+00 1.83E+03 H/A BONE LIVER T.BODY THYROID KIONEY LUNG .G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
- "MAXIMUMVALUfS FOR PATHWAYS"*"
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MfAT: VEGTBLE: INGEST: INHAL.
O.OOE+00 0-00E+00 1.08f+07 S.05E+06 O.OOE+00 3.29E+06 1.59E+07 7.92E+05
O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RAOIONUCLIDES OTHER THAN NOBLE GASES*
OPE: Cs-136
.HWAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG 'G. I. SKIN GROUND ADULT 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.69E+08 TEEN 1.49E+08 1 49E+08 1.49E+08 1.49E+08 1.49E+08
~ 1.49E+08 1.49E+08 l. 69E+08 CHILD 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.69E+08 ENFANT 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.49E+08 1.69E+0&
GOAT ADULT 3.57E+08 1.415-09 1.01E+09 0.00E+00 7.84E+08 1.07E+08 1.60E+08 H/A MILK TEEN 6.07E+08 2.39E+09 1.61E+09 O.OOE+00 1.30E+09 2.05E+08 1.92E+08 H/A CHILD 1.37E+09 3.77E+09 2.44E+09 0.00E+00 2.01E+09 2.99E+08 1.32E+08 N/A INFANT 8-93E+08 7.&BE+09 2.94E+09 0.00E+00 3.14E+09 6.42E+08 1.20E+08 'H/A COW ADULT 6.69E+07 2.64E+08 1.90E+08 0.00E+00 1.47E+08 2.02E+07 3.00E+07 H/A MILK TEEN 1.14E+08 4.4&E+08 3.0lf+08 0.00E+00 2.44E+08 3.85E+07 3.61E+07 H/A CHILD 2.57E+08 7.07E+08 4.58E+08 0.00E+00 3.77E+08 5.62E+07 2.48E+07 H/A INFANT 5.02E+08 1.48E+09 5.52E+08 0.00E+00 5.89E+08 1.20E+08 2.24E+07 H/A MEAT ADULT 4.00E+06 1.5&E+07 1. 14E+07 0.00E+00 8.7&E+06 1.20E+06 1.79E+06 H/A TEEN 3.12Ei06 1.23E+07 8.24E+06 O.OOE+00 6.68E+06 1.05E+06 9.87E+05 H/A CHILD 5.38E+06 1.48E+07 9.57E+06 0.00E+00 7.87E+06 1.17E+06 5.20E+05 H/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 N/A VEGTBLE ADULT 2.03E+07 8.01E+07 5.76E+07 0.00E+00 4.46E+07 6.11E+06 9.10E+06 H/A TEEN 2.43E+07 9.58E+07 6.43E+07 0.00E+00 5.21E+07 8.22E+06 7.71E+06 '/A CHILD 4.96E+07 1.36E+08 8.82E+07 0.00E+00 7.26E+07 1.08E+07 4.79E+06 H/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 N/A TOTAL ~
ADULT 4.4&E+08 1.77E+09 1.27E+09 O.OOE+OO 9.84E+OB 1.35E+O& 2.OlE+OB H/A INGEST. TEEN 7.49E+08 2.95E+09 1.9&E+09 O.OOE+00 1.60E+09 2.53E+08 2.37E+08 H/A CHILD 1.6&E+09 4.63E+09 2.99E+09 0.00E+00 2.46E+09 3.67E+08 I-;63E+OB '8/A INFANT 1.4OE+09 9.35E+09 3.49E+09 O.OOE+00 3.73E+09 7.62E+08 1.42E+08 H/A INHAL. ADULT 3.90E+04 1.46E+05 1.10E+05 0.00E+00 8.56E+04 1.20E+04 1.17E+04 N/A TEEN 5.15E+04 1.94E+05 1.37E+05 0;OOE+00 1.10E+05 1.7&E+04 1.09Ew04 H/A CHILD 6.51E+04 1.71E+05 1.16E+05 0.00E+00 9.55E+04 1.45E+04 4 l&E+03 H/A INFANT 4.83E+04 1.35E+05 5.29E+04 0.00E+00 5.64E+04 1. 1&E+04 1.43E+03 H/A BONE LIVER T.BODY 'THYROID KIDNEY LUNG G.I. SKIN "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
- ""MAXIMUMVALUES FOR PATHWAYS~"~
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST INHAL.
1.49E+08 1.69E+08 7.&BE+09 1.4&E+09 I.5&E+07 1.36E+08 9.35E+09 1.94E+05 PAGE: 4-32 V.
DAT
O.D.C.M. MAXIMUM PATHWAY POSE FACTORS: RAOIONUCLIOES OTHER THAN NOBLE GASES*
Cs-137 Y AGE GROUP BONE lIVER T.BODY THYROID KIONEY LUNG G:I. SKIN GROUND 'DULT 1.02E+10 1.02f+10 1.02E+10 1.02E+10 1.02E+10 1.02E+)0 1.02f+10 1. 19E+10 TEEN ).OZE+10 1.02E+10 ).OZE+10 1.02E+10 1.02E+10 1.02E+10 1.02E+10 1.19E+10 CHILD, 1.02E+10 1.02E+10 );ORE+)0 1.02E+10 1.02E+10 1.02E+10 1.02E+10 ).19E+10 INFANT 1.02E+10 1.02E+10 1.02E+10 ).QZE+10 1.02E+10 1.02E+10 ).OZE+10 1.19E+)0 GOAT ADULT 1.-42E+10 1.94E+)0 1.27E+10 0.00E+00 6.59E+09 2.19E+09 3.76E+08 H/A MILK TEEN 2.5&E+10 3.43E+10 1.19E+10 O.QOE+00 1.17E+10 4.53E+09 4.&BE+08 '/A CHILD 6.20E+10 5.94E+)0 8.77E+09 O.OOE+00 1.94E+10 6.96E+09 3.72E+08 N/A INFANT 3.30E+)0 1.16E+ll 8.22E+09 O.OQE+00 3.11E+10 1.26E+)0 3.62E+08 H/A COW ADULT 3 7&E+09 5.17E+Q9 3.39E+09 0.00E+OQ 1.76E+Q9 5.84E+Q& 1.00E+08 H/A MILK TEEN 6-86E+09 9.12f+09 3-1&E+09 0.00E+00 3.10E+09 1.2)E+09 1.30E+08 N/A CHILD 1.65E+10 1.5&E+10 2.33E+09 0-OOE+00 5-)SE+09 1-85E+09 9.90E+07 H/A INFANT 2.64E+10 3.09E+10 2.19E+09 0.00E+00 8.28E+09 3.35E+09 9.65E+07 N/A
'tfAT ADULT 4.9)E+08 6.TlE+08 4,40E+08 O.QQE+00 2.28E+08 T.SBE+07 1.30E+07 N/A
-TEEN 4.0&E+08 5.42E+08 1.89E+08 0.00E+00 1.&SF+08 7.)TE+07 7.7ZE+06 N/A CHILD 7.51E+08 7. 19f+08 1.06E+08 O.QOE+00 2.34E+08 8.42E+07 4.SOE+06 . N/A INFANT O.OOE+00 0.00E+00 0.00E+00 O.OQE+00 0.00E+00 O.OOE+00 O.QOE+00 N/A "ABLE ADULT 5.76E+09 7.88E+09 5.16E+09 0.00F+00 2.68E+09 8.89E+08 ).S3E+08 N/A TEEN 9.5&E+09 1.2TE+10 4.44E+09 0.00E+00 4.34E+09 1.69E+09 1.8)E+08 ~
H/A CHILD 2.29E+10 2.19E+10 3.24E+09 0.00E+QQ T. ISE+09 Z.STE+09 1.37E+08, H/A INFANT 0 00E+00 0.00E+00 0.00f+00 0.00E+00 0.00E+00 Q.QOE+00 O.OOE+00 H/A OTAL ADULT 2.42F+10 3.32E+10 2.)TE+)0 0.00E+00 1.13E+10 3.74E+09 6.42E+08 N/A NGEST. TEEN 4.26E+10 S.67f+10 1.97E+)0 O.QOE+00 1.93E+10 7.49E+09 8.06E+08 H/A CHILD INFANT 1.02E+11 5.94E+10 9.79f+10 1.44E+10 1.47f+11 1.04E+10 0.00E+00 3.19E+10 0.00E+00 3.94E+10 1.)SE+10 1.60E+10 6':.)3&08 4.59E+08
'/A H/A HHAL. ADULT 4.7&E+05 6.21E+05 4.2&E+05 0.00E+00 Z.ZZE+05 7.52E+04 8.40E+03 H/A TEEH 6.70E+05 8.48f+05 3.1)E+05 O.QOE+00 3.04E+05 1.21E+05 8.4&E+03 N/A CHILD 9.07E+05 8.25f+05 1.2&E+05 O.QQE+00 2.82E+05 1.04E+05 3.62E+03 N/A INFANT 5.49E+QS 6.)ZE+05 4.55E+04 O.QOE+00 1.72E+05 7. 13E+04 1.33E+03 N/A BONE LIVER T. BODY THYROID KIDNEY LUNG G.I. SKIN Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-mZ/yr/uCi/sec
"*"MAXIMUMVALUES FOR PATHWAYS**"
GROUND: GROUND: GOAT COW TOTAL T . B./ORG. SKIN MILK: MILK: MfAT: VEGTBLE: INGEST: IHHAL.
I-OZE+10 1.19f+10 1.16f+II 3.09f+10 7.5)f+0& 2.29fel0 1.47f+Il 9 'TE+05 4-33
O.D.C.M- MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIOES OTHER THAN NOBLE GASES"
'<OTOPE: Ba-140 THWAY AGE GROUP BONE L IVER T. BODY THYROID KIDNEY LUNG G. I. SKIN GROUND ADULT 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.32E+07 TEEN ?.'03E+07 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2 03E+07 2 03E+07 2 32E+07 CHILD 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.32E+07 INFANT 2.03E+Q7 2.03E+07 2.03E+07 2.03E+07 2.03E+07 2.03E+07, 2-Q3E+07 2.32E+07 GOAT ADULT 1.46E+06 1.83E+03 9.54E+04 Q.DOE+00 6.22f+02 1.-05E+03 3.00E+06 H/A MILK TEEN 2.63E+06 3.22E+03 1.69E+05 O.DOE+00 1.09E+03 2.17E+03 4.05E+06 H/A CHILD 6.35F+06 5.56E+03 3.70E+05 Q.QQE+00 1.81E+03 3.31E+03 3.22E+06 H/A INFANT 1.09E+08 1.31E+04 6.73E+05 0.00E+00 3.10E+03 B.OZE+03 3.21E+06 HJA COW ADULT 6.83E+06 8.58E+03 4.47E+05 0.00E+00 2.92E+03 4.91E+03 1.41E+07 H/A MILK TEEH 1.23E+OT 1.51E+04 T.94E+05 0.00E+00 5.12E+03 1.02E+04 1.90E+07 H/A CHILD 2.97E+07 2;61f+04 1.74E+06 0.00E+00 8.48E+03 1.55E+04 1.51E+07 H/A, INFANT 6.12E+07 6."12E+04 3.15E+06 0.00E+00 1.45E+04 3.76E+04 1.50E+07 H/A HEAT ADULT 9.52E+06 1.20E+04 6.24f+05 0.00E+00 4.07f+03 6.85E+03 1.96E+07 H/A TEEN 7.87E+06 9.65E+03 5.07f+05 0.DOE+00 3.27E+03 6.49E+Q3 1.21E+07 H/A
, CHILD 1.45E+07 1 27E+04 4.48E+05 0.00E+00 4.14E+03 7.59E+03 7.36E+06 N/A INFANT O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 H/A VEGTBLE . ADULT 5.98E+07 7.51E+04 3.92E+Q6 0.00E+00 2.55E+04 4.30E+04 1.23E+08 N/A TEEN 7.50E+07 9.19E+04 4.83E+06 0.00E+00 3.12E+04 6.18E+04 1.16E+08 H/A CHILD 1.62E+08 1.42E+05 9.48E+06 0.00E+00 4.63E+04 8.48E+04 8.23f+07 N/A INFANT O.DOE+00 0.00E+00 0.00E+00 0.DOE+00 Q.QOE+00 0.00E+00 0.00E+00 H/A TOTAL ADULT 7.76E+07 9.75E+04 5.08E+06 0.00E+00 3.31E+04 5.58E+04 1.60E+08 H/A INGEST. TEEN 9.78E+07 1.20E+05 6.31E+06 0.00E+00 4.07E+04 8.06E+04 1.51f+08 H/A CHILD 2.13E+08 1.87E+05 1.24E+07 0.00E+00 6.08E+04 1.11E+05 I 48E+QB H/A INFANT 1.TOE+08 7.43E+04 3.83E+06 Q.QOE+00 1.76E+04 4.56E+04 1.82E+07 H/A IHHAL. ADULT 3.90E+04 4.90E+Ol 2.57E+03 Q.QOE+00 1..67E+Ol 1.27E+06 2.18E+05 H/A TEEN 5.47E+04 6.94E+Ol 3.52E+03 0.00E+00 2.28E+01 2. 03E+06 2.29E+05 H/A CHILD 7.40E+04 6.48E+Ol 4.33E+02 0 DOE+00 2.11E+01 1.74E+06 1.02E+05 N/A IHFANT 5.60E+04 5.60E+Ql 2.90E+03 0.00E+00 1.34E+01 1.60E+06 3.84E+04 H/A BONE LIVER T. BODY THYROID KIDNEY LUNG G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
- ""MAXIMUMVALUES FOR PATHWAYS~*"
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: INHAL.
2.03E+07 2.32E+07 1.09E+08 6.12E+OT 1.96E+07 1.62E+08 2. 13E+08 2.03E+06 PAGE: 4-34
O.D.C.H. HAXIHUH PATHWAY DOSE FACTORS: RAOIONUCLIOES OTHER THAN NOBLE GASES*
E: La-14O
.I WAY AGE GROUP BONE LIVER T.BODY THYROIP KIDNEY LUNG G ~ I. SKIN GRQUND ADULT Q.QOE+aO O.aQE+OQ Q.QQE+00 0.00E+00 0.00E+00 Q.OOE+00 Q.OQE+00 o.ooE+oa TEEN 0.00E+00 O.QOE+00 0.00E+00 0.00E+00 0.00E+00 .0.00E+00 0.00E+00 0.00E+00 CHILD O.Oaf+00 0.00E+00 O.QOE+QQ Q.QOE+00 Q.QOE+00 Q.OOE+OQ O.Oaf+00 o.oaF+ao INFANT O.OOE+00 0.oaf+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 GOAT ADULT 2.44E-01 1.23E-Ol 3.25E-02 0.00E+00 0.00E+00 0.00E+00 9.02E+03 N/A MILK TEEN 4.38f-al 2.15E-O1 5.72E-a2 O.Oaf+00 Q.OOE+OO O.oaf+00 1.24E+O4 H/A CHILD 1.05E+00 3.66E-ol 1.23E-Ol 0.00E+00 0.00E+00 Q.QOE+00 1.02E+04 H/A INFANT 1.82E+01 8.63E-Ol 2.22E-ol 0.00E+00 Q.QQE+QQ Q.QOE+00 1.01E+04 'N/A caW ADULT 1.14E+00 5.73E-O1 1.51E-Ol Q.QOE+00 0.00E+00 Q.QOE+00 4.21E+04 H/A
.MILK TEEN 2.04E+00 1.00E+00 2.67E-Ol O.QOE+00 0.00E+00 0.00E+00 5.76E+04 H/A CHILD 4.89E+00 1.71E+00 5.76E-Ol 0.00E+00 O.QOE+00 Q.QOE+00 4.76E+04 N/A INFANT 1.02E+01 4.03E+00 1.04E+00 0.00E+00 0.00E+00 0.oaf+00 4.73E+04 A/A MEAT ADULT 1.22E-OZ 6.16E-03 1.63E-03 0.00E+00-0.00E+00 0.00E+00 4.53E+02 H/A TEEN 1.01E-OZ 4.94E-03 1.32E-03 O.QOE+00 O.OOE+00 O.OOE+00 2,.84E+02 H/A CHILD 1.84E-OZ 6.44E-03 '2.17E-03 O.QOE+00 0.00E+00 0.00E+00 1.79E+02 H/A INFANT O.OOE+00 0.00E+00 0.00E+00 Q.OOE+00 0.00E+00 0.00E+00 Q.OOE+00 N/A ADULT 6.53E+02 3.29E+02 8.69E+Ol O.oaf+00 0.00E+00 0.00E+00 2 41E+07 N/A TEEN 5.96E+02 2.93E+02 7.79E+01 O.OOE+00 O.OOE+00 O.OOE+00 1.68E+07 H/A CHILD 1.07E+03 3.74E+02 1.Z6E+02 O.OOE+00 0.00E+00 O.OOE+00 1.04E+07 N/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Q.OOE+00 0.00E+00 H/A TOTAL ADULT 6.54E+02 3.30E+02 8.71E+Ol 0.00E+00 0.00E+00 Q.oaf+00 2.42E+07 H/A INGEST. TEEN 5.99E+OZ 2.94E+02 7.83E+01 O.OOE+00 0.00E+00 O.OOE+00 1.69E+07 N/A CHILD 1.08E+03 3.76E+02 1.27E+02 0.oaf+00 0.00E+00 Q.OOE+00 1 OSE+07 N/A INFANT 2.85E+Ol 4.89E+00 1.26E+00 0.DOE+00 0.00E+00 O.OOE+00 5:74E+04 N/A IHHAL. ADULT 3.44E+02 1.74E+02 4.58E+Ol 0.00E+00 0.00E+00 1.36E+05 4.58E+05 N/A TEEN 4.79E+02 2.36E+02 6.26E+Ol 0.00E+00 0.00E+00 2.14E+05 4.87E+05 H/A CHILD 6.44E+02 2.25E+02 7.55E+01 O.oaf+00 0.00E+00 1.83E+05 2.26E+05 N/A INFANT 5.05E+02 2.oaf+02 5.15E+Ol 0.00E+00 0.00E+00 1.68E+05 8.48E+04 H/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"""MAXIMUMVALUES FOR PATHWAYS" GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: HEAT: V EGTBLE: INGEST: INHAL.
0.00E+00 0.00E+00 1.24E+04 5.76E+04 4.53E+02 2.41f+07 2.42E+07 4. 87E4 05 PAGE 4-35
O.D.C.M. MAXIMUM PATHMAY DOSE FACTORS: RAOIONUCLIOES OTHER THAN NOBLE GASES*
[,cmOPE: Ce-141 MAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G.. I. SKIN GROUND ADULT 1.35E+07 1.3SE+07 1.3SF+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.5ZE+07 TEEN 1.3SE+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 ).S2E+07 CHILD 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.3SE+07 1.35E+07 1.52E+07 INFANT ).35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.35E+07 1.52E+07 GOAT ADULT 2.7&E+02 1.&BE+02 2.13E+01 O.OOE+00 8.73E+01 O.OOE+00 7.19E+05 N/A MILK TEEH S. )OE+02 3.40E+02 3.9)E+Ol 0.00E+00 1.60E+02 0.00E+00 9.74E+05 N/A CHILD 1.26E+03 6.26E+02 9.30E+01 0.00E+00 2.75E+02 0.00E+00 7.81E+05 N/A INFANT 2.07E+04 1.52E+03 1.79E+02 0.00E+00 4.6&E+02 0.00E+00 7.84E+05 H/A COM ADULT ).41E+03 9.5)E+02 1.0&E+02 O.OOE+00 4.42E+02 O.OOE+00 3.64E+06 H/A MILK TEEN 2.5&E+03 1.72E+03 ).9&E+02 0.00E+00 8.1)E+OZ O.OOE+00 4.93E+06 N/A CHILD 6.35E+03 3. 17E+03 4.70E+02 0.00E+00, 1.39E+03 0.00E+00 3.95E+06 N/A INFANT 1.26E+04 7.6&E+03 9.04E+02 O.OOE+00 2.37E+03 0.00E+00 3.97E+06 N/A MEAT ADULT 5.11E+03 3.46E+03 3.92E+02 0.00E+00 1.61E+03 0.00E+00 1.32E+07 N/A TEEN 4.29F+03 2.87E+03 3.29E+QZ 0.00E+00 1.35E+03 0.00E+00 &.20E+06 CHILD 8.0&E+03 4.03E+03 5.99E+02 0.00E+00 1.77E+03 0.00E+00 5.03E+06 N/A INFANT 0 OOE+00 0.00E+00 0.00E+00 0.00E+00
~ 0.00E+00 0.00E+00 0.00E+00 H/A VEGTBLE ADULT 1.49E+05 1.01E+05 1.14E+04 0,00E+00 4.69E+04 O.OOE+00 3.86E+08 N/A TEEN 2.38E+05 1.59E+05 1.83E+04 O.OOE+00 7.49F+04 O.OOE+00 4.55E+08 N/A CH1LD 5.73E+05 2.86E+05 4.25E+04 0.00E+00 1.25E+05 0.00E+00 3.57E+08 N/A IHFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.DOE+00 N/A TOTAL ADULT 1.56E+05 1.06E+05 1.20E+04 O.OOE+00 4.90E+04 O.OOE+00 4.03E+08 N/A INGEST. TEEH 2.46E+05 1.64E+05 1.8&E+04 O.OOE+00 7.72E+04 0.00E+00 4.69E+08 N/A CHILD 5.89E+05 2.94E+05 4.36E+04 0.00E+00 1.29E+05 0.00E+00 3.'67f+'08 NgA INFANT 3.33E+04 9.20E+03 1.0&E+03 O.OOE+00 2.84E+03 O.OOE+00 4.75E+06 N/A IHHAL. ADULT 1.99E+04 1.35E+04 1.53E+03 0.00E+00 6.26E+03 3.62E+05 1.20E+OS N/A TEEN 2.84E+04 1.90E+04 2.17E+03 O.OOE+00 8.&BE+03 6.14E+05 1.26E+05 H/A CHILD 3.92E+04 1.95E+04 2.90E+03 0.00E+00 8.55E+03 S.44E+05 5.66E+04 H/A INFANT , 2.77E+04 1.67E+04 1.99E+03 0.00E+00 5.25E+03 5.17E+05 2.16E+04 H/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"~"MAXIMUMVALUES FOR PATHMAYS**"
GROUND: GROUND: GOAT COM TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: IHHAL.
- 1. 35E+07 1.52E+07 9.74E+05 4 '3E+06 1.32E+07 4.55E+08 4.69E+08 6.14Ee05 PAGE: 4-36 DAT
O.O.C.M. MAXIMUM PATHWAY DOSE FACTORS: RAOIONUCLIOES OTHER THAN NOBLE GASES*
Pr-143 Y AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG G..I. SKIN aROUND'DULT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+OO TEEN 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0-00E+00 0.00E+00 CHILD 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 OAT ADULT 8.57E+00 3.44E+00 4.25E-Ol O.OOE+00 1.98E+00 0-OOE+00 3.75f+04 H/A 41LK 'TEEN 1-57E+Ol 6.28E+00 7-83E-01 0-00E+00 3-65E+00 0-OOE+00 5-18E+04 N/A CHILD 3.89E+Ol 1 17E+Ol 1.93E+00 0.00E+00 6.33E+00 0.00E+00 4.20E+04
~
'/A INFANT 6.71E+02 3.01E+01 3.99E+00 O.OOE+00 1.12E+Ol O.OOE+00 4.25E+04 H/A
.OM ADULT 4.02E+01 1.61E+01 1.99E+00 O.OOE+00 9.31E+00 O.OOE+00 1.76E+05 H/A CILK TEEN 7.39E+Ol 2.95E+01 3.68E+00 O.OOE+00 1.71E+01 O.OOE+00 2.43E+05 H/A CHILD 1.83E+02 5.49f+01 9.07E+00 O.OOE+00 2.97E+01 O.OOE+00 1.97E+05 H/A INFANT 3.78E+02 1.41E+02 1..87E+Ol O.OOE+00 5.26f+Ol O.OOE+00 2.00E+05 A/A EAT ADULT 6.96E+03 2.79E+03 3-45E+02 0.00E+00 1.6lf+03 0.00E+00 3.0SE+07 H/A TEEN 5-86E+03 2.34E+03 2-92E+02 0.00E+00 1.36E+03 0.00E+00 1.93E+07 H/A .
CHILD 1.11E+04 3.33E+03 5.50E+02 0.00E+00 1.80E+03 0.00E+00 1.20E+07 H/A INFANT 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 'H/A GTBLE ADULT 3.04E+04 1.22E+04 1.51E+03 0.00E+00 7.04E+03 O.OOE+00 1.33E+08 H/A TEEN 4.00E+04 1.60E+04 1.99E+03 0.00E+00 9.27E+03 0.00E+00 1.31E+08 N/A CHILD 8.98E+04 2.69E+04 4.45E+03 0.00E+00 1.46E+04 0.00E+00 9.68E+07 H/A INFANT O.OOE+00 O.OOE+00 0-OOE+00 O.OOE+00 O.OOE+00 O.OOF+00 O.OOE+00 H/A OTAL ADULT 3.74E+04 1.50F+04 1.86E+03 0.00E+00 8.67E+03 0.00E+00 1.64E+08 H/A ',
NGEST. TEEN 4.59E+04 1.83E+04 2.28E+03 0.00E+00 1.07E+04 0.00E+00 1.51E+08 H/A CHILD 1.01E+05 3.03E+04 5.01E+03 0.00E+00 1.64E+04 0.00E+00 1;09E+08 H/A INFANT 1.05E+03 1.72E+02 2.27E+Ol O.OOE+00 6.38E+Ol O.OOE+00 2:42E+05 H/A NHAL. ADULT 9.36E+03 3.75E+03 4.64E+02 O.OOE+00 2.16E+03 2.81E+05 2.00E+05 .H/A TEEN 1.34E+04 5.31E+03 6.62E+02 0.00E+00 3.09E+03 4.83E+05 2.14E+05 H/A CHILD 1.85E+04 5.55E+03 9.14E+02 0.00f+00 3.00f+03 4.33E+05 9.73E+04 N/A INFANT 1.40E+04 5.24E+03 6.99E+02 0.00E+00 1.97E+03 4.33E+05 3.72E+04 N/A BONE LIVER T.BODY THYROID KIDNEY LUNG G ~ I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"""MAXIMUMVALUFS FOR PATHWAYS**"
GROUND: GROUND: GOAT COW TOTAL T. B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: INHAL.
O.OOE+00 O.OOE+00 5.18E+04 2.43E+OS 3.0SE+07 1.33f+08 1.64E+08 4.83E+05 PAGE: 4-37
O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIQNUCLIDES OTHER THAN NOBLE GASES" i~@TOPE: Ce-144 HWAY AGE GROUP BONE LIVER T.BODY THYROID KIONEY LUNG G. I. SKIN GROUND ADULT G.BBE+07 6.88F+Q7 6.88E+07 6.88E+07 6.88E+07 6.88E+07 6.88E+Q7 7.96E+07 TEEN 6.88E+07 6.88E+OT 6.88E+07 6.88E+07 6.88E+07 6.88E+07 6.8BE+07 7.96E+07 CHILD 6.88E+07 6.88E+07 6.88E+07 6.88E+07 6.88E+07 6.88E+07 6.88E+07 7.96E+07 INFANT 6.88E+07 6.88E+07 6.88E+07 6.88E+07 6.88E+07 6.88E+07 6.88E+07 7.96E+07 GOAT ADULT 2.60E+04 1.09E+04 1.39E+03 0.DOE+00 6.44E+03 0.00E+00 8.78E+06 H/A MELK TEEH 4-78E+04 1.9BE+04 Z.STE+03 0.00E+00 1.18E+04 0.00E+00 1.20E+07 N/A CHILD 1.18E+05 3.69E+04 6.28E+03 0.00E+00 2.04E+04 Q.QQE+00 9.63E+06 H/A INFANT 1.41E+06 6.91E+04 9.46E+03 0.00E+00 2.79E+04 Q.OQE+00 9.68E+06 ~
H/A COW ADULT 1.65E+05 6.91E+04 8.88f+03 Q.QQf+00 4.10E+04 0.00E+00 5.59E+OT H/A HELK TEEH 3.04E+05 1.26E+QS 1.63E+04 Q.QQE+00 7.52E+04 Q.QQE+00 7.65E+OT N/A CHILD 7.50E+05 2.3SE+05 4.00E+04 O.QQE+00 1.30E+05 0.00E+00 6.13E+07 H/A INFANT 1.0TE+06 4.40E+05 6.02E+04 0.00E+00 1.78E+D5 0.DOE+00 6.17E+07 N/A HEAT ADULT 7.55E+05 3.16E+05 4.05E+04 0.00E+00 1.87E+05 0.00E+00 2.55E+08 N/A TEEN 6.36E+OS 2.63E+05 3.42E+04 0.00E+00 1.57E+05 0.00E+00 I.GOE+08 H/A CHILD 1.20E+06 3.76E+05 6.40E+04 0.00E+00 2.08E+05 0.00f+00 9.80E+07 H/A INFANT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.DOE+00 0.00E+00 Q.QQE+00 H/A YEGTBLE 'ADULT 2.94E+07 1.23E+07 1.58E+06 O.QQE+00 7.30E+06 0.00E+00 9.95E+09 H/A.
TEEN 4.95E+07 2.05E+07 Z.66E+06 0.00E+00 1.22E+OT 0.00E+00 1.24E+10 N/A CHILD 1.21E+08 3.80E+07 6.46E+06 0.00E+00 2.10E+07 Q.QQE+00 9.90E+09 H/A INFANT O.QOE+00 Q.QQE+00 Q.DOE+00 0.00E+00 0.DOE+00 O.DOE+00 Q.QOE+00 N/A TOTAL ADULT 3.04E+07 1.27E+07 1.63E+06 0.00E+00 7.53E+06 0.00E+00 1.03E+10 H/A INGEST. TEEN 5.05E+07 2.09E+07 2.TIE+06 0.00E+00 1.25E+07 0.DOE+00 1.27E+10 N/A CHILD 1.23E+08 3.86E+07 6.57E+06 0.00E+00 2.14E+07 Q.QQE+00 ERIE+10 H/A IHFANT 2.48E+06 5.09E+05 6.97f+04 O.QQE+00 2.06E+QS O.QOE+00 7.14E+07 H/A IHHAL. ADULT 3.43E+06 1.43E+06 1.84E+05 Q.QQE+00 8.48E+05 7.78E+06 8.16E+05 N/A TEEN 4.89E+06 2.02E+06 2.62E+05 0 00E+00 1.21E+06 1.34E+07 8.64E+05 H/A CHILD 6.T7E+06 2.12E+06 3.61E+05 0.00E+00 1.17E+06 1.20E+07 3.89E+05 H/A INFANT 3.19E+06 1.21E+06 1.76E+05 0.00E+00 5.38E+05 9.84E+06 1.48E+05 N/A BONE LIVER T.BODY THYROID KIONEY LUNG G.I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Dep'osition pathways: units are mrem-mZ/yr/uCi/sec
"""MAXIMUMVALUES FOR PATHMAYS~**
GROUND: GROUND: GOAT . COW TOTAL T.B./ORG. SKIN MILK: MILK: HEAT: YEGTBLE: IHGfST: IHHAL.
6.88E+07 7.96E+07 1.20f+07 7.65E+07 2.55E+08 1.24E+10 1.27E+10 1 34E+07 PAGE 4-38 are v OAT
0-D-C-M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*
f: Pr-144 AY AGE GROUP BONE LlVER T.BODY THYROID KIDNEY LUNG G. I. SKIH GROUND ADULT O.OOE+00 O.OOE+00 0.00E+00 O.OQE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 TEEN O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.ooffoo 0.00E+00 0.00E+00 CHILD 0.00E+00 0.00E+00 0.00E+00 Q.oof+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.QQE+00 O.QOE+00 O.OOE+00 O.OOE+00 O.DOE+00
.GOAT ADULT O.OOE+00 Q.QOE+00 0.00E+OQ O.QQE+OQ Q.QOE+00 O.oof+OQ O.OOE+00 H/A
'M II K TEEN O.OOE+00 O.OOE+00 0.00E+00 Q.oofi00 0.00E+00 0.00E+00 0.00E+00 H/A CHILD O.OOE+00 O.OOE+00 0.00E+00 O.oof+00 O.oof+00 0.00E+00 O.oof+00 N/A INFANT 0-QOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 N/A COW ADULT 0.00E+00 O.oof+00 0.00E+00 0.00f+00 0.00E+00 0.00E+00 O.OQE+00 N/A MILK TEEN, Q.OOE+QQ 0.00E+00 0.00E+00 O.QQE+00 Q.OQE+00 0.00E+00 O.OOE+00 H/A CHILD 0.00E+00 0.00E+00 O.oof+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 N/A INFANT 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 H/A MEAT ADULT Q.OOE+00 0.00E+00 O.oof+00 0.00'E+00 0.00E+00 0.00E+00 0.00E+00 N/A TEEH O.OOE+00 0.00E+00 O.OQE+00 0.00E+00 Q.oof+00 Q.OOE+00 O.OOE+00 H/A CHILD O.OOE+OO O.OOE+OO O.OOE+OQ O.OOE+00 Q.oof+00 O.oof+00 O.OOE+00 H/A INFANT 0.00E+00 0.00E+00 0.00E+00 O.OQE+00 Q.QQE+00 0.00E+00 O.OOE+00 H/A
".TBLE ADULT 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 N/A TfEH 0.00E+00 O.OOE+00 O.OOE+00 O.OQE+00 O.OOE+00 0.00E+00 0.00E+00 H/A CHILD O.OOE+00 Q.QOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 H/A
.INFANT O.OOE+OO O.OQE+00 O.OOE+OO O.OOE+OQ O.OOE+00 0.00f+00 O.OQE+00 H/A TOTAL ADULT 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 N/A INGEST. TEEH O.OOE+00 O.OOE+00 O.OOE+00 O.OQE+00 O.OOE+00 O.OOE+00 O.OOE+00
'/A CHILD O.OOE+00 O.QOE+00 O.OOE+00 O.OQE+00 Q.OQE+00 O.OOE+00 0'..OOE+00 NlA INFANT O.OOE+OO O.OOE+QO O.OOE+OO O.OOE+Oo Q.OQE+Oo O.OOE+OO O.OOE+OO N/A NHAL. ADULT 3.01E-02 1.25E-OZ 1.53E-03 O.OOBOO 7.05E-03 1.02E+03 2.15E-OB H/A TEEH 4.30E-02 1.76E-OZ 2.18E-03 O.OOE+00 1.01E-OZ 1-75E+03 2.35E-04 H/A CHILD 5.96E-02 1.85E-02 3.00E-03 0.00E+00 9.77E-03 1.57E+03 1.97E+02 H/A INFANT 4.79E-OZ 1.85E-OZ 2.41E-03 0.00&00 6.72E-03 l.61E+03 4.28E+03 H/A BONE LIVER T.BODY THYROID KIDNEY LUNG G. I. SKIN
- Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
>>>>>>MAXIMUM VALUES FOR PATHWAYS>>>>>>
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: . MILK MEAT: VEGTBLE: INGEST: INHAL.
0.00E+QQ O.QOE+00 Q.QOE+00 Q.OQE+00 O.OQE+QQ O.OQE+00 Q.OOE+00 4.28E+03 PAGE: 4-39
O.D.C.M. MAXIMUM PATHMAY DOSE FACTORS: RADIONUCI IDES.OTHER THAN NOBLE GASES*
1 ISOl OPE: Nd-147 f MAY AGE GROUP BONE LIVER T . BODY THYROID KIDNEY LUNG G.. I. SKIN GROUND ADULT 8.31E+06 8.31f+06 8.31E+06 8.31E+06 8.31E+06 8.31E+06 8.31E+06 9.97f+06 TEEN 8.31E+06 8.31E+06 8.31E+06 8.31E+06 8.31E+06 8.31E+06 8.31E+06 9.97f+06 CHILD 8.31E+06 8.31E+06 8.31E+06 8.31E+06 8.31E+06 8.31E+06 8.31E+06 9.97E+06 INFANT 8.31E+06 8.31E+06 8.31E+06 8.31E+06 8.31E+06 8.31E+06 8.31E+06 9.97E+06 GOAT ADULT 5.09E+00 5.89E+00 3-SZE-Ol 0.00f+00 3.44E+00 O.OOE+00 2.83E+04 H/A MILK TEEN 9.80E+00 1.07E+01 6.38E-01 O.OOE+00 6.26E+00 O.OOE+00 3.84E+04 N/A CHILD 2.40E+Ol 1.9SE+Ol 1.51E+00 O.OOE+00 1.07E+01 O.OOE+00 3.09E+04 N/A 1HFANT 3.97E+02 4.90E+01 3.00E+00 O.OOE+00 1.89E+Ol 'O.OOE+00 3.10E+04 H/A COW ADULT 2 38E+01 2. 75E+O1 1. 65E+00 0. 00 f+00
~ 1. 61E+01 0. 00f+00 1.32E+05 H/A BILK TEEN 4.58E+Ol 4.98E+Ol 2.98E+00 0.00E+00 2.93E+Ol 0.00E+00 1.80E+05 H/A CHILD 1.12E+02 9.11E+Ol 7.05E+00 0.00E+00 5.00E+01 0.00E+00 1.44E+05 H/A INFANT 2.23E+02 2.29E+OZ 1.40E+01 O.OOE+00 8.8ZE+01 O.OOE+00 1.45E+05 N/A MEAT ADULT 2.34E+03 2.70E+03 1.62E+02 0.00E+00 1.58E+03 0.00f+00 1.30E+07 N/A TEEN 2.06E+03 2.24E+03 1.34E+07. 0.00E+00 1.31E+03 0.00f+00 8.08E+06 H/A CHILD 3.86E+03 3.13E+03 2.42E+02 O.OOE+00 1.72E+03 O.OOE+00 4.96E+06 H/A INFANT 'O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 H/A ffGTBLE ADULT 1.39E+04 1.61E+04 9.61E+02 O.OOE+00 9.39E+03 O.OOE+00 7.71E+07 H/A TEEN 1.72E+04 1.87E+04 1.12E+03 0.00E+00 1.10E+04 '0.00E+00 6.74E+07 H/A CHILD 3.65E+04 2.95E+04 2.29E+03 O.OOE+00 1.62E+04 O.OOE+00 4.68E+07 H/A INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 H/A OTAL ADULT 1.63E+04 1.88E+04 1.12E+03 O.OOE+00 1.10E+04 O.OOE+00 9.03E+07 H/A .
.NGEST. TEEN 1.93E+04 2.10E+04 1.26E+03 0.00E+00 1.23E+04 0.00E+00 7.57E+07 H/A CHILD 4.05E+04 3.28E+04 2.54E+03 O.OOE+00 1.80E+04 O.OOE+00 5:.19E<07 'N/A INFANT 6.20E+02 2.78E+02 1.70E+01 O.OOE+00 1.07E+02 O.OOE+00 1.76E+05 H/A
.HHAL. ADULT 5.27E+03 6.10E+03 3.65E+02 0.00f+00 3.56E+03 2.2IE+05 1.73E+05 H/A TEEN 7.86E+03 8.56E+03 5. 13E+02 0.00E+00 5.02E+03 3.72E+05 1.82E+OS H/A CHILD 1.08E+04 8.73E+03 6.81E+02 O.OOE+00 4.81E+03 3.28E+05 8.21E+04 N/A INFANT ?.94E+03 8.13E+03 S.OOE+02, O.OOE+00 3.15E+03 3.22E+05 3.12E+04 H/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.l. SKIN "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
"**MAXIMUMVALUES FOR PATHWAYS*"*
GROUND: GROUND: GOAT COW TOTAL T. B./ORG. SKIN MILK: MILK: NEAT- VEGTBLF: INGEST: INHAL.
- 8. 31E+06 9.97E+06 3.84E+04 1.80E+05 1.30E+07 7.71E+07 9-03E+07 3.72E+05 PAGE: 4-40 Hr'Y OAT
O.D.C.M. MAXIMUM PATHWAY DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES*
E: Hp-239 WAY AGE GROUP BONE LIVER T.BODY THYROID KIDNEY LUNG 'G. I. SKIN GROUND ADULT O.OOE+Oo 0.00E+00 Q.QOE+QQ Q.QOE+00 0.00E+00 O.OOE+OO O.OOE+OO O.OOE+00 TEEN O.OQE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Q.OOE+00 0.00E+00 CHILD O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Q.OQE+00 O.OOE+00 INFANT O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Q.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 GOAT ADULT 1.98E-Ol 1.95E-02 1.08E-02 O.OOE+00 6.08E-02 O.OOE+00 4-OOE+03 H/A MILK TEEN 3.79E-01 3.57E-02 1.98E-OZ 0-OOE+00 1.12E-01 O.OOE+00 5.74E+03 H/A CHILD 9.32E-01 6.69E-OZ 4.70E-02 0.00E+00 1;93E-Ol 0.00E+00 4.9SE+03 H/A INFANT 1.64E+Ol 9.96E-02 9.96E-02 O.OOE+00 3.51E-01 O.OOE+00 5.09E+03 'H/A COW ADULT 9.26E-01 9.10E-02 5.02E-02 O.OOE+Qo Z.84E-01 O.QOE+00 1.87E+04 H/A MILK TEEN 1.77E+OQ 1.67E-01 9.25E-02 O.QQE+00 5.23E-ol O.OQE+00 2.68E+04 H/A CHILD 4.35E+00 3.12E-01 2.19E-Ol O.OOE+00 9.02E-Ol O.OOE+00 2.31E+04 H/A INFANT 9. 19E+00 8.22E-01 4.64E-Ol O.OOE+00 1.64E+00 O.OOE+00 2.38E+04 H/A MEAT ADULT 8.54E-02 8.40E-03 4.63E-03 O.OOE+00 2.62E-02 O.OOE+00 1.72E+03 H/A TEEN 7.47E-02 7.04E-03 3.91E-03 O.OOE+00 2.21E-02 O.OOE+00 1.13E+03 H/A CHILD 1.41E-01 1.01E-02 7.09E-03 O.OOE+00 2.92E-OZ O.QOE+00 7.47E+02 N/A INFANT O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 H/A
"-GTBLE ADULT 4.71E+02 4.63E+01 2.55E+01 0.00E+00 1.45E+02 0.00E+00 9.50E+06 H/A TEEN 4.57E+02 4.3IE+Ql 2.40E+01 O.OOE+00 1.35E+OZ O.OQE+00 6.94E+06 N/A CHILD INFANT 8.44E+02 6.06E+Ol 4.26E+01 O.OQE+OQ 1.75E+02 0.00E+00 4.49E+06 O.OOE+OO O.OOE+00 Q.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+00 '/AH/A TOTAL ADULT 4.72E+02 4.64E+Ol 2.56E+01 O.OOE+00 1.45E+02 0.00E+00 9.53E+06 H/A INGEST. TEEN 4.60E+02 4.33E+01 2. 41E+Ol 0.00E+00 1.36E+02 Q.OOE+00 6.97E+06 H/A CHILD 8.50E+02 6.10E+01 4.29E+Ol O.OOE+00 1-76E+02 0-OOE+00 .4'SZE+06 H/A IHFANT Z.56E+01 9.22E-01 5.64E-ol O.OOE+00 1.99E+00 0.00E+00 2.89E+0'4 H/A IHHAL. ADULT 2.30E+02 2.26E+Rl 1.24E+Ol O.OOE+00 7.00E+Ol 3.76E+04 1.19E+05 H/A TEEN 3.38E+02 3.19E+01 1.77E+01 0.00E+00 1.00E+02 6.49E+04 1.32E+05 H/A CHILD 4.66E+02 3.34E+01'2 35E+01 0.00E+00 9.73E+Ol 5.81E+04 6.40E+04 H/A INFANT 3.71E+02 3.32E+01 1.88E+01 0.00E+00 6.6ZE+Ol 5.95E+04 Z.49E+04 N/A BONE LIVER T.BODY THYROID KIDNEY LUNG G.I. SKIN "Airborne pathways and tritium ingestion: units are mrem/yr/uCi/m3 Deposition pathways: units are mrem-m2/yr/uCi/sec
- "*MAXIMUMVALUES fOR PATHWAYS*""
GROUND: GROUND: GOAT COW TOTAL T.B./ORG. SKIN MILK: MILK: MEAT: VEGTBLE: INGEST: IHHAL.
O.OOE+00 O.OOE+00 5.74E+03 2.68E+04 l.7ZE+03 9.50E+06 9.53E+06 1.3ZF+05 PAGE: 4-41
5.0 INDIVIDUALDOSE DUE TO WATERBORNE EFFLUENT SPECIFICATION 3.11.1.2 - THE DOSE OR'DOSE COMMITMENTTO A MEMBER OF THE PUBLIC FROM RADIOACTIVE MATERIALS IN LIQUID EFFLUENTS RELEASED FROM EACH REACTOR UNIT TO UNRESTRICTED AREAS (SEE FIGURE 5.1.3-1) SHALL BE LIMITED:
- a. DURING ANY CALENDAR QUARTER TO LESS THAN OR EQUAL TO 1.5 MREM TO THE TOTAL BODYANDTO LESS THAN OR EQUAL TO 5 MREM TO ANY ORGAN, AND
- b. DURING ANY CALENDAR YEAR TO LESS THAN OR EQUAL TO 3 MREM TO THE TOTAL BODY AND TO LESS THAN OR EQUAL TO 10 MREM TO ANY ORGAN.
The calculations of dose received by the hypothetical maximally exposed individual are based on ingestion of fish, drinking water and exposure on Drinking water is taken from the nearest public drinking water intake the'horeline.
location (Danville Water Authority). Shoreline and fish ingestion are associated
'with the SSES river outfall (edge of initial mixing zone).
Methodology for calculating dose to the maximum hypothetical offsite individual has been developed"'"'or separate (fish, drinking water and shoreline exposure) and composite liquid effluent pathways. This methodology incorporates usage, dilution, and transit parameters specific to the SSES site.
Any revision to input parameters used to calculate dose from liquid effluent (such as dilution factors or usage factors) should be reviewed against FSAR Section 11.2"'.1 Fish Pathwa Li vid Effluent Dose Calculation Methodolo The following expression is used to calculate the fish ingestion pathway dose contribution for the total release period from all radionuclides released in liquid effluent to unrestricted areas:
Eq. 10
"'PPKL Calculation OT-93-RKB-019
"'PP8 L Calculation OT-93-RKB-021
'"Condition Report 96-0755 1pv
'21
Where:
R,yj Total fish ingestion dose during period to organ j to individuals of age group a from all radionuclides i in pathway p (mrem);
Kaipj Fish ingestion dose conversion factor to organ j of individuals of group a from all radionuclides i in pathway p (mrem-ft'/Ci-
'ge sec: Tables 5-1a, b, and c);
C; Average concentration of radionuclide i in undiluted liquid effluent during batch release from radwaste Vi , Total undiluted batch volume released from radwaste (gallons);
Conversion factor (3.785 e3 ml/gallon);
F Minimum blowdown flow (ft'/sec).
5.2 Potable Water Pathwa Effiuent Dose Calculation Methodolo The following expression is used to calculate the fish ingestion pathway dose contribution for the total release period from all radionuclides released in liquid effluent to unrestricted areas:
~[K ~ 'w(-2i'tp)'i I DF P 'F
'i '
Eq. 11 Where:
Rp, Total potable water ingestion dose during period to organ j to individuals of age group a from all radionuclides i in pathway p (mrem);
\
Kaipj Potable water ingestion Dose conversion factor to organ j of individuals of age group a from all radionuclides i in pathway p (mrem-ft ICi-sec: Tables 5-2a, b, c, and d);
Radioactive decay constant (hr '. Table 5-3);
t, = River transit time (hr: Table 5-4);
DF, = Dilution factor (unitless: Table 5-4);
Appv I ~
'ate Rev. 7 22
other factors described in Section 5.1.
5.3 Shoreline Ex osure Pathwa The following expression is used to calculate the shoreline exposure pathway dose contribution for the total release period from all radionuclides released in liquid effluent to unrestricted areas:
R =
I
""C V k Eq. 12 Where:
R 'pj . = -
Total shoreline dose during period to organ j (total body or skin) to individuals of age group a from all radionuclides i in pathway p (mrem);
K.;~ = Shoreline dose conversion factor to organ j of individuals of age group a from all radionuclides i in pathway p (mrem-ft'ICi-sec:
Table 5-5);
other factors described in Section 5,1.
5.4 Pro ected Dose from Li uid Effluent The following expression is used to estimate the combined fish, water ingestion and shoreline exposure pathway dose contribution for the projected release period and volume from all radionuclides released in liquid effluent to unrestricted areas:
Eq. 13 Where:
R 'pj = Total projected dose during period to organ j from fish, water ingestion and shoreline exposure to individuals of age group a from all radionuclides i in pathway p (mrem);
Composite dose conversion factor (adult, teen, child) or water ingestion dose factor (infant) to organ j of individuals to age group a from all radionuclides i in pathway p (mrem/Ci released:
Tables 5-6a, b, c, and d);
other factors described in Section 5.1.
Appv Date Rev. 7 23
The projected quarterly dose contribution from batch releases for which radionuclide concentrations are determined by periodic composite sample analysis, as stated in Table 4.11.1.1.1-1 of the SSES Technical Specification may be approximated by assuming an average concentration based on the previous monthly (rolling 31-day) or quarterly composite analysis.
The calculated dose contributions from these radionuclides shall be based on the actual composite analysis. The cumulative dose commitment to the total body or any organ for a quarterly or annual analysis shall be based on the calculated dose contributions from each batch release occurring during that time period.
In actual practice, the LADTAP II computer code developed by the NRC to implement the liquid dose methodology of Regulatory Guide 1'.109 will be used to perform the individual liquid pathway dose calculations for the SSES. The methods outlined above are consistent with those of the LADTAP II code.
A discussion of the LADTAP II code as applied to SSES liquid effluent, is given in Section A.3.1 of Appendix A.
Appv Rev. 7
Table 5-la: Dose Factors for Fish Pathway: Maximum Hypothetical Adult (Page I of 2)
Dose Factor Units: mrem-ft3/Ci-sec Locati on: Out fal l/FIXfD 0 I LUTIOH Ucoge luop) lkg/yr:FISH) ~
Oilution (1/Mp:FlSHI cr 15.9 Trench time ltf) hrc ~ 25 tcotepo Bone Liver T. Body Thyroid Kidney Lung G)-LLI Q.ooo+00 1.37o44 1.37e 04 1.37o44 1.37o-04 1.37o44 1.37o44 C-14 1.90o+01 3.80e+00 3.Boo+00 3.Boa+00 3.Boo+00 3 80o+00 3 Boo+00 No 24 7.79e-02 7.78o42 7.78o42 7.78e-02 7.78e42 7.78o42 7.780.02 P.32 B.ooe+02 4.97e+01 3.09a+Ol Q.ooa+00 Q.ooe+00 O.ooe+00 8.99 a+01 Cr.51 Q.ooo+00 O.ooo+00 7.53o44 4.50e44 1.60o.04 9.99o 04 1.89o.ol Mn 54 Q.ooo+00 . 2.65a+00 5.06o41 O.ooa+00 7.89o41 Q.ooe+00 8.12o+00 Mn-50 Q.ooe+00 8.06o45 1.43o45 Q.ooo+00 1.02o44 '.ooo+00 2.57e43 Fo.55 3.99o41 2.70o41 0.430-02 0.00a+00 Q.ooa+00 1.54o41 1.58e41 Fo.59 6.20o-o 1 1.40o+ 00 5.59o41 Q,ooe+QQ Q.ooe+00 4.07e4 4.86e+00 10 Ce 58 Q.ooe+00 5.36e42 1.20e41 O.ooo+00 Q.ooe+00 Q.ooe+00 1.OBe+OO Co 00 -
Q.ooe+00 1.55e-ol 3.43e-ol Q.ooo+00 Q.ooo+00 Q.ooe+00 2.92e+00 Ni.63 1.89e+01 l>1o+00 8.33o41 Q.ooa+00 Q.ooe+00 0.00e+00 2.73o41 13'4 Ni 05 7.91o45 1.03o45 4.09o40 Q.ooo+00 Q.ooo+00 Q.ooe+00 2.01o44 Q.oo a+00 1.55o43 7.26o 04 Q.ooo+00 380o43 O.oo a+00 '.32o41 15 1.40o+Ol 4A8o+01 2.02e+O1 Q.ooo+00 2.98a+01 Q.ooe+00 2.81 a+01 16 2.35o.lo 4A9o-10 3.13e.l 1 Q.ooe+00 2.92e-lo 0.00e+00 0.75e-l 1 17 Br-83 .Q.ooe+00 '.ooe+00 1.74o45 Q.ooe+00 Q.ooe+00 Q.ooe+00 2.51e45 18 Br.84 Q.ooe+00 O.ooo+00 2.14e 10 Q.ooo+00 Q.ooe+00 O.ooo+00 1.68e 21 19 Br.85 Q.ooe+00 0.00 a+00 O.ooo+00 Q.ooe+00 O.ooe+00 Q.ooe+00 Q.ooo+00 20 Q.ooo+00 5.90e+01 2.75a+01 Q.ooe+00 Q.ooo+00 O.ooa+00 1.16e+01
)tb 88 Q.ooa+ 00 O.ooe+00 O.ooe+00 O.ooo+00 Q.ooa+00 Q.ooe+00 Q.ooe+00 Rb.89 Q.ooo+00 Q.ooo+00 O.ooe+00 O.ooe+00 0.00e+00 O.OOe+Oo Q.ooe+00 Sr.89 1.32o+01 . Q.ooo+00 3.80a41 Q.ooo+ 00 Q.ooe+00 Q.ooe+00 2.12e+00 24 Sr.90 3.30e+02 Q.ooe+00 8.l ie+01 Q.ooa+00 Q.ooe+00 Q.ooe+00 9.54e+00 25 Sr 91 3.99a42 Q.ooe+00 1.0'l o43 O.ooe+00 Q.ooe+00 Q.ooa+00 1.90o41 20 Sr-92 1.57o44 O.ooe+00 6.77o48 . Q.ooe+00 Q.ooe+00 Q.ooe+00 3.10o43 27 Y90 2.67e44 Q.ooe+00 7.15o40 Q.ooa+00 Q.ooa+00 0.00a+00 2.83 a+00 28 Y-9 1m 2.84e-l 5 Q.ooe+00 1.10a-'l 0 Q.ooo+00 Q.ooo+00 Q.ooo+00 8>4o 15 29 Y-91 5.00o43 Q.ooe+00 1.35e44 Q.ooe+00 Q.ooo+00 O.ooa+00 2.78e+00 30 . Yr92 2>oa47 Q.ooe+00 .0.71 o49 Q.ooe+00 .Q.ooe+00 Q.ooa+00 4.02o43 31 Y93 1.75e45 Q.ooe+00 4.83o47 Q.ooo+00 Q.ooo+00 O.ooe+00 5.SSo41 32 Zr.95 1.44o44 4.02o45 3.13o45 O.ooe+00 7.25o45 O.ooa+00 1.40e41 33 2.89o40 S.83o47 2.07o47 Q.ooa+00 8.80o47 Q.ooo+ 00 1.81o41
'Nb 95 2.66o41 1.48o41 7.94e-02 O.ooe+00 1.46o41 Q.ooe+00 ~ 8.97o+ 02 35 Mo.99 Q.ooa+ 00 4.82e-02 9.10e-03 Q.ooa+00 1.09o41 Q.ooo+ 00 1.12o41 Pt 5-la(1)
~ '
DATE
Table 5-la: Dose Factors for Fish pathway: Maximum Hypothetical Adult (page 2 of 2)
Dose Factor Units: mrem-ft /Ci-sec Loca ti on: Qutfal 1 /FIXED DILUTION Isoto Liver T. B Ih roid OI-LLI 36 Tc-9%n 3.03c-a? 8.55c-07 1.09e-05 0.00c+00 1.30e-05 4.19e.07 5.06e.04 37 Tc-101 O.oac+00 O.ooc+00 O.ooe+00 O.ooc+00 O.ooe+00 O.oaccoo O.aoe+00 38 Ru-103 2.6Ce-03 O.ooe+00 1.14e-03 O.ooe+00 1~ Ole.02 O.aoe+00 3.08e-al 39 Ru 105 4.52e.06 O.ooccoo 1.78e-06 0 Ooc+00 5.84e-05 O.ooc+00 2.76e-03 40 Ru 106 3.99e-02 O.ooccoo 5.05e.03 O.ooe+00 7.70e-02 0.00c+00 2.58e+00 41 Ag-IIOm 5.33e.04 4.93c-04 2.93e-04 O.oae+00 9.?oe.04 O.aoc+00 2.0le 01 C2 Tc-125m . 1.5Ce+00 S.57e-al 2.06e-al 4.63e-at 6.26ecoo 0 Oat+00 6.14e+00 43 Te.12?m 3.9le+00 t'.Coccoo 4.76e-al 9.99e-al t.59e+01 O.aoe+00 1.3te+Ot 44 Te-12T 1.00e-02 3.60e-03 2.17c.03 7.42e-03 4.08e-02 O.ooe+00 7.90c. 01 45 Te- 129n 6.5Ce+00 2.C4e+00 t.04~00 '.2Se+00 2.?3cca'I O.aae+00 3.29ccat 46 Te-129 l.79e-02 6.7le-03 4.35e-03 1.3?c-02 7.51e.02 O.ooe+00 1.35e-02 47 Te-13tcs 5.64e.ol 2.76e-al 2.30e-al 4.37e-al 2.80~0 O.ooc+00 2 74ecat'9 Te-131 1.08e-20 4 ~ Sle-21 3.41e-21 8.87e-21 4.73e-20 O.ooe+00 1.53e.21 Tc-132 1.1?c+00 7.59e-ol "
7.12e-al . 838e-Ot 7.3tecao 0.00&00 3.59ecot 50 I 130 C.OSe-a3 1.20e-02 4.72e.03, l.ole%0 1.8Tc-02 O.ooc+00 1.03e 02 51 1.131 8.29e-02 1.19e.ol 6.79e-02 3.88e+Ot 2.03e"Ol O.ooecoo '3. t3e.02 I-132 2.36e.06 6.32e-06 2.21e.06 2.21e-oC 1.01e 05 O.oat+00'I 1.19c-06 I-133 I ~ 35e-02 2.34c-02 7.13e-03 3ACe+00 4.08e-02 O.aoccoo 2.10e 02 1-134 6.26e-12 1.?Oe-1'I 6.08e-12 2.94e-lo 2.70e-ll O.oae+00 t.48e 1C 55 I-135 7.02e-oC 1.84e.03 6.78e-04 1 21e-01 2.95e-a3 O.ooetoo 2.08c-03 56 Cs-13C 1.81e+02 4.30e+02 3.51e+02 O.aoe+00 1.39ec02 4.62e+01 7.52eao 57 C$ -136 1.79e+Ol 7.0?wot 5.09e+01 O.aoe+00 3 93') I 5.39~00 8.03e+00 58 Cs-137 2.32ec02 3.17+42 2.0?e+02 0.00~0 1.08cc02 3.5?e+01 6.13eHS 59 Cs-138 1.62e-15 3.20e.15 1.59e 15 O.ooe+00 ZQSe-15 2.32e-16 1.37e-20 60 Bc 139 2.13e-09 1.52e-12 6.23e 11 O.aoe+00 1A2e-12 8.60e 13 3.??e 09 61 Be-140 I. 1 le-01 1.40e.04 7.3Oe-a3 O.aae+00 4.T6e 05 8.02e-05 2.30e-al 62 85-141 O.aoe+00 O.aoe+00 O.ooe+00 O.ooe+00 O.ooe+00 0, aoe+00 O.ooe+00 63 Bc 142 O.ooe+00 O.aoe+00 O.aoe+00 O.ooecoo O.ooecoa O.aoe+00 O.ooecao La.1CO 5.90e.05 2.9?e.aS 7 86erM O.aoe+00 O.ooe+00 0 Oae+00 2.18e+00 65 L8.142 8.78e-ll 3.99e-l I 9.95e-12 O.ooe+00 O.oar<0 0 Ooe+00 2.92e 07 Ce-1CI 1 33c-05 8.99c."06 1.02c.06 0 ooe+00 C.'IBe-06 O.aoe+00 3.44e-02 67 Ce-1C3 1.C2e 06 1.05e 03 1.16e-oT O.ooe+00 4.6le 07 0 oae+00 3.92e-02 Ce-1C4 ?.07e-04 2.96e-04 3.80e.05 O.ooe+00 1.75e.04 O.aoe+00 2.39e-at 69 Pr-1C3 3.17e-04 1.27c;-OC 1.57e-05 O.ooe+00 ?.34e-05 O.aoe+00 1.39ecoo 70 Pr-144 0. Ooe+00 O.ooe+00 O.ooe+00 O.ooe+00 O.ooeH)0 O.ooe+00 O.ooecaa Hd-'l4? 2.14e.OC 2A7e-OC 1.48c.05 O.ooe+00 1A5e.oC O.aoe+00 l. 19et00 M.187 8.68e-02 7.25e.02 2.54e-02 O.aac+00 O.ooccao O.aac+00 2.38ccat Hp 239 1.27e.05 1.25e 06 6.90e-o? O.aoe+00 3.90e-06 0.00&00 2.57e-ot 5-Ia<Z>
DATc
Table 5-Ib: Dose Factors for Fish Pathway: Haximum Hypothetical Teen (Page 1 of 2)
Dose Factor Units: mrem-ft /Ci-sec Location: Outfall/FIXED 'DILUTION Ucego (Uop) (kg/yr:FISH) ~ 16 Oiiution (1/Mp:FISH) ~ 15.9 Trancit time Itf) hrc ~ 25 Icotopo T. Body Thyroid Kidney Lung ~ GHLI k-3 0.00a+00 1.06o44 1.06oC4 1.06o-04 1.06M4 1.06e-04 1.06ao4 C14 2.07o+01 4.13 a+00 4.13e+00 4.13 a+00 4.13o+00 4.1 3 a+00 4.13o+00 Na-24 8.02a.02 8.02o 02 8.02e02 8.02e-02 8.02e42 8.02~2 8.02a42 P-32 8.71e+02 5.40o+01 3.38e+Ol 0.00e+00 0.00a+00 0.00 a+00 7.32e+Ol 5 Cr51 0.00e+00 0.00a+00 7.76~4 441~4 1.70~4 1.1 1 cr03 1.30oo1 Mn-54 0.00a+00 2.6 la+00 5.17aO( 0.00e+00 7.77a01 0.00e+00 5.35a+00 Mn-58 0.00o+00 8.44e-05 1.50e05 0.00o+ 00 1.07e04 0.00o+ 00 5.55e4)3 Fo-55 4.18e41 2.96e01 0.91e02 0 00o+00 0 00e+00 1.88aol 1.28a01 Fo.59 6.39a01 1.49o+00 5.70e01 0.00e+00 0.00a+00 4.71e01 3.S3a+00 10 Co 58 0.00o+00 5,33cr02 1.23~1 0.00e+00 0.00o+00 0.00o+00 7.34ool Co.00 0.00 a+00 1.55~1 3.60o41 0.00e+00 0.00e+00 0.00a+00 2.02e+00 12 Ni 03 1.96e+01 1.38o+00 0.04e01 O.Ma+00 0.00o+00 0.00e+00 2.20aol 13 Ni-05 8.55eOS 1.09~5 4.98e06 ~
0.00et00 0.00e+00 0.00e+00 5.93e04 14 Cu-84 0.00e+00 1.03a03 7.05~4 0.00e+00 4.12eo3 0.00e+00 1.20aO1 15 2+45 1.27a+01 4.41o+01 2.06a+01 0.00 a+00 2.83a+01 0.00o+00 1.87e+01 18 Zn49 2.65e.10 4.87o-10 3.41e 11 0.00o+00 3.18a-lo 0.00e+00 8.97e 10
'17 Br4)3 0.00e+00 0.00o+00 1.89e45 0.00e+00 0.00e+00
~ 0.00 a+00 0.00e+00 18 Br-84 0.00e+00 0.00o+00 2.26o-l 6 O.Ma+00 0.00e+00 0.00o+00 19 Br.85 0.00e+00 0.00e+00 0.00e+00 0.00o+00 0.00e+00 0.00e+00 0.00o+00 20 Rb-80 0.00e+00 645e+01 2.98e+01 0.00o+00 0.00a+00 0.00o+00 9.'39a+00 21 Itb-88 0.00e+00 0.00e+00 0.00a+00 0.00e+00 0.00e+00 0.00e+00 0.00a+00 22 Rb 89 0.00e+00 0.00a+00 0;00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+ 00 23 Sr 89 1.44a+01 0.00a+00 4.12cr01 0.00e+00 0.00e+00 0.00e+00 1.72o+ 00 24 Sr 90 2.76e+02 0.00o+00 6.81e+01 0.00o+00 0.00e+00 0.00e+00 7.74 a+00 25 Sr-9'I 4>2e02 0.00a+00 1.72e43 0,00o+00 0.00o+00 0.00 a+00
. . 1.90a41 Sr-92 1.69a04 0.00 a+00 7.21e06 0.00a+00 0.00e+00 0.00o+00 4D1 e43 27 Y-90 2.89eo4 0.00o+00 7.78o00 0.00 a+00 0.00o+00 0.00a+00 Z39a+00 28 Y-91m 3.070-15 0.00o+00 1.17e-10 0.00e+00 0.00e+00 0.00e+00 1.45a-13 Y91 5.49e03 0.00o+00 1,47e04 0.00 a+00 0.00 a+00 0.00e+00 2.25o+00 30 Y-92 2.51~7 0.00e+00 7.25e09 0.00e+00 0.00e+00 0.00e+00 0.88ao3 31 Y-93 1.91a05 0.00 a+00 5.23e47 0.00 a+00 0.00e+00 0.00 a+00 S.82aol 32 Zr 95 1.49~4 4.70e45 3.23eOS 0.00o+00 6,90o45 0.00e+00 1.08a01 33 Zr-97 3.11e46 6.1 4o47 2.83e07 0.00o+ 00 9.32e07 0.00o+00 1.00eo 1 34 Nb-95 2.07~1 ~ 1.48~1 8.17e02 ~ 0.00e+00 1.44a01 0.00o+00 6.34a+ 02 35 Mo-99 0.00a+00 5.13~2 9.79e03 0.00o+00 1.17o.ol 0.00o+00 9.19~2 5-1b(1)
Rev. 1 DAT
Table 5-Ib: Qose Factors for Fish Pathway: Maximum Hypothetical Teen (Page 2 of 2)
Dose Factor Units: mrem-ft /Ci-sec Location: Outfal 1/FIXED DILUTION lsot I. I T. 8 Th roid Ol-LLl 36 Te-99m 3.10e-oF vct'.64e-07 1.12e-oS O.ooeKN 1.29e.oS 4.80e-07 5.68e-04 37 Te 101 0.00e+00 0.00eKS O.ooeKS 0.00eKN O.ooetoo 0 ooeKN 0.00eKS 38 RM 103 2.77e-03 0.00e+M 1.'lBe-03 O.ooeKO 9.77e-03 O.ooekN Rate.ot 39 RU 105 4.87e-06 O.ooeKS 1.89e-06 0.00eKS 6.54eioS O.Boer 3.93e-o3 40 Rtt 106 4.33e-02 O.ooetoo 5.46e-03 O.ooeKS 8.35e 02 O.Coed 2.05eKO 41 A ittom 5;20e 04 4.92e 04 3.00e 04 0.00~ 9.39e OC O.ooetoo 1 38e 0'I CR Te 525m 5.67e+00 6 03e-05 2.24e-ot 4.68e-ol O.ooeKS 0.00ekS 43 Te 527ta 4.25 a+00 1.51 a+00 5.06e 01 1.01etoo 1 72e+01 D.ooeKS 5.0&etot 44 Te-52F 1.10e 02 3 89e-03 2 36e 03 7.5&e-m 4.44e 02 O.ooetoo BATe 01 CS Te-129m 7.0&etoo 2.62eKS 5.52eKS 2 28etQO 2 9&et05 2.6SetOt C6 Te-129 '1 94e 02 7.24e 03 4 72e 03 1.39e 02 8.1Se-o2 O.ooeKS 1 06e 01'7 Te 131m 6.06e 01 2.91e 01 2A3e-01 C 37e 01 3.03 a+00 48 Te 131 1 16e 20 4.80e 21 3.6Ce 21 8.97e 21 5.09e 20 0.00eKS 9.56e-22 49 Te-132 5.24et00 7 84e 01 7~05 8.27e-ol 7.63e+00 0.00eKN 2ASeKlt 50 5-130 4.21e 03 1.22e 02 4.8&e-03 9.93e 05 1.88e-02 0.00eKN 51 1 131 8 88e-02 1.24e 01 6.68e-02 3.&3et05 2 1Ce-01 O.ooetOO 2.C6e 02 52 5-532 2ABe 06 6.48e 06 R~e 06 2.18e 04 1 02e-05 O.ooeKN 2.82e-06 53 5 533 1 45e 02 2A6e 02 7&le 03 3AC~ C.32e 02 O.ooetOO' 86e 02 54 l-13C 6.S6e 12 1.T4e 11 6.25e-12 2.90e-lo 2 74e 11 2.29e-t3 55 56 5 135 Cs-134 7.3&e 04 1.85 a+02 1
4~2 89e 03 7.02e 04 .
2 02e+02 1 22e.ol 0 Boa+00 2.99e-03 1 38e+02 0.~
O.OOe+OO 5.29~5 R.tO 5.42eKS 03 57 Cs 536 1.80M 5 T.OBetOt 4.7&etot O.ooetoo 3.86e+01 6.08e+00 5.70et00 58 Cs 137 2 48e+02 1.55~2 0.00etoo 1.52e+02 4.36')1 4.69e+00 59 Cs 538 1.74e-15 3~55 1.67e-tS O.ooe+00 2A6e 15 2.87e 16 1.5le 18 60 Ba-139 2 32e 09 1.64e-12 ~ 6.77e-ll O.ooeKS 1.5Ce 12 1 53e 12 2.07e 08 6l Ba-1CO 1.19e 01 1A6e 04 7.6&e 03 0.00e+0) 9.79e-OS 5.83e 01 62 Ba 1C1 O.ooe+00 0 Ooe+00 0.00eKS O.ooetoo O.ooe+00 0 OoetOO O.ooe+00 63 Ba-1C2 0.00~ O.ooetoo O.ooeKN O.oo AS 0.00e+00 O.ooe+00 O.ooetoo 64 La-1CO 6.26e 05 3.08e-oS 8.18e-06 0 OoetOO O.ooe+00 1.77e+00 '.ooetoo 65 La 142 9.36e-ll 4 16e-11 1.04e-l 'I 0.00et00 O.oo a+00 '1.27e 06 66 Ce 1C1 1.CCe-05 9.61e-06 1.10e 06 O.ooe+00 4.53e 06 D.ooe+00 2.75e 02 67 Ce-543 1 54e 06 1 12e-03 1.25e-07 0.00e+00 5.02e 07 0 Ooe+OO 3 37e-02 68 Ce-544 7.68e 04 3 18e-04 4.53e 05 0.00e+00 1.90e 04 O.OOeKN 1.93e 03.
69 Pr-5C3 3.44e-04 t.37e-OC 1 Fle OS 0.00eKS "
T.98e 05 O.ooetoo 1 13e+00 70 Pt -144 O.ooe+00 ~ 0 Boa+00 0 Boa+00 0.00etoo O.ooetOO 0 Ooe+00 0 Ooetoo Rd-547 R.C3e 04 2.64e OC 1.SBe 05 0.00eKO 1.55e-OC O.ooeHS 9.5Ce'5 72 M.187 9.37e 02 T.&Ca-OR 2.68e-02 O.ooe+Oo 0.00eKO O.ooe+00 2.07e+05 73 Rp-239 1Aae.OS 1.35e 0& 7.5\e-07 O.'Boa+00 4.24e-06 O.ooetoo 2 18e 01 5-Ib(2)
Table 5-Ic: Dose Factors for Fish Pathway: Maximum Hypothetical Child (Page 1 of 2)
Dose Factor Units: mrem-ft'/Ci-sec Location: Out fal l/FIXED DILUTION Ueetre (Uep) iktl/yrRSH) ~
Dilution illMp:RSHi ~ 15.S Tr~it time it& hre ~ 25 T. Body 0.00e+00 8.72o45 8.72e45 8.72e45 8.72e45 8.72e45 8.72e45 C14 2.Bee+01 6>le+00 6%le+00 6>1 e+00 5>le+00 6>l e+00 64let 00 No-24 8.72o02 8.72o02 8.72e42 8.72e42 8.72e42 . 8.72e42 S.72e42 P<2 '.12e+03 6>So+01 4~+01 OANe+00 OANe+00 0.00e+00 3.10e+0'l 0.00e+00 0.00o+00 0.00o+00 2.04e+00 B~
5A3o41 4.59o04 OANe+00 6.72e41 S~e44 OANe+00 4>So42 1.71e+00 OANo+00 7AtQo45 1.74e45 OANe+00 8~S ~ OANe+00 1.1le42'&le42 P 5$ 5.49o41 XSle41 9.02o42 OANe+00 OANe+00 '1.0Se41 7.76o41 1DSo+00 0~1 OANo+00 OANe+00 3Atie41 1>le+00 Co.SB 0.00o+00 4DSo42 1~1 OANe+00 OANe+00 OAX4+00 2A&e41 Co40 0.00e+00 1Aeo41 3.72e41 OANe+00 OANe+00 OANe+00 SAISe41 2.57e+01 147e+00 &.74e41 0.00e+00 0.00e+00 0.00e+00 13 '1.09e44 1At3o05 1.0lo40 OANe+00 OANe+00 OANe+00 OANe+00 1ASeO3 9ANo04 OANe+00 3Atle43 OANe+00 7A)le42 15 1 ~+01 3.47e+01 2.leo+01 OANe+00 2.1Qe+Ol OANe+00 1.1 De+00 10 328o-10 4.74o-le 4~1 1 OANe+00 2At&e.10 0.00e+00 LSQe48 0.00o+00, OANo+00 2A3e45 OAXb+00 OANe+00 OANo+00 OANo+00 18 0.00o+00 . OANe+00 2.0&e-l 0 OANe+00 OANe+00 OANe+00 0.00e+00 OANo+00 0.00e+00 0.00e+00 0.00o+00 OANo+CO OANo+00 OANe+00 OANe+00 0.1 So+01 3.7&e+01 OANe+00 0.00e+00 0.00e+00 3AHte+00 21 0.00o+00 0.00o+00 OANe+00 OANe+00 ,OANe+00 0.00e+00 OANe+00 22 0.00e+00 OANo+00 OANo+00 OANet00 OANe+00 0.00e+00 OANe+00 23 1.See+ Ol OANe+00 OANo+00 0.00e+00 OANe+00 741 e41 24 Sr 90 2A3e+02 0.00e+00 1.17e+01 0.00e+00 0.00e+00 0.00e+00 25 Sr 91 5.55o42 0.00e+00 2AlQo43 OANe+00 OANe+00 OANe+00 1~e41 2.10e04 0.00e+ 0'0 8.0~ OANe+00 OANe+00 0.00e+00 4ANe43 27 Y-90 3.74e44 0.00e+00 1.00o05 OANe+00 0.00e+00 0.00e+00 1.07e+00 28 Y.Birn 3AI2o-15 0.00e+00 1.43e 10 0.00e+00 0.00e+00 0.00e+00 7.0&o.12 Y41 7,10e03 OANo+00 1ANo44 OANe+00 OANe+00 0.00e+00 9ASe01 Y-92 3>1 e47 OANe+00 0.00e+00 OANe+00 OANe+00 31 Y93 2A6e45 OANo+00 0.72o47 OANe+00 OANe+00 'ANe+00 3AtSe41 32 1Ailo04 3Ai7o45 3.54o45 0.00o+00 S.eSo45 4.1 4e42 33 3.95e00 6.71o47 347o07 0.00o+00 8.19e47 OANe+00 &.04o42 Nb.95 3.10o01 1.23o41 8.78o42 0.00e+00 1.15o41 0.00e+00 X27e+02 0.00e+00 4ASo42 '1.21e42 1.04e41 0.00e+00 4.04e42 5-Ic(1)
A DAT Rev. 1
Table 5-1cl Dose Factors for Fish Pathway: Haximum Hypothetical Child (Page 2 of 2)
Dose Factor Units mrem-ft (Ci-sec Location: Outfall(FIXED DILUTION
}sot Limr Th id 0} LL}
36 Tc>>99m 3.72e-07 7.29e-07 1 21e 05 0.00e+00 1.06e-05 3.70e-07 4.15e OC O.IN}F00 0 00+HO 37 Tc-}0}
Ru-103 0.00@+00 3.43e 03 0.00e+00 0.~ 0,00eKK 1.3Ze-03 0.00ekS 0.00e+00 0.00eHR
'8.62e-03 5A6e-05 O.DQe+00 0.00eKS 8.~
4 06e 03 RQ 105 6.2}e 06 0.00eNO 2.25e 06 0.00e+00 CQ Ru 106 '5.57e-OZ 0.00e+00 6.96 03 0.00e+00 ~ 7 S3e 02 0.00eIOO 8.67~0}
hs-t }0m 5 90e-04 3.98e-04 3.19e OC 0.00e+00 7A2e-04 0.00e400 4.74e 02 42 Te-125m - 2.15e+00 SJSe 01 2.87e-01 6.03e 0} 0.00eKS 0.00e400 2.0?A@00 Te-}2?si 5 ASSN 1.48e+00 6.5}e-0} 1 Ate+00 1 S&ct0} 0.00e4R CA4e+00 Te-127 1A}e 02 3 Me-03 3.02e-03 9.'76e-03 4.01~2 0 00eKO S.51~}
Te-129m 9.10e+00 2.54 AN 1A}eHS 2.93+40 2.6?e4} O.NEO t.tteo0}
Te-129 2.50e-02 6.99e 03 5.94e-03 1.79e 02 ?D3c 02 0 00eHS }.56eKO 47 Te-131m ?.72e Ol 2 6?e 01 2.54e 01 5.49e-0} 0 OOeeOO 1 Odeoot Te-131 1.49e 20 4.55e-21 4A4e 21 1 14e-20 4.52e-20 0 00e400 F.dse-20 49 Te-132 }.55+40 6.84e-01 d.26e 01 9.96e-0} 6.35eKN 0.00eIM 6.85cKN 1.55~
~
I '}30 5 }5e-03 1 04e-02 5.36e 03 1.15eKS 0.00et00 4.86e 03 t.~t 1 Olc 02
~
51 I 131 1 ~ 13e-01 1.13e.01 6A3e 02 3.74eKI} 0.00e+00 I 132 5 2.5~ 2.61c 04 d.6}e 06 0.00eIOO 6.62~
l 133 .1.8Ce 02 Z.Z8 02 8.62~ 4.23eKS 3 0 00eKS 9 tdi 03 54 l-134 5.12e 12 1.51e-11 6.94e-12 3.47e 10 2.3}e 11 0 00eKS 1 00e 11 55 }-135 9.11e OC }.64~ ?.7~ 1.45e 01 2.5}~ 0.00eHR 1 25~
56 Cs-13C Za23c402 3 66eKR ?.~t 0.00eKS 1.1 Ca+02 4.0?eK)1 1.9?AN Cs-136 2.12~1 5.54 eel} 3.~} 0.00eKS 3.1'1 ~} 4.64e+00 2.05eKN 58 Cs 137 3.t2e+02 2.9&e+02 4.4}eH} 0.00eKS 9.74e+Ot 3 50e401 t.d?AN
~
Cs-}38 2.20e-15 3 06e 1S 1.94e-15 0.00eKS 2.15e-15 2.32e-16 1.C1e 15 Ba-}39 2.99e-09 1.59e 12 8.65e 11 0.00eKO 1.39e-lz 9.3?e 13 1.72~7 61 Ba~}40 1.50e-0} 1.31e-04 8.75~ 0.00eKS 4.~5 ?.83e 05 ?
62 Ba~'}C} 0.00eKS O.MeKS 0.00eKS 0.00eKN 0.00eKS O.OOc400 0.00eKO 0.00eKO 0 00eKR 0.00e+00 0.00eKN 0.00eKO 0.00eKS 0 00e400 65 Ba 1C2 La 1CQ La-}42
'F.83e-05 1.18e-10 2.74e 05 3.?Fe-'ll 9 23e-06 1 18e-11 0.00e+00 0.00eKO 0.00eKN 0.00eKO 0.~
D.OOPS
?~0}
?A6e 06 Ce 141 'l.85e 05 9.24e 06 1 3?e-06 0.00eKN 4.05e 06 0.00eKO }.15e 02 67 Ce t43 1.97e 06 1.07e 03 1.55e 07 0.00eKO C.C9e 07 0.00eHS Ce-}44 9.90e 04 3.'}0e 04 5 29e 05 0.00eKS t.ne-QC 0.00e+00 69 Pr-143 CA5e OC 1~e-OC 2.21 e 05 0 00eKN 7.23e 05 0.00eKO C.80e 01 70 lt 1CC O.Me+00 0.00eKN 0 00eKN 0.00eKN 0.00eKN 0.00e+00 0.00e400 7} IId- l47 3.12e-04 2.53e-OC 1.96e 05 0.00eKO 1.39e-OC 0.00eKS 4.00e 01 M-187 1.19e Oi 7.03e-02 3.16e.02 0.00eKS 0.00e+00 0.00eKO 9 55eKN Kp-239 1.84e-05 1.32e-06 9.3}e 07 0.00e+00 3.83e-06 ~ 0.00eKS 9.Me-02 5-jc(2)
~m!~~,~mEz~aam%MPRER~E~~~IMM~
~~REH~KRKIKRRKKZERKHKKKREHRRR3RZM ERIK%
~
KKRK~NKH~RKMRNKHKR~K?RRMKRRK'RRRKEHR RfE~ RKBK%RKz~ RKti~RKR~RKR~RKzKMRKR~
~kK~REHKRRX~MK362~R?E~RKH~~~NKZKR
~g~~~i,~i~ii i~i~~a~~~~~i~I
~ ~it ~~ll +~II ~I ~It IQ~1~1 ~ll ~ll ggg~l I I ~ I
~&R~RM~KK~KR~EERMM~RSE%5%RK~KEH~
RWRK~RKMMRK~KR~N2E~ K?E~KEX~RK3~
RWKKHW&EH~K3H~KKK~MK'~RE~RK~RK!%%i I K%RKEMREMMR3EKPR~~XR3%'~~~~~RKEKR~
RMKT~~KRRKK%KKG~&M~R3K~~~KKEHR
~i.Q~~+K+~i'~
RMKX~RRZE5%RKHKRRKVKRK?K~~~ME~MK~
K%EE~KKZ~RKIKRRKHKR~~EK%5RRPMM
~~~~ ~~I r
KRRK~R2E~RK~RKKX%%2E~R?E~RPM~KKKR'
~~~~~ ~~
K%KE~RKZKKSREHKKREE~R?K~MRKX~~R~K'%I ~
~~r!
~l~ ~ ~ ~
i~ .~<~iI
~~4 ~li ~~I ~~I ~It l~ll ~lll~ll ~l~ll ++~I
~ I~~~~i
~1 ~
~i~~I i~a
~
ammzmmnr~ammammmm~mam~mm~arama; I aammmmzaammaze~mmmmmrmmmaxznal K%NK~RK~RR?E~REH~LR?M~RK~ R362a~RIM~ I KSCHHkKKSRKMRKZHRRRKRK~~RRR&RHH%
K%RBKMRKCH5%3K~RKR5%NK"'.~RK~KlHE~RHKHRi KKIXHMRKWRR2E~KKiiEH%53M~RK~R3R~RKH~I KRIK2&RHKRRK~KKKRR2&MNK~KMMRK52%~
aaimmaanmaam~ammammmamm~mmmmmra~
KRIKQWRKHK%KKMREZKW~~RK~RKZKNREH~
RMRK~RRRKSRKHKRNKH~R2M~RHHKRKK~KK'5%I
~i maam~ammraammmammaammaammammm~ma~
RRKKWkKHKRRKVKRRKHKRNK~RRRHSRK~RE?HR~
KKNX~KZHKRKE~~R~HRRKE~MZEMREZ~REH~
~ '
table 5-Za: Dose Factors for Potable Mater Pathuay: -Kaxiassa gypothctical Adult (Pace 2 of 2)
Oose Factor Units: mrcm-f ts/Ci sec Location: Danvillc Receiver/VARlABLB DlLUT1DM lsot Liver T. Body Thyroid Ol-LLT To~99m 1.98e-04 5.60e-04 7. 14eHB 0.00et00 8.51e 03 2.75e-04 3.32e 01 37 Tc-101 2.04e-04 2.94e-OC 2.88e 03 0.00eHS 5.29e 03 1.50e-OC 8 83e 16 38 RQ-103 1.C9e-01 0.00e+00 6AOe 02 0.00eHN 5.67e-OI 0.00e40 1 2$ eCt 39 Ru.105 1.24e-02 0.00eHO 4 88e.03 0.00+HO 1.60 Ot 0.00eHS 7.56e400 40 Ru-106 2.21e+00 0.00e+00 2.79c-01 D.OOeHS 4.26eHS 0.00eHS 1A3e+02 41 Ag-ttOm 1.28e.01 1.19e-Ot 7.06e 02 0,00eHS 2.34e-01 0.00e+00 4.85e+01 42 Te-125m 2.15m+00 7.80e 01 2.88e 01 6A7e 01 8.75eHS 0.00eHN 8.59eHO C3 Te-127m 5.44e+00 1.94eHS 6.62e-01 lDQeKO 2 Ztet01 0.00eHO 1.82et01 Te-127 8.83e-DZ 3.17e-02 t.91~ 6 54e 02 3 60e 01 0.00et00. 6.97e40 CS 46 Cl Te 129m Te 129 Te-131m 9.23e+00 2.52e 02 1.39eKS 3ACet00 9 48e 03 6.79e 01 6 t~
1A6eKS 5 66e-01 3 17+HO 1.94e 02 1.08eKS 3.85etOt 1 06e 01 6 88eKS 0.00c+00 0 OOHOO 0.00eo00 4 65et01 1 90e 02 6.75')t Te-131 1.58e 02 6.61e-03 4 99e 03. '1~2 6.93e-02 0 00ekS 2.24~ .
49 Te-l32 2.02eKN 'l&teKS 1 23etO) 1 ASKS - 1 26eHIt 0.00eo00 6.t9e401 50 1-'130 6 07e-01 1.79e+00 7 Ole-01 1.52eN2 2.79e+00 ~ 0.00e+00 1.54eHS 51 1-13'I 3.34eKO 4.78et00 ~ 2.7C +HO 1.57e+03 8.19e+00 O.OOeHS 1 26eHS 52 l 132 1.63e-01 C 36e 01 1.53~1 1.53eaOt 6 95e 01 D.OOeHO 8.19e 02 1 133 t.tCeKN 1i98e+00 6.05~1 2.9teHIZ 3.46+HO 0.00eHN 1.78eHS t-t34 8.51e 02 2 31e D1 8.27e 02 C.Otal 3.68e 01 0.00e+00 2 02e OC 55 135 3.56e Ol ate 01 3A4e-01 6 Nest 1A9eHN 0.00e+00 1.05eHO t.~l 1
56 Cs-134 4.99+%1 1.19e+02 9.72e41 0.00eHS 3.85m% 1 2,08eHO 5.23e+00 2.06e+01 1.49+41 0.00eHO t.15+%1 1.57e+00 2.34 F00 Se Cs-137 6.40e+Ot 8.75~1 5.73+41 0 00eHS 2.97+%1 9.88et00 1.69+HO
~ 59 Cs 138 4.43e.OZ 8.75e 02 C 34e-02 0.00eHS 6.43e-02 6.35e-03 3.73e 07 Ba-'139 7.79o-02 S.SSe 05 2,28e 03 0 00eHS 5.19~05 3.15e-05 1.38e 01 61 8$ -1CO 1.63e+01 2 OSc-OZ 1.07eHS 0.00eHS 6.96e 03 1.17e 02 3.36e401 62 Ba-141 3.78e 02 1 28e 03 0.00e+00 2.66e 05 1.62e 05 1.78e 11 Ba-1C2 1.7le 02 1.76e-05 1.08e 03 0 00eKS 1A9e 05 9.96e 06 2Ate-20 La-140 2.0te-03 1 01e 03 2.67e-04 D.DOeHN 0.00e+00 0.00eHO 7A3et01 65 l.a-'ICZ 1.03e.04 4.67e.DS 1 16e-05 0.00eHN 0.00e+00 0.00e+00 3A1e 0'i Ce-141 7.52e.03 5.08e 03 S.lie 04 '.00eKN 2 36e.03 0.00e+00 1.94e+Ol 67 Ce 143 1.32e.03 9.80e.O'I 1.08e-04 0 00e+00 4.31e OC 0.00eHN 3.~1 Ce-IC4 3.92e 01 t 64e.01 2.10e 02 0.00e+00 9 72e-02 0.00e+00 1.32e+02 69 Pr~143 7.39e.03 2.96e.03 3.66e 04 0.00eKN 1.71e-03 0.00e+00 3.24eKlt 70 Pr-1CC 2.42e-05 1.00c-05 .t.27e 06 0.00w00 5.66e-06 0.00eHS 3ABe 12 Kd '147 5.05e..03 5.84e.03 3A9c-04 O.DOeK)0 3.41e.03 0.00e+00 2.50etOt M-187 8.27e-02 6.91e 02 ZA2e-02 0.00+88 0.~00 0.00eHS 2.26e+01 Kp.239 9.56e.OC 9.40e.05 5.18e-05 0.00eHS 2.93e.OC 0.00c+00 1.93~1 5-2a(2)
Table 5-2b: Dose factors for Potable Mater pathwy Naxissaa NYpothetical Teen (page 1 of 2)
Dose factor Units: ceo-ft /Ci-sec Location: Panvillc Receiver/VARIABLE OILUTIDN Usage <U
)sot N-3
) (kg/
O.ooetoo tMATER) a Liver 5.95e-02 T
510 8
5.95e-02 Th id 5 95e-02 Ni 5 95e 02 5.95e<<02 CI LLI 5.95e-02
~-
C-14 2.28e+00 C.56e-ol 4.56e 01 4.56e 01 4.5>-01 4.56e 01 4.56e 01 NB 24 1.29e+00 1.29'!0 1.29eKO 1.29eHO 1.29eHS 1.29eKS '1.29eHO I -32 1.55e+02 S.59c+00 6.00eHS O.Doe+00 O.Doe+00 0 OoeHS 1.3~1 Cr 51 0 Doe+00 0.00e+00 2.02e IG 1 12e 03 4.43e-04 2.88e-03 3.39e 01 O.ooeHO 3.31e+00 6.56e 01 D.ooeHS 9.8le-ol D.ooeHS Nn-56 O,ooeHS 8 86e 02 1 58e 02 1.12e 01 0 OoeHS 5.83e+00 fe 55 2.12e+00 1.50et00 3.51e 01 0.00eKS 0.00eKS 9.54~1. 8.51~5 fe-59 3.29e+00 7.69eKS 2.9?eHS O.Doe+00 O.ooeHS 2A2eHS 1.82et01 10 O.ooet00 5.CSe 01 1.26eHS O.ooeKS 0.00eKS 0 DoeHS 7.52eKS O.Doe+00 1.58eHS 3.55eHS 02'.ooeHS O.ooeKS O.Doer O.ooeHS 2.05eH)I 12 Ni 63 9.93eKII 7.01e+00 3.3?eKO O.ooeHS 0 DoeHS 0 00e+00 1 12eHS Ni 65 4.20e-ol 5.3?e-02 RASe 02 O.Doe+00 D.ooeKS D.Doe+00 2.91 AS 14 D.ooeHO 6ASe D2 3.0Ce-02 O.ooeHS 1.'63e 01 ~ 0 00et00 15 2n.65 3.23e+00 1.'l2e+01 5 23eHS O.ooeKS 7.18eKO O.ooeHS 4.?5eKN 16 Zn-69 8.25e 03 1.5?e-02 1 loe 03 O.ooeHS 1.03e 02 0.0~ 2.89~
Br 83 0 Doer 0.00eHS 3.22e-02 0.00e400 0 00eKS D.ooeKS 0 DORIS 18 Br-84 O.ooeHS 0.00e+00 C.05e D.Doe+00 O.ooeHO 0 00eKS Br-85 O.ooeKO 0 OoeKO 1.?le 03 O.ooeHS O.ooeKS D.ooeHS 0 00eKS O.ooeHO 1.6?~I 7.85eKS O.ooeHS O.Doer O.Doer 2A?eKO 21 O.ooeHS 47& 02 2.55e-02 O.ooeHS 0.00e+00 0.00eHS C.'loe 09 Rb 89 0.00e+00 3.09e 02 2.18e-02 0.00eKN O.ooeKS O.ooeKO 4.73e 11 2.47e+02 0 00eKO 7.0?F00 0 DoeKS D IOeHS O.ooeHS 2.94') I 24 4.66e+I)3 O.Doe HO l.'l5eKS 0 DoeHS 0.00eHS O.ooeHS 1.31e+02 dr-91 4.53eKO O.Doe+00 1.80e 01 0 00e+0) D.ooeHS 0 OoeHS 2.05etOI Sr-92 1.71eHN 0 Doe+00 7.29c 02 O.Doe+00 0 Doe+00 D.OOe+OO 4.3heo01 27 Y-90 7.69e 03. O.ooeHS 2.07~04 O.ooeKS O.ooeHS 0 OoeHO 6.34~1 Y Sle ?.24e 05 O.ooeHS 2.7?e-06 D.DOES 0 Doe+00 O.Doer 3A2e 03 Y-91 1.13e-D1 0 Doe+00 3.02e-03 O.ooeHS 0.00eHS O.ooeKS 4.62' 30 Y-92 6.79e.04 O.Doe+00 1 96e 05 D.ooeHS 0 00et00 O.ooeHS 1.86etOI Y-93 2.15e.03 O.Doe+00 5 89e-05 O.aOeCO O.Doe+00 O.Doe+00 6.5~1 32 Zri95 2.3le.oZ 7 29eeQ3 5 02e-03 0.00e400 '1 Ole 02 O.ooeHS 1.65')l Zr 97 1.33e.03 2.63e.04 1.21e-04 0.00et00 3.99e-oC O.Doe+00 7.12+41 4.6)e 03 2.56e 03 . 1.41e 03 D.ooeHO 2Ade 03 O.ooeNS 1 09e+01.
~ No-99 O.Doe+00 3.38e+00 . 6.CSe-ol O.Doer)0 ?.?4e+00 0 DoeHS 6 06eHN 5-Zb(1)
~EIKKNEKKKNKIIEIKKEHIR KESK mHBKKIRIK1 KRRIHHREHHERmKKRHHKRRH"-RR EEIR SERI EIRE EIEIII
~K4H&RKE~MH~MKKRMm~mmKRRK2%%RK25Ka, Kaarammmnmmam~ammmmmmamnamf B~IHRERIGmmt gag/g~l~~I~II I ~ll gyg~l~l KRRHHK KREERKR&HHKREI~EHHHKRHK"-RRHRHRI
~ I ~IH ~~H/~l ~
gy~~HH RKKRTRRNKIHHRNKHKRR~5ERR?MmaK=KRMM~KK HRI t~RRH&RIHE~RK~REZXERR3K~R3R~WM~KKMRI
~~EXMH~RK~IRRRKRRK~IMKK~~~~RKZHRi amamHmaemammmammmm~aaxz~am~ax.~m, aaaemammmmmmmmmam~mmmaam~am m; aaammmammmaxmmammmaam~mmmmam~am~
NKRRKR%MM&RKEHKMKKERRKKTRl~~RPK~KKZHRi
+gg~+gg+Q~~Q~~L~~S+g~+~~~~~L)
KKRREWRK~QK3~QKB~II RKH~ISKR~RPK~53H~
maam~ammmmmmammaam~manmam~m RKHRIM RHBEEEEKRHHBKRH KERI~EKEKSHHKKI aarnE~ammammnamrma~~amnaam~mmma',
KREHIIm HHHRREEKRHRIIREHIIRRRHE~RII-IMEEIIHRI
~ggg~~~lggg~~g~ll .~~/~II ~~l~l~ll /~~L ~IH aaNK~azenraamxmammmarmammmam~aamm,'NH&WEEHRRKH~RKEHR~'~KKH~WMHRR52~
~RKmNmmamnaaKmaam~mmnaem~Rm~l Kaamaamnnaammaaemamm~amzaamzmamazm',
RaRKEaRKmmam~am~a~mam~aam~Km~
maamEmMmmraam~ammaammmammam~~ennea!
KamEEmaEmmamrzamm~am~ax ammmmmmna:
CMlmEmmzemaxzname~am~aZmmasz~KK~%!
KaamEaaanmmammaammmam~mmaaemmmmmnm,'gg~lggg~l~~l~l~l
~ll ~I ~I ~I ~~l I I aaamammmam~am~aK~
~ ~HB ~ ~ ~
RMREEKMMHaam
~rmmamnaammaamrmarmmmmaam~amma'.
Kamasamrmmammmamm~am~am~am~am~
Kaemmmasmnxaemmam~am~ammaammmameal KamRKaaZmmaazmaammamm~aatmmammmatnÃa',
KRR HIE R RIES RIIRNRHHKR SHRIKE KERI aeam5maemaammammmmmmmaemmam~RA'.~
~l ~~lg~l~l ~ ~IB ~B ~l
~ I ~ ~IB ~II I
awemmazxmmmmcamamammmmzmmamr~RE?Ka,
f Teb4 5 2c: Oooo scaorc for potrb4 Waer Pachwey: Maxim Hypor~icci Ciiid iPhGE 1 OF 2i Qoee feccars: rrvem.tt'ICreec
- Donvide AeceivcrNARIASLE ORUAON Vroco giepi tkgIyrWATERi ~ 510 T. Sody Thyroid H3 1.14s01 1.14s01 1.14s01 1.14s01 1.14e01 1.14s01 O.79et 00 &Or+00 1 ddr +00 145yt00 1~t00 Ne 24 3.25e+00 XRQt00 345e+00 345e+00 3>Set00 3DSet00 345et00 P 32 4.03o+02 2.lie+01 1.78e+Ol 0.00e+00 OAX4+00 QAeo+00 1 ~t01 Cr 61 OAeot 00 7.57s04 0.00e+00 8.00e+00 '1 ASe+00 OAide+00 l.dde+00 0.00e+00 6.04e+00 Mn-SO 0.00e+00 1Aile01 4~2 OAQe+00 ZZVs01 OAidot00 2.72e+01 dASe+00 1Aidet00 One+00 OAidot00 1 Ji4et00 8~1
.9 MOe+01 7.4det00 0.00o+00 OAOet00 4$ 4ot00 1$ de+01 10 0.00e+00 1A)1 et00 3AXiet00 O.OQe+00 O.QQe+00 OANo+00 SAXie+00 0.00o+00 2Ailet00 S.VSe+00 OAT+ 00 OAOe+00 OAOot00 1.84o+0 1 12 3.02o+02 1.02e+01 1.03e+01 0.00e+00 0 Air+00 0.00e+00 1179e+00 Ni05 145et00 1.'17s01 OAee+00 1A4e'+01 14 0.00e+00 1>Vs01 8~2 OAOe+00 3>2s01 OASet00 OAS too 15 7.89 +00 2Al5e+01 127e+01 OAXie+00 . 1~+01 OANetQQ 3A10e+00 ld %28s03 One+00 2.15s02 OASet00 2.24ot00 OAidot00 'AXret00 8$ 8s02 OAOe+00 OAXie+00 OAOet00 OAide+00 18 OAidot00 0.00o+00 1.1 1 s01 One+00 QAXiet00 0AOet00 OANot00 Or45 0.00e+00 OAQot00 5.'l2s03 0.00e+00 OAQo+00 OAOot00 OAQe+00 0.00e+00 231e+01 OAide +00 OAidet00 OAXht00 2A2e+00 OAeet00 OAide+00 3.7de+01 1Ails01 O.Sds02 7Als02 5~2 OAXiet00 OAOe+00 OAOet00 OAI +00 OAXiot00 0.00e+00 S~
6.72s04 7Alr+02 OAeo+00 2.11e+01 OAQe+00 OAeo+00 OAXb+00 2Aile+O'1 24 8.64e+03 NStt00 2;42e+03 QAOotOQ OAide+00 OAXh+00 1 We+02 25 Sr Sl 1DSot01 0.00e+00 5Pds01 OAee+00 0.00e+00 OAide +00 ZAile+01 Sr-82 5.07r+00 OAOet00 OAXh+00 OAXiot00 S,SSo+01 27 Y 90 231 s02 OAee+00 O.1 Vs04 OAOe+00 OAXht00 0.00et00 d.Sde+01 Y Slm 2.14s04 0.00r+00 VAXis08 0.00e+00 OAidet00 OAXht00 4~1 29 Y-9'i 3~s01 0.00r+00 9AQeE73 OAiQet00 0.00o+00 OARo+00 4.50e+01 30 Y82 0.00e+00 5.78e05 0.00e+00 OAidot00 0.00e+00 M3et01 Y 93 , OAQe03 0.00 +00 1.7ds04 0.00e+00 0.00o+00 OAMot00 &.54e+01 Zr.85 8.51s02 1A3s02 'l.27s02 0.00e+00 2.05s02 0.00et00 1A9e+ 01 Zr.SV 3.82s03 5.dls04 344r04' 0.00o+00 8.13s04 OAidot00 8.58e+01
, 34 Nb-85 1.2ds02 4>1 s03 3$ 1s03 0.00e+00 4.82e03 0Aeet00 S,OSo+00 35 Mo 99 0.00et 00 VAde+00 1.85o +00 . 0.00e+00 1AiSet01 0.00o+00 O.lie+00
Table 5-2c: Dose factors for Potable Mater Pathuayt )iaaf~~ kypotheticaf Chfld (Page 2 of 2)
Oosc factors: caren-f t*/Ci-sec Location: Oetwf Lie Receiver/VARflSLB OTLf)TTOk isotope Liver Thyroid G)-Ll.l 36 Tc-99m 5.18e-04 1.02e 03 1.68e-02 0.00e+00 1.Cae-02 5.16e-04 5.?8e-01 37 Tc-10') 6.00e 04 6.28e 04 7.97e.03 0.00e+00 1.07e 02 3.32e-04 2.00e 03 38 Ru-103 4 10e 0'f 0.00e+00 1.58e 01 0.00e+00 1 03e+00 0.00eKS .1 06e+Ol Ru 105 3.62e 02 0.00~00 1.31e.02 0 00e+00 3.18e-O'1 0 00eKS 40 Ru-10& 6.56e+00 0.00e+00 8.19e 01 0.00et00 8.55e+00 0.00eKS l.'02e+02 41 lg 110m 3.02e-01 2.04e-01 1.63e-01 0.00e+00 3 80e Ol 0.00e+00 2A3e+0'f C2 Te.)25a 6AOet00 1.73e+00 8.53e.01 1 MeKS 0.00eKO 0.00eKS 6.17eKO 43 Te-12?a 1.62e+01 4.36eKS 1.92eKN 3.88eKS 4.62et01 0.00e+00 \Dfe+01 Te-127 2.64e-01 7.'12e-OZ 5.6?e 02 1.83e-01 7.52e 01 0.00eKS 1 03et01 45 Te.129m 2.73e+01 7 63eHS 4 24eKN 8.02eo01 0.00e+00 323e+Of 46
/7 Te-129 Te 13)m 7 S2e 02 4.04e+00 2.10e 02 1AOet00 1.~
1A9eKS 5.3&e 2.87eKN OZ 2 20 01 1.35e+Ol 0.00eKS 0.00eKS C.68eKS 5.6?e+N 48 Te-131 4 66e-02 1A2e-02 1.39e-02 3.56e 02 1Ale 01 0.00eKO 2ASe-Ol 49 Te 132 5.67e+00 2.51e+00 3.03eKN 3.&See)0 2.33e+01 0 00e400 2.52')1 50 1 130 1 64et00 3.3)eked 1 7)AN 3.&5et02 4.95e+00 '0 00+HE 1.55eKN 51 1 -131 9.65et00 9.71e+00 5.5 TAN 3.21e+03 1.59+&1 0.00e400 8.~1 52 )-132 C.49e 01 8.25e 01 3.79e O'I 3 83eKll 1.~0 9.71e 01 53 1 133 3.32~ 4.11et00 1.55e&0 7.63eo02 6.54eHS 0.00ef00 1 65~
f 134 2.35e Ol 4.36e 0'1 2.0le 01 1.00e401 6.68e 01 0.00eKO 2.89~1 1 135 9.82e-01 1.??eHS 8.3&e 01 1.5?ed@ 2.71e+00 0.00eKN 1.35eKS Cs-134 1.31e+02 2. 1 Set02 4.54+41 0.00e+00 6.68et0) 2.4lk+Of 1.1 6eKN 57 Cs-13& 1.32et01 3.&2e+Of 2.34eo01 0.00e+00 1 93e+0) 2 SSeKO 1.2?eKO 58 Cs.137 1.83e+02 ).7~2 2.59~1 0.00e+00 5.72e+01 2 06+4) 1 10eKS
'59 Cs-138 1.28e 01 1.78e 01 1.13e-01 0.00eKS 1.25e-01 1 35e 02 8.1~2 Ba 139 2 32e-01 1.24e 04 6 ?3e.03 0.00e+00 1 Oae 04 7.29e 05 1.3Ce+01 61 Be-140 4.66e+01 4.08e-02 2 720400 0.~0 1.33e 02 2A3e 02 2.36e40)
Ba 'l41 1.12e-01 6.28e 05 3.&5e 03 0.00et00 .5A4e'5 3.69e OC 6.4~2 Ba-142 4.90e-02 3.53e.05 2.74e 03 0.00e+00 2.86e-05 2.08e-05 &AOe 04 La.140 5.67e 03 1.98e-03 6.68e 04 0.00eKR 0.00et00 0.00et00 5.52@401 65 La.142 2.94e-OC 9 37e.05 2.93e-05 0.00ef00 0.00e+00 0.00e+00 '.8&e)01 Ce. 1C1 2.23e-02 1.11e-02 1.65e-03 0.00eKS 4.87e 03 0.00 F00 1.39et01 67 Ce-143 3.92e.03 2.13e+00 3.08e OC 0 00eKS 8.92~04 0.00et00 3 11e+01 Ce-144 1. 1?F00 3.6&e 01 &.23e.02 0.00e+00 2.03e Ol 0 00e+00 9.54et01 Pr 143 2.20e-d2 6.62e 03 1.09e.03 0.00e+00 3.SBe-03 0.00et00 2.38e+01 70 Pr 144 7.24e-05 2.24e-05 3.64e 06 0.00e+00 1.18e-05 0. 00et00 4 82~2 71 kd 147 1'.5?e.02 1.2?e-02 9.82e-OC 0.00e+00 6.96e-03 0.00eKS 2.01eKIT M-187 2.41e 01 1A2e.01 6AOe 02 0.00e+00 0.00e+00 0.00e+00 2.00etOf kp.239 2.95e.03 2.1 le-04 1.C9e 04 0.00e+00 6.11e-04 0.00e+M 1.5?e+01 5-2c(2)
Table 5-2d: Dose Factors for'Potable Mater pathway) Maxiatxa hypothetical infant (page 1 oF 2)
Dose Factors: Nreca-ft~/Ci sec Location: Danville Receiver per EROI. Table 5.2-23/VARTABLE 01IUYIOM Usage (Ua ) (kg/ :MAYER) a isot Bone Liver T. 8 Th id Ki Oi LLI M-3 O.ooe+Oo 1.12e Ol 1.12e-ol 1.12e 01 1.12e-ol 1.12~01 1.12e 01 C-14 8.6IM. 00 1.84eKIO 1.84e+00 1.84eHS 1.84eHS 1.84e+00 1 54e+00 Ma-24 3.6?F00 3.'67e+00 3.67e+00 3.6?eHS 3.67e+00 3.67e+00 3.6?eHS P-32 6.1?e+02 3.63etal 2.39e+01 O.aoeHS O.aoe+00 O.ooe<O 8.35eHN cr-51 0 Dao+00 0.00e+00 5.12e-03 3.3Ce 03 7 30e-04 6.50e-03 1 C9e-01 Mn-SC O.oae+00 7.22e+00 1.64eHS 0 IOet00 1 60eHS 2.65eHS 7 Mn 56 O.aaeHS 2 9?e 01 S.12e-02 O.aaeHN 2 55e 01 O.aoeKN 2.70')1 Fe 55 5.05e+00 3.26e+00 5.71~1 O.aoeHS O.aaeHS 1.59e400 C.TCe Of Fe 59 1.12~1 1.95 F01 7;7oeHS O.aoet00 0 aaeHS 5.7?eHN 9.33eKN 10 Co-Se 0 aoeHS 1.31eHS 3 26eNS O.aoeHS . 0 aoeHN O.aaeKN 3.26eH)a O.aoe+00 3.92eHN 9 26et00 0 Ooet00 a.aoeea 0 aaeHS 9 33eKS 12 Mi 63 2.30+42 1.42e+01 7.99eHS O.aaeHS O.aaeHN O.aaeHS 7.08e 01 13 Mi 6S 1.'?i &00 1 93e 01 8.75e 02 O.aaeHS O.aoeHS 0 Ooet00 1 4?eK)1 1C Cu-64 O.ooeHS 2.2le 01 1.02e-o I O.aaeHN 3.?4e 01 a.ooe+oa C.54 AS 15 Zn-65 6.68e+Oo 2.29~1 1 06e+01 0 00et00 1 11~1 'O.aoeHS 1 $ 5eKI1 16 Zn-69 3.39e 02 6.10e-02 O.aaeHS 2.53e 02 0 OoeH)a 4.9?eHN 17 Br 83 O.ooe+00 O.ooe+00 1.32~01 O.oae+00, t).aaeHN ~ O.aaeHN O.aoeKS Bri84 O.oae+00 O.aaeHN 1.39e.01 O.ooeHN O.aoeHS O.aaet00 O.aoeKS Br 85 O.aoe+00 O.aoeHS 7;04e-03 O.oaet00 0 OaeKS 0 Oae+00 O.aaeHS 20 Rb 86 O.aoeHS 6.17~1 3.05e401 0 aaeHS O.aaeHS O.aoeKN 1.See+00 21 Rb.ee O.aaeKO 1.8le-ol 9.91e-02 0 aoeHS O.aaeKS O.ooe+00 '1 76e 01 22 Rb 89 Sr-89 O.aaeKS
- 9. 1leKIZ 1.0Ce 01 o.aoe+oo 7.15e-02 2.61 F01 0.~
0 OaeHS 0 Oaeo00 O.oae+00 O.oaet00 0 00etOO 3.5Ce 02 1 57~1 24 Sr-90 6.72~3 O.oae+00 1.?1eH)3 O.aaeHS O.aaeHS O.aaet00 8D9eI01 25 Sr 91 1.82~1 O.Doe+00 6.5?e 01 0 Doe+00 O.aaeHS O.ooe+00 2.15eH)1 26 Sr 92 6.9?e+00 O.aaeHS 2.59e Oi O.aoeHS O.aoe+00 O.aoet00 ?.Sic<01 27 3.1Se 02 O.aoeKS 8.46 Oc 0 OoeHN O.aaeHS O.aae+00 4.~1 28 Y-91m 2.94e 04 O.aaeHS 1.00e-oS O.oae+00 0.00+%0 O.aoeHS 9.50e 01 29 Y-91 C.loe 01 O.oaet00 1 09e 02 O.aoeHN O.aoeKN O.aoeHS 2.94~'i 30 Y-92 2.7ee.03 O.oae+00 7.80e-aS O.aaeHIO O.aaeHS O.ooe+00 5.3~ I 31 Y-93 8.82e.03 0.0th+00 2.40e-aC O.aaeHS O.aoeHS a.aaeHS 6 97~1 32 Zr-95 ?.Cee-oZ 1.82e.02 1 29e-02 O.oae+00 1 96e 02 O.aae+00 9 OeeHS Zr-97 5.3?e-03 9.22e-a4 4.21e-OC O.aaeHS 9.29e OC O.oae+00 S.Me+01 34 Mb.95 1.52e-02 6.28e-03 3.63e.03 O.ooe+OO 4.5ae 03 O.ooe+00 5.30e+00 35 Ho-99 0 00etOO 1.23+41 2.C1e+00 0. Oae+00 1 84e+01 O.aae+00 C 0?e+aa 5-Zd(l)
Bypothctical Infant (Page 2 of 2) 1 I'able 5 2d: Dose Factors for potable Mater Pathways Haxieasa Dose Factors: grefa-f t ICi.sec Location: Oanvil lc RcceivcriVARINLK OILVTIOR ~
Isot Liver T. B Th id CI LLI 36 Tc-9%a 6.9?c.04 1A4e-03 1.85c-OZ 0.00cKN 1.55e 02 7.5'I e-04 4.5?e 01 Tc 101 8.2Cc.N 1.04e 03 1.03e-02 0.00e+00 1.23e 02 5.66e 04 1.76e O'I Ru-103 537c-05 O.QOeHN 1 80e-01 0.00c+00 1.52eHS 0.00eHO 6.53eHS RU-105 4.94e-OZ 0.00eHO 1.66e-02 0 OOeHN 3.63~I 0.00cHS 5.%5eo05 Ru 106 8.75eHN 0.00eHS 1.09eHS O.OOeHS 5.03e405 0.00c+00 6.64HOI Ag-51ha 3.62e 05 2.64e-OI 1.?Se-05 0.00eHN 3.78e 01 0.00e+00 'l F05 42 Te-IZSn 8.46eHN 2.83eHS 1.54eHS 2.85eHS 0.00cHS 0.00eHS C.03eHS Te 52?o 2.52e+05 7.04eHN 2.5?e+00 6.53eHS 5.23&05 0.00eHS 8.5?eHS Te.127 3.63e O'I 1 22e 01 7 80e-02 2.95~5 8.~5 0.00eHS 7.62cHS 45 Te~529o 3.63e+01 1.25+%5 5.59eHN 5.39~5 9 05et05 0.00eHS 2.5?e&5 46 47 Te-'529 Te-535n 1.03e 01 5.52eHS 3.55e-02 2.22eHN ZA5~
1.83eHS 8.~
C.SOeHS 2 57~5 5.53') 5 0 00e+00 0.00eHN 3.7~5
'.24eHS C8 49 Te-131 Te.'l32 6.39e-02 7.S5e+00 2.36e 02 3.74eHN 5.~ S.~
3.49eHN 5.52eKN 1.63e 0'I 2~+105 0 00eHN 0.00eHS 2 58eHN 1 3Set05 50 I. 130 2.18e+00 4.79e+00 1.92 F00 5.3?eHIZ 5.26eHN ~ 0 00eHN 1.03eHN 51 1-13'I 1.30+%5 1.54et05 6.75e+00 5.05eH8 5.79~5 0 OOeHN 5.~5 52 1-532 6.03e 05 1.22eHS 4.36 05 5.74~5 1.36eHN 0.00eKN 9.91~5 I-133 4.54et00 6.65eHS 1.93et00 1.20eH8 7.7?eKN 0.00eHS 1 12eHO-1-134 3.15c 01 -
6Abe Ol 2&~5 1.51+41 '7~5 0 00e400 6.~I 55 I 135 5.32eHN 2.63c+00 9 5~5 2DheKR 2.93eKO 0.00e+00 ~ 9.55~5 56 Cs-534 5.3?eK)2 2.SSe+02 2 58ee05 0.00eHS 6.5?eeOI 2.6~5 6.93~1 Cs 136 1,6?F01 C.90et05 1.83eKII 0.00eHN 1 95et05 3.99eHN 7 ~5
. 59 Cs-137 Cs-138 1.89e+02 1.?Se-01 2.22eKIZ 1 1~5 5?eHIT 0.~
0 OOeHS S.95 AN 5A2~5 2 Ale<05 2.21e 02 6.~5 4 ~5 Ba-139 3.20e-01 9 2bc 03 0 00eHO 1 2?e OC 1.29e OC 2.03e405 61 Ba 1CO 6.2'I e+05 6.21e-02 3.20eHO OiOOeHN 1A?e 02 3.81e 02 1 52eKI5 6.35~
'2 Ba.141 1 5Ce 01 1.06e OC 4.86e-03 O.QOeHS 6A3e 05 1 88eHS Ba 1CZ 6.68e-02 5.55e-05 3.29e-03 0 00eHS 3.~5 3.36e 05 2-7~5 La-1CO 7.66e 03 7.77e-04 0.00eHS 0.00et00 0.00e+00 3.S Seal 65 La.542 3.99e 04 5.4?e-04 3.51e-OS 0.00eHS 0.00eHN 0.00eHN 2A9e&5
'Cc 1C1 2.86e-OZ 5.74e-OZ 2.05c 03 0.00ekN 5.3?e 03 0 00eHN 9 00efOO ~
67 Ce.143 5.37e.03 3.56c+00 4.07e-04 0.00eHS 1.04c-03 0.00eHN 05eHl5 Ce 14C 5.08eHO C.43e-05 6.06 02 0.00eKO 1.79e-01 0 QOeHS 6 25e405 Pr 143 2.95e-02 1.10c-OZ 5A6c 03 0.00eHS 4.40e-03 0 00eHN 1 56e405 70 Pr-144 9.95e-05 3.85e 05 5.0le-06 0.00eHN 1.39e-05 . 0.00eHN 1 79eHS 71 Nd 547 2.01e-02 2.06e 02 1.26e-03 0.00eHN 7.95e 03 0.00et00 1 35e405 V 187 3.28c.01 2.28c 01 7.88c-02 0.00eKN 0.00+K)0 0.00eHN 1 34et05 Mp-239 4.03e.03 3.60e-04 2.0Ce-OC 0.00eHS 7.'59e 04 0.00eHN 1 ~5 5-2d(2)
NNLR
~~mEIE!mmS El&EM~
~ESmmRESIER~
~
NR~ ~mERHNRREEm~
~ASM
~RK5% ~EIMNRSRSS~
~mm
~EIRM ~ISHNRRRIRR
~ EIBIR~
~EE~
~KK~ mREmR
~mEEmmRESIRE~
~KK~ mRERER~
I ~ ~
~ SEm~
~ ~
~ERR~ mSESIH~
~m~
KREEZR
~EE~ ~mSRHmSRSER~
~WREH~m~
~ ~
~1~
HRRSE RKRR
~~55%~55~~
mEIEI&~ES~~
~REIEIR M SIMWXM
~ . 5
~RR~ ME%55~~
M!%SR~~ ~KEIIER~mW~
HRERW~
mRESEW~ ~MRSSR~ESSR~
EmlR~
~ ~
~BRIM~
%SEND~
mR5 MMM RR~~
ES~
~55~
~ ~mEERRmSEm!R~
~~SERNRERIIR~
~KH~KERH
~~HSWMKRR~
~~KEH~ERZK SKI~~~~RHM~RHKH
~~EH&~EHE~
REERERBRR ~~BRIC~
mRR~ ~RRW~Km%
5 ~
mRSE~~
mRmIRE~ ~~RW~RRZH ~ . ~
mRER~~
ASSR&~
URER 5M~EREW
~ESE~
mREISI~~
mREISRS~ ~mER
~%iERK~ER~
~RRSR~
~RR~ ~~RRW ~ERSR
Table 5-4 (Page I of 2)
Dilution Factors and Transit Times for SSES Effluents to Danville, Pa RIVER DEPTH RIVER DEPTH RIVER LEADING MEAS. AT ENV. LAB MEAS. AT MCR DISCHARGE EDGE DILUTION (FEET) ( INCHES) (CFS) (HOURS FACTOR 1.5 144 500 68.7 136.4
'1.6 145 530 67.8 140.1 1.8 148 600 66.3 147.3 150 670 64.8 155.5 2.2 152 730 63.3 164.5 2.4 155 780 61.8 173.9 2.5* 156* 825* 61.1* 179.1*
2.6 157 870 60.3 184.5 2.8 160 930 58.8 195.7 162 1000 57.2 208-3 3.2 164 1200 52.7 250.6 3.4 167 1400 48.2 291.5 3 5* 168* 1500* 45-9* 280.9*
3.6 169 1600 43.5 271.0 3.8 172 1800 39.0 250.6 174" 2000 35.5 250.6 4.2 176 2280 35.2 254.5 4.4 179 2560 34.7 259.1 5* 180* 2730* 34.5* 261.4*
4.6 181 2900 34.2 263.9 4.8 184 3300 33.7 270.3 186 3700 33.0 277.8 5.2 188 4140 32.3 284.1 5.4 191 4580 31.7 292.4 5 5* 192* 4820* 31.4* '297.2*
5.6 193 5060 31.0 302.1 5.8 196 5580 30.2 312.5 198 6100 29.5 323.6 6.2 200 6780 28.5 339.0 6.4 203 7460 27.5 35'4. 6 6.5* 204* 7890* 26.9* 366.3*
6.6 205 8320 26.2 378.8
- Interpolated value
Table 5-4 (Page 2 of 2)
Oilution Factors and Transit Times for SSES Effluents to Oanville, Pa RIVER OEPTH RIVER OEPTH RIVER LEAOING NEAS. AT ENV. LAB HEAS. AT HCR 0 ISCHARGE EOGE OILUTION (FEET) (INCHES) (CFS) HOURS) FACTOR 6.8 208 9360 24.7 413.2 210 10400 23. 0 456.6 7.5 216 12500 20.0 588.2 222 14900 16.5 869.6 8.5 228 17500 15.3 980.4 234 20700 14.7 1071.8 9.5 240 24000 14.2 1173.7 10 246 27000 13.5 1285.3 10.5 252 30100 13.0 1373. 6 258 34570 12.2 1567.4 11.5 264 38730 11.3 1795.3 12 270 42530 10.7" 2057.6 12.5 276 46490 10. 2398.1 0'0.0 13 282 50630 2597.4 13.5 288 54940. 10.0 2832.9 294 59430 9.8 3067.5 14.5 300 64090 9.8 3311.3 15 306 68930 9.8 3558.7 15.5* 312* 74030* 9.8' 3802.3' 16 318 79130 9.8 4081.6 16.5* 324* 84580* 9 8* 4347.8*
17 330 90030 9.7 4651.'2 17.5* 336* 95830* 9.7* 4926.1*
18 342 101630 9.7 5235.6 18.5* 348* 107780* 9 7* 5540.2*
19 354 '13930 9.7 5882.4 19.5* 360* 120430* 9.6* 6192.0*
20 366 126930 9.5 6535.9 372* 133780* 9 5* 6872.9*
21 378 140630 .9.5 7246.4 21.5* 384* 147830* 9.4* 7604.6*
22 390 155030 9.3 8000.0
- Interpolated value 5-4(2) r z%r DAT /d~~ G
Table 5-S: Dose Factors for Shore Exposure" pathway, All Age Groups (Page I of 2)
Dose Factor Units: mrem-ft /Ci-sec Location: Edge of Initia1.Hixing Zone/FIXED DILUTION Oiiution (1/K ISKORE) -" 15.9 Transit time (ts) hrs -"
Sediment dc . tine (tb) hrs = 13'1400 ADUl.T TEER CH11.0 Usage 12 14 (Ua )(hr/ r) =
Isoto T; Body Skin T. B Skin skin H-3 O.ooe+00 O.ooe+00 0 00c400 O.ooe+00 O.ooe+00 O.ooe+00 C-14 0.00~ 0.00~00 O.OOe OO O.OOe OO O.ooe+00 O.ooe+00 Ha-24 2.CBe-oC 2.87e-04 1.38e-03 1.60e-03 2.89e-04 3.35c.04 4 P-32 O.ooe+00 ,O.ooe+00 0.00ccOO '.OOe OO O.ooe+00 O.ooe+00 Cr-51 1.01e.OC 'I.19e-04 5.64e.04 6.67e-oC l.tee-04 1.39c.04 Hn-54 3.01e-02 3.53c-02 1.68e-ol 1.9?e-ol 3.51e-02 4.12c-02 i(n-56 1.50e-os 1.?Te-05 8.37e-os 9.90e-os 1.75e-os 2.0?e 05 Fe 55 O.ooe+00 0.00~0 0 00+8)0 O.ooe+00 O.ooe+00 O.ooe+00 Fe 59 5.92e-03 6.96e-03 3.31e-02 3.89e.02 6.91c:-03 8.12e-03 10 co-se 8.23e-03 9.64e-03 4.59e-02 5.38e-02 9.60e.03 1.12e.02 Co-60 4.68e-ol 5 Soe-01 2.61e+00 3.0?ecoo 5ASe.ol 6.42e-ol Ni 63 O.ooe+00 0 Ooc+00 0.00e+00 O.ooecoo O.ooze)0 O.ooe+00 13 Mi-65 C.90e.06 5 69e-0& 2.74e-oS '3. 18e-05 5.?2e~06 6.64e-06 14 Cu-64 1.25e-os 1Ale-05 6.9?e 05 7.90e 05 1.46e-os 1.65e 05 15 2n-65 1.62e-02 1.87e-02 9.06e 02 1.0Ce-01 1.89e.02 2.18e.02 16 Zn-69 0 00e+00 O. Ooe+00 O.ooe+00 O.ooe+00 O.ooecoo O.ooc+00 17 Br-83 7.92e-oe 1.15e-o? 4.42e.07 6A2e-0? 9.2Ce-08 1.34e.oT Br-84 1.20e-06 1.39e-06 6.67e-06 7.79e-06 1.39e-06 1 63e-06 19 Br-85 O.ooe+00 O.ooe+00 O.ooecOO O.ooe+00 O.oocIOO O.OOe+OO 20 Rb-86 1.95e-04 2.23e.04 1.09e~03 1.24e-03 2.2?c-OC 2.60e.04 21 Rb 88 6.99c-oe 7.99e-oe 3.90e-o? 4.C6e.07 8.16e-oe 9.32e.oe 22 Rb 89 1.82e-o? Z. lee-0? 1.02e.06 1.22e-06 2.12e-o? 2.55c-07 Sr-89 4.70e.o? S.CSe-07 2.62e-06 3.04e-o& S.CBe-o? 63&e-07 24 Sr-91 C.34e-os 5.07e-os 2.C2e-04 2.83c-04 S.O&e-oS 5.92e.os 25 Sr-92 1.31c-os 1.C5e.os 7: 9e.os 8.1'ie.oS 1.52e-05 1.69e.os 26 Y-90 9.65e.08 1.14e-o? 5 39e-07 6.37e-o? 1.13e-o? 1.33e 07 27 Y.91m 9.C7e-o? 1.10e-06 5.29e.06 6.12e-06 1 1oe 06 1.2ee-o&
Y 91 2.33e-os 2.62e-os 1.30e-04 1A6e-04 2.?2e-os 3.06e.os 29 Y 92 3.22e.o& 3.83e.06 '1.80e-os 2.1Ce-os 3.76c-06 C.46e 06 30 Y.93 3.?2e-o& 5.09e-06 2.08e-os 2.84e-os 4.34e-06 5.9Ce 06 31 Zr-95 5.31e-03 6.16e.03 2 9?e-02 3.C4e-02 6.20e-03 7.19e-03 32 ZI -97 6.1Te-os 7.18e 05 3.CSe-oC 4.01e-04 7.20e-os 8.38e 05 33 Nb-95 2.9?e-03 3.49e-03 1.66e 02 1.95e-02 3.C6e-03 4.0?c-03 34 Ho-99 8.59e-05 9 94e.os 4.79e-04 S.sse-OC 1.00e'04 1.16e-04
Table 5-5: Dose Factors for Shore Exposure pathway, All Age Groups (Page 2 of 2)
Dose Factor Units: mrem-ft /Ci-sec Location: Edge of Initial Mixing Zone/FIXED DILUTION ADULT TEEN CHILD lsoto T. Body Skin l. Body Skin T. Body Skin 35 Tc-99m 3.56e-06 4.08e-06 1.99c.os Z.ZSe-OS C.16c.06 4.76e.06 36 Tc-101 2.38e-08 2.65e.08 1.33e-o? 1.48e-o? 2.78e.08 3.09c-08 37 RQ-103 2.35e-03 2.74e-03 1.3te.02 1.53e.02 2.74e.03 3.20e-03 38 Ru-105 1.1Se-os 1.3Ce-os 6.60e-os 7.48e.os 1.3Se-oS 1.56e-os 39 Ru-106 9.t7e-03 1.10e-02 5. 12e-02 '.14e-oz 1.07e-OZ 1.28c-02 40 Ag-ttom 7.47e-oz 8.?te-OZ 4.17e.ol 4.86e.ol 8.?le-02 1.02e Ol 41 Te-125m 3.3?c.os 4.62e 05 1.88e-04 2 58e-04 3.93e-05 5.39e-os 42 Tc-127m 1.99e-06 2.35e-06 '1.11c-os 1.31e-os 2.32e-06 2.74e.06 43 Tc.'l27 6.01c-08 6.61e-08 3.35e-o? 3.69e.o? 7.01e.08 7.?le-08 44 Te-129m 4.29e-04 5.02e-04 2.40e-03 2.80c-03 S.ole.04 5.85e.04 45 Te-129 3.14e-o? 3.7Ze-o? 1.76e-06 2.0Se.06 3.67e.o? 4.3Ce.o?
Te-131m 1.70e-04 2.0le-oC 9 51e-04 1.12e-03 1.99e.04 2.34e-04 47 Te-131 1.21e 07 1.43e-04 6.74e-o? 7 97e-04 1.4le 07 1 6?e 04 48 Te-132 9 '12e-05 1.07e-04 5.09e-04 5 99c-OC 1.06c.04 1.25e-04 49 1 130 1.13e-OC 1.3?e.04 6 32e 04 7.67e-04 1.3ze-04 1.60c-04 50 1-131 3.72e-04 4.52e-04 ' 2.08e-03 2.53e.03 4.35e.04 5.2Sc-o4 51 1-132 2.00e-05 35e-05 1 12e-04 1.31e-04 2.33e.os 4.?se.os 52 1-133 5.'lse-05 6.26e-os 2.88e 04 3.50e-04 6.01e.05 7.3'le-05 53 1.134 4.42e-06 5.25e-06 2.47e-05 2.93e.os 5.15e.06 6.12e-06
. 6.?3e-os 54 1-135 4.9Ce 05 5.76e-os 2.?6e-04 3.22e-oC 5.?6e.05 55 Cs-13C 1 A9c-01 1.74e-ol 8.32e-O1 9.70e.ol 1.74e.ol 2;03e-01 56 Cs-'136 3.2?e.03 3.?tc.03 1.83e 02 2.0?e-02 3.82e-03 4.32e.o3 57 Cs-137 2.2Ce.ol 2.6le 01 t.zse+00 1.46~0 2.6le 01 3.05e.o'1 SS Cs-t38 2.15e.06 2.C6e.06 1.20e 05 1.3?e.os 2 51e-06 2.8?e.06 59 Ba-139 1.Coe-06 1.57e-06 ?.Slc-06 8.?8e-06 1.63c.06 1.84e-06 60 Ba-140 4A5e.04 5.08e-04, 2ASe-03 2.84e-03 5.19e-o4 5.93e.04 61 Ba-141 9.36e-OS 1.07e-07 5.23e-07 5.96e-07 1.09e-07 1.2Ce-07 62 Bo 142 2.02e.08 2.30e-08 1.13e-o? 1.28e 07 2.36e.oS 2.68c 08 63 La 140 4.10e-oC 4.65e-04 2.29e-03 2.60e.03 4.79e-oC 5.42e-04 La-142 1.0?e-oS 1.28c-os 5.97c 05 7.17e-oS 1.25e.os 1.50e-os 65 Ce. 1C1 2.97e.04 3.34e-04 1.66e 03 1.87e-03 3.46e.oC 3.90e-04 Ce.143 '.92+05 5.59e.os 2.?sc-04 3.12e.oC 5.74e.os 6.52e-os 67 Ce.144 1.51e.03 1.?se-03 8A3e.03 9.75e-03 'l.76e.03 2.04e.03 Pr-143 O.ooc+00 O.Boa+00 o~ooe+00 0 00e+00 O.ooe+00 O.ooe+00 69 Pr-144 3.62e.09. 4.16e-09 2.02e.08 2.32e-oS C.22e.09 4.85e-09 70 Nd 147 1.82e 04 2.1Se.04 1.02e.03 1.22e-03 2.tze.oC 2.55e.04
?1 M-187 4.96e-os 5.76e-os 2.7?c-oC 3.22e-04 5.?9e-os 6.73e-os Hp-239 3.67e 05 C.25e-os 2.05e-04 2.37e.04 4.28e 05 4.96e-oS 5-5(2)
- r DATE
Table 5-6a: Composite Dose Factors: Maximum Hypothetical Adult (Page 1 of 2)
Dose Factor Units: mrem/Ci Released Location: Danville (Water Ing.)/Outfall (Fish and Shoreline)/FIXED DILUTION e Ucago (Uep) (kg/yr:FISH)
Ucega (Uap) (hr/yrtSHORE) cc cc 21 12 Ucege (Uap) (kg/yrtWATER) o Dilution (1/Mp:SHORE) cc 730 15.9 Dilution (1/Mp:FISHl u- 15.9 Dilution (1/Mp:WATER) o 321 Trencit timo (tf) hra ~ 25 Trencit tune (tw) hrc cc 25.8 Trancit time (tp) hrc = Trancit time (tb) hrc uc 131400 Isotope Bone Liver T. Body Thyroid Kidnoy Lung GI.LLI Skin K3 0.00o+ 00 3.59e 05 3.59c>>05 3.59c>>05 3.59c>>05 3.59e.05 3.59c>>05 0.00a+ OO C-14 1.70e+00 3.41c>>01 3.41 c>>01 3.41o01 3.41c>>01 3.41c>>01 3Alc>>Ol 0.00 a+ OO No 24 7.09c>>03 7.09c>>03 7.12c>>03 7.09c>>03 7.09c>>03 7.09c>>03 7.09c>>03 .2.58c>>OS P-32 7.18e+01 4.46e+M 2.77o+00 0.00e+00 0.00o+00 0 Ogo+00 8.07o+00 0.00a+OO Cr-51 0.00 a+00 0.00 a+00 7.72c>>05 4.07c>>05 1.50c>>05 9.04c>>05 1.71c>>02 '.07c>>05 Mn.54 0.00o+ 00 2.39c>>01 4.82c>>02 0.00e+ 00 7.10c>>02 0.00e+00 7.31c>>01 3.17c>>03 Mn.56 0.00e+00 7.25c>>06 2.63c>>06 0.00e+ 00 9.21c>>06 0.00e+00 2>1 c>>04 1.59c>>06 Fc>>55 3.64c>>02 2.52c>>02. 5.87c>>03 0.00e+00 0.00e+00 1.40c>>02 1.44c>>02 0.00 a+ DO 5.66c>>02 1.33c>>01 5.15c>>02, 0.00e+00 0.00o+00 3.72c>>02 , 4.43c>>01 6.24c>>OC 10 Co 58 0.00o+ 00 4.97o03 1.19c>>02 .0.00o+00 0.00a+00 0,00a+00 1.01c>>01 8.64c>>04 Co 60 0.Doe+00 1.44c>>02 7.37oO2 0.00e+00 0.00e+00 0.00 a+00 2.71c>>01 4.83c>>02 12 1.72e+00 1.19c>>01 5.78c>>02 0.00e+00 0.00o+00 0.00o+00 2.49c>>02 0.Doe+ 00 Ni-65 7.20c>>06 9.35c>>07 8.66~7 0.00e+00 0.00o+00 0.00e+00 2.37c>>05 S.l 1 c>>07 14 C 64 0.00e+ 00 1.43c>>O4 6.84c>>05 0.00e+ 00 3.61c>>04 0.00e+00 1.22c>>02 1.27c>>06 15 2n.65 1.26 a+ 00 4.00e+00 1.81 a+00 0.00e+00 2.68e+00 0.00 a+00 2.52o+00 1.67c>>03 16 2.11 c>>1 1 4.03c>>11 2.80o-l 2 0.00e+00 2.62o.l 1 0.00 a+00 '.06a-12 0.00e+00 17 Br.83 0.00o+ 00 0.00e+ 00 1.57c>>06 0.00e+00 0.00o+00 0.00e+00 2.26c>>06 1.03c>>08 18 Br.84 0.00e+ 00 0.00e+00 1.07c>>07 0.00e+00 0.00e+ 00 0.00a+00 1.51 a-22 ~
1.25c>>07 19 Br.85 0.00e+ 00 0.00a+00 0.00 a+00 0.00e+00 0.00o+00 0.00a+00 0.00e+00 0.00o+00 20 0.00e+00 5.29a+00 2.47e+00 0.00e+00 0.00o+00 0.00a+00 1.04e+00 2.00c>>OS 21 Rb-88 0.00e+ 00 0.00e+00 6.27c>>09 0.00e+00 0.00a+00 0.00a+00 0.00o+00 7.17c>>09 22 0.00o+00 0.00e+00 1.63c>>08 0.00a+00 0.00o+00 0.00a+M 0.00e+00 1.96c>>OB 23 Sr-89 1.25e+ 00 0.00e+00 3.60c>>02 0.00e+00 0.00e+00 0.00e+00 2.01o-ol 4.89c>>08 24 Sr-90 3.13e+01 0.00o+00 7.69 a+00 0.00e+00 0.00e+00 0.00e+00 9.05c>>01 0.00a+00 25 Sc.91 3.77c>>03 0.00e+00 'l.56c>>04 0.00e+00 0.00e+ 00 0.00e+00 1.80c>>02 4.55c>>06 Sr-92 A7c>>OS 0.00e+00 1.81c>>06 0.00e+00 0.00o+00 0.00e+00 2.91o04 1.30c>>OB 27 '90 1 2.55c>>05 . 0.00e+00 6.94c>>07 0.00e+00 0.00e+ 00 0.00e+M 2.71c>>01 1.02c>>08 26 Y-91m 2.64e-16 0.00e+00 8.49c>>OB 0.00e+00 0.00o+00 0.00e+00 7.74c>>16 8.83c>>OB 29 Y 91 4.85c>>04 0.00e+00 1.51c>>05 0.00e+00 0.00e+ 00 0.00e+00 2.67c>>01 245c>>06 30 Y-92 2.18~8 0.00o+00 2~~7 0.00a+00 0.00o+00 0.00a+00 3.82c>>04 3.43c>>47 31 Y93 1.67c>>06 0.00e+00 3.80c>>07 0.00e+00 0.00 a+ 00 ~ 0.00 a+ 00 5.30c>>02 4.56c>>O7 32 2r 95 1.97c>>05 6.31'>>06 4.81c>>04 0.00o+00 9.90c>>06 0.00e+ 00 2.00c>>02 5.53c>>OC 33 2r-97 3.90c>>07 7.87oOB 5.57c>>06 0.00e+00 1.19c>>07 0.00e+ 00 2.44c>>02 6.44c>>06 Nb.95 2.38c>>02 1.33c>>02 7.39c>>03 0.00 a+00 1.31e.02 0.00o+ 00 8.04 a+01 3.13c>>OC 5-6a(1)
Table 5-6a: Composite Dose Factors: Maximum Hypothetical Adult (Page 2 of 2)
Dose Factor Units: mrem/Ci Released Location: Oanville (Water Ing'.)/Outfall- (Fish 8 Shorel inc)/FIXED DILUTION tsoto Liver T. B Th roid Lung 01 LLl Skin 35 No-99 0.00e+00 5.06c-03 9.70e-04 0.00e+00 1.15e 02 0.00e+00 1.17e.02 8.92e-06 Tc-9%a 3.00e-08 B.C7e 08 1.40e-06 0.00e+00 1.29e.06 4.15c-08 5.01 e.05 3.66e-07 37 Tc-101 0.00e+00 0.00e+00 2.14c-09 0.00e+00 0.00c+00 0.00c+00 0.00e400 2.3?e-09 Ru-103 . 2.77e-04 0.00e+00 3.30c.OC 0.00e+QO 1.06e.03 0.00e+00 3.24e.02 Z.46e-04 39 Ru-105 4.6?e-07 0.00e+00 1.24e-06 0.00wM 6.03e.06 0.00c+00 2.85e.04 1 20e-06 40 Ru-106 4.19e.03 0.00e+00 1.35e-03 0.00e+00 "
8.09e-03 0.00c+00 2.71e.01 9.8?e-04 41 Ag-110m 8.36e.05 7.73e 05 6.74e-03 0.00c+00 1.52e OC 0.00e+00 3.16e-02 ?.Ste-03 42 Tc-'125m 1.39e-ol 5.02e-02 1.86e-02 4.17e-02 5.63e-01 0.00e+00 5.53e.01 4.1Ce-06 43 Te- t 2?m 3.52e-01 1.26e-01 4.29e-02 9.00e OZ 1.C3e+00 0.00e+00 1.18&00 2.11e-07 44 Te-127 9.02e-OC 3.2Ce-04 1 95e-04 6.68e-04 3.67e-03 0.00c+00 ?.12e-02 5.93e-09 45 Te-129m 5.89e-01 2.20c 01 9.33c-02 2.02e-01 2.46e+00 0.00e+00 2.9?e+00 4.50e~
46 Te-129 1.6le 03 6.05e.04 4.2?e-04 t.23c.03 6.76e.03 0.00e+00 1.21e-03 4.20e-05 47 Te-131m 5.08e-02 2.49e-02 2.07e-02 3.94e.02 2.52c-01 0.00+40 2 47&00 1.80e-05 48 Tc-131 9.69e-22 4.05e.22 1.08e-OS 7.9?e-22 C.24e.21 0.00e+00 1.3?e.22 1.28e-05 49 Te-132 1.06e-01 6.84e.02 6 42e-02 7.55e.02 6.58e.01 0.00e+OO 3.23+40 9.62e-06 50 l-130 4.04e-04 1.19e.03 4.80e-04 1 Olc-Ol 1.86e 03 0.00e+00 1.02e.03 1.23e.05 51 t -131 8.28e-03 1.18e 02 6.82e-03 3.88e+00 2.03e-02 0.00@<00 3.13e-03 4.06e-05 52 l-132 2.31e-07 6.18e.07 2.01e-06 2.16e 05 9.85e.07 0.00e+M 1.16e.07 2.tlc-06 53 1-133 1.34e-03 2.33e.03 7.16e 04 3.43c-ol C.07e-03 '.00e+00 2.10e-03 5.62e-06 '
54 i 134 5.95e-l3 1.62e-12 3.96c-07 2.80e 11 2.5?e-12 0.00e+00 1.41e.15 70e 07 55 1-135 6.96e-05 1.82e-04 7.1?e.05 1.20e-02 2.92e-04 0.00c+00 2.06e.04 5.1?e-06 56 Cs-134 1.62e+Oi 3.86') 1 3.15et01 0.00&00 1.25 e+01 4.14e+00 6.75e.01 1 56e 02 57 cs-136 1. 6'i e+00 6.35e+00 C.57e+00 0.00e+00 3.53etM 4.8Ce-01 ?.21e 01 3.32e-04 Cs-137 2. 08e+0'i 2.84e+01 1.86e+01 0.00e+00 9.65e+00 3.21e+00 5.50e-01 2.34e 02 59 Cs-138 1.46e-16 2.87e-16 1.93e-07 0.00e+00 2.11e-16 2.09e-l? 1.23e-21 2.21e-07 60 Ba.139 2.46e-10 1.75e.13 1.25e-07 0.00e+00 1.64e-13 9.94e-tC C.36e.10 1.41e-07 61 Ba.140 1.43e-02 1.80e-05 9.77c-04 0.00e+00 6.11e.06 1.03e-05 2.9Ce-02 4.56e-05 62 Ba-1C1 0.00e+00 0.00e+00 839e.09 0.00e+00 0.00e+00 0.00 a+00 0.00e+00 9.5?e-09 Ba.142 0.00e+00 0.00~0 1.81e-09 0.00e+00 0.00e+00 0.00e+00 0.00e+00 2.06e La-140 5.65e-06 Z.SSe-06 3.75c-05 0.00e+00 0.00c+00 0 00e+00 2.09e-01 09'.17e-05 65 La-142 8.26e-12 3.76e.12 9.60e-07 0.00e+00 0.00e+00 0.00e+00 2.74e-08 1.15e 06 Ce-141 3.25e-06 2.19e.06 2.68e-05 0.00e+00 1.02e-06 O.BOMOS 8.39e-03 3 00e~
67 Ce-143 3.42e-07 2.53e-04 C.44c-06 0.00e+00 1 tie-07 0.00e+00 9.46e-03 5.01e-06 Ce-144 1.73e-04 7.22e.05 1.45e-04 0.00e+00 4.2Se-05 0.00e+00 5.84e.02 1.5?e-04 69 Pr-143 3.04e-05 1.22e.05 1.51e-06 0.00e+00 7.03c.06 0.00e+00 1;33e.01 0.00e+00 70 Pr-1CC 0.00e+00 0.00e+00 3.24e-10 0.00e+00 0.00e+00 0.00e+00 0.00e+00 3.73c-10 71 Md-tC7 2.05e-05 2.3?e'05 1.7?c.05 0.00e+00 1.39c.05 0.00e+00 1.14e.01 1.96e-05 1t-187 7.79e-03 6.52e.03 2.28c.03 0.00e+00 0.00e+00 0.00e+00 2.13e+00 5.17e-06 Rp-239 1.3Ce-06 1.31e 07 3.36e.06 0. 00e+00 4.10e.07 0.00e+00 2.69e.02 3.Sle-06 5-6a(2)
DAYc.
t Table 5-6b: Composite Dose Factors: Maximum Hypothetical Teen (Page I of 2)
Dose Factor Units: mrem/Ci Released Location: Danville (Water Ing.)/Outfall (Fish and Shoreline)/FIXED DILUTION Ucage lUsp) lkg/yr:FISH) o 16 Ucsgo lUsp) lkg/yrtWATEA) s: 510 Usage lUsp) lhr/yr:SHORE) sr 67 Dilution {1/IVlp:SHORE) sr 15.9 Dilution ll/Mp:FISH) e 15.9 Dilution lt/Mp:WATER) ~ 321 Trsncit time ltl) hrc ss 25 Trsncit time ltw) hrc n 25.8 Transit time ltp) hrc ~ Transit time ltb) hrc ss 131400 lcotope Bone T. Body Thyroid Kidney Lung GI.LU H-3 0.00 a+00 2.61o45 2.61e-05 2.61o45 2.61e45 2.61o45 2.61o45 0.00e+00 C-14 1.85e+00 3.7)e-01 3.71o41 3.71o41 3.71e41 3.71e41 3.71o41 0.00e+00 3 No.24 7.30o43 7.30o43 7.43o43 7.30o43 7>0e43 7.30o43 7.30o43 1.44o44 P-32 7.82e+ 01 4.84o+00 3.03o+00 0.00e+00 0.00o+00 0.00e+00 6.57e+00 0.00a+00 C(-51 0.00e+00 0.00o+00 1.21o44 3.90o45 1.54e45 1.00e44 1.18o42 5;98o45 Mn-54 0.00o+00 2.35e41 6.16o42 0.00e+ 00 7.00e42 0.00a+ 00 4.81o41 1.77o42 7 Mn-56 0.00 a+00 7.59o46 8.86o46 0.00a+ 00 9.61e46 0.00a+00 5.00o44 '8.88o46 8 Fe-55 3.81o42 2.70e42 6.300 03 0.00 a+00 0.00a+00 1.71 e42 1.17o42 0.00 a+00 9 Fe-59 5.82e42 1.36e41 5.55o42 0.00o+00 ~ 0.00e+00 '.29e42 3.21e41 3.4Se43 10 Co-58 0.00o+00 4.93o43 1.55e42 0.00o+ 00 0.00e+00 0.00e+00 6.79o42 4.82o43 11 Co.60 0.00e+00 1.44e42 2.67e41 0.00e+00 0.00e+00 0.00a+00 1.87o41 2.75o41 12 Ni-63 1.78o+00 1.26e41 6.05o42 0.00e+00 ~ 0.00a+00 0.00e+00 '2.01o42 0.00 a+00 .
13 Ni-65 7.77e46 9.93o47 2.91e48 0.00e+ 00 0.00o+00 0.00a+00 5.38o45 2.85e46 14 Cu 64 0.00 a+00 1.50e44 7.6Se45 0.00o+ 00 3.80e44 0.00e+00 1.17o42 7.08e46 15 'n-'65 l.'l4o+00 3.96a+00 1.86o+00 0.00e+00 2.54e+00 0.00e+00 1.68e+00 9.35o43 16 Zn-69 2.2Se-t 1 4.37o-l 1 3.060-12 0.00e+ 00 2.85e-l 1 0.00e+00 8.05e-l 1 0.00e+00 17 Br-83 0.00e+00 0.00o+00 1.74o46 0.00e+00 0.00e+00 0.00e+00 0.00 a+00 S.76o48 18 Br-84 0.00e+00 0.00o+00 5.99o47 1).00e+00 0.00e+00 0.00e+00 0.00e+00 6.98o47 19 Br-85 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 OA)Os+00 0.00o+00 20 Rb-86 0.00 a+00 5.70e+00 2.68o+ 00 0.00e+ 00 0.00e+00 0.00a+00 8.43e41 l.t 2o44 21 Rb.89 0.00o+00 0.00o+00 3.50o48 0.00e+00 0.00a+00 0.00a+00 0.00o+00 4.00o48 22 Rb.89 0.00o+00 0.00e+00 8.1 1 o48 0.00e+ 00 0.00 a+00 0.00e+00 0.00a+00 1.09o47 23 Sr-89 1.36o+00 0.00e+00 3.89o42 0.00e+ 00 0.00o+00 0.00e+00 1.62e4t 2.73e47 24 Sr-90 2.60e+01 0.00e+00 6.43o+00 0.00a+00 0.00a+00 0.00e+00 7.30e41 0.00e+00 25 Sr-Sl 4.07o43 0.00e+00 1.84o44 0.00e+00 0.00o+00 0.00e+00 1.85o42 . 2.54e45 26 Sr-92 1.58e45 0.00e+00 7.22o46 0.00 a+ 00 0.00e+00 0.00e+00 4.03e44 7.27o46 27 Y-90 2.76o45 0.00o+00 7.91e47, 0.00 a+00 0.00e+00 0.00e+00 2.27o41 5.71 o48 28 Y-91m 2.&4o-16 0.00e+00 4.74o47 0.00e+00 0.00e+00 0.00e+00 1.34e-14 5.49o47 29 Y.91 5.24e44 0.00e+00 2.57o45 0.00e+ 00 0.00e+00 0.00e+00 2.15e41 1.31 e45 30 Y-92 2.37e48 0.00e+00 1.61e46 0.00e+ 00 0.00e+00 0.00e+00 6.50o44 1.92o-06 31 Y-93 1.81o48 0.00o+ 00 1.91e46 0.00e+00 0.00e+00 0.00 a+00 5.53e42 2.55o46 32 Zr-95 1.97e45 6.23o46 2.66o43 0.00e+ 00 9.15e46 0.00a+00 1.44o42 3.09o43 33 Zr-97 4.07o47 8.06o48 3.09e45 0.00 a+ 00 1.22a47 0.00o+00 2.180 02 3.60e45 34 Nb-95 2.40o42 1.33e42 8.8 1 o43 0.00e+00 1.29e-02 0.00 a+ 00 5.69o+01 1.75o43 5-6b(1)
V Bev. 1 DATE,
3 t I~
~ . ~ ~ I MRE~RRHWNEHWRRE&Rmm%mmmMRmmaamim ggg~~~<j gg~~~t~ll gg~g~gggggig~j~~t~t<
.~t<
~<~II ~~I~I< ~l< /gg~t, /~~It ~~<~<~I,~
~ggg~<Qg~t-f I
I
~<t ~II glltlf~gtl+~gg~<l ~lt ~II ~t< ~I< ~i~it I 1 ~<< ~t< ~<t I
~<<i ~tj +~I< giirP~I<
ammmmmammmmmmmammmaammmammcammmmaammammma
~I+~<.~gggj~<~gii~~tgg~Q~<t ~tl ggggiiQ~I< I~II ~~t~g~~t I
Rmtnm',maznmaazammmimmam~ammmmmmzaaxmzaammna
+@~~~I' ggg~lg~+I~ggg~t~~jl ~~It
~II ~t' ~~~j~~t
~g~tgg~t~
~
K%RK~RKEKRRKRK%RSHK%RKEH%RKEK%REEEERRKHKESKKHK%
gg~~ ~ggii+~~i~<~IQ~t~t +~~tt ~<t ~t< ggg~jt ~~I+
kERRSK~RSHRKRRK~RK~RKHKK%RKBKERREEE5%RXHKK%KKBK%
i RWRKRMRR)KRREHR5%NKEHRRRZKERRK~REHK%%2iE5%EERK%
NaamE~~~ammammmmaxmaammmmmmaammaaxmm a%am~ammaameaaxmaammmammmammrammmanmm
%%~EK3%%ERHKKREBR%RZHRRm!HKREKC%%R%8%%RMK%
%R~RHRRKRRlRKZERRRKRRKHKXRSHKRR?HBMREKBERRKBK%
aaam~ammmammr~~mmmrmaazmmmmmmmrammmemmm
~ggg~Q+~t+~~<Q+g~<~+~tgiQQ~~<+~t~tj N%RK~KKHXEREEHRERRKHK!%RK3XMRXHRERRERKKRKHSM
~tj Q~<Q~P~ MK~
~ggg~gppgt~gg/gg ggg~g f~+~~ggg~~~<gg~g NRRRE~RlEE!CRRK2KRREZ~RXR~RKHEHRR%H~RKHKRKKHKE%
awamz~ammamvmaammammemammxmmmaammaamma
~.~~~QtQ Q/~I ~1~< ~t< I ~tt RRRRE~NK35IWRKKRRK~RK~RKZRRKKKRRKHKHRKZK%
kTRK~KE9%MNE55%REZ~RE3~NKZKRRKHKRRKEK%%~HF'K~REHKRRK)KRREHKHNKE~RKHKRREZKRRKHKH%KOHL
~ I ~t ~ ~t ~~1< ~~11 ~lt I ~I ~11 I ~lt
~ ~ ~ ~jt ~tt ~tl ~jt +gal~
t I II ~~II ~I< ~tt /gll]~t ~i~it ~t< ~II ~II ~jj ~jj ~jj ~tt ggg~j RK3Ã%RK~RK)~t~~t~t~j~t< ~t, ~+/~I~
I 1 I I
~Q~gPg~/~j. ~it ~tt ~t< ~lt ~tt ~tj Qgg~tggg~t, I I I Raemmasvmaammmmmmaxnmammamzmaaxnraammm Kg~tgg~t~~~t~+gg~t< +//~<~II ~~~I i gggg~~~gg~t+~~tggg~+g~j&REAM KXEK~KKHKMNKHK%RE9~%2ECK%%KHK!%RKHKRREZLHRRKH~
aaenmaammaenmmaammamammamnaammaaxnmmmma Qgg7gg~ggggtg~giigg~g++t~tggg~~<t aaam~ammmammaaemrammmmaammaaermaammaamrca i ~ggt~t+~+Q aam~~rmrmaremmamrmmaxnmaammaazzmsm~mm
Table 5-6c: Composite Dose Factors: Maximum Hypothetical Child (Page 1 of 2)
Dose Factor Units: mrem/Ci Released Location: Danville (Mater Ing.)/Outfall (Fish and Shoreline)/FIXED OILUTIOH Usage (Uop) (kg/yr:FISH) u Usage (Uop) (kglyr:WATER) ~ 5'I 0 Uaoga (Uop) (hrlyr:SHORE) Is DSution (1iMp:SHORE) u 1 6.9 Dilution (lilVlp:FISH) ~ 15.9 Dilution (lAlp:WATER) sr 321 Transit time (tf) hra ss Transit time (tw) hrs ~ 26.8 Transit time (tp) hrs s Transit time (tb) hrs rr 131400 Isotope Bona Liver T. Body Thyro)d Kidney Lung GI-LLI H-3 0.00 a+00 3.96o45 3.96o-05 3.96o45 3.96o45 3.960.05 3.SSo45 O.ooe+00 C14 2.38a+00 4.77o41 4.77e41 4.77e41 4.7?e41 4.7?e.ol 4.77o41 O.ooa+00 Ne 24 B.1 0o43 8.1 0e43 8.12o43 S.1 0e43 &.10a43 . 8.'loo-03 S.loo43 3.01o45 P-32 1.01e+02 4.72o too 3.89e+ 00 O.Boo+00 O.Boo+00 0.00o+00 2.79e+00 O.ooa+00 Q.ooo+00 0.00a+00 8.62a-05 4.20o45 1.15o45 7.660.05 4.01o43 1.25o45 Mn.54 O.ooo+00 1.84o41 5.23e.02 O.Boa+00 5.1?o42 0.00e+00 1.550-01 3.69o43 O.ooo+00 8.95o48 3.14e46 O.Doe+00 8.41o 08 O.ooo+00 1.01e43 1.85o48 Fe-55 5.10e42 2.71o42 8.38o43 O.ooe+00 O.ooo+00 1.53o42 6.01e43 O.ooe+00 Fe-59 7.21a42 1.17o41 5.870.02 O.ooe+ 00 O.ooe+00 3.38a42 1.21o41 7.28o44 10 Co-58 O.ooo+00 4.09o43 1.34o42 O.ooe+ 00 O.ooa+00 O.ooa+00 249o42 1.01e43 1'I Co-60 O.Doe+00 1.21e42 8.47o42 O.ooe+00 O.ooo+ 00 O.ooo+00 6.73o42 5.7$ a42 12 Ni-63 2.39 a+ 00 1.28o41 8.12o42 O.ooe+ 00 O.ooa+00 O.Boo+00 8.61o43 O.Doe+ 00 13 1.01e45 9.50o47 1.07o46 O.Doe+00 O.Doe+00 Q.Boa+00 1.16e44 14 Cu-64 O.Doe+00 1.43ao4 8.79o45 3 4?e44 O.ooo+00 6.73o43 1ASe46 15 -
Zrr85 1.17a+00 3.12e+00 1.94a+00 O.ooa+ 00 1.S?etoo O.ooa+ 00 5.48o41 1.95e43 16 Zn.69 2.950-11 4.26e.l 1 344a12 O.Boa+00 2.58 a-l 1 O.ooa+00 2.68o49, O.Doe+00 17 Br 83 Q.OQe+00 0.Boa+00 2.'2'1 o46 0.00etoo 0.00a+00 O.ooe+00 1.20o48 18 'r-84 O.ooo+ 00 ~ O.ooo+00 1.25o47 O.Doe+00 O.Doe+00 O.Doe+00 'Q.oootoo 1.48o47 19 Br&5 O.Doe+00 O.Doe+00 O.oootoo O.Doe+00 O.ooe+00 O.Doe+00 O.ooo+00 O.Doe+00 20 Rb-88 O.Doe+00 5.53o+00 3.40e+00 O.ooo+00 O.ooe+ 00 O.ooo+ 00 3.56e41 243o45 21 Rb-88 O.ooe+00 O.ooe+00 7.31o49 O.ooo+00 O.Doe+00 O.Doe+00 O.Boa+00 BASe49 22 Rb-89 O.Doe+ 00 O.ooe+00 1.80e48 O.ooe+00 O.Boo+00 O.Doe+00 O.ooe+00 2.28o4S 23 Sr-89 1.88a+00 O.Boo+00 6DSo42 O.Boa+00 O.ooo+00 O.Doe+00 7.26e42. 5.71o48 24 Sr-90 2.45e+01 0.00a+00 6.21e+00 O.Boo+00 O.ooe+00 O.Doe+00 3.30o41 o.ooetoo 25 Sr-91 5.55e43 0.00o+00 2.14o44 O.ooa+00 0.Boo+00 O.ooo+00 1.22a42 5.31ao6 26 Sr 92 2.13o45 O.ooe+00 2.22o46 O.ooe+00 O.Boo+00 O.OOe+OO 4.03o44 1.52o46 27 Y-90 3.84o45 0.Boo+00 1.04o46 O.ooa+ 00 O.ooa+00 O.ooo+00 1.09o4'I 1.19a48 28 Y-91m 3.78o-'1 6 . O.ooo+00 S.91a08 O.ooa+00 O.ooo+00 O.Doe+00 7.40a-l 3 1.15e4I 29 Y 91 ?Doo44 O.ooa+00 2.20o45 0.00e+00 O.ooo+00 O.Doe+00 L72e42 2.74e46 30 Y-92 3.24o48 0.00 a+00 3.38o47 O.ooo+00 O.ooe+00 O.ooo+00 9.37e44 4.00o47 Y93 2.50e46 0.00o+00 4.58o47 O.Doe+ 00 O.ooe+00 O.Doe+00 3.73o42 642e47 32 Zr-95 3.42o45 7.51e48 5.63o44 O.oooo 00 1.08o45 O.Boo+00 7.84o43 6.45e44 33 Zr-97 7.34a47 1.06o47 6.52e46 O.ooe+00 1.62o47 O.Boo+00 '.61e46 '.61o42 34 Nb-95 2.83o42 1.10o42 8.19o43 O.ooe+00 1.04o-02 Q.Boo+00 2.04o+01 3.65o44 A Pev. 1 DAY
Table 5-6cl Composite pose Factors: Maximum Hypothetical Child (Page 2 of 2)
Oose Factor Units: mrem/Ci Released Location: Danvil le (Water Ing.)/OIItfal1 (Fish 5, Shorel ine)/FIXED DILUTION Isoe L'Ivce Th old OI LLI Skin 35 Ilo-99 0.00eKS 5.9?e<3 1. C9e-03 0.00e+00 . 1.2?e 02 0.00e+00 4 94e-03 1.0Cc-o 36 Fc-99in 4.0?e.OS ?.99e-08 ! . ?0e-06 0.00e+00 1 ~ 16e-06 4.06e-OS C.55e.05 C.27e-07 jc-101 Ru-103 0.00eKR 4.20e-04 0.~
0.00eKR 2.49e-09 4.07e-04 0.00~
0.00eKN 0.00e+00 1.06c-03 0.00e+00 0.00~0 0.00~
1.09e-OZ 2.7?e-09 2.8?e-04 59 Ru-105 7.37e-0? 0.00e+00 1.50e-06 0.00e+00 6.CSe 06 0.00e+00 C.SIe.04 1.COe.06 40 Ru-106 6.83c-03 0.00cKQ 'l.81e-03 0.00e+00 Ichor 9.2Zc-03 0.00e+00 1.06e 01 1.15e.03 Cl A -110ra le-125m 1.3?e 04 1.95e-O'l 9.~
5.2?e 02 7.89e-03 2.59e-02 0.00e+00 S.C6e-02 1.73e-OC 0.00eKR 0.00e+00 0.00e+00 1.10e-OZ 1 88c 01 9.1'le-03 4.83c-06 le-12?a 4.9bc 01 1.34~1 5.89e-02 1.19e.01 1. 4 0.00e+00 4.02e.01 2.C6e-07 CC Te-127 1.2?e.03 2.73e-04 S.82e-04 3.63c.03 0.00eKN 4.98e-02 6.91c-09 C5 le-12%@ ~
8.24e 01 230e 0'I 1.28e-01 2.6be.01 2.C2e+00 O.DOc+00 '.00e+00 5.25e-05 46 le-129 2.2?e-03 6.33e-04 5.79e-04 1.62e 03 6.63e-03 0.00e+00 1.41e-01 C.90e-05 C7 le-13la 6.9Se 02 2.4 le<2 2.57e-02 C.9Te.02 2 34e.01 0.00e+00 9.79e.01 2.10e-05 48 le-l31 1.34c-ZI 4.09e 22 1.2be-OS 1.03e-21 4.0bc-21 0.00e+00 7.05e-21 1A9e 05 C9 Fe-132 1.COe 01 6.19e 02 7.CSe-02 9.01e.02 5.75e.01 0.00e+00 6.23e Ol 1.12c-05 50 I -130 5.69e-04 1.15e-03 6.04c-OC 1.2?e O'I 1.72c.03 0.00e+00 5.38c.04 1A4e-05 51 1-131 1.2be-02 1.26e 02 7.21e.03 4.18e+00 2.0?e.02 0.00e+00 1.12e-03 4.73e-05 52 I 132 ~ 3.27e&7 6.Oleic? 2.37e-06 2.79e 05 9.20e-07 0.00e+00 7.0Se-07 2A6a-06 53 I 133 2.05e&3 2.53~ 9.62e OC C.70e 01 C.22e.03 0.00e+00 1.02e 03 6.55e-06 54 1-134 8.23c 13 1.53a 12 4.62e-07 3.52e-ll 2.34e-l2 0.00e+00 1.01e 12 5A9e-07 55 1-135 1.00e 04 9.03e-05 1.59~2 2.76e.04 0.00e+00 1.37e-04 6 03e 06 56 . Cs-134 2.01~1 3.29e+01 6.96e+00 0.00e+00 1.02~1 3.66eKS 1.7?c.01 1.82c&2 57 Cs 136 1.91e+00 5.25 AN 3.39eKO 0.00e+00 2.79eKR C. 1?e-01 1.84e 01 5S Cs-137 2.~1 2.68e+01 3.99eKN 0.00eKS 3.15e+00 1.68e-01 Ze?3~2 59 Cs-138 1.95e-lb 2.75e 16 2.25e&7 0.00e+0) 1.93e 16 2 08e-17 1.26e-16 2.5?e 07 60 Ba 139 4.32e-10 2.31e-.13 1-~7 0.00eKN 2.01e 13 1.36e-13 2.49e-08 1.65 a-'0 61 Ba 140 Z.s?e-OZ 2 25~ 1.55~3 0.00eKS 7.34e-06 1.34e-05 1.30e 02 5.32e-05 62 Ba-141 0.00eKS 0 00a+00 0.00e+00 0.00e+00 0.00e+00 0.00 a+00 1.12c-08
' 2Alc Sa 142 0.00cNN 0 00eKS 2.11e~ 0.00e+00 0. 00eKR 0 00e+00 00e+00 09 La-1CO 8.04c-06 2.51e-06 4.39e-05 0.00e+00 0.00e+00 0.00e+00 7.83e-02 4.86e 05 65 La-1CZ 1.1Te 11 3.73e-lZ 1.12e-06 0.00 a+00 0.00@+00 0.00e+00 7 38e 07 1.34c-06 Ce-141 7.?Ce-06 3.16e-05 0.00eKS 1.69e-06 0.00eKN 4.82e 03 67 Ce-1C3 8.14e-07 C Ale-04 5 21e 06 0.00eKS 1.85e-07 0.00e+00 6.C7e.03 5.85e-06 Ce-144 4 IC~ 1.3~ 1.50e-OC 0.00e+00 7.19e-05 0 00e+00 3.38c-02 69 Pr -143 C.5?e-05 1.3?e-05 2.2?e-06 0.00e+00 7.43e-06 0.00e+00 4 93e 02 0 00e+00 70 Pc-144 0.00eKR 0.00cNS 3.78e-10 0.00eKO 0.00eKN 0.00~0 0.00e+00 4.35e 10 71 Nd-147 3.20e-05 2.60e-05 2.10e-05 0.00e+00 1.4Ze-05 0.00e+00 C lie-02 2.28e-05 II-187 1.07e.02 6.33~3 2.S4e-03 0.00eKS 0.00e+00 0.00c+00 8.89e Ol 6.03e-06 2.25e.06 1.62e-o? 3.95e-06 0.00e+00 4.68e.07 0 00e+00 1.20c-02 4A5e 06 5-6c(2)
Table 5-6d: Water Ingestion Dose Factors: gaximum Hypothetical Infant (Page 1 of 2)
Dose Factors: mrem/Ci Released Location: Danville Receiver/FIXED DILUTION usa c (ua ) (k / r:uATRR) 330 ollution (1/H:uhTER) ~ 321 Transit tieo (uATRR) hrs 25.8 lsot t iver T. 8 Thyroid Gl-i.Ll H-3 0.00e+00 3.12c-o5 3.12e-05 3.12e-05 3.12e-05 3.12e.oS 3.12e.05 C-14 Z.Coc-03 5.13e-04 5.13e.04 5.13c-04 5.13e-04 5.13e-oC 5.13e-04 Na-ZC 3.11c-04 3.lie-04 3.11e-o4 3.11e-oC 3.llc-04 3.11e-04 3.11e.04 P-32 1.6Ce 01 9.63e 03 6.34e-03 'O.ooe+00 Q.OOOO Q.ooe+00 2.21e-03 Cr-51 O.ooe+00 O.ooe+00 lee-06 9.08e-07 1.98 -or 1.77e-06 4.06e.05
)(n-54 O.ooe+00 2.0lc 03 4.S6e-04 O.ooe+00 4.46e-04 O.ooe+00 7.CQe-OC Hn-56 0.00eKO e.orc-oe 1.39e-oe O.ooe+00 6.93e-08 ~ Q ooe+00 7.33e-o&
Fe-55 1.41e.03 9. 10c.OC 2.C3e.04 ~ O.Me+00 O.ooc+00 4.CSe-OC I. '!6e-04 Fe-59 3.07c-03 5.37c.03 2.11e-03 O.Me+00 0.00eKN 1.59c-03 2.56e-03 10 Co-58 0.00eNN 3.61c.04 9.01c-OC 0.00eKS O.ooe+00 O.ooe+00 9.00e-04 Co-60 0.00eKO 1.09c-03 2.59e 03 0.00eKS O.ooe+00 O.ooe+00 2.61e.03 Mi-63 6.43e-02 3.98e-03 2.23e-03 O.ooe+00 O.ooe+00 O.ooe+00 '1.98e. 04 R I -65 3.95c-or 4.47c-oe 2.03e-08 O.ooe+00 3.Coe 06 14 15 Cu-64 Zn-65 0.~
1.86e-03 l.Sle 6.38c-03 05 7.00e-06 2.94e-03 O.ooe+00 0.00e+00 0.00e400 O.ooe+00 2.56e-05 3.09e-03 O.ooe+00 O.ooe+00 3.10e.04 5.39e.03 16 Zn-69 C.09e-'l4 7.36c-lC 5.48e 15 O.ooe+00 3.06e-14 O.ooe+00 . 6.0Qe-12 17 Sr-83 0.00eKS 0.00@KM 2.07e-oe O.ooc+00 O.ooe+00 0.00et00 le er-84 O.ooc+00 0.00eKS 9.19e-20 0.00eKS 0.00et00 O.ooe+00 0.00et00 19 Br-85 O.ooc+00 0.00eKN 0.00et00 0.00e+00 0.00eKS O.ooe+00 20 0.00@NO 1.66c OZ 8.19c-03 0.00eKS 0.00eKO O.ooe+00 4.24e-04 21 0.00e+00 0.00eKO O.ooe+00 O.ooe+00 O.ooe+00 O.ooe+00 O.SLttM Rb-89 Sr -89 Sr-90 0.00eKN 2.51eW1 1.88e+00 0.00eKM Q 00ctOQ O.ooc+00 0.00eKS 7.20c-03 4.78e-ol Q.ooe+00 0 00eKS 0.00cKO 0.00eKS O.ooe+00 0.~
Q.ooe+00 Q.ooe+00 0.00e+00 5 l~
0.00eKO 2.3Cc-02 Sr-91 .72e-04 0.00eKS 2.79e-05 0.00eKN O.ooe+00 O.Me+00 Sr-92 2.65e-06 0.00eKS 9.85e-oe O.ooe+00 O.ooe+00 0.00e+00 2.8&c-05 27 Y 90 6.67e-06 0.00eKS 1.79e-or 0.00eKN 0.00e+00 0.00eKR 9.21e '03 28 T 9)a 3.62e-)7 O.ooe+00 1.23e-le 0 Ooe+00 O.ooe+00 O.ooe+00 1.21e-13 T 91 1.13e 04 0.00eKN 3.01e-06 O.ooe+00 0.00@KM O.ooe+00 8.11e.03 30 Y 92 4.9&e-09 0.00c+00 1.Coe-lo 0.00~ O.ooe+00 O.ooe+00 9.47e-05 31 T 93 C.20e-or O.ooeNO 1 14e-08 0.00eKN 0.00eKS O.ooe+00 3.3le 03 Zr-95 2.07e-05 5.03e-o& 3.Sre.06 0.00cKN 5.42e-06 0.00eKS 2.51e.03 Zr-97 5.21e-07 8.94e-oe C Oee.oe O.ooe+00 9.0le-oe O.M~ S.roe.03 C. 17e-06 1.7Ze-06 ~ 9.93e-07 O.Me+%) '.23e-06 O.ooe+00 1 CSe.03 No-99 0.00eNM 2.63c.03 5.13e.04 O.ooe+00 3.93e.03 O.ooe+00 8.66c.04 5-6d(1)
Table 5-6d: Mater Ingestion Oose Factors: Naxililum Hypothetical Infant (Page 2 of 2)
Oose Factors: mrem/Ci Re'leased Loca t i on: Oanv i l e Receiver/F I XEO OILUTION 1
I soso L Iver f. 8 Th roid K Idne lung Gl I.I.I 36 Te-99m 9.980 09 2.060 08 2.65e-07 0.00e+00 2.22e-OT 1.08e-08 5.98e-Tc-101 0. 00eKN 0.00e+00 O.OOMOO 0.00e+00 0.00')0 0:00c+00 0.00e+00 Ru-103 I.CTe OC 0.00cNN 4.930-05 0.00c+00 3.0Te.OC 0.00e+00 I.T9e 03 39 Ru- IOS 2.460-07 0.00eNN 8.27e-08 0.00e+00 1.810.06 0.00e+00 9.7Te.05 40 Ru-106 Z.C4e-03 0.00e+00 3.05c.04 0.00c+00 2.88e-03 0.00e+00 1.85e.02 Cg- I IOe '.01e-04 F.350-05 4.860~05 0.00e+00 1.05e-04 0.00c+00 3.810 03 42 Te IZSa 2.330-03 7.800-04 3.'ISe OC 7.85e.04 0.00e+00 0.00e+00 1.11e 03 Te. 127m 5.890-03 1.950 03 7.130.04 1.70c-03 1.C50-02 0.00e+00 2.38e 03 Te-127 1.50e-05 5.020.06 3.220.06 1.22e-05 3.650 05 0.00e+00 3 15e 04 45 Te 129ra 9.92e 03 3.COe 03 1.53e.03 3.81e-03 2.48e 02 0.00c+00 5.920-03 Cb Te- I29 2.82e.05 9.7le 06 6.580-06 2.36c-05 7.01e-05 0.00e+M 2.2S0-03 47 Te I3ln S.Cge 04 3.C20 OC 2.820-04 6.93e-04 2.35e-03 0.00e+00 5 760 03 CS Te-131 C.460 ZC 1.65e 24 1.25e-zc 3.98e-24 1.140-23 0.00e+00 1.800-2Z I e-132 1.6Se-03 8.31e-04 F.FSe-oc 1.23e-03 5.200-03 0.00e+00 3.07e-03 50 I ~ 130 1.43e Oc 3.150-04 1.260-04 3.53e 02 3.Cbe-04 0.00e+00 6.75e-OS 51 I 131 3.320-03 3.91e.03 1.72e-03 1.28e+00 C.STe.03 0.00e+M 1.COe-OC 52 I-13Z F.OTe.08 I.cce 07 5 'ie-OS 6.73e-06 1.60e-07 0.00e+00 1.16e-07 53 I 133 5.37e-04 T.S\e 04 2.29e-04 1 Aze-01 9.19e-04 O.OOeHS .1.32e-OC 54 I -134 1.27e 13 2.600 13 9.25e-lc 6.06e-12 2.91e-13 0.00e+00 2.69e-13 55 I 135 2.C7e-05 C.gle-05 1.79e-05 4AOe-03 5.47e-OS 0.00e+00 56 Cs-134 3.820-02 7.120 OZ 7.'l9e 03 0.00e+00 1.830-02 7.52e-03 57 Cs 136 C.COe 03 1.29e 02 4.830-03 0.00eKN 5.16c-03 1.050-03 1.96e-04 58 Cs 137 5 .290.02 6.Z'Oe-OZ 4 'Be-03 0.00e+00 1.66e-02 6.73e-03 1.940-04 59 Cs-13S 1.T6e-19 2.860 19 l.39e-19 0.00e+00 1.43e-19 2.230-20 C.570-19 60 Be-139 2.26e-10 1.500-13 6.55e-12 0 00e+00 9.02e-lC 9 09e IC 1A30~
61 Ba-140 1 640 02 8.43e OC, 0.00e+00 3.88e-06 1.00e-05 62 Bs 'ICl 0.00eNR 0.000+00 0.00eKS 0.00e+00 0.00e+00 0 00e+00 0.00et00 60-142 0,00eKO O.OGHAM 0.00+40 0.00e+00 0 00e+00 0 00e+00 l.o. ICO 1.37e-06 5 Ale-OF 1.39e-OT 0.00e+00 O.OOe+00 0.00e+00 6.350-'03 65 l.s- 142 1.C90 12 5.47e 13 1.31e-13 0.00e+00 0.00et00 0.00e+00 9.2Se 08 Cc- IC 1 7.80e-06 4.760~06 5.60e-07 0.00e+00 1.C7e-06 0.00e+00 2.C6e 03 67 Ce-IC3 8.730 OT 5.790-04 6.61e-08 0.00eKS 1.69e 07 0.00~0 3.~3 Ce-144 3.010-04 1.230-04 1.69e-05 0.00eKN 4.99e.05 0.00e+00 1.730-02 69 Pr 1C3 7.800-06 2 920-06 3.87e.OF 0.00e+00 1.08c-06 0.00')0 4.'120-03 70 Pr ICC 0.00eNO 0.00eKN 0.00c+00 0.00e+00 0.00eKN 0.00e+00 0.00e+00 7'I Nd 147 S.ZCe-06 5.380-06 3.30c-07 0.00e+00 2.08e 06 0.00e+00 3A'le-03 72 V IS7 4.32e-05 3.0le-05 1.Gee-05 0.00e+00 0.00~0 0.00e 00 1.770-03 up-239 B.ZOe.OT T.3Ce.w C. ISe-08 0.00e+00 1.4 6e.07 0.00e+00 2.120-03 5-6d(23
6.0 INDIVIDUALDOSE DUE TO'AIRBORNE EFFLUENT 6.1 Noble Gases SPECIFICATION 3.11.2.2 - THE AIR DOSE DUE TO NOBLE GASES RELEASED IN GASEOUS EFFLUENTS, FROM EACH REACTOR UNIT, TO AREAS AT AND BEYOND THE SITE BOUNDARY (SEE FIGURE 5.1.3-
- 1) SHALL BE LIMITEDTO THE FOLLOWING:
- a. DURING ANY CALENDAR QUARTER: LESS THAN OR EQUAL TO 5 MRAD FOR GAMMARADIATIONAND LESS THAN OR EQUAL TO 10 MRAD FOR BETA RADIATION,AND
- b. DURING ANY CALENDAR YEAR: LESS THAN OR EQUAL TO 10 MRAD FOR GAMMARADIATIONAND LESS THAN OR EQUAL TO 20 MRAD FOR BETA RADIATION.
The air dose in unrestricted areas beyond the site boundary due to noble gases released in airborne effluents from the site shall be determined by the following equation for gamma radiation during any specific time period:
Dg -3.17 x10 g M, (X/Q)Q.
i (Eq. 14) and by the following equation for beta radiation during any specified time penod:
Db =3.17 x10 gI Ni (X/Q)v Q>> (Eq. 15)
Where:
M; the air dose factor due to gamma emissions for each identified noble gas radionuclide (i)(mrad/yr per pCi/m')
from Table 2.
the air dose factor due to beta emissions for each identified noble gas radionuclide (i) (mrad/yr per pCi/m')
from Table 2.
(x/Q) the highest calculated annual average relative concentration for any area at or beyond the site boundary in an unrestricted area from vent release point (v) (sec/m') such as from Table 3.
Appv Date Rev. 7 i >P r/
25
Dg the total gamma air dose from gaseous effluents for specified time period (mrad).
Db the total beta air dose for gaseous effiuents for a specified time period (mrad).
Q the integrated release of each identified noble gas radionuclide (I) in gaseous effluents from all vents (v) for a specified time period (pCi).
3.17 x 10 = the inverse of seconds in a year (yr/sec).
A discussion of the method used to calculate the individual dose from gaseous effluents is given in Section A.3.2 of Appendix A. Also, sample calculations for determining gamma and beta air doses from noble gas radionuclides released from the SSES are given.
6.2 Radionuclides Other Than Noble Gases SPECIFICATION 3.11.2.3 - THE DOSE'TO A MEMBER OF THE PUBLIC FROM IODINE-131, TRITIUM, AND ALL RADIONUCLIDES IN PARTICULATE FORM WITH HALF-LIVES GREATER THAN 8 DAYS IN GASEOUS EFFLUENTS RELEASED, FROM EACH REACTOR UNIT, TO AREAS AT AND BEYOND THE SITE BOUNDARY (SEE FIGURE 5.1.3-1)
SHALL BE LIMITEDTO THE FOLLOWING:
- a. DURING ANY CALENDAR QUARTER: LESS THAN OR EQUAL TO 7.5 MREMS TO ANY ORGAN, AND
- b. DURING ANY CALENDAR YEAR: LESS THAN OR EQUAL TO 15
. MREMS TO ANY ORGAN.
The critical organ dose to an individual from l-131, tritium, and radioactive materials in particulate form with half-lives greater than 8 days released in airborne effluents from the site to unrestricted areas can be determined by the following equation during any specified time period:
Dc =3.17x10 gI (R)(Wx)(QN) (Eq. 16)
Where:
Dc the total dose to a critical organ from radionuclides other than noble gases for a specified time period (mrem).
Appv / 4'ate Rev. 7 26
R; the dose parameter for each identified radionuclide (i) for the inhalation pathway (mrem/yr per pCi/m') arid for food and ground plane pathways (mrem-m'/yr per pCi/sec) from Table 4.
W the highest annual average dispersion parameter for estimating the dose to the critical individual; relative concentration (X/Q: (sec/m') for the inhalation pathway and relative deposition rate (D/Q: m') for the food and ground pathways such as from Table 3.
QN the integrated release of each identified radionuclide other than noble gases (i) in gaseous effluents from all vents (v) for a specified time period (IjCi).
3.17 x 10 = the inverse of seconds in a year (yr/sec).
In actual practice; the GASPAR computer code developed by the NRC to implement the airborne dose methodology of Regulatory Guide 1.109 will be used to perform the individual airborne pathway dose calculations for the SSES. The methods outlined above are consistent with those of the GASPAR code; site specific dose factors have been computed in Table 4 implementing the method described above, if required.
A discussion of the GASPAR code is given in Section A.3.2 of Appendix A.
f-Appv s.r" ~
Rev. 7 27
7.0 TOTAL DOSE SPECIFICATION 3.11.4- THE ANNUAL(CALENDARYEAR) DOSE OR DOSE COMMITMENTTO ANY MEMBER OF THE PUBLIC, DUE TO RELEASES OF RADIOACTIVITYAND RADIATION, FROM URANIUM FUEL CYCLE SOURCES SHALL BE LIMITEDTO LESS THAN OR EQUAL TO 25 MREMS TO THE TOTAL BODY OR ANY ORGAN EXCEPT THE THYROID, WHICH SHALL BE LIMITEDTO LESS THAN OR EQUAL TO 75 MREMS.
The cumulative dose to any member of the public due to radioactive releases from the SSES site is determined by summing the calculated doses to critical organs from the previously discussed effluent sources. The annual dose to critical organs of a maximally exposed individual for the liquid effluents is determined by using Equations 10, 11, and 12 of Section 5. The annual dose to critical organs of a real individual for the noble gases released in the gaseous effluents is determined by using Equation 14 modified by replacing Mi with Ki from Table 2 for the whole-body dose and by Equation 15 modified by replacing Ni by [L; + ((1.11 Mi)(SF))] from Table 2 for the skin dose of Section 6.0.
Dg 3 17 x10 K)(X I Q)y(Q jv)(SF) (Eq. 17)
Db = 317 x10 ILi +((111M; )(SF))](X I Q)(Q'w) (Eq. 18)
The annual dose to critical organs of a real individual for the radionuclides other than noble gases released in the gaseous effluents is determined by using Equation 16 of Section 6.0. For all dose calculations from airborne effluents, the deposition rate used in the analysis should be at the receiver location of the individual being evaluated, not the highest calculated annual average relative concentration or relative deposition rate for any area at or beyond the site boundary as given in Table 3. The direct radiation from the site should be determined from the environmental monitoring program's direct radiation (TLD) monitors. The Total Integrated Dose to a Member of the Public from fuel cycle sources has been evaluated."'n actual practice, the LADTAP and GASPAR computer code developed by the NRC to implement the liquid and gaseous dose methodology of Regulatory Guide 1.109 will be used to perform the effluent components of total dose calculations for the SSES. The methods outlined above are consistent with those of the LADTAP and GASPAR codes.
A discussion of the methods used to calculate the total dose to critical organs of a maximally exposed individual is given in Section A.4 of Appendix A.
"'PPKL Calculation EC-ENVR-1025
- 28 Rev. 7
8.0 OPERABILITYOF WASTE TREATMENT SYSTEMS 8.1 Li uid Waste Treatment SPECIFICATION 3.11.1.3 - THE LIQUID RADWASTE TREATMENT SYSTEM, AS DESCRIBED IN THE ODCM, SHALL BE OPERABLE. THE APPROPRIATE PORTIONS OF THE SYSTEM SHALL BE USED TO REDUCE THE RADIOACTIVEMATERIALS IN LIQUID WASTE PRIOR TO THEIR DISCHARGE WHEN THE PROJECTED DOSES DUE TO THE LIQUID EFFLUENT, FROM EACH REACTOR UNIT, TO UNRESTRICTED AREAS (SEE FIGURE 5.1.3-1) WOULD EXCEED 0.06 MREM TO THE TOTAL BODY OR 0.2 MREM TO ANY ORGAN IN A 31-DAY PERIOD.
The SSES Liquid Radwaste Management System consists of three processing sub-systems, liquid, chemical and laundry. Redundant and backup equipment, alternate process routes, interconnections
, and spare volumes are designed into the system to provide for operational and unanticipated surge waste volumes due to refueling, abnormal leakage rates, decontamination activities and equipment downtime, maintenance and repair. The Liquid Rad Waste Management System processes equipment drain and floor drain liquids collected in a common plant drainage system. The system also processes filter backwash, resin transfer liquids and resin cleaning liquids. The system has piping connections to allow the installation of vendor-supplied equipment to provide specific treatment of off-normal wastes or to enhance the normal treatment capabilities as necessary: Appropriate vendor-supplied equipment may also be used in place of installed equipment to allow for repair or replacement of components.
Low conductivity liquid wastes are processed in the Liquid Radwaste Treatment Sub-system. Liquid is collected in three pairs of LRW Collection tanks. Each pair of tanks has an approximate capacity of 28,000 gallons. Surge capacity is maintained with two pairs LRW Surge Tanks also with a 28,000 gallon/pair capacity.
Liquids from these tanks are normally processed through two vertical centrifugal discharge precoat filters with 300 ft'ilter area at a 200 gpm normal flow rate. Liquid from the filters is then sent to a mixed bed demineralizer with a volume of 140 ft'nd normal flow rate of 200 gpm. The demineralizer effluent is collected in three pairs of LRW Sample Tanks. Each pair of tanks has an approximate capacity of 28,100 gallons. The water is isolated in these tanks for analysis prior to recycle to Unit 1 or discharge to the Susquehanna river.
Appv Date Rev. 7 29
Off-specification liquids can be recycled back to the Liquid Rad Waste Management System for additional processing.
High conductivity wastes are collected in the Chemical Drain Tank and in specific sumps located in the Turbine and Radwaste Buildings.
Liquid from these sources is collected in a Chemical Waste Tank of approximately 12,000 gallons capacity. This liquid can then be sent to any one of two pairs of Chemical Waste Neutralizing Tanks. Each pair has a capacity of 31,000 gallons. The liquid is then sent to a vendor-supplied Chemical Waste Processing Sub-system for radionuclide removal. The effluent from the Chemical Waste Processing Sub-system is routed to the Evaporator Distillate Sample Tank where it can be isolated for analysis prior to'discharge. The capability exists to return the liquid to the Liquid Rad Waste Management System for additional processing if necessary.
The Laundry Waste Sub-system collects water from washdown, laundry and decontamination facilities in one of two Laundry Drain Tanks. Each tank has a capacity of approximately 820 gallons and has an independent mechanical filter system. One tank is normally valved to receive waste while the other is valved for processing.
Effluent from these tanks is routed to the Laundry Drain Sample Tank where it can be isolated for analysis prior to discharge. Off-specification liquid can be returned to the Chemical Waste Processing Sub-system.
A flow diagram of the Liquid Radwaste Management System is shown in Figure 1.
Appropriate treatment for liquid effluents from SSES is defined in ODCM Policy Statement 10.6. In cases when a batch of liquid, waste must be released with treatment less than that specified in Section 10.6, a dose assessment using LADTAP or the methodology of Section 5.4 shall be performed prior to release to ensure that the limits of Specification 3.11.1.3 are not exceeded.
8.2 Gaseous Waste Treatment SPECIFICATION 3.11.2.4 - THE GASEOUS RADWASTE TREATMENT SYSTEM SHALL BE IN OPERATION.
APPLICABILITY: WHENEVER THE MAIN CONDENSER AIR EJECTOR (EVACUATION)SYSTEM IS IN OPERATION.
'ppv Date I/'~ T 30 Rev. 7
SPECIFICATION 3.11.2.5 - THE APPROPRIATE PORTIONS OF THE VENTILATIONEXHAUST TREATMENT SYSTEM SHALL BE OPERABLE AND SHALL BE USED TO REDUCE RADIOACTIVEMATERIALS IN GASEOUS WASTE PRIOR TO THEIR DISCHARGE WHEN THE PROJECTED DOSES DUE TO GASEOUS EFFLUENT RELEASES FROM EACH REACTOR UNIT TO AREAS AT AND BEYOND THE SITE BOUNDARY (SEE FIGURE 5.1.3-1) WHEN AVERAGED OVER 31 DAYS WOULD EXCEED 0.3 MREM TO ANY'ORGAN IN A 31-DAY PERIOD.
The SSES off gas treatment system operates with four steam jet air ejectors maintaining condenser vacuum. Noncondensible gases are passed through one of three recombiners (one for each reactor unit plus a common recombiner), reducing the amount of gases to be filtered and released. Gases pass through a two to'nine minute holdup pipe before entering the off gas treatment system, which consists of one 100 percent capacity system per reactor unit. Each system consists of precoolers, chillers, reheaters, guard beds, and five charcoal absorbers and an outlet HEPA filter. Monitored, filtered air then exits to the turbine building vent.
A flow diagram of the off gas and recombiner system is shown in Figure 2.
Filtered exhaust systems serve selected areas of Zone I, II, and III of the SSES reactor building. The Zone I and Zone II equipment compartment and Zone III filtered exhaust systems each consist of two 100% capacity redundant fans and two 55% capacity filter trains. Each filter train has, in the direction of air flow, roughing filters, upstream HEPA filters, a charcoal filter bed, and downstream HEPA filters. Exhaust fan discharge is then routed to the atmosphere via the reactor building vents, where effluents are continuously sampled and monitored.
The turbine building filtered exhaust system draws air from those areas of the building that are most likely to become contaminated. Two 100%
capacity fans serve each system, which contains two 50% capacity filter housings rrIade up of a particulate prefilter, an upstream HEPA filter, a charcoal filter, and a downstream HEPA filter. Discharged air is released via the turbine building vents, which are continuously sampled and monitored.
The radwaste building filtered exhaust system draws potentially contaminated air from selected areas of the radwaste building. The system contains two 100% capacity fans and two 50% capacity filter housings, each containing a particulate filter bank and a HEPA filter.
Filtered air is discharged via the turbine building vent.
Appv Date a -"-'~/
Rev. 7
In order to minimize the quantities of radioactivity in airborne effluents from the station, the ventilation exhaust treatment (filtered exhaust) systems are normally kept in service at SSES.
As the need arises, these systems are periodically rendered inoperable for maintenance or testing activities. If any of the ventilation exhaust treatment systems in Table 12 are bypassed, degraded, or otherwise rendered inoperable, then vent evaluations should be performed"'. If the most recent 31-day. dose projection indicates that dose may exceed 0.3 mRem to any organ when averaged over the projected 31-day period, treatment systems rendered inoperable will be restored to operable status as quickly as is practicable.
The dose projections are performed at least once per 31 days based on the most recently available effluent data. If it is known prior to performing the dose projection that a treatment system will be out of service, and if data exists which indicates how the lack of treatment will impact effluents, these factors will be considered when performing the dose projection.
8.3 Solid Waste Treatment SPECIFICATION 3.11.3- THE SOLID RADWASTE SYSTEM SHALL BE USED IN ACCORDANCE WITH A PROCESS CONTROL PROGRAM, FOR THE PROCESSING AND PACKAGING OF RADIOACTIVEWASTES TO ENSURE MEETING THE REQUIREIVIENTS OF 10 CFR PART 20, 10 CFR 71, AND FEDERAL REGULATIONS COVERING THE 'ART DISPOSAL OF THE WASTE.
The SSES solid radwaste system.collects'all wet wastes produced from the operation of other plant systems. The wastes are then processed and packaged by a vendor-supplied system into a waste form that meets all applicable Federal, State and local requirements for transportation, storage and disposal. The processing methodology and acceptance criteria for the final waste forms are controlled by the Process Control Program.
"'Condition Report 96-0226 Appv Date Rev. 7 32
Filter material from the Reactor Water Clean-up Systems and the Fuel Pool Clean-up Systems are collected in Backwash Receiving Tanks. There is one RWCU tank per unit, each with a capacity of approximately 2450 gallons and one similar tank for the FPCU System. Wastes from these tanks are directed to one of two 6300 gallon capacity Phase Separators. Normally, one Phase Separator is valved to collect waste while the other is isolated to provide time for radioactive decay. The solid content of the waste is concentrated in the Phase Separator and transferred and processed through a vendor-supplied system and packaged for storage or final disposal. The supernatant liquid is collected and processed by the Liquid Rad Waste Management System.
The Waste Sludge Phase Separator is a 9500 gallon capacity phase separator tank that accepts input from the Regen Waste Surge Tanks. The concentrated waste is then transferred and processed through a vendor-supplied system and packaged for storage or final disposal The supernatant liquid is collected and
~
processed by the Liquid Rad Waste Management System.
Spent bead resin from the Condensate System and from the Liquid Radwaste Demineralizer are collected in the Spent Resin Tank.
These are then processed through a vendor-supplied system and packaged for storage or final disposal.
Spent filter material from the Liquid Radwaste Filters are collected in two Waste Mixing Tanks. The contents of these tanks are processed through a vendor-supplied system and packaged for storage or final disposal.
A flow diagram of the SSES solid radwaste treatment system is
'hown in Figure 3.
Dry Active Waste (DAW) consists of contaminated plastic, paper, clothing, metal or other trash and is collected throughout the RCA of SSES. DAW is processed and packaged for storage or disposal using off-site vendor-supplied super compaction and incineration services. DAW may also be compacted with an on-site drum compactor into 55-gallon drums. An automated DAW monitoring system is used to ensure non-radiological waste collected in the RCA is free from radiological contamination prior to release.
A flow diagram of DAW processing at SSES is shown in Figure 4.
~ . I ~ I' 0
~ I ~ '
I '
I I '
~ I
~ I
~ I I ~
~
I I~
P ~
~
~
I
~\ ~
I I
I ~
~
I I
~ ~
~
~
~ ~
I ~
I ~
AMOIENT 'TEMPERATUAE CHARCOAL Of f GAS A'fCOMOIHEA SYSTEM I OFF GAS SYSTEM UNIT I S'IEAM 2'll AIA E)ECIOA UNIT I TUR8INE 4LOG MAIN h AUX SIEAM EXIIAUST UNI'f I If 301OU LET IIEI'A flLTE IIAR GAL AOS ROEA bE S f ROM.JHII I EL IIEAT TAACING IT 200 I I 300 I f IIAS bYPA'SS IE 120 thE IT 310 IT 209 11301 Q
O'EATE II 10 t IA IE 20lh IE 3 h IT 70)4 MAIR Qf ~
) IE 122 MOTIVE STEAM JET IFS 1 I
STEAM DILUTIONSTEAM S f COH I OIH. TIE hb I I I IET I IS I 12% IHLFT tAE CHILI EA ~ GUARD UHII
'iISTAGE Alb El)C
'lOll c AECOMS VESS'EL
'. IE 121 MOTIVE ST EPM 112 HEPA flLTEA COOI.EA au 8 0 COH OTH. 2nd STAGa Qi- COHO Slh IE 127 AECOMb COHO COMMON OFFGAS AECOMOINEA SYSTEM STEAM lET AIA EJECTOA COHDENSEA Ilhlh UNIT 2 DELAY PIPE STEhs COH. AMbIENT TEMtEAATUAECIIAACOAI.
OEH. OF FGAS SYSTEM SEII UNIT 2 UHIT l OFFGAS AECOMOINEA SYSTEM 2 OFFGAS OYPASS MAlh W AUX TUAOIHE SLOG EXHAUST S'I'EAU UNIT 2 f AOM UHIT 2 FlGURE 2 OFFGAS AHO RECONB1HER SYSTEN FLOM OIAGRAN
~ ~
) ~ ~ I I I
~ I I '
~
~
I '
I
~
FIGURE 4 SSES DRY ACTIVE WASTE (DAW) PROCESSING Non- radiological Paper, Plastic, Rags, Trash f rom RCA Clothing from RCA Second-Sort DAW Dry Active Waste (DAW)
Monitoring System PP8cL Drum Compactor Vendor Yes Services Radioactive?
Supercompaction Incineration 55-gal. Drums or 8oxes No Free Released Appv Date Rev. 7 33D
9.0 RADIOLOGICALENVIRONMENTALMONITORING PROGRAM 9.1 . Definitions Weekly: Once in each calendar week at intervals of approximately 7 days, plus or minus 2 days.
Semi-Monthly: Twice each calendar month at intervals of approximately 15 days, plus or minus 4 days, Monthly: Once each calendar month at intervals of approximately 30 days, plus or minus 6 days.
Quarterly: Once in each three month period of a calendar year at of approximately 13 weeks, plus or minus 3 'ntervals weeks.
9.2 Monitorin Pro ram SPECIFICATION 3.12.'I - THE RADIOLOGICALENVIRONMENTAL MONITORING PROGRAM SHALL BE CONDUCTED AS SPECIFIED IN TABLE 3.12.1-1.
Environmental samples shall be collected and analyzed (as a minimum) according to Table 6.1 at locations shown in Figures 5 and 6. Analytical techniques used shall ensure that the detection capabilities in Table 7 are achieved.
A dust loading study (RMC-TR-81-01) was conducted to assure that the proper transmission factor was used in calculating gross beta activity of air particulate samples. This study concluded that the sample collection frequency of once per week was sufficient and that the use of 1 for the
'ransmission correction factor for gross beta analysis of air particulate samples is valid.
The charcoal sampler cartridges used in the airborne radioiodine sampling program (Science Applications, Inc., Model CP-100) are designed and tested by the manufacturer to assure a high quality of radioiodine capture. A certificate from the manufacturer is supplied and retained with each batch of cartridges certifying the percent retention of radioiodine versus air flow rate through the cartridge.
The results of the radiological environmental monitoring program are intended to supplement the results of the radiological effluent monitoring by verifying that the measurable concentrations of radioactive materials Appv 4 c..:-
Date Rev. 7
and levels of radiation are not higher than expected on the basis of the effluent measurements and modeling of the environmental exposure pathways. Thus, the specified environmental monitoring program provides measurements of radiation and of radioactive materials in those exposure pathways and for those radionuclides which lead to the highest potential radiation exposures of individuals resulting from station operation. Program changes may be proposed based on operational experience. Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment, and other legitimate reasons. If specimens are unobtainable due to sampling equipment malfunction, an effort shall be made to complete action prior to the end of the next sampling period. AII 'orrective deviations from the sampling schedule shall be documented in the next Annual Radioactive Effluent and Waste Disposal report. Reporting requirements for the radiological environmental surveillance program are given in Appendix B.
Annual doses to members of the public from ingestion of radioactive material are determined for various pathways, age groups and organs according to the following methodology (1):
DREMP/ING = DFCALC/ING RESREMP *FSAMP (Eq. 19)
Where:
DREMP/ING Annual dose from ingestion, as determined from REMP sample result.
I DCALC/ING Dose rate factor for ingestion pathway, in units mrem-
- liter/pCi-yr for liquid samples; mrem-kg/pCi-yr for solid samples: Tables 6-2a-f (Adult), 6-3a-f (Teen),
6-4a-f (Child), 6-5a-b (Infant).
RESREMP REMP sample result: pCi/liter for water or milk samples; pCi/kg for vegetable, fruit, meat or fish samples.
FSAMP Correction factor for the fraction of year represented by the sampling period (for cases where only periodic or seasonal sampling is conducted).
(1) PP8i Calculation EC-ENVR-1027 Appv Date u Rev. 7 35
Annual doses to members of the public from inhalation of radioactive material are determined for various pathways, age groups and organs according to the following methodology (1):
DaeMpnNH = DFcgg.cnNH RESasMp Fsagp (Eq. 20)
Where:
DREMP/INH Annual dose to organs or total body from inhalation, as determined from REMP sample result.
DF~~c/~NH = Dose rate factor for inhalation pathway, in units mrem-m'/pCi-yr: Tables 6-2g-h (Adult), 6-3g-h-(Teen), 6-4g-h (Child), 6-5c-d (Infant).
RESa~Mp = REIVIP sample result: pCi/m'or air samples.
Annual doses to members of the public from exposure to contaminated sediment are determined, for total body and skin dose, for various age groups according to the following methodology(1):
Damp/~ = DF~c/I RESasMp F~p (Eq. 21)
Damp/st = DF~c/sew RESaeMp Fsrzrp (Eq. 22)
Where:
Damp/Ta Annual total body dose, as determined from REMP sample result.
DafMp/sK N Annual skin dose, as determined from REMP sample result.
RESasMp REMP sample result: pCi/kg sediment.
D~c/Ta = . Total body dose rate factor from sediment, in mrem-kg/pCi-yr: Tables 6-6a (Adult), 6-6b (Teen) and 6-6c (Child).
(1) PPKL Calculation EC-ENVR-1027 Appv Date Rev. 7 i 36
D~~,>>,= Skin dose rate factor from sediment, in mrem-kg/pCi-yr: Tables 6-6a (Adult), 6, 4 Tt.~ %fasr
~ 544 5SS I
I I
SITE BOUNDARY i NIK 8 4"
gf~@~s';
/~ SUSQUEHANNA RIVER AIR SURFACE WATER T THERllOLUIONESCENT oosrsnav Appv Oate Rev. 7 39
FlGURE 6 ENVlRONMENTALMONITORING LOCATlONS GREATER THAN ONE MlLE FROM SSES SUSQUEHANNA NANYICOKE RIVER I
GLEN LYON SHICKSH INN Y 14 MOCANAQHA 4 i'
~ <<2 POND HILL RFRWIGK T
lXi c-~
+T W J283 gag
.T Q WAPlfALLOPEB 5E2 QfJW T
~
/
QKii 7Ei T
~ 1R NKSCOPECK gg MIFFLINVILLE 5 NIlES
/r CONYNGHAH HAZLEYON 19 HILES ucy 18 TCf ICI ux Wll4KNC WATCR SKNIIRNT 3f> mu 'WCRMOLVlllNISCENT DQQJCETRY Appv Date Rev. 7 40
OPERATIONAL RADIOLOGICALENVIRONMENTALMONITORING PROGRAM Exposure Pathways Number of Samples Sampling Type and
~and/or Sam lo and Locations* Frc uenc and'ollection Fre ucnc of Anal sis Airborne Radioiodine and I 0.4 mi WSW EOF Building Continual sampler operation with sample Radioiodine Canister: analyze Particulates'2S 9BI 1.3 mi S Transmission Line collection weekly." weekly for 1-131 SS4 0.8 mi E Environmental Laboratory 12E I 4.7 mi WSW Berwick Hospital 3S2 0.5 mi NE SSES Backup Mct. Tower Particulate Sample:
7S7 0.4 mi SE End of Kline's Road Analyze for gross beta 10S3 0.6 mi SSW East of Confer's Lane, South radioactivity following filter Club change. Perform isotopic ot'owers 13S6 0.4 mi W Former Laydown Area, analysis on composite sample West of Confer's Lane {by location) quarterly.
6G I 13.5 mi ESE Freeland Substation 8GI 12.2mi. SSE PP&L System Facilitics Center, Humbolt Industrial Park Direct Radiation IS2 Perimeter Fence -0.2 mi N Quarterly Gamma Dose: Quarterly.
IDS Mocanaqua Sewage Treatment Plant - 4.0 mi N 2S3 Perimenter Fence -0.2 mi NNE 2B3 Durabond Corporation - 1.3 mi NNE 2F I St. Adalberts Cemetery - 5.9 mi NNE 3S4 Perimeter Fence-0.3 mi NE 4S3 West of SSES APF - 0.2 mi ENE 4E2 Ruckles Hill &. Pond-Hill Roads Intersection: 4.7 mi ENE 4GI Crcstwood Industrial Park - 14 mi ENE'S7 Perimeter Fence - 0.3 mi E 5E2 Bloss Farm - 4.5 mi E 6S4 Perimeter Fence-0.2 mi ESE .
6A4 Restaurant - 0.6 tni ESF.
6EI St. James Church -4.7 mi ESE APPv Date
{)-'I(1 )
RdaM 7
TABl .. ~-1 (contintted)
Exposure Pathways Number of Samples Sampling and Type and a~nd/or Sam ale and Locations" Collection Frc ucncv Frc ucncv of Analysis 6S9 Pcrimctcr Fcncc -0.2 mi ESE 7S6 Perimeter Fence - 0.2 mi SE 7EI Harwood Transmission Line Pole N2 - 4.2 mi SE 7GI'P&L Hazlcton Complex-14 mi Perimeter Fence - 0.2 mi SSE SE'S2 8B2 LaWall Residence - 1.4 mi SSE 8D3 Mowry Residcncc - 4.0 mi SSE 9S2 Security Fence -0.2 mi S 9D4 Country Folk Store - 3.6 mi S 10SI Post South of Switching Station -0.4 mi SSW 10DI Ross Ryman Farm-3.0 mi SSW I I S3 Security Fence - 0.3 mi SW I IEI Thomas Rcsidcncc - 4.7 mi SW 12S3 Perimctcr Fence-0.4 mi WSW 12EI Bcrwick Hospital-4.7mi WSW 12GI PPEcL Bloomsburg Scrvicc Ccntcr - 15 mi WSW'3S2 Perimeter Fence-0.4 mi W 13E4 Kessler Farm-4.1 mi W 14SS Beach Grove Rd. Ec Confer's Lane intersection 0.5 mi WNW 14B3 Moskaluk Residence - 1.3 mi WNW 15FI Zawatski Farm-5.4mi NW 15SS Perimeter Fence-0.4 mi NW 16SI PerimeterFencc0.3mi NNW 16S2 Perimeter Fence -0.3 mi NNW 16FI Hidlay Residence - 7.8 NNW Waterborne Surface 6S6 river water intake line'onthly 2S7 Cooling Tower Blowdown discharge linc (rcstrictcd area) 6S7 cooling tower blowdown discharge linc (STP)
Monthly composite composite Monthly composite Gamma isotopic analysis.
Composite tritium analysis at least quarterly.
Drinking 12H2 Danville Water Company Monthly composite Gross beta and gamma isotopic (Approximately 30 miles downstream) analyses monthly. Composite for tritium analysis at least quarterly.
App C&
Date
'A -1 (con trtued)
Exposure Pathways Number of Samples Sampling and Type and
~and/or Sam le and Locations* Collection Fre uenc Fre ucnc ofAnal sis Sediment from Shoreline 7B Bell Bend - 1.2 mi SE Semi-annually Gamma isotopic analysis semi-annually.
Milk">> 12B3 Young Farm-2.0mi WSW Semi-monthly when animals are on pasture, Gamma isotopic and 1-131 IOGI Davis Farm - 14.0 mi. monthly otherwisc analysis of each sample Ray Ryman Farm - 3.5 mi. SSW SSW'OD2 IODI R&C Ryman Farm - 3.0 mi. SSW Fish and lnvcrtcbratcs Outfall area Semi-annually. One sample'rom each of Gamma isotopic on edible 2H Falls, Pa'. two rcacreationally.important species Irom 'ortions.
(Approximately 30 mi NNE) any of thc Iollowing families: bullhead cattish, sunfish, pikes, or perches.
Food Products I ID I Zehncr Farm - 3.3 mi SW vcgctnblc At time of harvest Gamma isotopic on edible portions.
12F7 Lupini Farm - 8.3 mi WSW vcgctablc
'The location of samples and equipmcnt were designed using thc guidance in thc Branch Technical Position to NRC Rev. Guide 4.8, Rev. I, Nov. 1979, Reg. Guide 48.1975 and ORP/SID 72-2 Environmental Radioactivity Surveillance Guide. Therefore, the airborne sampler locations were based upon X/Q and/or D/Q.
"Adust loading study (RMC-TR-8141) concluded that the assumption of I for the transmission correction factor for gross beta analysis of air particulate samples is valid. Air
~
particulate samples need not be weighed to determine a transmission correction factor.
">>Ifa milk sample is unavailable for more than two sampling periods from one or more of the locations, a vegetation sample shall be substituted until a suitable milk location is evaluated. Such an occurrence willbe documented in the REMP annual rcport.
'Control sample location.
'Two-week composite ifcalculated doses duc to consumption of water cxcecd onc millirem per year. In thcsc cases, I-131 analyses will be performed.
'The sample collector will dctcrminc the species based upon availability, which mny vary seasonally and yearly
~A sample from either or both locations 2S7 and 6S7 will be collected and analyzed according to thc required frequencies.
Appv srp Dale .
6-1(3)
Rev. 7
TABLE 6-2a REMP DOSE FACTORS FOR ADULTAGE GROUP; MILKSAMPLE (Page 1 of 2)
REM PS
. MPLE.DOSE CALC. FACTORS..:::<<..., ..:.,-, ADULT..MILK -.Il C"""" "
bf UCLIDE~~~ ::::::>BONE >:I -";-'>ll"IVER'!:,:,, .;:,,: T BODY,,:iiijTHYROID ii>a~KIDNEY;?;~
>; ',": hGI,"-L'U'::;>,,.
H-3 O.DOE+00 3.25E-05 3.25E-05 3.25E-OS 3.25E-OS 3.25E-05 3.25E-OS C-14 8.80E-04 1.76E-04 1.76E-04 1.76E-04 1.76E-04 1.76E-04 1.76E-04 Na-24 O.DOE+00 '.DOE+00 0.DOE+00 0.DOE+00 , O.DOE+00 O.DOE+00 O.DOE+00 P-32 5.43E-02 3.38E-03 2.10E-03 0.DOE+00 O.DOE+00 0.DOE+00 6.11E-03 Cr-51 O.DOE+00 O.DOE+00 7.84E-07 4.69E-07 1.73E-07 1.04E-06 1.97E-04 Mn-54 O.DOE+00 1.41E-03 2.69E-04 0.DOE+00 4.20E-04 O.DOE+00 4.32E-03 Mn-56 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Fe-55 8.51E-04 5.88E-04 1.37E-04 0.DOE+00 O.DOE+00 3.28E-04 3.37E-04 Fe-59 1.30E-03 3.07E-03 1.1 8E-03 O.DOE+00 O.DOE+00 8.56E-04 1.02E-02 Co-58 O.DOE+00 2.26E-04 5.08E-04 O.DOE+00 O.DOE+00 D.DOE+00 4.59E-03 Co-60 0.DOE+00 6.63E-04 1.46E-03 0.DOE+00 O.DOE+00 O.DOE+00 1.25E-02 Ni-63 4.03E-02 2.79E-03 1.35E-03 0.DOE+00 0.DOE+00 0.DOE+00 5.83E-04 Ni-65 0.00E+00 0.DOE+00 O.DOE+00 Q.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 Cu-64 O,OOEtoo O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 Zn-65 1.49E-03 4.75E-03 2.15E-03 D.DOE+00 3.17E-03 O.ODE+00 2.99E-03 Zn-69 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Br-83 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Br-84 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+
Br-85 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 0.00E+
Rb-86 O.DOE+00 6.07E-03 2.83E-03 O.DOE+00 O.DOE+00 O.DOE+00 1.20E-03 Rb-88 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Rb-89 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O,DOE+00 O.DOE+00 O.OOE+OO Sr-89 9.29E-02 0.DOE+00 2.67E-03 0.DOE+00 O.DOE+00 0.DOE+00 1.49E-02 Sr-90 2.35E+00 0.DOE+00 5.77E-01 0.DOE+00 O.DOE+00 0.DOE+00 6.79E-02
.Sr-91 O.DOE+00 O.DOE+00 D.DOE+00 '.DOE+00 O.DOE+00 O.ODE+DD O.DOE+00 Sr-92 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Y-90 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 Y-91m 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 Y-91 4.27E-05 0.DOE+00 1.14E-06 O.DOE+00 O.DOE+00 0.DOE+00 2.35E-02 Y-92 D.DOE+00 0.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 O.OOE+OD O.DOE+00 Y-93 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 Zr-95 9.22E-06 2.96E-06 2.00E-06 0.DOE+00 4.64E-06 O.DOE+00 9.37E-03 Zr-97 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 Nb-95 1.85E-06 1.03E-06 5.54E-07 0.DOE+00 1.02E-06 O.DOE+00 6.26E-03 Mo-99 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 D.ODE+00 O.ODE+OD 0.DOE+00 Tc-99m 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 Appv Date Rev. 7 6-2a(1)
a ~ ~ ~
~ ~ ~
~ ~ I ~
I II II I II II I II Il I I~ II I II ll I II II I II II I II II I I~ II I II Il ~ ~
~ I I II II I II II I II ~ I I ll II I II II I II II I II II I ~
I II II I ~ ~ II I II II I I~ II I II II II I ~
I II II ~
~
I I ll ll I II II I II ll I II I~ I II II I II II I II II
~ I I II II I II II I I ~
I II II I II lf I II I ~ I II II I Il II I II II I II II I II II I II II I ll II I II II I II II I II II I II II I II II I II II ~ I I II I II II I II II I Il II I II II I II II I II I I I I~ II I II II I If II I II II
~ II I ~
I II I~ I II tl ~ II I ~ I ~ I II I II Il f I I II I II II I II II I II II I If II I II If I II II I I ~ II I II II I II I ~ I Il lf ~ II I I I II Il I II ll I II II I II I ~
I II II I II II I ll II I II II I Il II I I ~ II I II II I II If ~ I I ~
I II ll I ~
I II ll I I ~ ~ I ~
I II II I II II I II II I II II I II II I ll II I II II Il II I II II I ff II I II tl I ll II I fl I II II I's
~ ~ ~
I II ff II II I Il II I II II I II ll I II I I I II II I II II I Il II I II II I II II I II Il II II I Il II I II II I II II I II II I II II I II II I II II I II II I li II I II I ~ I II II I II II I II II I II II I ll II I II II II I~ I II ll I II II I~ I~ I II II I II II I II II I II II I II II I II II I II fl ~ I~ Il I~ ~
I II I II II
~ II ~ I I II II I II II I II II I II II I Il Il I Il II I II II I lf I I I II II I II II I ~ I II I II ll I II II I lf II I II II
~ II II I II II I ll II I II II I II II I II II I II II
~ ~
TABLE 6-'2b REMP DOSE FACTORS FOR ADULTAGE VEG. SAMPLE (Page 1 of 2)
GROUP'EAFY REM PSALM PLE!DOSE';,"CALrC -'":FACTORS!::.'::.,:'~Z ADULT'LEAFY~VEGÃ4'4-:::I,"""..'~i"'>",',,'!
g';,"~":BONES'Ã~;"
j 9!m'r'em+igl p C yr7!.."-:,'jg.".~
4>hlUCl IDE::;,":,"; " '"'NLrIVERQ.=";:: ":"..'T';BODY,'":,-".. ';i 'THYROlDj", PQKIDNEY::.."::,. I(j--:RLUN~G'~("'j':,,::GI"-,LL'f)
H-3 O.OOE+00 6.72E-06 6.72E-06 6.72E-06 6.72E-06 6.72E-06 6.72E-06 C-14 1.82E-04 3.64E-05 3.64E-05 3.64E-05 3.64E-05 3.64E-05 3.64E-05 Na-24 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 P-32 1.18E-02 7.32E-04 4.55E-04 0.00E+00 O.OOE+00 0.00E+00 1.32E-03 Cr-51 O.OOE+00 O.OOE+00 'I.66E-07 9.92E-OS 3.66E-OS 2.20E-07 4.1 8E-05 Mn-54 O.OOE+00 2.92E-04 5.57E-05 O.OOE+00 8.68E-05 0.00E+00 8.94E-04 Mn-56 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Fe-55 1.76E-04 1.22E-04 2.83E-05 0.00E+00 0.00E+00 6.78E-05 6.97E-05 Fe-59 2.73E-04 6.43E-04 2.46E-04 0.00E+00 0.00E+00 1.80E-04 2.14E-03 Co-58 O.OOE+00 4.72E-05 1.06E-04 O.OOE+00 0.00E+00 0.00E+00 9.57E-04 C~O O.OOE+00 1.37E-04 3.02E-04 0.00E+00 0;OOE+00 0.00E+00 2.57E-03 Ni-63 8.32E-03 5.77E-04 2.79E-04 0.00E+00 0.00E+00 0.00E+00 1.20E-04 Ni-65 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Cu-64 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 Zn-65 3.09E-04 9.83E-04 4.44E-04 0.00E+00 6.57E-04 O.OOE+00 6.'I 9E-04 Zn-69 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Br-83 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+
Br-84 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+
Br-85 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-86 . '.00E+00 1.30E-03 6.06E-04 0.00E+00 0.00E+00 0.00E+00 2.57E-04 Rb-88 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Rb-89 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-89 1.94E-02 0.00E+00 5.58E-04 0.00E+00 0.00E+00 O.OOE+00 3.12E-03 Sr-90 4.85E-01 O.OOE+00 1.19E-01 0.00E+00 O.OOE+00 0.00E+00 1.40E-02 Sr-91 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Sr-92 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 Y-90 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Y-91m O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Y-91 8.92E-06 0.00E+00 2.38E-07 O.OOE+00 0.00E+00 0.00E+00 4,91E-03 Y-92 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Y-93 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Zr-95 1.92E-06 6.17E-07 4.18E-07 O.OOE+00 9.69E-07 O.OOE+00 1.96E-03 Zr-97 O.OOE+OO O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Nb-95 3.90E-07 2.17E-07 1.17E-07 O.OOE+00 2.15E-07 0.00E+00 1.32E-03 Mo-99 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Tc-99m O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+0 Appv Date ~ >
7 5'ev.
6-2b(1)
TABLE 6-2b REMP DOSE FACTORS FOR ADULTAGE GROUP:
LEAFY VEG. SAMPLE (Page 2 of 2)
REMP'lSA'MPL'E O'OSE:::CAL'C:;::FACTORS';::."":,~::!h..IADULTXEAFY--;VE'G".',!,;',l:-":;:: :~:;::;,.':;gq4:.':;::!::.:'.:::Q'iiir'em'-'Rg%p'Cf.yak:,;',:i';;f45::I
",',".'NVCUD'i::;"~p'-BONE:.'~i~>'(s :;":-.'.'.'iL~IVER>:: .;~ .:-.':, T BODY.,:":~ :"THYROID:":'::KIDNEY;"::;."..'.OOE+00 ,",,~i",'",sGl l"L'l:"::.
Tc-101 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ru-103 1.16E-05 0.00E+00 5.01E-06 0.00E+00 4.44E-05 O.OOE+00 1.36E-03 Ru-105 0,00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 RU-106 1.76E-04 0.00E+00 2.22E-05 0.00E+00 3.99E-04 O.OOE+00 1.14E-02 Ag-110m 1.02E-05 9.45E-06 5.61E-06 '.00E+00 1.86E-05 0.00E+00 3.85E-03 Te-125m 1.69E-04 6.14E-05 2.27E-05 5.10E-05 6.89E-04 0.00E+00 6.77E-04 Te-127m 4.31E-04 1.54E-04 5.25E-05 1.10E-04 1.75E-03 O.OOE+00 '1.44E-03 Te>>127 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Te-129m 7.21E-04 2.69E-04 1.14E-04 2.48E-04 3.01E-03 0.00E+00 3.63E-03 Te-129 1.97E-06 7.40E-07 4.80E-07 1.51E-06 8.28E-06 O.OOE+00 1.49E-06 Te-131m O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Te-131 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-132 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 1-1 30 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 1-1 31 2.44E-04 3.49E-04 2.00E-04 1.14E-01 O.OOE+00 9.22E-05 5.99E-04':OOE+00 1-132 O.OOE+00 O.OOE+00 'O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 1-133 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 1-134 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 1-135 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Cs-134 3.98E-03 9.46E-03 7.74E-03 0.00E+00 3.06E-03 1.02E-03 1.66E-04 Cs-136 3.95E-04 1.56E-03 1.1 2E-03 O.OOE+00 8.68E-04 1.19E-04 1.77E-04 Cs-137 5.10E-03 6.98E-03 4.57E-03 0.00E+00 2.37E-03 7.87E-04 1.35E-04 Cs-138 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+OO Ba-139 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Ba-140 1.23E-03 1.55E-06 8.06E-05 O.OOE+00 5.26E-07 8.85E-07 2.53E-03 Ba-141 0.00E+00 O.OOE+OO O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Ba-142 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 La-14O 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 La-142 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ce-141 5.86E-07 3.97E-07 4.50E-08 O.OOE+00 1.84E-07 O.OOE+00 1.52E-03 Ce-143 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Ce-144 3.12E-05 1.30E-05 1.67E-06 0.00E+00 7.73E-06 O.OOE+00 1.05E-02 Pr-143 5.59E-07 2.24E-07 2.77E-08 0.00E+00 1.30E-07 O.OOE+OO 2.45E-03 Pr-144 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Nd-147 3.78E-07 4.37E-07 2.61E-08 0.00E+00 2.55E-07 O.OOE+00 2.10E-03 W-187 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Np-239 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Appv Date Rev. 7 6-2b(2)
TABLE 6-2c REMP DOSE FACTORS FOR ADULTAGE GROUP: FRUlT SAMPLE (Page 1 of 2)
R EMP:SAMPLELO 'OSE,"CA 'C;!FACTORS:,:,:<<:::'!I>>!R'j ADUL ., R::~~>~,>'.',~",p,':.'; '~;; ~<:,:, ~~~',.'mrem+g/pC)';Yr> ':>'~'~
iI~N'U:CLIDEij"":;-'j'.i',!iBONE t'ai,'5j '::::"::."'L'IVER::,l> ,:"aT;:BODY;.'l ') I.:.'>>THYROlD::" 4i'",KlD'NEY~g( :~l.;> KUNG":,.'.> !jI IÃ",.ji;P!G'f/<>'L,>~
H-3 0.DOE+00 5.41E-05 5.41E-05 5.41E-05 5.41E-05 5.41E-05 5.41E-05 C-14 1.48E-03 2.95E-04 2.95E-04 2.95E-04 2.95E-04 2.95E-04 2.95E-04 Na-24 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 P-32 5.47E-03 3.40E-04 2.11E-04 O.DOE+00 O.DOE+00 O.DOE+00 6.14E-04 Cr-51 O.DOE+00 0.DOE+00 3.08E-07 1.84E-07 6.79E-08 4.09E-07 7.75E-05 Mn-54 O.DOE+00 2.08E-03 3.97E-04 O.DOE+00 6.19E-04 O.DOE+00 6.37E-03 Mn-56 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Fe-55 1.37E-03 9.47E-04 2.21E-04 O.DOE+00 O.DOE+00 5.28E-04 5.43E-04 Fe-59 8.89E-'04 2.09E-03 8.01E-04 O.DOE+00 0.DOE+00 5.84E-04 . 6.96E-03 Co-58 . 0.DOE+00 2.15E-04 4.83E-04 O.DOE+00 0.DOE+00 O.DOE+00 4.36E-03 Co-60 0.DOE+00 1.09E-03 2.40E-03 0.00E+OD 0.DOE+00 O.DOE+00 2.05E-02 Ni-63 6.75E-02 4.6 8E-03 2.26E-03 O.DOE+00 O.DOE+00 0.DOE+00 9.76E-04 Ni-65 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Cu-64 O.DOE+00 O.OOF+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Zn-65 2.12E-03 6.75E-03 3.05E-03 0.00E+0D 4.52E-03 O.DOE+00 4.25E-03 Zn-69 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 Br-83 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Br-84 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0 OOE Br-85 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.00E+
Rb-86 O.DOE+00 1.18E-03 5.50E-04 O.DOE+00 O.DOE+00 0.DOE+00 2.33E-04 Rb-88 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Rb-89 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 Sr-89 7.03E-02 0.DOE+00 2.02E-03 0.DOE+00 O.DOE+00 O.DOE+00 1.13E-02 Sr-90 3.93E+00 O.DOE+00 9.63E-01 0.DOE+00 0.DOE+00 0.DOE+00 1.13E-01 Sr-91 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 Sr-92 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 Y-90 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O,DOE+00 0.DOE+00 O.DOE+00 Y-91m 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Y-91 3.60E-05 0.DOE+00 9.63E-07 0.DOE+00 0.DOE+00 0.DOE+00 1.98E-02 Y-92 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Y-93 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Zr-95 8.26E-06 2.65E-06 1.79E-06 O.DOE+00 4.15E-06 O.DOE+00 8.39E-03 Zr-97 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Nb-95 9.88E-07 5.49E-07 2.95E-07 0.DOE+00 5.43E-07 O.ODE+,00 3.33E-03 Mo-99 O.DOE+00 0.DOE+00 O.DOE+00 D.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Tc-99m O.DOE+00 .O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Appv C
Date Rev. 7 6-2c(1)
TABLE 6-2c REMP DOSE FACTORS FOR ADULTAGE GROUP: FRUIT SAMPLE (Page 2 of 2)
';:i::hlUCLIDE."I" :.".;:.'g'.i;lVER::i,::i".:j f::::":iT'.BODY:::":. ,'":;THYROID.'; $'KlDNEY,.::",'; !:::::!g<uNs~~;.:,:, ! ':jtJ','~~hei-:&L'I'.:::
Tc-101 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 RU-103 3.34E-05 0.DOE+00 1.44E-OS 0.DOE+00 1.28E-04 O.DOE+00 3.90E-03 RU-105 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Ru-1 06 1.28E-03 O.DOE+00 1.62E-04 O.DOE+00 2.47E-03 O.DOE+00 8.27E-02 Ag-110m 7.04E-05 6.52E-05 3.87E-OS 0.DOE+00 1.28E-04 O.DOE+00 2.66E-02 Te-125m 6.80E-04 2.46E-04 9.11E-05 2.05E-04 2.77E-03 O.DOE+00 2.72E-03 Te-127m 2.40E-03 8.59E-04 2.93E-04 6.14E-04 9.76E-03 0.DOE+00 8.06E-03 Te-127 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 '0.DOE+00 Te-129m 1.73E-03 6.47E-04 2:74E-04 5.96E-04 7.24E-03 O.DOE+00 8.73E-03 Te-129 4.74E-06 1.78E-06 1.1 5E-06 3.63E-06 1.99E-05 O.DOE+00 3.57E-06 Te-131m O.DOE+00 O.ODE+OO O.DOE+DO O.ODE+OD D.ODE+OD O.DOE+00 O.DOE+00 Te-131 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Te-'I 32 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+DO O.DOE+00 I-130 O.DOE+00 O.DOE+00 O.DOE+00 0;DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 I-131 1.23E-05 1.75E-05 1.01E-05 5.75E-03 3.01E-05 O.DOE+00 4.63E-06 I-132 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 1-133 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 0.00E+00 I-134 O.DOE+00 O.DOE+OD O.ODE+DO O.ODE+00 O.DOE+00 O,DOE+00 O.DOE+00 I-135 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Cs-134 3.06E<<02 7.28E-02 5.95E-02 O.DOE+00 2.36E-02 7.82E-03 1.27E-O3 Cs-136 1.44E-04 5.67E-04 . 4.08E-04 0.DOE+00 3.15E-04 4.32E-05 6.44E-05 Cs-137 4.13E-02 5.65E-02 3.70E-02 O.DOE+00 1.92E-02 6.37E-03 1.09E<<03 Cs-138 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 Ba-139 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+90 Ba-140 4.09E-04 5.13E-07 2.68E-05 0.DOE+00 1.74E-07 2.94E-07 8.41E-04 Ba-141 O.DOE+00 O.DOE+00 O.DOE+00 . 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Ba-142 O.DOE+00 O.DOE+00 O.ODE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 La-140 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 La-142 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.OOE+00 Ce-141 1.35E-06 9.16E-07 1.04E-07 O.DOE+00 4.25E-07 O.DOE+00 3:50E-03 Ce-143 O.DOE+00 O.DOE+GO O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 Ce-144 2.19E-04 9.16E-05 1.1 8E-OS 0.DOE+00 5;44E-05 0.DOE+00 7.41E-02 Pr-143 2.23E-07 8.93E-08 1.10E-08 0.DOE+00 5.16E-08 O.DOE+00 9.76E-04 Pr-144 O.DOE+00 O.DOE+00 O.DOE+Do O.DOE+00 O.DOE+00 O.DOE+00 O.ODE+OD Nd-147 7.41E-08 8.56E-08 5.12E-09 0.DOE+00 5.01E-08 0.DOE+00, 4.11E-04 W-187 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Np-239 O.DOE+00 O.DOE+00 0.00E+'00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 Appv .44.>
Date PQ cjp Rev. 7 6-2c{2)
TABLE 6-2d REMP DOSE FACTORS FOR ADULTAGE GROUP: MEAT SAMPLE (Page 1 of 2)
'AfUCL"IDE ~4'::BONE:"~~ :i'%LIVER '.:::":!iT.-;BODY:.:".'.i.: :. THYROID!: ;. ii KIDNEY.-)g "'-:,~i'.UN8'~<".!~
'<-'.15E-05 K-3 0.00E+00 1.15E-05 1.15E-05 1.15E-05 1.15E-05 1.15E-05 C-14 3.12E-04 6.25E-05 6.25E-05 6.25E-05 6.25E-05 6.25E-05 6.25E-05 Na-24 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 P-32 8.05E-03 5.00E-04 3.11E-04 0.00E+00 O.OOE+00 0.00E+00 9.05E-04 Cr-51 O.OOE+00 O.OOE+00 1.77E-07 1.06E-07 3.91E-08 2.35E-07 4.46E-05 Mn-54 O.OOE+00 4.81E-04 9.18E-05 0.00E+00 1 43E-04 0.00E+00 1.47E-03 Mn-56 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Fe-55 2.98E-04 2.06E-04 4.80E-05 O.OOE+00 0.00E+00 1.15E-04 1.18E-04 Fe-59 3.50E-04 8.22E-04 3.15E-04 0.00E+00 0.00E+00 2.30E-04 2.74E-03 Co-58 0.00E+00 6.74E-05 1.51E-04 O.OOE+00 O.OOE+00 0.00E+00 1.37E-03 C~0 O.OOE+00 2.34E-04 5.1 5E-04 0.00E+00 0.00E+00 O.OOE+00 4.39E-03 Ni-63 1.43E-02 9.9'1E-04 4.79E-04 O.OOE+00 ~
O.OOE+00 O.OOE+00 2.07E-04 Ni65 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00-Cu~ 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Zn-65 5.03E-04 1.60E-03 7.23E-04 0.00E+00 1.07E-03 O.OOE+00 1.01E-03 Zn-69 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-83 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Br-85 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+OO O.OOE+00 O.OOE+0 Rb-86 O.OOE+00 1.10E-03 5.14E-04 0.00E+00 0.00E+00 0.00E+00 2.18E-04 Rb-88 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-89 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-89 2.58E-02 O.OOE+00, 7.39E-04 0.00E+00 O.OOE+00 O.OOE+00 4.13E-03 Sr-90 8.33E-01 0.00E+00 2.04E-01 0.00E+00 O.OOE+00 O.OOE+00 2.41E-02 Sr-91 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-92 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00,. O.OOE+00 Y-90 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91m O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Y-91 1.22E-05 O.OOE+00 3.27E-07 0.00E+00 O.OOE+00 O.OOE+00 6.74E-03 Y-92 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-93 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Zr-95 2.69E-06 8.64E-07 5.85E-07 0.00E+00 1.36E-06 O.OOE+00 2.74E-03 Zr-97 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 '.OOE+00 O.OOE+00 O.OOE+00 Nb-95 4.61E-07 2.56E-07 1.38E-07 0.00E+00 2.53E-07 O.OOE+00 1.56E-03 Mo-99 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Tc-99m 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rev. 7 6-2cI(1)
TABLE 6-2d REMP DOSE FACTORS FOR ADULT AGE GROUP: MEAT SAMPLE (Page 2 of 2) i.:':NU.CLAUDE'.,"
l:""'B'ONE>@:"- il'::~d'IYER l'.""'iC~T:BPDY'"i~ Ii".THQROlD:,'> @(~KIONEY-";;.::",:' i .',Gl-.'1'Ll);I~
Tc-101 O.OOE+00 . O.OOE+00 '.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Ru-103 1.43E-05 0.00E+00 6.16E-06 0.00E+00 5.46E-05 O.OOE+00 1.67E-03 RU-105 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ru-106 2.91E-04 O.OOE+00 3.69E-05 0.00E+00 5.63E-04 0.00E+00 1.89E-02 Ag-110m 1.67E-05 1.54E-05 9.15E-06 0.00E+00. 3.03E-05 0.00E+00 6.29E-03 Te-125m 2.32E-04 8.41E-05 3.11E-05 6.98E-05 9.44E-04 O.OOE+00 9.27E-04 Te-127m 6.56E-04 2.34E-04 7.99E-05 1.68E-04 2.66E-03 O.OOE+00 2.20E-03 Te-127 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Te-129m 8.37E-04 3.12E-04 1.33E-04 2.88E-04 3.50E-03 O.OOE+00 4.22E-03 Te-129 2.29E-06 8.59E-07 5.57E-07 1.75E-06 9.61E-06 O.OOE+00 1.73E-06 Te-131m 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 OgOOE+00 Te-131 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Te-132 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 I-130 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 I-131 8.16E-05 1.17E-04 6.69E-05 3,82E-02 2.00E-04 0.00E+00 3.08E-05 I-132 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 I-133 O.OOE+00 O.OOE+00 O.OOE>00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 I-134 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00- O.OOE+00 O.OOE+00 I-135 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 Cs-134 6.72E-03 1.60E-02 1.31E-02 0.00E+00 5.17E-03 1.72E-03 2.80E-04 Cs-136 2.50E-04 9.86E-04 7.10E-04 O.OOE+00 5.49E-04 7.52E-05 1.12E-04
'1.20E-02 1.35E-03 . 2.32E-04 Cs-137 8.76E-03 7.84E-03 0.00E+00 4.06E-03 Cs-138 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Ba-139 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+Ob Ba-140 7.55E-04 9.49E-07 4.95E-05 0.00E+00 3.23E-07 5.43E-07 1.56E-03 Ba-141 O.OOE+00 0.00E+00 0.00E+00 0;OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Ba-142 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 La-140 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 La-142 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Ce-141 6.72E-07 4.55E-07 5.16E-08 O.OOE+00 2.1 1E-07 O.OOE+00 1:74E-03 Ce-143 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Ce-144 5.11E-05 2.14E-05 2.74E-06 0.00E+00 1.27E-05 O.OOE+00 1.73E-02 Pr-143 3.64E-07 1.46E-07 1.80E-08 0.00E+00 8.43E-08 O.OOE+00 1.59E-03 Pr-144 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Nd-147 1.96E-07 2.26E-07 1.35E-08 0.00E+00 1.32E-07 O.OOE+00 1.09E-03 W-187 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Np-239 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Appv Date ~o(/'
Rev. 7 6-2d(2)
TABLE 6-2e REMP DOSE FACTORS FOR ADULT AGE GROUP: FlSH SAMPLE (Page 1 of 2)
REMP,: SAMPLE>DOSE-"CAL'C;::::FACTGRS'.").';.:;: ~<'""ADULTFISH'!l>'.':!'"-.M>>-:"> '~A"'"4::-:..;~gmrern'4g'Ipci"-yr,-',.'.,"..'.".;",~
k~",'4L'[VER>h>K>
,(MUCID E::::i ::'iT;BODY -.':::>T>.HYROID.:;;: '"~~KlDNEY:.!i,>> ""'.L'UNG'"""'l~-"Gl>I "Lt":".
H-3 O.OOE+00 2.20E-06 2.20E-06 2.20E-06 2.20E-06 2.20E-06 2.20E-06 C-14 5.96E-05 1.19E-05 1.19E-05 1.1 9E-05 1.19E-05 1.19E-05 1.19E-05 Na-24 1.18E-05 1.18E-05 1.18E-05 1.18E-05 1.18E-05 1.18E-05 1.18E-05 P-32 3.86E-03 2.40E-04 1.49E-04 O.OOE+00 0.00E+00 O.OOE+00 '4.34E-04 Cr-51 O.OOE+00 0.00E+00 5.45E-08 3.26E-08 1.20E-08 7.23E-08 1.37E-OS Mn-54 O.OOE+00 9.58E-05 1.83E-05 0.00E+00 2.85E-05' O.OOE+00 2.93E-04 Mn-56 0.00E+00 3.81E-09 6.76E-10 0.00E+00 4.84E-09 O.OOE+00 1.22E-07 Fe-55 5.77E-05 3.99E-05 9.30E-06 0.00E+00 O.OOE+00 2.22E-05 2.29E-05 Fe-59 8.97E-.05 2.11E-04 8.08E-05 0.00E+00 0.00E+00 5.89E-05 7.03E-04 Co-58 O.OOE+00 1.55E-05 3.47E-05 0.00E+00 O.OOE+00 O.OOE+00 3.14E-04 Co-60 0.00E+00 4.49E-05 9.91E-05 0.00E+00 0.00E+00 O.OOE+00 8.44E-04 Ni-63 2.73E-03 1.89E-04 9.16E-05 O.OOE+00 0.00E+00 0.00E+00 .3.95E-05 Ni<5 1.51E-08 1.96E-09 8.93E-10 0.00E+00 0.00E+00 O.OOE+00 4.96E-08 0.00E+00 4.72E-07 2.22E-07 0.00E+00 1.19E-06 0.00E+00 4.02E-05 Zn-65 1.01E-04 3.22E-04 1.46E-04 0.00E+00 2.16E-04 O.OOE+00 2.03E-04 Zn<9 3.58E-1 5 6.85E-1 5 4.76E-16 0.00E+00 4.45E-15 O.OOE+00 'l.03E-15 Br-83 O.OOE+00 O.OOE+00 8.01E-10 O.OOE+00 O.OOE+00 O.OOE+00 1.15E-09 B 84 O.OOE 00 0.00E 00 2.72E 20 O.OOE 00 O.OOE 00 Br-85 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+
Rb-86 O.OOE+00 4.27E-04 1.99E-04 0.00E+00 0.00E+00 0.00E+00 8.42E-05 Rb-88 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Rb-89 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Sr-89 6.38E-03 0.00E+00 1.83E-04 0.00E+00 0.00E+00 0.00E+00 1.02E-03 Sr-90 1.59E-01 O.OOE+00 3.91E-02 O.OOE+00 0.00E+00 0.00E+00 4.60E-03 Sr-91 2.07E-05 0.00E+00 8.35E-O7 0.00E+00 O.OOE+00 O.OOE+00 9.84E-05 Sr-92 9.74E-08 O.OOE+00 4.21E-09 0.00E+00 O.OOE+00 0.00E+00 1.93E-06 Y-90 1.56E-07 O.OOE+00 4.18E-09 0.00E+00 O.OOE+00 O.OOE+00 1.65E-03 Y-91m 3.78E-18 0.00E+00 1.47E-19 O.OOE+00 O.OOE+00 0.0 0E+00 1.11E-17 Y-91 2.93E-06 0.00E+00 7.82E-08 0.00E+00 0.00E+00 0.00E+00 1.61E-03 Y-92 1.62E-10 0.00E+00 4.72E-12 0.00E+00 0.00E+00 0.00E+00 2.83E-06 Y-93 1.08E-08 0.00E+00 2.99E-1 0 0.00E+00 O.OOE+00 O.OOE+00 3.44E-04 Zr-95 6.32E-07 2.03E-07 1.37E-07 0.00E+00 3.18E-07 0.00E+00 6.42E-04 Zr-97 1.32E-08 2.66E-09 1.22E-09 O.OOE+00 4.02E-09 0.00E+00 8.24E-04 Nb-95 1.28E-07 7.12E-08 3.83E-08 0.00E+00 7.04E-08 0.00E+00 4.32E-04 Mo-99 O.OOE+00 7.04E-05 1.34E-05 O.OOE+00 1.59E-04 O.OOE+00 1.63E-04 Tc-99m 3.27E-10 9.25E-10 1.18E-08 O.OOE+00 1.40E-08 4.53E-10 5.47E-07 Appv Date Rev. 7 6-2e(1)
TABLE 6-2e REMP DOSE FACTORS FOR ADULTAGE GROUP: FISH SAMPLE (Page 2 of 2)
- "tuUCLjDElI: ; BONE::4!:>> .."',-:4L'lYERi";,::;I "':::: T;B.ODY,;.' ~;THYROID,'::",
Tc-1 01 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ru-103 3.82E-06 0.00E+00 1.64E-06 O.OOE+00 1.46E-05 O.OOE+00 4 46E-04
'Ru-105 7.63E-09 O.OOE+00 3.01E-09 O.OOE+00 9.86E-OS 0.00E+00 4.67E-06 Ru-106 5.76E-05 O.OOE+00 7.29E-06 0.00E+00 1.11E-04 O.OOE+00 3.73E-03 Ag-110m 3.35E-06 3.10E-06 1.84E-06 O.OOE+00 . 6.09E-06. O.OOE+00 1Z6E-03 Te-125m 5.56E-05 2.01E-05 7.45E-06 1.67E-05 2.26E-04 0.00E+00 2.22E-04 Te-127m 1.41E-04 5.05E-05 1.72E-05 3.61E-OS 5.74E-04 O.OOE+00 4.74E-04 Te-127 3.90E-07 1.40E-07 8.44E-OS 2.89E-07 1.59E-06 O.OOE+00 3.08E-05 Te-129m 2.37E-04 8.83E-05 3.74E-05 8.13E-05 9.87E-04 O.OOE+00 1.19E-03 Te-129 6.46E-07 2.43E-07 1.57E-07 4.96E-07 2.72E-06 O.OOE+00 4.88E-07 Te-1 31m 2.09E-05 1.02E-05 8.50E-06 1.62E-05 1.03E-04 O.OOE+00 1.01E-03 Te-131 2.05E-24 0.00E+00 O.OOE+00 1.69E-24 8.98E-24 O.OOE+00 .O.OOE+00 Te-132 4.28E-05 2.77E-05 2.60E-05 3.06E-05 2.67E-04 0.00E+00 1.31E-03 I-1 30 4.13E-06 1.22E-05 4.81E-06 1.03E-03 1.90E-05 O.OOE+00 1.05E-05 I-131 8.01E-05 1.15E-04 6.57E-05 , 3.76E-02, 1.97E-04 O.OOE+00 3.02E-05 I-132 3.08E-09 8.24E-09 2.88E-09 2.88E-07 1.31E-08 0.00E+00 1.55E-09 I-133 1.34E-05 2.33E-05 7.11E-06 3.43E-03 4.07E-05 O.OOE+00 2.10E-05 I-134 1.33E-14 3.61E-14 1.29E-14 6.25E-13 5.73E-14 O.OOE+00 3.14E-17 I-1 35 7.51E-07 1.97E-06 7.26E-07 1.30E-04 3.15E-06 O.OOE+00 2.22E-06 Cs-134 1.30E-03 3.11E-03 2.54E-03 0.00E+00 1,00E-03 3.34E-04 5.43E-05 Cs-136 1.30E-04 5.12E-04 3.69E-04 0.00E+00 2.85E-04 3.90E-05 5.82E-05 Cs-137 1.67E-03 2.29E-03 1.50E-03 O.OOE+00 7.77E-04 2.58E-04 4.43E-05 Cs-138 4.25E-20 8.40E-20 4.16E-20 O.OOE+00 6.17E-20 6.1 0E-21 0.00E+00 Ba-139 1.27E-11 9.03E-15 3.71E-1 3 0.00E+00 8.44E-15 5.12E-1 5 2.25E-1 1 Ba-140 4.04E-04 5.07E-07 2.65E-05 O.OOE+00 1.72E-07 2.90E-07 8.31E-04 Ba-141 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-142 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 La-140 3.47E-08 1.75E-08 4.62E-09 0.00E+00 0.00E+00 O.OOE+00 1.28E-03 La-142 7.85E-14 3.57E-14 8.89E-1 5 0.00E+00 0.00E+00 O.OOE+00 2.61E-10 Ce-141 1.92E-07 1.30E-07 1.48E-08 0.00E+00 6.04E-08 0.00E+00 4.97E-04 Ce-143 2.09E-OS 1.55E-05 1.71E-09 0.00E+00 6.81E-09 O.OOE+00 5.78E-04 Ce-144 ,
1.02E-05 4.27E-06 5.49E-07 0.00E+00 2.53E-06 O.OOE+00 3.46E-03 Pr-143 1.84E-07 7.36E-08 9.10E-09 0.00E+00 4'.25E-08 O.OOE+00 8.04E-04 Pr-144 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Nd-147 1.24E-07 1.43E-07 8.58E-09 0.00E+00 8.38E-OS O.OOE+00 6.88E-04 W-187 1.08E-06 9.00E-07 3.14E-07 0.00E+00 0.00E+00 O.OOE+00 < 2.95E-04 Np-239 1.86E-08 1.83E-09 1.01E-09 O.OOE+00 5.71E-09 O.OOE+00 3.75E-04 Appv Date Rev. 7 6-2e(2)
TABLE 6-2f REMP DOSE FACTORS FOR ADULTAGE GROUP: DRINKING WATER (Page 1 of 2)
REMP:,-:SAtIHPLE~OOSE:,CALC~<FACTORS;,;i:;@ADULT>GRtNKtNG,ÃATER,i 'g,,r,,;:>,:; g~ynremdtterlpCtyg
,;-';NVGUDE;:: t""O'O'NE<"' ;:> q~ILlVER'>>.'!',":.:~ t'":!iT,";BODY;';!i~":THYR'OJDjI3: ,";:.;:I.,4'.:UNG'Tjgj, H-3 O.OOE+00 7.66E-05 7.66E-05 7.66E-05 7.66E-05 7.66E-05 7.66E-05 C-14 2.07E-03 4.15E-04 4.15E-04 4.15E-04 4.15E-04 4.15E-04 4.15E-04 Na-24 7.13E-04 7.13E-04 7.1 3E-04 7.13E-04 7.13E-04 7.13E-04 7.13E-04 P-32 1.38E-01 8.55E-03 5.32E-03 0.00E+00 O.OOE+00 O.OOE+00 1.55E-02 Cr-51 ,
0.00E+00 O.OOE+00 1.92E-06 1.1 5E-06 4.22E-07 2.54E-06 4.82E-04 Mn-54 O.OOE+00 3.33E-03 6.36E-04 O.OOE+00 9.92E-04 O.OOE+00 1.02E-02 Mn-56 O.OOE+00 3.33E-06 5.92E-07 0.00E+00 4.23E-06 O.OOE+00 1.06E-04 Fe-55 2.01E-03 1.39E-03 3.23E-04 O.OOE+00 O.OOE+00 7.74E-04 "7.95E-04 Fe-59 3.14E-03 7.39E-03 2.83E-03 O.OOE+00 O.OOE+00 2.06E-03 2.46E-02 Co-58 O.OOE+00 5.41 E-04 1.21E-03 O.OOE+00 O.OOE+00 O.OOE+00 1.10E-02 Co-60 O.OOE+00 1.56E-03 3.44E-03 O.OOE+00 O.OOE+00 O.OOE+00 2.93E-02 Ni-63 9.49E-02 6.58E-03 3.18E-03 O.OOE+00 0.00E+00 0.00E+00 1.37E-03 Ni-65 1.42E-05 1.85E-06 8.42E-07 0.00E+00 O.OOE+00 0.00E+00 4.68E-05 Cu-64 O.OOE+00 3.16E-05 1.48E-05 O.OOE+00 7.96E-05 0.00E+00 2.69E-03 Zn-65 3.53E-03 1.12E-02 5.07E-03 O.OOE+00 7.51E-03 O.OOE+00 7.07E-03 Zn-69 9.68E-10 1.85E-09 1.29E-10 O.OOE+00 '.20E-09 O.OOE+00 2.78E-10 Br-83 O.OOE+00 O.OOE+00 9.04E-07 O.OOE+00 O.OOE+00 O.OOE+00 1.30E-06 Br-84 O.OOE+00 O.OOE+00 6.00E-12 O,OOE+00 O.OOE+00 O.OOE+00 4.71E Br-85 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+
Rb-86 0.00E+00 1.51E-02 7.04E-03 O.OOE+00 O.OOE+00 O.OOE+00 2.98E-03 Rb-88 O.OOE+00 3.11E-17 1.65E-17 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Rb-89 0.00E+00 2.86E-19 2.01E-19 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-89 2.23E-01 O.OOE+00 6 41E-03 0.00E+00 0.00E+00 0.00E+00 3.58E-02 Sr-90 5.53E+00 0.00E+00 1.36E+00 O.OOE+00 0.00E+00 O.OOE+00 1.60E-OI Sr-91 1.72E-03 O.OOE+00 6.96E-05 O.OOE+00 O.OOE+00 O.OOE+00 8.21E-03 Sr-92 7.29E-05 O.OOE+00 3.15E-06 0.00E+00 O.OOE+0 0 0.00E+00 1.44E-03 Y-90 6.17E-06 0.00E+00 1.65E-07 0.00E+00 0.00E+00 0.00E+00 6.54E-02 Y-91m 2.95E-12 0.00E+00 1.14E-13 O.OOE+00 O.OOE+00 0.00E+00 8.68E-12 Y-91 1.02E-04 0.00E+00 2.74E-06 O.OOE+00 O.OOE+00 0.00E+00 5.63E-02 Y-92 5.88E-08 O.OOE+00 1.72E-09 O.OOE+00 O.OOE+00 0.00E+00 1.03E-03 Y-93 8.59E-07 0.00E+00 2.37E-08 O.OOE+00 0.00E+00 0.00E+00 2.72E-02 Zr-95 2.21E-05 7.08E-06 4.79E-06 0.00E+00 1.11E-05 0.00E+00 2.24E-02 Zr-97 7.50E-07 1.51E-07 6.92E-08 O.OOE+00 2.28E-07 O.OOE+00 4.69E-02 Nb-95 4.50E-06 2.50E-06 1.34E-06 0.00E+00 2.47E-06 O.OOE+00 1.52E-02 Mo-99 0.00E+00 2.77E-03 5.28E-04 O.OOE+00 6.28E-03 O.OOE+00 6.43E-03 Tc-99m 4.53E-08 1.28E-07 1.63E-06 O.OOE+00 1.94E-06 6.27E-08 . 7.57E-05 Appv Date Rev. 7 6-2f(1)
TABLE 6-2f REMP DOSE fACTORS FOR ADULTAGE GROUP: DRINKING WATER (Page 2 of 2) r REMP-;O'O'IHPLEiOOSElC'ALC:.';FA'CTORS+,!.,'-O'DUL'":6,:
.<BPP j>>$.>w THYRO.lDi.' .p;:.'jNDNEY!j~'!i:;;::";N."UNG Tc-101 1.08E-22 1.56E-22 -'.53E-21 0.00E+00 2.81E-21 7.98E-23 O.OOE+00 Ru-103 1.34E-04 O.OOE+00 5.77E-05 O.OOE+00 5.11E-04 O.OOE+00 1.56E-02 Ru-105 1.73E-'06 O.OOE+00 6.82E-07 O.OOE+00 2.23E-05 O.OOE+00 1.06E-03 RU-106 2.01E-03 O.OOE+00 2.54E-04 O.OOE+00 3.87E-03 0.00E+00 1.30E-01 Ag-110m 1.17E-04 1.08E-04 6.41E-05 0.00E+00 2.12E-04 0.00E+00 4.40E-02 Te-125m 1.94E-03 7.05E-04 2.61E-04 5.85E-04 7.91E-03 O.OOE+00 7.76E-03 Te-127m 4.93E-03 1.76E-03 6.00E-04 1.26E-03 2.00E-02 O.OOE+00 1.65E-02 Te-127 3.30E-05 1.18E-05 7.14E-06 2.44E-05 1.34E-04 O.OOE+00 2.60E-03 Te-129m 8.31E-03 3.10E-03 1.31E-03 2.85E-03 3.47E-02 0.00E+00 4.1 8E-02 Te-129 2.27E-05 8.53E-06 5.53E-06 1.74E-05'.41 9.54E-05 0.00E+00 1.71E-05 Te-131m 9.57E-04 4.68E-04 3.90E-04 E-04 4.74E-03 O.OOE+00 4.65E-02 Te-131 3.20E-14 1.34E-14 1.01E-14 2.63E-14 1.40E-13 O.OOE+00 4.53E-15 Te-132 1.65E-03 1.07E-03 1.00E-03 1.18E-03 1.03E-02 0.00E+00 5.06E-02 I-130 2.82E-04 8.31E-04 3.28E-04 7.04E-02 1.30E-03 0.00E+00 7.15E-04 l-131 2.91E-03 4.16E-03 2.38E-03 1.36E+00 7.13E-03 0;OOE+00 1.10E-03 1-132 3.98E-06 1.07E-05 3.73E-06 '3.73E-04 1.70E-05 0.00E+00 2.00E-06 I-133 6.95E-04 3.69E-04 1.78E-01 2.11E-03 O.OOE+00 1.09E-03 1.21E-03'.97E-09 l>>134 1.62E-08 5.81E-09 2.81E-07 2.58E-08 0.00E+00 1.41E-11 l-135 9.19E-05 2.41E-04 8.88E-05 1.59E-02 3.86E-04 O.OOE+00 2.72E-04 Cs-134 4.54E-02 1.08E-01 8.83E-02 0.00E+00 3.50E-02 1.16E-02 1.89E-03 Cs-136 4.63E-03 1.83E-02 1.32E-02 0.00E+00 1.02E-02 1.39E-03 2.08E-03 Cs-137 5.82E-02 7.96E-02 5.21E-02 0.00E+00 2.70E-02 8.98E-03 1.54E-03 Cs-138 7.72E-12 1.52E-11 7.55E-12 0.00E+00 1.12E-11 1.1 1E-12 6.50E-17 Ba-1 39 1.77E-07 1.26E-10 5.17E-09 0.00E+00 1.18E-10 7.14E-11 3.13E-07 Ba-140 1.44E-02 1.81E-05 9.45E-04 0.00E+00 6.'I6E-06 1.04E-05 2.97E-02 Ba-141 4.97E-17 3.76E-20 1.68E-18 0.00E+00 3.50E-20 2.1 3E-20 0.00E+00 Ba-142 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 La-140 1.48E-06 7.48E-07 1.98E-07 0.00E+00 O.OOE+00 O.OOE+00 5.49E-02 La-142 5.05E-10 2.30E-10 5.72E-11 0.00E+00 O.OOE+00 0.00E+00 1.68E-06 Ce-141 6.76E-06 4.57E-06 5.19E-07 O.OOE+00 2.12E-06 O.OOE+00 1.75E-02 Ce-143 9.36E-07 6.92E-04 7.66E-08 O.OOE+00 3.05E-07 0.00E+00 2.59E-02 Ce-144 3.56E-04 1.49E-04 1.91E-05 O.OOE+00 8.82E-05 O.OOE+00 1.20E-01 Pr-143 6.55E-06 2.63E-06 3.24E-07 O.OOE+00 1.52E-06 O.OOE+00 2.87E-02 Pr-144 6.67E-21 2.77E-21 3.39E-22 0.00E+00 1.56E-21. O.OOE+00 O.OOE+00 Nd-147 4.45E-06 5.14E-06 3.08E-07 O.OOE+00 3.01E-06 0.00E+00 2.47E-02 W-187 5.30E-05 4.43E-05 1.55E-05 O.OOE+00 0.00E+00 0.00E+00; 1.45E-02 Np-239 7.50E-07 7.37E-08 4.06E-08 0.00E+00 2.30E-07 O.OOE+00 1.51E-02 Appv /~r, "i' Date g' Rev. 7 / 6-2f(2)
TABLE 6-2g REMP DOSE FACTORS FOR ADULTAGE GROUP:
INHALATION- QUARTERLY SAMPLING (Page 1 of 2)
REMP~SAMPL'E(DOSE
- .".NU,CLlDE 0,-'-3
- '"-;;!i.'.!L'IVER:ii~i:;";g;SODY!i~ jiTHYROIDi:~)~KIDNEY;~!:,,"< Ki!: LUNG'"Rj '.:::,.!~Gt-'4'Ll,.l::ii,';!l O.OOE+00 1.27E-03 1.27E-03 1.27E-03 1.27E-03 1.27E-03 1.27E-03 C-14 1.82E-02 3.41E-03 3.41E-03 3.41E-03 3.41E-03 3.41E-03 3.41E-03 Na-24 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 P-32 1.21E+01 7.05E-01 4.58E-01 0.00E+00 O.OOE+00 0.00E+00 7.90E-01 Cr-51 0.00E+00 0.00E+00 3.1 3E-04 '.86E-04 7.14E-05 4.51E-02 1.04E-02 Mn-54 0.00E+00 4.38E-02 6.97E-03 O.OOE+00 1.09E-02 1.55E+00 8.56E-02 Mn-56 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Fe-55 2.54E-02 1.75E-02 4.07E-03 0.00E+00 0.00E+00 7.44E-02 6.23E-03 Fe-59 2.39E-02 5.64E-02 2.14E-02 0.00E+00 O.OOE+00 2.06E+00 3.82E-01 Co-58 O.OOE+00 2.48E-03 '.24E-03 0.00E+00 O.OOE+00 1.45E+00 1.66E-01 Co-60 O.OOE+00 1.17E-02 1.50E-02 0.00E+00 O.OOE+00 6.07E+00 2.90E-01 Ni-63 4.32E-01 3.1 5E-02 1.45E-02 Q.OOE+00 O.OOE+00 1.79E-01 1.34E-02 Ni5 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 Cu-64 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Zn5 3.69E-02 1.17E-01 5.30E-02 O.OOE+00 7.85E-02 9.83E-01 6.08E-02 Zn-69 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+OO Br-83 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+
Br-84 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOEioo 0.00E+00 O.OOE+
Br-85 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Rb-86 O.OOE+00 7.36E-01 3.21E-01 O.OOE+00 O.OOE+00 O.OOE+00 9.06E-02 Rb-88 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 . 0.00E+00 Rb-89 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 Sr-89 5.68E-01 0.00E+00 1.63E-02 O.OOE+00 0.00E+00 2.62E+00 6.54E-01
.Sr-90 9.95E+01 O.OOE+00 6.11E+00 '.OOE+00 O.OOE+00 9.63E+00 7.24E-01 Sr-91 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Sr-92 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-90 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Y-91m 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91 7.94E-01 0.00E+00 2.13E-02 O.OOE+00 O.OOE+00 2.93E+00 6.61E-01 Y-92 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Y-93 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Zr-95 1.76E-01 5.64E-02 3.82E-02 O.OOE+00 8.88E-02 2.90E+00 2.46E-01 Zr-97 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Nb-95 3.47E-02 1.93E-02 1.04E-02 O.OOE+00 1.91E-02 1.24E+00 2.56E-01 Mo-99 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 . 0.00E+00 Tc-99m 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+0 Appv '-ic'~
Date Rev. 7 6-2g(1)
TABLE.6-2g REMP DOSE FACTORS FOR ADULTAGE GROUP:
INHALATION- QUARTERLY SAMPLING (Page 2 of 2)
~;;;:i::,LlVER:.;::i::".::': Ii-:T;.'B;ODY:;:i' .;::g HYROlD:"::: :.,! ~! ".%HAGI-'L~L'I',Y
KIDNEY!;:.:,'.OOE+00 Tc-101 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Ru-103 3.41E-03 0.00E+00 1.47E-03 O.OOE+00 1.30E-02 1.13E+00 2.47E-01 RU-105 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ru-106 7.53E-02 0.00E+00 9.50E-03 0.00E+00 1,46E-01 1.02E+01 9.94E-01 Ag-110m 1.23E-02 1.13E-02 6.75E-03 0.00E+00 2.23E-02 5.26E+00 3.43E-01 Te-125m 5.89E-03 2.73E-03 8.06E-04 1.81E-03 2.14E-02 5.41E-01 1.22E-01 Te-127m 1.69E-02 7.71E-03 2.10E-03 4.39E-03 6.12E-02 1.28E+00 2.00E-01 Te-127 0.00E+00 . 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Te-129m 2.50E-02 4.06E-03 '.20E-02 8.82E-03 9.37E-02 2.97E+00 9.82E-01 Te-129 1.28E-07 6.13E-08 3.18E-08 9.99E-08 4.80E-07 4.96E-03 4.02E-04 Te-131m 0.00E+00 O.OOE+0 0 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-131 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Te-132 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 I-'I30 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 l-131 1.29E+00 1.83E+00 1.05E+00 6.09E+02 3.1 3E+00 O.OOE+00 3.21E-01 I-132 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 I-133 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 I-134 0.00E+00 0.00E+00 O.OOE+00 O.OQE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Cs-134 3.89E-01 8.84E-01 7.59E-01 O.OOE+00 3.00E-01 1.02E-01 1.08E-02 Cs-136 4.32E-01 1.62E+00 1.22E+0$ 0.00E+00 9.47E-01 1.33E-01 1.29E-01 Cs-1 37 4.80E-01 6.23E-01 4.29E-01 0.00E+00 2.23E-01 7.54E-02 8.42E-03 Cs-138 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Ba-139 O.OOE+00 0.00E+00 ~
0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Ba-140 4.63E-01 5.81E-04 3.04E-02 O.OOE+00 1.98E-04 1.51E+01 2.59E+00 "Ba-141 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Ba-142 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 La-140 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 La-142 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ce-141 5.27E-02 3.58E-02 4.04E-03 0.00E+00 1.66E-02 9.57E-01 3.18E-01 Ce-143 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 Ce-144 3.84E+00 1.60E+00 2.06E-01 0.00E+00 9.48E-01 8.69E+00 9.12E-01 Pr-143 9.64E-02 3.86E-02 4.78E-03 0.00E+00 2.22E-02 2.89E+00 2.06E+00 Pr-144 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Nd-147 9.39E-02 1.09E-01 6.50E-03 O.OOE+00 6.34E-02 3.93E+00 3.08E+00 W-187 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Np-239 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Appv Rev. 7 6-2g(2)
TABLE 6-2h REMP DOSE FACTORS FOR ADULTAGE GROUP:
INHALATION- WEEKLY SANIPLING (Page 1 of 2) i>:-":JUL,"tDE';:"j,".;:;:"".',B'O<NE-..'f!::I l,';:",:ll.!UVER;:g::i),.:"...".T';BODY,:::::,::!:": ~T:H,YROfp.:~jig H-3 O.OOE+00 1.26E-03 1.26E-03 1.26E-03 1.26E-03 1.26E-03 1.26E-03 C-14 1.82E-02 3.41E-03 3.41E-03 3.41E-03 3.41E-03 3.41E-03 3.41E-03 Na-24 O.OOE+00 O.OOE+00 . O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 P-32 1.56E+00 9.14E-02 5.93E-02 0.00E+00 O.OOE+00 0.00E+00 1.02E-01 Cr-51 O.OOE+00 O.OOE+00 1.09E-04 6.50E-05 2.49E-05 1.57E-02 3.62E-03 Mn-54 0.00E+00 3.99E-02 6.35E-03 O.OOE+00 9.92E-03 1.41E+00 7.80E-02 Mn-56 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 'O.OOE+00 Fe-55 2.46E-02 1.70E-02 3.95E-03 0.00E+00 0.00E+00 7.23E-02 6.05E-03 Fe-59 1.24E-02 2.93E-02 1.11E-02 O.OOE+00 0.00E+00 1.07E+00 1.99E-01 Co-58 O.OOE+00 1.64E-03 2.14E-03 O.OOE+00 0.00E+00 9.60E-01 1.10E-01 Co-60 O.OOE+00 1.15E-02 1.48E-02 0.00E+00 0.00E+00 5.98E+00 2.85E-01 Ni<3 4.32E-01 3.14E-02 1.45E-02 O.OOE+00 O.OOE+OO 1.78E-01 1.34E-02 Ni-65 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Cu-64 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Zn-65 3.27E-02 1.04E-01 4.70E-02 0.00E+00 6;96E-02 8.73E-01 5.40E-02 Zn-69 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-83 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+
Br-84 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+
Br-85 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-86 0.00E+00 1.54E-01 6.71E-02 0.00E+00 O.OOE+00 0.00E+00 1.90E-02 Rb-88 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 . O.OOE+00 Rb-89 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-89 3.19E-01 0.00E+00 9.15E-03 0.00E+00 O.OOE+00 1.47E+00 3.67E-01 Sr-90 9.92E+01 O.OOE+00 6.10E+00 O.OOE+00 O.OOE+00 9.60E+00 7.22E-01 Sr-91 O.OOE+00 O.OOE+00 O.OOE+00 0:OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-92 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-90 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91m O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91 4.82E-01 0.00E+00 1.29E-02 0.00E+00 O.OOE+00 1.78E+00 4.01E-01 Y-92 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00
, Y-93 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00
'Zr-95 1.11E-01 3.57E-02 2.42E-02 0.00E+00 5.63E-02 1.84E+00 1.56E-01 Zr-97 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Nb-95 1.51E-02 8.38E-03 4.51E-03 0.00E+00 8.29E-03 5.41E-01 1.11E-01 Mo-99 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Tc-99m 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+0 Appv Rev. 7 6-2h(1)
TABLE 6-2h REMP DOSE FACTORS FOR ADULTAGE GROUP:
INHALATION- WEEKLY SAMPLING (Page 2 of 2) l:,"::NUCUD.E.'-;,':": ::::i '."'-.BONE';::,"::.j:,';:,,:-;L'lVER~:"'I ~.:>.'T~B;0DY:i','"':: Tg YRO!D:E igjglP,NEYgj!. ~'j-;;>'LUNSj,'::.".,":; ';i,:~GI,LLI,"'l4 Tc-101 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Ru-1 03 1.63E-03 0.00E+00 7.00E-04 O.OOE+00 6.20E-03 5.37E-01 1.17E-01 Ru-1 05 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ru-106 6.96E-02 0.00E+00 8.78E-03 0.00E+00 1.34E-01 9.42E+00 9'.1 8E-01 Ag-110m 1.09E-02 1.01E-02 6.00E-03 0.00E+00 1.99E-02 4.68E+00 3.05E-01 Te-125m 3.56E-03 1.65E-03 4.87E-04 1.09E-03 1.29E-02 3.27E-01 7.37E-02 Te-127m 1.29E-02 5.90E-03 1.60E-03 3.36E-03 4.68E-02 9.82E-01 1.53E-01 Te-127 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+Otl Te-129m 1.05E-02 5.02E-03 1.70E-03 3.70E-03 3.93E-02 1.25E+00 4.12E-01 Te-129 5.35E-08 2.57E-08 1.33E-08 4.19E-08 2.01E-07 2.08E-03 1.69E-04 Te-131m O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-131 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Te-132 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 1>>130 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 1-131 2.52E-02 3.58E-02 2.05E-02 1.1 9E+01 6.13E-02 0.00E+00 6.28E-03 1-132 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 '.OOE+00 0;OOE+00 O.OOE+00 1-133 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 1-134 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0".OOE+00 O.OOE+00 O.OOE+00 1-135 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Cs-134 3.74E-01 8.51E-01 7.30E-01 O.OOE+00 2.88E-01 9.79E-02 1.04E-02 Cs-136 4.69E-02 1.76E-01 1.33E-01 O.OOE+00 1.03E-01 1.44E-02 1 40E-02 Cs-137 4.79E-01 6.21E-01 4.28E-01 0.00E+00 2.22E-01 7.52E-02 8.40E-03
~ Cs-138 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Ba-139 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Ba-140 4.72E-02 5.93E-05 3.10E-03 O.OOE+00 2.02E-05 1.54E+00 2.64E-01 Ba-141 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Ba-142 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00, 0.00E+00 La-140 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 La-142 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00. 0.00E+00 O.OOE+00 O.OOE+00 Ce-141 2.15E-02 1.46E-02 1.65E-03 0.00E+00 6.75E-03 3.90E-01 1.29E-01 Ce-143 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Ce-144 3.46E+00 1.44E+00 1.86E-01 O.OOE+00 8.55E-01 7.84E+00 8.23E-01 Pr-143 1.12E-02 4.49E-03 5.55E-04 0.00E+00 2.58E-03 3.36E-01 2.39E-01 Pr-144 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Nd-147 6.58E-03 7.60E-03 4.55E-04 O.OOE+00 4.44E-03 2.75E-01 ~ 2.16E-01 W-'187 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Np-239 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Appy .i:c- ~
Rev. 7 6-2h(2)
TABLE 6-3a REMP DOSE FACTORS FOR TEEN AGE GROUP: MILK(Page 1 of 2)
REMI?,'SAMPL>>IDOSE;: CALC'.~,:FACTORS"P:~j'~ ~.,'::,',-'>TEEN>MIL>K':."~:F4'j.:$:I: Ijt:.::>,":":::;>'<~m'remdit'er/p'I-'.ijr:"; ':"'"
IINUCU'D'Egk " "~BONE:@>>- :;":>~ILIVERk!.":i > <<~T";BODY:")~": ,T.HYROID.'; P",: KIDNEY,.:>:'.;. .".."::::">.",'l",UN G;-.'j,.'.'".'> I:::.',Gl4".L'I~j~, >',."
H-3 O.DOE+00 4.24E-05 4.24E-05 4.24E-05 4.24E-05 4.24E-05 4.24E-05 C-14 1.62E-03 3.25E-04 3.25E-04 3.25E-04 3.25E-04 3.25E-04 3.25E-04 Na-24 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 P-32 1.00E-01 6.21E-03 3.88E-03 0.DOE+00 O.DOE+00 O.DOE+00 8.42E-03 Cr-51 0.DOE+00 O.DOE+00 1.37E-06 7.61E-07 3.00E-07 1.96E-06 2.30E-04 Mn-54 0.DOE+00 2.35E-03 4.66E-04 0.DOE+00 7.01E-04 O.DOE+00 4.82E-03 Mn-56 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Fe-55 1.51E-03 1.07E-03 2.50E-04 O.DOE+00 0.DOE+00 6.79E-04 4.63E-04 Fe-59 2.28E-03 5;31E-03 2.05E-03 0.DOE+00 O.DOE+00 1.68E-03 1.26E-02 Co-58 0.DOE+00 3.81E-04 8.79E-04 0.DOE+00 0.DOE+00 0.DOE+00 5.26E-03 Co-60 O.DOE+00 1.12E-03 2.53E-03 O.DOE+00 O.DOE+00 0.DOE+00 1.46E-02 Ni-63 7.08E-02 5.00E-03 2.40E-03 O.DOE+00 D.DOE+00 0.DOE+00,7.96E;04 Ni-65 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Cu~ O.DOE+00 0'.DOE+00 0.DOE+00 O.ODE+0D 0.DOE+00 O.DOE+00 0.DOE+00 Zn-65 2.29E-03 7.95E-03 3.71E-03 O.DOE+00 5.09E-03 0.DOE+00 3.37E-03 Zn-69 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 Br-83 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Br-84 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+
Br-85 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+0 Rb-86 O.DOE+00 1.11E-02 5.20E-03 O.DOE+00 O.DOE+00 0.DOE+00 1.64E-03 Rb-88 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Rb-89 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 Sr-89 1.71E-01 O.DOE+00 4.90E-03 0.DOE+00 0.DOE+00 0.DOE+00 2.04E-02 Sr-90 ~
3.32E+00 0.DOE+00 8.20E-01 0.DOE+00 0.DOE+00 0.DOE+00 9.32E-02 Sr-91 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Sr-92 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 Y-90 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 Y-91m 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Y-91 7.85E-05 O.DOE+00 2.11E-06 0.DOE+00 0.DOE+00 0.DOE+00 3.22E-02 Y-92 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Y-93 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.00E+00 Zr-95 1.61E-05 5.09E-06 3.50E-06 O.DOE+00 7.48E-06 0.DOE+00 1.17E-02 Zr-97 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Nb-95 3.16E-06 1.75E-06 9.65E-07 O.DOE+00 1.70E-06 0.DOE+00 7.50E-03 Mo-99 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Tc-99m O.DOE+00 Q.DOE+00 O.DOE+00 0.00E+00 0.DOE+00 Q.DOE+00 O.DOE+00 Appv Date ~ ~ Lr/r?
Rev. 7 6-3a(1)
TABLE 6-3a REMP DOSE FACTORS FOR TEEN AGE GROUP: MILK(Page 2 of 2)
REMP~SAMPLE>DOSE::.:CALC&FACTORS ~!l'>>F:::-.::-:::.::::"~TEEN "jl'i-"m'rem-.kiter/pCI-:yt<@';>4!~~>>j~~'-"
MILKj"'"'";g.-".".-:"'~>.:>>vi::-':"
.;:.j" hlU.CLI DE~:", :;-::":.'BONE)'.;"','."':.::LlVER:.:::.:', ",:".:';:T;BODYg~~j" '.::::..:":fHYROID)
Tc-1 01 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 RU-1 03 9.85E-05 0.00E+00 4.21E-05 O.OOE+00 3.47E-04 O.OOE+00 8.23E-03 Ru-1 05 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 RU-106 1.56E-03 . 0.00E+00 1.97E-04 O.OOE+00 3.01E-03 O.OOE+00 7.49E-02 Ag-110m 8.15E-05 7.72E-05 4.69E-05 O.OOE+00 1.47E-04 O.OOE+00 2.17E-02 Te-125m 1.50E 03 5.39E-04 2.00E-04 4.18E-04 O.OOE+00 O.OOE+00 4.41E-03 Te-127m 3.82E-03 1.35E-03 4.54E-04 9.08E-04 1.55E-02 0.00E+00 9.52E-03 Te-127 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Te-129m 6.26E-03 2.32E-03 9.90E-04 2.02E-03 2.62E-02 O.OOE+00 2.35E-02 Te-129 1.72E-05 6.41E-06 4.18E-06 1.23E-05 7.22E-05 0.00E+00 9.4OE-O5 Te-131m 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Te-131 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 .0.00E+00 Te-132 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 I-130 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 l-131 1.97E-03 2.76E-03 1.48E-03 8.05E-01 4.75E-03 O.OOE+00 5.45E-04 I-132 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 I-133 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00,0.00E+00 0.00E+00 l-134 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 l-135 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 Cs-134 3.34E-02 7.87E-02 3.65E-02 O.OOE+00 2.50E-02 9.54E-03 9.78E-04 Cs-136 3.09E-03 1.22E-02 8.17E-03 O.OOE+00 6.62E-03 1.04E-03 9.79E-04 Cs-137 4.48E-02 5.96E-02 2.08E-02 O.OOE+00 2.03E-02 7.88E-03 8.48E-04 Cs-138 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 Ba-139 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-140 1.02E-02 1.25E-06 6.57E-04 O.OOE+00 4.24E-06 8.40E-06 1.57E-02 Ba-141 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-142 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 '.OOE+00 O.OOE+00 La-140 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 La-142 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Ce-141 5.10E-06 3.40E-06 3.91E-07 O.OOE+00 1.60E-06 O.OOE+00 9.74E-03 Ce-143 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 Ce-144 2.77E-04 1.15E-04 1.49E-05 O.OOE+00 6.85E-05 O.OOE+00 6.97E-02 Pr-143 4.73E-06 1.89E-06 2.35E-07 O.OOE+00 1.10E-06 0.00E+00 1.56E-02 Pr-144 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Nd-147 3.31E-06 3.60E-06 2.15E-07 0.00E+00 2.11E-06 O.OOE+00 1.30E-02 W-187 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Np-239 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 Appv l~c; )
Date i/~/9' 6-3a(2)
TABLE 6-3b REMP DOSE FACTORS FOR TEEN AGE GROUP: LEAFYVEG. SAMPLES (Page 1 of 2)
REMP,,-',SAMPL'd(DOSE: CALrC.
8B.ONE'i"Ã
':NUCLrIDE.";:.". ,".';":(>USER(gq I'.'-:~ T;:BODY::::";:. i":: ~)kiDNEY.-'.,'., L>UNG f~."'~I,-LLt:::::.,
THYROID"'.45E-06 H-3 O.OOE+00 4.45E-06 4.45E-06 4.45E-06 4.45E-06 4.45E-06 C-14 1.71E-04 3.41E-05 3.41E-05 3.41E-05 3.41E-05 3.41E-05 3.41E-05 Na-24 '.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 P-32 1.10E-02 6.84E-04 4.28E-04 O.OOE+00 0.00E+00 0.00E+00 9.28E-04 Cr-51 0.00E+00 0.00E+00 1.47E-07 8.1 9E-08 3.23E-08 2.11E-07 2.48E-05 Mn-54 0.00E+00 2.47E-04 4.90E-05 0.00E+00 7.38E-05 0.00E+00 5.07E-04 Mn-56 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Fe-55 1.59E-04 1.12E-04 2.62E-05 0.00E+00 O.OOE+00 7.13E-05 4.87E-05 Fe-59 2.43E-04 5.67E-04 2.19E-04 0.00E+00 0.'OOE+00 1.79E-04 1.34E-03 Co-58 0.00E+00 4.04E-05 9.32E-05 0.00E+00 O.OOE+00 O.OOE+00 5.57E-04 Co-60 O.OOE+00 1.18E-04 2.66E-04 0.00E+00 0.00E+00 0.00E+00 1.54E-03 Ni-63 7.43E-03 5.25E-04 2.52E-04 O.OOE+00 0.00E+00 O.OOE+OO 8.36E-05 Ni-65 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00- O.OOE+00 O.OOE+00 O.OOE+00 Cu-64 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Zn-65 2.41E-04 8.38E-04 3.91E-04 0.00E+00 5.36E-04 O.OOE+00 3.55E-04 Zn-69 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Br-83 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Br-84 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+
Br-85 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+0 Rb-86 0.00E+00 1.21E-03 5.67E-04 0.00E+00 0.00E+00 0.00E+00 1.78E-04 Rb-88 0.00E+00 0.00E+00 . O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 '.OOE+00 Rb-89 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Sr-89 1.82E-02 0.00E+00 5.22E-04 0.00E+00 O.OOE+00 O.OOE+00 2.17E-03 Sr-90 3.49E-01 O.OOE+00 8.61E-02 0.00E+00 0.00E+00 O.OOE+00 9.79E Sr-91 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-92 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Y-90 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91m 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Y-91 8.34E-06 0.00E+00 2.24E-07 0.00E+00 0.00E+00 O.OOE+00 3.42E-03 Y-92 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Y-93 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Zr-95 1.71E-06 5.40E-07 3.71E-07 O.OOE+0 0 7;94E-07 0.00E+00 1.25E-03 Zr-97 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Nb-95 3.38E-07 1.88E-07 1.03E-07 O.OOE+00 1.82E-07 0.00E+00 8.03E-04 Mo-99 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 Tc-99m 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Appv c +~< i Rev. 7 6-3b(1)
.TABLE 6-3b REMP DOSE FACTORS FOR TEEN AGE GROUP: LEAFY VEG. SAMPLES (Page 2 of 2)
REMP.':SAMPLE DOSEiCALC.;FACTORS'.='gj::-:,.',::TEEN'L'EAF
.)HAGI-",LL'I:;!i::!'(
j
":::::h'IU.'CLI1DE :-"..:::::::::BONE:,,".'.: -'~."L'IVER".".::: 'j,'::":T BODY..:!..'- ':.'THYROID:.: I I>i-.'KIDNEY.;$
Tc-1 01 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Ru-103 1.05E-05 O.OOE+00 4.50E-06 0.00E+00 3.71E-05 O.OOE+00 8.79E-04 Ru-105 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0;OOE+00 O.OOE+00 0.00E+00 RU-106 1.64E-04 O.OOE+00 2.07E-05 0.00E+00 3.17E-04 0.00E+00 7.88E-03 Ag-110m 8.59E-06 8.13E-06 4.94E-06 0,00E+00 1.55E-05 O.OOE+00 2.28E-03 Te-125m 1.59E-04 5.73E-05 . 2.12E-05 4.44E-05 O.OOE+00 0.00E+00 4.69E-04 Te-127m 4.04E-04 1.43E-04 4.80E-05 9.60E-05 1.64E-03 O.OOE+00 1.01E-03 Te-127 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0 OOE+00 Te-129m 6.7'I E-04 2.49E-04 1.06E-04 2.16E-04 2.81E-03 0.00E+00 2.52E-03 Te-129 1.84E-06 6.87E-07 4.48E-07 1.32E-06 7.73E-06 O.OOE+00 1.01E-05 Te-131m O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Te-131 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Te-132 0.00E+00 O.OOE+00 0.00E+00 .O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 I-130 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I-1 31 2.25E-04 3.16E-04 1.70E-04 9.21E-02 5.43E-04 0.00E+00 6.24E-05 I-132 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 I<<133 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 I-134 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 I-135 0.00E+00 O.OOE+OO O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Cs-134 3.51E-03 8.27E-03 3.84E-03 O.OOE+00 2.63E-03 1.00E-03 1.03E-04 Cs-136 3.42E-04 1.35E-03 9.04E-04 0.00E+00 7.33E-04 1.16E-04 1.08E-04 Cs-137 4.70E-03 6.26E-03 2.18E-03 0.00E+00 2.13E-03 8.27E-04 8.90E-05 Cs-138 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O,OOE+00 O.OOE+00 O.OOE+00 Ba-139 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ba-140 1.13E-03 1.38E-07 7.28E-'05 '.00E+00 4.69E-07 9.31E-07 1.74E-03 Ba-141 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Ba-142 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 La-140 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 La-142 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Ce-141 5.47E-07 3.65E-07 4.19E-08 O.OOE+00 1.72E-07 O.OOE+00 1.04E-03 Ce-143 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Ce-144 2.92E-05 1.21E-05 1.57E-06 O.OOE+00 7.21E-06 O.OOE+00 7.33E-03 Pr-143 5.23E-07 2.09E-07 2.60E-08 O.OOE+00 1Z1E-07 O.OOE+00 1.72E-03 Pr-144 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Nd-147 3.70E-07 4.02E-07 2.41E-08 0.00E+00 2.36E-07 0.00E+00 1.45E-03 W-187 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Np-239 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Appv Date Rev. 7 6-3b(2)
TABLE 6-3c REMP DOSE FACTORS FOR TEEN AGE GROUP: FRUIT SAMPLES (Page 1 af 2)
,"g4U.CL~lDFe"~ ~->>.":-'-"'::BOIIIEg::.g '-:,,:hiL'IVER:i;i>;"!:;:;T;BODY!::P, THYROID.,":": :;:'~~Pl':UNG$..;.,-':: ',~FGl-L'L$.'~'.e H-3 0.00E+00 6.62E-05 6.62E-05 6.62E-05 6.62E-05 6.62E-05 6.62E-05 C-14 2.56E-03 5.'I 2E-04 5.12E-04 5.12E-04 5.12E-04 .5.12E-04 5.12E-04 Na-24 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 P-32 9.47E-03 5.87E-04 3.67E-04 0.00E+00 O.OOE+00 0.00E+00 7.96E-04 Cr-51 O.OOE+00 0.00E+00 5.05E-07 2.81E-07 ~ 1.11E-07 7.22E-07 8.49E-05 Mn-54 0.00E+00 3.25E-03 6 45E-04 O.OOE+00 9.71E-04 0.00E+00 6.67E-03 Mn-56 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Fe-55 2.28E-03 1.62E-03 3.77E-04 O.OOE+00 O.OOE+00 1.03E-03 7.01E-04 Fe-59 1.46E-03 3.40E-03 1.3'IE-03 O.OOE+00 O.OOE+00 1.07E-03 8.04E-03 Co-58 O.OOE+00 3.40E-04 7.84E-04 O.OOE+00 0.00E+00 0.00E+00 4.69E-03 Co-60 0.00E+00 1.73E-03 3.90E-03 0.00E+00 0.00E+00 0.00E+00 2.26E-02 Ni-63 1.11E-01 7.87E-03 3.78E-03 0.00E+00 0.00E+00 0.00E+00 1.25E-03 Ni-65 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Cu-64 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Zn-65 3.06E-03 1.06E-02 4.96E-03 0.00E+00 6.80E-03 O.OOE+00 4.50E-03 Zn-69 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00
~
Br-83 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE'+00 O.OOE+00 Br-84 0.00E+00 O.OOE+00 O.DOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+
Br-85 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+0 Rb-86 0.00E+00 2.02E-03 9.50E-04 0.00E+00 O.OOE+00 0.00E+00 2.99E-04 Rb-88 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-89 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 '.OOE+00 Sr-89 1.22E-01 0.00E+00 3.49E-03 0.00E+00 0.00E+00 0.00E+00 1.45E-02 Sr-90 5.21E+00 O.OOE+00 1.29E+00 O.OOE+00 O.OOE+00 O.OOE+00 1.46E-01 Sr-91 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Sr-92 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-90 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Y-91m O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91 6.22E-05 O.OOE+00 1.67E-06 0.00E+00 O.OOE+00 0.00E+00 2.55E-02 Y-92 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Y-93 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Zr-95 1.36E-05 4.28E-06 2.94E-06 O.OOE+00 6.28E-06 O.OOE+00 9.87E-03 Zr-97 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Nb-95 1.58E-06 8.77E-07 4.83E-07 0.00E+00 8.50E-07 O.OOE+00 3.75E-03 Mo-99 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0;00E+00 O.OOE+00 O.OOE+00 Tc-99m O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Appv Rev. 7 6-3C(1)
TABLE 6-3c REMP DOSE FACTORS FOR TEEN AGE GROUP: FRUIT SAMPLES (Page,2 of 2)
REMPSAMPL'E:DOSE",CALCIC)',:FACTORS """."".:;::: '<TEEN FRUITIER;::::::-"..';::.:."ll:I,;:gg.'."I NUCLIDE BONE LIVER T.BODY THYROID KIDNEY LUNG Gl-LLI Tc-101 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 RU-103 5.58E-05 0.00E+00 2.39E-05 O.OOE+00 1.97E-04 O.OOE+00 4.66E-03 Ru-105 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ru-106 2.21E-03 O.OOE+00 2.78E-04 O.OOE+00 4.25E-03 0.00E+00 1.06E-01 Ag-110m 1.09E-04 1.03E-04 6.29E-05 0.00E+00 1.97E-04 0.00E+00 2.91E-02 Te-125m 1.18E-03 4.24E-04 1.57E-04 3.29E-04 O.OOE+00 O.OOE+00 3.48E-03 Te-127m 4.16E-03 1.48E-03 4.95E-04 9.89E-04 1.69E-02 0.00E+00 1.04E-02 Te-127 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+0 0 O.OOE+00 Te-129m 2.98E-03 1.1 1E-03 4.71E-04 9.61E-04 1.25E-02 0.00E+00 1.'I2E-02 Te-129 8.19E-06 3.05E-06 1.99E-06 5.85E-06 3.44E-05 0.00E+00 4.48E-05 Te-1 31m O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Te-131 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-132 O.OOE+00 Q.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 I-130 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 I-1 31 2.09E-05 2.93E-05 1.57E-05 8.54E-03 5.04E-05 0.00E+00 5.79E-06 I-132 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 I-133 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 I-134 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 I-135 O.OOE+00 . O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Cs-134 4.99E-02 1.17E-01 5.45E-02 0.00E+00 3.73E-02 1.42E-02 1.46E-03 Cs-136 2.30E-04 9.03E-04 6.07E-04 O.OOE+00 4.92E-04 7.75E-05 7.27E-05 Cs-137 7.03E-02 9.35E-02 3.26E-02 O.OOE+00 3.1 8E-02 1.24E-02 1.33E-03 Cs-138 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Ba-139 O.OOE+00 O.OOE+00 O.OOE+00 O.0OE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-140 6.92E-04 8.48E-08 4.46E-O5 0.00E+00 2.88E-07 5.71E-07 1.07E-03 Ba-141 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-142 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 La-140 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 La-142 O.OOE+OO O.OOE+OO 0.00E+00 0.00E+00 0;OOE+00 O.OOE+00 0.00E+00 Ce-141 2.33E-06 1.56E-06 1.79E-07 0.00E+00 7.32E-07 0.00E+00 4.45E-03 Ce-143 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ce-144 3.79E-04 1.57E-04 2.04E-05 0.00E+00 9.36E-05 0.00E+00 9.52E-02 Pr-143 3.84E-07 1.53E-07 1.91E-08 O.OOE+00 8.92E-08 O.OOE+00 1.26E-03 Pr-144 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Nd-147 1.34E-07 1.46E-07 8.72E-09 0.00E+00 8.55E-08 0.00E+00 5.25E-04 W-187 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Np-239 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Appv i'~c'~
Date:
Rev. 7
~u <
6-3c(2)
TABLE 6-3d REMP DOSE FACTORS FOR TEEN AGE GROUP: MEAT SAMPLES (Page 1 of 2) ji~NU.GLIDE<~'.:. 'j::I 'jIIIIVERHi:": ;-"T BODY:: i: ; THYROID'(>> ';i,'.","IKIDII1EY~<
H-3 0.DOE+00 6.87E-06 6.87E<<06 6.87E-06 6.87E-06 6.87E-06 6.87E-06
,C-14 2.64E-04 5.28E-05 5.28E-05 5.28E-05 5.28E-05 5.28E-05 5.28E-05 Na-24 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 P-32 6.80E-03 4.21E-04 2.64E-04 0.DOE+00 0.DOE+00 O.DOE+00 5.72E-04 Cr-51 O.DOE+00 0.DOE+00 1.42E-07 7.88E-08 3.11E-08 2.03E-07 2.38E-05 Mn-54 O.DOE+00 3.67E-04 7.28E-05 O.DOE+00 1.09E-04 0.DOE+00 7.52E-04 Mn-56 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Fe-55 2.42E-04 1.72E-04 4.01E>>05 O.DOE+00 0.DOE+00 1.09E-04 7.43E-05 Fe-59 2.80E-04 6.53E-04 2.52E-04 O.DOE+00 0.DOE+00 2.06E-04 1.54E-03 Co-58 O.OOE+00 5.19E-05 1.20E-04 O.DOE+00 O.DOE+00 O.DOE+00 7.16E-04 Co-60 O.DOE+00, 1.81E-04 4.08E-04 0.DOE+00 0.DOE+00 O.DOE+00 2.36E-03 Ni-63 1.15E-02 8.12E-04 3.90E-04 O.DOE+00 O.DOE+00 O.DOE+00, 1.29E-04 Ni-65 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Cu-64 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Zn-65 3.54E-04 . 1.23E-03 5.73E-04 0.DOE+00 7.86E-04 0.DOE+00 5.20E-04 Zn-69 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 .O.OOE+00 Br-83 O.OOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Br-85 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.00E+
Rb-86 O.OOE+00 9.21E-04 4.33E-04 O.DOE+00 0.DOE+00 O.DOE+00 1.36E-04 Rb-88 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 '.DOE+00 Rb-89 O.DOE+00 O.DOE+00 O.DOE+00 O.OOE+OD 0.DOE+00 0.DOE+00 0.DOE+00 Sr-89 2.17E-02 0.DOE+00 6.23E-04 O.DOE+00 0 DOE+00 O.DOE+00 2.59E-03 Sr-90 5.39E-01 0.DOE+00 1.33E-01 0.DOE+00 O.DOE+00 0.DOE+00 1.51E-02 Sr-91 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Sr-92 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 Y-90 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Y-91m O.OOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Y-91 1.03E-05 0.DOE+00 2.76E-07 O.DOE+00 0.DOE+00 0.DOE+00 4.23E-03 Y-92 O.DOE+00 O.DOE+00 O.DOE+00 0.00E+OD O.DOE+00 O.DOE+00 O.DOE+00 Y-93 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Zr-95 2.1 6E-06 6.80E-07 4.68E-07 0.DOE+00 1.00E-06 O.DOE+00 1.57E-03 Zr-97 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Nb-95 3.60E-07 2.0 0E-07 1.1 0E-07 O.DOE+00 1.93E-07 O.DOE+00 8.54E-04 Mo-99 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Tc-99m O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Appy //A Rev. 7 6-3(j(1)
TABLE 6-3d REMP DOSE FACTORS FOR TEEN AGE GROUP: MEAT SAMPLES (Page 2 of 2) k;:NUCuD'E'~:: l:;'-:.:".':B'ONE'i'-":;.',. ::'-;-;l LIVER.-:.-4 ':-::;:.".T.'.:BGDY:;.j'::::::.,":THYRO1D;:-i'j,'.:=:','KlDNEY.:;,.~i! ;:Y f LUNG-",.-".:.: ;,::;;.:':-;G1 i'U";':: '::j:;::
Tc-101 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ru-103 1.17E-05 O.OOE+00 4.98E-06 0.00E+00 4.11E-05 O.OOE+00 9.73E-04 Ru-105 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Ru-1 06 2.45E-04 O.OOE+00 3.09E-05 0.00E+00 4.73E-04 O.OOE+00" 1.18E-02 Ag-110m 1.26E-05 1.19E-05 7.26E-06 0.00E+00 2.28E-05 0.00E+00 3.35E-03 Te-125m 1.96E-04 7.06E-05 2.62E-05 5.48E-05 0.00E+00 0.00E+00 5.78E-04 Te-127m 5.53E-04 1.96E-04 6.58E-05 1.32E-04 2.24E-03 O.OOE+00 1.38E-03 Te-127 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Te-129m 7.01E-04 2.60E-04 1.11E-04 2.26E-04 2.93E-03 O.OOE+00 2.63E-03 Te-129 1.93E-06 7.19E-07 4.69E-07 1.38E-06 8.09E-06 0.00E+00 1.05E-05 Te-131m O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Te-131 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 D.OOE+00 Te-132 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 I-130 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 I-'131 6.78E-05 9.49E-05 5.10E-05 2.77E-02 1.63E-04 0.00E+00 1.88E-05 I-132 0.00E+00 O.OOE+00 O.OOF+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 l-133 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 1-134 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 1-135 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 '.00E+00 O.OOE+00 O.OOE+00 Cs-134 5.34E-03 1.26E-02 5.83E-03 0.00E+00 3.99E-03 1.53E-03 1.56E-04 Cs-136 1.95E-04 7.66E-04 5.15E-04 0.00E+00 4.17E-04 6.57E-05 6.17E-05 Cs-137 7.27E-03 9.67E-03 3.37E-03 0.00E+00 3.29E-03 1.28E-03 1.38E-04 Cs-138 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-139 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ba-140 6.24E-04 7.65E-08 4.02E-05 0.00E+00 2.59E-07 5.14E-07 9.63E-04 Ba-141 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ba-142 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 La-140 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 La-142 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ce-141 5.64E-07 3.77E-07 4.33E-08 0.00E+00 1.77E-07 0.00E+00 1.08E-03 Ce-143 O.OOE+00 0.00E+00 '.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ce-144 4.31E-05 1.78E-05 2.32E-06 0.00E+00 1.06E-05 0.00E+00 1.08E-02 Pr-143 3.06E-07 1.22E-07 1.52E-08 0.00E+00 7.11E-08 0.00E+00 1.01E>>03 Pr-144 O.OOE+00 0.00E+00 O.OOE+00 0.'OOE+00 0.00E+00. O.OOE+00 O.OOE+00 Nd-147 1.73E-07 1;88E-07 1.12E-08 O.OOE+00 1.10E-07 O.OOE+00 6.77E-04 W-187 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00; O.OOE+00 Np-239 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Appv Date Rev. 7
'~ 6-3d(2)
TABLE 6-3e REMP DOSE FACTORS FOR TEEN AGE GROUP: FlSH SAMPLES (Page 1 of 2)
REMP. SAMPLE;DOSE';GAL'C;":FACTORS:"::,',i;.:,:: 'j;i TEEN:FIS (i:.'blU.CL'ID'> fj<~:BONE;:,g.:'g ~'-;i)I'lVERjN!i', ::::I::T BODY'.:'t x!:THYROlD'.."'"5~>::.iKIDNEY!!a', "~ "'I';UIIIG%-"~~
H-3 0.00E+00 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 C-14 6.50E-05 1.30E-05 1.30E-05 1.30E-05 1.30E-05 1:30E-05 1.30E-05 Na-24 1.218-05 1.21E-05 1.21E-05 1.21E-05 1.21E-05 1.21E-05 1.21E-05 P-32 4.21E-03 2.61E-04 1.63E-04 O.OOE+00 O.OOE+00 O.OOE+00 3.54E-04 Cr-51 O.OOE+00 0.00E+00 5.62E-08 3.12E-08 1.23E-08 8.02E-08 9.44E-06 Mn-54 O.OOE+00 9.42E-05 1.87E-05 0.00E+00 2.81E-05 O.OOE+00 1.93E-04 Mn-56 0.00E+00 3.99E-09 7.09E-10 O.OOE+00 5.05E-09 O.OOE+00 2.63E-07 Fe-55 6.04E-05 4.28E-05 9.99E-06 0.00E+00 0.00E+00 2.72E-OS 1.85E-05 Fe-59 9.25E-05 2.16E-04 8.33E-05 O.OOE+00 O.OOE+00 6.81E-05 5.10E-04 Co-58 O.OOE+00 1.54E-05 3.55E-05 O.OOE+00 O.OOE+00 O.OOE+00 2.12E-04 Co-60 0.00E+00 4.49E-.05 1.01E-04 O.OOE+00 O.OOE+00 O.OOE+00 5.85E-04 Ni<3 2.83E-03 2.00E-04 9.60E-05 O.OOE+00 O.OOE+00 O.OOE+00 .3.18E-05 Ni-65 1.63E-08 2.08E-09 9.48E-10 O.OOE+00 O.OOE+00 0.00E+00 1.13E-07 Cu-64 O.OOE+00 4.97E-07 2.34E-07 0.00E+00 1.26E-06 O.OOE+00 3.85E-05 Zn-65 9.19E-OS 3.19E-04 1.49E-04 0.00E+00 2.04E-04 O.OOE+00 1.35E-04 Zn-69 3.90E-15 7.42E-15 5.19E-16 0.00E+00 4.85E-15 O.OOE+00 1.37E-14 Br-83 O.OOE+00 O.OOE+00 8.71E-10 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Br-85 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+
Rb-86 O.OOE+00 4.59E-04 2.16E-04 0.00E+00 0.00E+00 O.OOE+00 6.80E-05 Rb-88 O.OOE+00 0.00E+00 . 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-89 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-89 6.94E-03 0.00E+00 1.99E-04 O.OOE+00 0.00E+00 O.OOE+00 8.27E-04 Sr-90 1.33E-01 0.00E+00 3.28E-02 0.00E+00 0.00E+00 O.OOE+00 . 3.73E-03 Sr-91 2.24E-05 O.OOE+00 8.92E-07 O.OOE+00 O.OOE+00 O.OOE+00 1.02E-04 Sr-92 1.05E-07 O.OOE+00 4.49E-09 O.OOE+00 O.OOE+00 O.OOE+00 2.68E+04 Y-90 1.69E-07 O.OOE+00 4.55E-09 0.00E+00 0.00E+00 1.39E-03 O.OOE+00'.OOE+00 Y-91m 4.09E-18 O.OOE+00 1.56E-19 O.OOE+00 0;OOE+00 1.93E-16 Y-91 3.18E-06 0.00E+00 8.52E-08 0.00E+00 0.00E+00 O.OOE+00 1.30E-03 Y-92 1.76E-10 O.OOE+00 5.10E-12 ~ O.OOE+00 O.OOE+00 O.OOE+00 4.83E-06 Y-93 1.18E-08 0.00E+00 3.24E-10 0.00E+00 0.00E+00 O.OOE+00 3.61E-04 Zr-95 6.52E-07 2.06E-07 1.41E-07 0.00E+00 3;02E-07 O.OOE+00 4.75E-04 Zr-97 1.42E-08 2.80E-09 1.29E-09 0.00E+00 4.25E-09 O.OOE+00 7.59E-04 Nb-95 1.29E-07 7.15E-08 3.94E-08 0.00E+00 6.93E-08 O.OOE+00 3.06E-04 Mo-99 O.OOE+00 7.50E-05 1.43E-05 O.OOE+00 1.72E-04 0.00E+00 1.34E-04 Tc-99m 3.35E-10 9.35E-10 1.21E-08 O.OOE+00 1.39E-08 5.19E-10 I 6.14E-07 Appv i .K Rev. 7 6-3e(1)
TABLE 6-3e REMP DOSE FACTORS FOR TEEN AGE GROUP: FlSH SAMPLES (Page 2 of 2)
~:N0 CL1 DE" """'IL'IVER"""":::'rT'.BODY. .: .'THYROID.':..':." ':;:"'KIDhlEYP<" ~::,.L'UN G'~,:'.:::;',",'I Tc-101 0.00E+00 O.OOE+00 . O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Ru-103 4.01E-06 0.00E+00 1.71E-06 O.OOE+00 1.41E-05 3.35E-04 O.OOE+00'.OOE+00 Ru-1 05 8.23E-09 0.00E+00 3.19E-09 0.00E+00 1.04E-07 6.64E-06 Ru-106 6.26E-05 O.OOE+00 7.89E-06 O.OOE+00 1.21E-04 0.00E+00 3.00E-03 Ag-110m 3.27E-06 3.10E-06 1.88E-06 0.00E+00 5.90E-06 O.OOE+00 8.70E-04 Te-125m 6.06E-05 2.18E-05 8.09E-06 1.69E-05 0.00E+00 0.00E+00 1'.79E-04 Te-127m 1.54E-04 5.45E-05 1.83E-05 3.66E-05 6.23E-04 0.00E+00 3.83E-04 Te-127 4.27E-07 1.51E-07 9.18E-08 2.94E-07 1.73E-06 O.OOE+00 3.29E-05 Te-129m 2.55E-04 , 9.48E-05 4.04E-05 8.24E-05 1.07E-03 0.00E+00 9.59E-04 Te-129 7.02E-07 2.62E-07 1.71E-07 5.02E-07 2.95E-06 O.OOE+00 3.84E-06 Te-131m 2.24E-05 1.08E-05 8.97E-06 1.62E-05 1.12E-04 0.00E+00 8.63E-04 Te-131 2.21E-24 0.00E+00 0.00E+00 1.71E-24 9.68E-24 0.00E+00 .O.OOE+00 Te-132 4.51E-05 2.86E-05 2.69E-05 ~ 3.01E-05 2.74E-04 O.OOE+00 9.05E-04 I-130 4.29E-06 1.24E-05 4.96E-06 1.01E-03 1.91E-05 0.00E+00 9.54E-06 I-131 8.59E-05 1.20.E-04 6 46E-05 3.51E-02 2.07E-04 O.OOE+00 2,38E-05 1-132 3.23E-09 8.44E-09 3.03E-09 2.84E-07 1.33E-08 o.ooE+00 3.68E-09 I-133 1.45E-05 2 45E-05 7.48E-06 3.42E-03 4.30E-05 O.OOE+00 1.86E-05 I-'1 34 1.39E-14 3.69E-14 1.33E-14 6.15E-13 5.82E-14 O.OOE+00 4.86E-16 I-135 7.88E-07 2.03E-06 7.52E-07 1.30E-04 3.20E-06 0.00E+00 2.25E-06 Cs-134 1.34E-03 3.15E-03 1.46E-03 0.00E+00 1.00E-03 3.82E-04 3.92E-05 Cs-136 1.30E-04 5.13E-04 3.45E-04 0.00E+00 2.79E-04 4.40E-05 4.13E-05 Cs-137 1.79E-03 2.38E-03 8.30E-04 0.00E+00 8.11E-04 3.15E-04 3.39E-05 Cs-138 4.56E-20 8.75E-20 4.37E-20 0.00E+00 6.46E-20 7.52E-21 3.97E-23 Ba-139 1.38E-11 9.74E-15 4.03E-1 3 O.OOE+00 9.18E-1 5 6.71E-15 1.23E-10
. Ba-140 4.30E-04 5.27E-OS 2.77E-05 0.00E+00 1.79E-07 3.55E-07 6.64E-04 Ba-141 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-142 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 La-140 3.68E-08 1.81E-OS 4.81E-09 0.00E+00 0.00E+00 0.00E+00 1.04E-03 La-142 8.36E-14 3.71E-14 9.25E-15 0.00E+00 O.OOE+00 OA)OE+00 1.13E-09 Ce-141 2.08E-07 1.39E-07 1.60E-08 0.00E+00 6.55E-OS O.OOE+00 3.98E-04 Ce-143 2.27E-OS 1.65E-05 1.85E-09 0.00E+00 7.41E-09 O.OOE+00 4.97E-04 Ce-144 1.11E-05 4.60E-06 5.97E-07 0.00E+00 2.75E-06 O.OOE+00 2.79E-03 Pr-143 1.99E-07 7.95E-OS 9.91E-09 0.00E+00 4.62E-08 O.OOE+00 6.55E-04 Pr-144 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Nd-147 1.41E-07 1.53E-07 9.18E-09 O.OOE+00 9.00E-08 O.OOE+00 5.53E-04 W-187 1.16E-06 9.47E-07 3.32E-07 O.OOE+00 O.OOE+00 O.OOE+00 I 2.56E-04 Np-239 2.10E-08 1.98E-09 1.10E-09 O.OOE+00 6.21E-09 O.OOE+00 3.18E-04 Appv Date Rev. 7 6-3e(2)
TABLE 6-3f REMP DOSE FACTORS FOR TEEN AGE GROUP: DRINKING WATER (Page 1 of 2)
REMP'SAMPLE DOSE:.CALC:;:FACTORS: ~pj!TEEN.:DRINKING;WATER.":.g~pI ~.;-:;.-'-; ~~.mrem",lite'ilpCi-',yrIg.;":. ':
j,'"::hlUCL'lOE,": "',-,'":.:BONg:";."g j"- 'L'IVER '"."~ :.",'W.":T BODY: IiTHYR'OID)>~ )qK!DNEYq~~,l ~r".(."I.'LUNG:j<i',',j ;"; '::Gl-."'1".LI. l g
H-3 O.OOE+00 5.41E-05 5.41E-05 5.41E-05 5.41E-05 5.41E-05 5.41E-05 C-14 2.07E-03 4.14E-04 4.14E-04 '4.14E-04 4.14E-04 4.14E-04 4.14E-04 Na-24 6.74E-04 6.74E-04 6.74E-04 6.74E-04 6.74E-04 6.74E-04 6.74E-04 P-32 1.37E-01 8.51E-03 5.33E-03 0;00E+00 0.00E+00 0.00E+00 1.15E-02 Cr-51 O.OOE+00 0.00E+00 1.81E-06 1.01E-06 3.97E-07 2.59E-06 3.05E-04 Mn-54 0.00E+00 3.01E-03 5.96E-04 0.00E+00 8.97E-04 O.OOE+00 6.16E-03 Mn-56 O.OOE+00 3.20E-06 5.69E-07 0.00E+00 4.05E-06 O.OOE+00 2.11E-04
'e-55 1.93E-03 1.37E-03 3.19E-04 0.00E+00 O.OOE+00 8.67E-04 5.91E-04 Fe-59 2.97E-03 6.93E-03 2.68E-03 O.OOE+00 O.OOE+00 2.19E-03 1.64E-02 Co-58 0.00E+00 4.93E-04 1.14E-03 0.00E+00 0.00E+00 0.00E+00 6.80E-03 Co-60 O.OOE+00 1.43E-03 3.23E-03 O.OOE+00 O.OOE+00 O.OOE+00 1.87E-02 Ni-63 9.03E-02 6.37E-03 3.06E-03 O.OOE+00 O.OOE+00 O.OOE+00 .1.01E-03 Ni-65 1.41E-05 1.80E-06 8.20E-07 O.OOE+00 O.OOE+00 O.OOE+00 9.76E-05 Cu-64 O.OOE+00 3.05E-05 1.43E-05 O.OOE+00 7.71E-05 O.OOE+00 2.36E-03 Zn-65 2.93E-03 1.02E-02 4.75E-03 O.OOE+00 6.52E-03 0.00E+00 4.31E-03 Zn-69 9.65E-1 0 1.84E-09 1.29E-10 0.00E+00 1;20E-09. 0.00E+00 3.39E-09 Br-83 0.00E+00 0.00E+00 9.02E-07 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Br-85 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+
Rb-86 0.0,0E+00 1.49E-02 7.01E-03 O.OOE+00 O.OOE+00 O.OOE+00 2.21E-03 Rb-88 O.OOE+00 3.06E-17 1.63E-17 O.OOE+00 O.OOE+00 O.OOE+00 2.62E-24 Rb-89 0.00E+00 2.74E-19 1.94E-19 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-89 2.23E-01 0.00E+00 6.38E-03 O.OOE+00 O.OOE+00 '.OOE+00 2.65E-02 Sr-90 4.23E+00 O.OOE+00 1.05E+00 O.OOE+00 O.OOE+00 O.OOE+00 1.19E-01 Sr-91 1.71E-03 0.00E+00 6.82E-05 O.OOE+00 O.OOE+00 0.00E+00 7.78E-03 Sr-92 7.23E-05 O.OOE+00 3.08E-06 0:OOE+00 0.00E+00 O.OOE+00 I 84E 03 Y-90 6.14E-06 O.OOE+00 1.65E-07 O.OOE+00 O.OOE+00 O.OOE+00 5.06E-02 Y-91m 2.93E-12 O.OOE+00 1.12E-13 O.OOE+00 O.OOE+00 O.OOE+00 1.38E-1 0 Y-91 1.02E-04 O.OOE+00 2.73E-06 O.OOE+00 O.OOE+00 O.OOE+00 4.18E-02 Y-92 5.89E-08 O.OOE+00 1.70E-09 O.OOE+00 O.OOE+00 0.00E+00 1.62E-03 Y-93 8.57E-07 O.OOE+00 2.35E-08 '.OOE+00 O.OOE+00 O.OOE+00 2.62E-02 Zr-95 2;09E-05 6.59E-06 4.53E-06 O.OOE+00 9.69E-06 0.00E+00 1.52E-02 Zr-97 7.39E-07 1.46E-07 6.73E-08 O.OOE+00 2.22E-07 0.00E+00 3.96E-02 Nb-95 4.15E-06 2.30E-06 1.27E-06 0.00E+00 2.23E-06 0.00E+00 9.85E-03 Mo-99 O.OOE+00 2.71E-03 5.17E-04 0.00E+00 6.20E-03 O.OOE+00 4.86E-03 Tc-99m~ 4.25E-08 1.19E-07 1.54E-06 0.00E+00 1.77E-06 6.58E-08 7.79E-05 Appv Date Rev. 7 6-3f(1)
TABLE 6-3f REMP DOSE FACTORS FOR TEEN AGE GROUP: DRINKING WATER (Page 2 of 2)
REMP.,:SA'MPLE.DOSE.'CA'L'C'::FA'CTORS': ':.:TEEN':DRlNKING;WATER"~$j~.
i;.:"::NUCLlD'E::!: !ij::,":BONE.'-~i@ l~I~;::T: BODY;::":;::. :THYROlD.";
- ;:::;:0'KID'NEY,::", I! '::"::;::L'UNG"::;':~~
Tc-1 01 1.07E-22 1.53E-22 1.50E-21 0.00E+00 2.76E-21 9.30E-23 O.QOE+00 Ru-1 03 1.29E-04 0.00E+00 5,51E-05 0.00E+00 4.54E-04 0.00E+00 1.08E-02 RU-105 1.71E-06 0.00E+00 6.63E-07 0.00E+00 2.15E-05, O.OOE+00 1.38E-03 Ru-106 2.00E-03 0.00E+00 2.52E-04 O.OOE+00 3.85E-03 O.OOE+00 9.58E-02 Ag-110m 1.04E-04 9.88E-05 6.01E-05 0.00E+00 1.88E-04 0.00E+00 2.78E-02 Te-125m 1.94E-03 7.00E-04 2.60E-04 5.42E-04 O.OQE+00 O.OOE+00 5.73E-03 Te-127m '.92E-03 1.74E-03 5.85E-04 1.17E-03 1.99E-02 O.OOE+00 1.23E-02 Te-127 3.31E-05 1.17E-05 7.12E-06 2.28E-05 1.34E-04 0.00E+00 2.56E-03 Te-129m 8.23E-03 3.05E-03 1.30E-03 2.66E-03 3.44E-02 0.00E+00 3.09E-02 Te-129 2.26E-05 8.43E-06 5.50E-06 1.62E-05 9.49E-05 0.00E+00 1.24E-04 Te-131m 9.43E-04 4.52E-04 3.77E-04 6.80E-04 4.72E-03 0.00E+00 3.63E-02 Te-131 3.17E-14 1.31E-14 9.90E-15 2.44E-14 1.39E-13 O.OOE+00 .2.60E;15 Te-132 '.60E-03 1.01E-03 9.54E-04 1.07E-03 9.72E-03 O.OOE+00 3.21E-02 I-130 2.68E-04 7.75E-04 3.10E-04 6.32E-02 1.19E-03 O.OOE+00 5.96E-04 I-1 31 2.86E-03 4.00E-03 2.1 5E-Q3 1.17E+00 6.89E>>03 0.00E+00 7.91E-04 l-1 32 3.82E-06 1.00E-05 3.59E-06 3.37E-04 1.58E-05 O.OOE+00 4.36E-06 I-133 6.87E-04 1.17E-03 3.56E-04 1.63E-01 2.04E-03 O.OOE+00 8.82E-04 I-134 5.75E-09 1.52E-08 5.47E-09 2.54E-07 2.40E-08 ,. O.OOE+00 2.01E-10 I-135 8.84E-05 2.27E-04 8.43E-05 1.46E-02 3.59E-04 O.OOE+00 2.52E-04 Cs-134 4.27E-02 1.00E-01 4.66E-02 0.00E+00 3.19E-02 1.22E-02 1.25E-03 Cs-136 4.27E-03 1.68E-02 1.13E-02 0.00E+00 9.14E-03 1.44E-OS 1.35E-03 Cs-137 5.71E-02 7.60E-02 2.65E-02 O.0QE+00 2.59E-02 1.00E-02 1.08E-03 Cs-138 7.58E-12 1 46E-11 7.28E-12 0.00E+00 1.07E-11 1.25E-12 6.60E-15 Ba-139 1.77E-07 1.24E-10 5.1 5E-09 0.00E+00 1.17E-10 8.57E-11 1.58E-06 Ba-140 1.41E-02 1.73E-06 9.08E-04 0.00E+00 5.86E-06 1.16E-05 2.17E-02 Ba-141 4.95E-17 3.70E-20 1.65E-18 0.00E+00 3.43E-20 2.53E-20 1.06E-22 Ba-142 O.OOE+00 O.OOE+00 O.OOE+00 O.OQE+00 O.OOE+00 O.OOE+00 0.00E+00 La-140 1.44E-06 7.09E-07 1.89E-07 0.00E+00 O.OQE+00 O.OOE+00 4.07E-02 La-142 4.93E-10 2.19E-10 5.46E-11 O.OOE+00 0.00E+00 O.OOE+00 6.67E-06 Ce-141 6.71E-06 4.48E-06 5.15E-07 O.OOE+00 2.11E-06 O.OQE+00 1.28E-02 Ce-143 9.31E-07 6.78E-04 7.57E-08 0.00E+00 3.04E-07 O.OOE+00 2.04E-02 Ce-144 3.55E-04 1.47E-04 1.91E-05 O.OQE+00 8.76E-05 O.OOE+00 8.91E-02 Pr-143 6.51E-06 2.60E-06 3.24E-07 0.00E+00 1.51E-06 O.OOE+00 2.14E-02 Pr-144 6.66E-21 2.72E-21 3.37E-22 0.00E+00 1.56E-21 O.OOE+00 7.34E-24 Nd-147 4.64E-06 5.04E-06 3.02E-07 O.OQE+00 2.96E-'06 O.OOE+00 1.82E-02 W-187 5.25E-05 4.28E-05 1.50E-05 O.OQE+00 0.00E+00 0.00E+00.< 1.16E-02 Np-239 7.75E-07 7.31E-08 4.06E-08 0.00E+00 2.29E-07 O.OOE+00 1.18E-02 Appv Date Rev. 7 6-3f'(2)
TABLE 6-3g REMP DOSE FACTORS FOR TEEN AGE GROUP:
INHALATION- QUARTERLY SAMPLING (Page 1 of 2)
REMP,":SAMPL'E.:DOSE~CALC.,FACTORS'.@TEEM.'.INH;::QUARTERLY::;:.':,,':"'j;:g~.j;;:~.,";,':-".:"mrern~:ipCigj';'gg~~:'.';jg
- K
- :NUCL'IDE.".:~:::;;:BONE::;":." ',",'$""L'IVER::-:,::!::i:: i!l ~T'ODY,'.i'.$ :;::<THYROID.:": iiFKIDNEY..!!:,"'.":.!.:'"LUNG"'.'.i!.":',',;"ggG1 1.'L'I":';i',~
H-3 O.OOE+00 1.28E-03 1.28E-03 1.28E-03 1.28E-03 1.28E-03 1.28E-03 C-14 2.60E-02 4.87E-03 4.87E-03 4.87E-03 4.87E-03 4.87E-03 4.87E-03 Na-24 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0;OOE+00 O.OOE+00 O.OOE+00 P-32 1.73E+01 1.00E+00 6.55E-01 O.OOE+00 0;OOE+00 O.OOE+00 8.49E-01 Cr-51 0.00E+00 0.00E+00 4.23E-04 2.35E-04 9.62E-05 6.56E-02 9.39E-03 Mn-54 O.OOE+00 5.66E-02 9.29E-03 O.OOE+00 1.41E-02 2.20E+00 7.39E-02 Mn-56 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Fe-55 3.45E-02 2.46E-02 5.72E-03 0.00E+00 0.00E+00 1.28E-01 6.60E-03 Fe-59 ~
3.23E-02 7.51E-02 2.91E-02 O.OOE+00 O.OOE+00 3.10E+00 3.62E-01 Co-58 .O.OOE+00 3.24E-03 4.34E-03 O.OOE+00 0.00E+00 2.10E+00 1.49E-01 Co-60 O.OOE+00 1.54E-02 2.02E-02 0.00E+00 O.OOE+00 8.86E+00 2.63E-01 Ni-63 5.81E-01 4.35E-02 1.98E-02 0.00E+00 0.00E+00 3.07E-01 1.42E-02 Ni-65 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Cu-64 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Zn-65 4.39E-02 1.52E-01 7.10E-02 0.00E+00 9.83E-02 1.41E+00 5.31E-02 Zn-69 O.OOE+00 0.00E+00 . 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-83 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+
Br-84 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+0 Br-85 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 Rb-86 0.00E+00 1.04E+00 4.57E-01 0.00E+00 O.OOE+00 0.00E+00 9.63E-02 Rb-88 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Rb-89 0.00E+00 0.00E+00 "
O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-89 8.12E-01 0.00E+00 2.33E-02 O.OOE+00 O.OOE+00 4.52E+00 6.94E-01
.Sr-90 1.08E+02 0.00E+00 6.70E+00 0.00E+00 0.00E+00 1.65E+01 7.67E-01 Sr-91 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-92 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-90 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91m 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91 1.13E+00 0.00E+00 3.04E-02 0.00E+00 0.00E+00 5.04E+00 7.02E-01 Y-92 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-93 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Zr-95 '.39E-01 7.51E-02 5.17E-02 O.OOE+00 1.10E-01 4.41E+00 2.44E-01 Zr-97 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 Nb-95 4.57E-02 2.54E-02 1.40E-02 0.00E+00 2.46E-02 1.85E+00 2.39E-01 Mo-99 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 ! 0.00E+00 Tc-99m O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O,OOE+00 O.OOE+00 O.OOE+
Appv Date Rev. 7
'~ ?
6-3g(1)
TABLE 6-3g REMP DOSE FACTORS FOR TEEN AGE
- QUARTERLY SAMPLING (Page 2 of 2) GROUP'NHALATION REMP!SAMPL'E DOSE'"CA1'C;":FACTORS "TEEN;INH;:.::QUARTERLY::
l~NUGU" DE:;.;i ':>V)%BONES': R i ii-'ghL'IVER,,,'~ .~T:.'BODY,,'! i,i:THYROlD:;i!i."".'K ID N EY,",,'j'". < ',::<<L'UNG,".,'" 'i <<gQI LKLI?
Tc-101 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 Ru-103 4.70E-03 0.DOE+00 2.00E-03 0.DOE+00 1.66E-02 1.75E+00 2.43E-01 Ru-1 05 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Ru-106 1.07E-01 0.DOE+00 1.35E-02 0.DOE+00 2.07E-01 1.75E+01 1.05E+00 Ag-110m 1.57E-02 1.49E-02 9.07E-03 O.DOE+00 2.84E-02 7.66E+00 3.10E-01 Te-125m 8.42E-03 3.86E-03 1.15E-03 2.42E-03 O.DOE+00 9.25E-01 1.29E-01 I Te-127m 2.41E-02 1.09E-02 2.92E-03 5.86E-03 8.74E-02 221E+00 '2.13E-01 Te-127 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 Te-129m 3.57E-02 1.69E<<02 5.76E-03 1.17E-02 1.33E-01 5.06E+00 1.04E+00 Te-129 1.82E-07 8.65E-08 4.51E-08 1.33E-07 6.81E-07 8.45E-03 4.14E-03 Te-131m O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 Te-131 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 Te 132 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 ~
I-130 0.DOE+00 O.DOE+00 0.00E+OD 0.DOE+00 0;DOE+00 O.DOE+00 O.DOE+00 I-131 1.81E+00 2.51E+00 1.35E+00 7.48E+02 4.29E+00 O.DOE+00 3.31E-01 I-132 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 I-133 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 G.DOE+00 O.DOE+00 O.DOE+00
!-1 34 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 I-135 O.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Cs-134 5.24E-01 1.18E+00 5.72E-01 O.ODE+00 3.91E-01 1.53E-01 1.02E-02 Cs-136 5.70E-01 2.14E+00 1.51E+00 O.DOE+00 1.22E+00 1.96E-01 1.20E-01 Cs-137 6.72E-01 8.50E-01 3.12E-01 O.DOE+00 3.05E-01 1.21E-01 8.50E-03 Cs-138 0.00E+00 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Ba-139 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00
~ Ba-140 6.49E-01 7.95E-04 4.17E-02 O.DOE+00 2.70E-04 2.41E+01 2.71E+00 Ba-141 O.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 0.DOE+00 Ba-142 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 La-140 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.OOE+00 La-142 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Ce-141 7.51E-02 5.02E-02 5.74E-03 0.DOE+00 2.35E-02 1.62E+00 3.34E-01 Ce-143 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 O.DOE+00 Ce-144 5.46E+00 2.26E+00 2.93E-01 0.DOE+00 1.35E+00 1.49E+01 9.66E-01 Pr-143 1.38E-01 5.47E-02 6.82E-03 O.DOE+00 3.18E-02 4.98E+00 2.20E+00 Pr-144 O.DOE+00 D.DOE+00 O.DOE+00 O.DOE+00 0.DOE+00 O.DOE+00 O.DOE+00 Nd-147 1.40E-01 1.53E-01 9.1 4E-03 O.DOE+00 8.95E-02 6.63E+00, 3.25E+00 W-187 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Np-239 O.DOE+00 O.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 0.DOE+00 O.DOE+00 Appv '
Date Rev. 7 6-3g(2)
TABLE 6-3h REMP DOSE FACTORS FOR TEEN AGE GROUP:
INHALATION- WEEKLY SAMPLING (Page 1 of 2)
PEMP,,::,SAMPLEDOSE~CALCgFA'CTORS:".,'EEN::INH
~:;:NUCLIDE-:,"::;" ",,,':"',~BONE.'.,:,::-:"i'". "~L'IVER.!',i:,i;: ,":~
T';BODY,:iii :'i::THYROID" '"!KIDNEY:,::: i:,'@LUNG g:,~." ';.::,::.:!Gl~LLI: 4 H-3 O.OOE+00 1.27E-03 1.27E-03 1.27E-03 1.27E-03 1.27E-03 1.27E-03 C-14 2.60E-02 4.87E-03 4.87E-03 4.87E-03 4.87E-03 4.87E-03 4.87E-03 Na-24 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00, O.0OE+00 P-32 2.24E+00 1.30E-01 8.48E-02 O.OOE+00 0.00E+00 O.OOE+00 1.10E-01 Cr-51 O.OOE+00 0.00E+00 1.48E-04 8.18E-05 3.35E-05 2.29E-02 3.27E-03 Mn-54 O.OOE+00 5.1'5E-02 8.47E-03 0.00E+00 1.28E-02 2.00E+00 . 6.73E-02
'n-56 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 . O.OOE+00 Fe-55 3.35E-02 2.39E-02 5.56E=03 0.00E+00 0.00E+00 1.24E-01 6.41E-03 Fe-59 1.68E-02 3.90E-02 1.51E-02 0.00E+00 O.OOE+00 1.61E+00 1.88E-01 Co-58 O.OOE+00, 2.14E-03 2.87E-03 O.OOE+00 O.OOE+00 1.39E+00 9.85E-02 Co-60 O.OOE+00 1.51E-02 1.99E-02 O.OOE+00 O.OOE+00 8.73E+00 2.60E-01 Ni-63 5.80E-01 4.34E-02 1.98E-02 0.00E+00 0.00E+00 3.07E>>01 1A2E-02 Ni-65 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Cu-64 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Zn-65 3.89E-02 1.35E-01 6.30E-02 O.OOE+00 8.73E-02 1.25E+00 4.71E-02 Zn-69 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Br- 0 0 OOE+
Br-84 , O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00F+00 0.00E+00 0.00E+
Br-85 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-86 O.OOE+00 2.17E-01 9.57E-02 0.00E+00 0.00E+00 O.OOE+00 2.01E-02 Rb-88 0.00E+00 O.OOE+00 0.00E400 0.00E+00 0.00E+00 O.OOE+00. O.OOE+00 Rb-89 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Sr-89 . 4.56E-01 0.00E+00 1.31E-02 0.00E+00 0.00E+00 2.53E+00 .3.89E-01 Sr-90 1.08E+02 O.OOE+00 6.68E+00 0.00E+00 O.OOE+00 1.65E+01 7.65E-01 Sr-91 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Sr-92 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 '.OOE+00 Y-90 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Y-91m O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91 6.89E-01 O.OOE+00 1.84E-02 0.00E+00 0.00E+00 3.06E+00 4.26E-01 Y-92 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Y-93 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Zr-95 1.51E-01 4.76E-02 3.27E-02 O.OOE+00 7.00E-02 2.79E+00 1.55E-01 Zr-97 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Nb-95 1.99E-02 1.11E-02 6.07E-03 0.00E+00 1.07E-02 8.05E-01 1.04E-01 Mo-99 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Tc-99m O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+0 Appv Date /2v 7 Rev. 7 6-3I1(1)
TABLE 6-3h REMP DOSE FACTORS FOR TEEN AGE GROUP:
INHALATION WEEKLY SAMPLING (Page 2 of 2)
@NUCLIDE;-'".:;:".,j',;";B'ONE:-"."I :."::!~L'IVER::i,:.:":; "<<~T>8 QDY.-,',':i'"::: .".":!jTHYROID'"::;I,':j'KID,NEYj:;,-:', --"L'UNG'~"'-'""'Gl'1'L'f'~'~-'.OOE+00 Tc-101 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Ru-103 2.24E-O3 0.00E+00 9.53E-04 O.OOE+00 7.90E-03 8.33E-OI 1.16E-OI Ru-105 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Ru-106 9.91E-02 0.00E+00 1.25E-02 0.00E+00 1.92E-OI 1.62E+01 9.66E-OI Ag-1 10m 1.40E-02 1.32E-02 8.07E-03 0.00E+00 2.53E-02 6.82E+00 2.75E-OI Te-125m 5.09E-03 2.34E-03 6.96E-04 1.46E-03 0.00E+00 5.59E-OI 7.82E-02 Te-127m 1.84E-02 8.34E-03 2.23E-03 4.48E-03 6.68E-02 1.69E+00 1.63E-OI Te-127, 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-129m 1.50E-02 7.08E-03 2.42E-03 4.92E-03 5.58E-02 2.12E+00 4.35E-OI Te-129 7.63E-08 3.63E-08 1.89E-08 5.57E-08 2.85E-07 3.54E-03 1.74E-03 Te-131m O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 . O.OOE+00 Te-131 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Te-132 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 1-130 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 I-131 3.54E-02 4.91E-02 2.64E-02 1.46E+01 8.40E-02 O.OOE+00 6.49E-03 I- I 32 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 l-133 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 I-134 O.OOE+00 O.OOE+00 O.OOE+00 0;OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 1-135 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Cs-134 5.04E-OI 1.13E+00 5.51E-OI 0.00E+00 3.76E-OI 1.47E-OI 9.79E-03 Cs-136 6.19E-02 2.33E-OI 1.64E-OI 0.00E+00 1.33E-OI 2.14E-02 '.31E-02 Cs-137 6.71E-OI 8.48E-OI 3.11E-OI 0.00E+00 3.04E-OI 1.21E-OI 8.48E-03 Cs-138 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 '.00E+00 Ba-139 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-140 6.61E-02 8.10E-05 4.26E-03 O.OOE+00 2.76E-05 2.46E+00 2.77E-OI Ba-141 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Ba-142 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 La-140 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 La-142 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Ce-141 3.06E-02 2.04E-02 2.34E-03 0.00E+00 9.57E-03 6.61E-OI 1.36E-OI Ce-143 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00
.Ce-144 4.93E+00 2.04E+00 2.65E-OI 0.00E+00 1.22E+00 1.35E+01 8.71E-OI Pr-143 1.60E-02 6.35E-03 7.92E-04 0.00E+00 3.69E-03 5.78E-OI 2.55E-OI Pr-144 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Nd-147 9.81E-03 1.07E-02 6.40E-04 0.00E+00 6.27E-03 4.64E-OI 2.28E-OI W-I 87 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Np-239 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Appv '-.-'
Date . ~ 4 i 6-3h(2)
Rev. 7
TABLE 6-4a REMP DOSE FACTORS FOR CHILD AGE GROUP: MILK(Page 1 of 2)
REINP,,:'S'AMPL'E'DOSE:::CALC':"::FA'CTORS!'.:g:"i"""CHIL'DlMIL~K:'! ,>;ii:,":-;:il<,"~,".":"?:":-,".mr'em liter/jiCi-',y'r~~F:;;"";::i,.
'?.:'::??;j""::"-":;:~":,","':z
jW-IiCL'IOEg$ :;.;::jB;ONE,, ".~ ii.'!L'IVER'::,'i;";":: .:"j'.~T BODY;:,::,::::",:: '::::THYROID!g,. ::.:;':,'KIDNEY",::;:;: ::":;:,:-"f'UNGY-".e iii? ?......... ( ..i%?k
'?.
.i'-3 O.OOE+00 6.70E-05 6.70E-05 6.70E-05 6.70E-05 6.70E-OS 6.70E-05 C-14 3.99E-03 7.99E-04 7.99E-04 7.99E-04 7.99E-04 7.99E-04 7.99E-04 Na-24 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 P-32 2.47E-01 1.1 6E-02 9.52E-03 O.OOE+00 O.OOE+00 0.00E+00 6.83E-03 Cr-51 O.OOE+00 O.OOE+00 2.79E-06 1.55E-06 4.24E-07 '2.83E-06 1.48E-04 Mn-54 O.OOE+00 3.52E-03 9.36E-04 O.OOE+00 9.86E-04 0.00E+00 2.95E-03 Mn-56 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Fe-55 3.79E-03 2.01E-03 6.23E-04 0.00E+00 0.00E+00 1.14E-03 3.72E-04 Fe-59 5.28E-03 8.54E-03 4.25E-03 O.OOE+00 O.OOE+00 2.48E-03 8.89E-03 Co-58 O.OOE+00 5.82E-04 1.78E-03 0.00E+00 O.OOE+00 O.OOE+00 3.40E-03 Co-60 O.OOE+00 1.74E-03 5.14E-03 O.OOE+00 O.OOE+00 0.00E+00 9.66E-03 Ni-63 1.78E-01 9.50E-03 6.04E-03 0.00E+00 O.OOE+00 O.OOE+00, 6.40E-04 Ni-65 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 CU-64 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Zn-65 4.50E-03 1.20E-02 7.45E-03 0.00E+00 7.55E-03 O.OOE+00 2.10E-03 Zn-69 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Br-83 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Br-85 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+0 Rb-86 0.00E+00 2.05E-02 1.26E-02 0.00E+00 O.OOE+00 0.00E+00 1.32E-03 Rb-88 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-89 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Sr-89 4.24E-01 O.OOE+00 1.21E-02 0.00E+00 O.OOE+00 0.00E+00 1.64E-02 Sr-90 5.61E+00 O.OOE+00 1.42E+00 0.00E+00 O.OOE+00 O.OOE+00 7.56E-02
.Sr-91 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Sr-92 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Y-90 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Y-91m O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Y-91 1.94E-04 0.00E+00 5.19E-06 0.00E+00 0;OOE+00 0.00E+00 2.58E-02 Y-92 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Y-93 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Zr-95 3.75E-05 8.23E-06 7.33E-06 0.00E+00 1.18E-05 0.00E+00 8.59E-03 Zr-97 O.OOE+00 O.OOE+00 0.00E+00 0;OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Nb-95 7.14E-06 2.78E-06 1.99E-06 0.00E+00 2.61E-06 0.00E+00 5.14E-03 Mo-99 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Tc-99m O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00; O.OOE+00 Appv Rev. 7 6-4a(1)
TABLE 6<a REMP DOSE'FACTORS FOR CHILD AGE GROUP: MILK(Page 2 of 2)
- iiiiLUNG;~, >0 I
- i:NUCLID'E.'=,+ H::
L'IVER""-'.OOE+00 j ii',T"BODY!I;",:" "::;: THYROID:.! ,;."::,: .::K!DNEY:::,:"':;
>LYI'If'.OOE+00 Tc-101 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Ru-103 2.33E-04 O.OOE+00 8.95E-05 O.OOE+00 5.86E-04 O.OOE+00 6.02E-03 RU-105 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Ru-106 3.85E-03 0.00E+00 4.80E-04 0.00E+00 5.19E-03 0.00E+00 5.98E-02 Ag-110m 1.77E-04 '.19E-04 9.55E-05 O.OOE+00 ~ 2,23E-04, 0.00E+00 1 42E-02 Te-125m 3.67E-03 9.96E-04 4.90E-04 1.03E-03 0.00E+00 O.OOE+00 3.54E-03 Te-127m 9.42E-03 2.53E-03 1.12E-03 2.25E-03 2.68E-02 O.OOE+00 7.62E-03 Te-127 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-129m 1.54E-02 4.31E-03 2.39E-03 4.97E-03 4.53E-02 0.00E+00 1.88E-02 Te-129 4.24E-05 1.18E-05 1.01E-05 3.03E-05 1.24E-04 O.OOE+00 2.64E-03 Te-131m O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Te-131 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-132 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 1-130 O.0 0E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 I-131 4.78E-03 4.80E-03 2.73E-03 1.59E+00 7.89E-03 O.OOE+00 4.28E-04 1-132 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 I-133 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E400 0.00E+00 I-134 O.OOE+00 'O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 I-135 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Cs-134 7.71E-02 1.26E-01 2.67E-02 0.00E+00 3.92E-02 1.41E-02 6.82E-04 Cs-136 6.98E-03 1.92E-02 1.24E-02 0.00E+00 1.02E-02 1.52E-O 6.74E-04 Cs-137 1.08E-01 1.03E-01 1.52E-02 O.OOE+00 3.37E-02 1.21E-02 6.47E-04 Cs-138 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Ba-139 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOEioo O.OOE+00 O.OOE+00 Ba-140 2.46E-02 2.16E-05 1.44E-03'.OOE+00 7.02E-06 1.29E-05 1.25E-02 Ba-141 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+OO Ba-142 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 La-140 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 La-142 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Ce-141 1.26E-05 6.26E-06 9.30E-07 0.00E+00 2.74E-06 O.OOE+00 7.81E-03 Ce-143 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Ce-144 6.83E-04 2.14E-04 3.65E-05 '.00E+00 1.19E-04 0.00E+00 5.58E-02 Pr-143 1.17E-05 3.52E-06 5.81E-07 0.00E+00 1.90E-06 O.OOE+00 1.26E-02 Pr-144 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Nd-147 8.1 1E-06 6.57E-06 5.09E-07 0.00E+00 3;61E-06 O.OOE+00 1.04E-02 W-187 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00; O.OOE+00 Np-239 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Appv Date />if '0 6-4a(2)
Rev. 7
TABLE 6-4b REMP DOSE FACTORS FOR CHILD AGE GROUP: LEAFY VEG. (Page 1 of 2)
REMP,,.:'SAII/IPLrE:DDSE,'CALC',":FA'CTORS';:,::",,::;:;CHILD,"LrEAFY,'VEG;:";-';":;~:'.;>>;,i,:,,"":",>>'j(~",'-,i4.'=.;Imrem'ling/p'i yap:;i '>>';,,
.': '.NUCLIDE'll";:::,i,:') BONEp~";-':":".:;,ii.'OVER".,'::":",',:::;:!T;.',B.ODY;::::;'.",THYROID,:.'D.NEY,',,',':; F:,~ii~l'UNG"~$g!"'i i'":,'Gl-',L'L'I>';
H-3 0.00E+00 5.28E-06 5.28E-06 5.28E-06 5.28E-06 5.2&E-06 5.28E-06 C-14 3.15E-04 6.29E-05 6.29E-05 6.29E-05 6.29E-05 6.29E-05 6.29E-05 Na-24 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 ~
O.OOE+00 O.OOE+00 0.00E+00 P-32 2.04E-02 9.56E-04 7.8&E-04 0.00E+00 O.OOE+00 0.00E+00 5.65E-04 Cr-51 0.00E+00 O.OOE+00 2.26E-07 1.25E-07 3.42E-08 2.29E-07, 1.20E-05 Mn-54 0.00E+00 2.78E-04 7.39E-05 0.00E+00 7.7&E-05 0.00E+00 2.33E-04 Mn-56 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Fe-55 2.99E-04 1.58E-04 4.91E-05 0.00E+00 0.00E+00 8.96E-05 2.94E-05 Fe-59 4.22E-04 6.84E-04 3.40E-04 O.OOE+00 0.00E+00 1.98E-04 7.12E-04 Co-58 0.00E+00 4.63E-05 1.42E-04 0.00E+00 0.00E+00 0.00E+00 2.70E-04 Co-60 0.00E+00 1.37E-04 4.05E-04 0.00E+00 0.00E+00 0.00E+00 7.62E-04 Ni-63 1.40E-02 7.49E-04 4.76E-04 0.00E+00 O.OOE+00 0.00E+00 5.04E-05 Ni-65 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Cu-64 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Zn-65 3.55E-04 9.46E-04 5.89E-04 0.00E+00 5.96E-04 0.00E+00 1.66E-04 Zn-69 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 Br-83 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+0 Br-84 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00 Br-85 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 '.00E+00 0.00E+00 0.00E+0 Rb-86 O.OOE+00 1.68E-03 1.03E-03 0.00E+00 O.OOE+00 0.00E+00 1.0&E-04 Rb-88 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Rb-89 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Sr-89 3.39E-02 O.OOE+00 9.67E-04 O.OOE+00 O.OOE+00 0.00E+00 1.31E-03 Sr-90 4.42E-01 0.00E+00 1.12E-01 0.00E+00 O.OOE+00 O.OOE+00 5.95E-03 Sr-91 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Sr-92 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Y-90 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Y-91m O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Y-91 1.55E-05 0.00E+00 4.14E-07 0.00E+00 O.OOE+00 0.00E+00 2.06E-03 Y-92 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Y-93 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Zr-95 2.98E-06 6.56E-07 5..84E-07 0.00E+00 9.39E-07 0.00E+00 6.84E-04 Zr-97 0.00E+00 O.OOE+00 '.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Nb-95 5.74E-07 2.23E-07 1.60E-07 0.00E+00 2.10E-07 0.00E+00 4.13E-04 Mo-99 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Tc-99m 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00: 0.00E+00 Appv Date Rev. 7 6-4b(1)
TABLE 6>,-:.':;::",'":.:;,: :::~;;;~pj:-,:-.::,::.,imrem-'kg/p'i-.'yr;,.","I ~>>,.:.".,':~
~;:;NUCLIDE".:g :',<<!,:BONE:',:i!>> ':",? LlVER::""~:-:,T BODY:, ."., 'i!THYROID,,'::,';',::,'"KIDNEY:,.',:"":,";
"::-"-,,iL'UNG~';:,":::j , ""'HAGI-,'LL$
Tc-101 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Ru-103 1.87E-05 0.00E+00 7.18E-06 O.OOE+00 4.70E-05 0.00E+00 4.83E-04 RU-105 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 . O.OOE+00 0.00E+00 RU-106 3.04E-04 0.00E+00 3.79E-05 0.00E+00 4.10E-04 0.00E+00 4.72E-03 Ag-1 10m 1.40E-05 9.44E-06 7.55E-06 0.00E+00 '.76E-05'.00E+00 1.12E-03 Te-125m 2.93E-04 7.94E-05 3.91E-05 8.22E-05 0.00E+00 O.OOE+00 2.83E-04 Te-127m 7.47E-04 2.01E-04 8.86E-05 1.79E-04 2.13E-03 O.OOE+00 6.05E-04 Te-127 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Te-129m 1.24E-03 3.46E-04 1.93E-04 4.00E-04 3.64E-03 O.OOE+00 1.51E-03 Te-129 3.41E-06 9.53E-07 8.10E-07 2.43E-06 9.98E-06 O.OOE+00 2.12E-04 Te-131m 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Te-131 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 .Q.OOE+00 Te-132 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 I-130 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 l-131 4.10E-04 4.13E-04 2.34E-04 1.36E-01 6.77E-04 0.00E+00 3.67E-05 I-132 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I-1 33 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 l-134 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 I-135 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Cs-134 6.08E-03 9.97E-03 2.10E-03 O.OOE+00 3.09E-03 1.11E-03 5.38E-05 Cs-136 5.80E-04 1.59E-03 1.03E-03 0.00E+00 8.49E-04 1.27E-04 5.60E-05 Cs-137 8.50E-03 8.14E-03 1.20E-03 0.00E+00 2.65E-03 9.54E-04 5.10E-05 Cs-138 0.00E+00 O.OOE+00 O.GOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Ba-139 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Ba-140 2.05E-03 . 1.79E-06 1.19E-04 0.00E+00 5.84E-07 1.07E-06 1.04E-03 Ba-141 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ba-142 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 La-140 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 La-142 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Ce-141 1.01E-06 5.04E-07 7.48E-08 O.OOE+00 2.21E-07 0.00E+00 6.29E-04 Ce-143 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 Ce-144 5.39E-05 1.69E-05 2.88E-06 0.00E+00 9.36E-06 O.OOE+00 4.41E-03 Pr-143 9.71E-07 2.92E-07 4.82E-08 0.00E+00 1.58E-07 O.OOE+00 1.05E-03 Pr-144 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Nd-147 6.81E-07 5.52E-07 4.27E-08 0.00E+00 3.03E-07 O.OOE+00 8.74E-04 W-187 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 I O.OOE+00 Np-239 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Appv Date 7
l~-'il'ev.
6-4b(2)
TABLE 6%c REINP DOSE FACTORS FOR CHILD AGE GROUP: FRUIT (Page 1 of 2)
P~SAMPLE:DOSE:,CALC<<:,:FAC<<TORS,;,"::,:,,-",;CHILD,FRUlT:;;,:,:;:,<,,',q,.;;,:,.;:,::,.:;;, ;;,,, :)~,,~~,mrem,.kg/pCLyrgg.:;:;...
~NUCLrlDE!j~ ',:.-';t~BONE:,:::-:,"; ~.:!'DELIVER.'"~'j<<<<ip, :":::,=<<7;BODY,:i>> "";.THYROlD,':."i ",'i;:IIllDNEY:.,".:~~,: ';jLUblG"'-"'."" ,iAii';GI-;LL'1:,":.. 3 H-3 O.OOE+00 1.05E-04 1.05E-04 1.05E-04 1.05E-04 1.05E-04 1.05E-04 C-14 6.29E-03 1.26E-03 1.26E-03 1.26E-03 1.26E-03 1.26E-03 1.26E-03 Na-24 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 P-32 2.34E-02 1.09E-03 9.00E-04 O.OOE+00 O.OOE+00 O.OOE+00 6.46E-04 Cr-51 O.OOE+00 O.OOE+00 1.03E-06 5.72E-07 1.56E-07 1.05E-06 5.47E-05 Mn-54 0.00E+00 4.87E-03 1.30E-03 O.OOE+00 1.37E-03 0.00E+00 4.09E-03 Mn-56 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Fe-55 5.73E-03 3.04E-03 9.42E-04 O.OOE+00 O.OOE+00 1.72E-03 5.63E-04 Fe-59 3.38E-03 5.47E-03 2.72E-03 O.OOE+00 O.OOE+00 1.59E-03 5.69E-03 Co-58 0.00E+00 5.20E-04 1.59E-03 0.00E+00 O.OOE+00 O.OOE+00 3.03E-03 Co-60 0.00E+00 2.69E-03 7.94E-03 0.00E+00 0:OOE+00 O.OOE+00 1.49E-02 Ni-63 2.79E-01 1.50E-02 9.51E-03 0.00E+00 O.OOE+00 O.OOE+00 1.01E-03 Ni-65 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 CU-64 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Zn-65 6.01E-03 1.60E-02 9.96E-03 0.00E+00 ~ 1.01E-02 O.OOE+00 2.81E-03 Zn-69 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-83 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+0 B 84 0.00E 00 0.00E 00 0,00E 00 O.OOE 00 O.OOE 00 O.OOE 00 O.OOE Br-85 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+0 Rb-86 O.OOE+00 3.75E-03 2.31E-03 0.00E+00 0.00E+00 O.OOE+00 2.41E-04 Rb-88 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Rb-89 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Sr-89 3.01E-01 0.00E+00 8.61E-03 O.OOE+00 0.00E+00 O.OOE+00 1.17E-02 Sr-90 8.80E+00 O.OOE+00 2.23E+00 O.OOE+00 O.OOE+00 0.00E+00 1.19E-01 Sr-91 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 Sr-92 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-90 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Y-91m O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Y-91 1.54E-04 0.00E+00 4.1 1E-06 0.00E+00 0.00E+00 O.OOE+00 2.05E-02 Y-92 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-93 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Zr-95 3.15E-05 6.92E-06 6.16E-06 O.OOE+00 9.91E-06 O.OOE+00 7.22E-03 Zr-97 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+OG O.OOE+00 0.00E+00 Nb-95 3.57E-06 1.39E-06 9.94E-07 0.00E+00 1.31E-06 0.00E+00 2.57E-03 Mo-99 . O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Tc-99m O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 ! O.OOE+00 Appv Date '/ ~~ 6-4c(1)
Rev. 7
TABLE 6<c REMP DOSE FACTORS FOR CHILD AGE GROUP: FRUIT (Page 2 of 2)
REMPiSAMPLrEIDOSECALC.;~PA'CTORS;:,i"~"CHILD,:.FRUIT;,';;".";.,-".-'..'::::,j,::g--:".~P-
- ,;,, NUCL1DE
- ,-., gi'. ):BONE>j iii .:",':,.:"jlL'IVER,::,"':",:," .-;::,::!T,:,'BODY, :",:,THYROID;;."5 >>~.'KIDNEY. ':"j"':.UNG,:: "'j '-':"VGl-'L'Ll,.":';.
Tc-101 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 RU-103 1.32E-04 0.00E+00 5.08E-05 O.OOE+00 3.33E-04 0.00E+00 3.42E-03 RU-105 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 RU-106 5.43E-03 0.00E+00 6.78E-04 O.OOE+00 7.34E-03 O.OOE+00 8.45E-02 Ag-110m 2.37E-04 1.60E-04 1.28E-04 O.OOE+00 2.98E-04 0.00E+00 1.91E-02 Te-125m 2.89E-03 7.84E-04 3.86E-04 8:12E-04 0.00E+00 0.00E+00 ~ 2.79E-03 Te-127m 1.03E-02 2.76E-03 1.22E-03 2.45E-03 2.93E-02 0.00E+00 8.31E-03 Te-127 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-129m 7.34E-03 2.05E-03 1.14E-03 2.37E-03 2.16E-02 O.OOE+00 8.96E-03 Te-129 2.02E-05 5.64E-06 4.80E-06 1.44E-05 5.91E-05 0.00E+00 1.26E-03 Te-131m 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-131 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Te-132 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 I-130 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 . O.OOE+00 l-131 5.07E-05 5.10E-05 2.90E-05 1.69E-02 8.37E-05 O.OOE+00 4.54E-06 l-132 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 I-133 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 l-134. O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+'00 O.OOE+00 I-135 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Cs-134 1.15E-01 1.89E-01 3.99E-02 O.OOE+00 5.86E-02 2.10E-02 1.02E<<03 Cs-136 5.18E-04 1.42E-03 9.22E-04 O.OOE+00 7.59E-04 1.'13E-04 5.01E-05 Cs-137 1.69E-01 1.62E-01 2.39E-02 O.OOE+00 5.28E-02 '1.90E-02 1.02E-03 Cs-138 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-139 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Ba-140 1.67E-03 1.47E-06 9.76E-05 O.OOE+00 4.77E-07 .8.73E-07 8.47E-04 Ba-141 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-142 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 La-140 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 La-142 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ce-141 5.74E-06 2.86E-06 4.25E-07 O.OOE+00 1.26E-06 O.OOE+00 3.57E-03 Ce-143 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O,OOE+00 0.00E+00 Ce-144 9.34E-04 2.93E-04 4.99E-05 O.OOE+00 1.62E-04 O.OOE+00 7.64E-02 Pr-143 9.51E-07 2.86E-07 4.72E-08 O.OOE+00 1.55E-07 O.OOE+00 1.03E-03 Pr-144 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Nd-147 3.29E-07 2.66E-07 2.06E-08 O.OOE+00 1.46E-07 O.OOE+00 4.22E-04 W-1 87 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 ~
. O.OOE+00 Np-239 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Appv />~6 ~ .
Rev. 7 6-4c(2)
TABLE 6<d REMP DOSE FACTORS FOR CHILD AGE GROUP,: MEAT (Page 1 of 2)
REplP,.'SAMPLrE:DOSE:CAL'C';:FA<<CTORS!$ :"z.">>.CHILD.",MEATp<<<<:.".;:;g,,'.'",.":.;."i"::;::j~;~:.'":.:!:.55,";~,"':"::iii'r'eiji-'It.'gljiCi-"y'r~P~<.<<.;'.:~<<
,~NUCL<<1DE'"'<<', ;,:i:."<<Q,'SONE;,,:, I:,") ,'."-:,'::,'<<LIVER!~,:.j <<':'::T BODY,,"':",:!":THYROlD,;>:;","jKIDhlEYP',';): i',>i'".UNGAG'Y~g ','.;i.:'Gl-'.L'L'I'"-3 O.OOE+00 8.30E-06 8.30E-06 8.30E-06 8.30E-06 8.30E-06 8.30E-06 C-14 4.96E-04 9.92E-05 9.92E-05 9.92E-05 9.92E-05 9.92E-05 9.92E-05 Na-24 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 P-32 1.28E-02 6.00E-04 4.94E-04 O.OOE+0 0 O.OOE+00 O.OOE+00 3.54E-04 Cr-51 O.OOE+00 0.00E+00 2.21E-07 1.23E-07 3.366-08 2.24E-07 1.17E-OS Mn-54 0.00E+00 4.20E-04 1.12E-04 0.00E+00 1.18E-04 0.00E+00 3.52E-04 Mn-56 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Fe-55 4.65E-04 2.47E-04 7.64E-05 O.OOE+00 0.00E+00 1.39E-04 4.57E-05 Fe-59 4.96E-04 8.02E-04 4.00E-04 0.00E+00 0.00E+00 2.33E-04 8.35E-04 Co-58 O.OOE+00 6.07E-05 1.86E-04 O.OOE+00 O.OOE+00 0.00E+00 3.54E-04 Co-60 O.OOE+00 2.15E-04 6.35E-04 0.00E+00 O.OOE+00 0.00E+00 1.19E-03 Ni-63 2.20E-02 1.18E-03 7.50E-04 0.00E+00 O.OOE+00 0.00E+00 7.95E-05 Ni-65 O.OOE+00 O.OOE+00 0.00E+00 '.00E+00 O.OOE+00 O.OOE+00 0.00E+00 Cu-64 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Zn-65 5.31E-04 1.41E-03 8.79E-04 O.OOE+00 8.91E-04 0.00E+00 2.48E-04 Zn-69 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0:OOE+00 0.00E+00 O.OOE+00 Br-83 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0 B 84 O.OOE 00 0.00E+00 0.00E 00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE Br-85 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+
Rb-86 O.OOE+00 1.31E-03 8.04E-04 0.00E+00 O.OOE+00 0.00E+00 8.41E-05 Rb-88 O.OOE+00 0.00E+00 '.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Rb-89 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Sr-89 4.11E-02 O.OOE+00 1.17E-03 0.00E+00 O.OOE+00 0.00E+00 1.59E-03 Sr-90 6.96E-01 O.OOE+00 1.76E-01 O.OOE+00 O.OOE+00 O.OOE+00 9.38E-03 Sr-91 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Sr-92 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-90 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Y-91m O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Y 91 1.95E-05 O.OOE+00 5.21E-07 O.OOE+00 O.OOE+00 0.00E+00 2.59E-03 Y-92 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Y-93 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Zr-95 3.83E-06 8 42E-07 7.49E-07 O.OOE+00 1.21E-06 0.00E+00 8.78E-04 Zr-97 O.OOE+00 O.0OE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Nb-95 6.21E-07 2 42E-07 1.73E-07 0.00E+00 2.27E-07 0.00E+00 4.47E-04 Mo-99 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Tc-99m O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Appv Rev. 7
~~/" 6-4d(1)
TABLE 64d REMP DOSE FACTORS FOR CHILD AGE GROUP: MEAT (Page 2 of 2)
- (ii,;'l-'LLil
- ','!T.'BODY!:". :",;THYROID;:.;,':"; <'-:>! KIDNEY.:,!;'~':i'.:;:j",'L'UNG!,:.
-'-'NUCLIDE"j":.;:"''-"-iBONE!:"i'",',',":"::/LIVER!:;.:::-::::.
Tc-101 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Ru-103 2.11E-05 O.OOE+00 8.10E-06 O.OOE+00 5.30E-05 0.00E+00 5.45E-04 Ru-105 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Ru-106 4.62E-04 0.00E+00 5.76E-05 0.00E+00 6.24E-04 0.00E+00 7.19E-03 Ag-110m 2.09E-05 1.41E-05 1.13E-05 0.00E+00 ~
2.63E-05 0.00E+00 1.68E-03 Te-125m 3.68E-04 9.98E-05 4.91E-05 1.03E-04 0.00E+00 0.00E+00 3.55E-04 Te-127m 1.04E-03 2.81E-04 1.24E-04 2.49E-04 2.97E-03 0.00E+00 8.45E-04 Te-127 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-129m 1.32E-03 3.69E-04 2.05E-04 4.26E-04 3.88E-03 0.00E+00 1.61E-03 Te-129 3.64E-06 1.02E-06 8.63E-07 2.59E-06 1;06E-05 O.OOE+00 2.26E-04 Te-131m O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-131 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00,0.00E+00 Te-132 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 I-130 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 I-131 1.26E-04 1.26E-04 7.19E-05 4.18E-02 2.08E-04 O.OOE+00 1.13E-05 I-132 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0
I-1 33 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 I-134 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 I-135 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Cs-134 9.42E-03 1.55E-02 3.26E-03 0.00E+00 4.79E-03 1.72E-03 8.33E-05 Cs-136 3.36E-04 9.24E-04 5.98E-04 O.OOE+00 4.92E-04 7.34E-05 3.25E-05 Cs-137 1.34E-02 1.28E-02 1.89E-03 0.00E+00 4.18E-03 1.50E-03 '.03E-05 Cs-138 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 '0.00E+00 O.OOE+00 0.00E+00 Ba-139 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-140 1.15E-03 1.01E-06 6.73E-05'.00E+00 3.29E-07 6.02E-07 5.84E-04 Ba-141 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-142 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 La-140 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 La-142 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Ce-141 1.06E-06 5.30E-07 7.87E-08 0.00E+00 2.32E-07 O.OOE+00 6.61E-04 Ce-143 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Ce-144 8.12E-05 2.55E-05 4.33E-06 O.OOE+00 1.41E-05 0.00E+00 6.64E-03 Pr-143 5.80E-07 1.74E-07 2.88E-08 0.00E+00 9.43E-08 0.00E+00 6.25E-04 Pr-144 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Nd-147 3.24E-07 2.62E-07 2.03E-08 0.00E+00 1.44E-07 0.00E+00 4.15E-04 W-187 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Np-239 0.00E+00 '.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Appv Date ~ < 7 Rev. 7 6-4d(2)
TA8LE 6<e REMP DOSE FACTORS FOR CHILD AGE GROUP: FISH (Page 1 of 2)
" 'EIDOS, E CAL'C:;,F>ACTGRS;":!-;::4 REM P,.:SAIYIP,,
""',CHIL'D FISH:::.i::
QNU.GLIDE,~ ~~ 'LrlVER;:;,;: .; .-::::!T:.BODY ::THYROID.:;" 'j
- ,'KID>N>EY>.:.":.~"::",";:wLUNG:.':,. Gl'L>LV H-3 O.OOE+00 1.40E-06 1.40E-06 1.40E-06 1.40E-06 1.40E-06 1.40E-06 C-14 8.35E-05 1.67E-05 1.67E-05 1.67E-05 1.67E-05 1.67E-05 1.67E-05 Na-24 1.32E-05 1.32E-05 1.32E-05 1.32E-05 1.32E-05 1.32E-05 1.32E-05 P-32 5.42E-03 2.54E-04 2.09E-04 O.OOE+00 0.00E+00 0.00E+00 1.50E-04 Cr-51 O.OOE+00 O.OOE+00 5.99E-08 3.32E-08 9.08E-09 6.07E-08 3.18E-06 Mn-54 0.00E+00 7.37E-05 1.96E-05 O.OOE+00 2.07E-05 0.00E+00 6.18E-05 Mn-56 O.OOE+00 3.64E-09 8.21E-I 0 O.OOE+00 4.40E-09 O.OOE+00 5.27E-07 Fe-55 7.93E-05 4.21E-05 1.30E-05 0.00E+00 0.00E+00 2.38E<<05 7.79E-06 Fe-59 1.12E-.04 1.81E-04 9.04E-05 O.OOE+00 O.OOE+00 5.26E-05 1.89E-04 Co-58 O.OOE+00 1.23E-05 3.76E-05 0.00E+00 0.00E+00 O.OOE+00 7.17E-05 Co-60 0.00E+00 3.65E-05 1.08E-04 O.OOE+00 0.00E+00 O.OOE+00 2.02E-04 Ni-63 3.71E-03 1.99E-04 1.26E-04 O.OOE+00 0.00E+00 0.00E+00 .1.34E-05 Ni-65 2.08E-08 1.96E-09 1.14E-09 0.00E+00 0.00E+00 O.OOE+00 2.40E-07 Cu-64 O.OOE+00 4.56E-07 2.76E-07 0.00E+00 1.10E-06 O.OOE+00 2.14E-05 Zn-65 9.43E-05 2.51E-04 1.56E-04 O.OOE+00 1.58E-04 O.OOE+00 4.41E-05 Zn-69 5.01E-15 7.23E-15 6.69E-16 O.OOE+00 4.39E-15 O.OOE+00 4.56E-1 3 Br-83 O.OOE+00 O.OOE+00 1.12E-09 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 B 84 O.OOE+00 0.00E+00 3.40E-20 0.00E+00 0.00E+00 O.OOE+00 O.OOE+
Br-85 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+
Rb-86 O.OOE+00 4.45E-04 2.74E-04 O.OOE+00 0.00E+00 O.OOE+00 2.87E-05 Rb-88 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Rb-89 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Sr-89 ( 8.98E-03 0.00E+00 2.57E-04 O.OOE+00 0.00E+00 O.OOE+00 3.48E-04 Sr-90 1.17E-01 O.OOE+00 2.97E-02 O.OOE+00 O.OOE+00 O.OOE+00 1.58E-03 Sr-91 2.87E-05 O.OOE+00 1.09E-06 O.OOE+00 0.00E+00 O.0OE+00 6.35E-05 Sr-92 1.34E-07 0.00E+00 5.39E-09 0.00E+00 0.00E+00 0.00E+00 2.55E-06 Y-90 2.19E-07 -O.OOE+00 5.86E-09 0.00E+00 0.00E+00 0.00E+00 6.23E-04 Y-91m 5.22E-18 0.00E+00 1.90E-1 9 . 0.00E+00 0.00E+00 O.OOE+00 1.02E-14 Y-91 4.10E-06 O.OOE+00 1.10E-07 O.OOE+00 O.OOE+00 O.OOE+00 5.47E-04 Y-92 2.26E-1 0 0.00E+00 6.47E-12 O.OOE+00 0.00E+00 0.00E+00 6.53E-06 Y-93 1.52E-08 O.OOE+00 4.16E-10 0.00E+00 0.00E+00 O.OOE+00 2.26E-04 Zr-95 7.92E-07 1.74E-07 1.55E-07 O.OOE+00 2.49E-07 0.00E+00 1.82E-04 Zr-97 1.80E-08 2.60E-09 1.54E-09 0.00E+00 3.74E-09 O.OOE+00 3.94E-04 Nb-95 1.52E-07 5.93E-08 4.23E-08 O.OOE+00 5.57E-08 0.00E+00 1.10E-04 Mo-99 O.OOE+00 7.13E-05 1.76E-05 0.00E+00 1.52E-04'.OOE+00 5.90E-05 Tc-99m 4.02E-10 7.88E-10 1.31E-08 0.00E+00 4.00E-10 4.48E-07. '.14E-08 Appv Rev. 7 6-4e(1)
TABLE 6<e REMP DOSE FACTORS FOR CHILD AGE GROUP: FISH (Page 2 of 2) i;NU.CL'!DE$ :":-:::::-;.:;:B'ONE"::<'g ~p>':;:,'I'IVER.'::::;:;":: ;";,:"!T:BODY:::.::i'.:. @THYROID'!) :."~/KIDNEYS::~j bgalhUNGNi:'%':,+.! i.L'<!J4~~
Tc-101 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 RU-103 4.96E-06 0.00E+00 1.91E-06 0.00E+00 1.25E-05 O.OOE+00 1.28E-04 Ru-105 1.05E-08 O.OOE+00 3.81E-09 0.00E+00 9.23E-08 O.OOE+00 6.85E-06 Ru-106 8.06E-05 0.00E+00 1.01E-05 O.OOE+00 1.09E-04 O.OOE+00 1.25E-03 Ag-110m 3.71E-06 2.50E-06 2.00E-06 0.00E+00, 4.67E-06 O.OOE+00 2.98E-04 Te-125m 7.77E-05 2.11E-05 1.04E-05 2.18E-05 0.00E+00 O.OOE+00 7.50E-05 Te-127m 1.98E-04 5.33E-05 2.35E-05 4.74E-05 5.65E-04 O.OOE+00 1.60E-04 Te-127 5.48E-07 1.48E-07 1.18E-07 3.80E-07 1.56E-06 O.OOE+00 2.14E-05 Te-129m 3.29E-04 9.19E-05 5.11E-05 1.06E-04 9.67E-04 O.OOE+00 4.01E-04 Te-129 9.06E-07 2.53E-07 2.15E-07 6.46E-07 2.65E-06 O.OOE+00 5.64E-05 Te-131m 2.85E-05 9.87E-06 1.05E-05 2.03E-05 9.55E-05 0.00E+00 4.00E-04 Te-1 31 2.84E-24 O.OOE+00 O.OOE+00 2.17E-24 8.59E-24 O.OOE+00 .1.49E;23 Te-132 5.63E-05 2.49E-05 3.01E-05 3.63E-05 2.31E-04 0.00E+00 2.51E-04 1-130 5.24E-06 1.06E-05 5.46E-06 1.17E-03 1.58E-05 O.OOE+00 4.96E-06 1-131 1.09E-04 1.10E-04 6.22E-05 3.62E-02 1;80E-04 O.OOE+00 9.75E-06 1-132 3.99E-09 7.33E-09 3.37E-09 3.40E-07 1.12E-08 O.OOE+00 8.62E-09 1-133 1.84E-05 2.27E-05 8.59E-06 4.22E-03 3.78E-05 O.OOE+00 9.15E-06 1-134 1.72E-14 3.20E-1 4 1.47E-14 7.36E-.13 4.89E-14 0.00E+00 2.12E-14 I-135 9.75E-07 1.75E-06 8.30E-07 1.55E-04 2.69E-06 O.OOE+00 1.34E-06 Cs-134 1.61E-03 2.65E-03 5.58E-04 O.OOE+00 8.20E-04 2.94E-04 1.43E-05 Cs-136 1.54E-04 4.23E-04 2.74E-04 0.00E+00 2.25E-04 3.36E-05 1.49E-05 Cs-137 2.26E-03 2.16E-03 3.1 9E-04 O.OOE+00 7.04E-04 2.53E-04 1.35E-05 Cs-138 5.77E-20 8.03E-20 5.09E-20 0.00E+00 5.65E-20 6.08E-21 3.70E-20 Ba-139 1.78E-11 9.49E-15 5.15E-13 O.OOE+00 8.29E-15 5.58E-15 1.03E-09 Ba-140 5.43E-04 4.76E-07 3.17E-05 O.OOE+00 1.55E-07 2.84E-07 2.75E-04 Ba-141 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Ba-142 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 La-140 4.61E-08 1.61E-08 5.43E-09 O.OOE+00 O.OOE+00 O.OOE+00 4.49E-04 La-142 1.06E-13 3.36E-14 1.05E-14 0.00E+00 0.00E+00 O.OOE+00 6.67E-09 Ce-141 2.68E-07 1.34E-07 1.99E-08 O.OOE+00 5.86E-08 O.OOE+00 1.67E-04 Ce-143 2.91E-08 1.58E-05 2.29E-09 0.00E+00 6.63E-09 0.00E+00 2.31E-04 Ce-144 1.43E-05 4.49E-06 7.64E-07 0.00E+00 2.48E-06 O.OOE+00 1.17E-03 Pr-143 2.58E-07 7.74E-08 1.28&08 0.00E+00 4.1 9E-08 O.OOE+00 2.78E-04 Pr-144 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Nd-147 1.81E-07 1.46E-07 1.13E-08 0.00E+00 8.03E-08 O.OOE+00 2.32E-04 W-187 1.47E-06 8.72E-07 3.91E-07 O.OOE+00 O.OOE+00 O.OOE+00 1.23E-04 Np-239 2.70E-08 1.94E-09 1.36E-09 0.00E+00 5.60E-09 O.OOE+00 1.43E-04 Appv Date .~4. r7 Rev. 7 6-4e(2)
TABLE 6-4f REMP DOSE FACTORS FOR CHILD AGE GROUP: DRINKING WATER (Page 1 of 2)
REMP, S'AMPLE!DOSE,CALC'.:">FACTOR',S '!CHILD,DRiNKiNG'.W+TER':..-:,':,,: ..;:":~::- ':>";."',mrem"-Iiter/pCi.gr
';:"-;NUCLIDE,:'".,;"$ ,:BOQE,! i",: ':"'": :"",:,""L'IV.ER.'".:.':. ;:T BODY:::i::::! THYROID."" :'-'.KIDNEY,.".:;:" '-"::.i':,::,-:LUNG..:'::f;!i >i! >>GI,'-L'U)g H-3 0.00E+00 1.04E-04 1.04E-04 1.04E-04 1.04E-04 1.04E-04 1.04E-04 C-14 6.17E-03 1.23E-03 1.23E-03 1.23E-03 1.23E<<03 1.23E-03 1.23E-03 Na-24 1.70E-03 1.70E-03 1.70E-03 1.70E-03 1.70E-03 1.70E-03 1.70E-03 P-32 4.11E-01 1.92E-02 1.58E-02 0.00E+00 0.00E+00 0.00E+00 1.13E-02 Cr-51 0.00E+00 0.00E+00 4.48E-06 2.49E-06 6.80E-07 4.54E-06 2.38E-04 Mn-54 0.00E+00 5.45E-03 1.45E-03 O.OOE+00 1.53E-03 O.OOE+00 4.57E-03 Mn-56 O.OOE+00 6.77E-06 1.53E-06 O.OOE+00 8.18E-06 0.00E+00 9.81E-04 Fe-55 5.86E-03 3.11E-03 9.64E-04 0.00E+00 O.OOE+00 1.76E-03 5.76E-04 Fe-59 8.35E-03 1.35E-02 6.73E-03 O.OOE+00 0:00E+00 3.92E-03 1.41E-02 Co-58 O.OOE+00 9.14E-04 2.80E-03 0.00E+00 O.OOE+00 O.OOE+00 5.33E-03 Co-60 0.00E+00 2.70E-03 7.95E-03 O.OOE+00 O.OOE+00 O.OOE+00 1.49E-02 Ni-63 2.74E-01 1.47E-02 9.33E-03 O.OOE+00 O.OOE+00'.OOE+00 - 9.89E-04 Ni-65 4.17E-05 3.93E-06 2.29E-06 0.00E+00 O.OOE+00 O.OOE+00 4.81E-04 CU-64 0.00E+00 6.49E-05 3.92E-05 0.00E+00 1.57E-04 0.00E+00 3.05E-03 Zn-65 6.98E-03 1.86E-02 1.16E-02 0.00E+00 1.17E-02 O.OOE+00 3.26E-03 Zn-69 2.87E-'09 4.15E-09 3.84E-10 0.00E+00 2.52E-09 O.OOE+00 2.62E-07 Br-83 O.OOE+00 O.OOE+00 2.69E-06 0.00E+00 O.OOE+00 O.OOE+00 0.00E+0 B 84 O.OOE 00 O.OOE 00 1.59E 11 0.00E+00 0.00E+00 O.OOE 00 0.00E Br-85 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+0 Rb-86 0.00E+00 3.35E-02 2.06E-02 0.00E+00 O.OOE+00 O.OOE+00 2.16E-03 Rb-88 O.OOE+00 6.83E-17 4.74E-17 O.OOE+00 O.OOE+00 O.OOE+00 3.35E-18 Rb-89 O.OOE+00 5.84E-19 5.19E-19 O.OOE+00 0.00E+00 O.OOE+00 5.09E-21 Sr-89 6.69E-01 0.00E+00 1.91E-02 O.OOE+00 O.OOE+00 O.OOE+00 2.59E-02 Sr-90 8.67E+00 O.OOE+00 2.20E+00 0.00E+00 O.OOE+00 '.00E+00 1.17E-01 Sr-91 5.10E-03 O.OOE+00 1.93E-04 0.00E+00 0.00E+00 O.OOE+00 1.13E-02 Sr-92 2.14E-04 0.00E+00 8.58E-06 0.00E+00 O.OOE+00 O.OOE+00 4.05E-03 Y-90 1.84E-05 O.OOE+00 4.93E-07 0.00E+00 0.00E+00 O.OOE+00 5.24E-02 Y-91m 8.67E-12 0.00E+00 3.16E-1 3 0.00E+00 O.OOE+00 O.OOE+00 1.70E-08 Y-91 3.05E-04 O.OOE+00 8.16E-06 0.00E+00 O.OOE+00 O.OOE+00 4.07E-02 Y-92 1.75E-07 0.00E+00 5.01E-09 0.00E+00 O.OOE+00 O.OOE+00 5.06E-03 Y-93 2.55E-06 7.01E-08 0.00E+00 O.OOE+00 O.OOE+00 3.81E-02 0.00E+00'.29E-05 Zr-95 5.88E-05 1.15E-05 O.OOE+00 1.85E-05 O.OOE+00 1.35E-02 Zr-97 2.18E-06 3.15E-07 1.86E-07 O.OOE+00 4.52E-07 ~ O.OOE+00 4.77E-02 Nb-95 1.14E-05 4.42E-06 3.16E-06 0.00E+00 4.16E-06 O.OOE+00 8.18E-03 Mo-99 O.OOE+00 5.98E-03 1.48E-03 0.00E+00 1.28E-02 O.OOE+00 4.95E-03 Tc-99m 1.18E-07 2.32E-07 3.84E-06 0.00E+00 3.37E-06 1.18E-07 1.32E-04 Appv Rev. 7 6-4f(1)
TABLE 6-4f REMP DOSE FACTORS FOR CHILD AGE GROUP: DRINKING WATER (Page 2 of 2)
EMP.'S'AMPL'E:;DOSE<CA'L'C".~FA'CTORS';;.."CHIL'D,:,DRINKING,','WATER;.,:':';,,:P'."-".',;-:,:":: ':,,",'"::m' "g NUCU'DE';:"., :"i:,:":-;,BONE!,:"f, ':a;"','(;.'Ll VER;",;-"'i":,~ '.,'.T,'BODY,::.,,::, f ',;;;.;:THYROID;j .:'.,.'.-',! KlDNEY...>",": ::i', j~LUNG~,:~~": ',i::",',Gl'-',L'L"I;,;,'" "',~
Tc-101 3.19E-22 3.34E-22 4.23E-21 0.00E+00 5.70E-21 1.77E-22 1.06E-21 RU-103 3.70E-04 O.OOE+00 1.42E-04 O.OOE+00 9.30E-04 O.OOE+00 9.55E-03 Ru-105 5.05E-06 0.00E+00 1.83E-06 0.00E+00 4;44E-05 O.OOE+00 3.30E-03 Ru-106 5.96E-03 0.00E+00 7.44E-04 0.00E+00 8.05E-03 0.00E+00 9.27E-02 Ag-110m 2.75E-04 1.85E-04 1.48E-04 0.00E+00 3.45E-04 O.OOE+00 2.21E-02 Te-125m 5.78E-03 1.57E-03 7.71E-04 1.62E-03 0.00E+00 O.OOE+00 5.58E-03 Te-127m 1.47E-02 3.96E-03 1.74E-03 3.51E-03 4.19E-02 O.OOE+00 .1.19E-02 Te-127 9.87E-05 2.66E-05 2.12E-05 6.83E-05 2.81E-04 O.OOE+00 3.86E-03 Te-129m 2.46E-02 6.86E-03 3.82E-03 7.92E-03 7.22E-02 0;OOE+00 3.00E-02 Te-129 6.76E-05 1.89E-05 1.61E-05 4.83E-05 1.98E-04 0.00E+00 4.2'I E-03 Te-131m 2.78E-03 9.62E-04 1.02E-03 1.98E-03 9.31E-03 O.OOE+00 3.90E-02 Te-131 9.43E-14 2.87E-14 2.80E-14 7.21E-14 2.85E-13 0.00E+00 4.95E-13 Te-132 4.63E-03 2.05E-03 2.48E-03 2.99E-03 1.90E-02 0.00E+00 2.06E-02 I-130 7.60E-04 1.54E-03 7.91E-04 1.69E-O "i 2.29E-03 O.OOE+00 7.18E-04 I-131 8.40E-03 8.45E-03 4.80E-03 2.79E+00 1.39E-02 O.OOE+00 7.52E-04 1-132 1.10E-05 2.02E-05 9.27E-06 9.35E-04 3.08E-'05 0.00E+00 2.37E-05 1-1 33 2.02E-03 2.50E-03 9 47E-04 4.65E-01 4.17E-03 O.OOE+00 1.01E-03 l-134 1.65E-08 3.06E-08 1.41E-08 7.05E-07 4.69E-08 0.00E+00 2.03E-08 l-135 2.54E-04 4.56E-04 2.1'6E-04 4.04E-02 7.00E-04 O.OOE+00 3.48E-04 Cs-134 1.19E-01 1.96E-01 4.1 3E-02 O.OOE+00 6.07E-02 2.18E-02 1.06E-03 Cs-136 1.17E-02 3.21E-02 2.08E-02 0.00E+00 1.71E-02 2.55E-03 1.13E-03 Cs-137 1.67E-01 1.60E-01 2.36E-02 0.00E+00 5.20E-02 1.87E-02 1.00E-03 Cs-'138 2.23E-11 3.10E-11 1.96E-1 1 0.00E+00 2.18E-11 2.34E-12 1.43E-11 Ba-139 5.27E-07 2.81E-10 1.53E-08 0.00E+00 2.46E-10 1.65E-10 3.04E-05 Ba-140 4.12E-02 '.61E-05 2.41E-03 0.00E+00 1.18E-OS 2.15E-05 2.09E-02 Ba-141 1.48E-16 8.26E-20 4.80E-18 O.OOE+00 7.15E-20 4.86E-19 8.41E-17 Ba-142 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 La-140 4.19E-06 1.46E-06 4.94E-07 0.00E+00 0.00E+00 0.00E+00 4.08E-02 La-142 1.44E-09 4.60E-10 1.44E-10 0.00E+00 0.00E+00 O.OOE+00 9.12E-05 Ce-141 2.00E-05 9.99E-06 1.48E-06 O.OOE+00 4.38E-06 0.00E+00 1.25E-02 Ce-143 2.77E-06, 1.50E-03 2.1 8E-07 O.OOE+00 6.30E-07 O.OOE+00 2.20E-02 Ce-144 1.06E-03 3.32E-04 5.65E-05 0.00E+00 1.84E-04 O.OOE+00 8.66E-02 Pr-143 1.95E-05 5.87E-06 9.69E-07 0.00E+00 3.18E-06 0.00E+00 2.11E-02 Pr-144 2.00E-20 6.18E-21 1.00E-21 0.00E+00 3.27E-21 0.00E+00 1.33E-17 Nd-147 1.38E-05 1.12E-05 8.65E-07 0.00E+00 6.13E-06 O.OOE+00 1.77E-02 W-1 87 1.54E-04 9.14E-05 4.10E-05 O.OOE+00 O.OOE+00 O.OOE+00: 1.28E-02 Np-239 2.31E-06 1.66E-07 1.17E-07 0.00E+00 4.80E-07 0.00E+00 1.23E-02 Appv Date '+'
Rev. 7 6-4f(2)
TABLE 6-4g REMP DOSE FACTORS FOR CHILD AGE
- QUARTERLY SAMPLING (Page GROUP'NHALATION 1 of 2)
REMP..:S'AMPLE DOSE;O'A'LC,'FA'CTORS':";-:::,CHIL'D',INH;QUARTERLY;!I:::")jj;.'<<!L<<~:.:-.'m'rem'm<lpCi-'.yrp.:':i:-,:'Ig';:";,y:.it
- !.";NUCLIDE'jij !.
- ',,<<,-e ONE."!':.:';.:;:; I".:-: LIVER!I:'::ii,- !i::::'T.'BODY,.:,:::.i .'<<WH~OID,.!)KlDNEY"'.:I"" 'l"UNG<i".'i';:;i',."'I,"LLIP'-3 O.OOE+00 1.13E-03 1.13E-03 1.13E-03 1.1 3E-03 1.13E-03 1.13E-03 C-14 3.59E-02 6.73E-03 6.73E-03 6.73E-03 6.73E-03 6.73E-03 6.73E-03 Na-24 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 P-32 2.38E+01 1.05E+00 9.03E-01 O.OOE+00 0.00E+00 0.00E+00 3.86E-01 Cr-51 0.00E+00 O.OOE+00 4.83E-04 2.68E-04 7.61E-05 5.32E-02 3.39E-03 Mn-54 O.OOE+00 4.75E-02 1.05E-02 0.00E+00 1.11E-02 1.74E-02 2.53E-02 Mn-56 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00=
Fe-55 4.89E-02 2.60E-02 8.02E-03 0.00E+00 0.00E+00 1.15E-01 2.96E-03 Fe-59 4.20E-02 6.79E-02 3.39E-02 O.OOE+00 O.OOE+00 2.58E+00 1.44E-01 Co-58 O.OOE+00 2.77E-03 4.94E-03 0.00E+00 0.00E+00 1.73E+00 5.37E-02 Co-60 O.OOE+00 1.34E-02 2.30E-02 O.OOE+00 O.OOE+00 7.1 8E+00 9.78E-02 Ni-63 8.22E-01 4.63E-02 2.80E-02 .0.00E+00 0.00E+00 2.75E-01 6.33E-03 Ni-65 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Cu-64 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Zn-65 4.84E-02 1.29E-01 8.00E-02 O.OOE+00 8.13E-02 1.13E+00 1.86E-02 Zn-69 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-83 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+
Br-84 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+
Br-85 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-86 0.00E+00 1.08E+00 6.23E-01 0.00E+00 O.OOE+00 O.OOE+00 4.35E-02 Rb-88 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-89 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-89 1.12E+00 0.00E+00 3.22E-02 0.00E+00 O.OOE+00 4.03E+00 3.1 3E-01
, Sr-90 1.01E+02 0.00E+00 6.46E+00 O.OOE+00 0.00E+00 1.48E+01 3.44E-01 Sr-91 0.00E+00 O.OOE+00 '.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-92 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-90 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91m 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91 1.57E+00 0.00E+00 4.19E-02 O.OOE+00 0.00E+00 4.51E+00 3.16E-01 Y-92 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-93 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Zr-95 3.11E-01 6.85E-02 6.06E-02 O.OOE+00 9.76E-02 3.66E+00 1.00E-01 Zr-97 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Nb-95 5.79E-02 2.26E-02 1.61E-02 O.OOE+00 2.12E-02 1.51E+00 9.12E-02 Mo-99 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 . O.OOE+00 Tc-99m O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+0 Appv:
Date
"~C> i
'~. 7 Rev. 7 6-4g(1)
TA8LE 6%g REMP DOSE FACTORS FOR CHILD AGE GROUP:
INHALATION- QUARTERLY SAMPLING (Page 2 of 2)
REMP,,::SAMPLrE,DOSE.:.CANC.,:FACTORS,. CHILD,',INH -:QUARTERLY
.." NU,C,LIDE-;.':'+,:::,","BONE:"' g';.':,'.LlVER:,jP ~JEST".BODY' 'j>1'HYROID~i j .':""',jKIDNEY:"'<5jj',.";1"UMG!j:",jil;"."-',Gl-'L'Ll+~i Tc-101 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Ru-103 6.24E-03 O.OOE+00 2.40E-03 O.OOE+00 1.57E-02 1.48E+00 1.00E-01 Ru-105 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 RU-106 1.48E-01 O.OOE+00 1.84E-02 O.OOE+00. 2.00E-O'I 1.56E+01 4.68E-01 Ag-110m 1.91E-02 1.29E-02 1.04E-02 0.00E+00 2.41E-02 6.21E+00 1.14E-01 Te-125m 1.16E-02 4.01E-03 1.58E-03 3.32E-03 O.OOE+00 8.23E-01 5.83E-02 Te-127m 3.32E-02 1.14E-02 4.04E-03 8.11E-03 8.51E-02 1.98E+00 9.54E-02 Te-127 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-129m 4.92E-02 1.75E-02 7.80E-03 1.62E-02 1.29E-01 4.51E+00 4.66E-01 Te-129 2.50E-07 8.96E-08 6.11E-08 1.83E-07 6.58E-07 7.52E-03 6.53E-02 Te-131m 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 ,0.00E+00 Te-131 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-'.32 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 I-130 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 I-131 2.46E+00 2.46E+00 1.39E+00 8.30E+02 4.03E+00 O.OOE+00 1.45E-01
~
I-132 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 I-133 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 I-134 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 I-135 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Cs-134 6.79E-01 1.06E+00 2.34E-01 O.OOE+00 3.45E-01 1.26E-01 4.01E-03 Cs-136 7.20E-01 1.89E+00 1.28E+00 0.00E+00 1.06E+00 1.61E-01 4.62E-02 Cs-137 9.09E-01 8.27E-01 1.29E-01 O.OOE+00 2.83E-01 1.04E-01 3.63E-03 Cs-138 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-139 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-140 8.77E-01 7.68E-04 5.13E-02 0;OOE+00 2.50E-04 2.07E+01 1.21E+00 Ba-141 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-142 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00.
La-140 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE400 La-142 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Ce-141 1.04E-01 5.17E-02 7.67E-03 O.OOE+00 2.26E-02 1.44E+00 1.50E-01 Ce-143 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Ce-144 7.57E+00 2.37E+00 4.04E-01 O.OOE+00 1.31E+00 1.34E+01 4.34E-01 Pr-143 1.90E-01 5.72E-02 9.41E-03 O.OOE+00 3.09E-02 . 4.46E+00 1.00E+00 Pr-144 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Nd-147 1.93E-01 1.56E-01 1.21E-02 O.OOE+00 8.57E-02 5.85E+00; 1.46E+00 W-187 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Np-239 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Appv Rev. 7 6-4g(2i
TABLE 6-4h REMP DOSE FACTORS FOR CHILD AGE GROUP:
INHALATION- WEEKLY SAMPLING (Page 1 of 2)
REMP.. SAMPL'E!DOSE CALC!FACTORS'.::,::CHILD:fNH;:.:.WEEKLY:-'.":::::::".'g'..:-:.::: -:::: i."::;::,::::::;: Vmrerji~~lpCi~r;,".:,.,::,::.::I>~::
~>.. NUCL1DE":ii !pii!F,BONE. <g>> ""i"'L'IVER.,"i,';::,'.13E-03
',::,':T'.BODYI,:'i,:; THYROlD,!',! ."".;L'i'KfDNEY,-',:; :"""<iLUMG.'.;::@ 46l-L'Lf H-3 O.OOE+00 1.13E-03 1.13E-03 1.1 3E-03 1.13E-03 1.13E-03 C-14 3.59E-02 6.73E-03 6.73E-03 6.73E-03 6.73E-03 6.73E-03 6.73E-03 Na-24 O.OOE+00 O.OOE+00 0.00E+00 '.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 P-32 3.09E+00 1.35E-01 1.17E-01 0.00E+00 0.00E+00 O.OOE+00 5.00E-02 Cr-51 0.00E+00 O.OOE+00 1.68E-04 9.33E-05 2.65E-05 1.85E-02 1.18E-03 Mn-54 O.OOE+00 4.33E-02 9.58E-03 O.OOE+00 1.01E-02 1.59E-02 2.31E<<02 Mn-56 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Fe-55 4.75E-02 2.52E-02 7.79E-03 O.OOE+00 O.OOE+00 1.11E-01 2.87E-03 Fe-59 2.18E-02 3.53E-02 1.76E-02 0.00E+00 0.00E+00 1.34E+00 7.46E-02 Co-58 O.OOE+00 1.83E-03 3.27E-03 O.OOE+00 0.00E+00 1.14E+00 3.56E-02 Co-60 O.OOE+00 1.32E-02 2.27E-02 0.00E+00 0.00E+00 7.08E+00 9.63E-02 Ni-63 8.21E-01 4.63E-02 2.80E-02 0.00E+00 O.OOE+00 2.75E-01 6.33E-03 Ni-65 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Cu-64 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Zn-65 4.30E-02 1.14E-01 7.10E-02 0.00E+00 7.21E-02 1.01E+00 1.65E-02 Zn-69 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 '0.00E+00 0.00E+00 O.OOE+00 Br-84 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+0 0 0.00E+
Br-85 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 Rb-86 0.00E+00 2.26E-01 1.30E-01 O.OOE+00 0.00E+00 0.00E+00 9.10E-03 Rb-88 O.OOE+00 O.OOE+00 0.00E+00 '0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Rb-89 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Sr-89 6.29E-01 O.OOE+00 1.81E-02 0.00E+00 0.00E+00 2.26E+00 1.75E-01 Sr-90 1.01E+02 0.00E+00 6.44E+00 0.00E+00 O.OOE+00 1.48E+01 3.43E-01 Sr-91 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Sr-92 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Y-90 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91m O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Y-91 9.53E-01 O.OOE+00 2.54E-02 0.00E+00 0.00E+00 2.74E+00 1.92E-01 Y-92 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Y-93 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Zr-95 1.97E-01 4.34E-02 3.84E-02 0.00E+00 6.19E-02 2.32E+00 6.34E-02 Zr-97 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Nb-95 2.52E-02 9.83E-03 7.02E-03 0.00E+00 9.24E-03 6.58E-01 3.97E-02 Mo-99 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 . 0.00E+00 Tc-99m 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+0 Appv Date Rev. 7 6-4h(1)
TABLE 6-4h i';
REMP DOSE FACTORS FOR CHILD AGE
- WEEKLY SAMPLING (Page 2 of 2) GROUP'NHALATION REMP,,:SAMPLE!DOSE"GAL'O';":FACTORSI!'CHIL'DINH WEEKLY!";i':->'i':: :".: ';ll:"i i"".:-~-'."ll::::,m'rem~~JpCi-'yr'.'~4":~~;""'<'::""."l6
'.'":NU.CL~lDE I,'."~ILlVER':,,-':',I "4:T';BODY:;"'::":": ,:",THYROID,':". ;,,:KlDNEYg,",q Tc-101 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 .
RU-103 2.97E-"03 O.OOE+00 1.14E-03 0.00E+00 7.48E-03 7.04E-01 4.76E-02 Ru-105 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Ru-106 1.37E-01 O.OOE+00 1.70E-02 O.OOE+00 1.85E-01 1.44E+01 4.32E-01 Ag-110m 1.70E-02 1.15E-02 9.23E-03 0.00E+00 2.14E-02 5.53E+00 1.01E-01 Te-125m 7.02E-03 2.43E-03 9.53E-04 2.01E-03 O.OOE+00 4.98E-01 3.52E-02 Te-127m 2.54E-02 8.74E-03 3.09E-03 6.20E-03 6.51E-02 1.51E+00 7.30E-02 Te-127 '.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Te-129m 2.06E-02 7.36E-03 3.27E-03 6.80E-03 5.41E-02 1.89E+00 1.95E-01 Te-129 1.05E-07 3.76E-08 2.56E-08 7.68E-08 2.76E-07 3.1 5E-03 2.74E-02 Te-131m 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Te-131 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.'OOE+00 0.00E+00 O.OOE+00 Te-132 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 I-130 0.00E+00 '.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1-131 4.81E-02 4.81E-02 2.73E-02 1.62E+01 7.88E-02 O.OOE+00 2.84E-03 l-132 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 l-133 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 l-134 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I-135 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Cs-134 6.53E-01 1.02E+00 2.25E-01 0 00c+00 3 31E 01 1 21E.01 3.86E-03 Cs-136 7.83E-02 2.06E-01 1.40E-01 O.OOE+00 1.15E-01 1.75E-02 5.03E-03 Cs-137 9.07E-01 8.25E-01 1.28E-01 0.00E+00 2.82E-01 1.04E-01 3.62E-03 Cs-138 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Ba-139 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Ba-140 8.95E-02 7.83E-05 5.23E-03 0.00E+00 2.55E-05 2.11E+00 1.23E-01 Ba-141 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Ba-142 0.00E+00 ~
O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
~
La-140 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 La-142 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Ce-141 4.23E-02 2.11E-02 3.12E-03 0.00E+00 9.21E-03 5.86E-01 . 6.10E-02 Ce-143 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Ce-144 6.83E+00 2.13E+00 3.65E-01 0.00E+00 1.18E+00 1.21E+01 3.92E-01 Pr-143 2.21E-02 6.64E-03 1.09E-03 0.00E+00 3.59E-03 5.18E-01 1.16E-01 Pr-144 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Nd-147 1.35E-02 1.09E-02 8.49E-04 0.00E+00 6.00E-03 4.09E-01 1.02E-01 W-187 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Np-239 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Appv Date Rev. 7 6-4h(2)
TABLE 6-5a
~
REMP DOSE FACTORS FOR INFANT AGE GROUP: MILK(Page 1 of 2)
R>ENIP, SAMPL'EKDOSE';.CALC:"::FA'CTORS!'::"::::;:,::-INFANT:NIL'K;'>
- "
- .II>IUCL'ID'E;:ii!; ii':":;PBQNE::::->:::";: !:::: L'IVER:!>j::> :i,:,IT BODY, .". THYROID.!ii:: !,'.:,i:: KIDNEY%::.I :,".;:iIL'UN,G!4 '-".!."',:~jt'Gt-",LL'f)'j-3 0.00E+00 1.02E-04 1.02E-04 1.02E-04 1.02E-04 1.02E-04 1.02E-04 C-14 7.82E-03 1.67E-03 1.67E-03 1.67E-03 1.67E-03 1.67E-03 1.67E-03 Na-24 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 P-32 5.09E-01 2.99E-02 1.97E-02 O.OOE+00 O.OOE+00 O.OOE+00 6.89E-03 Cr-51 O.OOE+00 0.00E+00 4.43E-06 2.89E-06 6.31E-07 5.62E-06 1.29E-04 Mn-54 0.00E+00 6.54E-03 1 48E-03 0.00E+00 1.45E-03 O.OOE+OO 2.40E-03 Mn-56 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Fe-55 4.58E-03 2.96E-03 7.91E-04 0.00E+00 O.OOE+00 1.45E-03 3.76E-04 Fe-59 9.85E-03 1.72E-02 6.78E-03 0.00E+00 O.OOE+00 5.09E-03 8.22E-03 Co-58 O.OOE+00 1.16E-03 2.91E-03 O.OOE+00 O.OOE+00. 'O.OOE+00 2.90E-03 Co-60 O.OOE+00 3.56E-03 8.41E-03 O.OOE+00 O.OOE+00 O.OOE+00 8.47E-03 Ni-63 2.09E-01 1.29E-02 7.26E-03 O.OOE+00 0.00E+00 0.00E+00 .6.43E-04 Ni-65 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Cu-64 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 Zn-65 6.04E-03 2.07E-02 9.55E-03 O.OOE+00 1.00E-02 O.OOE+00 1.75E-02 Zn-69 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Br-83 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Br-84 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+
Br-85 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+
Rb-86 O.OOE+00 5.21E-02 2.57E-02 O.OOE+00 O.OOE+00 O.OOE+00 1.33E-03 Rb-88 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Rb-89 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-89 8.06E-01 O.OOE+00 2.31E-02 O.OOE+00 0.00E+00 0.00E+00 1.66E-02 Sr-90 6.10E+00 O.OOE+00 '1.55E+00 0.00E+00 O.OOE+00 O.OOE+00 7.62E-02 Sr-91 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Sr-92 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Y-90 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91m O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91 3.64E-04 0.00E+00 9.?OE-06 0.00E+00 0.00E+00 O.OOE+00 2.61E-02 Y-92 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-93 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Zr-95 6.65E-05 1.62E-05 1.15E-05 O.OOE+00 1.75E-05 0.00E+00 8.07E-03 Zr-97 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Nb-95 1.33E-05 5.49E-06 3.17E-06 O.OOE+00 3.93E-06 O.OOE+00 4.63E-03 Mo-99 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Tc-99m O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Appv Date ri -'N 7 Rev. 7 6-5a(.S)
TABLE 6-5a REMP DOSE FACTORS FOR lNFANT AGE GROUP: MtLK (Page 2 of 2)
REMP.::SAMPLE.DOSE'O'ALC::FA'CTORS::::::;:.";.INFANT!MILK.">>;"';:<,::
jNUCL'I DE'>>~.. :":BONE::::(I.""'." '::-:LIVER:'"::" 'T.'BODY>> ':: .:
fHYi01b4: "'h"KIDNEY:":: ""~i+Ug@i@I Tc-101 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ru-103 4.71E-04 0.00E+00 1.58E-04 0.00E+00 9.81E-04 0.00E+00 5.73E-03 RU-105 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 RU-106 7.92E-03 0.00E+00 9.90E-04 0.00E+00 9.37E-03 O.OOE+00 6.02E-02 Ag-110m 3.27E-04 2.39E-04 1.58E-04 0.00E+00 3.41E-04 0.00E+00 1.24E-02 Te-125m 7.51E-03 2.51E-03 1.01E-03 2.53E-03 O.OOE+00 O.OOE+00 3.58E-03 Te-127m 1.91E-02 6.32E-03 2.31E-03 5.51E-03 4.69E-02 O.OOE+00 7.69E-03 Te-127 0.00E+0 0 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Te-129m 3.17E-02 1.09E-02 4.88E-03 1.22E-02 7.92E-02 O.OOE+00 1.89E-02 Te-129 8.99E-05 3.10E-05 2.1 0E-05 7.54E-05 2.24E-04 O.OOE+00 7.19E-03 Te-131m 0.00E+00 '.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+OO Te-131 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 .0.00E+00 Te-132 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l-130 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 I-131 '.17E-02 5.17E-03 3.86E+00 '.97E-03 1.37E-02 0.00E+00 4.19E-04 I-132 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 l-133 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 I-134 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 I-135 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Cs-134 1.24E-01 2.32E-01 2.34E-02 O.OOE+00 5.96E-02 2A4E-02 6.29E-04 Cs-136 1.36E-02 4.01E-02 1.50E-02 0.00E+00 1.60E-02 3.27E-03 6.09E-04 Cs-137 1.72E-01 2.02E-01 1.43E-02 0.00E+00 5.41E-02 2.19E-02 6.30E-04 Cs-138 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00. 0.00E+00 O.OOE+00 Ba-139 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 ~ O.OOE+00 Ba-140 5.06E-02 5.06E-05 2.61E-03 0.00E+00 1.20E-05 3.11E-05 1.24E-02 Ba-141 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Ba-142 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 La-140 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 La-142 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Ce-141 2.49E-05 1.52E-05 1.79E-06 0.00E+00 4.68E-06 0.00E+00 7.84E-03 Ce-143 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ce-144 9.79E-04 4.01E-04 5.48E-05 0.00E+00 1.62E-04 0.00E+00 5.62E-02 Pr-143 2.42E-05 9.06E-06 1.20E-06 0.00E+00 3.37E-06 0.00E+00 '.28E-02 Pr-144 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 N(f-147 1.61E-05 1.65E-05 1.01E-06 0.00E+00 6.37E-06 0.00E+00 1.05E-02 W-187 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 . O.OOE+00 Np-239 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 Appv Rev. 7 6-5a(2)
TABLE 6-5b REMP DOSE FACTORS FOR INFANT AGE GROUP: DRINKING WATER (Page 1 of 2)
REMP S'AlIIIPL'E DO SE.CALC FACTORS. plNFANT~DRINKtiIlGWA'TERi:q~...y;-:.p~.q:;i,;mrerndrterlyCt~r:.,-,~.:.,i,
': $8 i!i'NUCLIDE!,'ll0: ~
B'Q NE ). 'P~jT;.'BODY~:".:i ':THYROID'!j ~"~~KIDNEYiI..'-)
H-3 O.OOE+00 1.02E-04 1.02E-04 1.02E-04 1.02E-04 1.02E-04 1.02E-04 C-14 7.82E-03 1.67E-03 1.67E-03 1.67E-03 1.67E-03 1.67E-03 1.67E-03 Na-24 1.91E-03 1.91E-03 1.91E-03 1.91E-03 1.91E-03 1.91E-03 1.91E-03 P-32 5.48E-01 3.22E-02 2.12E-02 O.OOE+00 0.00E+00 0.00E+00 7.41E-03 Cr-51 O.OOE+00 O.OOE+00 4.60E-06 3.00E-06 6.55E-07 5.83E-06 1.34E-04 Mn-54 O.OOE+00 6.56E-03 1.49E-03 O.OOE+00 1.45E-03 O.OOE+0 0 2.41E-03 Mn-56 O.OOE+00 1.07E-05 1.85E-06 0.00E+00 . 9.22E-06 O.OOE+00 9.74E-04 Fe-55 4.59E-03 2.96E-03 7.92E-04 0.00E+00 0.00E+00 1.45E-03 3.76E-04 Fe-59 1.01E-02 1.76E-02 6.94E-03 O.OOE+00 O.OOE+00 5.21E-03 8.42E-03 Co-58 O.OOE+00 1.18E-03 2.95E-03 O.OOE+00 0.00E+00 0.00E+00 2.95E-03 Co-60 O.OOE+00 3.56E-03 8.41E-03 0.00E+00 0.00E+00 O.OOE+00 8.48E-03 Ni-63, 2.09E-01 1.29E-02 7.26E-03 O.OOE+00 0.00E+00 0.00E+00 6.43E-04 Ni-65 5.72E-05 6.47E-06 2.94E-06 . 0.00E+00 O.OOE+00 0.00E+00 4.93E-04 CU-64 O.OOE+OO 1.04E-04 4.83E-05 O.OOE+00 1.77E-04 0.00E+00 '2.14E-03 Zn-65 6.06E-03 2.08E-02 9.59E-03 O.OOE+00 1.01E-02 0.00E+00 1.76E-02 Zn-69 3.96E-09 7.13E-09 5.31E-10 O.OOE+00 2.96E-09 O.OOE+00 5.82E-07 Br-83 O.OOE+00 O.OOE+00 3.69E-06 O.OOE+00 O.OOE+00 0.00E+00 O.ooh+00 Br-84 O.OOE+00 0.00E+00 1.99E-11 O.OOE+00 0.00E+00 O.OOE+00 0.00E+
Br-85 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+
Rb-86 O.OOE+00 5.51E-02 2.72E-02 O.OOE+00 O.OOE+00 O.OOE+00 1.41E-03 Rb-88 O.OOE+00 1.16E-16 6.35E-17 O.OOE+00 O.OOE+00 O.OOE+00 1.1 3E-16 Rb-89 O.OOE+00 9.23E-19 6.36E-1 9 O.OOE+00 0.00E+00 O.OOE+00 3.14E-1 9 Sr-89 8.23E-01 0.00E+00 2.36E-02 O.OOE+00 O.OOE+00 O.OOE+00 1.69E-02 Sr-90 6.10E+00 0.00E+00 1.55E+00 0.00E+00 0.00E+00 0.00E+00 7.62E-02 Sr-91 6.87E-03 O.OOE+00 2.49E-O4 O.OOE+00 O.OOE+00 O.OOE+00 8.14E-03 Sr-92 2.94E-04 O.OOE+00 1.09E-05 0.00E+00 0.00E+00 0.00E+00 3.17E-03 Y-90 2.52E-05 O.OOE+00 6.75E-07 O.OOE+00 0.00E+00 0.00E+00 3.48E-02 Y-91m 1.19E-11 O.OOE+00 4.06E-13 0.00E+00 0.00E+0 0 O.OOE+00 3.97E-08 Y-91 3.71E-04 0.00E+00 9.87E-06 O.OOE+00 0.00E+00 O.OOE+00 2.66E-02 Y-92 2.41E-07 0.00E+00 6.77E-09 O.OOE+00 O.OOE+00 0.00E+00 4.60E-03 Y-93 3.52E-06 O.OOE+00 9.59E-08 O.OOE+OO 0.00E+00 O.OOE+00 2.78E-02 Zr-95 6.76E-05 1.65E-05 1.17E-05 O.OOE+00 1.78E-05 0.00E+00 8.21E-03 Zr-97 2.99E-06 5.12E-07 2.34E-07 0.00E+00 5.1 6E-07 0.00E+00 3.27E-02 Nb-95 1.37E-05 5.65E-06 3.27E-06 O.OOE+00 4.05E-06 O.OOE+00 4.77E-03 Mo-99 O.OOE+00 9.89E-03 1.93E-03 ,
O.OOE+00 1.48E-02 0.00E+00 3.26E-03 Tc-99m 1.59E-07 3.28E-07 4.23E-06 O.OOE+00 3.53E-06 1.72E-07 9.53E-05 Appv Date Rev. 7 6-5b(1)
TABLE 6-5b REMP DOSE FACTORS FOR INFANT AGE GROUP: DRINKING WATER (Page 2 of 2)
EMP,;::SAMPLE,'DOSE'CALC';..:F<ACTORS':.,',i/PANT:;DRINKING:MAYER:"::,;<<?...':;,.?'~,":-';";::,mre'inditer/pCiyr,::,:,::,::,
'.;:",.:"',LIVER."";~', ?::THBQDY;',,", ;',':,:'THYROID;':" 4" KIDNEY,;'i:":; i'.?N?i!L?'0'<<'%9?
MUCL'lDE':
Tc-1 01 4.38E-22 5.52E-22 5.46E-21 0.00E+00 6.56E-21 3.01E-22 9.38E-20 Ru-103 4.84E-04 0.00E+00 1.62E-04 0.00E+00 1.01E-03 0.00E+00 5.89E-03 Ru-105 6.89E-06 O.OOE+00 2.32E-06 0.00E+00 5.07E-05 0.00E+00 2.74E-03 RU-106 7.95E-03 O.OOE+00 9.92E-04 0.00E+00 9.40E-03 0.00E+00 6.03E-02 Ag-110m 3.28E-04 2.40E-04 1.59E-04 0.00E+00 3.43E-04 ~ O.OOE+Og 1.24E-02 Te-125m 7.64E-03 2.56E-03 1.03E-03 2.57E-03 0.00E+00 O.OOE+00 3.64E-03 Te-127m 1.92E-02 6.38E-03 2.33E-03 5.56E-03 4.74E-02 0.00E+00 7.76E-03 Te-127 1.36E-04 4.54E-05 2.91E-05 1.1 0E-04 3.31E-04 0.00E+00 2.85E-03 Te-129m 3.27E-02 1.12E-02 5.03E-03 1.25E-02 8.17E-02 O.OOE+00 1.95E-02 Te-129 9.28E-05 3.20E-05 2.17E-05 7.77E-05 2.31E-04 O.OOE+00 7.41E-03 Te-131m 3.80E-03 1.53E-03 1.26E-03 3.10E-03 1.05E-02 0.00E+00 2.58E-02 Te-131 1.29E-13 4.78E-14 3.63E-14 1.15E-13 3.31E-13 0.00E+00 5.22E-.12 Te-132 6.17E-03 3.06E-03 2.85E-03 4.51E-03 1.91E-02 0.00E+00 1.13E-02 I-130 1.01E-03 2.22E-03 8.92E-04 2.49E-01 2.44E-03 O.OOE+00 4.76E-04 I-131 1.13E-02 1.34E-02 5.88E-03 4.39E+00 1.56E-02 0.00E+00 4.77E-04 I-132 1.47E-05 2.99E-05 1.06E-05 1.40E-03 3.34E-05 0.00E+00 2.42E-05 l-133 2.77E-03 4.03E-03 1.18E-03 7.32E-01 4.73E-03 0.00E+00 6.81E-04 I-134 2.21E-08 4.54E-08 1.61E-08 1.06E-06 5.07E-08 O.OOE+00 4.69E-08 I-135 3.41E-04 6.79E-04 2.48E-04 6.08E-02 7.57E-04 O.OOE+00 2.46E-04 Cs-134 1.24E-01 2.32E-01 2.34E-02 O.OOE+00 5.97E-02 2.45E-02 6.30E-04 Cs-136 1.48E-02 4.34E-02 1.62E-02 0.00E+00 1.73E-02 3.54E-03 6.59E-04 Cs-137 1.72E-01 2.02E-01 1.43E-02 O.OOE+00 5.41E-02 2.1 9E-02 6.30E-04 Cs-138 3.04E-11 4.94E-1 1 2.40E-11 O.OOE+00 2.47E-11 3.85E-12 7.90E-11 Ba-139 7.25E-07 4.81E-1 0 2.10E-08 O.OOE+00 2.89E-10 2.91E-1 0 4.59E-05 Ba-140 5.49E-02 5.49E-05 2.83E-03 0.00E+00 1.30E-05 3.37E-05 1.35E-02 Ba-141 2.03E-16 1.39E-19 6.40E-18 O.OOE+00 8.36E-20 8.45E-20 2.48E-15 Ba-142 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1.52E-24 La-140 5.66E-06 2.23E-06 5.74E-07 0.00E+00 0.00E+00 0.00E+00 2.62E-02 La-142 1.96E-09 7.20E-10 1.72E-10 O.OOE+00 O.OOE+00 O.OOE+00 1.22E-04 Ce-141 2.57E-05 1.57E-05 1.84E-06 0.00E+00 4.83E-06 0.00E+00 8.1QE-03 Ce-143 3.80E-06 2.52E-03 2.87E-07 0.00E+00 7.34E-07 0.00E+00 1.47E-02 Ce-144 9.82E-04 4.02E-04 5.50E-05 0.00E+00 1.62E-04 0.00E+00 5.64E-02 Pr-143 2.62E-05 9.78E-06 1.30E-06 O.OOE+00 3.63E-06 0.00E+00 1.38E-02 Pr-144 2.74E-20 1.06E-20 1.38E-21 0.00E+00 3.85E-21 0.00E+00 4.94E-16 Nd-147 1.77E-05 1.82E-05 1.11E-06 O.OOE+00 7.00E-06 0.00E+00 1.15E-02 W-187 2.10E-04 1.46E-04 5.05E-05 O.OOE+00 O.OOE+00 0.00E+00 8.59E-03 Np-239 3.16E-06 2.83E-07 1.60E-07 O.OOE+00 5.64E-07 0.00E+00 8.17E-03 Appv Date cj Rev. 7 6-5b(2)
TABLE 6-5c REMP DOSE FACTORS FOR INFANTAGE GROUP:
INHALATION- QUARTERLY SAMPLING (Page 1 of 2)
REMP,S'AMPLE DOSE::C'ALC,'FA'CTORS fNFANT;...'fNH QUARTERLV"I." .":,",,~".":!
INU,CL<tOE',:I "",.,"jT".BODY,;.",:.,.'I -';,:T,HYRGfD'::~ :,', ','".UMGYl.'ll:"' l,","":al-,'LL'f;'::,-":i'",;
H-3 O.OOE+00 6.51E-04 6.51E-04 6.51E-04 6.51E-04 6.51E-04 6.51E-04 C-14 2.65E-02 5.31E-03 5.31E-03 5.31E-03 5.31E-03 5.31E-03 5.31E-03 Na-24 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 P-32 1.86E+01 1.03E+00 7.08E-01 O.OOE+00 O.OOE+00 O.OOE+00 1.47E-01 Cr-51 O.OOE+00 O.OOE+00 2.80E-04 1.80E-04 4.14E-05 4.02E-02 1.12E-03 Mn-54 O.OOE+00 2.80E-02 5.51E-03 0.00E+00 5.51E-03 1.1'f E+00 7.81E-03 Mn-56 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Q.OOE+00 Fe-55 .2.04E-02 1.21E-02 3.44E-03 0.00E+00 0.00E+00 8.98E-02 1.13E-03 Fe-59 2.76E-02 4.78E-02 1.93E-02 O.OOE+00 0.00E+00 2.06E+00 5.03E-02 Co-58 0.00E+00 1.91E-03 2.84E-03 O.OOE+00 0.00E+00 1.21E+00 1.74E-02 Co-60 0.00E+00 8.1 5E-03 1.20E-02 0.00E+00 0.00E+00 4.58E+00 3.24E-02 Ni-63 3.39E-01 2.05E-02 1.16E-02 O.OOE+00 O.OOE+00 2.09E-01 2.42E-03 Ni-65 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00
'CU-64 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Zn-65 2.20E-02 7.12E-02 3.54E-02 O.OOE+00 3.70E-02 7.36E-01 5.85E-02 Zn-69 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 '.OOE+00 O.OOE+00 0.00E+00 OOE Br-84 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+
Br-85 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 Rb-86 O.OOE+00 1.04E+00 4.80E-01 0.00E+00 0.00E+00 O.OOE+00 1.65E-02 Rb-88 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Rb-89 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Sr-89 7.43E-01 0.00E+00 2.13E-02 O.OOE+00 O.OOE+00 3.79E+00 1.20E-01 Sr-90 4.10E+01 0.00E+00 2.60E+00 O.OOE+00 O.OOE+00 1.13E+01 1.31E-01 Sr-91 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Sr-92 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-90 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 Y-91m O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91 1.01E+00 0.00E+00 2.69E-02 0.00E+00 O.OOE+00 4.21E+00 1.2'f E-01 Y-92 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-93 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 Zr-95 1.89E-01 4.57E-02 3.33E-02 0.00E+00 5.09E-02 2.87E+00 3.56E-02 Zr-97 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Nb-95 3.86E-02 1.58E-02 9.32E-03 O.OOE+00 1.16E-02 1.1 8E+00 3.12E-02 Mo-99 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Tc-99m O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+0 Appv Date s ~ '?
Rev. 7 6-5c(1)
TABLE 6-5c REMP DOSE FACTORS FOR INFANT AGE GROUP:
INHALATION- QUARTERLY SAMPLING (Page 2 of 2)
REMP,,S'AMPLEIDOSE':CALCIC'~ ,,FACIORS,@lNFANT,.INH,,QUARTERf Y...,..., ...,...,.,,,,:.~mremgn,jpCl,yr,, ..., ...,,...,,,
RINUCLIDEN "::;g:BONE".,'::'", , Gl-,'L'LI ."'
k."L<IVER:;i,,';'.-,:,'T:;BODY!,'::,':,::,',"THYROlD~":,'I:','!KIDNEY!'I',;""':::,'i'"UNG':;i.':,i.:"','.,'j 0.00E+00 0.00E+00 0.00E+00
.'c-101 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ru-103 4.50E-03 '.OOE+00 1.52E-03 O.OOE+00 9.48E-03 1.23E+00 3.60E-02 Ru-105 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ru-106 9.46E-02 . 0.00E+00 1.19E-02 O.OOE+00 , 1.16E-01 1.26E+01 1.78E-01 Ag-110m 1.13E-02 8.20E-03 5.67E-03 0.00E+00 1.24E-02 4.16E+00 3.75E-02 Te-1)5m 8.21E-03 3.43E-03 1.14E-03 2.80E-03 O.OOE+00 7.70E-01 2.23E-02 Te-127m 2.23E-02 9.23E-03 2.77E-03 6.51E-03 5.01E-02 1.75E+00 3.65E-02 Te-127 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Te-129m 3.62E-02 1.56E-02 5.71E-03 1 40E-02 8.15E-02 '.31E+00 1.77E-01 Te-129 2.02E-07 8.90E-08 4.81E-08 1.73E-07 4.49E-07 7.68E-03 6.75E-02 Te-131m O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Te 131 O.OOE+00 O.OOE+00 0.00E+00 O.OOEtoo O.OOE+00 O.OOE+00 O.OOE+00 Te-132 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 I-130 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 l-131 3.79E-02 4.44E-02 1.96E-02 1.48E+01 5.18E-02 O.OOE+00 1.06E-03 I-1 32 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 I-133 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 I-134 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 l-135 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Cs-134 , 4.13E-O 1 7.33E-01 7.77E-02 O.OOE+00 1.99E-01 8.31E-02 1.39E-03 Cs-136 5.34E-01 1.49E+00 5.85E-01 O.OOE+00 6.24E-01 1.30E-01 1.58E-02 Cs-137 5.50E-01 6.14E-01 4.56E-02 0.00E+00 1.73E-01 7.15E-02 1.34E-03 Cs-138 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Ba-139 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 Ba-140 6.64E-01 6.64E-04 3.44E-02 O.OOE+00 1.59E-04 1.89E+01 4.55E-01 Ba-141 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ba-142 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 La-140 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 La-142 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 , 0.00E+00 0.00E+00 O.OOE+00 Ce-141 7.33E-02 4.41E-02 5.26E-03 0.00E+00 1.39E-02 1.37E+00 5.70E-02 Ce-148 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 Ce-144 3.57E+00 1.35E+00 1.97E-01 O.OOE+OO 6.01E-01 1.10E+01 1.66E-01 Pr-143 1.44E-01 5.39E-02 . 7.20E-03 O.OOE+00 2.03E-02 4.46E+00 3.84E-01 Pr-144 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Nd-147 1.41E-01 1.45E-01 8.91E-03 O.OOE+00 5.61E-02 5.74E+00 5.56E-01 W-187 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Np-239 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Appv I iC..r Date Rev. 7 6-5c(2) ~
TABLE 6-5d REMP DOSE FACTORS FOR INFANT AGE
- WEEKLY SAMPLING (Page GROUP'NHALATION 1 of 2)
REMP.,"SAMPL'E': DOSE~CALC::FA'CTDRS".;",-INFANl'."INH:WEEKLY,",.::,j:,:,'<': .gg~j::i:,,':::l,.".":.""'iiir l:"'NUCLIDE-'i::i'::r..;,BONEj:".~$ ,:";l'HYROlD~~< ,'KIDNEY,."~j', .'":F~".l~UNG <.."K H-3 O.OOE+00 6.47E-04 6.47E-04 6.47E-04 6.47E-04 6.47E-04 6.47E-04 C-14 2.65E-02 5.31E-03 5.31E-03 '5.31E-03 5.31E-03 5.31E-03 5.31E-03 Na-24 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+OO O.OOE+00 O.OOE+00 P-32 2.41E+00 1.33E-01 9.17E-02 0.00E+00 0.00E+00 O.OOE+00 1.91E-02 Cr-51 O.OOE+00 O.OOE+00 9.76E-05 6.28E-05 1.44E-05 1.40E-02 3.90E-04 Mn-54 0.00E+00 2.55E-02 5.02E-03 O.OOE+00 5.02E-03 1.01E+00 7.11E-03 Mn-56 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 'O.OOE+00 Fe-55 1.98E-02 1.18E-02 3.34E-03 0.00E+00 O.OOE+00 8.72E-02 ~ 1.10E-03 Fe-59 1.43E-02 2.48E-02 1.00E-02 O.OOE+00 0.00E+00 1.07E+00 2.62E-02 Co-58 0.00E+00 1.26E-03 1.88E-03 O.OOE+00 0.00E+00 8.04E-01 1.15E-02 Co-60 O.OOE+00 8.03E-03 1.18E-02 O.OOE+00 0.00E+00 4.51E+00 3.20E-02 Ni-63 3.39E-01 2.04E-02 1.16E-02 O.OOE+00 0.00E+00 2.09E-01 2.42E-03 Ni-65 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Cu-64 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Zn-65 1.95E-02 6.32E-02 3.14E-02 0.00E+00 3.28E-02 6.53E-01 5.19E-02 Zn-69 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Br-83 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+
Br-84 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+
Br-85 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Rb-86 0.00E+00 2.17E-01 1.00E-01 O.OOE+00 O.OOE+00 O.OOE+00 3.46E-03 Rb-88 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Rb-89 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Sr-89 4.17E-01 0.00E+00 1.20E-02 0.00E+00 O.OOE+00 2.13E+00 6.71E-02 Sr-90 4.09E+01 O.OOE+00 2.59E+00 O.OOE+00 0.00E+00 1.12E+01 1.31E-01 Sr-91 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-92 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-90 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Y-91m O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 Y-91 6.13E-01 O.OOE+00 1.63E-02 O.OOE+00 0.00E+00 2.55E+00 7.33E-02 Y-92 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Y-93 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Zr-95 1.20E-01 2.89E-02 2.11E-02 0.00E+00 3.23E-02 1.82E+00 2.25E-02 Zr-97 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Nb-95 1.68E-02 6.89E-03 4.05E<3 0.00E+00 5.06E-03 5.13E-01 1.36E-02 Mo-99 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 Tc-99m O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+0 Appv Rev. 7 6-5d(1)
TABLE 6-5d REMP DOSE FACTORS FOR INFANT AGE GROUP:
INHALATION- WEEKLY SAMPLING (Page 2 of 2)
REM P,.,SAMPLE,.DOSE...CALC,,FACTORS.;;,INFANT,,INH,!WEEKLY,.,:,.:p,...-:,.:,,.,i,
',NUCLIDE'i ",:::::",BONE::",:',",'; ~,"".(:,.:,4'lVER,'ji.:!I
':-"~'::-"'"'"'"""-i
-. "-"~""'-:'-
iibTHYRQlD::;,'", ';.:;i'jKlDNEY,'.I:;.:",
...,mre'iii~~lpCi Li".UMG;;":.'I TG 101 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 Ru-103 ~ 2.14E-'03 O.OOE+00 7.22E-04 O.OOE+00 4.51E-03 5.87E-01 1.71E-02 Ru-105 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ru-1 06 8.74E-02 0.00E+00 1.09E-02 O.OOE+00 1.07E-01 1.16E+01 1.65E-01 Ag-110m 1.01E-02 7.29E-03 5.05E-03 O.OOE+00 1.10E-02 3.70E+00 3.34E-02 Te-125m 4.96E-03 2.07E-03 6.86E-04 1.69E-03 O.OOE+00 4.66E-01 1.35E-02 Te-127m 1.70E-02 7.06E-03 2.12E-03 4.98E-03 3.84E-02 1.34E+00 '2.79E>>02 Te-127 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 g.ooE+00 0.00E+00 Te-129m 1.52E-02 6.55E-03 2.39E-03 5.88E-03 3.42E-02 1.81E+00 7.42E-02 Te-129 8.47E-08 3.73E-08 2.02E-08 7.25E-08 1.88E-07 3.22E-03 2.83E-02 Te-131m O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+OO O.OOE+00 O.OOE+00 Te-1 31 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 Te 132 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I-130 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 I-131 3.79E-02 4.44E-02 1.96E-02 1.48E+O'I 5.18E-02 O.OOE+00 1.06E-03 I-132 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 0 OOE+00 0 OOE+00 1-133 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 0.00E+00 I-134 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 I-135 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Cs-134 3.97E-01 7.05E-01 7..47E-02 O.OOE+00 1.91E-01 7.99E-02 1.34E-03 Cs-136 5.81E-02 1.62E-01 6.36E-02 O.OOE+00 6.78E-02 1.41E-02 1.72E-03 Cs-137 5.49E-01 6.12E-01 4.55E-02 O.OOE+00 1.72E-01 7.13E-02 1.33E-03 Cs-138 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-139 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-140 6.77E-02 6.77E-05 3.50E-'03 0.00E+00 1.62E-05 1.93E+00 4.64E-02 Ba-141 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ba-142 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 La-140 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 La-142 0.00E+00 O.OOE+00 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 O.OOE+00 Ce-141 2.99E-02 1.80E-02 2.14E-03 0.00E+00 5.66E-03 5.57E-01 2.32E-02 Ce-143 O.OOE+00 O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 Ce-144 3.22E+00 1.22E+00 1.78E-01 O.OOE+00 5.42E-01 9.93E+00 1.50E-01 Pr-143 1.67E-02 6.26E-03 8.35E-04 0.00E+00 2.36E-03 5.17E-01 4.4 5E-02 Pr-144 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 Nd-147 9.90E-03 1.01E-02 6.23E-04 0.00E+00 3.93E-03 4.02E-01 3.89E-02 W-187 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Np-239 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Appv Date Rev. 7 6-5d(2)
~ ~
0 o'
~ ~ - ~ i ~ 0
~ o ~ ~ o ~
~ a 0 '
I II II I II II I ~ I~ I I II I~ I II II I ~ ~ I ~ ~
~ I I~ I~ ~ ~ ~ I I II ~ I I II I I ' I I ~ ~ I I ~
~ ~
~ ~ ~ I e lo I~ I I I ~ I I ~
I II I I I II II I~ ~ I I~ ~ I
~ ~ ~ ~ I~ I ~ 'I I ~
~ ~ I ~ ~ ~ ~ I~ ~ ~
I II II I II II ~ ~
I I ~ ~ I I ~ ~ I~
I I ~ I ~ I ' I
~ ~ I ~ ~ I I ~ ~ I ~
I I~ II I II II ~ ~
I e ~
I II I
I~
I~
II I
~
II
'o I~ I I
I I
~
~
~
~
~
~ 'o o
I lo
~
~ ~ ~ ~ I ~ ~ I ~ ~ I~
~ ~ ~ I ~ ~ I ~ I ~ I e ~ I ~ ~ I~ I~ ~ I~
I ~ I ~ I
~
I I ~ I II I II II o. I I I ~ I o I~ I~ ~ ~ ~, I I~ I~ I~ I~
~ ~
~ ~ I ~ ~ I~
I I ~ I ~ o I~ ~ I ~
~ I o
~ I o I~ I I I ~ I ~ I I le I I I I I I I
~ ~ ~
~ I I I ~ I II II I II II I~ I ~ I ~
~
~ ~
I~ I I
~ ~
~ ~ I
~ ~ ~
~
~ I ~ I
TABLE 6-6c REMP DOSE FACTORS FOR CHILD AGE GROUP:
SHORELINE/SEDIMENT TOTAL BODY AND SKIN DOSE
¹,',:<..:.,-:-...-",;".:.'-:'.:.ij::-:"';:-:~"::;;;:,'~':~g,:,~:,",'CHlL'D,:(mrem-,'.kgl pCijrei'r}.:;,.:.:(.:.'..'-.".:>$gz,".',
..,:-'-3
, !NU'CL'lDE:-"'jl.;;j+T; BODY/,'~jNUCUD'E,":,)< T.::..'800sY;"'~(i:::" i- 'S;K!bf,"f,"
O.OOE+00 O.OOE+00 Ru-103 8.06E-07 9.41E-O?
C-14 O.OOE+00 O.OOE+00 Ru-105 1.01E-06 1.14E-06 Na-24 5.60E-QG 6.50E-06 Ru-106 3.36E-07 4.03E-07 P-32 O.OQE+00 O.OOE+00 Ag-110m 4.03E-06 4.70E-06 Cr-51 4.93E-08 5.82E-08 Te-125m 7.84E-09 1.0&E-O&
Mn-54 1.30E-06 1.52E-06 Te-127m 2.46E-10 2.91E-1 0 Mn-56 2.46E-OG 2.91E-06 Te-127 2.24E-09 2.46E-09 Fe-55 O.OOE+00 O.OOE+00 Te-129m 1.72E-O? 2.02E-07 Fe-59 1.79E-06 2.11E-06 Te-129 1.59E-07 1.88E-07 Co-58 1.57E-OG 1.84E-06 Te-131m 1.8&E-OG 2.22E-06 Co-60 3.81E-06 4.48E-06 Te-131 4.93E-O? 5.82E-04 Ni-63 O.QOE+00 O.OOE+00 Te-132 3.81E-07 4.4&E-07 Ni-65 8.29E-07 9.63E-07 I-130 3.14E-06 3.81E-06 Cu-64 3.55E-07 3.81E 07 I-131 6.2?E-07 7.62E-O?
Zn-65 8.96E-07 1.03E-06 I-132 3.81E-06 4.4&E-06 Zn-69 O.OOE+00 O.OOE+00 I-133 8.29E-07 1.01E-06 Br-83 1.43E-08 2.08E-08 I-134 3.58E-06 4.26E-06 Br-84 2.69E-OG 3.14E-06 I-135 2.69E-06 3.14E-OG Br-85 O.OQE+00 O.OOE+00 C~134 2.69E-06 3.14E-06 Rb-86 1.41E-07 1.61E-07 Cs-136 3.36E-06 3.81E-06 Rb-88 7.84E-O? 8.96E-07 Cs-137 9.41E-07 1.10E-06 Rb-89 3.36E-Q6 4.03E-06 Cs-138 4.70E-OG 5.38E-OG Sr-89 1.25E-10 1.46E-10 Ba-139 5.3&E-O? 6.05E-07 Sr-90 O.OOE+00 O.OOE+00 Ba-140 4.7OE-07 5.3&E-07 Sr-91 1.59E-06 1.86E.06 Ba-141 9.63E-O? 1.10E-06 Sr-92 2.02E-06 2.24E-06 Ba-142 1.7?E-06 2.02E-06 Y-90 4.93E-1 0 5.82E-10 La-140 3.36E-06 3.81E-06 Y-91m 8.51E-07 9.86E-07 La-142 3.36E-06 4.03E-06 Y-91 5.38E-09 6.05E-09 Ce-141 1.23E-O? 1.39E-07 Y-92 3.58E-O? 4.26E-07 Ce-143 4.93E-07 5.60E-07 Y;93 1.2&E-O? 1.75E-07 Ce-144 ?.17E-0& 8.29E-08 Zr-95 1.12E-06 1.30E-OG Pr-143 O.OOE+OO O.OOE+OO Zr-97 1.23E-06 1.43E-06 Pr-144 4.48E-08 5.15E-O&
~ Nb-95 1.14E-06 1.34E-06 Nd-147 2.24E-07 2.69E-07 Mo-99 4.26E-07 4.93E-07 W-187 6.94E-07 '.06E-07 Tc-99m 2.15E-07 2.46E-Q? Np-239 2.13E-07 2.46E-07 Tc-101 6.05E-07 6.72E-07 Appv Date Rev. 7 6-6c
Cc CCI
';ii:, i,:?.-,:g
- .,:c ck':p:::Q
'j5 I O.'a~W 2
- Q
- ::.D-,"
- o..a$ ~
Co Co Jl 'Q:~
~::::":g""g 0- i m:.:"':. CL-! c
- >': k ~ $V@
cC R
IJJ Q.
Cfl O
I JJJ 0
O 0 Cl c':ÃX'c::>a
-::. Ca,g Cc C7 Cc Cc LA Cl)
Cl
- ..:::::.jo:
0'Ll 0
0 LL E
'i'::CO:I k M
UJ ':"-,,',:5':--'kM:t I- 0 c c?c c?c cv
":E Cc Cc Q Cc LQ V X X X X CL tY:.~ c lA CD O
z0 I-(tJ kk CO I- O O CCJ ILJ O I- 'c+ MC LIJ O.
CI Cc CD C) CL Cc Co CV O
O I-CD CD O
kZ" CU Ql JQ Cc Cl 1
I C
ch lA CD lA lA CO 0) ch lA CD O C9 O lo CL I
D) x O N N cc)
O Cb CD CO
TABLE 7 (Continued)
The LLD is the smallest concentration of radioactive material in a sample that will be detected with 95 percent probability and with 5 percent probability of falsely concluding that a blank observation represents a "real" signal.
For a particular measurement system (which may include radiochemical separation):
4.66 Sb 222EVY exp(-X, h t) ~
Where:
LLD is the "a priori" lower limit of detection as defined above (as pCi per unit mass or volume).
sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate {as counts per minute)
E is the counting efficiency (as counts per transformation)
V is the sample size (in units of mass or volume) 2.22 is the number of disintegrations per minute per picocurie Y is the fractional radiochemical yield (when applicable)
X, is the radioactive decay constant for the particular radionuclide, and ht is the elapsed time between sample collection (or end of the sample collection period) and time of counting.
In calculating the LLD for a radionuclide determined by gamma-ray spectrometry, the background should include the contributions of other radionuclides normally present in the samples (e.g., potassiumQO.milk samples). Typical values for E, V, Y, and t should be used in the calculations.
It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the oapabitity of a measurement system and not as a gosteriori tatter the fact) limit for a particular measurement.
b LLD for drinking water.
Appv C ~
Date Rev. 7 42
10.0 DOSE ASSESSMENT POLICY STATEMENTS 10.1 Selection of Anal sis Results for Dose Calculations For determination of compliance with SSES Technical Specification dose limits, effluent totals shall be based only on activity positively detected at the 95% confidence level.
10.2 Assi nment of Releases to the Reactor Units For determination of compliance with SSES radioactive effluent dose limits which are on a "per reactor unit" basis:
I
- a. Effluents from the Unit 1 Reactor Building vent and the Unit 1 Turbine Building vent shall be included as Unit 1 releases.
- b. Effluents from the Unit 2 Reactor Building vent and the Unit 2 Turbine Building vent shall be included as Unit 2 releases.
- c. Effluents from the Standby Gas Treatment System vent shall be equally divided between Unit 1 and Unit 2 release totals.
- d. Waterborne effiuents shali be equally divided between Unit 1 and Unit 2 release totals.
10.3 Evaluation and Monitorin Criteria for Effluent Pathwa s Potential effluent pathways will be evaluated on a case-by-case basis.
The evaluation will include identiTication of systems which are normally non-radioactive (as described in the FSAR) but could possibly become radioactive through interfa'ces with radioactive systems (
Reference:
NRC IE Bulletin No. 80-1 0). The evaluation will determine the significance of any potential effluents pathways and extent of sampling and/or monitoring required. The frequency of sampling or monitoring will be determined based on the potential for contamination, the potential for inadvertent releases, the potential levels of contamination and releases, and the potential impact on station offsite doses.
r Results of sampling and/or evaluation will be used to classify potential effluent pathways into one of the following categories:
- a. Not an Effluent Pathwa: Realistic evaluation (e.g., engineering design, system operation, radionuclide inventory) demonstrates that the pathway has no potential for release of radioactive material Appv k-c4.
Date 2'/
Rev. 7 43
(Table 8). Although not required, periodic sampling may at times be performed to confirm the result of the evaluation.
- b. Insi nificant Effluent Pathwa: Evaluation and/or periodic sampling demonstrate that the pathway may contain radioactive effluents, however, these effluents may not be reasonably expected to exceed 10 percent of the appropriate unrestricted area MPC value (fractional MPCs summed when appropriate) listed in Table II of Appendix B to 10 CFR 20 (Table 9). A release pathway which falls'in this category will be sampled periodically.
- c. Si nificant Effluent Pathwa: Evaluation and/or periodic sampling demonstrate that the pathway may'contain radioactive effluents, and these effluents may be reasonably expected to exceed 10 percent of the appropriate unrestricted area MPC value (fractional MPCs summed when appropriate) listed in Table II of Appendix B to 10 CFR 20 (Table 10). A release pathway which falls in this category will be sampled continuously.
If sampling indicates a non-radioactive system has become contaminated, further use of the system shall be restricted until the cause of the contamination has been corrected and the system is decontaminated. If continued operation of the system as contaminated is necessary, a 10CFR50.59 safety evaluation of the operation of the system as a radioactive system shall be performed immediately by the system operator/engineer. The safety evaluation will include any changes in the.
effluent pathways and the impacts to offsite doses. (Ref. NRC IE Bulletin 80-10). Systems with NRC I/E Bulletin applicability are designed to be used as non-radioactive, but which could possibly become radioactive through interface(s) with radioactive systems, and which have a path for unmonitored and/or uncontrolled release to the environment. (Table 11)-
Positively detected radioactive material in samples collected from all airborne and waterborne offsite release pathways will be reported in the Annual Effluent and Waste Disposal Report.
10A Flow from the SGTS Vent when the S stem is Not in Use When the Standby Gas Treatment is not being used, there remains a small amount of flow from the SGTS vent. This residual flow is exhaust from the battery rooms in the control structure. Because there are no identifiable sources of radioactivity in these rooms, auxiliary particulate and iodine sample and noble gas grab sample at 4-hour intervals are not required from the SGTS vent when the SGTS continuous vent monitor is out of service, trrovided that-Appv Date Rev. 7
- a. the Standby Gas Treatment System is not being used,
- b. there are proper administrative controls in place to ensure that the required sampling will begin within 4 hours4.62963e-5 days <br />0.00111 hours <br />6.613757e-6 weeks <br />1.522e-6 months <br /> if the treatment system is operated.
10.5 ODCM Set pints are U er Limit Values Effluent monitor alarm/trip setpoints calculated in accordance with the ODCM shall be considered upper limit values. Higher (less conservative) setpoints shall not be used, however lower (more conservative) setpoints may be used as required to maximize the utility of the monitor.
10.6 Definition of "A ro riate Treatment" for Li uid Wastes Technical Specification 3.11.1.3 requires that the appropriate portions of liquid waste treatment system be operable and be used to reduce
'he radioactivity in liquid wastes prior to their release when projected doses from each reactor unit to unrestricted areas would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31 day period.
o The normal treatment, which is considered appropriate for each subsystem, is as follows:
Filtration is considered appropriate treatment for the Liquid Radwaste Laundry Processing Subsystem, which consists of high
-'conductivity liquid wastes, such as those from equipment washdown and personnel decontamination facilities, or laundry.
The atmospheric demineralizer (a vendor-supplied system which is directed to the Distillate Sample Tank) is considered appropriate for the Liquid Radwaste Chemical Processing Subsystem.
Demineralization and filtration are considered appropriate treatment for low conductivity/low organic contaminant liquid wastes entering the Liquid Radwaste Processing Subsystem (LRW collection tanks), except for batches which yield projected doses prior to treatment of less than or equal to 6.45-04 mrem to the total body and 2.15E-03 mrem to any organ, where filtration alone is appropriate, of Appv Date Rev. 7
~ For batches which have no identified gamma activity above the Technical Specification Liquid Effluent LLD level (Table 4.11.1.1.1-1),
release without treatment is considered appropriate.
BASES The projected dose threshold values used are derived by dividing the site-total maximum projected doses without treatment (0.12 and 0.4 mrem) by 31 days and by 6, the maximum possible number of batches released per day, to yield per-batch dose action levels..The two levels of "appropriate" treatment are in place so as not to require application of demineralization for treating low activity, high conductivity water
. (e.g., from Circulating or Service Water leakage). This would increase the overall efficiency of the solid radwaste program while ensuring calculated doses remain at a suitable fraction of 10 CFR 50 design objectives and Technical Specification 3.11.1.2 limit."'"'0.7 Monitor Line Loss Corrections In order to correct for airborne effluent monitor sample line loss, the following correction factors shall be applied to monitor data and sample analysis results:
CORRECTION FACTORS Routine Effluent Monitors iodine Particulates Reactor Building Unit 1 1.5 3.2 Reactor Building Unit 2 1.5 3.2 Turbine Building Unit 1 1.6 3.6 Standby Gas Treatment 1.5 3.9 Turbine Building Unit 2 1.6 3.6
"'Reference Calculation No. OT-RKB-92-001: Calculation of Liquid Isotope Offsite Dose Consequences for Use of Atmospheric Demineralizer System, PLI-70360, t
2/4/92.
+Reference Letter R. K. Barclay to R. A. Breslin: Atmospheric Demineralizer Effluent Results, PLI-70612, 3/4/92.
Appv Date Rev. 7 46
CORRECTION FACTORS Post-Accident Vent Monitors iodine Particulates Turbine Building Unit 1 1.7 4.2 Standby Gas Treatment 1.6 44 Turbine Building Unit 2 1.7 4.3 Each indicated iodine and particulates concentration shall be multiplied by the appropriate correction factor to estimate the actual concentration at the inlet to the sample line.
10.8 Selection of Data for Determination of Dose Rate Com liance Airborne effluent monitor setpoints are maintained in accordance with Section 2.2 to alarm before the dose rate limits of Specification 3.11.2.1 are exceeded. Station alarm response procedures contain instructions for investigation and verification of monitor alarms. Because setpoint calculations must include assumptions about the composition of the monitored effluent, a monitor high alarm does not necessarily indicate that a dose rate limit has been exceeded.
Valid ten-minute averaged data should be the primary information used to determine the compliance status of an incident. One-minute averaged data should also be reviewed if available, but they may or may not provide additional information depending on the magnitude of the release due to the manner in which the monitors update values to be stored and associated statistical considerations. Averages over a longer period should be used only when data with higher resolution is not available.
Grab sample analyses should be performed whenever possible to confirm or disprove monitor data, and to provide indication of the nuclide-specific composition of the effluent. When grab sample data are available which, based on vent monitor data, are indicative of the period of elevated release, dose rate calculations should be performed using the actual effluent mix. The determination of compliance status should not be based on monitor data alone when it is possible to collect and analyze a vent sample which will be representative of the period of elevated release.
Appv . c--~
Date ~ 7 Rev. 7
10.9 Low-Level Radioactivi in the Sewa e Treatment Plant Like all sewage processing facilities, the SSES sewage treatment plant can under certain conditions receive low levels of radioactive materials.
The most notable scenario is when individuals who work on-site have been subjected to the medical administration of radiopharmaceuticals for diagnostic or therapeutic purposes. In these cases, normal biological elimination processes can easily result in levels of radioactivity in sewage treatment plant solutions and suspensions which are within the detection capabilities of the associated sampling and analysis program.
Because disposal of sewage treatment plant sludge by controlled dispersal on specified tracts of land is a common practice, the following guidelines have been established:
- a. All sludge collected in the sludge holding tank should be sampled and analyzed prior to land disposal to quantify any radioactivity above natural background levels. 'resent
- b. Sludge containing nuclides with short half-lives, for example iodine-131, should be contained on-site to permit decay to less than detectable levels.
When sludge is contaminated with nuclides which have half-lives sufficientl long to make hold-up for decay impractical, the following options should be considered:
- 1. Dispose of the sludge as low level radioactive waste.
- 2. Obtain a special permit pursuant to the requirements of 10 CFR 20.2002.
- d. The sewage treatment plant liquid effluent should be sampled monthly for radioactivity. This can be accomplished by drawing a sample from the chlorine contact chamber.
Appv Date Rev. 7 48
TA8LE 8 SYSTEMS CLASSIFIED AS NOT AN EFFLUENT PATHWAY(Page 1 of 3)
'-""'-'::: 'i:-:"'<:::.'::::-','3i'lg@M::-:;!i::;::,';,::SYSTEM;9ESCRIPTIOM:;-;I!':-:4!i'ill!':;::;:.ll'i",:iiii~."i'l Water I:'omestic
~ t River Water Makeup Intake Compressed Air Screens and Screenwash Fire Protection Water Fire Protection CO2 Fire Protection Ha!on Turbine Building Closed Cooling Water Building Drains: NON RAD
~ I Water Pretreatment Condensate and Refuel Water Transfer Low Pressure Air Condensate Demins Lube Oil Transfer/Purification Cooling Tower Acid/Chlorination Circulating Water Condenser Tube Cleaning Feedwater Extraction Steam
~ I Feedwater Heaters Residual Heat Removal Reactor Core Isolation Cooling Core Spray High Pressure Coolant Injection Standby Liquid Control Control Rod Drives (1) PP&L Calculation EC-ENVR-1008 Appv Date Rev. 7 49
TABLE 8 SYSTEMS CLASSIFIED AS NOT AN EFFLUENT PATHWAY(Page 2 of 3)
- ": -----"'-'.- -'~- >'"SYSTENI DESCRIPTION""'~"("":~ "'~":"::::"""~::~~~ ';::::::REFEREIIICE~"
Suppression Pool Primary. Containment Vacuum Breakers Suppression Pool Cleanup Reactor Water Cleanup Reactor Pressure Vessel Reactor Recirculation System Radwaste Chilled Water Solid Radwaste/Cement Silo LRW Collection/Tb and Cond. Outer Area Sumps LRW Processing/Radwaste Evaporator Gaseous Radwaste'Recombiner Closed Cooling Water Nitrogen Storage Hydrogen Storage Sampling Stations Post Accident Sampling System Bypass Steam Main Steam Isolation Valves/ Nuclear Steam Supply System Shutoff Automatic Depressurization System MSIV Leakage Control Moisture Separators Turbine Steam Seals Electrohydraulic Control Stator Cooling Main Generator Storm Drains (1) PPBL Calculation EC-ENVR-1008 Appv Date Rev. 7 50
TABLE 8 SYSTEMS CLASSIFIED AS NOT AN EFFLUENT PATHWAY, (Page 3 of 3)
YSTEM'SCRIPTIOt4,",:.!i.:i!
Makeup Demineralizers Fuel Oil Containment Instrument Gas Control Structure Chilled Water Turbine Bldg. Chilled Water Reactor Bldg. Chilled Water Auxiliary Boilers Fuel Pool Cooling Fuel Pool Demineralizers Fuel Pools.
Temporary SDHR System Temporary Laundry Facility (1) PP8 L Calculation EC-ENVR-1 008 (2) Safety Evaluation NL-95-001: Refueling Outage Decay Heat Removal and Tie-In of the SDHR Temporary Cooling Equipment Safety Evaluation NL-9029: Temporary Laundry Facility Appv Date ~r 4 Rev. 7 51
TABLE 9 SYSTEMS CLASSIFIED AS INSIGNIFICANTEFFLUENT PATHWAY S'YSTEIli5ESCRIPTIO'N:.j,:.'j>,'v'i,,'!."l=';i',ll:,l>>".,",";;;l~4';"~j:;:.~;:RE'FERENC'E..4 H2 Seal Oil Condensate Storage Tank and Berm Main Turbine/RFPT Lube Oil (i)(4)
Second Sort (DAW Volume Reduction) Facility Low Level Radwaste Handling Facility Sewage Treatment Plant
( I) PPRL Calculation EC-ENVR-1008 (2) Safety Evaluation NL-89-002: Dry Active Waste Volume Reduction System (3) Safety Evaluation NL-92-007: Operation of LLRWHF at SSES (4) Main Tb/RFPT Lube Oil are designed to be operated as non-radioactive systems. They are classified as Insignificant Effluent Pathways based on source terms and offsite dose rate results for consideration of a contaminated source term.
(5) Sewage treatment plant is designed to be operated as a non-radioactive system.
Classification as an insignificant Effluent Pathway is in accordance with Safety NL-95-015. 'valuation Appv Date Rev. 7 52
TABLE 10 SYSTEMS CLASSIFIED AS SIGNIFICANT EFFLUENT PATHWAY
- -: "'::-:.'".~;:;.:',";,.:".,:..:SYSTEMlDESgRlPTfON ':,'-',,",:i;,::',',,::;.;:":::,':I~ j"','";-'i,'I+~PP,::,'j":;":,i!i;,,";.~"'REFERENCEl'::;:i':g..,i::ii.:'::ll::i::.":.::i:::ii:::"'::l4 Liquid Waste Management Systems Gaseous Waste Management Systems (1) SSES FSAR Chapter 11.2 (2) SSES FSAR Chapter 11.3 Appv Date Rev. 7 53
TABLE 11 SYSTEMS WITH NRC I/E BULLETIN80-10 APPLICABILITY Service Water (F/P HTX Discharge) 16 RHR Service Water 18 instrument Air 19 Service Air 27 Auxiliary Boilers
- 35 Shutdown Decay Heat Removal System 40 Batch Lube Oil Tank 48 Feedwater Pump Turbine Lube Oil 52 H2 Seal Oil Tank Emergency Service Water 93 Main Turbine Lube Oil 99D Sewage Treatment Plant Appv Date Rev. 7 54
TABLE 12 VENTILATIONEXHAUST TREATMENT SYSTEMS WHICH REQUIRE OFF SITE VENT EVALUATIONSWHEN BYPASSED, DEGRADED, OR OTHERWISE RENDERED INOPERABLE Unit 1 Turbine Building 1F157NB 1F158NB N/A Unit 2 Turbine Building 2F157NB 2F158NB N/A Unit 1 Zone 1 Reactor Building 1F255NB 1F257A/8 1F258NB Unit 1 Zone 3 Reactor Building 1F216A/B 1F217NB 1F218A/B Unit 2 Zone 2 Reactor Building 2F255NB 2F257NB 2F258NB Unit 2 Zone 3 Reactor Building 2F216NB 2F217A/B 2F218NB Radwaste Building Exhaust OF355A/B N/A NIA Radwaste Tank Vent OF358 OF359 N/A Radwaste Degasifier OF372 OF373 OF374 Control Structure Sample Room OF134 OF135 N/A Control Structure Rad Chem Lab OF137 OF138 NIA Control Structure Rad Chem Lab OF140 OF141 N/A Control Structure Decon Area OF143 OF144 N/A S8A Building OF716 N/A N/A Appv 4~
Date Rev. 7 55
11.0 ODCM REVIEW AND REVISION CONTROL The Supervisor-Environmental Services-Nuclear shall ensure that a total review of the ODCM is performed during each even-numbered year. Comments shall be documented and revisions initiated as appropriate.
Revisions to the ODCM shall be initiated in accordance with NEPM-QA-1011.
Each ODCM page shall be numbered and provided with an approval and date box. The ODCM Table of Contents shall present the current revision date for each page so that any manual holder can check manual completeness based on a current Table of Contents.
All ODCM revisions shall be reviewed by PORC after approval by the Manager-Nuclear Technology. PORC review shall be indicated'by PORC chairperson or designee signature on ODCM cover.
ODCM copies shall be issued in a controlled fashion by SSES Document Control Services'. The distribution list shall be maintained by SSES Document Control Services.
Any comments on ODCM contents or proposed revisions should be directed to the Supervisor-Environmental Services-Nuclear.
Appv Date Rev. 7 56
APPENDIX A
'SAMPLE CALCULATIONS OF ODCM PARAMETERS A. 1 SETPOINTS A. 1 . 1 Waterborne Effluent Moni tors
'.l.l.l Li uid Radwaste Oischar e Line Monitor For an unidentified mixture with an assumed MPC of IE-7 uCi/ml, an actual activity concentration of lE-5 uCi/ml, and a blowdown flow setpoint of 5000 gpm, the high radiation setpoint concentration, c, can be determined from c x(A). If x 3, then the actual high radiation setpoint concentration is:
c ~ 3 (A) ~ 3 (lE-5) c 3E-5 uCi/ml The Alert radiation setpoint is 0.8 times the high radiation setpoint, or 1.6 times the actual activity concentration. The setpoint value for the liquid effluent monitors is then determined by Equation 3 in the ODCM. For the above release conditions, the setpoint value, assuming a typical calibration factor of 1.3 x 10 uCi/ml per cpm, would be.
Setpoint cpm + Background (cpm)
Cal. Factor Setpoint cpm 3E-5 + Background 1.3 x 10 Setpoint cpm 2.3E3 + Background The LRW discharge f'low setpoint is then determined as follows:
A-1
F where Y is made equal to 10.
5000+/'0 (1E-5) f 1E-7 f 5 gpm For an identified mixture with an actual HPC of 7.22E-7 uCi/ml and the same activity concentration, blowdown flow and X and Y values as above, the LRW discharge monitor setpoint value and LRW discharge flow setpoint become:
High radiation setpoint concentration (c) 3E-5 uCi/ml High radiation setpoint value 2.3E3 cpm + Background LRW discharge flow setpoint (f) 36 gpm A. 1.1.2 Service Mater Monitor Background 300 cps Calibration Factor - 1.5E-8 uCi/ml per cps Activity concentration 2E-5 uCi/ml (2E-5)/Cal. Factor-', = 1333 cps Because 300 cps is less than 1333 cps:
HI RAD Setpoint 0.5 Background + (2E-5)/Cal. Factor 0.5 (300 cps) + (2E-5)/(1.5E-B)
= 150 cps + 1333 cps ~ 1483 cps DOWNSCALE Setpoint - 0.5 Background (0.5)'(300 cps) 150 cps Cal ibration Factor 1.5E-8 uCi/ml per cps (2E-5)/Cal. Factor 1333 cps Because 1400 cps is greater than 1333 cps:
HI RAO Setpoint = Background + (0.5)(2E-5)/Cal. Factor
= 1400 cps + (lE-5)/(1.5E-8) 2067 cps A-2
DOWNSCALE Setpoint = Background 0.5 (2E-5)/Cal.
Factor, 1400 cps'- 0.5 (2E-5)/1.5E-8)
~ 1400 cps 667 cps 733 cps A. 1. 1.3 RHR Service Water Monitor k d = 160 cpm Calibration Factor = 3.9E-9 uCi/ml per cpm (2E-5)/Cal. Factor 5128 cpm Because 160 cpm is less than 5128 cpm:
HI RAD Setpoint 0.5 Background + (2E-5)/Cal. Factor
- 0.5 (160 cpm) + (2E-5)/(3.9E-9) 80 cpm + 5128 cpm 5208 cpm LOW RAD Setpoint 0.5 Background 0.5 (160 cpm) 80 cpm Setpoint = 0.8 HI Setpoint 4166 cpm d>>
ALERT RAD d k d Calibration Factor = 3.9E-9 uCi/ml per cpm (2E-5)/Cal. Factor 5128 cpm Because 6000.cpm is greater than 5128 cpm:
'HI RAD Setpoint Background + (0.5)(2E-5)/Cal. Factor
- 6000 cpm + (lE-5)/(3.9E-9)
= 6000 cpm + 2564 cpm
- 8564 cpm LOW RAD Setpoint - Background 0.5 (2E-5)/Cal. Factor 6000 cpm 0.5 (2E-5)/(3.9E-9)
= 6000 cpm 2564 cpm = 3436 cpm ALERT Setpoint - 0.8 HI RAD Setpoint - 6851 cpm A.l.2 Gaseous Effluent Monitors k
A.l.2.1 Noble Gas Monitor To determine the release rate limit for noble gases, an isotopic mixture representative of plant effluents is selected. For example, the following mixture from Table 4.4 of the SSES Final Environmental Statement (FES) can be used:
rut'V Rev. 6 A-3 DAT
Argon-41 25 Ci/yr per reactor Krypton-83m 4 Krypton-85m 1,700 Krypton-85 270 Krypton-87 32 Krypton-88 660 Xenon-131m 71 Xenon-133m 14 Xenon-133 12,500 Xenon-135m 220 Xenon-135 590 Xenon-138 290 Total 16,376 Ci/yr per reactor The above annual release quantities are entered into GASPAR with the following annual average dispersion estimates (
Reference:
1982 SSES Heteorology Report):
Relative Concentration 4.1E-5 sec/m 3 Decayed Relative Concentration 4.1E-5 sec/m Decayed Depleted Relative Concentration 3.8E-5 sec/m 4.2E-8 m
-2 Deposition Rate This set of annual aver age meteorological parameters's the most conservative over the period 1973-1982.
The total body dose via the plume pathway which results is 18.3 mrem. Equation 5 of the ODCM is then used to calculate the limiting release rate from each of the five plant release points:
Limiting Release Rate 32 752 Ci 500 mrem r = 8.95E4 Ci/yr per vent (36.6 mrem) (5 vents)
A-4
This limiting release rate is then converted to limiting (setpoint) concentrations using Equation 6 of the ODCH and high limit vent flow rates.
Sample High Limit Vent Flow Rates:
Unit I Reactor Building Vent 4.77E9 cc/min Unit 2 Reactor Building Vent 4.77E9 cc/min Standby Gas Treatment System Vent 5.05E8 cc/min Unit I Turbine Building Vent 8.64E9 cc/min Unit 2 Turbine Building Vent 6.52E9 cc/min Limiting Vent Concentration =
8.9SE4 Ci r vent IE6 uCi Ci 3.57E-5 uCi/cc (5.26ES min/yr) (4.77E9 cc/min) ,
for Reactor Buildings 152 Substituting the other vent flow rates into Equation 6 as above, the following noble gas high radiation set-point concentrations are calculated for the remaining vents:
Standby Gas Treatment System 3.37E-4 uCi/cc Unit I Turbine Building 1.97E-S uCi/cc Unit 2 Turbine Building 2.61E-S uCi/cc A.1.2.2 Iodine -131 Honitor When the FES expected annual release quantity for I-131 (2.40E-I curies) is entered into GASPAR with the dispersion estimates of A.I.2.1, the maximum calculated organ dose via the inhalation pathway is 4.88 mrem to the child thyroid. Using Equation 5 of the ODCH, the limiting 1-131 release rate is calcu-lated as follows:
A-5
, Limiting Release Rate =
.24 Ci 1500 mrem r 1.48E1 Ci/yr/ven
,(4.88 mrem) (5 vents)
Using Equation 6 of the ODCM, the limiting (setpoint)
I-131 concentrations can be calculated for each of the five plant vents.
Limiting Vent Concentration 14.8 Ci r vent lE6 uCi Ci 5.90E-9 uCi/cc for.
(5.26E5 min/yr) (4.77E9 cc/min) Reactor Buildings 15.2 Substituting the other vent flow rates into Equation 6 of the ODCM above, the high radiation setpoints for the remaining plant vents are calculated to be the following:
Standby Gas Treatment System 5.57E-B uCi/cc Unit 1 Turbine Building 3.26E-9 uCi/c" Unit 2 Turbine Building 4.32E-9 uCi/cc A. 1.2.3 Particulate Monitor Following are the SSES Final Environmental Statement (FES) expected annual release quantities for particu-late radionuclides:
A-6
Cr-51 1.2E-4 Ci/yr per reactor Hn-54 3.6E-4 Fe-59 1. 6E-4 Co-58 5.8E-5 Co-60 1.1E-3 Zn-65 5.5E-5 Sr-89 1.8E-5 Sr-90 3. 1E-6 Zr-95 8.7E-6 Sb-124 5.1E-6 Cs-134 1.3E-4
.Cs-136 1.3E-3 Cs-137 2: lE-4 Ba-140 4.2E-5 Ce-141 2.9E-B Total 3.6E-3 Ci/yr per reactor Mhen the above annual. release quantities are entered into GASPAR=with the annual average dispersion esti-'ates oF A. 1.2. 1, the maximum calculated organ dose
'ia the inhalation pathway is 1.33E-2 mrem to the teen lung. Using Equation 5 of the ODCM, the limiting release rate of particulates can be calculated:
Limiting Release Rate 7.2E-3 Ci 1500 mrem r 8.12E1 Ci/yr/vent (2.66E-2 mrem) (5 vents)
Using Equation 6 of the ODCH, the limiting (setpoint) particulate concentrations can be calculated for each of the f'ive plant vents.
Limiting Yent Concentration =
8.12E1 Ci r vent 166 uCi Ci =3.24E-8 uCi/cc for (5.26E5 min/yr) (4.77E9 cc/min) Reactor Buildings 182 A-7
When the vent flow rates for the remaining five plant vents are 'substituted into Equation 6 as above, the following high radiation setpoint concentrations result.
Standby Gas Treatment System 3.06E-7 uCi/cc Unit 1 Turbine Building le79E-8 uCi/cc Unit 2 Turbine Building 2.37E-B uCi/cc A. 2 A IRBORNE EFFLUENT DOSE RATE CALCULATIONS A.2.1 Noble Gases To evaluate the annual whole-body or skin dose from noble gas'elease rates, the highest calculated annual average relative concentration for any sector is selected from Table 3. For the SSES site, the critical downwind sector is the West 'sector with an annual dispersion factor of 2.6 x 10 sec/m . The expected release rate of the principal noble gas radionuclide,'xenon-133, is 396 uCi/sec. To calculate the annual whole-body dose due to the release of any nob'le gas in the gaseous effluent, Equation 7 in the ODCH should be used. The whole-body dose factor (K.)
1 from Table 2 for xenon-133 is 2.94 x 10 mrem/yr per uCi/m . Substituting these values in Equation 7, the whole-body dose contribution from xenon-133 releases from the SSES would be 3.0 mrem/yr:
D = (K ) (X/g)(g 'v) (Equation 7) b 2
Db
= (2.94 x 10 m~rem r) (2.6 x 10 sec) 3 uCi/m X (396 uCi/sec) 3.0 mrem/year To calculate the annual skin dose due to release of any noble gas in the gaseous effluent, Equation 8 in A-8 yp~ C
the 00CM should be used. The skin dose factor (L.) i 2
from Table 2 for xenon-133 is 3.06 x 10 mrem/yr per uCi/m . The air dose factor (H.) from Table 2 for 3
1 2
xenon-133 is 3e53 x 10 mrad/yr per uCi/m .
Substituting these values and the previous values for .
release rate and annual dispersion factor in Equation 8, the skin dose contribution from xenon-133 from the SSES would be 7.1 mrem/yr:
0 = (L. + 1.1 M-) (X/9) (g'- ) (Equation 8) 0 = (3.06 102 ~mrem r s
uCi/m
+ 1.1 (3.53 x 10 ~))
uCi/m 3
(2.6 x 10 m
)
x (396 uCi/sec) - 7.1 mrem/year D-9 ar)-3 OAT
I A.2.2 Radionuc ides Other Than Noble Gases To evaluate the annual critical organ dose from radionuclides other than noble gases, the highest annual average dispersion parameter for estimating the dose to the critical receptor is selected from Table 3. The highest annual dispersion factor is
-5 3 2.6 x 10 sec/m in the West sector. The expected release rate of iodine-131 is 3e8 x 10 uCi/sec. The expected release rate of cesium-137 is 6.66 x 10 uCi/sec.
To calculate the annual critical organ dose due to the release of radionuclides other than noble gases in the gaseous effluent, Equation 9 in the ODCH should be used. The inhalation pathway parameter (R.) from 1
Table 4 for iodine-131 is 1.62 x 10 mrem/yr per uCi/m . Substituting these values in Equation 9, the maximum thyroid dose contribution from iodine-131 would be 1.6 mrem/yr from the inhalatioh pathway.
(Ri ) (Wv) (0 i v) (Equation 9) 0 (1.62 x 10 m~rem r) (2.6 x 10 sec) 3
~
uCi/m m X (3.8 x 10 uCi/sec) 1.6 mrem/year INHALATION PATHWAY, I-131 A-10 OAT
A.3 INDIVIDUAL DOSE A.3.1 Waterborne Effluents The liquid effluent dose calculations are performed using the Liquid Annual Dose To All Persons (LAOTAP II) computer program.
This program may be used to calculate the quarterly (or any other time period) doses to the maximum individual. The computer code LAOTAP II, which was developed by the'NRC to perform dose calculations in accordance with Regulatory Guide 1. 109, is used.
The User's Manual for the LAOTAP II program contains details of.
the calculational procedures. The total number of curies released for each radionuclide during the time period being evaluated must be supplied from the SSES radiation monitoring program.
A.3.2 Airborne Effluents The airborne effluent dose calculations are performed using the GASPAR computer program. This program may be used to calculate the maximum individual and population doses due to radionuclides released in gaseous effluents from the SSES. The code implements the semi-infinite cloud model and the dose calculational models of Regulatory Guide 1.109 and is used to calculate all maximum individual and population doses and maximum individual organ doses from the SSES. A more detailed description of the GASPAR code can be found in the GASPAR dose code manuals dated October 17, 1975, and February 20, 1976. The total number of curies released for eacn radionuclide during the time period being evaluated must be supplied from 'the SSES radiation monitoring program. The meteorological parameters must be provided from the SSES meteorology program.
To evaluate the air dose from noble gas release rates, the highest calculated annual average relative concentration for any sector is selected from Table 3. This critical downwind sector is -5the Mest sector with an annual dispersion factor of 2.6 x 10 sec/m . The expected release rate of the principal noble gas radionuclide, xenon-133, is 396 uCi/sec. The total release 6
in a calendar quarter would be 7.9 x 10 seconds times 9
396 uCi/sec or 3.13 x 10 uCi. To calculate the quarterly gamma air dose due to the Xenon-133 release in the gaseous effluent, Equation 12 in the ODCH should be used. The gamma air dose factor (H.) from Table 2 for xenon-133 is 3.53 x 10 2 mrad/yr per uCi/m .. Substituting these values in Equation 12, the quarterly gamma air dose contribution from xenon-133 releases from the SSFS would be 0.9 mrad:
- ( /0)v 0iv (Equation 14) sec D (3.17 x 10 ~r(3.53 x 10 ~mrad r)(2.6 x 10 sec) 3 sec uCi/m m
/
X (3.13 x 10 uCi/qtr)
= .9 mrad/quarter To calculate the quarterly beta air dose due to the xenon-133 release in the gaseous effluent, Equation 13 in the ODCH should be used. The beta air dose factor (H;) from Table 2 for xenon-3 133 is 1.05 x 10 mrad/yr per uCi/m . Substituting these values 3'n Equation 13, the quarterly beta air dose contribution from xenon-133 releases from the SSES would be 2.7 mrad:
Ob 3.17 x 10 ~r N. (X/Q} 9'. (Equation 15) sec 0> = (3.17 x 10 xr )(1.05 x 10* meadr)(2.6 x 10 sec) sec 3 uC /
9 X (3.13 x 10 uCi/qtr) = 2.7 mrad/quarter
Since the beta air dose is greater than the gamma air dose by a factor of 3 for xenon-133 and the dose limits are only a factor of 2 greater for beta than gamma radiation, the beta air dose would be controlling for xenon-l33 releases.
A.4 TOTAL DOSE The total cumulative annual dose'to any member of'the public from operations at the SSES should be determined by summing the critical organ doses to real individuals from all three sources of radiation. Only the maximum dose or dose commitment to a real individual needs to be evaluated.
A.4.1 Li uid Effluents The cumulative dose to any member of the public due to liquid effluents from the SSES should be determined from the LADTAP II program used for evaluating the individual doses as stated in Section A.3. 1 of this Appendix.
A.4.2 Gaseous Effluents The cumulative dose to any member of the public due to gaseous effluents from the SSES should be determined from the GASPAR program used for evaluating the individual doses as stated in Section A.3.2 of this Appendix.
P A.4.3 Direct Radiation The direct radiation to any member of the public due to operations at the SSES should be determined from the environmental monitoring program results.
A-13
APPEHOIX 8 REPORTING RE UIREHENTS B.l ANNUAL ENVIRONHENTAL OPERATING REPORT, PART B, RAOIOLOGICAL A report on the radiological environmental surveillance program for the previous calendar year shall be submitted to the Oirector of the NRC Regional Office (with a copy to the Oirector, Office of Nuclear Reactor
.Regulation} as a separate document'by Hay of each year. The period of the first report shall begin with the date of initial criticality. The.
reports shall include a sugary (format of Table B-l), interpretations',
and-an analysis of trends from the results of the radiologica1 environmental surveillance activities for the.report'period, including a comparison with operational controls, preoperatfonal. studies (as-appropriate), and previous environmental surveillance reports and an-assessment of the-observed impacts of. the station operation on the-.
environment.
In the event that some results are not available, the report shall noting and explaining the reasons for the missing results:be-'ubmitted The missing data shall be submitted as soon as possible in a supplementary report.
B. 2 NONROUTINE RADIOLOGICAL ENVIRONMENTAL OPERATING 'REPORTS When the level of radioactivity in an environmental sampl'ing medium averaged over any quarterly sampling period exceeds the reporting level given in Table 8-2, a written report shall be submitted to the Director of the NRC Regional Office (with a copy to the Director, Office of Nuclear Reactor Regulation) within 30 days. If it can be demonstrated that the level is not a result of station effluents (i.e., by comparison with control station or preoperational data) a 'report need not be submitted, but an explanation shall be given in the Annual Radiological Environmental Operating Report.
When more than one of the r adionuclides in Table B-2 are detected in the medium, the reporting level will have been exceeded if:
concentration I + concentration 2 + ... I reporting level (I) reporting level (2)
If radionuclides other than those in Table B-2 are detected and are due from station effluents, a reporting level is exceeded if the,potentia'1 annual dose to an individual is equal to or greater than the design objective doses of 10 CFR,Part 50, Appendix I. This report shall include an evaluation of any release conditions, environmental factor, or other aspects necessary to explain the anomalous result.
B-2
TABLE B-I SAHPLE ENVIROHHENTAL RADIOLOGICAL HONITORING PROGRAH ANNUAL SUHHARY Reporting Period: 1/1/79 - 12/31/79 All Indicator Location with Nighest Hedium or Type and Lower Limit Locations Annual Hean Control Locations Number of .
Pathway Sampled Total Number of Name, Honroutine (Unit of of Analyses Detection Hean Distance E -Mean Reported Heasurement Performed DP Ran e Hean Ran e Heasurements Air Particulates (10 pei/m ) Gross Beta 336 26.6(234/234) 1D2 29.9(52/52) 28~2(102/,102}
(7.7-71) 3.7 mi N (11-71) (9.8-64)
Gatana 28 Be-7 81(20/20) 301 82(4/4) as(a/8)
(37-1303 3.2 mi NE (54-130) (51-140)
Cs-137 0.6 1.6(4/20) 102 S.?(2/4) 2.?(1/8)
(1.1-1.8) 3.7 mi NE (2.3-9.0) (2.7)
Air Iodine 1-131 160 1.5 - (0/109) N/A -(0/sl)
(10 pei/m )
o e: e examp e a a are provided for illustrative purposes only.
11 198g
TABLE 8-2 REPORTING LFVELS FOR HOHROUTIHE OPERATING REPORTS Broad Leaf Mater Airborne Particulate Fish Hilk Yegetation A~nal sis Q)Ci Ql of Gases~Ci/m~s Ci k, wet ~Ci /1 Ci/k wet H-3 Mn-54 1x10 3 x 10 4
Fe-59 4 x 10 1 x 10 Co-58 1x10 3 3 x 10 Co-60 3x 10 2 1 x 10 2
Zn-65 3 x 10 2 x 10 Zr-Hb-95 4 x 102
2 0.9 3 1x10 2 3
Cs-134 30 10 1x10 60 1 x 10 Cs-137 50 20 2 x 10 70 2x10 Ba-La-140 2 x 102(b) 3 10 C7 For drinking water samples. This is 40 CFR Part 141 value.
Total for parent and daughter.
APPENOIX C SITE SPECIFIC INFORMATION USEO BY GASPAR COOE
- 1) The distan ance from the miles 590 miles. facility to the NE ..
corner of thee U.S ((Maine)) in 2)) Fract action of year leafy vegetables are grown 0.33
- 3) Fraction of year cows are on pasture'0.60 (April-Nov.)
- 4) Fraction of crop from garden 0-76
- 5) Fraction of daily intake of cows derived from pasture while on pasture-
- 6) Ahsolute humidity over growing season 9.0 im-Relative humidity is 67.66 if T is supplied.
7)) Av Average temperature over growing season 60.2'F
- 6) Fraction of year goats are on pasture 0 60'.
- 9) Fraction of dail y i ntake of goat from. pasture while on pasture-0 75
- 10) Fraction of year beef cattle are on pasture 0.60
- 11) Fraction of dail y in take oa pasture 0.55 beef'cattle derived from pasture pastur wh~le h 1 on-
APPENDIX D SITE SPECIFIC INFORMATION USED BY LADTAP II CODE
- 1) Tota1 discharge per unit: ll cubic feet per second, or specific to release per'iod.
- 2) Total Annual Blowdown Volume: 6.94E8 cubic feet
- 3) Dose to Haximum Hypothetical Individual Shorewidth Factor: 0.2 Sediment exposure time: 131,400 hr.
USAGE FACTORS PATHWAY CHILD ADULT Fish k yr 6.9 16 21 Potable Mater 330 510 510 730 liter yr Shoreline 12 hr/yr DILUTION FACTORS (DF)
PATHWAY LOCATION DF Outfall 15 '
Potable Mater l DaO.vi1 e 321*
Shoreline Outfall 15.9
- For estimating purposes. Actual dilution factors at Danville, Pa., for various river. levels located in Table 5-4.
TRANSIT TINES (Tp)
PATHWAY LOCATION T hr Fish Outfall Potable Mater Danville 25.8*
Shoreline Outfall
- For estimating purposes. Actual river transit times at Danville, Pa., for various river levels located in Table'-4.
- Includes one hour transit from outfall plus 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br /> to consumption.
D-l
APPENDIX B REVISIONS TO SSES SOLID WASTE PROCESS CONTROL PROGRAM (NDAP-QA-0646)
PROCEDURE CHANGE APPROVAL FORM I. 2.
1 PCAFNO. ~9~t+I 7 PAGE I OF PROCEDURE NO NDAP-QA-0646 REV. 4. FORM NO. NIA REV.
- 5. PROCEDURE TITLE Solid Radioactive Waste Process Control
- 6. PROCEDURE TYPE:
QA PROGRAM PLANT PROC
~
~ YES YES
~
~ NO NO
- 7. REQUESTED CHANGE DELETE PCAFs QQ NO ~ YES ¹ ADD Step 4.5.13 Ensure that radwaste tanks are prepared with Operations support.
- 8. REASON FOR CHANGE Continued ~
To prevent recurrence of.CR 96-0630.
- 9. RECOMMENDED FOR PERMANENT STATUS? ~) YES Continued ~
( ) NO, EXPIRATION DATE (60 DAY MAXIMUMFOR TE RA Y STATUS)
- 10. IF PLANT PROCEDURE COMPLETE ITEMS 11 THRU 15 ON PAGE 2 OF THIS FORM 16.
INITIATOR: Alise C. Seibert DATE: 1/3/97 17.
a.
b.
~
MANAGEMENTREVIEW
~ QADR NOT REQUIRED QADR PERFORMED, NO COMMENTS
- 18. AUTH RIZAT ON
\ .
SHI R PLANT PROCEDURES) a PERVISOR
~) I 8 NAGE ER refDATE
- 19. COMMITTEE M TING TYPE: RECOMMENDED: NO MTG ¹ REVISED: NO
- 20. APPROVAL
~ ev'l rsvp I ~ ~
DATE CIMAOVlY &iME5ifkiiiE HOT OOX FORM NDAP-QA<003-1, Rev. 2, DUPLEX, Page 1 of 2.
PO
-lCW8
~ ' ' ~ ~
~ ~ ~ ~ ~ ~ ~
~ I ~ ]r ~ '
~ I ~ 0 ~ ~
' ~
~ ~ ~ ~
/ / ~ r
~ ~ ~ ~
1~ I I ~ ~
~ ~
~
~ '
~ I
~
~
't
~
.4 ~ ~
I
~ A ~
' 'P'
~ A
~-
'll
~ I
~ '
I
I.:
~ ~ ~
IAt
~
O."I
~ ~ ~ I~la '
~ ~ '
~
~
~ ~
~ ii
~ ~
. - pi@/I ~
~ ' ' ~0 I ~ A I I
~ ' ~ ~ ' '
~ ' ' ' ' ~ ~ ~ I I
~ ' ' r I ~
Oo I I I I
~ ' ~ ' ~ ~
PROCEDURE COVER SHEET
.~p N~ NUCLEAR DEPARTHENT PROCEDURE SOLID RADIOACTIVE WASTE 'DAP-QA-O646 PROCESS CONTROL PROGRAH Revision 4
~O Page I of 63
'Hie s >
EFFECTIVE DATE: /0 PERIODIC REVIEM PREOUEMCY: + ~ ~I571C icP~
> >M'7 PERIODIC REVIEW DUE DATE:
REVISED PERIODIC REVIEM DUE DATE: ~ 7J Tf 'i~
~x.sf~&
PROCEDURE TYPE: gA Program ( g/ ) YES ( ) NO Plant Procedure (+) YES ( ) MO REVIEW HETHOD:
( ) Alternate ( ) Expedited (Q) PORC ( ) ERC Prepared by Date J -><-'PS Reviewed by Superv Recommended ctiona Un'anager PORC Committee Heeting No.
Date ERC Co tt Approved by Date fflfmffltflllilllllfllffitllIIIllIlflflSflllllfIllll NDRP" GR-BE'AID lllllmlIflllllflfll!lllifIllll
NDAP-gA-0646 Revision 4 Page 2 of 63 PROCEDURE REVISION
SUMMARY
SOLID RADIOACTIVE WASTE PROCESS CONTROL PROGRAM t
The following changes will not reduce the overall conformance of the solidified waste product to existing criteria for solid wastes.
- 1) Incorporated PCAF 1-94-1330 revising the PCP implementing procedure matrix to reflect actual procedures in use and changed the requirements for disposal of radioactive waste samples after packaged radioactive waste has been in its designated storage area.
- 2) Added SEG NRC approved Topical Report STD-P-05-Oll-P-A to Contracted Vendor Services to reflect use of SEG for waste processing equipment, methods and verification of acceptable waste forms for dewatering and solidification.
- 3) Added Activated Carbon as a new waste type which is generated from processing of liquid wastes using vendor provided demineralization services.
- 4) Added the Solidification/Dewatering/Services Vendor may perform test solidification and determination of mixing ratios for solidification performed offsite (vendor facility)
- 5) Added Radlok (SEG) type containers to High Integrity Container approved for use list.
- 6) Added SNM inventory requirements during processing per SOOR 94-581 resolution.
- 7) Added NRC Technical Position on Concentration Averaging and Encapsulation to Radioactive Maste Analysis and Classification to ensure that radionuclide/concentrations are adequately distributed over the volume or weight of the waste.
NDAP-0A-0646 Revision 4 Page 3 of 63 TABLE OF CONTENTS SECTION PAGE 1.0 PURPOSE
- 2. 0 POLICY/DISCUSSION.
3.0 REFERENCES
4.0 RESPONSIBILITIES 4.1 EFFLUENTS MANAGEMENT SUPERVISOR 4.2 SUPERVISOR - OPERATIONS TECHNOLOGY 4.3 POWER PRODUCTION ENGINEER - EFFLUENTS MANAGEMENT 4.4 HEALTH PHYSICIST - EFFLUENTS MANAGEMENT 10 .
- 4. 5 RADMASTE SUPERVISOR 10
- 4. 6 CHEMISTRY SUPERVISOR 4.7 HP FOREMAN EFFLUENTS MANAGEMENT 12 4.8 MANAGER-NUCLEAR ASSESSMENT SERVICES 13 4.9 AUXILIARY SYSTEMS OPERATOR 13 4.10 SOLIDIFICATION/DEWATERING/SERVICES VENDOR 13 4.11 MANAGER - NUCLEAR PROCUREMENT 14
- 4. 12 MANAGER NUCLEAR SYSTEMS ENGINEERING 14 4.13 MANAGER - NUCLEAR MAINTENANCE 14 4.14 LICENSING SUPERVISOR 14 4.15 MANAGER NUCLEAR TRAINING 15 4.16 MANAGER NUCLEAR SECURITY
- 5. 0 DEFINITIONS 15
NDAP-gA-0646 Revision 4 Page 4 of 63
~
TABLE OF CONTENTS Continued
'E PAGE 6.0 PROCEDURE 20
- 6. 1 CONTRACTED VENDOR SERVICES 20 6.2 WASTE TYPES 21 6.3 RADIOACTIVE WASTE ANALYSIS AND CLASSIFICATION 27 6.4 TESTING/TREATMENT OF SOLIDIFIED RADWASTE FOR 30 COMBUSTIBLE GASES 6.5 RADIOACTIVE WASTE SOLIDIFICATION 30 6.6 RADIOACTIVE WASTE DEWATERING 40 6.7 HIGH INTEGRITY CONTAINERS (HIC) 6.8
- 6. 9 IRRADIATED HARDWARE PROCESSING AND DEWATERING CONTAINER INSPECTIONS 4S 46
~
6.10 WASTE CONTAINER SPACE UTILIZATION 47 6.11 STORAGE OF PACKAGED RADIOACTIVE WASTE 6.12 TRANSPORTATION, SHIPPING AND DISPOSAL REGULATIONS
'6.13 SHIPPING OF RADIOACTIVE WASTE 6.14 SHIPMENT CONFIRMATION 51 6.15 CHANGES TO THE SOLID RADIOACTIVE WASTE PROCESS CONTROL PROGRAM 6.16 EVALUATION OF PROCESS OR OPERATIONAL CHANGES 51 6.17 REPORTING OF MISHAPS INVOLVING LOW LEVEL WASTE FORMS 6.18 PCP IMPLEMENTING PROCEDURES 7.0 RECORDS
NDAP-gA-0646
.Revision 4 Page 5 of 63 ATTACHMENTS ATTACHMENT PAGE A Solidification Record Sheet Dewatering Record Sheet 56 Susquehanna Guaranteed Solidified/Dewatered Waste 59 Volume Record PCP Implementing Procedure Matrix 60 Materials not Compatible with Polyethylene Containers
NDAP-QA-0646
, Revision 4 Page 6 of 63 1.0 PURPOSE Provide administrative control, guidance and records for the processing, packaging, transportation, and disposal of radioactive waste. This procedure is the Process Control Program required by SSES Technical Specifications.
I. ~IY I I This procedure is applicable to Low Level Radwaste (LLRW) generated as a result of the operation of the Susquehanna Steam Electric Station (SSES). The waste streams include solid and liquid waste as defined in the FSAR, but do not include spent fuel or greater than Class C waste.
Efficient generation and processing of radioactive waste is very important to the overall operation of SSES. An important objective with respect to radioactive waste generation is to minimize the volume of waste generated. The processing of large volumes of waste can result in the inability to dispose of or store all waste packaged, the significant increased costs associated with increased waste generation, and the-potential to over-burden the processing system and degrade its long term reliability. The Process Control Program describes the envelope within which processing and packaging of radioactive waste is accomplished to provide reasonable assurance of compliance with Low-Level Radwaste regulations and requirements. This procedure is applicable to SSES installed systems, temporary systems and equipment provided by vendors for processing, packaging, transportation, and disposal of applicable waste forms.
3.0. REFERENCES 3.1 49CFR100 - 177, Transportation 3.2 10CFR20, Standards for Protection Against Radiation 3.3 10CFR61, Licensing Requirement for Land Disposal of Radioactive Waste 3.4 10CFR71, Packaging and Transportation of Radioactive Material 3.5 40CFR261, Identification and Listing of Hazardous Waste 3.6 SSES Technical Specifications Section 3/4.11.3, Solid Radwaste System 3.7 SSES Technical Specifications Section 6.13, Process Control Program (PCP)
NDAP-gA-0646 Revision 4 Page 7 of 63 3.8 NUREG 0800, Standard Review Plan 11.4 Solid Waste Management Systems 3.9 Technical Position on Waste Form Rev. 1, 1991 3:10 Technical Position on Radioactive Waste Classification, Rev. 0, 1983 3.11 Technical Position on Concentration Averaging and Encapsulation, Rev. 0, 1995 3.12 Regulatory Guide 1.21, Measuring, Evaluating and Reporting Radioactive Haterial in Solid Wastes and Release of Radioactive Material in Liquid and Gaseous Effluents from Light Mater Cooled Nuclear Power Plants 3.13 Regulatory Guide 1.143, Design Guidance of Solid Maste Management Systems 3.14 Regulatory Guide 7.1, Administrative Guide for Packaging and Transporting Radioactive Material 3.15 ANSI/ANS 40.35, Volume Reduction of Low Level Radioactive Maste 3.16 ANSI/ANS40.37, Hobi le Radioactive Waste Processing Systems 3.17 ANSI/ANS 55.1, Solid Radioactive Waste Processing System for Light Water Cooled Reactor Plant 3.18 Pacific Nuclear Dewatering System Topical Report No. TP-02-P-A, Rev. 3 3.19 Pacific Nuclear Solidification Process Control Procedure No.
PT-51-MS, Rev. 40 3.20 Scientific Ecology Group Hobile Incontainer Dewatering and Solidification System (NDSS) Topical Report No. STD-R-05-011-P-A, Rev. 2
- 3. 21 Disposal Site Criteria for Barnwell, S.C.
3.22 DHEC-HIC-PL-.001 South Carolina Certificate of Compliance for CNSI High Integrity Containers 3.23 DHEC-HIC-P0-006, South Carolina Certificate of Compliance for CNSI Overpack High Integrity Containers 3.24 South Carolina Certificate of Compliance for
'HEC-HIC-PL-012, Vectra Technologies, Inc. High Integrity Container
NDAP-OA-0646 Revision 4 Page 8 of 63 3.25 DHEC-HIC-PL-005, South Carolina Certificate of Compliance for Scientific Ecology Group, Inc. High Integrity Containers 3.26 DHEC-HIC-PL-017, South Carolina Certificate of Compliance for Scientific Ecology Group, Inc. High Integrity Containers 3.27 PLA-1237, Process Control Program, August 17, 1982 3.28 Review of Process Control Program for Susquehanna, Unit 1, Youngblood to Curtis, September 30, 1982 3.29 Safety Evaluation NL-93-008, Solid Radwaste Waste Processing Services Utilizing Pacific Nuclear Processing System 3.30 IE Bulletin 79-19, Packaging of Low Level Radioactive Waste for Transportation and Burial
(') 3.31 NRC Information Notice No. 90-50, Minimization of Methane Gas Generation in Plant Systems and Radwaste Shipping Containers
(~) 3.32 Generic Letter 91-02, Reporting Mishaps Involving LLW Forms
(~) 3.33 Prepared for Disposal SOOR-1-90-148, Flammable Gas Barnwell Received Container Pressurized with e
(") 3.34 SOOR 1-90-172, Incorrect Sampling Method Used on Resin Liner
(~) 3.35 SOOR 1-91-322, Dose Rates on Container Higher Than Expected
( ) 3.36 SOOR 94-581, Spent TIP Found, Unexpectedly in TIP Room.
- 4. 0 RESPONSIBILITIES 4.1 Effluents Management Supervisor responsibilities:
4.1.1 Developing and implementing programs and procedures for radioactive waste processing, packaging, transportation and disposal.
4.1.2 Maintaining the overall radkaste program to ensure compliance with applicable radiological and shipping regulations.
4.1.3 Ensuring personnel who perform support activities such as processing, packaging, and transportation of low level radioactive waste are available and meet all qualifications and training required by SSES procedures.
NDAP-gA-0646 Revision 4 Page 9 of 63 4.1.4 Collecting, maintaining, reviewing and submitting accurate data/information related to waste stream quantity and nuclide composition for inclusion into Annual Radioactive Effluent Release Report and State DER-BRP quarterly Report.'.2 Supervisor - Operations Technology responsibilities:
4.2.1 Providing technical assistance to Effluents Management personnel. This includes interpretations of state, federal, and disposal facility regulations regarding new, imminent, or proposed regulatory changes governing processing, packaging, transportation, and disposal.
4.2.2 Naintaining a current copy of local, state, federal and disposal facility regulations pertaining to disposal and transportation of low level radioactive waste.
4.2.3 Coordinating the submittal of the Annual Radioactive Effluent Release Report as per the SSES Technical Specifications.
4.3 Power Production Engineer - Effluents Management responsibilities:
4.3.1 Ensure procedures are adequate to provide for proper solidification and dewatering of waste.
4.3.2 Ensure test data or rationale is available to justify applicable solidification and dewatering functions of each waste type, or any combinations, to address disposal and regulatory agencies'equirements.
4.3.3 Evaluate services provided by various vendors to ensure contracted solidification and dewatering operations are performed in the most efficient and economical method, as required by the applicable regulatory agencies.
4.3.4 Perform the duties of'Radwaste'upervisor as.specifi'ed in this procedure in his absence.
4.3.5 Define waste streams based on generator, filtration media and means of processing.
4
/
8
" " .".-,Revision,.4;
,. NDAP-gA-0646"," .
Page .10'of, 63 V
4.3.6 ~
Co11ecting, reviewing'hand'.submitting data-.related to '-
the reporting of mishaps ind results of PCP specimen..examinations,to applicable ...""::. .,'surveillance regul atory agencies.i".'.," ..-...... *
.4.4 Health Physicist - Effluents.Hanagement responsibilities:." . -::
4.4.1 = Naintain a sampling and analysis,.program to ensure 1DCFR61 compliance.
Vt 4.4.2 Ensure procedures are adequate to provide for proper packaging and.shipment of waste.to ensure compliance with all applicable. regulations.,
4.4.3 Evaluate services provided by various vendors to ensure contracted waste packaging, processing, and transportation services are pei formed in the most efficient and economical, method, as required by applicable regulatory agencies.
4.4.4 the duties of HP Foreman 'erfortti
- Effluents Management as specified in this procedure in his absence.
4.4.5 Coordinate radioactive material evaluation of product
, acceptability for disposal. at specific disposal facilities.
4.5 Radwaste Supervisor responsibilities:
4.5.1 Ensure Solidification/Oewatering Equipment is operated in accordance with approved operating procedure, including vendor supplied equipment.
4.5.2 Ensure appropriate'aste so1idification and dewatering 4
records are generated.. ""
r, ~
4.5.3 Interface with station support groups to ensure .proper implementation, of process,-control~programs~'~'<:::-".-::.'~- ':."<<..~:.-;.=":.
4 ',4 Provide direction-. to/contr.actor,personnel,;.'.iriyolved.'~in~-; .'.".'.":,w;"H solid. waste processing~activities=.including:;-~~K:-'"'. .".'a~~k
- a. Ens'uring,.'.test::.datazi's'available:.to'- justify;;-'.-,.: .",'~-'..',,".".'.,~":
specific~processing>techniques':::;:.:::-:,".':..'>24--;.'-:.; ..>>.',;'>".k.':+
b..-,-,- Ensuping<a'pp1icabl jqyendor',::" proc'eduresi,-'and~>..;":~.".-.."'~.::::-
revisions'-ar'm$ ncor'porated':;into'ippl cable%pl ant~
,. proceduregaiid.'approved;;by',PORC.';*~'~@~."~-~Ai--"
i N 8'
~=
I-9'7- ODl ). A 2 aFQ, NDAP-QA-'0646 Revision'4 Page'll of 63 C. Coordinating pre-processing and post-processing treatment activities..
U
- d. Evaluating services provided to ensure efficient and economical methods are used. .
r 4.5.5 Ensure Solidification and Dewatering operations out in, an ALARA manner.
are'arried 4.5.6 Interface with HP Foreman Effluents Management for liner and cask selection for solid waste. shipping activities.
4.5.7 Ensure proper marking of containers prior to filling.
4.5.8 Ensure solidification/dewatering personnel are adequately trained per NTP-gA-42.6..
4.5.9 Estimate classification of waste for container selection and processing method.
4.5.10 that waste streams loaded into 'nsure High Integrity Containers are sampled for radionuclide and evaluated for chemical compatibility applicable to the use of High Integrity Containers.
4.5.11 Ensure proper inspections and documentation are complete prior to use of a High Integrity Container and ensure that container is properly used up to the point of transfer to HP Foreman - Effluents Management.
4,.5.12 Complete and process High Integrity Container User Certification Statement to ensure the container is used properly.
Ensure that radwaste tanks are prepared with Operations support; 4.6 Chemistry Supervisor'esponsibilities:
I 4.6.1 Perform,r'equfred sample 'pr'eparation and analysis in-,Z'.~>"-,."='i-'.
accordance with approved:chemistry procedur s.""".-';-':...:.,"~~: .~-;".'.
4.6.2 Perform test solidification solidification'billet..if required.
if required.',.Store-test~,j.~';.>.='"-.-,<~
4.6.3 Provide density'of'-;iiiitial: and final waste -form'-"=.;:';a-".."-:;-.~"'"=.",
4.6.4 Provide the'sotopic:mix and concentration of- isotopes'~.->,;'~~~..:~
in the. material sampled for solidification; orwj~'"..'; 'e
NDAP-QA-0646 Revision 4 Page 12 of'3 4.6.5 Complete Chemistry portion of the Solidification and Dewatering Records.
4.6.6 Ensure personnel are adequately trained per NTP-QA-41.2.
4.6.7 Provide chemical analysis and/or treatment support as necessary for'se of High Integrity Containers and liners.
4.7 HP-Foreman - Effluents Management responsibilities:
4.7.1 Interface with Radwaste Supervisor for liner and cask selection and scheduling for solid waste shipping activities.
4.7.2 Complete, process, and file radioactive waste .shipping documentation.
4.7.3 Storage of packaged radioactive waste within the radwaste facilities.
4.7.4 Determine waste classification and description of solidified, dewatered, and other packaged waste.
4.7.5 Final disposition of solidified, dewatered and other packaged waste.
4.7.6 Ensures SSES is a registered user of applicable High Integrity Containers at specific disposal facilities.
4.7.7 Ensures HP personnel involved with radioactive waste handling have received Radwaste Worker training per NTP-QA-42.6.
4.7.8 Evaluate vendor services provided to ensure efficient and economical methods are used.
4.7.9 Complete and process Certification Statement for Disposal of High Integrity Containers as required by applicable regulatory agencies.
4.7.10 Process and package Cartridge Filters, Dry Active Waste, solid sealed sources and other non process wastes.
4.7.11 Collection of DAW and non-process waste (10CFR61) samples.
NDAP-gA-0646 Revision 4 Page 13 of 63 4.8 Manager-Nuclear Assessment Services responsibilities:
4.8.1 Perform periodic audit of implementation of this program and review of radwaste service vendor<s gA Programs.
4.8.2 Inspection of Radwaste Containers as required by applicable procedures.
4.8.3 Ensure process controls are adhered to by inspection of test solidification, waste volumes, solidification agent additions, product acceptability checks, dewatering process sequence/acceptance criteria and records review.
4.8.4 Inspection of packaging, storage, and shipping activities, as required by applicable procedures.
4.9 Auxiliary Systems Operator is responsible for operating the plant solid and liquid radwaste equipment in accordance with approved operating procedures as directed by the Radwaste Supervisor and Assistant Unit Supervisor.
4.10 Solidification/Dewatering/Services Vendor responsibilities:
4.10. 1 Provide solidification, dewatering and/or volume reduction services in accordance with a valid contract for said services.
4.10.2 Pr'ovide test data or make data available for PP8L review during vendor audits to demonstrate that their services and equipment meet the applicable regulatory and disposal facility limitations for the service they are providing.
4.10.3 Provide training documentation to demonstrate that the personnel being provided, to conduct the applicable service, are in fact trained and knowledgeable in the applicable services.
4.10.4 Provide procedures that are or can be placed into the SSES procedure format for the services being provided.
4.10.5 Ensure an approved guality Assurance Program exists that covers the services being provided. The work within the SSES guality Assurance Program vendor'hall when applicable.
NDAP-gA-0646 Revision 4 Page 14 of 63 4.10.6 Complete applicable sections of Solidification and Dewatering Records required for each container processed.
Ensure pre-qualification test data for each waste form shall be submitted to the Nuclear Regulatory 4.10.7'.10.8 Commission.
Provide a description of the equipment/process that is used in processing waste.
4.10.9 Obtain waste samples from processing equipment in accordance with approved operating procedures.
4.10.10 Perform all pre and post treatment activities as determined by Radwaste Supervisor.
4.11 Manager Nuclear Procurement responsibi 1 i ties:
4.11.1 Ensure High .Integrity Containers are not exposed to ultra violet light (sunlight).
4.11.2 Ensure proper material certification is complete prior to issuance of High Integrity Containers to plant for use.
4.11.3 Receipt inspection of High Integrity Containers and document review to ensure conformance.
4.11.4 Ensure Certificate of Compliance (C of C) is received with High Integrity Container.
4.12 Manager Nuclear Systems Engineering is responsible for providing engineering support as required for operation of assigned radwaste systems and equipment.
4.13 Manager- Nuclear Maintenance responsibilities:
- 4. 13. 1 Calibration and maintenance of applicable plant equipment in Radwaste Processing Systems.
4.13.2 Provide maintenance personnel to support processing, packaging and transportation of low level radioactive waste.
4.14 Licensing Supervisor responsibilities:
4.14.1 Submitting transportation cask user registration requests to NRC per 10CFR71.12.
NDAP-gA-0646 Revision 4 Page 15 of 63 4.14.2 Submitting to the NRC the Annual Radioactive Effluent Release Report.
4.14.3 Coordinating and submitting to the NRC the reports required as a result of Condition Report (CR) events, investigations, and resolutions.
4.15 Manager Nuclear Training responsibilities:
4.15.1 Providing training and re-training in applicable regulatory requirements to personnel directly involved in transfer, processing, packaging, storage, and transport of radioactive waste.
4.15.2 Maintaining a record of training, attendees, and .
subject material for all Low Level Radioactive Maste training.
4.16 Manager - Nuclear Security is responsible for notifying appropriate law enforcement agencies in the event of lost radioactive material shipments.
5.1 APPROVED CONTAINERS: Approved means approval issued or recognized by the NRC fot use in shipment of radioactive material.
5.2 BATCH
The total volume of waste contained in a liner, isolated waste mixing tank spent resin tank - concentrates tank or-phase separator that has been sampled for solidificationj'dewatering.
5.3 BILLS OF LADING: Shipping papers or manifests serving a similar purpose and containing the information required by 49 CFR 172.202, 203, and 204.
5.4 CARRIER
Means a person engaged in the transportation of passengers or property. (10CFR71.4) 5.5 CERTIFICATE OF COMPLIANCE: License requirements established by the Nuclear Regulatory Commission for the use of approved Radioactive Material Shipping Containers.
5.6 CHELATING AGENT: A chemical which combines with a metal so as to form a ring structure held by coordination bonds.
NDAP-gA-0646 Revision 4 Page 16 of 63 5.7 CHEMICAL FORM: The chemical content of the Radioactive Material being shipped.
5.8 CLOSED TRANSPORT VEHICLE: A vehicle equipped with a securely attached exterior enclosure, which during normal transport, restricts the access of unauthorized persons to the cargo space.
(49 CFR 173-403[C])
5.9 COMPOSITE SAMPLE: A mixture of samples collected representing conditions at time of sampling, from the same sampling point, at di fferent times.
5.10 CONSIGNEE: The individual or organization to whom the shipment is consigned or intended.
5.11 CURING TIME: The time allowed for the solidified product to set prior to its evaluation for product acceptability.
5.12 DECAY HEAT: The heat produced by radioactive decay, usually expressed, in Watts or BTU/hr, but can be related to Curie Content.
5.13 DEWATERED: 'he removal of free liquid from solid material to a point where less than IX for HIC's and less than 0.5X for steel liners by waste volume remains as required by the disposal facility license.
5.14 EXCLUSIVE USE VEHICLE (a/k/a: Sole Use or Full Load): Shipment from a single consignor, having the exclusive use of a transport vehicle and for which all initial, intermediate, and final loading and unloading is carried out by, or under the direction of the consignor, consignee, or, his designated agent. (49 CFR 173.403[i])
5.15 FREE LI(UID: Liquid which is still visible after solidification or dewatering is complete, or is drainable from the low point of a punctured container.
5.16 HAZARDOUS MATERIAL A substance or material, including a hazardous substance which has been determined by the Secretary of Transportation to be capable of posing a threat to health, safety, and property when'transported in commerce, and which has been so designated. The term includes hazardous substances, hazardous wastes, marine pollutants, and elevated temperature materials as defined in 49CFR171.8, materials designated as hazardous under the provisions of 49CFRI72.101 and 172.102, and materials that meet the defining criteria for hazard classes and divisions in 49CFR173.
NDAP-gA-0646 Revision 4 Page 17 of 63 5.17 HAZARDOUS WASTE: Waste which contains material listed in 40 CFR 261, Subpart D and/or exhibits one or more of the four characteristics cited in 40 CFR 261, Subpart C, and is not excluded from regulation under 40 CFR 261, Subpart A.
5.18 Hazmat Employee means a person who is employed by a Hazmat Employer who during the course of employment:
5.18.1 Loads, unloads or handles hazardous materials.
5.18.2 Prepares hazardous materials for transportation.
5.18.3 Modifies, marks, or otherwise represents containers, drums, or packagings as qualified for use in transport of hazardous materials.
5.18.4 Is responsible for safety of transporting hazardous material.
5.19 HIGH INTEGRITY CONTAINER (HIC): A disposal site approved container that has an expected life of 300 years and provides the structural stability to meet disposal requirements.
5.20 HIGHWAY ROUTE CONTROLLED QUANTITY: A quantity, the aggregate radioactivity of which exceeds that specified in (49 CFR 173.403[1]).
5.21 ISOTOPIC ANALYSIS: The identification of the isotopic elements involved in a sample of Radioactive Material.
5.22 LABELING: Labels applied to a container denoting the contents of the container and degree .of hazard associated with the containers.
The labels are identified as the White I label, the Yellow II, and Yellow III label. A label stating Radioactive LSA can also be applied to a container when appropriate. (49 CFR 172, Subpart E) 5.23 LIMITED QUANTITY OF RADIOACTIVE MATERIAL: Means a quantity of radioactive material not exceeding the material package limits specified in 49 CFR 172.423, and which conforms with requirements specified in 49 CFR 173.421. (49 CFR 173.403[m])
5.24 LINER: Steel container in which dewatered or solidification product is deposited.
5.25 LOW SPECIFIC ACTIVITY: Material in which the activity is essentially uniformly distributed and in which the estimated average concentration per gram of contents does not exceed the specification as stated in 49 CFR 173.403 (n).
NDAP-0A-0646 Revision 4 Page 18 of 63 5.26 LOW LEVEL RADIOACTIVE WASTE (LLRW): Radioactive waste generated as a result of operation of SSES, excluding spent fuel or by product material, is classified by the NRC as low-level radioactive waste. LLRW does not include "greater than class C" waste.
5.27 MIXING RATIO: The ratio of waste to cement and additives required for satisfactory solidification.
5.28 MIXING RECIPE: The amount of waste, cement and additives mixed to solidify waste.
5.29 MIXED WASTE: ,A mixture of'ow level radioactive and hazardous waste.
5.30 NORMAL FORM RADIOACTIVE MATERIALS: Means radioactive materials which do not meet the requirements of Special Form Radioactive Materials (49 CFR 173.403[s]).
5.31 PLACARDING: A label affixed to all four sides of the transport vehicle denoting the presence and level of Radioactive material on the vehicle. (49 CFR 172, Subpart F) 5.32 PROCESS CONTROL PROGRAM (PCP): Program which contains the sampling, analysis, and formulation determination by which solidification of radioactive wastes from liquid systems is assured.
5.33 RADIOACTIVE MATERIAL: For purposes of transportation only, material in which the activity is essentially uniformly distributed and the estimated specific activity exceeds 0.002 microcuries per gram of material. (49 CFR 173.403[y] and [aa])
5.34 RADWASTE WORKER: A Hazmat Employee involved with the collection, packaging, and transportation of radioactive waste.
5.35 SEALED SOURCES: Any by-product material that is encased in a capsule designed to prevent leakage or escape of by-product material.
5.36 SOLIDIFICATION: A conversion of radioactive materials from liquid and solid systems to a homogeneous (uniformly distributed) monolithic, immobilized solid with definite volume and shape, bounded by a stable surface of distinct outline on all sides (free standing).
NDAP-gA-0646 Revision 4 Page 19 of 63 5.37 SOLIDIFIED RADWASTE: Wet waste which is solidified (e.g.
evaporator concentrates, sludge), meets the free liquid criteria, and satisfies applicable transportation and disposal site requirements. Dewatered resins or filter sludge satisfying the two latter criteria shall also be defined. as solidified radwaste.
5.38 SPECIAL FORH RADIOACTIVE HATERIALS: Radioactive material that is either a single piece, or is contained in a sealed capsule, that can be opened only be destroying the capsule and meets the additional requirements specified in 49 CFR 'Part 173.403(z).
5.39 STABLE AND UNSTABLE WASTE FORHS: Shall be defined as stated in 10CFRPart 61 and other supporting regulatory documents.
5.40 TEST SOLIDIFICATION: The mixing of waste(s) and solidification agents in the laboratory to support selection of mixing ratios and provide insurance for final product acceptability.
5.41 TRANSPORT INDEX (TI): The dimensionless number placed on the label of a package to designate the degree of control to be exercised by the carrier during transportation. The transport index will be determined in accordance with 49 CFR 173.403(bb).
5.42 TYPE "A" PACKAGING: Packaging which is designed in accordance with the general packaging requirements of 49 CFR 173.24, and which is adequate to prevent the loss or dispersal of the radioactive contents, and to retain the efficiency of its radiation shielding properties if the package is subjected to the test described in 49 CFR 173.465 or 173.466, as appropriate.
(49 CFR 173.403[gg])
5.43 TYPE "A" QUANTITY RADIOACTIVE HATERIAL: That material which may be transported in Type "A" packaging. (49CFR 173.431[a])
5.44 TYPE "B" PACKAGING: Packaging which meets the standards for "A" Packaging, and in addition, meets the standards for the Type hypothetical accident conditions set forth in 10CFR71.
(49 CFR 173.403[hh])
5.45 TYPE "B" QUANTITY RADIOACTIVE HATERIAL: That material which may be transported in Type "B" packaging. (49CFR 173.431[b])
5.46 WASTE STREAH: A by-product of a process system or component with unique characteristics and maintained separate from other waste streams.
5.47 WASTE TYPE: Specific contents of a liner or tank which may contain one or multiple waste streams, the category of waste suitable for a particular means of processing.
NDAP-gA-0646 Revision 4 Page 20" of 63 5.48 MASTE PRE-CONDITIONING: The physical or chemical adjustment of the waste to bring it within an established envelope to assure solidification.
6.0 PROCEDURE 6.1 CONTRACTED VENDOR SERVICES 6.1.1 Solidified radwaste processing services are provided by Vectra, Inc. for waste types included in this Process Control Program.
6.1.2 NRC approved Topical Report TP-02-P-A, describes Vectra Inc. waste processing equipment, methods and verification of acceptable waste forms for dewatering.
6.1.3 Vectra Inc. Solidification Process Control Procedure PT-51-MS, describes waste processing equipment, methods and verification of acceptable waste forms for solidification. This procedure does not provide
'tability per the Branch Technical Position on Maste form, Rev. l.
6.1.4 Volume reduction services are provided by Scientific Ecology Group (SEG) for waste types included in the Process Control Program.
6.1.5 NRC approved Topical Report STD-P-05-011-P-A, describes Scientific Ecoplogy Group (SEG) waste processing, equipment, methods and verification of acceptable waste forms for dewatering and solidification. Selected solidified waste forms have been approved to provide stability per the Branch Technical Position on Maste Form, Rev. l.
6.1.6 Other contracted vendor services which are required for solidification, dewatering and volume reduction services shall be evaluated to the requirements stated in this Process Control Program on a case by case basis.
NDAP-gA-0646 Revision 4 Page 21 of 63 6.2 MASTE TYPES The following waste types shall be processed in accordance with this procedure or in combinations as defined. The waste should be dewatered whenever possible to minimize disposal volume.
6.2.1 . Evaporator Concentrates The following are concentrated with the Radwaste Evaporators and are considered Evaporator Concentrates waste stream:
(1) Condensate Demineralizer regeneration effluent (2) Decon Shop drains (3) Chemistry Laboratory sink drains (4) Auxiliary Boiler blowdown effluent
- b. The constituents of this waste stream may include the following:
(1) Tri-Sodium Phosphate (2) Sodium Sulfate (3) Phosphoric Acid (4) Sul furic Acid (5) .Sodium Hydroxide (6) Decontamination solutions (7) Negligible amounts of reagent chemicals used for chemistry analysis C. Evaporator Concentrates in the range of 0-24 weight percent sodium sulfate (equivalent) shall be solidified for final disposal.
- d. Evaporator Concentrates shall not be mixed with any other waste type in final processing.
NDAP-QA-0646 Revision 4 Page 22 of 63 Mixed Solids
- a. The following process waste streams are collected either in Waste Mix Tanks, Waste Sludge Phase Separator or transferred directly to a liner/High Integrity Container and are considered Mixed Solids:
(I) L'RW Filter Media and drain liquid (2) Sump Sludge (3) Ultrasonic Resin Cleaner Waste (URC Waste)
- b. The constituents of these waste streams may include the following:
(I) Diatomaceous Earth (2)" Powdered Resins (3) Fibrous material (4) Carbon material (5) Corrosion products (6) Various solids and dirt in small concentrations C. Hixed Solids may be solidified or dewatered for final disposal.
- d. Each waste stream should be processed separately.
RMCU Filter Media a~ The Reactor Mater Cleanup System and Fuel Pool Cooling and Cleanup System filter/demineralizer waste are collected in the RWCU Phase Separator and should be allowed to decay for 60 days.
This waste stream is considered RWCU Filter Media.
- b. The constituents of this waste stream may include anion and cation powdered resin, corrosion and contaminants removed from the primary coolant.
NDAP-gA-0646 Revision 4 Page 23 of 63 C. RWCU Filter Hedia shall be dewatered in High Integrity Containers. If this waste must be solidified, Technical Specification 3/4.11.3 action statement must be performed.
Condensate/Radwaste/Atmospheric Oemineralizer Bead Resin a~ Resins from the Condensate Demineralizers, Liquid Radwaste Demineralizer and vendor provided demineralization are collected in the Spent Resin Tank or transferred directly to a liner/High Integrity Container. This is considered to be Condensate/Radwaste/Atmospheric Demineralizer Bead Resin.
- b. The constituents'f this waste stream may include various types of anion, cation, mixed bead resin and corrosion and contaminates removed from liquid waste streams.
c~ Bead Resin may be used to demineralize Liquid Waste in either steel liners or High Integrity Containers.
- d. Condensate Demineralizer bead resin should be ultrasonically cleaned prior to collection in the Spent Resin Tank.
- e. Bead Resin may be solidified or dewatered for final disposal.
Bead Resin may also be processed by volume reduction methods which include drying, incineration, compaction, use as fill materials or other evaluated method(s) on a case by case basis.
Cartridge Filters
'a ~ Cartridge .Filter waste type consists of the following waste streams and constituents:
CRD Filters - CRD or other filters and small un-irradiated primary system equipment such as valves, CRD lift filters, Rinse Tank filters and other pump metal components.
NDAP-gA-0646 Revision 4 Page 24 of 63 (2) RMCU Septa - Septa from RWCU Filter Demineralizer including septa from Fuel Pool Cleanup Filter Demineralizer.
(3) Radwaste Filters - including degasifier filters and other fiber or paper filters other than primary system.
(4) Underwater Vacuum Filters - non-process filters generated from wet cleaning activities.
- b. Cartridge Filters may be processed by the following methods:
(I) Emplacement in a cement matrix in a steel drum/liner or in a High Integrity Container.
(2) Dried to a point where no free liquid is visible. Absorbent material may be included to absorb unintentional and incidental amounts of liquids.
(3) Dewatered if drying is impractical.
(4) Incineration or other volume reduction methods.
- c. Cartridge Filters to be solidified for final disposal shall not be mixed with any other waste type.
- d. Each cartridge filter waste stream should be packaged separately unless analyzed prior to packaging in accordance with the requirements of this procedure.
Irradiated Hardware a ~ Irradiated hardware is neutron activated metal removed from the internal area of the reactor pressure vessel.. This waste stream is considered Irradiated Hardware.
NDAP-gA-0646 Revision 4 Page 25 of 63
- b. The constituents of this waste stream may include control rod blades, LPRNS's, IRM's, TIP's and components expended during hardware processing and packaging activities. Startup sources may also be processed as part of this waste stream.
- c. Irradiated hardware is packaged in steel liners for disposal.
- d. Liquid shall be drained to ensure free liquid Acceptance Criteria are met.
- e. Irradiated hardware shall not be mixed with any other waste type in final processing.
Dry Active Waste (DAW)
- a. Dry Active Waste is a waste stream.
- b. The constituents of this waste stream consist of contaminated paper, plastic, wood, metal and other discarded material.
C. Dry Active Waste shall be processed by volume reduction methods which may include incineration, compaction, decontamination and metal melting.
- d. At a minimum, DAW shall be packaged in strong-tight containers for disposal.
'I Liquid Oil Waste or Petroleum Based Naterials
- a. The constituents of this waste stream may include turbine lubricating oil, EHC fluid and other petroleum based materials.
- b. Contaminated Liquid Oil Waste generated at the facility should be processed by a decontamination system, solidified for final disposal, volume reduced by incineration, or other acceptable methods.
NDAP-0A-0646 Revision 4 Page 26 of 63
- c. Liquid Oil Haste at concentrations IX and
.greater may be solidified provided the following are adhered to:
(1) An emulsification agent is added at required concentrations.
(2) The Liner is NOT SHIPPED to a disposal facility without prior disposal facility approval.
Solid Sealed Sources
- a. Solid Sealed Sources requiring disposal shall be packaged .for disposal as requested by Health Physics Supervision.
- b. Method of disposal is dependent on waste class of the Solid Sealed Source and disposal facility requirements.
Co Acceptable methods of disposal include:
(1) Placement within a container consisting of another waste type provided:
(a) The source contains isotopics already in the waste.
(b) The source activity is significantly less than the waste activity.
(2) Class B and C sources shall be stabilized within an approved solidification or encapsulation media.
Activated Carbon a~ Activated Carbon from vendor provided liquid waste demineralization is transferred directly to a liner/High Integrity Container. This waste stream is considered Activated Carbon.
- b. The constituents of this waste stream may include various types of charcoal, ion specific carbon filter media and corrosion and contaminants from liquid waste streams.
NDAP-gA-0646 Revision 4 Page 27 of 63 C. Activated Carbon may be solidified, dewatered or processed by volume reduction methods which include drying, incineration, compaction, use as fill materials or other evaluated methods on a case by case basis.
6.2.11 , A Waste Type that is combined with a known amount of hazardous waste or "Hixed Waste" shall be processed fot final disposal pending approval obtained from the processing and disposal facilities, Environmental Protection Agency, U.S. Nuclear Regulatory Commission and other regulatory agencies as required.
6.2.12 Waste types containing chelating agents within the range of 0.1 to 8.0 percent by weight shall be processed to a stable waste form in accordance with and authorized by disposal facility requirements and approvals.
6.2.13 Various other materials not specifically identified as
, waste types will be evaluated for solidification, dewatering volume reduction or other processing on a case by case basis.
(") 6.3 RADIOACTIVE WASTE ANALYSIS AND CLASSIFICATION 6.3.1 Radionuclide concentrations of radioactive waste are used to classify waste for shipping and disposal.
Radionuclide concentrations'should be determined based upon isotopic analysis, volume and weight of final waste form.
6.3.2 The 10CFR61'Compliance Program establishes a methodology for characterizing radioactive waste through the use of correlation factors. This program shall require as a minimum that:
a0 Samples representative of Susquehanna's waste streams are collecte" and analyzed such that results are obtained from a designated laboratory at least every two years (Class A) for development of specific correlation factors.
Waste streams known or suspected to be classified Class B or Class C should be analyzed on an annual basis.
NDAP-gA-0646 Revision 4 Page 28'f 63
- b. Technical basis documentation and justification of correlation factors are developed for each waste stream and are acceptable for use.
Periodic evaluations and necessary adjustments to established ratios are performed in a timely manner.
C. Correlation factors are re-evaluated following significant changes (greater than a factor of
- 10) in plant operations (such as significant changes in fuel leakage, radwaste operations, or equipment).
Determination of waste classification shall be in accordance with 10CFR61.55, Waste Classification, and its supplementary Branch Technical Position on Radioactive Waste Classification as follows:
a~ Class A - Usually segregated from other waste classes at the disposal facility. Physical form and characteristics shall meet the minimum requirements specified in 10CFR61.56(a). If the stability requirements in 10CFR61.56(b) are met, the waste does not have to be segregated for disposal.
- b. Class B - Physical form and characteristics shall meet both the minimum and stability requirements specified in 10CFR61.56.
C. Class C -,Physical form and characteristics shall meet both the minimum and stability requirements specified in 10CFR61.56. In addition, measures shall be taken at the disposal facility to protect against inadvertent intrusion.
Isotopic analysis may be performed by:
- a. 'amma spectrometry of a sample and use of correlation factors.
- b. Direct gamma spectrometry of waste and use of correlation factors.
c Complete radionuclide analysis of waste sample.
- d. Dose to Curie calculations.
NDAP-gA-0646 Revision 4 Page 29 of 63
- e. Activation analysis.
Volume and weight of final waste may be determined by:
- a. Calculation using analytically derived sample densities.
'b. Calculation using standard waste densities.
- c. Direct measurement of volume and weight.
- d. Acceptable methods described in the Technical Position on Concentration Averaging and Encapsulation.
'f samples of waste are used for sampling program shall include:
classification,
- a. Samples shall be obtained and analyzed for each batch of wet waste if practical and ALARA.
- b. Preferentially, samples should be taken for analysis following processing into a final waste form.
- c. Samples taken prior to final processing should enable results of sample analysis to be directly translated to final waste form.
- d. Bead resin and Activated Carbon used for chemical demineralization shall be sampled after having has been depleted in process.
- e. Solidification/Dewatering Services Vendor or another qualified individual shall obtain required samples.
Preparation of waste for sampling or analysis a~ Met Maste Collection tanks shall be recirculated in accordance with approved operating procedures prior to sampling or analysis.
- b. Maste processing in solidification liners/High Integrity Containers shall be mixed in accordance with approved procedures prior to sampling or analysis.
NDAP-gA-0646 Revision 4 Page 30 of 63
- c. Wet waste to be processed 'may'also be mixed, recirculated and sampled or analyzed from mobile processing equipment.
6.3.8 Final waste form containing a mixture of waste types or streams shall be individually analyzed to determine
.radionuclide concentrations. The summation of each individual radionuclide concentration shall be used to characterize the final waste form for shipping and disposal. Waste types or streams of different waste classes (estimated by historical precedent or projected analysis) shall not be mixed.
6.3.9 Deviations from sampling and analysis requirements shall be approved by Chemistry Supervisor and Effluents Management Supervision.
( ) 6.4 TESTING/TREATMENT OF SOLIDIFIED RADWASTE FOR COMBUSTIBLE GASES
() 6.4.1 Solidified waste shall be tested and/or treated to ensure it is not capable of generating quantities of flammable or toxic gases, vapors or fumes which may be harmful to persons transporting, handling, storing or disposing 'of the waste.
6.5 RADIOACTIVE WASTE SOLIDIFICATION 6.5.1 General Requirements a~ Wet Waste Types which may be solidified in High Integrity Containers are Evaporator Concentrates, Mixed Solids, Condensate/Radwaste Demineralizer Bead Resin, RWCU Filter Media and Liquid Oil Waste or Petroleum Based Material, Cartridge Filters, Solid Sealed Sources and Activated Carbon.
b; High Integrity Containers shall be used to meet the stability criteria in accordance with federal and disposal facility regulations.
- c. Solidification processing shall be conducted by qualified SSES or Solidification/Dewatering/
Services Vendor personnel.
- d. The solidification process shall be operated in accordance with approved procedures. Procedures shall specify waste stream, amounts of solidification agent and additives or method for determination.
NDAP-gA-0646 Revision 4 Page 31 of 63 Waste Preconditioning
- a. Waste preconditioning requirements shall be determined by chemistry analysis.
- b. Preconditioning of waste shall be performed if required prior to determining mixing ratios.
- c. Waste preconditioning is required when any of the following conditions exist:
(1) A high or low pH condition, as determined by chemical analysis.
(2) Liquid content of the batch is out of the acceptable envelope for solidification.
(3) Solids content of the batch is out of the acceptable envelope for solidification.
(4) Known potential problem chemicals and constituents within waste that may adversely affect setting and stability of cement-solidified waste form.
- d. Waste preconditioning shall be performed in accordance with approved procedures to ensure waste is within the acceptable envelope for solidification.
- e. Upon completion of waste preconditioning, additional samples, as required, shall be obtained in accordance with Radioactive Waste Analysis and Classification section of this procedure.
Determination of Nixing Ratios a~ Determination of mixing ratios shall be performed for each waste batch to be processed.
- b. Deviation from the recommended mixing ratios shall be reviewed by Plant Operations Review Committee (PORC).
C. Chemistry Group determines:
(1) Density of the waste samples.
NDAP-gA-0646 Revision 4 Page 32 of 63 (2) Specific gravity of Sodium Sulfate Solution in Evaporator Concentrates.
- d. Solidification/Dewatering/Services Vendor determines if the final mixing ratios are within the acceptable envelope for solidification.
- e. For solidification performed on site:
(1) Chemistry Group shall perform test solidification of waste as required by Test Solidification section of this procedure.
(2) Chemistry Group determines mixing ratios to ensure proper solidification.
- f. For solidification performed offsite:
(1) Solidification/Dewatering/Services Vendor .
'fshall perform test solidification of waste as required by Test Solidification section this procedure.
(2) Solidification/Dewatering/Services Vendor determines mixing ratios to ensure proper solidification.
Test Solidification Test solidification shall be performed to support waste mixing ratios as follows:
(1) At least every tenth (10th) batch of the same waste stream.
(2) When sample analysis fall outside the established range and criteria indicating a change in waste characteristics.
(3) When it is believed that some unexpected or abnormal contaminant may be present.
(4) When'equested by Radwaste Supervisor.
NDAP-gA-0646 Revision 4 Page 33 of 63 (5) Mixing of materials shall be accomplished in a manner that duplicates, to the extent practical, mixing conditions that are obtained with full-scale mixing in container.
(6) Curing shall be performed under conditions similar to those used in laboratory qualification test program.
- b. Upon failure of a test solidification, an LCO is entered, additional samples shall be obtained, alternative solidification parameters are determined and a subsequent test verifies solidification. Test solidification shall be performed on each subsequent batch of the same waste stream until at least three (3) consecutive initial test solidification demonstrate acceptability in accordance with Technical Specification 3/4.11.3.
c guality Control shall verify test solidification acceptability and indicate the acceptability on the surveillance documentation. The acceptability requirements are defined in the PCP Surveillance Specimen section of this procedure.
- d. Extra sample volume for backup testing shall be disposed of after acceptable container checks are completed.
- e. High Integrity Container test solidification billets should be disposed after acceptable container checks are completed.
Test solidification should be performed with samples from waste obtained as follows:
- (I) In accordance with Radioactive Waste Analysis and Classification section of this procedure.
(2) Sampling of the solids in the container and the liquids used for hydration, then mixed to the ratios that exist in the container.
NDAP-QA-0646 Revision 4 Page 34 of 63
- g. Test Solidification Procedures shall be developed for each specific waste type as required.
- h. Cement, water. type and additives to be used in actual solidification shal'I be used in preparation of test solidification.
PCP Surveillance Specimens
- a. High Integrity Container test solidification billets shall be examined and tested for acceptability after the specified cure time for:
(I) Liquid on surface of solidified product less 'that 1.0X by waste volume.
(2) Visible defects, such as cracking, spalling, or disintegration.
(3) Strength by physically poking the surface of solidified product with a rigid unyielding device. Nominal surface denting is acceptable.
- b. If cement solidification in steel liners is NRC approved to provide stability, PCP surveillance specimen examination, testing and reporting is required in accordance'ith the Branch Technical Position on Maste Form, Rev. l.
Curing Time a~ A minimum of 30 hours3.472222e-4 days <br />0.00833 hours <br />4.960317e-5 weeks <br />1.1415e-5 months <br /> shall be allowed for curing prior to capping or transporting container.
- b. The container may be moved during the first hour after solidification but must remain undisturbed for the remaining 29 hours3.356481e-4 days <br />0.00806 hours <br />4.794974e-5 weeks <br />1.10345e-5 months <br />.
c ~ Deviations from minimum required curing time shall be approved by Radwaste Supervisor and justifications documented in remarks section of Solidification Record.
NDAP-gA-0646 Revision 4 Page 35 of 63 Sol idification Product gual ity a ~ Solidification- product quality is assured by use of predetermined mixing ratios of waste, cement and additive. Liquid to be used for solidification should be demineralized water.
- b. Pre-qualification mixing ratios are based on laboratory testing using non-radioactive waste materials.
- c. Mixing ratios are re-enforced by the following:
(I) Test solidification performed periodically as stated in Test Solidification section of this procedure.
(2) Visually and physically checking at least every fifth (5th) container of the same waste type.
- d. Container checks shall consist of:
(I) A visual check of solidified product for liquid on surface of product not to exceed 1.0X by waste volume.
(2) Physically poking the surface of solidified product with a rigid unyielding device prior to capping (Nominal surface denting may occur and is acceptable).
- e. guality Control shall verify acceptability of solidified product when containers are checked.
- f. Deviation from the container checking requirement shall be approved by the Radwaste Supervisor.
Handling of Unacceptable Solidified Maste Containers.
a~ If a solidified waste container does not meet acceptability requirements, a Condition Report (CR) shall be issued.
- b. If the reason for unacceptability is free liquid:
(I) The free liquid will be removed; or
NDAP-gA-0646 Revision 4 Page 36 of 63 (2) Extra cement/additive will be added to solidify free liquid.
If portions or all of the product did. not solidify after three days:
(1) The waste container will be capped and placed in a storage location and periodically checked until such a time product is acceptable; or (2) Additional solidification agents may be added to achieve satisfactory solidification, as determined by the Radwaste Supervisor.
If the product solidifies prematurely prior to completing the addition of required amount of cement and additive, as calculated on the solidification calculation sheet for the specific procedure used, the following is required:
(1) A test solidification shall be performed
, using the actual ratio of cement and waste in the container, provided sufficient sample volume remains to complete this item.
(2) guality Control shall check the product for acceptability in accordance with Container Checks section of this procedure.
(3) The container is considered to meet acceptable waste form criteria for shipping provided the subsequent test solidification and/or container checks are acceptable to guality Control and concurrence of the Radwaste Supervisor is obtained.
(4) The above apply only if the Effluents Management Supervisor determines that the product can be classified as "Class A Unstable" or is placed in a High Integrity Container or structure that provides stability in accordance with 10CFR61 and the disposal facility criteria.
NDAP-gA-0646 Revision 4 Page 37 of 63
- e. If the product does not solidify'roperly in accordance with the specific solidification procedure, the following is required:
.(I) An evaluation of the liner shall be made by the following personnel:
(a) Effluents Management Supervision (b) Solidification Vendor Operations (c) Solidification Vendor Engineering (2) Disposal facilities shall be contacted and requirements for receipt of the liner in question shall be defined.
(3) Alternative packaging/processing shall be evaluated.
(4) Recommendations for final disposition shall be made to the Power Production Engineer-Effluents Management.
Final disposition shall be reviewed by Plant Operations Review Committee (PORC).
'I (6) Records shall be kept and documentation supportive of final disposition attached to the solidification record package.
(7) The liner may be shipped after g.C. review of documentation is complete and disposal facility concurrence is received in letter form.
- f. Specific instructions shall be established for handling unacceptable solidified waste container on a case by case basis.
- g. guality Control shall re-verify acceptability of solidified product by performance of Container Checks.
Capping of Solidified Waste Containers
- a. The requirements of Solidification Product guality section of this procedure shall be met prior to capping the container.
NDAP-gA-0646 Revision 4 Page 38 of 63
- b. If the container is not equipped with a passive vent and its contents are within the requirements of Low Specific Activity (LSA) ensure one of the following:
(1) The container should be shipped within (10) ten days after capping; or (2) If a container has been capped for longer than (10) days, it shall be opened, vented, and re-capped within (10) ten days of shipment.
C. If the container exceeds the limits for Low Specific Activity and contains water and/or organic substances which could radiolytically generate combustible gases, determination must be made such that'the following criteria are met over a period of time that is twice the expected shipment time:
(1) The hydrogen generated shall be limited to a molar quantity that would be no more than 5% by volume of the container gas void; or (2) The container and shipping cask cavity
.shall be inerted with a diluent to assure that oxygen is limited to less than 5X by volume in those portions of the package which could have hydrogen greater than 5X.
Solidification Agent Control
- a. Portland Cement ASTM C-150 Type I shall be used for the mobile solidification process.
- b. Other solidification agents may be used only after acceptable testing of the agent has been
'completed that demonstrates acceptable solidification and disposal facility approval has been obtained.
NDAP-gA-0646 Revision 4 Page 39 of 63
- c. Documented Certification is not required for materials received in bags provided material verification can be obtained as follows:
(1) Cement is acceptable provided the bag containing the cement indicates that cement is Portland Type I.
(2) Sodium Silicate is acceptable provided the bag containing the additive indicates Anhydrous Sodium Hetasilicate.
(3) Other additives are acceptable provided the container is clearly marked indicating the type, of additive.
- d. Other additives may be used for enhancement of solidification process as specified in the solidification procedure and documented in the solidification records.
Radioactive Waste Solidification Records A Solidification Record Sheet (Form NDAP-gA-0646-1) shall be completed for each container filled with solidification products.
Completion of the Solidification Record Sheet and the required accompanying documentation shall be as follows:
- a. The Radwaste Supervisor is responsible for initiating this form and completing Parts 1 and 2.
- b. Effluents Hanagement Supervision, Chemistry and Solidification/Dewatering/Services Vendor personnel shall provide and check off the required documentati~ri specified in Part 3.
C. guality Control shall provide review as required for the Solidification Records.
NDAP-gA-0646 Revision Page 40'f4 63 6.6 RADIOACTIVE WASTE DEWATERING 6.6.1 General Requirements a0 Waste Streams which may be dewatered in either High Integrity Containers or steel liners are LRW Filter Media, Ultrasonic Resin Cleaner Waste, Sump Sludge, RWCU Filter Media, Condensate/Radwaste Demineralizer Bead Resin, Cartridge Filters and Activated Carbon. The type of container used shall be based on the waste classification and stability criteria in accordance with federal and disposal facility regulations.
- b. Dewatering o'f Radioactive Waste shall be performed by qualified SSES or Solidification/
Dewatering Services Vendor personnel.
C. Dewatering of Radioactive Waste shall be performed in accordance with approved procedures.
- d. Dewatering procedures shall be based on documented test data that has demonstrated the ability to achieve free liquid limits as specified by disposal facilities and applicable regulatory agencies. Liquid volume and drainage calculations and actual drainage verification may also be used to meet free liquid limits.
- e. High Integrity Containers shall be used for disposal when the concentration of radionuclides with half-lives greater than 5 years exceeds I pCi/cc.
Each waste stream which may be dewatered should be characterized by the Solidification/
Dewatering Services Vendor to ensure the operating parameters and effectiveness of the dewatering system are in accordance with the parameters established in the Topical Report.
NDAP-gA-0646 Revision 4 Page 41 of 63 Dewatered Product Control a 0 The final dewatered product shall contain less than 1X non-corrosive free liquid for High Integrity Containers and 0.5X for steel liners.
guality Control checks shall be performed on process steps.
- b. If a dewatered waste container does not meet acceptability requirements, a Condition Report (CR) shall be issued.
- c. Specific instructions shall be established for handling unacceptable dewatered waste container on a case-by-case basis.
- d. 'eviation from the container checking requirement shall be approved by the Power Production Engineer-Effluents Management.
Radioactive Maste Dewatering Records A Dewatering Record Sheet (Form NDAP-gA-0646-2) shall be completed for each container filled with dewatered waste streams. Parts of the form shall be completed by the following responsible individuals or groups:
a ~ The Radwaste Supervisor is responsible for initiating this form and completing Parts I and 2.
- b. Chemistry Group shall complete Part 3 Sampling and Analysis.
C. Effluents Management Supervision, Chemistry and Solidification/Dewatering/Services Vendor personnel shall provide and check off the required documentation specified in Part 4.
- d. guality Control shall provide review as required for the Dewatering Records.
NDAP-gA-0646
-Revision 4 Page 42 of 63 6.7 HIGH INTEGRITY CONTAINERS (HIC) 6.7.1 Storage of High Integrity Containers a e Vectra, Radlok and CNSI High Integrity Containers (HIC) stored in direct sunlight or in areas where there is a strong source of ultraviolet radiation shall be filled and disposed of within one year of manufacturing date.
- b. Once filled a High Integrity Container may be stored for a period until a total of one (1) year of ultraviolet radiation is received.
C. Short exposures (i.e., several hours) to sunlight, such as occurring during shipment and on site transfer need not be counted when determining total ultraviolet exposure.
6.7.2 Uses of High Integrity Containers a ~ High Integrity Containers may be used to package the following waste materials for disposal:
(1) Dewatered bead resin, powdered resin and diatomaceous earth.
(2) Compressible and non-compressible solid wastes.
(3) 'Filter elements and cartridges.
(4) Solidified resins, sludges, and liquid wastes.
(5) Incinerator ash, residuals, or equivalent waste which has been rendered non-dispensable in a binding matrix.
(6) Other dewatered and dry material provided concurrence is received'by container vendor and disposal facility.
NDAP-gA-0646 Revision 4 Page 43 of 63 Prior to using a High Integrity Container for a specific waste material, procedures shall be established to define the specific requirement that shall be met during use of the container.
The procedures shall contain:
Documentation requirements that specific conditions have been met such as inspection and exposure to degrading conditions.
Instructions as to how to handle and
'roperly close the container.
Instructions for on-site storage of loaded containers for ultimate shipment for disposal.
The procedures shall provide a method for documenting required information relevant to the container from initial receipt to shipping for disposal.
Required information shall be based upon the container certificate of compliance and disposal facility requirements.
Retention and utilization of the documentation shall be defined in the procedures.
The procedures shall establish specific equality Control inspection requirements.
Prior to the first shipment of a specific type of High Integrity Container, authorization shall be requested from the applicable regulatory agency governing use of the container in question at the disposal facility of concern.
NDAP-gA-0646 Revision 4 Page 44 of 63 High Iritegrity Container Limitations
- a. High Integrity Containers are approved for use provided the following physical limitations of the waste are met:
(1) Vectra Payload density <1.47 gms/cc (2) Loading temperature S170 F (3) Vectra EL-50 N.S. loaded weight <4200 lb (4) Vectra EL-142 N.S. loaded weight : <8250 lb (5) Vectra EL-142 S. loaded weight : <11250 .lb (6) Vectra EL-190 N.S. loaded weight : <11950 lb (7) Vectra EL-190 S. loaded weight : <14800 lb (8) Vectra EL-210 N.S. loaded weight : gl3000 lb (9) Vectra EL-210 S loaded weight : g17300 (10) CNSI Small loaded weight g2500 lb (11) CNSI Medium loaded weight <2500 lb (12) CNSI Large loaded weight g2500 lb (13) Radlok 179 loaded weight 518500 lb
,(14) Radlok 195 loaded weight gl8500 lb (15) Enduropak 105 loaded weight : gl700 lb (16) Enduropak 205 loaded weight : g1900 lb (17) Enduropak 150 loaded weight : g2400 lb
- b. The maximum concentration of radionuclides with half lives greater than (5) five years that may be disposed of in a High Integrity Container is 350 pCi/cc. Other waste forms shall not exceed 1.0 X 10 rads maximum integrated dose to the container.
0
NDAP-gA-0646 Revision 4 Page 45 of 63
- c. The polyethylene High Integrity Containers shall not come into contact with materials listed in Attachment E.
- d. A passive vent design shall be incorporated into the container to relieve internal container pressure.
Closure of High Integrity Containers a~ Closure of High Integrity Containers shall be completed in accordance with approved procedures.
b; If the container is not equipped with a passive vent and its contents are within the limits of Low Specific Activity ensure one'of the following:
(1) The container is shipped within (10) ten days after closing; or (2) If the container has been closed for
~
longer than (10) ten days, it shall be
,opened, vented, and re-closed within ten (10) days of shipment.
C. If the container exceeds the limits for Low Specific Activity or contains water and/or organic substances which could radiolytically generate combustible gases, determination must be made such that the following criteria are met over a period of time that is twice the expected shipment time:
(1) The hydrogen generated shall be limited to a molar quantity that would be no more than 5X by volume of the container gas void; or (2) The container and .shipping cask cavity shall be inerted with a diluent to assure that oxygen is limited to <5X by volume in those portions of the package which could have hydlogen greater than 5X.
- d. Step 6.7.4.b and 6.7.4.c shall also apply to dewatered waste in steel liners.
NDAP gA 0646 Revision 4 Page 46 of 63 6.8 IRRADIATED HARDWARE PROCESSING, AND. DEWATERING 6.8.1- General Requirements
- a. Processing and dewatering of Irradiated Hardware.
'" 'shall be performed by .qualified personnel.
SSES or vendor
- b. Processing and dewatering of Irradiated Hardware be. performed fn accordance with approved 'hall procedures.
c., Irradiated Hardware consisting of non-fuel Special Nuclear Material shall be inventoried during processing in accordance with NDAP-qA-0337.
- d. Dewatering procedures shall be based on liquid volume and drainage calculations and actual drainage verificatiop to demonstrate the .ability, to achieve free liquid limits as specified by disposal facilities and'applicable regulatory agencies.
6.8.2 Dewatered Product Control The final dewatered product shall contain. less than 0.5X free liquid for steel liners.
- b. guality Control checks shall be performed on process steps.
6.8.3 Irradiated Hardware Processing and Dewatering Records
- a. All records generated shall be completed and filed in accordance with approved implementing procedures.
6.9 CONTAINER INSPECTIONS-6.9.1 ~
guality Control. shall inspect containers to be used:
fbr solidification, dewatering, and other packaging.
for disposal.
6.9.2 inspection shall assure that prior to use,'the"
'his containers to be used for solidification, dewatering, or other'ackaging are.'intact and their internals are free of. any visual damage that would prevent them from '-.
performing .theii 'intended:function.
- >r ',.' ', , ~
1 P
v J
f>.-/~> 7 NDAP-qA-0646 Revision 6 PAGF '>~IF + . 'Pege'RT of 63 6.9:3 Packages shall meet the. general criteria for normal transport conditions in accordance with the requirements of 49'CFR. Type A packages shall meet the additional design requirements specified in 49 CFR.
6.10 MASTE CONTAINER SPACE UTILIZATION 6.10.1 Maste volume shall be maximized within the guidelines of specific procedures to void space at the top of waste minimize:.'otential containe'r. after s'olidification or dewatering is '.
complete.
- a. AcMitional radioactive material should be added only after the initial waste volume is in final form and sampled and the added waste
, volume is in final form and sampled.
- b. The additional material may be drawn into containers able to withstand higher external pressures without degredation by creating of low prcssure inside the container, an'rea such as with stc'el liners.
- c. Poz all othez containers, the additional
. material, shall be added via mechanical processes or by other conveyance which does not exert higher external pressures.
6.10.2 . ~ Maste volumes shall meet or exceed disposal site criteria. If waste volume ds less than disposal facility'criteria; requirement's.for disposal of the container in question shall be defined" by the disposal facility.
6.10.3 Specific waste volumes committed to by the .
Solidification/Dewatering/Services Vendor shall be met or otherwise justified as to why waste volumes were not achieved.
6.10.4 Susquehanna Guaranteed Solidified/Dewatered Maste Volume Record, Form NDAP-gA-0646-3; shall'e completed by the Solidification/Dewatering/
Services vendor personnel, approved by. Radwaste Supervisor and shall be used to track..
solidified/dewatered waste volumes'chieved in each individual container.
6.11 STORAGE OF PACKAGED RADIOACTIVE MASTE
- 6. 11. 1 Radwaste Supervisor shall provide Solidification and/or Dewatering Record sheets that have been reviewed by 'guality Control personnel stating that processed waste has been solidified or de-watered 'in accordance with the Process Control Program and meets the applicable shipping and disposal criteria.
6.11.2 So'lidification and Dewatering Records shall include the isotopic mix, isotopic concentration of the waste.
that was packaged, the total volume of the waste, and the amount of water, cement or other solidification agent used, as appropriate.
NDAP-gA-0646
, Revision 4 Page 48 of 63 6.11.3 Solidification and Dewatering Records shall be part of the permanent shipping records and adhere to requirements of the Process Control Program.
6.11.4 For materials packaged in a high integrity container, documentation shall be maintained on HIC storage and pre-shipment checklist information.
6.11.5 Packaged radioactive waste shall be stored in areas designated by HP Foreman Effluents Management.
Storage of packaged radioactive waste in the Low Level
,Radwaste Holding Facility (LLRWHF) shall be in accordance with approved procedures.
6.11.6 An inventory of stored, packaged waste shall be maintained in accordance with approved procedures.
6.12 TRANSPORTATION, SHIPPING AND DISPOSAL REGULATIONS 6.12.1 Specific regulatory documents shall be maintained on site in a status that is current. Specific
'regulations that shall be maintained include but are not limited to the following:
10CFR71 Packaging of Radioactive Material for transport and transportation of radioactive material under certain conditions.
- b. 49CFR100 - 199 Transportation.
C. Chem-Nuclear Systems Inc. Barnwell S.C. disposal site operating license number 097 State of South Carolina, as required.
- d. Chem-Nuclear System Inc. NRC Material License 12-13536-01, as required.
- e. Chem-Nuclear System Inc. Barnwell S.C. disposal site operating procedures and site criteria, as required.
Scientific Ecology Group Licenses R-73008-E94, R-01052-A91.
- g. Cask Manuals for c'asks of which PPKL is an authorized user.
- h. A copy of the license for each facility to which Radioactive Material is sent.
NDAP-gA-0646 Revision 4 Page 49 of 63
- i. 10CFR61 Licensing requirements for land disposal of Radioactive Waste.
6.12.2 Procedures applicable to transportation, shipping and disposal shall be developed.
a~ Procedures shall be established and maintained to provide directions and assure regulatory compliance for manifesting, which include applicable federal, state, and disposal facility regulations, and NRC guidance.
- b. Procedures shall contain check off lists where and when applicable to assure specific attention is paid to the critical function being controlled.
- c. Procedures shall contain guality Control notifications or hold points.
6.12.3 Computer software used to implement applicable portions of the Process Control Program shall be in accordance with NDAP-gA-0801.
6.13 SHIPPING OF RADIOACTIVE WASTE 6.13.1 All radioactive waste shall be shipped by Effluents Management.
6.13.2 All radioactive waste shipped from SSES shall only be to facilities licensed to receive the waste and in accordance with 10CFR20, IOCFR71 and 49CFRI00-199.
6.13.3 Dry Active Waste (DAW) should normally be shipped as Type A quantities and therefore do not require specific licensed containers.
6.13.4 Waste containers shall be placed in a USNRC approved licensed shipping container if it:
'a ~ Exceeds Type A quantities
- b. Exceeds 1000 mr/hr on contact c- Exceeds 1000 dpm/100 cm~ loose surface contamination on the exterior of the container.
NDAP-QA-0646 Revision 4 Page 50 of 63 The specific conditions of the Certificate of Compliance for each approved shipping cask shall be strictly adhered to.
Packaged waste may be shipped unshielded if:
- a. Contact dose rates are less than 200 mrem/hr and dose rates at 6 feet are less than 10mrem/hr.
- b. Curie content of the package shall be a Type A quantity.
- c. Container shall be a minimum of a strong tight container.
Prior to the shipment of a package of radioactive waste, the HP Foreman Effluents Management shall assure the container is surveyed for contact dose rates and surface contamination. Decontamination, if required, shall be done under the direction of the HP Foreman Effluents Management. Decontamination may be waived based upon radiological conditions.
All vehicles used'to transport radioactive waste requiring the vehicle to be placarded shall be checked for adequate operation and safety conditions.
All Radwaste shipments from SSES sha11 normally be via "Exclusive Use" vehicles. Specific instructions given to the driver include:
- a. Expected route of travel to his final destination.
- b. Maintaining "Exclusive Use" status.
- c. Specific actions to be taken in the event of an accident.
No vehicle carrying radioactive waste that is overweight shall leave SSES without a Pennsylvania overweight permit.
A DAM shipment or other shipment capable of having its weight adjusted, shall not be allowed to leave SSES overloaded.
- b. An overloaded condition for any vehicle is based on total weight and weight per axle.
NDAP-gA-0646 Revssson 4 Page 51 of 63 6.13.11 In the event access is denied to SSES at all operating disposal facilities, PPEL will provide carrier with a letter stating that SSES will meet all applicable federal, state, and compact requirements for receipt back of the radioactive waste/material in carrier15X) void space within the container.
C. Production of a cement solidified Class B or C waste form that has any of the following characteristics:
(1) Contains free liquid in quantities exceeding 0.5 percent of the volume of the waste.
(2) Contains waste with radionuclides in concentrations exceeding those considered during waste form qualification testing accepted by the regulatory agency, which could lead to errors in assessment of waste class.
(3) Contains a significantly different waste loading than that used in qualification testing accepted by the regulatory agency.
NDAP-gA-0646 Revision 4 Page 53 of 63 (4) Contains chemical ingredients not present in qualification testing accepted by the regulatory agency, and.those quantities are sufficient to unacceptably degrade the waste product.
Shows instability evidenced by crumbling, cracking, spalling, voids, softening, disintegration, non-homogeneity, or dimensional changes.
(6) Evidence of processing phenomena that exceed the limiting processing conditions identified in applicable topical reports or process control plans, e.g., foaming, temperature extremes, premature or slow hardening, and production of volatile material.
- d. Failure to adhere to high integrity container limitations as required by container certificate of compliance.
- e. Notification of violation by disposal facility regulatory authorities at time of container receipt for disposal.
Failure of cement-solidified stable waste form long term PCP surveillance specimens due to evidence of significant cracking, spalling, or bulk disintegration, compression or penetrometer strength and .immersion test results.
6.17.3 Requirements for reporting of mishaps shall apply only to processing liners and high integrity containers containing radioactive waste in its final product form.
6.17.4 A Condition Report (CR) shall the mishaps mentioned occurs.
be generated if one of 6.18 PCP IMPLEMENTING PROCEDURES Procedures required for implementation of the Process Control Program are shown in Attachment D.
NDAP-gA-0646 Revision 4 Page 54 of 63 7.0 RECORDS 7.1 The Solidification Records or Dewatering Records and the attached documents shall be forwarded to Effluents Management Supervision for retention until such time as the container identified on Record is shipped for final disposition.
7.2 Mhen the identified container is shipped the Solidification Records or Dewatering Records and other documents concerning the Shipment shall be filed with the shipping documentation and forwarded to DCS for retention.
7.3 Documentation of Radioactive Waste Shipments shall be retained as required by SSES Technical Specifications.
7.4 Radioactive waste shipping documentation shall consist of, but not limited to, the following records:
7.4.1 Radioactive Material Shipping Hanifest 7.4.2 Evaluation of isotopic mix and concentration 7.4.3 Radiological surveys of:
- a. Vehicle upon arrival
- b. 'ackage to be shipped
- c. Loaded vehicle prior to shipment 7.4.4 Vehicle Safety inspection 7.4.5 Check-off sheet for loading procedure 7.4.6 Documentation of adherence to Process Control Program (if applicable) 7.4.7 Special instructions to driver
g Attachment A NDAP-gA-0646 SOLIDIFICATION RECORD SHEET Revision 4 Page 55 of 63 PART 1: Container Identification Information t
- 1. PPSL Liner Number 2. Container Vendor Serial Number
- 3. Waste Stream (RWCU Filter Hedia cannot be entered)
- 4. Test Solidification required? YES NO (circle one)
PART 2: Container Selection (Refer to WH-PS-100)
- l. Estimated Liner Contact Dose Rates t.
3.
g>>'t Expected Waste t t t tt ~ti/g Classification/Stability mR/hr
- 4. Container Type to be Used 5. Empty Weight of Container lbe
- 6. Expected Cask Type to be Used ~
e PART 3:
l.
2.
Documentation Checklist Form NDAP-gA-0646-1 (or iginal)
Waste Form Documentatio n WH-RP- Forms (original)
SC-068-002 Forms (copy)
Waste Form: STABLE UNSTABLE (circle one)
Z85A Liner Volume Utilized: YES NO (circle one)
- 3. Qaste Activity Documentation CH-RC- Forms (copy)
Isotopic Analysis (copy)
Compost added/Log entry made on CH-TP-055-1
- 4. Health Physics Data Liner Radiological Survey (original)
Actual Filled Container Weight lb. (If available ALARA)
PART 4: REMARKS:
Attachment B NDAP-gA-0646 Revision 4 Page 56 of 63 DEWATERING RECORD SHEET PART 1: Container Identification Information
- 1. PP8L Liner Number 2. Container Vendor Serial Number
- 3. Waste Stream PART 2: Container Selection (Refer to RN-PS-100)
- l. Estimated Liner Contact Dose Rates mR/hr
- 2. Projected Curie Concentration pCi/gm
- 3. Expected Waste Classification/Stability
- 4. Liner Type to be Used 5. Empty Weight of Container
- 6. Expected Cask Type to be Used a waste Supervisor ate ime FORM NDAP-gA-0646-2, Rev. 3, (DUPLEX), Page 1 of 3 (File R69-1)
Attachment 8 NDAP-gA-0646 Revision 4 Page 57 of 63 DEWATERING RECORD SHEET PART 3: Sampling and Analysis
- 1. Tank/Container sampled
- 2. Sample Number
- 3. Waste Stream
- 4. Isotopic Analysis attached
- 5. Specific activity of Dewatered Sample 'pCi/gm
- 6. a. Dewatered Volume
- b. Dewatered Weight
- c. Sample density gm/cc x 62.43 = lb/ft
- 7. Composite added/Log entry made on CH-TP-055-1 The above tank/container containing solids has been analyzed in accordance with CH-RC-075 and found to contain the isotopes and specific activities as indicated on the attached data sheets.
C emistry upervision ate ime FORM NDAP-gA-0646-2, Rev. 3, (DUPLEX) Page 2 of 3 (File R69-I)-
Attachment B NDAP-gA-0646 Revision 4 Page 58 of 63 DEWATERING RECORD SHEET PART 4: Container Shipment Information Summary PP8L Liner Number 2. Waste Volume
- 3. Form NDAP-gA-0646-2 (original)
Waste Form Documentation WH=RP- I Forms (original)
Calculate'd Waste Weight lb/ft x lb.
Part 3.6.c Part 4.2 Actual Filled Container weight lb. (i f available ALARA) 100 x (gewatered Baste Volume) ft ~ ft part 4.2 ~vai olume
>85% Container Volume Util ized YES / NO (Circle one)
Waste Form: STABLE UNSTABLE (Circle one)
Waste Activity Documentation CH-RC- Forms (Copy)
Isotopic Analysis (Copy)
PART 5 REMARKS:
a waste upv ate ev> ew bate oreman . gmt..))ate FORM NDAP-gA-0646-2, Rev. 3, (DUPLEX), Page 3 of 3 (File R69-I)
Attachment C NDAP-gA-0646 Revision 4 Page 59 of 63 SUS UEHANNA GUARANTEED SOLIDIFIED DEWATERED WASTE VOLUHE RECORD Date Liner number
- 2. Waste Type
- 3. Container Type Burial Volume Useable Container Volume Guaranteed Hinimum Waste Volume fts
- 7. Waste Volume Attained inches x ft~ /inch ftS
- 8. Waste Volume Container Usage 100 x (Waste Vol. ft' Guaranteed Min. Waste Vol. ft>) -100 =
0 Dead band Assessment Volume Guaranteed Hin. Waste Vol. ft + (0.01 X Guaranteed Hin. Waste Vol. ft Hinimum(-) ft to Maximum(+) ft
- 10. Performance Assessment Volume Dead band Assessment Vol. ft Waste Vol. ft = ft
- 11. Remarks:
- 12. Signature o s i ication en or epresentat>ve
- 13. Signature a waste Supervisor FORM NDAP-gA-0646-3, Rev. 2, Page 1 of 1 (File R69-1)
Attachment D NDAP-gA-0646 Revision 4 Page 60 of 63 PCP IMPLEMENTING PROCEDURE MATRIX WASTE PROCESSING Eva orator Concentrates Solidified Pacific Nuclear PT-51-WS Pacific Nuclear OM-114-NS Pacific Nuclear OM-104 Mixed Solids - Solidified Pacific Nuclear PT-51-WS Pacific Nuclear OM-104 Pacific Nuclear OM-114-NS LRW Filter Media URC Waste RWCU Filter Media Sum Slud e Dewatered Pacific Nuclear OM-43-WS WM-RP-107 Condensate Radwaste Demineralizer Bead Resin - Solidified Pacific Nuclear PT-51-WS Pacific Nuclear OM-114 Pacific Nuclear ON-104 Condensate Radwaste Demineralizer Bead Resin - Dewatered Pacific Nuclear OM-43-WS SEG STD-P-22-002 SEG STD-P-03-051 (Resin Express)
WM-RP-106 WM-RP-104 WM-RP-108 Cartrid e Filters CNSI FO-OP-019 (Overpack)
WM-PS-230 Pacific Nuclear OM-16-NS WM-RP-105 Page 1 of 3
Attachment D NDAP-QA-0646 Revision 4 Page 61 of 63 PCP IMPLEMENTING PROCEDURE MATRIX Irradiated Hardware - Dewatered Steel Liner None Dr Active Waste DAW - Packa in WM-PS-210 Li uid Oil Waste - Solidified Li uid Oil Waste Decontamination None None Solid Sealed Sources None WASTF. ANALYSIS AND CLASSIFICATION - 10CFR61 Pacific Nuclear OM-45 NS WM-RP-008 CH-RC-075 WM-PS-155 CH-RC-076 WM-PS-160 CH-TP-055 WM-PS-170 TESTING TREATMENT COMBUSTIBLE GASES WM-RP-009 WM-RP-301 RADIOACTIVE WASTE SOLIDIFICATION - GENERAL CEMENT Pacific Nuclear OM-114-NS SC-068-002 (Test Solidification)
Page 2 of 3
Attachment D NDAP-gA-0646 Revision 4 Page 62 of 63 PCP IHPLEHENTING PROCEDURE MATRIX RADIOACTIVE WASTE DEWATERING GENERAL Pacific Nuclear OH-60-WS MH-RP-010 WH-RP-011 HIGH INTEGRITY CONTAINERS Pacific 'Nucl ear OH-16-NS Pacific Nuclear H-18-NS MH-RP-012 DISPOSAL FACILITY RE UIREHENTS MH-PS-180 WH-PS-401 (LLRWHF)
PACKAGING WH-PS-310 (HN-142) WH-PS-354 (CNSI'14-215)
MH-PS-311 (LN-142) WH-PS-316 (SEG 14-215)
MH-PS-315 (SEG 3-82) WH-PS-318 (Westinghouse TCT)
WH-PS-345 (CNSI 14-195)
MH-PS-351 (CNSI 21-300)
MH-PS-352 (CNSI 8-120A)
WH-PS-356 TRANSPORTATION 49CFR 10CFR71 WH-PS-100 MH-PS-120 MH-PS;140 WH-PS-180 WH-PS-240 MH-PS-250 Page 3 1
of 3
Attachment E NDAP-gA-0646 Revision 4 Page 63 of 63 MATERIALS NOT COMPATIBLE WITH POLYETHYLENE CONTAINERS Aliphatic hydrocarbons (hexane, octane, Gasoline bexene, octane, etc.)
Acetone Iodine Amyl Acetate Amyl Chloride Methyl bromide Aniline Hethyl Chloride Aqua Regia Hethyl ethyl ketone (HEK)
Hethylene Chloride Benzene Hoist Chlorine gas Bromine liquid Butane Nitric Acid (50X weight concentration)
Camphor Oil Organ Peroxides Carbon Disulphide Octyl cresol Carbon Tetrachloride Oleic acid Chlorine liquid Oleum Chlorobenzene Chloroform Pentane Chlorosulfonic acid Petroleum ether Chromic/sulfuric acid Phenol Cyclohexanone Propane Propylene dichloride Dibutylphtalate Dimethylamine Sul fric acid (60X weight concentration)
Diesel fuel Tetrahydrofurance Ethyl acetate Titanium tetrachloride Ethyl butyrate Toulene Ethyl chloride Trichloroethylene Ethyl ether Turpentine Ethylene chloride Tetralin Ethylene chlorohydrin Ethylene dichloride Xylene Fluorine Furfural Furfuryl alcohol Fuel Oil-Page I of I